GeneSymbol	GeneID	ChemicalName	ChemicalID	CasRN	Interaction	InteractionActions	PubMedIDs
AAAS	8086	14-deoxy-11,12-didehydroandrographolide	C495626		14-deoxy-11,12-didehydroandrographolide results in decreased expression of AAAS mRNA	decreases^expression	22101062
AAAS	8086	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AAAS mRNA	affects^cotreatment|increases^expression	19167446
AAAS	8086	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of AAAS mRNA	decreases^expression	19320972
AAAS	8086	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AAAS mRNA	affects^cotreatment|increases^expression	19167446
AAAS	8086	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of AAAS mRNA	increases^expression	19167446
AAAS	8086	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of AAAS mRNA	decreases^expression	29803840
AAAS	8086	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AAAS protein	decreases^activity|increases^O-linked glycosylation	23301498
AAAS	8086	MLN7243	C000622638		MLN7243 results in increased sumoylation of AAAS protein	increases^sumoylation	31285264
AAAS	8086	Paraquat	D010269	4685-14-7	AAAS protein affects the susceptibility to Paraquat	affects^response to substance	23315990
AAAS	8086	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of AAAS mRNA	affects^binding|decreases^expression|increases^activity	19710929
AAAS	8086	Sunitinib	D000077210		Sunitinib results in decreased expression of AAAS mRNA	decreases^expression	31533062
AARS1	16	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of AARS1 mRNA	increases^expression	24810058
AARS1	16	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of AARS1 mRNA	increases^expression	19095052
AARS1	16	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AARS1 mRNA	affects^cotreatment|increases^expression	27188386
AARS1	16	(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	C517041		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of AARS1 mRNA	increases^expression	19561079
AARS1	16	4-phenylbutyric acid	C075773	1821-12-1	4-phenylbutyric acid results in decreased expression of AARS1 mRNA	decreases^expression	14583596
AARS1	16	4-phenylbutyric acid	C075773	1821-12-1	4-phenylbutyric acid results in increased expression of AARS1 mRNA	increases^expression	14583596
AARS1	16	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of AARS1 mRNA	increases^expression	29067470
AARS1	16	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational results in decreased expression of AARS1 mRNA	decreases^expression	23195993
AARS1	16	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased expression of AARS1 protein	decreases^expression	19364129
AARS1	16	Ascorbic Acid	D001205	50-81-7	Ascorbic Acid results in decreased expression of AARS1 mRNA	decreases^expression	19197388
AARS1	16	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of AARS1 intron	affects^methylation	30157460
AARS1	16	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of AARS1 mRNA	increases^expression	29275510
AARS1	16	C646 compound	C584509		C646 compound results in increased expression of AARS1 mRNA	increases^expression	26191083
AARS1	16	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride affects the localization of AARS1 protein	affects^localization	18261755
AARS1	16	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of AARS1 mRNA	decreases^expression	25596134
AARS1	16	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of AARS1 mRNA	affects^expression	25979313
AARS1	16	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde results in decreased expression of AARS1 mRNA	decreases^expression	25596134
AARS1	16	chloropicrin	C100187	76-06-2	chloropicrin results in decreased expression of AARS1 mRNA	decreases^expression	26352163
AARS1	16	Cidofovir	D000077404	113852-37-2	Cidofovir results in decreased expression of AARS1 mRNA	decreases^expression	25596134
AARS1	16	Cisplatin	D002945	15663-27-1	Cisplatin affects the expression of AARS1 mRNA	affects^expression	23300844
AARS1	16	Cisplatin	D002945	15663-27-1	Cisplatin affects the reaction [Piroxicam results in decreased expression of AARS1 mRNA]	affects^reaction|decreases^expression	21858171
AARS1	16	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of AARS1 mRNA	decreases^expression	25596134
AARS1	16	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in decreased expression of AARS1 mRNA	decreases^expression	25596134
AARS1	16	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of AARS1 mRNA	decreases^expression	19320972
AARS1	16	Copper	D003300	7440-50-8	[Disulfiram binds to Copper] which results in increased expression of AARS1 mRNA	affects^binding|increases^expression	24690739
AARS1	16	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of AARS1 mRNA	increases^expression	19167446
AARS1	16	Curcumin	D003474	458-37-7	Curcumin results in decreased expression of AARS1 mRNA	decreases^expression	17198877
AARS1	16	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of AARS1 mRNA	increases^expression	20106945|21632981|22147139|25224403|25562108|25596134|27989131
AARS1	16	Decitabine	D000077209	2353-33-5	Decitabine affects the expression of AARS1 mRNA	affects^expression	23300844
AARS1	16	Disulfiram	D004221	97-77-8	[Disulfiram binds to Copper] which results in increased expression of AARS1 mRNA	affects^binding|increases^expression	24690739
AARS1	16	dorsomorphin	C516138		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AARS1 mRNA	affects^cotreatment|increases^expression	27188386
AARS1	16	Drugs, Chinese Herbal	D004365		Drugs, Chinese Herbal results in increased expression of AARS1 mRNA	increases^expression	29667321
AARS1	16	entinostat	C118739		entinostat results in increased expression of AARS1 mRNA	increases^expression	26272509
AARS1	16	entinostat	C118739		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AARS1 mRNA	affects^cotreatment|increases^expression	27188386
AARS1	16	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
AARS1	16	Fluorouracil	D005472	51-21-8	TP53 protein affects the reaction [Fluorouracil results in decreased expression of AARS1 mRNA]	affects^reaction|decreases^expression	15016801
AARS1	16	Genistein	D019833	446-72-0	Genistein results in increased expression of AARS1 mRNA	increases^expression	26865667
AARS1	16	GSK-J4	C000593030		GSK-J4 results in decreased expression of AARS1 mRNA	decreases^expression	29301935
AARS1	16	ICG 001	C492448		ICG 001 results in increased expression of AARS1 mRNA	increases^expression	26191083
AARS1	16	JP8 aviation fuel	C098607		JP8 aviation fuel results in decreased expression of AARS1 mRNA	decreases^expression	16835149
AARS1	16	methylparaben	C015358	99-76-3	methylparaben results in increased expression of AARS1 mRNA	increases^expression	31745603
AARS1	16	Nickel	D009532	7440-02-0	Nickel results in decreased expression of AARS1 mRNA	decreases^expression	23195993
AARS1	16	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	C044387	16858-02-9	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of AARS1 mRNA	decreases^expression	19013360
AARS1	16	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of AARS1 mRNA	decreases^expression	30559759
AARS1	16	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of AARS1 mRNA	decreases^expression	25596134
AARS1	16	Particulate Matter	D052638		Particulate Matter results in decreased expression of AARS1 mRNA	decreases^expression	24769257
AARS1	16	perfluorononanoic acid	C584865		perfluorononanoic acid results in increased expression of AARS1 mRNA	increases^expression	32588087
AARS1	16	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of AARS1 protein	increases^expression	26879310
AARS1	16	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of AARS1 mRNA	affects^expression	19159669
AARS1	16	Piroxicam	D010894	36322-90-4	Cisplatin affects the reaction [Piroxicam results in decreased expression of AARS1 mRNA]	affects^reaction|decreases^expression	21858171
AARS1	16	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of AARS1 mRNA	decreases^expression	21858171
AARS1	16	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of AARS1 mRNA	decreases^expression	28595984
AARS1	16	Sunitinib	D000077210		Sunitinib results in increased expression of AARS1 mRNA	increases^expression	31533062
AARS1	16	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of AARS1 mRNA	increases^expression	26179874
AARS1	16	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of AARS1 mRNA	increases^expression	22378314|29453283
AARS1	16	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of AARS1 protein	increases^expression	29453283
AARS1	16	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of AARS1 mRNA	affects^expression	25979313
AARS1	16	Zinc	D015032	7440-66-6	Zinc deficiency results in increased expression of AARS1 mRNA	increases^expression	22171008
AARS1	16	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of AARS1 mRNA	decreases^expression	25596134
AASDH	132949	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of AASDH mRNA	decreases^expression	22378314
AASDH	132949	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of AASDH mRNA	increases^expression	26472689
AASDH	132949	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of AASDH mRNA	decreases^expression	28302478
AASDH	132949	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of AASDH mRNA	affects^cotreatment|decreases^expression	22079256
AASDH	132949	jinfukang	C544151		jinfukang results in decreased expression of AASDH mRNA	decreases^expression	27392435
AASDH	132949	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in increased expression of AASDH mRNA	increases^expression	24796395
AASDH	132949	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of AASDH mRNA	affects^cotreatment|decreases^expression	22079256
AASDH	132949	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of AASDH mRNA	decreases^expression	22079256
AASDH	132949	Sunitinib	D000077210		Sunitinib results in increased expression of AASDH mRNA	increases^expression	31533062
AASDH	132949	Urethane	D014520	51-79-6	Urethane results in decreased expression of AASDH mRNA	decreases^expression	28818685
AASDH	132949	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of AASDH mRNA	decreases^expression	23179753
ABCB6	10058	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	9,10-dihydro-9,10-dihydroxybenzo(a)pyrene	C020738	24909-09-9	9,10-dihydro-9,10-dihydroxybenzo(a)pyrene results in increased expression of ABCB6 mRNA	increases^expression	26238291
ABCB6	10058	abrine	C496492		abrine results in decreased expression of ABCB6 mRNA	decreases^expression	31054353
ABCB6	10058	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of ABCB6 mRNA	decreases^expression	21420995|26690555
ABCB6	10058	Air Pollutants	D000393		Air Pollutants analog results in decreased expression of ABCB6 mRNA	decreases^expression	21757418
ABCB6	10058	Amitrole	D000640	61-82-5	ABCB6 inhibits the reaction [[Amitrole results in decreased activity of CAT protein] which results in increased susceptibility to sodium arsenite]	decreases^activity|decreases^reaction|increases^response to substance	21266531
ABCB6	10058	Amitrole	D000640	61-82-5	Amitrole inhibits the reaction [ABCB6 protein results in increased activity of CAT protein]	decreases^reaction|increases^activity	21266531
ABCB6	10058	Antirheumatic Agents	D018501		Antirheumatic Agents results in increased expression of ABCB6 mRNA	increases^expression	24449571
ABCB6	10058	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of ABCB6 mRNA	decreases^expression	22378314
ABCB6	10058	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of ABCB6 mRNA	increases^expression	16545412|20064835|20106945|21632981|22316170|22761424|26238291
ABCB6	10058	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of ABCB6 protein	increases^expression	22761424
ABCB6	10058	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ABCB6 5' UTR	increases^methylation	27901495
ABCB6	10058	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ABCB6 promoter	increases^methylation	27901495
ABCB6	10058	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of ABCB6 mRNA	increases^expression	29275510
ABCB6	10058	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of ABCB6 mRNA	increases^expression	25596134
ABCB6	10058	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde affects the expression of ABCB6 mRNA	affects^expression	25596134
ABCB6	10058	Cidofovir	D000077404	113852-37-2	Cidofovir results in increased expression of ABCB6 mRNA	increases^expression	25596134
ABCB6	10058	Cisplatin	D002945	15663-27-1	ABCB6 mRNA affects the susceptibility to Cisplatin	affects^response to substance	18610736
ABCB6	10058	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27392435
ABCB6	10058	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of ABCB6 mRNA	decreases^expression	20737486
ABCB6	10058	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of ABCB6 mRNA	increases^expression	25596134|27392435
ABCB6	10058	clothianidin	C480342		clothianidin results in decreased expression of ABCB6 mRNA	decreases^expression	29044138
ABCB6	10058	Cobalt	D003035	7440-48-4	[tungsten carbide co-treated with Cobalt] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	18078969
ABCB6	10058	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of ABCB6 mRNA	increases^expression	19320972|22202117
ABCB6	10058	cobaltous chloride	C018021	7646-79-9	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ABCB6 mRNA]	decreases^reaction|increases^expression	22202117
ABCB6	10058	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ABCB6 mRNA	decreases^expression	25562108
ABCB6	10058	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of ABCB6 mRNA	increases^expression	20106945|25596134
ABCB6	10058	Docetaxel	D000077143		[Docetaxel results in decreased susceptibility to Docetaxel] which results in increased expression of ABCB6 mRNA	decreases^response to substance|increases^expression	19944135
ABCB6	10058	dorsomorphin	C516138		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of ABCB6 mRNA	increases^expression	23649840
ABCB6	10058	Fluorouracil	D005472	51-21-8	Fluorouracil results in decreased expression of ABCB6 mRNA	decreases^expression	20737486
ABCB6	10058	glycidamide	C071834		glycidamide results in increased expression of ABCB6 mRNA	increases^expression	17822822
ABCB6	10058	Heme	D006418	14875-96-8	Heme results in increased expression of ABCB6 mRNA	increases^expression	17006453
ABCB6	10058	Heme	D006418	14875-96-8	Heme results in increased expression of ABCB6 protein	increases^expression	17006453
ABCB6	10058	ICG 001	C492448		ICG 001 results in decreased expression of ABCB6 mRNA	decreases^expression	26191083
ABCB6	10058	Ifosfamide	D007069	3778-73-2	Ifosfamide results in increased expression of ABCB6 mRNA	increases^expression	25596134
ABCB6	10058	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27392435
ABCB6	10058	jinfukang	C544151		jinfukang results in increased expression of ABCB6 mRNA	increases^expression	27392435
ABCB6	10058	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of ABCB6 mRNA	decreases^expression	28988120|29427785
ABCB6	10058	mercuric bromide	C042720	7789-47-1	mercuric bromide results in increased expression of ABCB6 mRNA	increases^expression	26272509
ABCB6	10058	mercuric bromide	C042720	7789-47-1	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	Methylcholanthrene	D008748	56-49-5	Methylcholanthrene results in increased expression of ABCB6 mRNA	increases^expression	22761424
ABCB6	10058	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of ABCB6 mRNA	increases^expression	28001369
ABCB6	10058	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of ABCB6 mRNA	increases^expression	23649840
ABCB6	10058	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of ABCB6 mRNA	decreases^expression	19287073
ABCB6	10058	Oxygen	D010100	7782-44-7	Oxygen deficiency results in increased expression of ABCB6 mRNA	increases^expression	25596134
ABCB6	10058	Paclitaxel	D017239		Paclitaxel results in decreased expression of ABCB6 mRNA	decreases^expression	20737486
ABCB6	10058	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	p-Chloromercuribenzoic Acid	D020245	59-85-8	p-Chloromercuribenzoic Acid results in increased expression of ABCB6 mRNA	increases^expression	26272509
ABCB6	10058	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of ABCB6 mRNA	affects^expression	19159669
ABCB6	10058	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of ABCB6 mRNA	increases^expression	26272509
ABCB6	10058	Reactive Oxygen Species	D017382		ABCB6 protein results in decreased abundance of Reactive Oxygen Species	decreases^abundance	21266531
ABCB6	10058	Rifampin	D012293	13292-46-1	Rifampin results in increased expression of ABCB6 mRNA	increases^expression	27199754
ABCB6	10058	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in decreased expression of ABCB6 mRNA	decreases^expression	25895662
ABCB6	10058	sodium arsenite	C017947	13768-07-5	ABCB6 inhibits the reaction [[Amitrole results in decreased activity of CAT protein] which results in increased susceptibility to sodium arsenite]	decreases^activity|decreases^reaction|increases^response to substance	21266531
ABCB6	10058	sodium arsenite	C017947	13768-07-5	ABCB6 protein results in decreased susceptibility to sodium arsenite	decreases^response to substance	21266531
ABCB6	10058	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of ABCB6 mRNA	increases^expression	21266531|21281968|24516582|25493608
ABCB6	10058	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of ABCB6 protein	increases^expression	21266531
ABCB6	10058	Sodium Dodecyl Sulfate	D012967	151-21-3	Sodium Dodecyl Sulfate results in decreased expression of ABCB6 mRNA	decreases^expression	31734321
ABCB6	10058	sulforafan	C016766	4478-93-7	sulforafan results in increased expression of ABCB6 mRNA	increases^expression	31838189
ABCB6	10058	Sunitinib	D000077210		Sunitinib results in increased expression of ABCB6 mRNA	increases^expression	31533062
ABCB6	10058	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of ABCB6 mRNA	affects^expression	22574217
ABCB6	10058	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of ABCB6 mRNA	increases^expression	20106945|22761424
ABCB6	10058	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of ABCB6 mRNA	decreases^expression	28065790
ABCB6	10058	tungsten carbide	C002802	11130-73-7	[tungsten carbide co-treated with Cobalt] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	18078969
ABCB6	10058	Urethane	D014520	51-79-6	Urethane results in decreased expression of ABCB6 mRNA	decreases^expression	28818685
ABCB6	10058	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCB6 mRNA	affects^cotreatment|increases^expression	27188386
ABCB6	10058	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of ABCB6 mRNA	affects^expression	25979313
ABCB6	10058	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ABCB6 mRNA	increases^expression	23179753|24383497|26272509|28001369
ABCB6	10058	Vincristine	D014750		[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCB6 mRNA	affects^expression|decreases^response to substance	19944135
ABCB6	10058	Vitallium	D014800	12629-02-6	Vitallium analog results in increased expression of ABCB6 mRNA	increases^expression	23825117
ABCB6	10058	zinc chloride	C016837	7646-85-7	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ABCB6 mRNA]	decreases^reaction|increases^expression	22202117
ABCB6	10058	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of ABCB6 mRNA	decreases^expression	24714768|25596134
ABHD12	26090	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA	affects^cotreatment|increases^expression	19167446
ABHD12	26090	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of ABHD12 protein	increases^expression	26194647
ABHD12	26090	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA	affects^cotreatment|increases^expression	27188386
ABHD12	26090	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA	affects^cotreatment|increases^expression	27188386
ABHD12	26090	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of ABHD12 mRNA	increases^expression	22230336
ABHD12	26090	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of ABHD12 mRNA	decreases^expression	22378314
ABHD12	26090	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA	affects^cotreatment|increases^expression	19167446
ABHD12	26090	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA	affects^cotreatment|increases^expression	27188386
ABHD12	26090	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA	affects^cotreatment|increases^expression	27188386
ABHD12	26090	Estradiol	D004958	50-28-2	[Estradiol co-treated with Progesterone] results in increased expression of ABHD12 mRNA	affects^cotreatment|increases^expression	20660070
ABHD12	26090	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of ABHD12 mRNA	increases^expression	23649840
ABHD12	26090	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of ABHD12 mRNA	decreases^expression	30851411
ABHD12	26090	Lead	D007854	7439-92-1	Lead results in decreased expression of ABHD12 mRNA	decreases^expression	19921347
ABHD12	26090	nickel sulfate	C029938	7786-81-4	nickel sulfate results in decreased expression of ABHD12 mRNA	decreases^expression	22714537
ABHD12	26090	Orlistat	D000077403	96829-58-2	Orlistat results in decreased activity of ABHD12 protein	decreases^activity	18657971
ABHD12	26090	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA	affects^cotreatment|increases^expression	27188386
ABHD12	26090	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of ABHD12 mRNA	increases^expression	26272509
ABHD12	26090	Progesterone	D011374	57-83-0	[Estradiol co-treated with Progesterone] results in increased expression of ABHD12 mRNA	affects^cotreatment|increases^expression	20660070
ABHD12	26090	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of ABHD12 mRNA	decreases^expression	22714537
ABHD12	26090	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA	affects^cotreatment|increases^expression	27188386
ABHD12	26090	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of ABHD12 mRNA	affects^expression	25979313
ABHD12	26090	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ABHD12 mRNA	increases^expression	23179753|24383497|25192806|26272509|27188386
ABHD12	26090	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of ABHD12 gene	increases^methylation	29154799
ABHD12	26090	Vorinostat	D000077337		Vorinostat results in increased expression of ABHD12 mRNA	increases^expression	27188386
ABHD5	51099	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	28628672
ABHD5	51099	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	28628672
ABHD5	51099	2-methyl-4-isothiazolin-3-one	C011506	2682-20-4	2-methyl-4-isothiazolin-3-one results in increased expression of ABHD5 mRNA	increases^expression	31629900
ABHD5	51099	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	27188386
ABHD5	51099	(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	C517041		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of ABHD5 mRNA	increases^expression	19561079
ABHD5	51099	4-aminophenylarsenoxide	C032642	1122-90-3	4-aminophenylarsenoxide binds to ABHD5 protein	affects^binding	26598702
ABHD5	51099	4-aminophenylarsenoxide	C032642	1122-90-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ABHD5 protein]	affects^binding|decreases^reaction	26598702
ABHD5	51099	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ABHD5 mRNA	decreases^expression	20018196
ABHD5	51099	abrine	C496492		abrine results in increased expression of ABHD5 mRNA	increases^expression	31054353
ABHD5	51099	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of ABHD5 mRNA	increases^expression	21420995
ABHD5	51099	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of ABHD5 gene	decreases^methylation	27153756
ABHD5	51099	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of ABHD5 mRNA	increases^expression	22100608
ABHD5	51099	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ABHD5 protein]	affects^binding|decreases^reaction	26598702
ABHD5	51099	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of ABHD5 mRNA	increases^expression	21632981|22316170|26238291
ABHD5	51099	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	28628672
ABHD5	51099	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	28628672
ABHD5	51099	Cisplatin	D002945	15663-27-1	Cisplatin affects the expression of ABHD5 mRNA	affects^expression	23300844
ABHD5	51099	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of ABHD5 mRNA	affects^cotreatment|decreases^expression	27392435
ABHD5	51099	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of ABHD5 mRNA	increases^expression	19549813
ABHD5	51099	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of ABHD5 mRNA	increases^expression	20106945|25562108|27989131
ABHD5	51099	Decitabine	D000077209	2353-33-5	Decitabine affects the expression of ABHD5 mRNA	affects^expression	23300844
ABHD5	51099	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of ABHD5 mRNA	increases^expression	25047013
ABHD5	51099	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	28628672
ABHD5	51099	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	28628672
ABHD5	51099	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of ABHD5 mRNA	decreases^expression	28302478
ABHD5	51099	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	27188386
ABHD5	51099	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of ABHD5 mRNA	decreases^expression	29803840
ABHD5	51099	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of ABHD5 mRNA	increases^expression	23649840
ABHD5	51099	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of ABHD5 mRNA	increases^expression	23649840
ABHD5	51099	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	28628672
ABHD5	51099	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	28628672
ABHD5	51099	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of ABHD5 mRNA	decreases^expression	20436886
ABHD5	51099	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of ABHD5 mRNA	affects^cotreatment|decreases^expression	27392435
ABHD5	51099	jinfukang	C544151		jinfukang results in decreased expression of ABHD5 mRNA	decreases^expression	27392435
ABHD5	51099	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of ABHD5 mRNA	decreases^expression	30851411
ABHD5	51099	Levonorgestrel	D016912	797-63-7	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ABHD5 mRNA	affects^cotreatment|decreases^expression	19074003
ABHD5	51099	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of ABHD5 mRNA	increases^expression	28001369
ABHD5	51099	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of ABHD5 mRNA	increases^expression	23649840
ABHD5	51099	Nickel	D009532	7440-02-0	Nickel results in decreased expression of ABHD5 mRNA	decreases^expression	24768652
ABHD5	51099	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of ABHD5 mRNA	affects^expression	19159669
ABHD5	51099	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ABHD5 mRNA	affects^binding|decreases^expression|increases^activity	19710929
ABHD5	51099	Plant Oils	D010938		Plant Oils results in increased expression of ABHD5 mRNA	increases^expression	23370395
ABHD5	51099	Progesterone	D011374	57-83-0	Progesterone results in increased expression of ABHD5 mRNA	increases^expression	20864642
ABHD5	51099	Quercetin	D011794	117-39-5	Quercetin affects the expression of ABHD5 mRNA	affects^expression	21632981
ABHD5	51099	Raloxifene Hydrochloride	D020849		Raloxifene Hydrochloride affects the expression of ABHD5 mRNA	affects^expression	14699072
ABHD5	51099	sodium arsenite	C017947	13768-07-5	sodium arsenite affects the methylation of ABHD5 gene	affects^methylation	28589171
ABHD5	51099	testosterone undecanoate	C010792		[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ABHD5 mRNA	affects^cotreatment|decreases^expression	19074003
ABHD5	51099	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of ABHD5 mRNA	increases^expression	19684285
ABHD5	51099	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of ABHD5 mRNA	increases^expression	28065790
ABHD5	51099	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of ABHD5 mRNA	increases^expression	26179874
ABHD5	51099	Urethane	D014520	51-79-6	Urethane results in increased expression of ABHD5 mRNA	increases^expression	28818685
ABHD5	51099	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD5 mRNA	affects^cotreatment|increases^expression	27188386
ABHD5	51099	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of ABHD5 mRNA	affects^expression	25979313
ABHD5	51099	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of ABHD5 mRNA	decreases^expression	25716160
ABHD5	51099	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of ABHD5 protein	decreases^expression	29501571
ABHD5	51099	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ABHD5 mRNA	increases^expression	23179753|26272509
ABHD5	51099	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of ABHD5 mRNA	affects^expression	20044591
ABHD5	51099	Zinc Sulfate	D019287	7733-02-0	Zinc Sulfate results in decreased expression of ABHD5 mRNA	decreases^expression	16330358
ABHD6	57406	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	27188386
ABHD6	57406	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	27188386
ABHD6	57406	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	27188386
ABHD6	57406	abrine	C496492		abrine results in decreased expression of ABHD6 mRNA	decreases^expression	31054353
ABHD6	57406	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of ABHD6 gene	increases^methylation	27153756
ABHD6	57406	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of ABHD6 mRNA	decreases^expression	24449571
ABHD6	57406	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ABHD6 mRNA	decreases^expression	32234424
ABHD6	57406	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ABHD6 promoter	increases^methylation	27901495
ABHD6	57406	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of ABHD6 mRNA	increases^expression	29275510
ABHD6	57406	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of ABHD6 mRNA	affects^cotreatment|increases^expression	27392435
ABHD6	57406	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of ABHD6 mRNA	increases^expression	27392435
ABHD6	57406	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of ABHD6 mRNA	decreases^expression	19549813
ABHD6	57406	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ABHD6 mRNA	decreases^expression	20106945|25562108
ABHD6	57406	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of ABHD6 gene	increases^methylation	22964155
ABHD6	57406	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	27188386
ABHD6	57406	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	27188386
ABHD6	57406	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	27188386
ABHD6	57406	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of ABHD6 mRNA	decreases^expression	29803840
ABHD6	57406	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	22079256
ABHD6	57406	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of ABHD6 mRNA	decreases^expression	23649840
ABHD6	57406	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of ABHD6 mRNA	decreases^expression	23649840
ABHD6	57406	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of ABHD6 mRNA	affects^cotreatment|increases^expression	27392435
ABHD6	57406	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of ABHD6 mRNA	decreases^expression	30851411
ABHD6	57406	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of ABHD6 mRNA	decreases^expression	28001369
ABHD6	57406	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of ABHD6 mRNA	decreases^expression	23649840
ABHD6	57406	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	27188386
ABHD6	57406	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	22079256
ABHD6	57406	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of ABHD6 mRNA	decreases^expression	22079256
ABHD6	57406	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of ABHD6 mRNA	decreases^expression	21632981
ABHD6	57406	Sunitinib	D000077210		Sunitinib results in increased expression of ABHD6 mRNA	increases^expression	31533062
ABHD6	57406	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of ABHD6 mRNA	decreases^expression	20106945|21632981
ABHD6	57406	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	27188386
ABHD6	57406	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of ABHD6 mRNA	decreases^expression	24935251|26272509
ABHD6	57406	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of ABHD6 mRNA	increases^expression	24935251|28542535
ABHD6	57406	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD6 mRNA	affects^cotreatment|decreases^expression	27188386
ABHD6	57406	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of ABHD6 mRNA	affects^expression	25979313
ABHD6	57406	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of ABHD6 mRNA	decreases^expression	26272509
ABHD6	57406	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ABHD6 mRNA	increases^expression	19101580|23179753|24935251|27188386|29154799
ACAA1	30	1-UFT protocol	C031903		ACAA1 protein results in increased susceptibility to 1-UFT protocol	increases^response to substance	16734730
ACAA1	30	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	27188386
ACAA1	30	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of ACAA1 mRNA	decreases^expression	22230336|29067470
ACAA1	30	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of ACAA1 protein	affects^expression	20106945
ACAA1	30	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of ACAA1 mRNA	decreases^expression	22100608
ACAA1	30	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ACAA1 mRNA	decreases^expression	32234424
ACAA1	30	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ACAA1 promoter	increases^methylation	27901495
ACAA1	30	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of ACAA1 mRNA	affects^expression	30903817
ACAA1	30	Capecitabine	D000069287		ACAA1 protein results in increased susceptibility to Capecitabine	increases^response to substance	16734730
ACAA1	30	ciglitazone	C039671	74772-77-3	[ciglitazone binds to PPARG protein] which results in increased expression of ACAA1 mRNA	affects^binding|increases^expression	16197558
ACAA1	30	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	27392435
ACAA1	30	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of ACAA1 mRNA	increases^expression	27594783
ACAA1	30	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of ACAA1 mRNA	decreases^expression	19549813
ACAA1	30	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ACAA1 mRNA	decreases^expression	20106945|25562108
ACAA1	30	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased methylation of ACAA1 promoter	decreases^methylation	27989131
ACAA1	30	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in decreased expression of ACAA1 protein	decreases^expression	31163220
ACAA1	30	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in increased expression of ACAA1 mRNA	increases^expression	31163220
ACAA1	30	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	27188386
ACAA1	30	doxifluridine	C025034	05/09/3094	ACAA1 protein results in increased susceptibility to doxifluridine	increases^response to substance	16734730
ACAA1	30	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	30611723
ACAA1	30	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of ACAA1 mRNA	increases^expression	24752549
ACAA1	30	GW 7647	C453899		[GW 7647 co-treated with Oleic Acid] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	30611723
ACAA1	30	GW 7647	C453899		GW 7647 results in increased expression of ACAA1 mRNA	increases^expression	30611723
ACAA1	30	Hydralazine	D006830	86-54-4	[Hydralazine co-treated with Valproic Acid] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	17183730
ACAA1	30	Hydrogen Peroxide	D006861	7722-84-1	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ACAA1 protein	affects^cotreatment|decreases^expression	18951874
ACAA1	30	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of ACAA1 mRNA	decreases^expression	20436886
ACAA1	30	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	27392435
ACAA1	30	jinfukang	C544151		jinfukang results in increased expression of ACAA1 mRNA	increases^expression	27392435
ACAA1	30	K 7174	C410337		K 7174 results in decreased expression of ACAA1 mRNA	decreases^expression	24086573
ACAA1	30	methyleugenol	C005223	93-15-2	methyleugenol results in decreased expression of ACAA1 mRNA	decreases^expression	32234424
ACAA1	30	obeticholic acid	C464660		obeticholic acid results in increased expression of ACAA1 mRNA	increases^expression	27939613
ACAA1	30	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of ACAA1 mRNA	decreases^expression	19287073
ACAA1	30	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	30611723
ACAA1	30	Oleic Acid	D019301	112-80-1	[GW 7647 co-treated with Oleic Acid] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	30611723
ACAA1	30	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	27188386
ACAA1	30	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of ACAA1 mRNA	increases^expression	26272509
ACAA1	30	S 1 (combination)	C079198	150863-82-4	ACAA1 protein results in increased susceptibility to S 1 (combination)	increases^response to substance	16734730
ACAA1	30	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of ACAA1 mRNA	decreases^expression	29301061
ACAA1	30	Theophylline	D013806	58-55-9	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ACAA1 protein	affects^cotreatment|decreases^expression	18951874
ACAA1	30	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of ACAA1 mRNA	decreases^expression	26179874
ACAA1	30	Valproic Acid	D014635	99-66-1	[Hydralazine co-treated with Valproic Acid] results in increased expression of ACAA1 mRNA	affects^cotreatment|increases^expression	17183730
ACAA1	30	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of ACAA1 mRNA	affects^expression	25979313
ACAA1	30	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of ACAA1 gene	decreases^methylation	29154799
ACAA1	30	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ACAA1 mRNA	increases^expression	23179753
ACAA2	10449	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACAA2 mRNA	affects^cotreatment|decreases^expression	19167446
ACAA2	10449	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of ACAA2 mRNA	affects^cotreatment|increases^expression	30611723
ACAA2	10449	abrine	C496492		abrine results in increased expression of ACAA2 protein	increases^expression	31054353
ACAA2	10449	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of ACAA2 gene	decreases^methylation	27153756
ACAA2	10449	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational results in decreased expression of ACAA2 mRNA	decreases^expression	23195993
ACAA2	10449	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of ACAA2 mRNA	increases^expression	15761015
ACAA2	10449	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of ACAA2 mRNA	decreases^expression	22378314
ACAA2	10449	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ACAA2 mRNA	decreases^expression	16269432
ACAA2	10449	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of ACAA2 mRNA	affects^expression	30903817
ACAA2	10449	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of ACAA2 protein	increases^expression	24527689
ACAA2	10449	ciglitazone	C039671	74772-77-3	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACAA2 mRNA	affects^binding|increases^expression	16197558
ACAA2	10449	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of ACAA2 mRNA	affects^cotreatment|decreases^expression	27392435
ACAA2	10449	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of ACAA2 mRNA	decreases^expression	19549813
ACAA2	10449	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACAA2 mRNA	affects^cotreatment|decreases^expression	19167446
ACAA2	10449	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ACAA2 mRNA	decreases^expression	20106945|23830897|25562108
ACAA2	10449	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of ACAA2 mRNA	decreases^expression	29803840
ACAA2	10449	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACAA2 mRNA	affects^cotreatment|increases^expression	30611723
ACAA2	10449	Farnesol	D005204	4602-84-0	Farnesol analog results in increased expression of ACAA2 mRNA	increases^expression	30611723
ACAA2	10449	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of ACAA2 mRNA	increases^expression	25572481
ACAA2	10449	flavone	C043562	525-82-6	flavone results in increased expression of ACAA2 protein	increases^expression	14750173
ACAA2	10449	Genistein	D019833	446-72-0	Genistein results in decreased expression of ACAA2 mRNA	decreases^expression	22228119
ACAA2	10449	GSK-J4	C000593030		GSK-J4 results in decreased expression of ACAA2 mRNA	decreases^expression	29301935
ACAA2	10449	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACAA2 mRNA	affects^cotreatment|decreases^expression	30611723
ACAA2	10449	GW 7647	C453899		[GW 7647 co-treated with Oleic Acid] results in increased expression of ACAA2 mRNA	affects^cotreatment|increases^expression	30611723
ACAA2	10449	GW 7647	C453899		GW 7647 results in increased expression of ACAA2 mRNA	increases^expression	30611723
ACAA2	10449	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of ACAA2 mRNA	decreases^expression	20436886
ACAA2	10449	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of ACAA2 mRNA	affects^cotreatment|decreases^expression	27392435
ACAA2	10449	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of ACAA2 mRNA	decreases^expression	23086925
ACAA2	10449	K 7174	C410337		K 7174 results in decreased expression of ACAA2 mRNA	decreases^expression	24086573
ACAA2	10449	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of ACAA2 mRNA	increases^expression	17400583
ACAA2	10449	Nickel	D009532	7440-02-0	Nickel results in decreased expression of ACAA2 mRNA	decreases^expression	23195993
ACAA2	10449	obeticholic acid	C464660		obeticholic acid results in increased expression of ACAA2 mRNA	increases^expression	27939613
ACAA2	10449	Oleic Acid	D019301	112-80-1	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of ACAA2 mRNA	affects^cotreatment|increases^expression	30611723
ACAA2	10449	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACAA2 mRNA	affects^cotreatment|increases^expression	30611723
ACAA2	10449	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACAA2 mRNA	affects^cotreatment|decreases^expression	30611723
ACAA2	10449	Oleic Acid	D019301	112-80-1	[GW 7647 co-treated with Oleic Acid] results in increased expression of ACAA2 mRNA	affects^cotreatment|increases^expression	30611723
ACAA2	10449	Oleic Acid	D019301	112-80-1	Oleic Acid results in increased expression of ACAA2 mRNA	increases^expression	30611723
ACAA2	10449	Ouabain	D010042	630-60-4	Ouabain affects the expression of ACAA2 protein	affects^expression	17268060
ACAA2	10449	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of ACAA2 mRNA	decreases^expression	19695866
ACAA2	10449	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of ACAA2 protein	increases^expression	26879310
ACAA2	10449	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of ACAA2 mRNA	decreases^expression	21632981
ACAA2	10449	Sarin	D012524	107-44-8	Sarin results in decreased expression of ACAA2 mRNA	decreases^expression	19522546
ACAA2	10449	Selenium	D012643	7782-49-2	Selenium results in increased expression of ACAA2 mRNA	increases^expression	19244175
ACAA2	10449	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of ACAA2 mRNA	increases^expression	18175754
ACAA2	10449	Sunitinib	D000077210		Sunitinib results in decreased expression of ACAA2 mRNA	decreases^expression	31533062
ACAA2	10449	Urethane	D014520	51-79-6	Urethane results in decreased expression of ACAA2 mRNA	decreases^expression	28818685
ACAA2	10449	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of ACAA2 gene	decreases^methylation	29154799
ACAA2	10449	Vitamin E	D014810	1406-18-4	Vitamin E results in increased expression of ACAA2 mRNA	increases^expression	19244175
ACOT2	10965	2,3-dimethoxy-1,4-naphthoquinone	C063002	6956-96-3	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of ACOT2 mRNA	decreases^expression	17547211
ACOT2	10965	abrine	C496492		abrine results in increased expression of ACOT2 protein	increases^expression	31054353
ACOT2	10965	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of ACOT2 mRNA	decreases^expression	22230336|29067470
ACOT2	10965	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of ACOT2 mRNA	decreases^expression	22100608
ACOT2	10965	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of ACOT2 intron	increases^methylation	30157460
ACOT2	10965	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACOT2 promoter	affects^methylation	27901495
ACOT2	10965	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ACOT2 mRNA	decreases^expression	26238291|32234424
ACOT2	10965	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ACOT2 5' UTR	increases^methylation	27901495
ACOT2	10965	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of ACOT2 mRNA	decreases^expression	19549813
ACOT2	10965	Doxorubicin	D004317	23214-92-8	Doxorubicin affects the expression of ACOT2 mRNA	affects^expression	29803840
ACOT2	10965	Hydralazine	D006830	86-54-4	[Hydralazine co-treated with Valproic Acid] results in decreased expression of ACOT2 mRNA	affects^cotreatment|decreases^expression	17183730
ACOT2	10965	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of ACOT2 mRNA	decreases^expression	20436886
ACOT2	10965	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of ACOT2 mRNA	decreases^expression	23086925|24796395
ACOT2	10965	Mitomycin	D016685	50-07-7	ACOT2 protein affects the susceptibility to Mitomycin	affects^response to substance	16217747
ACOT2	10965	nickel sulfate	C029938	7786-81-4	nickel sulfate results in increased expression of ACOT2 mRNA	increases^expression	16780908
ACOT2	10965	Particulate Matter	D052638		Particulate Matter results in increased expression of ACOT2 mRNA	increases^expression	29703138
ACOT2	10965	perfluorononanoic acid	C584865		perfluorononanoic acid results in decreased expression of ACOT2 mRNA	decreases^expression	32588087
ACOT2	10965	Phenol	D019800	108-95-2	Phenol results in decreased expression of ACOT2 mRNA	decreases^expression	17547211
ACOT2	10965	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of ACOT2 mRNA	decreases^expression	22714537
ACOT2	10965	Selenium	D012643	7782-49-2	[Selenium co-treated with Vitamin E] results in increased expression of ACOT2 mRNA	affects^cotreatment|increases^expression	19244175
ACOT2	10965	Selenium	D012643	7782-49-2	Selenium results in increased expression of ACOT2 mRNA	increases^expression	19244175
ACOT2	10965	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of ACOT2 mRNA	increases^expression	20371982|22714537
ACOT2	10965	Toluene	D014050	108-88-3	Toluene results in decreased expression of ACOT2 mRNA	decreases^expression	26717081
ACOT2	10965	Toluene	D014050	108-88-3	Toluene results in increased methylation of ACOT2 gene	increases^methylation	26717081
ACOT2	10965	Urethane	D014520	51-79-6	Urethane results in decreased expression of ACOT2 mRNA	decreases^expression	28818685
ACOT2	10965	Valproic Acid	D014635	99-66-1	[Hydralazine co-treated with Valproic Acid] results in decreased expression of ACOT2 mRNA	affects^cotreatment|decreases^expression	17183730
ACOT2	10965	Vitamin E	D014810	1406-18-4	[Selenium co-treated with Vitamin E] results in increased expression of ACOT2 mRNA	affects^cotreatment|increases^expression	19244175
ACOT2	10965	Vitamin E	D014810	1406-18-4	Vitamin E results in increased expression of ACOT2 mRNA	increases^expression	19244175
ACOT7	11332	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACOT7 mRNA	affects^cotreatment|decreases^expression	28628672
ACOT7	11332	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACOT7 mRNA	affects^cotreatment|decreases^expression	28628672
ACOT7	11332	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT7 mRNA	affects^cotreatment|increases^expression	19167446
ACOT7	11332	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of ACOT7 mRNA	affects^cotreatment|increases^expression	30611723
ACOT7	11332	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of ACOT7 mRNA	increases^expression	30611723
ACOT7	11332	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of ACOT7 mRNA	increases^expression	25704631|29067470
ACOT7	11332	Acetaminophen	D000082	103-90-2	ACOT7 gene polymorphism affects the susceptibility to Acetaminophen	affects^response to substance	26104854
ACOT7	11332	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of ACOT7 mRNA	decreases^expression	22100608
ACOT7	11332	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of ACOT7 gene	increases^methylation	27153756
ACOT7	11332	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of ACOT7 gene	affects^methylation	25304211
ACOT7	11332	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in increased expression of ACOT7 mRNA	increases^expression	29523930
ACOT7	11332	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of ACOT7 mRNA	decreases^expression	22378314
ACOT7	11332	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ACOT7 promoter	increases^methylation	27901495
ACOT7	11332	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACOT7 mRNA	affects^cotreatment|decreases^expression	28628672
ACOT7	11332	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACOT7 mRNA	affects^cotreatment|decreases^expression	28628672
ACOT7	11332	Bortezomib	D000069286		Bortezomib results in decreased expression of ACOT7 mRNA	decreases^expression	20977926
ACOT7	11332	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of ACOT7 mRNA	increases^expression	19320972
ACOT7	11332	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT7 mRNA	affects^cotreatment|increases^expression	19167446
ACOT7	11332	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of ACOT7 mRNA	affects^cotreatment|increases^expression	19167446
ACOT7	11332	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of ACOT7 mRNA	increases^expression	19167446
ACOT7	11332	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ACOT7 mRNA	decreases^expression	27989131
ACOT7	11332	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACOT7 mRNA	affects^cotreatment|decreases^expression	28628672
ACOT7	11332	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACOT7 mRNA	affects^cotreatment|decreases^expression	28628672
ACOT7	11332	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ACOT7 protein	decreases^activity|increases^O-linked glycosylation	23301498
ACOT7	11332	Estradiol	D004958	50-28-2	Estradiol results in increased expression of ACOT7 mRNA	increases^expression	19167446
ACOT7	11332	Ethanol	D000431	64-17-5	Ethanol results in decreased expression of ACOT7 mRNA	decreases^expression	23378141
ACOT7	11332	Fluorouracil	D005472	51-21-8	ACOT7 protein affects the susceptibility to Fluorouracil	affects^response to substance	15548681
ACOT7	11332	GSK-J4	C000593030		GSK-J4 results in decreased expression of ACOT7 mRNA	decreases^expression	29301935
ACOT7	11332	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACOT7 mRNA	affects^cotreatment|decreases^expression	30611723
ACOT7	11332	GW 4064	C412815		GW 4064 results in increased expression of ACOT7 mRNA	increases^expression	30611723
ACOT7	11332	Hydrogen Peroxide	D006861	7722-84-1	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ACOT7 protein	affects^cotreatment|decreases^expression	18951874
ACOT7	11332	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACOT7 mRNA	affects^cotreatment|decreases^expression	28628672
ACOT7	11332	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACOT7 mRNA	affects^cotreatment|decreases^expression	28628672
ACOT7	11332	jinfukang	C544151		jinfukang results in increased expression of ACOT7 mRNA	increases^expression	27392435
ACOT7	11332	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of ACOT7 mRNA	decreases^expression	23086925
ACOT7	11332	Nanotubes, Carbon	D037742		Nanotubes, Carbon results in increased expression of ACOT7 mRNA	increases^expression	28673683
ACOT7	11332	Nickel	D009532	7440-02-0	Nickel results in increased expression of ACOT7 mRNA	increases^expression	25583101
ACOT7	11332	Oleic Acid	D019301	112-80-1	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of ACOT7 mRNA	affects^cotreatment|increases^expression	30611723
ACOT7	11332	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACOT7 mRNA	affects^cotreatment|decreases^expression	30611723
ACOT7	11332	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in increased expression of ACOT7 mRNA	increases^expression	27153767
ACOT7	11332	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ACOT7 mRNA	affects^binding|decreases^expression|increases^activity	19710929
ACOT7	11332	quinoline	C037219	91-22-5	quinoline analog results in increased expression of ACOT7 protein	increases^expression	18645022
ACOT7	11332	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of ACOT7 mRNA	affects^cotreatment|increases^expression	19167446
ACOT7	11332	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of ACOT7 mRNA	increases^expression	28595984
ACOT7	11332	Sunitinib	D000077210		Sunitinib results in decreased expression of ACOT7 mRNA	decreases^expression	31533062
ACOT7	11332	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of ACOT7 mRNA	decreases^expression	19684285
ACOT7	11332	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of ACOT7 mRNA	increases^expression	19684285
ACOT7	11332	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of ACOT7 mRNA	decreases^expression	22378314
ACOT7	11332	Theophylline	D013806	58-55-9	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ACOT7 protein	affects^cotreatment|decreases^expression	18951874
ACOT7	11332	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of ACOT7 mRNA	decreases^expression	22378314
ACOT7	11332	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of ACOT7 mRNA	affects^expression	25979313
ACOT7	11332	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ACOT7 mRNA	increases^expression	23179753
ACOT8	10005	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in decreased expression of ACOT8 mRNA	affects^cotreatment|decreases^expression	30611723
ACOT8	10005	Amiodarone	D000638	1951-25-3	Amiodarone results in increased expression of ACOT8 mRNA	increases^expression	19774075
ACOT8	10005	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of ACOT8 mRNA	decreases^expression	24449571
ACOT8	10005	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of ACOT8 mRNA	decreases^expression	22378314
ACOT8	10005	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ACOT8 promoter	increases^methylation	27901495
ACOT8	10005	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of ACOT8 mRNA	decreases^expression	21457566
ACOT8	10005	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of ACOT8 mRNA	increases^expression	19549813
ACOT8	10005	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of ACOT8 mRNA	decreases^expression	29803840
ACOT8	10005	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACOT8 mRNA	affects^cotreatment|decreases^expression	30611723
ACOT8	10005	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of ACOT8 mRNA	decreases^expression	30851411
ACOT8	10005	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of ACOT8 mRNA	increases^expression	23649840
ACOT8	10005	Oleic Acid	D019301	112-80-1	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in decreased expression of ACOT8 mRNA	affects^cotreatment|decreases^expression	30611723
ACOT8	10005	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACOT8 mRNA	affects^cotreatment|decreases^expression	30611723
ACOT8	10005	Orlistat	D000077403	96829-58-2	Orlistat results in decreased expression of ACOT8 protein	decreases^expression	30667213
ACOT8	10005	Paclitaxel	D017239		Paclitaxel results in decreased expression of ACOT8 protein	decreases^expression	30667213
ACOT8	10005	Plant Extracts	D010936		Plant Extracts results in increased expression of ACOT8 mRNA	increases^expression	23557933
ACOX1	51	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	27188386
ACOX1	51	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	27188386
ACOX1	51	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	27188386
ACOX1	51	4-aminophenylarsenoxide	C032642	1122-90-3	4-aminophenylarsenoxide binds to ACOX1 protein	affects^binding	26598702
ACOX1	51	4-aminophenylarsenoxide	C032642	1122-90-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ACOX1 protein]	affects^binding|decreases^reaction	26598702
ACOX1	51	4-hydroxy-equilenin	C065250	81608-60-8	4-hydroxy-equilenin results in decreased expression of ACOX1 mRNA	decreases^expression	15135645
ACOX1	51	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of ACOX1 mRNA	decreases^expression	21420995|29067470
ACOX1	51	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of ACOX1 gene	decreases^methylation	27153756
ACOX1	51	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational results in decreased expression of ACOX1 mRNA	decreases^expression	23195993
ACOX1	51	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ACOX1 protein]	affects^binding|decreases^reaction	26598702
ACOX1	51	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ACOX1 mRNA	decreases^expression	16269432
ACOX1	51	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ACOX1 3' UTR	increases^methylation	27901495
ACOX1	51	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in decreased methylation of ACOX1 intron	decreases^methylation	30157460
ACOX1	51	Bezafibrate	D001629	41859-67-0	Bezafibrate results in increased expression of ACOX1 mRNA	increases^expression	21640707
ACOX1	51	Capsaicin	D002211	404-86-4	Capsaicin results in increased expression of ACOX1 mRNA	increases^expression	18533110
ACOX1	51	chiglitazar	C515629		chiglitazar results in increased expression of ACOX1 mRNA	increases^expression	23150725
ACOX1	51	ciprofibrate	C019304	52214-84-3	[ciprofibrate co-treated with Fatty Acids, Unsaturated deficiency] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	11172741
ACOX1	51	ciprofibrate	C019304	52214-84-3	ciprofibrate results in increased expression of ACOX1 mRNA	increases^expression	24986865
ACOX1	51	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of ACOX1 mRNA	decreases^expression	19549813
ACOX1	51	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ACOX1 mRNA	decreases^expression	20106945|23830897|25562108|27989131
ACOX1	51	cyproconazole	C093628		cyproconazole results in decreased expression of ACOX1 protein	decreases^expression	29995386
ACOX1	51	dorsomorphin	C516138		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	27188386
ACOX1	51	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	27188386
ACOX1	51	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	27188386
ACOX1	51	enilconazole	C017435		enilconazole results in decreased expression of ACOX1 mRNA	decreases^expression	32201337
ACOX1	51	entinostat	C118739		entinostat results in increased expression of ACOX1 mRNA	increases^expression	26272509
ACOX1	51	entinostat	C118739		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	27188386
ACOX1	51	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of ACOX1 mRNA	increases^expression	23649840
ACOX1	51	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	30611723
ACOX1	51	Fatty Acids, Nonesterified	D005230		Fatty Acids, Nonesterified affects the expression of ACOX1 mRNA	affects^expression	24735863
ACOX1	51	Fatty Acids, Nonesterified	D005230		Fatty Acids, Nonesterified results in decreased expression of ACOX1 protein	decreases^expression	24735863
ACOX1	51	Fatty Acids, Nonesterified	D005230		[Fenofibrate co-treated with Fatty Acids, Nonesterified] results in increased expression of ACOX1 protein	affects^cotreatment|increases^expression	24735863
ACOX1	51	Fatty Acids, Nonesterified	D005230		Fenofibrate inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of ACOX1 mRNA]	decreases^expression|decreases^reaction	24735863
ACOX1	51	Fatty Acids, Nonesterified	D005230		Fenofibrate inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of ACOX1 protein]	decreases^expression|decreases^reaction	24735863
ACOX1	51	Fatty Acids, Nonesterified	D005230		Fenofibrate promotes the reaction [Fatty Acids, Nonesterified results in increased expression of ACOX1 mRNA]	increases^expression|increases^reaction	24735863
ACOX1	51	Fatty Acids, Nonesterified	D005230		[hugan qingzhi co-treated with Fatty Acids, Nonesterified] results in increased expression of ACOX1 protein	affects^cotreatment|increases^expression	24735863
ACOX1	51	Fatty Acids, Nonesterified	D005230		hugan qingzhi inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of ACOX1 mRNA]	decreases^expression|decreases^reaction	24735863
ACOX1	51	Fatty Acids, Nonesterified	D005230		hugan qingzhi inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of ACOX1 protein]	decreases^expression|decreases^reaction	24735863
ACOX1	51	Fatty Acids, Nonesterified	D005230		hugan qingzhi promotes the reaction [Fatty Acids, Nonesterified results in increased expression of ACOX1 mRNA]	increases^expression|increases^reaction	24735863
ACOX1	51	Fatty Acids, Unsaturated	D005231		[ciprofibrate co-treated with Fatty Acids, Unsaturated deficiency] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	11172741
ACOX1	51	Fenofibrate	D011345	49562-28-9	[Fenofibrate co-treated with Fatty Acids, Nonesterified] results in increased expression of ACOX1 protein	affects^cotreatment|increases^expression	24735863
ACOX1	51	Fenofibrate	D011345	49562-28-9	[Fenofibrate co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	24534255
ACOX1	51	Fenofibrate	D011345	49562-28-9	Fenofibrate inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of ACOX1 mRNA]	decreases^expression|decreases^reaction	24735863
ACOX1	51	Fenofibrate	D011345	49562-28-9	Fenofibrate inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of ACOX1 protein]	decreases^expression|decreases^reaction	24735863
ACOX1	51	Fenofibrate	D011345	49562-28-9	Fenofibrate promotes the reaction [Fatty Acids, Nonesterified results in increased expression of ACOX1 mRNA]	increases^expression|increases^reaction	24735863
ACOX1	51	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of ACOX1 mRNA	increases^expression	24752549|24986865|25572481
ACOX1	51	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of ACOX1 protein	increases^expression	24752549
ACOX1	51	Fenofibrate	D011345	49562-28-9	PPARA protein promotes the reaction [Fenofibrate results in increased expression of ACOX1 protein]	increases^expression|increases^reaction	24752549
ACOX1	51	Genistein	D019833	446-72-0	ESR2 promotes the reaction [Genistein results in decreased expression of ACOX1 protein]	decreases^expression|increases^reaction	20884965
ACOX1	51	Genistein	D019833	446-72-0	Genistein results in decreased expression of ACOX1 protein	decreases^expression	20884965
ACOX1	51	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACOX1 mRNA	affects^cotreatment|decreases^expression	30611723
ACOX1	51	GW 4064	C412815		GW 4064 results in decreased expression of ACOX1 mRNA	decreases^expression	31437187
ACOX1	51	GW 7647	C453899		[GW 7647 co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	30611723
ACOX1	51	GW 7647	C453899		GW 7647 results in increased expression of ACOX1 mRNA	increases^expression	30611723|31437187
ACOX1	51	hugan qingzhi	C000594496		[hugan qingzhi co-treated with Fatty Acids, Nonesterified] results in increased expression of ACOX1 protein	affects^cotreatment|increases^expression	24735863
ACOX1	51	hugan qingzhi	C000594496		hugan qingzhi inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of ACOX1 mRNA]	decreases^expression|decreases^reaction	24735863
ACOX1	51	hugan qingzhi	C000594496		hugan qingzhi inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of ACOX1 protein]	decreases^expression|decreases^reaction	24735863
ACOX1	51	hugan qingzhi	C000594496		hugan qingzhi promotes the reaction [Fatty Acids, Nonesterified results in increased expression of ACOX1 mRNA]	increases^expression|increases^reaction	24735863
ACOX1	51	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in increased expression of ACOX1 mRNA	increases^expression	24796395
ACOX1	51	linalool	C018584	78-70-6	linalool results in increased expression of ACOX1 mRNA	increases^expression	24752549
ACOX1	51	linalool	C018584	78-70-6	linalool results in increased expression of ACOX1 protein	increases^expression	24752549
ACOX1	51	linalool	C018584	78-70-6	PPARA protein promotes the reaction [linalool results in increased expression of ACOX1 protein]	increases^expression|increases^reaction	24752549
ACOX1	51	Methapyrilene	D008701	91-80-5	Methapyrilene results in decreased methylation of ACOX1 intron	decreases^methylation	30157460
ACOX1	51	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of ACOX1 mRNA	increases^expression	28001369
ACOX1	51	muraglitazar	C500085		[muraglitazar co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	24534255
ACOX1	51	Nickel	D009532	7440-02-0	Nickel results in decreased expression of ACOX1 mRNA	decreases^expression	23195993
ACOX1	51	nickel chloride	C022838	7718-54-9	nickel chloride results in decreased expression of ACOX1 mRNA	decreases^expression	17312168
ACOX1	51	obeticholic acid	C464660		obeticholic acid results in increased expression of ACOX1 mRNA	increases^expression	27939613
ACOX1	51	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	30611723
ACOX1	51	Oleic Acid	D019301	112-80-1	[Fenofibrate co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	24534255
ACOX1	51	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACOX1 mRNA	affects^cotreatment|decreases^expression	30611723
ACOX1	51	Oleic Acid	D019301	112-80-1	[GW 7647 co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	30611723
ACOX1	51	Oleic Acid	D019301	112-80-1	[muraglitazar co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	24534255
ACOX1	51	Oleic Acid	D019301	112-80-1	[Rosiglitazone co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	24534255
ACOX1	51	Oleic Acid	D019301	112-80-1	[tesaglitazar co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	24534255
ACOX1	51	perfluorohexanesulfonic acid	C471071	355-46-4	perfluorohexanesulfonic acid results in increased expression of ACOX1 mRNA	increases^expression	23567314
ACOX1	51	perfluoro-n-nonanoic acid	C101816	375-95-1	perfluoro-n-nonanoic acid results in increased expression of ACOX1 mRNA	increases^expression	23567314
ACOX1	51	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of ACOX1 mRNA	increases^expression	21723365|22425687|23978341
ACOX1	51	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	27188386
ACOX1	51	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of ACOX1 mRNA	increases^expression	26272509
ACOX1	51	pirinixic acid	C006253	50892-23-4	pirinixic acid results in decreased activity of ACOX1 protein	decreases^activity	19571398
ACOX1	51	pirinixic acid	C006253	50892-23-4	pirinixic acid results in increased expression of ACOX1 mRNA	increases^expression	24986865|27551952
ACOX1	51	Plant Extracts	D010936		Plant Extracts results in increased expression of ACOX1 mRNA	increases^expression	23557933
ACOX1	51	propiconazole	C045950	60207-90-1	[propiconazole co-treated with tebuconazole] results in decreased expression of ACOX1 mRNA	affects^cotreatment|decreases^expression	30989312
ACOX1	51	Raffinose	D011887	512-69-6	Raffinose results in increased expression of ACOX1 mRNA	increases^expression	29458019
ACOX1	51	Rosiglitazone	D000077154		[Rosiglitazone co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	24534255
ACOX1	51	Rosiglitazone	D000077154		Rosiglitazone results in increased expression of ACOX1 mRNA	increases^expression	23150725
ACOX1	51	tebuconazole	C087114		[propiconazole co-treated with tebuconazole] results in decreased expression of ACOX1 mRNA	affects^cotreatment|decreases^expression	30989312
ACOX1	51	tebuconazole	C087114		tebuconazole results in decreased expression of ACOX1 mRNA	decreases^expression	30989312
ACOX1	51	tesaglitazar	C501413		[tesaglitazar co-treated with Oleic Acid] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	24534255
ACOX1	51	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of ACOX1 mRNA	increases^expression	12377990|15345368
ACOX1	51	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACOX1 mRNA	affects^cotreatment|increases^expression	27188386
ACOX1	51	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of ACOX1 mRNA	increases^expression	26272509
ACOX1	51	Triclosan	D014260	3380-34-5	Triclosan results in decreased expression of ACOX1 mRNA	decreases^expression	25193434
ACOX1	51	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of ACOX1 mRNA	affects^expression	25979313
ACOX1	51	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of ACOX1 mRNA	decreases^expression	29501571
ACOX1	51	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ACOX1 mRNA	increases^expression	23179753|28001369
ACOX1	51	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of ACOX1 gene	increases^methylation	29501571
ACOX1	51	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of ACOX1 mRNA	decreases^expression	28871336
ACOX1	51	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of ACOX1 protein	decreases^expression	28871336
ACOX3	8310	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of ACOX3 mRNA	decreases^expression	21420995
ACOX3	8310	Acetaminophen	D000082	103-90-2	ACOX3 gene polymorphism affects the susceptibility to Acetaminophen	affects^response to substance	26104854
ACOX3	8310	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of ACOX3 intron	decreases^methylation	30157460
ACOX3	8310	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of ACOX3 polyA tail	decreases^methylation	30157460
ACOX3	8310	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of ACOX3 gene	increases^methylation	27153756
ACOX3	8310	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACOX3 intron	affects^methylation	30157460
ACOX3	8310	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of ACOX3 5' UTR	decreases^methylation	27901495
ACOX3	8310	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in decreased methylation of ACOX3 intron	decreases^methylation	30157460
ACOX3	8310	Calcitriol	D002117	32222-06-3	Calcitriol results in increased expression of ACOX3 mRNA	increases^expression	21592394
ACOX3	8310	Calcitriol	D002117	32222-06-3	[Testosterone co-treated with Calcitriol] results in increased expression of ACOX3 mRNA	affects^cotreatment|increases^expression	21592394
ACOX3	8310	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ACOX3 mRNA	decreases^expression	27989131
ACOX3	8310	Methapyrilene	D008701	91-80-5	Methapyrilene results in decreased methylation of ACOX3 intron	decreases^methylation	30157460
ACOX3	8310	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of ACOX3 mRNA	decreases^expression	28001369
ACOX3	8310	obeticholic acid	C464660		obeticholic acid results in increased expression of ACOX3 mRNA	increases^expression	27939613
ACOX3	8310	Plant Extracts	D010936		Plant Extracts results in increased expression of ACOX3 mRNA	increases^expression	23557933
ACOX3	8310	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of ACOX3 mRNA	decreases^expression	21632981
ACOX3	8310	sodium arsenite	C017947	13768-07-5	sodium arsenite affects the methylation of ACOX3 gene	affects^methylation	28589171
ACOX3	8310	Testosterone	D013739	58-22-0	[Testosterone co-treated with Calcitriol] results in increased expression of ACOX3 mRNA	affects^cotreatment|increases^expression	21592394
ACOX3	8310	Testosterone	D013739	58-22-0	Testosterone results in increased expression of ACOX3 mRNA	increases^expression	21592394
ACOX3	8310	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of ACOX3 mRNA	decreases^expression	29154799
ACOX3	8310	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of ACOX3 gene	decreases^methylation	29154799
ACSBG1	23205	4-aminophenylarsenoxide	C032642	1122-90-3	4-aminophenylarsenoxide binds to ACSBG1 protein	affects^binding	26598702
ACSBG1	23205	4-aminophenylarsenoxide	C032642	1122-90-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ACSBG1 protein]	affects^binding|decreases^reaction	26598702
ACSBG1	23205	abrine	C496492		abrine results in increased expression of ACSBG1 mRNA	increases^expression	31054353
ACSBG1	23205	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of ACSBG1 mRNA	increases^expression	22230336
ACSBG1	23205	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of ACSBG1 gene	increases^methylation	27153756
ACSBG1	23205	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in decreased methylation of ACSBG1 exon	decreases^methylation	30157460
ACSBG1	23205	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ACSBG1 protein]	affects^binding|decreases^reaction	26598702
ACSBG1	23205	Benzene	D001554	71-43-2	Benzene results in decreased expression of ACSBG1 mRNA	decreases^expression	19162166
ACSBG1	23205	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACSBG1 promoter	affects^methylation	27901495
ACSBG1	23205	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of ACSBG1 mRNA	affects^expression	25979313
ACSBG1	23205	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of ACSBG1 mRNA	decreases^expression	20436886
ACSBG1	23205	Lead	D007854	7439-92-1	Lead results in decreased expression of ACSBG1 mRNA	decreases^expression	19921347
ACSBG1	23205	Nickel	D009532	7440-02-0	Nickel results in decreased expression of ACSBG1 mRNA	decreases^expression	24768652
ACSBG1	23205	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of ACSBG1 mRNA	decreases^expression	21998131
ACSBG1	23205	Urethane	D014520	51-79-6	Urethane results in increased expression of ACSBG1 mRNA	increases^expression	28818685
ACSF2	80221	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^expression	28628672
ACSF2	80221	2-methyl-4-isothiazolin-3-one	C011506	2682-20-4	2-methyl-4-isothiazolin-3-one results in decreased expression of ACSF2 mRNA	decreases^expression	31629900
ACSF2	80221	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^expression	27188386
ACSF2	80221	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^expression	27188386
ACSF2	80221	abrine	C496492		abrine results in decreased expression of ACSF2 mRNA	decreases^expression	31054353
ACSF2	80221	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of ACSF2 mRNA	decreases^expression	29067470
ACSF2	80221	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of ACSF2 mRNA	increases^expression	25704631
ACSF2	80221	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of ACSF2 mRNA	decreases^expression	27153756
ACSF2	80221	afuresertib	C000593263		afuresertib results in increased expression of ACSF2 mRNA	increases^expression	28960945
ACSF2	80221	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACSF2 intron	affects^methylation	30157460
ACSF2	80221	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ACSF2 mRNA	decreases^expression	32234424
ACSF2	80221	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of ACSF2 promoter	decreases^methylation	27901495
ACSF2	80221	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ACSF2 3' UTR	increases^methylation	27901495
ACSF2	80221	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	bis(4-hydroxyphenyl)sulfone results in increased expression of ACSF2 mRNA	increases^expression	27685785
ACSF2	80221	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of ACSF2 mRNA	affects^expression	30903817
ACSF2	80221	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of ACSF2 mRNA	increases^expression	27685785
ACSF2	80221	Cisplatin	D002945	15663-27-1	Cisplatin affects the expression of ACSF2 mRNA	affects^expression	23300844
ACSF2	80221	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of ACSF2 mRNA	decreases^expression	19549813
ACSF2	80221	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ACSF2 mRNA	decreases^expression	20106945|25562108
ACSF2	80221	Decitabine	D000077209	2353-33-5	Decitabine affects the expression of ACSF2 mRNA	affects^expression	23300844
ACSF2	80221	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of ACSF2 mRNA	increases^expression	25047013
ACSF2	80221	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^expression	28628672
ACSF2	80221	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^expression	27188386
ACSF2	80221	dorsomorphin	C516138		[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^expression	27188386
ACSF2	80221	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of ACSF2 mRNA	decreases^expression	29803840
ACSF2	80221	Gasoline	D005742		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
ACSF2	80221	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^expression	28628672
ACSF2	80221	isobutyl alcohol	C040507	78-83-1	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
ACSF2	80221	K 7174	C410337		K 7174 results in decreased expression of ACSF2 mRNA	decreases^expression	24086573
ACSF2	80221	Nickel	D009532	7440-02-0	Nickel results in decreased expression of ACSF2 mRNA	decreases^expression	24768652|25583101
ACSF2	80221	Particulate Matter	D052638		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
ACSF2	80221	perfluorononanoic acid	C584865		perfluorononanoic acid results in decreased expression of ACSF2 mRNA	decreases^expression	32588087
ACSF2	80221	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in decreased expression of ACSF2 mRNA	decreases^expression	32588087
ACSF2	80221	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of ACSF2 protein	increases^expression	26879310
ACSF2	80221	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
ACSF2	80221	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of ACSF2 mRNA	decreases^expression	21632981
ACSF2	80221	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in decreased expression of ACSF2 mRNA	decreases^expression	25895662
ACSF2	80221	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide results in decreased expression of ACSF2 mRNA	decreases^expression	28425640
ACSF2	80221	sulforafan	C016766	4478-93-7	sulforafan results in decreased expression of ACSF2 mRNA	decreases^expression	31838189
ACSF2	80221	Sunitinib	D000077210		Sunitinib results in increased expression of ACSF2 mRNA	increases^expression	31533062
ACSF2	80221	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of ACSF2 mRNA	increases^expression	24935251
ACSF2	80221	Triclosan	D014260	3380-34-5	Triclosan results in decreased expression of ACSF2 mRNA	decreases^expression	30510588
ACSF2	80221	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of ACSF2 mRNA	decreases^expression	26179874
ACSF2	80221	tris(2-butoxyethyl) phosphate	C013320	78-51-3	tris(2-butoxyethyl) phosphate affects the expression of ACSF2 mRNA	affects^expression	29024780
ACSF2	80221	Urethane	D014520	51-79-6	Urethane results in decreased expression of ACSF2 mRNA	decreases^expression	28818685
ACSF2	80221	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^expression	27188386
ACSF2	80221	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of ACSF2 mRNA	affects^expression	25979313
ACSF2	80221	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of ACSF2 gene	decreases^methylation	29154799
ACSF2	80221	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ACSF2 mRNA	increases^expression	23179753|26272509
ACSF2	80221	Vanadates	D014638		Vanadates results in increased expression of ACSF2 mRNA	increases^expression	22714537
ACSF2	80221	Vorinostat	D000077337		[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSF2 mRNA	affects^cotreatment|increases^expression	27188386
ACSF3	197322	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of ACSF3 intron	increases^methylation	30157460
ACSF3	197322	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of ACSF3 intron	increases^methylation	30157460
ACSF3	197322	Amiodarone	D000638	1951-25-3	Amiodarone results in increased expression of ACSF3 mRNA	increases^expression	19774075
ACSF3	197322	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of ACSF3 gene	affects^methylation	25304211
ACSF3	197322	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACSF3 intron	affects^methylation	30157460
ACSF3	197322	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ACSF3 mRNA	decreases^expression	32234424
ACSF3	197322	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ACSF3 3' UTR	increases^methylation	27901495
ACSF3	197322	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of ACSF3 mRNA	decreases^expression	19549813
ACSF3	197322	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of ACSF3 mRNA	decreases^expression	29803840
ACSF3	197322	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in increased expression of ACSF3 mRNA	increases^expression	27153767
ACSF3	197322	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of ACSF3 protein	increases^expression	26879310
ACSF3	197322	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of ACSF3 mRNA	decreases^expression	23724009
ACSF3	197322	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of ACSF3 gene	increases^methylation	29154799
ACSL1	2180	1-(2-trifluoromethoxyphenyl)-2-nitroethanone	C576882		1-(2-trifluoromethoxyphenyl)-2-nitroethanone results in increased expression of ACSL1 mRNA	increases^expression	25596134
ACSL1	2180	1-Butanol	D020001	71-36-3	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
ACSL1	2180	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	28628672
ACSL1	2180	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	28628672
ACSL1	2180	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	28628672
ACSL1	2180	2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine	C532162		[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in increased expression of ACSL1 mRNA	increases^expression|increases^response to substance	20453058
ACSL1	2180	2,3-dimethoxy-1,4-naphthoquinone	C063002	6956-96-3	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of ACSL1 mRNA	decreases^expression	17547211
ACSL1	2180	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of ACSL1 protein	increases^expression	26194647
ACSL1	2180	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone	C016583	64091-91-4	[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	20146248
ACSL1	2180	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of ACSL1 mRNA	increases^expression	22230336|25704631
ACSL1	2180	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of ACSL1 mRNA	decreases^expression	22100608|27153756
ACSL1	2180	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of ACSL1 intron	increases^methylation	30157460
ACSL1	2180	Antimony	D000965	7440-36-0	Antimony results in decreased expression of ACSL1 mRNA	decreases^expression	17547211
ACSL1	2180	Antimony Potassium Tartrate	D000966	28300-74-5	Antimony Potassium Tartrate results in decreased expression of ACSL1 mRNA	decreases^expression	17547211
ACSL1	2180	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of ACSL1 mRNA	increases^expression	29266867
ACSL1	2180	Arsenic Trioxide	D000077237	1327-53-3	Dasatinib inhibits the reaction [Arsenic Trioxide results in increased expression of ACSL1 mRNA]	decreases^reaction|increases^expression	29266867
ACSL1	2180	arsenite	C015001	15502-74-6	arsenite results in increased expression of ACSL1 mRNA	increases^expression	23974009
ACSL1	2180	Benzene	D001554	71-43-2	Benzene affects the expression of ACSL1 mRNA	affects^expression	21147609|30300410
ACSL1	2180	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACSL1 5' UTR	affects^methylation	27901495
ACSL1	2180	Benzo(a)pyrene	D001564	50-32-8	[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	20146248
ACSL1	2180	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ACSL1 mRNA	decreases^expression	20106945|21632981|30453624|32234424
ACSL1	2180	Bezafibrate	D001629	41859-67-0	Bezafibrate results in increased expression of ACSL1 mRNA	increases^expression	19682441|21640707
ACSL1	2180	bicalutamide	C053541		bicalutamide results in increased expression of ACSL1 mRNA	increases^expression	15790403
ACSL1	2180	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	28628672
ACSL1	2180	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	28628672
ACSL1	2180	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of ACSL1 mRNA	increases^expression	25596134
ACSL1	2180	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of ACSL1 mRNA	affects^expression	25979313
ACSL1	2180	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde results in decreased expression of ACSL1 mRNA	decreases^expression	25596134
ACSL1	2180	Chromium	D002857	7440-47-3	Chromium results in decreased expression of ACSL1 mRNA	decreases^expression	17547211
ACSL1	2180	Cidofovir	D000077404	113852-37-2	Cidofovir results in decreased expression of ACSL1 mRNA	decreases^expression	25596134
ACSL1	2180	ciglitazone	C039671	74772-77-3	[ciglitazone binds to PPARG protein] which results in increased expression of ACSL1 mRNA	affects^binding|increases^expression	16197558
ACSL1	2180	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of ACSL1 mRNA	decreases^expression	25596134
ACSL1	2180	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of ACSL1 mRNA	increases^expression	27594783
ACSL1	2180	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in decreased expression of ACSL1 mRNA	decreases^expression	25596134
ACSL1	2180	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of ACSL1 mRNA	affects^binding|decreases^expression	20971185
ACSL1	2180	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of ACSL1 mRNA	increases^expression	19549813
ACSL1	2180	Cyclosporine	D016572	59865-13-3	Cyclosporine affects the expression of ACSL1 mRNA	affects^expression	25596134
ACSL1	2180	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ACSL1 mRNA	decreases^expression	20106945
ACSL1	2180	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased methylation of ACSL1 promoter	decreases^methylation	27989131
ACSL1	2180	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of ACSL1 mRNA	increases^expression	25562108
ACSL1	2180	Dasatinib	D000069439		Dasatinib inhibits the reaction [Arsenic Trioxide results in increased expression of ACSL1 mRNA]	decreases^reaction|increases^expression	29266867
ACSL1	2180	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of ACSL1 mRNA	increases^expression	25047013
ACSL1	2180	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	28628672
ACSL1	2180	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	28628672
ACSL1	2180	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	28628672
ACSL1	2180	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in decreased expression of ACSL1 protein	decreases^expression	31163220
ACSL1	2180	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in increased expression of ACSL1 mRNA	increases^expression	31163220
ACSL1	2180	Dimethylnitrosamine	D004128	62-75-9	Dimethylnitrosamine results in decreased expression of ACSL1 mRNA	decreases^expression	17547211
ACSL1	2180	dorsomorphin	C516138		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	dorsomorphin	C516138		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	dorsomorphin	C516138		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of ACSL1 mRNA	decreases^expression	29803840
ACSL1	2180	entinostat	C118739		entinostat results in increased expression of ACSL1 mRNA	increases^expression	26272509
ACSL1	2180	entinostat	C118739		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	Estradiol	D004958	50-28-2	[Estradiol co-treated with Progesterone] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	20660070
ACSL1	2180	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	30165855
ACSL1	2180	Estradiol	D004958	50-28-2	[Progesterone co-treated with Estradiol] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	17404688
ACSL1	2180	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of ACSL1 mRNA	decreases^expression	23649840
ACSL1	2180	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of ACSL1 mRNA	increases^expression	24752549|25596134
ACSL1	2180	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of ACSL1 protein	increases^expression	24752549
ACSL1	2180	Fenofibrate	D011345	49562-28-9	PPARA protein promotes the reaction [Fenofibrate results in increased expression of ACSL1 protein]	increases^expression|increases^reaction	24752549
ACSL1	2180	fenofibric acid	C006012	26129-32-8	[fenofibric acid binds to PPARA protein] which results in increased expression of ACSL1 mRNA	affects^binding|increases^expression	16197558
ACSL1	2180	gardiquimod	C546771		gardiquimod results in increased expression of ACSL1 mRNA	increases^expression	28003376
ACSL1	2180	gardiquimod	C546771		Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ACSL1 mRNA]	decreases^reaction|increases^expression	28003376
ACSL1	2180	Gasoline	D005742		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
ACSL1	2180	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of ACSL1 mRNA	affects^expression	20044591
ACSL1	2180	Ibuprofen	D007052	15687-27-1	Ibuprofen results in increased expression of ACSL1 mRNA	increases^expression	25596134
ACSL1	2180	Ifosfamide	D007069	3778-73-2	Ifosfamide results in decreased expression of ACSL1 mRNA	decreases^expression	25596134
ACSL1	2180	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	28628672
ACSL1	2180	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	28628672
ACSL1	2180	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	28628672
ACSL1	2180	K 7174	C410337		K 7174 results in increased expression of ACSL1 mRNA	increases^expression	24086573
ACSL1	2180	linalool	C018584	78-70-6	linalool results in increased expression of ACSL1 mRNA	increases^expression	24752549
ACSL1	2180	linalool	C018584	78-70-6	linalool results in increased expression of ACSL1 protein	increases^expression	24752549
ACSL1	2180	linalool	C018584	78-70-6	PPARA protein promotes the reaction [linalool results in increased expression of ACSL1 protein]	increases^expression|increases^reaction	24752549
ACSL1	2180	Medroxyprogesterone Acetate	D017258	71-58-9	Medroxyprogesterone Acetate results in increased expression of ACSL1 mRNA	increases^expression	18497975
ACSL1	2180	mercuric bromide	C042720	7789-47-1	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	Mercury	D008628	7439-97-6	Mercury results in decreased expression of ACSL1 mRNA	decreases^expression	17547211
ACSL1	2180	methoxyacetic acid	C013598	625-45-6	methoxyacetic acid promotes the reaction [Promegestone results in increased expression of ACSL1 mRNA]	increases^expression|increases^reaction	15103026
ACSL1	2180	methyleugenol	C005223	93-15-2	methyleugenol results in decreased expression of ACSL1 mRNA	decreases^expression	32234424
ACSL1	2180	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of ACSL1 mRNA	increases^expression	28001369
ACSL1	2180	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of ACSL1 mRNA	decreases^expression	23649840
ACSL1	2180	Mitomycin	D016685	50-07-7	ACSL1 protein affects the susceptibility to Mitomycin	affects^response to substance	16217747
ACSL1	2180	nickel chloride	C022838	7718-54-9	nickel chloride results in decreased expression of ACSL1 mRNA	decreases^expression	17547211
ACSL1	2180	Niclosamide	D009534	50-65-7	Niclosamide results in decreased expression of ACSL1 mRNA	decreases^expression	22576131
ACSL1	2180	Nicotine	D009538		Nicotine results in increased splicing of ACSL1 mRNA alternative form	increases^splicing	23825647
ACSL1	2180	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of ACSL1 mRNA	affects^binding|decreases^expression	20971185
ACSL1	2180	obeticholic acid	C464660		obeticholic acid results in decreased expression of ACSL1 mRNA	decreases^expression	27939613
ACSL1	2180	Oleic Acid	D019301	112-80-1	[Palmitic Acid co-treated with Oleic Acid] affects the expression of ACSL1 mRNA	affects^cotreatment|affects^expression	30547786
ACSL1	2180	Oleic Acid	D019301	112-80-1	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ACSL1 mRNA	affects^cotreatment|affects^expression	30547786
ACSL1	2180	osthol	C046627	484-12-8	osthol results in increased expression of ACSL1 mRNA	increases^expression	19682441
ACSL1	2180	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of ACSL1 mRNA	decreases^expression	25596134
ACSL1	2180	Oxygen	D010100	7782-44-7	Oxygen deficiency results in increased expression of ACSL1 protein	increases^expression	26087400
ACSL1	2180	Palmitic Acid	D019308	57-10-3	[Palmitic Acid co-treated with Oleic Acid] affects the expression of ACSL1 mRNA	affects^cotreatment|affects^expression	30547786
ACSL1	2180	Palmitic Acid	D019308	57-10-3	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ACSL1 mRNA	affects^cotreatment|affects^expression	30547786
ACSL1	2180	Panobinostat	D000077767		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	Panobinostat	D000077767		Panobinostat results in increased expression of ACSL1 mRNA	increases^expression	26272509
ACSL1	2180	Particulate Matter	D052638		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
ACSL1	2180	perfluorodecanoic acid	C036567	335-76-2	perfluorodecanoic acid results in increased expression of ACSL1 mRNA	increases^expression	23567314
ACSL1	2180	perfluorohexanesulfonic acid	C471071	355-46-4	perfluorohexanesulfonic acid results in increased expression of ACSL1 mRNA	increases^expression	23567314
ACSL1	2180	perfluorohexanoic acid	C479228		perfluorohexanoic acid results in increased expression of ACSL1 mRNA	increases^expression	23567314
ACSL1	2180	perfluoro-n-heptanoic acid	C101815	375-85-9	perfluoro-n-heptanoic acid results in increased expression of ACSL1 mRNA	increases^expression	23567314
ACSL1	2180	perfluoro-n-nonanoic acid	C101816	375-95-1	perfluoro-n-nonanoic acid results in increased expression of ACSL1 mRNA	increases^expression	23567314
ACSL1	2180	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of ACSL1 mRNA	increases^expression	23567314|32068100|32588087
ACSL1	2180	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of ACSL1 protein	increases^expression	26879310
ACSL1	2180	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of ACSL1 mRNA	increases^expression	26272509
ACSL1	2180	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACSL1 mRNA	affects^binding|increases^activity|increases^expression	19710929
ACSL1	2180	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
ACSL1	2180	Potassium Dichromate	D011192	7778-50-9	Potassium Dichromate results in decreased expression of ACSL1 mRNA	decreases^expression	17547211
ACSL1	2180	Prednisolone	D011239	50-24-8	Prednisolone results in increased expression of ACSL1 mRNA	increases^expression	17379860
ACSL1	2180	Progesterone	D011374	57-83-0	[Estradiol co-treated with Progesterone] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	20660070
ACSL1	2180	Progesterone	D011374	57-83-0	[Progesterone co-treated with Estradiol] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	17404688
ACSL1	2180	Progesterone	D011374	57-83-0	Progesterone results in increased expression of ACSL1 mRNA	increases^expression	17404688|20864642|21795739
ACSL1	2180	Promegestone	D011397	34184-77-5	methoxyacetic acid promotes the reaction [Promegestone results in increased expression of ACSL1 mRNA]	increases^expression|increases^reaction	15103026
ACSL1	2180	Promegestone	D011397	34184-77-5	Promegestone results in increased expression of ACSL1 mRNA	increases^expression	15103026
ACSL1	2180	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ACSL1 mRNA]	decreases^reaction|increases^expression	28003376
ACSL1	2180	Pyrrolizidine Alkaloids	D011763		Pyrrolizidine Alkaloids results in decreased expression of ACSL1 mRNA	decreases^expression	26100227
ACSL1	2180	Raloxifene Hydrochloride	D020849		[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	19059307
ACSL1	2180	senkirkine	C009238	2318-18-5	senkirkine results in decreased expression of ACSL1 mRNA	decreases^expression	26100227
ACSL1	2180	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of ACSL1 mRNA	increases^expression	21457566
ACSL1	2180	sulforafan	C016766	4478-93-7	sulforafan results in increased expression of ACSL1 mRNA	increases^expression	26833863|31838189
ACSL1	2180	Tamoxifen	D013629	10540-29-1	Tamoxifen affects the expression of ACSL1 mRNA	affects^expression	14699072
ACSL1	2180	Tamoxifen	D013629	10540-29-1	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of ACSL1 mRNA	affects^cotreatment|decreases^expression	19059307
ACSL1	2180	tanshinone	C021751	568-73-0	tanshinone results in increased expression of ACSL1 mRNA	increases^expression	15849732
ACSL1	2180	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ACSL1 gene]	affects^binding|increases^reaction	28681081
ACSL1	2180	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of ACSL1 mRNA	decreases^expression	20106945|21632981|26238291
ACSL1	2180	Tolcapone	D000077867	134308-13-7	Tolcapone results in decreased expression of ACSL1 mRNA	decreases^expression	29688484
ACSL1	2180	Tolcapone	D000077867	134308-13-7	Tolcapone results in decreased expression of ACSL1 protein	decreases^expression	29688484
ACSL1	2180	Toluene	D014050	108-88-3	Toluene results in decreased expression of ACSL1 mRNA	decreases^expression	26717081
ACSL1	2180	Toluene	D014050	108-88-3	Toluene results in increased methylation of ACSL1 gene	increases^methylation	26717081
ACSL1	2180	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of ACSL1 mRNA	increases^expression	21934132
ACSL1	2180	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of ACSL1 mRNA	increases^expression	24935251
ACSL1	2180	Triclosan	D014260	3380-34-5	Triclosan results in decreased expression of ACSL1 mRNA	decreases^expression	30510588
ACSL1	2180	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA	affects^cotreatment|increases^expression	27188386
ACSL1	2180	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of ACSL1 mRNA	affects^expression	25979313
ACSL1	2180	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ACSL1 mRNA	increases^expression	23179753|24383497|24935251|26272509|28001369|29501571
ACSL1	2180	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of ACSL1 mRNA	affects^expression	20044591
ACSL1	2180	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of ACSL1 mRNA	decreases^expression	25596134
ACSL1	2180	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of ACSL1 protein	decreases^expression	28871336
ACSL3	2181	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ACSL3 mRNA	decreases^expression	19150397
ACSL3	2181	Acetaminophen	D000082	103-90-2	Acetaminophen affects the expression of ACSL3 mRNA	affects^expression	25704631
ACSL3	2181	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of ACSL3 mRNA	increases^expression	11793227|22230336
ACSL3	2181	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of ACSL3 intron	increases^methylation	30157460
ACSL3	2181	Air Pollutants	D000393		[[Coal results in increased abundance of Smoke] which results in increased abundance of Air Pollutants] which results in decreased expression of ACSL3 mRNA	decreases^expression|increases^abundance	26468118
ACSL3	2181	Antirheumatic Agents	D018501		Antirheumatic Agents results in increased expression of ACSL3 mRNA	increases^expression	24449571
ACSL3	2181	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ACSL3 mRNA	decreases^expression	19221603|20064835|20106945|21632981
ACSL3	2181	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of ACSL3 3' UTR	decreases^methylation	27901495
ACSL3	2181	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of ACSL3 mRNA	affects^expression	30903817
ACSL3	2181	Caffeine	D002110	58-08-2	Caffeine results in increased expression of ACSL3 mRNA	increases^expression	11793227
ACSL3	2181	Calcitriol	D002117	32222-06-3	Calcitriol results in increased expression of ACSL3 mRNA	increases^expression	21592394
ACSL3	2181	Calcitriol	D002117	32222-06-3	[Testosterone co-treated with Calcitriol] results in increased expression of ACSL3 mRNA	affects^cotreatment|increases^expression	21592394
ACSL3	2181	Capsaicin	D002211	404-86-4	Capsaicin results in decreased expression of ACSL3 mRNA	decreases^expression	18533110
ACSL3	2181	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of ACSL3 mRNA	affects^expression	25979313
ACSL3	2181	Cisplatin	D002945	15663-27-1	ACSL3 protein results in decreased susceptibility to Cisplatin	decreases^response to substance	16734730
ACSL3	2181	Coal	D003031		[[Coal results in increased abundance of Smoke] which results in increased abundance of Air Pollutants] which results in decreased expression of ACSL3 mRNA	decreases^expression|increases^abundance	26468118
ACSL3	2181	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of ACSL3 mRNA	increases^expression	19376846
ACSL3	2181	Colforsin	D005576	138605-00-2	Colforsin results in increased expression of ACSL3 mRNA	increases^expression	16751804
ACSL3	2181	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of ACSL3 mRNA	affects^binding|decreases^expression	20971185
ACSL3	2181	Coumestrol	D003375	479-13-0	Coumestrol results in decreased expression of ACSL3 mRNA	decreases^expression	19167446
ACSL3	2181	cupric oxide	C030973	1317-38-0	cupric oxide results in increased expression of ACSL3 protein	increases^expression	25470785
ACSL3	2181	Cycloheximide	D003513	66-81-9	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] affects the expression of ACSL3 mRNA	affects^cotreatment|affects^expression	19684285
ACSL3	2181	Cyclosporine	D016572	59865-13-3	Cyclosporine affects the expression of ACSL3 mRNA	affects^expression	25562108
ACSL3	2181	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of ACSL3 mRNA	increases^expression	20106945|21632981
ACSL3	2181	daidzein	C004742	486-66-8	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA	affects^cotreatment|decreases^expression	27424125
ACSL3	2181	daidzin	C013908	552-66-9	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA	affects^cotreatment|decreases^expression	27424125
ACSL3	2181	Decitabine	D000077209	2353-33-5	Decitabine results in increased expression of ACSL3 mRNA	increases^expression	19221603
ACSL3	2181	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of ACSL3 mRNA	decreases^expression	28302478
ACSL3	2181	Dihydrotestosterone	D013196	521-18-6	Dihydrotestosterone results in increased expression of ACSL3 mRNA	increases^expression	29581250
ACSL3	2181	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of ACSL3 mRNA	decreases^expression	23649840
ACSL3	2181	Etoposide	D005047	33419-42-0	ACSL3 protein affects the susceptibility to Etoposide	affects^response to substance	16217747
ACSL3	2181	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of ACSL3 mRNA	decreases^expression	23649840
ACSL3	2181	Genistein	D019833	446-72-0	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA	affects^cotreatment|decreases^expression	27424125
ACSL3	2181	Genistein	D019833	446-72-0	Genistein results in increased expression of ACSL3 mRNA	increases^expression	18847459
ACSL3	2181	genistin	C040641	529-59-9	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA	affects^cotreatment|decreases^expression	27424125
ACSL3	2181	glycitein	C086566	40957-83-3	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA	affects^cotreatment|decreases^expression	27424125
ACSL3	2181	glycitin	C433283		[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of ACSL3 mRNA	affects^cotreatment|decreases^expression	27424125
ACSL3	2181	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACSL3 mRNA	affects^cotreatment|decreases^expression	30611723
ACSL3	2181	GW 4064	C412815		GW 4064 results in increased expression of ACSL3 mRNA	increases^expression	30611723
ACSL3	2181	GW 7647	C453899		GW 7647 results in increased expression of ACSL3 mRNA	increases^expression	30611723
ACSL3	2181	Isoflavones	D007529		Isoflavones results in increased expression of ACSL3 mRNA	increases^expression	16365062
ACSL3	2181	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of ACSL3 mRNA	decreases^expression	20436886
ACSL3	2181	Leflunomide	D000077339	75706-12-6	Leflunomide results in increased expression of ACSL3 mRNA	increases^expression	28988120
ACSL3	2181	Lipopolysaccharides	D008070		[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of ACSL3 mRNA	affects^cotreatment|decreases^expression	26667767
ACSL3	2181	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of ACSL3 mRNA	decreases^expression	23649840
ACSL3	2181	methylselenic acid	C008493		methylselenic acid affects the expression of ACSL3 mRNA	affects^expression	14617803
ACSL3	2181	methylselenic acid	C008493		methylselenic acid results in decreased expression of ACSL3 mRNA	decreases^expression	18548127
ACSL3	2181	Metribolone	D015741	965-93-5	Metribolone promotes the reaction [NDRG1 protein binds to ACSL3 protein]	affects^binding|increases^reaction	17220478
ACSL3	2181	Metribolone	D015741	965-93-5	Metribolone results in increased expression of ACSL3 mRNA	increases^expression	16751804|17010675
ACSL3	2181	Mitomycin	D016685	50-07-7	ACSL3 protein affects the susceptibility to Mitomycin	affects^response to substance	16217747
ACSL3	2181	Mitoxantrone	D008942	65271-80-9	ACSL3 protein affects the susceptibility to Mitoxantrone	affects^response to substance	16217747
ACSL3	2181	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of ACSL3 mRNA	affects^binding|decreases^expression	20971185
ACSL3	2181	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACSL3 mRNA	affects^cotreatment|decreases^expression	30611723
ACSL3	2181	Oxyquinoline	D015125	148-24-3	Oxyquinoline results in decreased expression of ACSL3 mRNA	decreases^expression	21632981
ACSL3	2181	Potassium Dichromate	D011192	7778-50-9	Potassium Dichromate results in increased expression of ACSL3 protein	increases^expression	23718831
ACSL3	2181	Resveratrol	D000077185		[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of ACSL3 mRNA	affects^cotreatment|decreases^expression	26667767
ACSL3	2181	senecionine	C009237	130-01-8	senecionine results in decreased expression of ACSL3 mRNA	decreases^expression	26100227
ACSL3	2181	Smoke	D012906		[[Coal results in increased abundance of Smoke] which results in increased abundance of Air Pollutants] which results in decreased expression of ACSL3 mRNA	decreases^expression|increases^abundance	26468118
ACSL3	2181	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of ACSL3 mRNA	decreases^expression	28595984
ACSL3	2181	Sunitinib	D000077210		Sunitinib results in increased expression of ACSL3 mRNA	increases^expression	31533062
ACSL3	2181	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of ACSL3 mRNA	decreases^expression	15336504
ACSL3	2181	Testosterone	D013739	58-22-0	[Testosterone co-treated with Calcitriol] results in increased expression of ACSL3 mRNA	affects^cotreatment|increases^expression	21592394
ACSL3	2181	Testosterone	D013739	58-22-0	Testosterone results in increased expression of ACSL3 mRNA	increases^expression	21592394
ACSL3	2181	Tetrachlorodibenzodioxin	D013749	1746-01-6	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] affects the expression of ACSL3 mRNA	affects^cotreatment|affects^expression	19684285
ACSL3	2181	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of ACSL3 mRNA	decreases^expression	19684285|20106945|21632981
ACSL3	2181	Thioacetamide	D013853	62-55-5	Thioacetamide results in increased expression of ACSL3 mRNA	increases^expression	11793227
ACSL3	2181	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of ACSL3 protein	affects^expression	30291989
ACSL3	2181	Topotecan	D019772	123948-87-8	ACSL3 protein affects the susceptibility to Topotecan	affects^response to substance	16217747
ACSL3	2181	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of ACSL3 mRNA	affects^expression	28542535
ACSL3	2181	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of ACSL3 mRNA	increases^expression	24935251
ACSL3	2181	Urethane	D014520	51-79-6	Urethane results in increased expression of ACSL3 mRNA	increases^expression	28818685
ACSL3	2181	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of ACSL3 mRNA	affects^expression	25979313
ACSL3	2181	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of ACSL3 protein	decreases^expression	29501571
ACSL3	2181	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ACSL3 mRNA	increases^expression	23527032|24935251|28001369|29154799|29501571
ACSL3	2181	Vorinostat	D000077337		Vorinostat results in increased expression of ACSL3 mRNA	increases^expression	22083351
ACSL3	2181	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of ACSL3 protein	decreases^expression	28871336
ACSL4	2182	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	27188386
ACSL4	2182	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of ACSL4 mRNA	decreases^expression	29067470
ACSL4	2182	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of ACSL4 mRNA	decreases^expression	22100608
ACSL4	2182	beauvericin	C004456	26048-05-5	[beauvericin co-treated with enniatins] results in decreased expression of ACSL4 protein	affects^cotreatment|decreases^expression	32407736
ACSL4	2182	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACSL4 5' UTR	affects^methylation	27901495
ACSL4	2182	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACSL4 intron	affects^methylation	30157460
ACSL4	2182	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACSL4 promoter	affects^methylation	27901495
ACSL4	2182	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ACSL4 mRNA	decreases^expression	22316170|32234424
ACSL4	2182	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of ACSL4 exon	increases^methylation	27901495
ACSL4	2182	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in decreased methylation of ACSL4 intron	decreases^methylation	30157460
ACSL4	2182	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of ACSL4 mRNA	affects^expression	30903817
ACSL4	2182	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of ACSL4 mRNA	decreases^expression	29275510
ACSL4	2182	cadmium sulfate	C037123	10124-36-4	[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	18654764
ACSL4	2182	Caffeine	D002110	58-08-2	Caffeine results in decreased expression of ACSL4 protein	decreases^expression	31195006
ACSL4	2182	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of ACSL4 mRNA	affects^cotreatment|decreases^expression	27392435
ACSL4	2182	cobaltous chloride	C018021	7646-79-9	[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	18654764
ACSL4	2182	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of ACSL4 mRNA	decreases^expression	19320972
ACSL4	2182	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of ACSL4 mRNA	decreases^expression	19549813
ACSL4	2182	cupric oxide	C030973	1317-38-0	cupric oxide results in decreased expression of ACSL4 protein	decreases^expression	25470785
ACSL4	2182	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	27188386
ACSL4	2182	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of ACSL4 mRNA	decreases^expression	29803840
ACSL4	2182	Dronabinol	D013759		Dronabinol results in increased expression of ACSL4 mRNA	increases^expression	15454482
ACSL4	2182	enniatins	C100264		[beauvericin co-treated with enniatins] results in decreased expression of ACSL4 protein	affects^cotreatment|decreases^expression	32407736
ACSL4	2182	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ACSL4 protein	decreases^activity|increases^O-linked glycosylation	23301498
ACSL4	2182	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	30165855
ACSL4	2182	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of ACSL4 mRNA	decreases^expression	23649840
ACSL4	2182	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	30611723
ACSL4	2182	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of ACSL4 mRNA	decreases^expression	23649840
ACSL4	2182	gossypol acetic acid	C028178	12542-36-8	gossypol acetic acid results in decreased expression of ACSL4 protein	decreases^expression	29938581
ACSL4	2182	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACSL4 mRNA	affects^cotreatment|decreases^expression	30611723
ACSL4	2182	GW 7647	C453899		[GW 7647 co-treated with Oleic Acid] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	30611723
ACSL4	2182	GW 7647	C453899		GW 7647 results in increased expression of ACSL4 mRNA	increases^expression	30611723
ACSL4	2182	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of ACSL4 mRNA	affects^cotreatment|decreases^expression	27392435
ACSL4	2182	jinfukang	C544151		jinfukang results in decreased expression of ACSL4 mRNA	decreases^expression	27392435
ACSL4	2182	K 7174	C410337		K 7174 results in decreased expression of ACSL4 mRNA	decreases^expression	24086573
ACSL4	2182	Lactic Acid	D019344	50-21-5	Lactic Acid results in increased expression of ACSL4 mRNA	increases^expression	30851411
ACSL4	2182	lead chloride	C029891	7758-95-4	[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	18654764
ACSL4	2182	Methapyrilene	D008701	91-80-5	Methapyrilene results in decreased methylation of ACSL4 intron	decreases^methylation	30157460
ACSL4	2182	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of ACSL4 mRNA	increases^expression	17400583
ACSL4	2182	Methylcholanthrene	D008748	56-49-5	Methylcholanthrene promotes the reaction [AHR protein binds to ACSL4 promoter]	affects^binding|increases^reaction	20348232
ACSL4	2182	methyleugenol	C005223	93-15-2	methyleugenol results in decreased expression of ACSL4 mRNA	decreases^expression	32234424
ACSL4	2182	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of ACSL4 mRNA	decreases^expression	23179753|28001369
ACSL4	2182	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of ACSL4 mRNA	decreases^expression	23649840
ACSL4	2182	Nickel	D009532	7440-02-0	Nickel results in increased expression of ACSL4 mRNA	increases^expression	24768652|25583101
ACSL4	2182	obeticholic acid	C464660		obeticholic acid results in increased expression of ACSL4 mRNA	increases^expression	27939613
ACSL4	2182	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	30611723
ACSL4	2182	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACSL4 mRNA	affects^cotreatment|decreases^expression	30611723
ACSL4	2182	Oleic Acid	D019301	112-80-1	[GW 7647 co-treated with Oleic Acid] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	30611723
ACSL4	2182	Oleic Acid	D019301	112-80-1	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	30547786
ACSL4	2182	Palmitic Acid	D019308	57-10-3	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	30547786
ACSL4	2182	perfluorononanoic acid	C584865		perfluorononanoic acid results in decreased expression of ACSL4 mRNA	decreases^expression	32588087
ACSL4	2182	periodate-oxidized adenosine	C027579	34240-05-6	periodate-oxidized adenosine affects the expression of ACSL4 mRNA	affects^expression	17097637
ACSL4	2182	Plant Extracts	D010936		Plant Extracts results in increased expression of ACSL4 mRNA	increases^expression	23557933
ACSL4	2182	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in increased expression of ACSL4 mRNA	increases^expression	25895662
ACSL4	2182	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of ACSL4 mRNA	decreases^expression	26238291
ACSL4	2182	Thimerosal	D013849	54-64-8	Thimerosal results in increased expression of ACSL4 mRNA	increases^expression	27188386
ACSL4	2182	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL4 mRNA	affects^cotreatment|increases^expression	27188386
ACSL4	2182	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of ACSL4 mRNA	increases^expression	26272509
ACSL4	2182	Triclosan	D014260	3380-34-5	Triclosan affects the expression of ACSL4 mRNA	affects^expression	31714634
ACSL4	2182	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of ACSL4 mRNA	decreases^expression	26179874
ACSL4	2182	Urethane	D014520	51-79-6	Urethane results in decreased expression of ACSL4 mRNA	decreases^expression	28818685
ACSL4	2182	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of ACSL4 mRNA	decreases^expression	29501571
ACSL4	2182	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of ACSL4 gene	decreases^methylation	29501571
ACSL4	2182	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ACSL4 mRNA	increases^expression	23179753
ACSL4	2182	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of ACSL4 gene	increases^methylation	29154799
ACSL4	2182	Vorinostat	D000077337		Vorinostat results in increased expression of ACSL4 mRNA	increases^expression	27188386
ACSL5	51703	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ACSL5 mRNA	increases^expression	19692669
ACSL5	51703	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of ACSL5 mRNA	affects^cotreatment|increases^expression	30611723
ACSL5	51703	abrine	C496492		abrine results in decreased expression of ACSL5 mRNA	decreases^expression	31054353
ACSL5	51703	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of ACSL5 mRNA	decreases^expression	21420995|25704631|29067470
ACSL5	51703	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of ACSL5 mRNA	increases^expression	26690555
ACSL5	51703	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of ACSL5 protein	affects^expression	20106945
ACSL5	51703	afuresertib	C000593263		afuresertib results in increased expression of ACSL5 mRNA	increases^expression	28960945
ACSL5	51703	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of ACSL5 mRNA	decreases^expression	24449571
ACSL5	51703	Azathioprine	D001379	446-86-6	Azathioprine results in increased expression of ACSL5 mRNA	increases^expression	22623647
ACSL5	51703	belinostat	C487081		belinostat results in decreased expression of ACSL5 mRNA	decreases^expression	27188386
ACSL5	51703	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the expression of ACSL5 mRNA	affects^expression	20106945
ACSL5	51703	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACSL5 5' UTR	affects^methylation	27901495
ACSL5	51703	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACSL5 promoter	affects^methylation	27901495
ACSL5	51703	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ACSL5 mRNA	decreases^expression	22316170|32234424
ACSL5	51703	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	bis(4-hydroxyphenyl)sulfone results in increased expression of ACSL5 mRNA	increases^expression	27685785
ACSL5	51703	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of ACSL5 mRNA	increases^expression	19549813
ACSL5	51703	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ACSL5 mRNA	decreases^expression	20106945
ACSL5	51703	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of ACSL5 mRNA	increases^expression	25562108|27989131
ACSL5	51703	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of ACSL5 mRNA	increases^expression	25047013
ACSL5	51703	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of ACSL5 mRNA	decreases^expression	29803840
ACSL5	51703	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ACSL5 mRNA	affects^cotreatment|decreases^expression	30165855
ACSL5	51703	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of ACSL5 mRNA	decreases^expression	20106945
ACSL5	51703	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACSL5 mRNA	affects^cotreatment|increases^expression	30611723
ACSL5	51703	GW 4064	C412815		GW 4064 results in increased expression of ACSL5 mRNA	increases^expression	30611723
ACSL5	51703	GW 7647	C453899		[GW 7647 co-treated with Oleic Acid] results in increased expression of ACSL5 mRNA	affects^cotreatment|increases^expression	30611723
ACSL5	51703	GW 7647	C453899		GW 7647 results in increased expression of ACSL5 mRNA	increases^expression	30611723|31628012
ACSL5	51703	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of ACSL5 mRNA	decreases^expression	20436886
ACSL5	51703	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of ACSL5 mRNA	decreases^expression	21889194|22904298|23086925|24796395|26752646
ACSL5	51703	methyleugenol	C005223	93-15-2	methyleugenol results in decreased expression of ACSL5 mRNA	decreases^expression	32234424
ACSL5	51703	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of ACSL5 mRNA	increases^expression	28001369
ACSL5	51703	nickel sulfate	C029938	7786-81-4	nickel sulfate results in decreased expression of ACSL5 mRNA	decreases^expression	22714537
ACSL5	51703	obeticholic acid	C464660		obeticholic acid results in increased expression of ACSL5 mRNA	increases^expression	27939613
ACSL5	51703	Oleic Acid	D019301	112-80-1	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of ACSL5 mRNA	affects^cotreatment|increases^expression	30611723
ACSL5	51703	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of ACSL5 mRNA	affects^cotreatment|increases^expression	30611723
ACSL5	51703	Oleic Acid	D019301	112-80-1	[GW 7647 co-treated with Oleic Acid] results in increased expression of ACSL5 mRNA	affects^cotreatment|increases^expression	30611723
ACSL5	51703	Petroleum	D010578		ACSL5 gene SNP affects the susceptibility to Petroleum	affects^response to substance	22919386
ACSL5	51703	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACSL5 mRNA	affects^binding|increases^activity|increases^expression	19710929
ACSL5	51703	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of ACSL5 mRNA	decreases^expression	22714537
ACSL5	51703	Quercetin	D011794	117-39-5	Quercetin results in increased expression of ACSL5 mRNA	increases^expression	21632981
ACSL5	51703	Smoke	D012906		Smoke results in decreased expression of ACSL5 mRNA	decreases^expression	21095227
ACSL5	51703	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of ACSL5 mRNA	affects^expression	22298810
ACSL5	51703	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of ACSL5 mRNA	decreases^expression	20106945|21632981
ACSL5	51703	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of ACSL5 mRNA	increases^expression	19692669
ACSL5	51703	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of ACSL5 mRNA	decreases^expression	28065790|30291989
ACSL5	51703	Tolcapone	D000077867	134308-13-7	Tolcapone results in decreased expression of ACSL5 protein	decreases^expression	29688484
ACSL5	51703	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of ACSL5 mRNA	decreases^expression	29501571
ACSL5	51703	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ACSL5 mRNA	increases^expression	28001369
ACSL5	51703	Zoledronic Acid	D000077211		Zoledronic Acid results in increased expression of ACSL5 mRNA	increases^expression	24714768
ACSL6	23305	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of ACSL6 mRNA	increases^expression	26690555
ACSL6	23305	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of ACSL6 mRNA	decreases^expression	21641981
ACSL6	23305	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of ACSL6 promoter	affects^methylation	27901495
ACSL6	23305	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of ACSL6 mRNA	increases^expression	22316170
ACSL6	23305	butylparaben	C038091	94-26-8	butylparaben results in increased expression of ACSL6 mRNA	increases^expression	17121429
ACSL6	23305	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of ACSL6 mRNA	decreases^expression	19549813
ACSL6	23305	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ACSL6 mRNA	decreases^expression	27989131
ACSL6	23305	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of ACSL6 mRNA	increases^expression	28302478
ACSL6	23305	Methamphetamine	D008694	537-46-2	ACSL6 gene SNP affects the susceptibility to Methamphetamine	affects^response to substance	18316681
ACSL6	23305	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of ACSL6 mRNA	increases^expression	17400583
ACSL6	23305	methylparaben	C015358	99-76-3	methylparaben results in increased expression of ACSL6 mRNA	increases^expression	17121429
ACSL6	23305	obeticholic acid	C464660		obeticholic acid results in increased expression of ACSL6 mRNA	increases^expression	27939613
ACSL6	23305	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of ACSL6 mRNA	decreases^expression	21632981
ACSL6	23305	quinocetone	C502851		quinocetone results in increased expression of ACSL6 mRNA	increases^expression	27046791
ACSL6	23305	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of ACSL6 mRNA	increases^expression	11489354|20106945|21632981
ACSL6	23305	tris(2-butoxyethyl) phosphate	C013320	78-51-3	tris(2-butoxyethyl) phosphate affects the expression of ACSL6 mRNA	affects^expression	29024780
ACSL6	23305	Urethane	D014520	51-79-6	Urethane results in decreased expression of ACSL6 mRNA	decreases^expression	28818685
ACSL6	23305	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ACSL6 mRNA	increases^expression	27188386|29154799
ACSL6	23305	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of ACSL6 gene	increases^methylation	29501571
AGPAT1	10554	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AGPAT1 mRNA	affects^cotreatment|increases^expression	28628672
AGPAT1	10554	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone	C016583	64091-91-4	[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of AGPAT1 mRNA	affects^cotreatment|increases^expression	20146248
AGPAT1	10554	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of AGPAT1 mRNA	increases^expression	30611723
AGPAT1	10554	Antirheumatic Agents	D018501		Antirheumatic Agents results in increased expression of AGPAT1 mRNA	increases^expression	24449571
AGPAT1	10554	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of AGPAT1 gene	affects^methylation	25304211
AGPAT1	10554	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of AGPAT1 3' UTR	affects^methylation	27901495
AGPAT1	10554	Benzo(a)pyrene	D001564	50-32-8	[Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of AGPAT1 mRNA	affects^cotreatment|increases^expression	20146248
AGPAT1	10554	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of AGPAT1 mRNA	decreases^expression	20106945|32234424
AGPAT1	10554	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of AGPAT1 mRNA	affects^expression	30903817
AGPAT1	10554	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AGPAT1 mRNA	affects^cotreatment|increases^expression	28628672
AGPAT1	10554	cadmium acetate	C028031	543-90-8	cadmium acetate results in increased expression of AGPAT1 mRNA	increases^expression	12965115
AGPAT1	10554	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of AGPAT1 mRNA	decreases^expression	19376846
AGPAT1	10554	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of AGPAT1 mRNA	decreases^expression	20106945|25562108
AGPAT1	10554	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AGPAT1 mRNA	affects^cotreatment|increases^expression	28628672
AGPAT1	10554	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of AGPAT1 mRNA	increases^expression	28302478
AGPAT1	10554	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in decreased expression of AGPAT1 mRNA	affects^cotreatment|decreases^expression	30611723
AGPAT1	10554	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of AGPAT1 mRNA	affects^cotreatment|decreases^expression	30611723
AGPAT1	10554	GW 4064	C412815		GW 4064 results in increased expression of AGPAT1 mRNA	increases^expression	30611723
AGPAT1	10554	GW 7647	C453899		GW 7647 results in increased expression of AGPAT1 mRNA	increases^expression	30611723
AGPAT1	10554	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AGPAT1 mRNA	affects^cotreatment|increases^expression	28628672
AGPAT1	10554	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in decreased expression of AGPAT1 mRNA	affects^cotreatment|decreases^expression	30611723
AGPAT1	10554	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of AGPAT1 mRNA	affects^cotreatment|decreases^expression	30611723
AGPAT1	10554	perfluorononanoic acid	C584865		perfluorononanoic acid results in decreased expression of AGPAT1 mRNA	decreases^expression	32588087
AGPAT1	10554	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of AGPAT1 mRNA	affects^expression	19159669
AGPAT1	10554	Plant Extracts	D010936		Plant Extracts results in decreased expression of AGPAT1 mRNA	decreases^expression	23557933
AGPAT1	10554	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of AGPAT1 mRNA	decreases^expression	23152189
AGPAT1	10554	Thimerosal	D013849	54-64-8	Thimerosal results in decreased expression of AGPAT1 mRNA	decreases^expression	27188386
AGPAT1	10554	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of AGPAT1 mRNA	decreases^expression	26179874
AGPAT3	56894	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	affects^cotreatment|increases^expression	27188386
AGPAT3	56894	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	affects^cotreatment|increases^expression	27188386
AGPAT3	56894	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AGPAT3 mRNA	decreases^expression	20018196
AGPAT3	56894	abrine	C496492		abrine results in decreased expression of AGPAT3 mRNA	decreases^expression	31054353
AGPAT3	56894	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of AGPAT3 mRNA	decreases^expression	21420995
AGPAT3	56894	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of AGPAT3 gene	decreases^methylation	27153756
AGPAT3	56894	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of AGPAT3 gene	increases^methylation	28458013
AGPAT3	56894	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in decreased methylation of AGPAT3 intron	decreases^methylation	30157460
AGPAT3	56894	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of AGPAT3 mRNA	decreases^expression	24449571
AGPAT3	56894	Arbutin	D001104	497-76-7	Arbutin results in decreased expression of AGPAT3 mRNA	decreases^expression	17103032
AGPAT3	56894	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of AGPAT3 gene	affects^methylation	25304211
AGPAT3	56894	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of AGPAT3 mRNA	increases^expression	22378314
AGPAT3	56894	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of AGPAT3 mRNA	decreases^expression	26238291|32234424
AGPAT3	56894	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of AGPAT3 5' UTR	increases^methylation	27901495
AGPAT3	56894	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of AGPAT3 promoter	increases^methylation	27901495
AGPAT3	56894	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of AGPAT3 mRNA	increases^expression	17553155
AGPAT3	56894	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of AGPAT3 mRNA	decreases^expression	19549813
AGPAT3	56894	Coumestrol	D003375	479-13-0	Coumestrol results in decreased expression of AGPAT3 mRNA	decreases^expression	19167446
AGPAT3	56894	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of AGPAT3 mRNA	decreases^expression	20106945|25562108
AGPAT3	56894	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased methylation of AGPAT3 promoter	decreases^methylation	27989131
AGPAT3	56894	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	affects^cotreatment|increases^expression	27188386
AGPAT3	56894	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	affects^cotreatment|increases^expression	27188386
AGPAT3	56894	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of AGPAT3 mRNA	decreases^expression	29803840
AGPAT3	56894	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of AGPAT3 mRNA	decreases^expression	23649840
AGPAT3	56894	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of AGPAT3 mRNA	decreases^expression	23649840|27905399
AGPAT3	56894	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of AGPAT3 mRNA	decreases^expression	20436886
AGPAT3	56894	Lactic Acid	D019344	50-21-5	Lactic Acid results in increased expression of AGPAT3 mRNA	increases^expression	30851411
AGPAT3	56894	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of AGPAT3 mRNA	increases^expression	17400583
AGPAT3	56894	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of AGPAT3 mRNA	decreases^expression	23649840
AGPAT3	56894	Nickel	D009532	7440-02-0	Nickel results in decreased expression of AGPAT3 mRNA	decreases^expression	25583101
AGPAT3	56894	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	affects^cotreatment|increases^expression	27188386
AGPAT3	56894	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of AGPAT3 mRNA	increases^expression	26272509
AGPAT3	56894	Plant Extracts	D010936		Plant Extracts results in increased expression of AGPAT3 mRNA	increases^expression	23557933
AGPAT3	56894	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of AGPAT3 mRNA	decreases^expression	23152189
AGPAT3	56894	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of AGPAT3 mRNA	increases^expression	20106945|21632981
AGPAT3	56894	torcetrapib	C483909		torcetrapib results in increased expression of AGPAT3 mRNA	increases^expression	23228038
AGPAT3	56894	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of AGPAT3 mRNA	increases^expression	21934132
AGPAT3	56894	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	affects^cotreatment|increases^expression	27188386
AGPAT3	56894	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of AGPAT3 mRNA	increases^expression	24935251|26272509
AGPAT3	56894	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of AGPAT3 mRNA	increases^expression	23179753|27188386
AGPAT3	56894	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of AGPAT3 gene	increases^methylation	29154799
AGPAT3	56894	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of AGPAT3 mRNA	affects^expression	20044591
AGPAT4	56895	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AGPAT4 mRNA	decreases^expression	20382639
AGPAT4	56895	Am 580	C068073	102121-60-8	Am 580 results in increased expression of AGPAT4 mRNA	increases^expression	16982809
AGPAT4	56895	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of AGPAT4 mRNA	increases^expression	21461292
AGPAT4	56895	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of AGPAT4 5' UTR	affects^methylation	27901495
AGPAT4	56895	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of AGPAT4 mRNA	decreases^expression	20064835
AGPAT4	56895	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of AGPAT4 promoter	decreases^methylation	27901495
AGPAT4	56895	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of AGPAT4 mRNA	affects^expression	21179406
AGPAT4	56895	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of AGPAT4 mRNA	decreases^expression	25047013
AGPAT4	56895	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of AGPAT4 mRNA	affects^cotreatment|decreases^expression	27392435
AGPAT4	56895	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of AGPAT4 mRNA	increases^expression	19549813
AGPAT4	56895	Dexamethasone	D003907	50-02-2	Dexamethasone results in decreased expression of AGPAT4 mRNA	decreases^expression	25047013
AGPAT4	56895	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in decreased expression of AGPAT4 mRNA	decreases^expression	31163220
AGPAT4	56895	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of AGPAT4 mRNA	decreases^expression	29803840
AGPAT4	56895	Estradiol	D004958	50-28-2	[Progesterone co-treated with Estradiol] results in decreased expression of AGPAT4 mRNA	affects^cotreatment|decreases^expression	17404688
AGPAT4	56895	GSK-J4	C000593030		GSK-J4 results in increased expression of AGPAT4 mRNA	increases^expression	29301935
AGPAT4	56895	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of AGPAT4 mRNA	affects^cotreatment|decreases^expression	27392435
AGPAT4	56895	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of AGPAT4 mRNA	decreases^expression	30851411
AGPAT4	56895	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of AGPAT4 mRNA	decreases^expression	28001369
AGPAT4	56895	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of AGPAT4 mRNA	decreases^expression	22714537
AGPAT4	56895	Progesterone	D011374	57-83-0	[Progesterone co-treated with Estradiol] results in decreased expression of AGPAT4 mRNA	affects^cotreatment|decreases^expression	17404688
AGPAT4	56895	Rosiglitazone	D000077154		Rosiglitazone results in increased expression of AGPAT4 mRNA	increases^expression	16982809
AGPAT4	56895	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in decreased expression of AGPAT4 mRNA	decreases^expression	25895662
AGPAT4	56895	sodium arsenite	C017947	13768-07-5	sodium arsenite affects the methylation of AGPAT4 gene	affects^methylation	28589171
AGPAT4	56895	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of AGPAT4 mRNA	decreases^expression	28065790
AGPAT4	56895	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of AGPAT4 mRNA	affects^expression	25979313
AGPAT4	56895	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of AGPAT4 mRNA	decreases^expression	23179753|28001369
AGPAT4	56895	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of AGPAT4 mRNA	increases^expression	29154799
AGPAT5	55326	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of AGPAT5 mRNA	affects^expression	20382639
AGPAT5	55326	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AGPAT5 mRNA	decreases^expression	19150397
AGPAT5	55326	abrine	C496492		abrine results in decreased expression of AGPAT5 mRNA	decreases^expression	31054353
AGPAT5	55326	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of AGPAT5 mRNA	decreases^expression	25704631
AGPAT5	55326	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of AGPAT5 mRNA	increases^expression	29067470
AGPAT5	55326	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational affects the expression of AGPAT5 mRNA	affects^expression	27809917
AGPAT5	55326	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased expression of AGPAT5 mRNA	decreases^expression	26705709
AGPAT5	55326	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of AGPAT5 mRNA	decreases^expression	20678512
AGPAT5	55326	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of AGPAT5 mRNA	decreases^expression	19549813
AGPAT5	55326	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of AGPAT5 mRNA	increases^expression	20106945|25562108|27989131
AGPAT5	55326	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of AGPAT5 mRNA	decreases^expression	28302478
AGPAT5	55326	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of AGPAT5 mRNA	decreases^expression	20655997
AGPAT5	55326	Lead	D007854	7439-92-1	Lead affects the splicing of AGPAT5 mRNA	affects^splicing	28903495
AGPAT5	55326	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of AGPAT5 mRNA	decreases^expression	28988120
AGPAT5	55326	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of AGPAT5 mRNA	decreases^expression	23649840
AGPAT5	55326	methylparaben	C015358	99-76-3	methylparaben results in increased expression of AGPAT5 mRNA	increases^expression	31745603
AGPAT5	55326	Mitoxantrone	D008942	65271-80-9	AGPAT5 protein affects the susceptibility to Mitoxantrone	affects^response to substance	16217747
AGPAT5	55326	Nickel	D009532	7440-02-0	Nickel results in increased expression of AGPAT5 mRNA	increases^expression	25583101
AGPAT5	55326	obeticholic acid	C464660		obeticholic acid results in decreased expression of AGPAT5 mRNA	decreases^expression	27939613
AGPAT5	55326	Oleic Acid	D019301	112-80-1	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of AGPAT5 mRNA	affects^cotreatment|affects^expression	30547786
AGPAT5	55326	Palmitic Acid	D019308	57-10-3	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of AGPAT5 mRNA	affects^cotreatment|affects^expression	30547786
AGPAT5	55326	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of AGPAT5 mRNA	decreases^expression	23152189
AGPAT5	55326	Urethane	D014520	51-79-6	Urethane results in decreased expression of AGPAT5 mRNA	decreases^expression	28818685
AGPAT5	55326	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of AGPAT5 mRNA	affects^expression	25979313
AGPAT5	55326	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of AGPAT5 mRNA	decreases^expression	23179753
AGPAT5	55326	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of AGPAT5 gene	decreases^methylation	29154799
AGPAT5	55326	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of AGPAT5 mRNA	increases^expression	28001369|29154799
AGPAT5	55326	Zoledronic Acid	D000077211		Zoledronic Acid results in increased expression of AGPAT5 mRNA	increases^expression	24714768
AHCTF1	25909	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AHCTF1 mRNA	decreases^expression	19150397|26238291
AHCTF1	25909	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of AHCTF1 mRNA	increases^expression	21420995
AHCTF1	25909	Arsenic	D001151	7440-38-2	Arsenic affects the expression of AHCTF1 mRNA	affects^expression	18414638
AHCTF1	25909	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in decreased expression of AHCTF1 mRNA	decreases^expression	29523930
AHCTF1	25909	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of AHCTF1 mRNA	decreases^expression	22378314
AHCTF1	25909	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased mutagenesis of AHCTF1 gene	increases^mutagenesis	25435355
AHCTF1	25909	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of AHCTF1 mRNA	decreases^expression	20678512
AHCTF1	25909	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of AHCTF1 mRNA	affects^binding|decreases^expression	20971185
AHCTF1	25909	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of AHCTF1 mRNA	increases^expression	19549813
AHCTF1	25909	Cyclosporine	D016572	59865-13-3	Cyclosporine affects the expression of AHCTF1 mRNA	affects^expression	25562108
AHCTF1	25909	Endosulfan	D004726	115-29-7	Endosulfan results in decreased expression of AHCTF1 mRNA	decreases^expression	28108160
AHCTF1	25909	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of AHCTF1 mRNA	decreases^expression	20655997
AHCTF1	25909	geraniol	C007836	624-15-7	geraniol results in decreased expression of AHCTF1 mRNA	decreases^expression	27683099
AHCTF1	25909	Hydrogen Peroxide	D006861	7722-84-1	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of AHCTF1 protein	affects^cotreatment|increases^expression	18951874
AHCTF1	25909	ICG 001	C492448		ICG 001 results in increased expression of AHCTF1 mRNA	increases^expression	26191083
AHCTF1	25909	jinfukang	C544151		jinfukang results in decreased expression of AHCTF1 mRNA	decreases^expression	27392435
AHCTF1	25909	Levonorgestrel	D016912	797-63-7	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of AHCTF1 mRNA	affects^cotreatment|increases^expression	19074003
AHCTF1	25909	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of AHCTF1 mRNA	affects^binding|decreases^expression	20971185
AHCTF1	25909	Plant Extracts	D010936		Plant Extracts results in increased expression of AHCTF1 mRNA	increases^expression	23557933
AHCTF1	25909	Sunitinib	D000077210		Sunitinib results in increased expression of AHCTF1 mRNA	increases^expression	31533062
AHCTF1	25909	testosterone undecanoate	C010792		[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of AHCTF1 mRNA	affects^cotreatment|increases^expression	19074003
AHCTF1	25909	Theophylline	D013806	58-55-9	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of AHCTF1 protein	affects^cotreatment|increases^expression	18951874
AHCTF1	25909	torcetrapib	C483909		torcetrapib results in increased expression of AHCTF1 mRNA	increases^expression	23228038
AHCTF1	25909	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of AHCTF1 mRNA	decreases^expression	23179753|27188386
AHCTF1	25909	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of AHCTF1 mRNA	increases^expression	29154799
AHCTF1	25909	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of AHCTF1 gene	increases^methylation	29154799
APIP	51074	abrine	C496492		abrine results in decreased expression of APIP mRNA	decreases^expression	31054353
APIP	51074	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of APIP mRNA	increases^expression	22378314
APIP	51074	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of APIP mRNA	decreases^expression	19376846
APIP	51074	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of APIP mRNA	decreases^expression	28302478
APIP	51074	Dihydrotestosterone	D013196	521-18-6	Dihydrotestosterone results in increased expression of APIP mRNA	increases^expression	29581250
APIP	51074	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of APIP protein	decreases^activity|increases^O-linked glycosylation	23301498
APIP	51074	Ethanol	D000431	64-17-5	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of APIP mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
APIP	51074	Gasoline	D005742		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of APIP mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
APIP	51074	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of APIP mRNA	affects^expression	21179406
APIP	51074	ICG 001	C492448		ICG 001 results in decreased expression of APIP mRNA	decreases^expression	26191083
APIP	51074	Particulate Matter	D052638		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of APIP mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
APIP	51074	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of APIP mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
APIP	51074	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of APIP mRNA	decreases^expression	29301061
APIP	51074	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of APIP mRNA	decreases^expression	23179753|25192806
APIP	51074	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of APIP gene	decreases^methylation	29154799
CARS1	833	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CARS1 mRNA	affects^cotreatment|decreases^expression	28628672
CARS1	833	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CARS1 mRNA	affects^cotreatment|decreases^expression	28628672
CARS1	833	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of CARS1 mRNA	increases^expression	24810058
CARS1	833	2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine	C532162		[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased expression of CARS1 mRNA	decreases^expression|increases^response to substance	20453058
CARS1	833	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of CARS1 mRNA	increases^expression	19095052
CARS1	833	4,4'-hexafluorisopropylidene diphenol	C583074		4,4'-hexafluorisopropylidene diphenol results in decreased expression of CARS1 mRNA	decreases^expression	25912373
CARS1	833	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	27188386
CARS1	833	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	27188386
CARS1	833	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	27188386
CARS1	833	(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	C517041		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of CARS1 mRNA	increases^expression	19561079
CARS1	833	4-aminophenylarsenoxide	C032642	1122-90-3	4-aminophenylarsenoxide binds to CARS1 protein	affects^binding	26598702
CARS1	833	4-aminophenylarsenoxide	C032642	1122-90-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CARS1 protein]	affects^binding|decreases^reaction	26598702
CARS1	833	4-phenylbutyric acid	C075773	1821-12-1	4-phenylbutyric acid results in decreased expression of CARS1 mRNA	decreases^expression	14583596
CARS1	833	4-phenylbutyric acid	C075773	1821-12-1	4-phenylbutyric acid results in increased expression of CARS1 mRNA	increases^expression	14583596
CARS1	833	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CARS1 mRNA	decreases^expression	19150397|20018196
CARS1	833	8-Bromo Cyclic Adenosine Monophosphate	D015124	23583-48-4	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CARS1 mRNA	increases^expression	22079614
CARS1	833	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in decreased methylation of CARS1 intron	decreases^methylation	30157460
CARS1	833	AM 251	C103505		AM 251 results in increased expression of CARS1 mRNA	increases^expression	16500647
CARS1	833	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CARS1 protein]	affects^binding|decreases^reaction	26598702
CARS1	833	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased expression of CARS1 mRNA	decreases^expression	12852829
CARS1	833	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of CARS1 mRNA	increases^expression	24356939
CARS1	833	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene metabolite results in decreased expression of CARS1 mRNA	decreases^expression	24356939
CARS1	833	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in decreased methylation of CARS1 intron	decreases^methylation	30157460
CARS1	833	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of CARS1 mRNA	affects^expression	20170705
CARS1	833	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of CARS1 mRNA	decreases^expression	20678512
CARS1	833	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of CARS1 mRNA	increases^expression	19371625|29275510
CARS1	833	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CARS1 mRNA	affects^cotreatment|decreases^expression	28628672
CARS1	833	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CARS1 mRNA	affects^cotreatment|decreases^expression	28628672
CARS1	833	C646 compound	C584509		C646 compound results in increased expression of CARS1 mRNA	increases^expression	26191083
CARS1	833	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of CARS1 mRNA	increases^expression	25596134
CARS1	833	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of CARS1 mRNA	affects^expression	25979313
CARS1	833	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde results in decreased expression of CARS1 mRNA	decreases^expression	25596134
CARS1	833	Cidofovir	D000077404	113852-37-2	Cidofovir results in decreased expression of CARS1 mRNA	decreases^expression	25596134
CARS1	833	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of CARS1 mRNA	decreases^expression	25596134
CARS1	833	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of CARS1 mRNA	increases^expression	27594783
CARS1	833	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in decreased expression of CARS1 mRNA	decreases^expression	25596134
CARS1	833	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of CARS1 mRNA	increases^expression	19549813
CARS1	833	Cyclophosphamide	D003520	50-18-0	Cyclophosphamide metabolite results in decreased expression of CARS1 mRNA	decreases^expression	24356939
CARS1	833	Cyclosporine	D016572	59865-13-3	Cyclosporine affects the expression of CARS1 mRNA	affects^expression	25224403
CARS1	833	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of CARS1 mRNA	increases^expression	20106945|21632981|25562108|25596134
CARS1	833	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CARS1 mRNA	affects^cotreatment|decreases^expression	28628672
CARS1	833	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CARS1 mRNA	affects^cotreatment|decreases^expression	28628672
CARS1	833	dorsomorphin	C516138		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	27188386
CARS1	833	dorsomorphin	C516138		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	27188386
CARS1	833	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	27188386
CARS1	833	entinostat	C118739		entinostat results in decreased expression of CARS1 mRNA	decreases^expression	27188386
CARS1	833	entinostat	C118739		entinostat results in increased expression of CARS1 mRNA	increases^expression	26272509
CARS1	833	entinostat	C118739		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	27188386
CARS1	833	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
CARS1	833	Ethinyl Estradiol	D004997	57-63-6	Ethinyl Estradiol affects the expression of CARS1 mRNA	affects^expression	20170705|26865667
CARS1	833	Genistein	D019833	446-72-0	Genistein affects the expression of CARS1 mRNA	affects^expression	26865667
CARS1	833	Genistein	D019833	446-72-0	Genistein results in increased expression of CARS1 mRNA	increases^expression	19371625
CARS1	833	Hexachlorocyclohexane	D001556		Hexachlorocyclohexane results in increased expression of CARS1 mRNA	increases^expression	24356939
CARS1	833	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of CARS1 mRNA	affects^expression	21179406
CARS1	833	ICG 001	C492448		ICG 001 results in increased expression of CARS1 mRNA	increases^expression	26191083
CARS1	833	Ifosfamide	D007069	3778-73-2	Ifosfamide results in decreased expression of CARS1 mRNA	decreases^expression	25596134
CARS1	833	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CARS1 mRNA	affects^cotreatment|decreases^expression	28628672
CARS1	833	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CARS1 mRNA	affects^cotreatment|decreases^expression	28628672
CARS1	833	K 7174	C410337		K 7174 results in increased expression of CARS1 mRNA	increases^expression	24086573
CARS1	833	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of CARS1 mRNA	decreases^expression	30851411
CARS1	833	Lamivudine	D019259	134678-17-4	[Zidovudine co-treated with Lamivudine] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	15784690
CARS1	833	mercuric bromide	C042720	7789-47-1	mercuric bromide results in increased expression of CARS1 mRNA	increases^expression	26272509
CARS1	833	mercuric bromide	C042720	7789-47-1	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	27188386
CARS1	833	Methapyrilene	D008701	91-80-5	Methapyrilene results in decreased methylation of CARS1 intron	decreases^methylation	30157460
CARS1	833	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of CARS1 mRNA	decreases^expression	24449571
CARS1	833	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of CARS1 mRNA	increases^expression	28001369
CARS1	833	nickel chloride	C022838	7718-54-9	nickel chloride results in increased expression of CARS1 mRNA	increases^expression	17312168
CARS1	833	o,p'-DDT	C016340	789-02-6	o,p'-DDT results in increased expression of CARS1 mRNA	increases^expression	19371625
CARS1	833	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of CARS1 mRNA	decreases^expression	25596134
CARS1	833	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	27188386
CARS1	833	p-Chloromercuribenzoic Acid	D020245	59-85-8	p-Chloromercuribenzoic Acid results in increased expression of CARS1 mRNA	increases^expression	26272509
CARS1	833	PCI 5002	C568608		[PCI 5002 co-treated with Zinc] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	18593933
CARS1	833	perfluorononanoic acid	C584865		perfluorononanoic acid results in increased expression of CARS1 mRNA	increases^expression	32588087
CARS1	833	potassium bromate	C019536	02/01/7758	potassium bromate results in decreased expression of CARS1 mRNA	decreases^expression	30559759
CARS1	833	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in increased expression of CARS1 mRNA	increases^expression	22714537
CARS1	833	Silver	D012834	7440-22-4	Silver results in increased expression of CARS1 mRNA	increases^expression	26014281
CARS1	833	sulforafan	C016766	4478-93-7	sulforafan results in increased expression of CARS1 mRNA	increases^expression	31838189
CARS1	833	Sunitinib	D000077210		Sunitinib results in increased expression of CARS1 mRNA	increases^expression	31533062
CARS1	833	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of CARS1 protein	affects^expression	30291989
CARS1	833	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of CARS1 mRNA	decreases^expression	24935251
CARS1	833	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of CARS1 mRNA	increases^expression	26179874
CARS1	833	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of CARS1 mRNA	increases^expression	22378314|29453283
CARS1	833	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of CARS1 mRNA	affects^expression	25979313
CARS1	833	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of CARS1 mRNA	decreases^expression	24935251
CARS1	833	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of CARS1 protein	decreases^expression	29501571
CARS1	833	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of CARS1 mRNA	increases^expression	28001369|29501571
CARS1	833	Zearalenone	D015025	17924-92-4	Zearalenone results in increased expression of CARS1 mRNA	increases^expression	19371625
CARS1	833	Zidovudine	D015215	30516-87-1	[Zidovudine co-treated with Lamivudine] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	15784690
CARS1	833	Zinc	D015032	7440-66-6	[PCI 5002 co-treated with Zinc] results in increased expression of CARS1 mRNA	affects^cotreatment|increases^expression	18593933
CARS1	833	Zoledronic Acid	D000077211		Zoledronic Acid results in increased expression of CARS1 mRNA	increases^expression	20977926
CDS1	1040	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of CDS1 mRNA	increases^expression	24810058
CDS1	1040	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA	affects^cotreatment|decreases^expression	19167446
CDS1	1040	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	abrine	C496492		abrine results in decreased expression of CDS1 mRNA	decreases^expression	31054353
CDS1	1040	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of CDS1 mRNA	increases^expression	29633893
CDS1	1040	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of CDS1 promoter	decreases^methylation	27901495
CDS1	1040	butyraldehyde	C018475	123-72-8	butyraldehyde results in increased expression of CDS1 mRNA	increases^expression	26079696
CDS1	1040	Calcitriol	D002117	32222-06-3	Calcitriol results in increased expression of CDS1 mRNA	increases^expression	16002434|26485663
CDS1	1040	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA	affects^cotreatment|decreases^expression	19167446
CDS1	1040	Coumestrol	D003375	479-13-0	Coumestrol results in decreased expression of CDS1 mRNA	decreases^expression	19167446
CDS1	1040	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of CDS1 mRNA	decreases^expression	27989131
CDS1	1040	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of CDS1 mRNA	decreases^expression	28302478
CDS1	1040	dorsomorphin	C516138		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	Doxorubicin	D004317	23214-92-8	Doxorubicin affects the expression of CDS1 mRNA	affects^expression	25529476
CDS1	1040	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of CDS1 mRNA	decreases^expression	29803840
CDS1	1040	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of CDS1 mRNA	decreases^expression	19167446
CDS1	1040	ICG 001	C492448		ICG 001 results in increased expression of CDS1 mRNA	increases^expression	26191083
CDS1	1040	Lead	D007854	7439-92-1	Lead affects the expression of CDS1 mRNA	affects^expression	28903495
CDS1	1040	mercuric bromide	C042720	7789-47-1	mercuric bromide results in increased expression of CDS1 mRNA	increases^expression	26272509
CDS1	1040	mercuric bromide	C042720	7789-47-1	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of CDS1 mRNA	increases^expression	24449571
CDS1	1040	Nicotine	D009538		Nicotine results in increased splicing of CDS1 mRNA alternative form	increases^splicing	23825647
CDS1	1040	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of CDS1 mRNA	increases^expression	26272509
CDS1	1040	propionaldehyde	C005556	123-38-6	propionaldehyde results in increased expression of CDS1 mRNA	increases^expression	26079696
CDS1	1040	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of CDS1 mRNA	decreases^expression	21632981
CDS1	1040	Selenium	D012643	7782-49-2	Selenium results in decreased expression of CDS1 mRNA	decreases^expression	19244175
CDS1	1040	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in decreased expression of CDS1 mRNA	decreases^expression	25895662
CDS1	1040	Sunitinib	D000077210		Sunitinib results in increased expression of CDS1 mRNA	increases^expression	31533062
CDS1	1040	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of CDS1 mRNA	increases^expression	21934132
CDS1	1040	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of CDS1 mRNA	increases^expression	24935251|26272509
CDS1	1040	Triclosan	D014260	3380-34-5	Triclosan results in increased expression of CDS1 mRNA	increases^expression	30510588
CDS1	1040	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of CDS1 mRNA	increases^expression	26179874
CDS1	1040	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDS1 mRNA	affects^cotreatment|increases^expression	27188386
CDS1	1040	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of CDS1 mRNA	affects^expression	25979313
CDS1	1040	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of CDS1 mRNA	increases^expression	23179753|24383497|24935251|26272509|27188386|28001369|29154799
CDS1	1040	Vitamin E	D014810	1406-18-4	Vitamin E results in decreased expression of CDS1 mRNA	decreases^expression	19244175
CDS2	8760	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDS2 mRNA	affects^cotreatment|increases^expression	28628672
CDS2	8760	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDS2 mRNA	affects^cotreatment|increases^expression	28628672
CDS2	8760	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of CDS2 protein	increases^expression	26194647
CDS2	8760	abrine	C496492		abrine results in increased expression of CDS2 protein	increases^expression	31054353
CDS2	8760	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of CDS2 gene	decreases^methylation	27153756
CDS2	8760	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of CDS2 3' UTR	increases^methylation	30157460
CDS2	8760	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of CDS2 mRNA	decreases^expression	22378314
CDS2	8760	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of CDS2 exon	affects^methylation	30157460
CDS2	8760	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of CDS2 mRNA	increases^expression	29275510
CDS2	8760	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDS2 mRNA	affects^cotreatment|increases^expression	28628672
CDS2	8760	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDS2 mRNA	affects^cotreatment|increases^expression	28628672
CDS2	8760	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of CDS2 mRNA	affects^expression	25979313
CDS2	8760	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDS2 mRNA	affects^cotreatment|increases^expression	28628672
CDS2	8760	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDS2 mRNA	affects^cotreatment|increases^expression	28628672
CDS2	8760	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of CDS2 mRNA	increases^expression	23649840
CDS2	8760	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDS2 mRNA	affects^cotreatment|increases^expression	28628672
CDS2	8760	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDS2 mRNA	affects^cotreatment|increases^expression	28628672
CDS2	8760	K 7174	C410337		K 7174 results in increased expression of CDS2 mRNA	increases^expression	24086573
CDS2	8760	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of CDS2 mRNA	decreases^expression	28001369
CDS2	8760	nickel sulfate	C029938	7786-81-4	nickel sulfate results in decreased expression of CDS2 mRNA	decreases^expression	22714537
CDS2	8760	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of CDS2 mRNA	decreases^expression	22714537
CDS2	8760	Sunitinib	D000077210		Sunitinib results in increased expression of CDS2 mRNA	increases^expression	31533062
CDS2	8760	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of CDS2 mRNA	increases^expression	21632981
CDS2	8760	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of CDS2 mRNA	affects^expression	25979313
CDS2	8760	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of CDS2 mRNA	increases^expression	23179753|24935251
CDS2	8760	Vorinostat	D000077337		Vorinostat results in increased expression of CDS2 mRNA	increases^expression	27188386
COQ6	51004	1-Butanol	D020001	71-36-3	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of COQ6 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
COQ6	51004	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	C511621		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in increased expression of COQ6 mRNA]	decreases^reaction|increases^expression	28655636
COQ6	51004	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	C511621		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in increased expression of COQ6 mRNA]	decreases^reaction|increases^expression	28655636
COQ6	51004	abrine	C496492		abrine results in increased expression of COQ6 mRNA	increases^expression	31054353
COQ6	51004	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of COQ6 mRNA	decreases^expression	29067470
COQ6	51004	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone	D002259	370-86-5	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in increased expression of COQ6 mRNA	increases^expression	21308897
COQ6	51004	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of COQ6 mRNA	affects^cotreatment|increases^expression	27392435
COQ6	51004	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of COQ6 mRNA	increases^expression	27392435
COQ6	51004	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of COQ6 mRNA	decreases^expression	29803840
COQ6	51004	epigallocatechin gallate	C045651	989-51-5	epigallocatechin gallate results in increased expression of COQ6 protein	increases^expression	31195006
COQ6	51004	Gasoline	D005742		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of COQ6 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
COQ6	51004	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased expression of COQ6 mRNA	increases^expression	21308897
COQ6	51004	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of COQ6 mRNA	affects^cotreatment|increases^expression	27392435
COQ6	51004	jinfukang	C544151		jinfukang results in increased expression of COQ6 mRNA	increases^expression	27392435
COQ6	51004	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of COQ6 mRNA	increases^expression	23649840
COQ6	51004	Particulate Matter	D052638		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in increased expression of COQ6 mRNA]	decreases^reaction|increases^expression	28655636
COQ6	51004	Particulate Matter	D052638		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of COQ6 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
COQ6	51004	Particulate Matter	D052638		Particulate Matter results in increased expression of COQ6 mRNA	increases^expression	28655636
COQ6	51004	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of COQ6 mRNA	affects^expression	19159669
COQ6	51004	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of COQ6 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
COQ6	51004	Vehicle Emissions	D001335		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in increased expression of COQ6 mRNA]	decreases^reaction|increases^expression	28655636
COQ6	51004	Vehicle Emissions	D001335		Vehicle Emissions results in increased expression of COQ6 mRNA	increases^expression	28655636
COX4I1	1327	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	C095284		1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Resveratrol results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one	C095284		1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [S-nitro-N-acetylpenicillamine results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	1-methyl-4-phenyl-2,3-dihydropyridinium	C044755	94613-45-3	1-methyl-4-phenyl-2,3-dihydropyridinium results in decreased expression of COX4I1 protein	decreases^expression	21856379
COX4I1	1327	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	2-amino-14,16-dimethyloctadecan-3-ol	C507616		2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of COX4I1 protein	decreases^expression	32044396
COX4I1	1327	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	C549041		3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of COX4I1 protein]	decreases^expression|decreases^reaction	27318970
COX4I1	1327	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	C010643	56305-04-5	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid results in increased expression of COX4I1 protein	increases^expression	27385396
COX4I1	1327	8-bromocyclic GMP	C016276	31356-94-2	8-bromocyclic GMP results in increased expression of COX4I1 protein	increases^expression	24041027
COX4I1	1327	8-bromocyclic GMP	C016276	31356-94-2	tin protoporphyrin IX inhibits the reaction [8-bromocyclic GMP results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	Acetaminophen	D000082	103-90-2	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX4I1 mRNA	affects^cotreatment|decreases^expression	31059760
COX4I1	1327	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of COX4I1 gene	increases^methylation	28458013
COX4I1	1327	Arsenic Trioxide	D000077237	1327-53-3	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of COX4I1 protein]	decreases^expression|decreases^reaction	27318970
COX4I1	1327	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased expression of COX4I1 protein	decreases^expression	27318970
COX4I1	1327	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of COX4I1 mRNA	increases^expression	20458559
COX4I1	1327	Arsenic Trioxide	D000077237	1327-53-3	Cyclosporine inhibits the reaction [Arsenic Trioxide results in decreased expression of COX4I1 protein]	decreases^expression|decreases^reaction	27318970
COX4I1	1327	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of COX4I1 mRNA	decreases^expression	22378314
COX4I1	1327	Carbonyl Cyanide m-Chlorophenyl Hydrazone	D002258	555-60-2	Carbonyl Cyanide m-Chlorophenyl Hydrazone results in decreased expression of COX4I1 protein	decreases^expression	27318970
COX4I1	1327	Catechin	D002392	154-23-4	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of COX4I1 mRNA	affects^cotreatment|increases^expression	24763279
COX4I1	1327	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of COX4I1 mRNA	increases^expression	26352163
COX4I1	1327	cobaltiprotoporphyrin	C007095	14325-03-2	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	cobaltiprotoporphyrin	C007095	14325-03-2	cobaltiprotoporphyrin results in increased expression of COX4I1 protein	increases^expression	24041027
COX4I1	1327	cobaltiprotoporphyrin	C007095	14325-03-2	NFE2L2 mutant form inhibits the reaction [cobaltiprotoporphyrin results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of COX4I1 protein	decreases^expression	18515279
COX4I1	1327	Copper	D003300	7440-50-8	[AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of COX4I1 protein	affects^metabolic processing|decreases^expression	23423674
COX4I1	1327	Cyclosporine	D016572	59865-13-3	Cyclosporine inhibits the reaction [Arsenic Trioxide results in decreased expression of COX4I1 protein]	decreases^expression|decreases^reaction	27318970
COX4I1	1327	Deferoxamine	D003676	70-51-9	Deferoxamine inhibits the reaction [EPAS1 protein results in increased degradation of COX4I1 protein]	decreases^reaction|increases^degradation	18515279
COX4I1	1327	Dimethyl Sulfoxide	D004121	67-68-5	Dimethyl Sulfoxide results in increased expression of COX4I1 protein	increases^expression	27385396
COX4I1	1327	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of COX4I1 protein	decreases^expression	28456571|29729358
COX4I1	1327	Doxorubicin	D004317	23214-92-8	Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of COX4I1 protein]	decreases^expression|decreases^reaction	28456571
COX4I1	1327	ebselen	C042986	60940-34-3	ebselen results in increased expression of COX4I1 protein	increases^expression	27385396
COX4I1	1327	Erythropoietin	D004921	11096-26-7	Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of COX4I1 protein]	decreases^expression|decreases^reaction	28456571
COX4I1	1327	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of COX4I1 mRNA	increases^expression	18045764
COX4I1	1327	Glucose	D005947	50-99-7	Glucose deficiency results in increased expression of COX4I1 mRNA	increases^expression	26811028
COX4I1	1327	gossypol acetic acid	C028178	12542-36-8	ATG5 protein affects the reaction [gossypol acetic acid results in decreased expression of COX4I1 protein]	affects^reaction|decreases^expression	29938581
COX4I1	1327	gossypol acetic acid	C028178	12542-36-8	gossypol acetic acid results in decreased expression of COX4I1 protein	decreases^expression	29938581
COX4I1	1327	Grape Seed Proanthocyanidins	C511402		[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of COX4I1 mRNA	affects^cotreatment|increases^expression	24763279
COX4I1	1327	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in decreased expression of COX4I1 protein	decreases^expression	18515279
COX4I1	1327	lipopolysaccharide, E coli O55-B5	C482199		lipopolysaccharide, E coli O55-B5 promotes the reaction [Resveratrol results in increased expression of COX4I1 protein]	increases^expression|increases^reaction	24041027
COX4I1	1327	lipopolysaccharide, E coli O55-B5	C482199		lipopolysaccharide, E coli O55-B5 results in increased expression of COX4I1 protein	increases^expression	24041027
COX4I1	1327	lipopolysaccharide, E coli O55-B5	C482199		Resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of COX4I1 protein]	increases^expression|increases^reaction	24041027
COX4I1	1327	lipopolysaccharide, E coli O55-B5	C482199		tin protoporphyrin IX inhibits the reaction [lipopolysaccharide, E coli O55-B5 promotes the reaction [Resveratrol results in increased expression of COX4I1 protein]]	decreases^reaction|increases^expression|increases^reaction	24041027
COX4I1	1327	lipopolysaccharide, E coli O55-B5	C482199		tin protoporphyrin IX inhibits the reaction [Resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of COX4I1 protein]]	decreases^reaction|increases^expression|increases^reaction	24041027
COX4I1	1327	Lipopolysaccharides	D008070		[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX4I1 mRNA	affects^cotreatment|decreases^expression	31059760
COX4I1	1327	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of COX4I1 mRNA	decreases^expression	24449571
COX4I1	1327	Methylcholanthrene	D008748	56-49-5	Methylcholanthrene promotes the reaction [AHR protein binds to COX4I1 promoter]	affects^binding|increases^reaction	20348232
COX4I1	1327	metoprine	C006308		metoprine results in decreased expression of COX4I1 mRNA	decreases^expression	30818834
COX4I1	1327	Mitotane	D008939	53-19-0	Mitotane results in decreased expression of COX4I1 mRNA	decreases^expression	23696597
COX4I1	1327	OSW 1	C106408	145075-81-6	OSW 1 results in increased expression of COX4I1 mRNA	increases^expression	16333034
COX4I1	1327	Poly(amidoamine)	C531249		Poly(amidoamine) results in decreased expression of COX4I1 mRNA	decreases^expression	19643170
COX4I1	1327	Resveratrol	D000077185		1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Resveratrol results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	Resveratrol	D000077185		HMOX1 mutant form inhibits the reaction [Resveratrol results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	Resveratrol	D000077185		lipopolysaccharide, E coli O55-B5 promotes the reaction [Resveratrol results in increased expression of COX4I1 protein]	increases^expression|increases^reaction	24041027
COX4I1	1327	Resveratrol	D000077185		Resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of COX4I1 protein]	increases^expression|increases^reaction	24041027
COX4I1	1327	Resveratrol	D000077185		tin protoporphyrin IX inhibits the reaction [lipopolysaccharide, E coli O55-B5 promotes the reaction [Resveratrol results in increased expression of COX4I1 protein]]	decreases^reaction|increases^expression|increases^reaction	24041027
COX4I1	1327	Resveratrol	D000077185		tin protoporphyrin IX inhibits the reaction [Resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of COX4I1 protein]]	decreases^reaction|increases^expression|increases^reaction	24041027
COX4I1	1327	Resveratrol	D000077185		tin protoporphyrin IX inhibits the reaction [Resveratrol results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	Rotenone	D012402	83-79-4	CRTC3 protein affects the reaction [Rotenone results in increased expression of COX4I1 mRNA]	affects^reaction|increases^expression	21536665
COX4I1	1327	Rotenone	D012402	83-79-4	CRTC3 protein affects the reaction [Rotenone results in increased expression of COX4I1 protein]	affects^reaction|increases^expression	21536665
COX4I1	1327	Rotenone	D012402	83-79-4	Rotenone results in increased expression of COX4I1 mRNA	increases^expression	18191903|21536665
COX4I1	1327	Rotenone	D012402	83-79-4	Rotenone results in increased expression of COX4I1 protein	increases^expression	21536665
COX4I1	1327	S-nitro-N-acetylpenicillamine	C110881		1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [S-nitro-N-acetylpenicillamine results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	S-nitro-N-acetylpenicillamine	C110881		HMOX1 mutant form inhibits the reaction [S-nitro-N-acetylpenicillamine results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	S-nitro-N-acetylpenicillamine	C110881		S-nitro-N-acetylpenicillamine results in increased expression of COX4I1 protein	increases^expression	24041027
COX4I1	1327	S-nitro-N-acetylpenicillamine	C110881		tin protoporphyrin IX inhibits the reaction [S-nitro-N-acetylpenicillamine results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	sodium bichromate	C016104	10588-01-9	sodium bichromate results in increased expression of COX4I1 mRNA	increases^expression	17685462
COX4I1	1327	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of COX4I1 mRNA	increases^expression	18175754
COX4I1	1327	Temozolomide	D000077204	85622-93-1	COX4I1 protein affects the susceptibility to Temozolomide	affects^response to substance	20870728
COX4I1	1327	Temozolomide	D000077204	85622-93-1	Temozolomide results in increased expression of COX4I1 protein	increases^expression	20870728
COX4I1	1327	Thimerosal	D013849	54-64-8	Thimerosal results in increased expression of COX4I1 mRNA	increases^expression	27188386
COX4I1	1327	tin protoporphyrin IX	C032628	14325-05-4	tin protoporphyrin IX inhibits the reaction [8-bromocyclic GMP results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	tin protoporphyrin IX	C032628	14325-05-4	tin protoporphyrin IX inhibits the reaction [lipopolysaccharide, E coli O55-B5 promotes the reaction [Resveratrol results in increased expression of COX4I1 protein]]	decreases^reaction|increases^expression|increases^reaction	24041027
COX4I1	1327	tin protoporphyrin IX	C032628	14325-05-4	tin protoporphyrin IX inhibits the reaction [Resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of COX4I1 protein]]	decreases^reaction|increases^expression|increases^reaction	24041027
COX4I1	1327	tin protoporphyrin IX	C032628	14325-05-4	tin protoporphyrin IX inhibits the reaction [Resveratrol results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	tin protoporphyrin IX	C032628	14325-05-4	tin protoporphyrin IX inhibits the reaction [S-nitro-N-acetylpenicillamine results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	Tretinoin	D014212	302-79-4	[IFNB1 protein co-treated with Tretinoin] results in increased expression of COX4I1 protein	affects^cotreatment|increases^expression	16826196
COX4I1	1327	tricarbonylchloro(glycinato)ruthenium(II)	C476530		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	tricarbonylchloro(glycinato)ruthenium(II)	C476530		NFE2L2 mutant form inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of COX4I1 protein]	decreases^reaction|increases^expression	24041027
COX4I1	1327	tricarbonylchloro(glycinato)ruthenium(II)	C476530		tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of COX4I1 protein	increases^expression	24041027
COX4I1	1327	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of COX4I1 mRNA	increases^expression	23179753
COX4I1	1327	XCT790	C488234		XCT790 results in decreased expression of COX4I1 mRNA	decreases^expression	30818834
COX5A	9377	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of COX5A mRNA	decreases^expression	25704631
COX5A	9377	Arsenic	D001151	7440-38-2	COX5A gene SNP affects the susceptibility to Arsenic	affects^response to substance	29751399
COX5A	9377	Arsenic	D001151	7440-38-2	[COX5A gene SNP affects the susceptibility to Arsenic] which affects the abundance of Arsenicals	affects^abundance|affects^response to substance	29751399
COX5A	9377	Arsenicals	D001152		[COX5A gene SNP affects the susceptibility to Arsenic] which affects the abundance of Arsenicals	affects^abundance|affects^response to substance	29751399
COX5A	9377	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of COX5A mRNA	increases^expression	22521957
COX5A	9377	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of COX5A mRNA	decreases^expression	22378314
COX5A	9377	Capsaicin	D002211	404-86-4	Capsaicin results in increased expression of COX5A protein	increases^expression	18991268
COX5A	9377	chloropicrin	C100187	76-06-2	chloropicrin results in decreased expression of COX5A mRNA	decreases^expression	26352163
COX5A	9377	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of COX5A protein	decreases^expression	16622835
COX5A	9377	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of COX5A mRNA	affects^binding|decreases^expression	20971185
COX5A	9377	dibutyldi(4-chlorobenzohydroxamato)tin(IV)	C542282		dibutyldi(4-chlorobenzohydroxamato)tin(IV) results in decreased expression of COX5A protein	decreases^expression	22732634
COX5A	9377	Doxorubicin	D004317	23214-92-8	COX5A protein affects the susceptibility to Doxorubicin	affects^response to substance	16217747
COX5A	9377	Doxorubicin	D004317	23214-92-8	Doxorubicin affects the expression of COX5A protein	affects^expression	29385562
COX5A	9377	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of COX5A mRNA	decreases^expression	23649840
COX5A	9377	gossypol acetic acid	C028178	12542-36-8	gossypol acetic acid results in decreased expression of COX5A protein	decreases^expression	29938581
COX5A	9377	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of COX5A mRNA	decreases^expression	20436886
COX5A	9377	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of COX5A mRNA	decreases^expression	28001369
COX5A	9377	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of COX5A mRNA	decreases^expression	23649840
COX5A	9377	microcystin RR	C063855		microcystin RR results in decreased expression of COX5A protein	decreases^expression	19111056
COX5A	9377	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of COX5A mRNA	affects^binding|decreases^expression	20971185
COX5A	9377	Particulate Matter	D052638		Particulate Matter results in decreased expression of COX5A mRNA	decreases^expression	29703138
COX5A	9377	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in decreased expression of COX5A protein	decreases^expression	26879310
COX5A	9377	pinosylvin	C049032	102-61-4	pinosylvin results in decreased expression of COX5A mRNA	decreases^expression	23333577
COX5A	9377	Rotenone	D012402	83-79-4	Rotenone results in increased expression of COX5A mRNA	increases^expression	18191903
COX5A	9377	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of COX5A mRNA	increases^expression	18175754
COX5A	9377	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of COX5A mRNA	increases^expression	23179753
COX5A	9377	Vinblastine	D014747	865-21-4	COX5A protein affects the susceptibility to Vinblastine	affects^response to substance	16217747
COX5A	9377	Zidovudine	D015215	30516-87-1	Zidovudine results in decreased expression of COX5A protein	decreases^expression	7807166
COX5B	1329	1-methyl-4-phenyl-2,3-dihydropyridinium	C044755	94613-45-3	1-methyl-4-phenyl-2,3-dihydropyridinium results in decreased expression of COX5B mRNA	decreases^expression	21856379
COX5B	1329	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	C472791		3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of COX5B mRNA	decreases^expression	12958071
COX5B	1329	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of COX5B mRNA	decreases^expression	20018196
COX5B	1329	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of COX5B mRNA	increases^expression	19150397
COX5B	1329	Atrazine	D001280	1912-24-9	Atrazine affects the expression of COX5B mRNA	affects^expression	27114639
COX5B	1329	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of COX5B mRNA	decreases^expression	22378314
COX5B	1329	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of COX5B promoter	decreases^methylation	27901495
COX5B	1329	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of COX5B mRNA	affects^expression	30903817
COX5B	1329	Cadmium	D002104	7440-43-9	Cadmium results in decreased expression of COX5B mRNA	decreases^expression	23369406
COX5B	1329	chloropicrin	C100187	76-06-2	chloropicrin affects the expression of COX5B mRNA	affects^expression	26352163
COX5B	1329	chloropicrin	C100187	76-06-2	chloropicrin results in decreased expression of COX5B mRNA	decreases^expression	28476498
COX5B	1329	Decitabine	D000077209	2353-33-5	Decitabine results in increased expression of COX5B protein	increases^expression	19294695
COX5B	1329	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of COX5B mRNA	decreases^expression	28302478
COX5B	1329	Environmental Pollutants	D004785		Environmental Pollutants affects the expression of COX5B mRNA	affects^expression	19118595
COX5B	1329	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of COX5B mRNA	decreases^expression	23019147
COX5B	1329	Homocysteine	D006710	454-28-4	[Methionine deficiency co-treated with Homocysteine] affects the expression of COX5B protein	affects^cotreatment|affects^expression	17116298
COX5B	1329	Hydrogen Peroxide	D006861	7722-84-1	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of COX5B protein	affects^cotreatment|decreases^expression	18951874
COX5B	1329	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of COX5B mRNA	decreases^expression	20436886
COX5B	1329	Magnetite Nanoparticles	D058185		[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COX5B mRNA	affects^cotreatment|decreases^expression	26378955
COX5B	1329	Methionine	D008715	63-68-3	[Methionine deficiency co-treated with Homocysteine] affects the expression of COX5B protein	affects^cotreatment|affects^expression	17116298
COX5B	1329	myricetin	C040015	529-44-2	myricetin results in increased expression of COX5B protein	increases^expression	29698783
COX5B	1329	ochratoxin A	C025589	303-47-9	ochratoxin A results in increased expression of COX5B mRNA	increases^expression	17316727
COX5B	1329	Particulate Matter	D052638		Particulate Matter results in decreased expression of COX5B mRNA	decreases^expression	24769257
COX5B	1329	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in decreased expression of COX5B protein	decreases^expression	26879310
COX5B	1329	Rotenone	D012402	83-79-4	Rotenone results in increased expression of COX5B mRNA	increases^expression	18191903
COX5B	1329	Succimer	D004113	304-55-2	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COX5B mRNA	affects^cotreatment|decreases^expression	26378955
COX5B	1329	tetrathiomolybdate	C020809	16330-92-0	tetrathiomolybdate analog results in increased expression of COX5B mRNA	increases^expression	19323979
COX5B	1329	Theophylline	D013806	58-55-9	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of COX5B protein	affects^cotreatment|decreases^expression	18951874
COX5B	1329	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of COX5B protein	increases^expression	19294695
COX5B	1329	tris(2-butoxyethyl) phosphate	C013320	78-51-3	tris(2-butoxyethyl) phosphate results in increased expression of COX5B mRNA	increases^expression	29024780
COX5B	1329	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of COX5B mRNA	affects^expression	25979313
COX5B	1329	Vorinostat	D000077337		Vorinostat results in increased expression of COX5B protein	increases^expression	17593366|20543569
COX5B	1329	Zidovudine	D015215	30516-87-1	Zidovudine results in decreased expression of COX5B protein	decreases^expression	7807166
COX6A1	1337	10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone	C471674		10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased expression of COX6A1 mRNA	increases^expression	23088786
COX6A1	1337	5-hydroxythalidomide	C544471		5-hydroxythalidomide binds to COX6A1 protein	affects^binding	27464947
COX6A1	1337	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of COX6A1 mRNA	increases^expression	26352163
COX6A1	1337	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of COX6A1 mRNA	increases^expression	29803840
COX6A1	1337	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of COX6A1 mRNA	decreases^expression	23019147
COX6A1	1337	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of COX6A1 mRNA	decreases^expression	20436886
COX6A1	1337	Lactic Acid	D019344	50-21-5	Lactic Acid results in increased expression of COX6A1 mRNA	increases^expression	30851411
COX6A1	1337	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of COX6A1 mRNA	decreases^expression	17400583
COX6A1	1337	MT19c compound	C568376		MT19c compound results in decreased expression of COX6A1 mRNA	decreases^expression	21781307
COX6A1	1337	OSW 1	C106408	145075-81-6	OSW 1 results in increased expression of COX6A1 mRNA	increases^expression	16333034
COX6A1	1337	Particulate Matter	D052638		Particulate Matter results in decreased expression of COX6A1 mRNA	decreases^expression	29703138
COX6A1	1337	Sarin	D012524	107-44-8	Sarin results in decreased expression of COX6A1 mRNA	decreases^expression	19522546
COX6A1	1337	Selenium	D012643	7782-49-2	Selenium results in decreased expression of COX6A1 mRNA	decreases^expression	19244175
COX6A1	1337	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of COX6A1 mRNA	increases^expression	23179753|28001369
COX6A1	1337	Vitamin E	D014810	1406-18-4	Vitamin E results in decreased expression of COX6A1 mRNA	decreases^expression	19244175
COX6B1	1340	5-hydroxythalidomide	C544471		5-hydroxythalidomide binds to COX6B1 protein	affects^binding	27464947
COX6B1	1340	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of COX6B1 mRNA	decreases^expression	29067470
COX6B1	1340	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of COX6B1 mRNA	increases^expression	25704631
COX6B1	1340	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of COX6B1 gene	affects^methylation	25304211
COX6B1	1340	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of COX6B1 mRNA	affects^expression	30903817
COX6B1	1340	chloropicrin	C100187	76-06-2	chloropicrin affects the expression of COX6B1 mRNA	affects^expression	26352163
COX6B1	1340	Cisplatin	D002945	15663-27-1	[Quercetin co-treated with Cisplatin] results in increased expression of COX6B1 mRNA	affects^cotreatment|increases^expression	24999622
COX6B1	1340	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of COX6B1 mRNA	decreases^expression	20106945
COX6B1	1340	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of COX6B1 mRNA	increases^expression	29803840
COX6B1	1340	Environmental Pollutants	D004785		Environmental Pollutants affects the expression of COX6B1 mRNA	affects^expression	19118595
COX6B1	1340	Hydralazine	D006830	86-54-4	[Hydralazine co-treated with Valproic Acid] results in increased expression of COX6B1 mRNA	affects^cotreatment|increases^expression	17183730
COX6B1	1340	K 7174	C410337		K 7174 results in decreased expression of COX6B1 mRNA	decreases^expression	24086573
COX6B1	1340	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of COX6B1 mRNA	decreases^expression	17400583
COX6B1	1340	MT19c compound	C568376		MT19c compound results in decreased expression of COX6B1 mRNA	decreases^expression	21781307
COX6B1	1340	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in decreased expression of COX6B1 protein	decreases^expression	26879310
COX6B1	1340	Quercetin	D011794	117-39-5	[Quercetin co-treated with Cisplatin] results in increased expression of COX6B1 mRNA	affects^cotreatment|increases^expression	24999622
COX6B1	1340	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of COX6B1 mRNA	decreases^expression	22378314
COX6B1	1340	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of COX6B1 protein	affects^expression	30291989
COX6B1	1340	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of COX6B1 mRNA	decreases^expression	22378314
COX6B1	1340	Uranium Compounds	D017974		Uranium Compounds results in decreased expression of COX6B1 mRNA	decreases^expression	19654044
COX6B1	1340	Valproic Acid	D014635	99-66-1	[Hydralazine co-treated with Valproic Acid] results in increased expression of COX6B1 mRNA	affects^cotreatment|increases^expression	17183730
COX6B1	1340	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of COX6B1 mRNA	affects^expression	25979313
COX6B1	1340	Vinblastine	D014747	865-21-4	COX6B1 protein affects the susceptibility to Vinblastine	affects^response to substance	16217747
COX6C	1345	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	C472791		3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of COX6C mRNA	decreases^expression	12958071
COX6C	1345	Acetaminophen	D000082	103-90-2	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX6C mRNA	affects^cotreatment|decreases^expression	31059760
COX6C	1345	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of COX6C mRNA	increases^expression	25704631
COX6C	1345	Antirheumatic Agents	D018501		Antirheumatic Agents results in increased expression of COX6C mRNA	increases^expression	24449571
COX6C	1345	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of COX6C mRNA	increases^expression	25258189
COX6C	1345	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of COX6C mRNA	decreases^expression	22378314
COX6C	1345	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of COX6C promoter	affects^methylation	27901495
COX6C	1345	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of COX6C mRNA	affects^expression	30903817
COX6C	1345	CD 437	C099555		CD 437 results in decreased expression of COX6C mRNA	decreases^expression	12958071
COX6C	1345	chloropicrin	C100187	76-06-2	chloropicrin affects the expression of COX6C mRNA	affects^expression	26352163
COX6C	1345	Cocaine	D003042	50-36-2	Cocaine results in decreased expression of COX6C mRNA	decreases^expression	12629581
COX6C	1345	Crack Cocaine	D016578		Crack Cocaine results in increased expression of COX6C mRNA	increases^expression	12629581
COX6C	1345	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of COX6C mRNA	decreases^expression	28302478
COX6C	1345	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of COX6C mRNA	increases^expression	29803840
COX6C	1345	Environmental Pollutants	D004785		Environmental Pollutants affects the expression of COX6C mRNA	affects^expression	19118595
COX6C	1345	epicatechin gallate	C062669	863-03-6	ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]]	affects^cotreatment|affects^reaction|decreases^expression|decreases^reaction	29061316
COX6C	1345	epicatechin gallate	C062669	863-03-6	[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]	affects^cotreatment|decreases^expression|decreases^reaction	29061316
COX6C	1345	epigallocatechin gallate	C045651	989-51-5	ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]]	affects^cotreatment|affects^reaction|decreases^expression|decreases^reaction	29061316
COX6C	1345	epigallocatechin gallate	C045651	989-51-5	[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]	affects^cotreatment|decreases^expression|decreases^reaction	29061316
COX6C	1345	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of COX6C mRNA	decreases^expression	23019147
COX6C	1345	Gallic Acid	D005707	149-91-7	ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]]	affects^cotreatment|affects^reaction|decreases^expression|decreases^reaction	29061316
COX6C	1345	Gallic Acid	D005707	149-91-7	[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]	affects^cotreatment|decreases^expression|decreases^reaction	29061316
COX6C	1345	gallocatechol	C057580	1617-55-6	ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]]	affects^cotreatment|affects^reaction|decreases^expression|decreases^reaction	29061316
COX6C	1345	gallocatechol	C057580	1617-55-6	[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]	affects^cotreatment|decreases^expression|decreases^reaction	29061316
COX6C	1345	Hydrogen Peroxide	D006861	7722-84-1	ARNTL protein affects the reaction [[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]]	affects^cotreatment|affects^reaction|decreases^expression|decreases^reaction	29061316
COX6C	1345	Hydrogen Peroxide	D006861	7722-84-1	ARNTL protein affects the reaction [Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]]	affects^reaction|decreases^expression|decreases^reaction	30316844
COX6C	1345	Hydrogen Peroxide	D006861	7722-84-1	[Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]	affects^cotreatment|decreases^expression|decreases^reaction	29061316
COX6C	1345	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in decreased expression of COX6C mRNA	decreases^expression	29061316|30316844
COX6C	1345	Hydrogen Peroxide	D006861	7722-84-1	Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]	decreases^expression|decreases^reaction	30316844
COX6C	1345	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of COX6C mRNA	decreases^expression	30851411
COX6C	1345	Lipopolysaccharides	D008070		[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX6C mRNA	affects^cotreatment|decreases^expression	31059760
COX6C	1345	O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate	C009618	5598-15-2	PON1 gene polymorphism affects the susceptibility to [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate affects the expression of COX6C mRNA]	affects^expression|affects^response to substance	21673326
COX6C	1345	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in decreased expression of COX6C protein	decreases^expression	26879310
COX6C	1345	Plant Extracts	D010936		Plant Extracts results in increased expression of COX6C mRNA	increases^expression	23557933
COX6C	1345	Polyphenols	D059808		ARNTL protein affects the reaction [Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]]	affects^reaction|decreases^expression|decreases^reaction	30316844
COX6C	1345	Polyphenols	D059808		Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of COX6C mRNA]	decreases^expression|decreases^reaction	30316844
COX6C	1345	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of COX6C mRNA	increases^expression	18175754
COX6C	1345	tetrahydropalmatine	C014215	10097-84-4	tetrahydropalmatine results in increased expression of COX6C protein	increases^expression	20109541
COX6C	1345	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of COX6C mRNA	decreases^expression	22378314
COX6C	1345	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of COX6C mRNA	decreases^expression	22378314
COX6C	1345	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of COX6C mRNA	affects^expression	25979313
COX6C	1345	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of COX6C mRNA	increases^expression	23179753
COX6C	1345	Zidovudine	D015215	30516-87-1	Zidovudine results in decreased expression of COX6C protein	decreases^expression	7807166
COX7A1	1346	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of COX7A1 mRNA	increases^expression	20382639
COX7A1	1346	Acetaminophen	D000082	103-90-2	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX7A1 mRNA	affects^cotreatment|decreases^expression	31059760
COX7A1	1346	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of COX7A1 mRNA	decreases^expression	31059760
COX7A1	1346	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	bis(4-hydroxyphenyl)sulfone results in increased expression of COX7A1 mRNA	increases^expression	25912373
COX7A1	1346	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of COX7A1 mRNA	affects^cotreatment|increases^expression	27392435
COX7A1	1346	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of COX7A1 mRNA	increases^expression	27392435
COX7A1	1346	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of COX7A1 mRNA	increases^expression	25047013
COX7A1	1346	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of COX7A1 mRNA	decreases^expression	29803840
COX7A1	1346	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of COX7A1 mRNA	affects^cotreatment|increases^expression	27392435
COX7A1	1346	JP8 aviation fuel	C098607		JP8 aviation fuel results in decreased expression of COX7A1 mRNA	decreases^expression	16835149
COX7A1	1346	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of COX7A1 mRNA	decreases^expression	30851411
COX7A1	1346	Lipopolysaccharides	D008070		[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX7A1 mRNA	affects^cotreatment|decreases^expression	31059760
COX7A1	1346	Nickel	D009532	7440-02-0	Nickel results in decreased expression of COX7A1 mRNA	decreases^expression	25583101
COX7A1	1346	Progesterone	D011374	57-83-0	Progesterone results in decreased expression of COX7A1 mRNA	decreases^expression	18070364
COX7A1	1346	Selenium	D012643	7782-49-2	Selenium results in decreased expression of COX7A1 mRNA	decreases^expression	19244175
COX7A1	1346	Triclosan	D014260	3380-34-5	Triclosan results in decreased expression of COX7A1 mRNA	decreases^expression	30510588
COX7A1	1346	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of COX7A1 mRNA	decreases^expression	29154799
COX7A1	1346	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of COX7A1 gene	increases^methylation	29154799
COX7A1	1346	Zidovudine	D015215	30516-87-1	Zidovudine results in decreased expression of COX7A1 protein	decreases^expression	7807166
COX7A2	1347	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	C472791		3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of COX7A2 mRNA	decreases^expression	12958071
COX7A2	1347	Acetaminophen	D000082	103-90-2	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX7A2 mRNA	affects^cotreatment|decreases^expression	31059760
COX7A2	1347	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of COX7A2 mRNA	decreases^expression	29067470|31059760
COX7A2	1347	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of COX7A2 mRNA	increases^expression	25704631
COX7A2	1347	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of COX7A2 gene	increases^methylation	27153756
COX7A2	1347	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of COX7A2 mRNA	decreases^expression	22378314
COX7A2	1347	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of COX7A2 promoter	affects^methylation	27901495
COX7A2	1347	CD 437	C099555		CD 437 results in decreased expression of COX7A2 mRNA	decreases^expression	12958071
COX7A2	1347	chloropicrin	C100187	76-06-2	chloropicrin affects the expression of COX7A2 mRNA	affects^expression	26352163
COX7A2	1347	Cyclophosphamide	D003520	50-18-0	Cyclophosphamide results in decreased expression of COX7A2 mRNA	decreases^expression	17403535
COX7A2	1347	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of COX7A2 mRNA	increases^expression	25562108
COX7A2	1347	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of COX7A2 mRNA	decreases^expression	28302478
COX7A2	1347	Doxorubicin	D004317	23214-92-8	Doxorubicin affects the expression of COX7A2 mRNA	affects^expression	29803840
COX7A2	1347	Environmental Pollutants	D004785		Environmental Pollutants affects the expression of COX7A2 mRNA	affects^expression	19118595
COX7A2	1347	ICG 001	C492448		ICG 001 results in increased expression of COX7A2 mRNA	increases^expression	26191083
COX7A2	1347	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of COX7A2 mRNA	decreases^expression	20436886
COX7A2	1347	Lipopolysaccharides	D008070		[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX7A2 mRNA	affects^cotreatment|decreases^expression	31059760
COX7A2	1347	O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate	C009618	5598-15-2	PON1 gene polymorphism affects the susceptibility to [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate affects the expression of COX7A2 mRNA]	affects^expression|affects^response to substance	21673326
COX7A2	1347	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in decreased expression of COX7A2 protein	decreases^expression	26879310
COX7A2	1347	Rotenone	D012402	83-79-4	Rotenone results in increased expression of COX7A2 mRNA	increases^expression	18191903
COX7A2	1347	Selenium	D012643	7782-49-2	Selenium results in decreased expression of COX7A2 mRNA	decreases^expression	19244175
COX7A2	1347	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of COX7A2 mRNA	increases^expression	28595984
COX7A2	1347	Sunitinib	D000077210		Sunitinib results in decreased expression of COX7A2 mRNA	decreases^expression	31533062
COX7A2	1347	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of COX7A2 mRNA	increases^expression	17218384
COX7A2	1347	tris(2-butoxyethyl) phosphate	C013320	78-51-3	tris(2-butoxyethyl) phosphate results in increased expression of COX7A2 mRNA	increases^expression	29024780
COX7A2	1347	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of COX7A2 mRNA	affects^expression	25979313
COX7A2	1347	Zidovudine	D015215	30516-87-1	Zidovudine results in increased expression of COX7A2 mRNA	increases^expression	16894629
COX7B	1349	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	28628672
COX7B	1349	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	28628672
COX7B	1349	1-methyl-4-phenyl-2,3-dihydropyridinium	C044755	94613-45-3	1-methyl-4-phenyl-2,3-dihydropyridinium results in decreased expression of COX7B mRNA	decreases^expression	21856379
COX7B	1349	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	C472791		3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of COX7B mRNA	decreases^expression	12958071
COX7B	1349	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	27188386
COX7B	1349	Acetaminophen	D000082	103-90-2	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX7B mRNA	affects^cotreatment|decreases^expression	31059760
COX7B	1349	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of COX7B mRNA	decreases^expression	22230336
COX7B	1349	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of COX7B mRNA	increases^expression	25704631
COX7B	1349	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of COX7B mRNA	increases^expression	25258189
COX7B	1349	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of COX7B mRNA	decreases^expression	22378314|27114639
COX7B	1349	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of COX7B exon	affects^methylation	27901495
COX7B	1349	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of COX7B promoter	increases^methylation	27901495
COX7B	1349	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of COX7B mRNA	affects^expression	21179406
COX7B	1349	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	28628672
COX7B	1349	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of COX7B mRNA	affects^expression	30903817
COX7B	1349	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	28628672
COX7B	1349	bleomycetin	C025703	11116-32-8	bleomycetin results in decreased expression of COX7B mRNA	decreases^expression	21040473
COX7B	1349	C646 compound	C584509		C646 compound results in decreased expression of COX7B mRNA	decreases^expression	26191083
COX7B	1349	CD 437	C099555		CD 437 results in decreased expression of COX7B mRNA	decreases^expression	12958071
COX7B	1349	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of COX7B mRNA	increases^expression	26352163
COX7B	1349	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of COX7B mRNA	decreases^expression	19376846
COX7B	1349	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of COX7B mRNA	affects^binding|decreases^expression	20971185
COX7B	1349	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of COX7B mRNA	decreases^expression	20106945|25562108
COX7B	1349	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	28628672
COX7B	1349	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	28628672
COX7B	1349	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of COX7B mRNA	decreases^expression	28302478
COX7B	1349	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	27188386
COX7B	1349	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of COX7B mRNA	increases^expression	29803840
COX7B	1349	Environmental Pollutants	D004785		Environmental Pollutants results in decreased expression of COX7B mRNA	decreases^expression	19118595
COX7B	1349	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of COX7B mRNA	decreases^expression	23019147
COX7B	1349	ICG 001	C492448		ICG 001 results in increased expression of COX7B mRNA	increases^expression	26191083
COX7B	1349	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	28628672
COX7B	1349	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	28628672
COX7B	1349	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of COX7B mRNA	decreases^expression	20436886
COX7B	1349	K 7174	C410337		K 7174 results in decreased expression of COX7B mRNA	decreases^expression	24086573
COX7B	1349	Lipopolysaccharides	D008070		[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX7B mRNA	affects^cotreatment|decreases^expression	31059760
COX7B	1349	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of COX7B mRNA	decreases^expression	28001369
COX7B	1349	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of COX7B mRNA	decreases^expression	23649840
COX7B	1349	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of COX7B mRNA	affects^binding|decreases^expression	20971185
COX7B	1349	OSW 1	C106408	145075-81-6	OSW 1 results in increased expression of COX7B mRNA	increases^expression	16333034
COX7B	1349	Particulate Matter	D052638		Particulate Matter results in decreased expression of COX7B mRNA	decreases^expression	28412507|29703138
COX7B	1349	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of COX7B mRNA	affects^expression	19159669
COX7B	1349	Plant Extracts	D010936		Plant Extracts results in increased expression of COX7B mRNA	increases^expression	23557933
COX7B	1349	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of COX7B mRNA	decreases^expression	22714537
COX7B	1349	Rotenone	D012402	83-79-4	Rotenone results in increased expression of COX7B mRNA	increases^expression	18191903
COX7B	1349	Selenium	D012643	7782-49-2	Selenium results in decreased expression of COX7B mRNA	decreases^expression	19244175
COX7B	1349	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of COX7B mRNA	increases^expression	23152189
COX7B	1349	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of COX7B mRNA	decreases^expression	22378314
COX7B	1349	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of COX7B mRNA	decreases^expression	22378314
COX7B	1349	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COX7B mRNA	affects^cotreatment|increases^expression	27188386
COX7B	1349	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of COX7B mRNA	affects^expression	25979313
COX7B	1349	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of COX7B mRNA	increases^expression	23179753|26272509|27188386
COX7B	1349	Zidovudine	D015215	30516-87-1	Zidovudine results in decreased expression of COX7B protein	decreases^expression	7807166
COX7B	1349	Zidovudine	D015215	30516-87-1	Zidovudine results in increased expression of COX7B mRNA	increases^expression	16894629
COX7C	1350	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	C472791		3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of COX7C mRNA	decreases^expression	12958071
COX7C	1350	Acetaminophen	D000082	103-90-2	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX7C mRNA	affects^cotreatment|decreases^expression	31059760
COX7C	1350	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of COX7C mRNA	decreases^expression	29067470|31059760
COX7C	1350	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of COX7C promoter	affects^methylation	27901495
COX7C	1350	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of COX7C mRNA	affects^expression	30903817
COX7C	1350	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of COX7C mRNA	decreases^expression	29275510
COX7C	1350	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of COX7C mRNA	affects^expression	25979313
COX7C	1350	CD 437	C099555		CD 437 results in decreased expression of COX7C mRNA	decreases^expression	12958071
COX7C	1350	chloropicrin	C100187	76-06-2	chloropicrin results in decreased expression of COX7C mRNA	decreases^expression	26352163
COX7C	1350	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of COX7C mRNA	decreases^expression	28302478
COX7C	1350	Doxorubicin	D004317	23214-92-8	Doxorubicin affects the expression of COX7C protein	affects^expression	29385562
COX7C	1350	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of COX7C mRNA	increases^expression	29803840
COX7C	1350	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of COX7C mRNA	decreases^expression	23019147
COX7C	1350	Gasoline	D005742		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COX7C mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
COX7C	1350	Hydralazine	D006830	86-54-4	[Hydralazine co-treated with Valproic Acid] results in increased expression of COX7C mRNA	affects^cotreatment|increases^expression	17183730
COX7C	1350	isobutyl alcohol	C040507	78-83-1	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COX7C mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
COX7C	1350	K 7174	C410337		K 7174 results in decreased expression of COX7C mRNA	decreases^expression	24086573
COX7C	1350	Lipopolysaccharides	D008070		[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX7C mRNA	affects^cotreatment|decreases^expression	31059760
COX7C	1350	ochratoxin A	C025589	303-47-9	ochratoxin A results in increased expression of COX7C protein	increases^expression	26861962
COX7C	1350	Particulate Matter	D052638		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COX7C mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
COX7C	1350	Particulate Matter	D052638		Particulate Matter results in decreased expression of COX7C mRNA	decreases^expression	24769257
COX7C	1350	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in decreased expression of COX7C protein	decreases^expression	26879310
COX7C	1350	pinosylvin	C049032	102-61-4	pinosylvin results in decreased expression of COX7C mRNA	decreases^expression	23333577
COX7C	1350	Plant Extracts	D010936		Plant Extracts results in increased expression of COX7C mRNA	increases^expression	23557933
COX7C	1350	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of COX7C mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
COX7C	1350	Selenium	D012643	7782-49-2	Selenium results in decreased expression of COX7C mRNA	decreases^expression	19244175
COX7C	1350	tris(2-butoxyethyl) phosphate	C013320	78-51-3	tris(2-butoxyethyl) phosphate results in increased expression of COX7C mRNA	increases^expression	29024780
COX7C	1350	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of COX7C mRNA	decreases^expression	22378314
COX7C	1350	Valproic Acid	D014635	99-66-1	[Hydralazine co-treated with Valproic Acid] results in increased expression of COX7C mRNA	affects^cotreatment|increases^expression	17183730
COX7C	1350	Zidovudine	D015215	30516-87-1	Zidovudine results in decreased expression of COX7C protein	decreases^expression	7807166
COX8A	1351	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of COX8A mRNA	increases^expression	22230336|25704631
COX8A	1351	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of COX8A mRNA	affects^expression	30903817
COX8A	1351	Bortezomib	D000069286		Bortezomib results in decreased expression of COX8A mRNA	decreases^expression	30818834
COX8A	1351	carfilzomib	C524865		carfilzomib results in decreased expression of COX8A mRNA	decreases^expression	30818834
COX8A	1351	chloropicrin	C100187	76-06-2	chloropicrin results in decreased expression of COX8A mRNA	decreases^expression	26352163
COX8A	1351	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of COX8A mRNA	increases^expression	27594783
COX8A	1351	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of COX8A gene	increases^methylation	22964155
COX8A	1351	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of COX8A mRNA	increases^expression	29803840
COX8A	1351	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of COX8A mRNA	decreases^expression	23086925
COX8A	1351	K 7174	C410337		K 7174 results in decreased expression of COX8A mRNA	decreases^expression	24086573
COX8A	1351	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of COX8A mRNA	decreases^expression	30851411
COX8A	1351	ochratoxin A	C025589	303-47-9	ochratoxin A results in increased expression of COX8A mRNA	increases^expression	17316727
COX8A	1351	Particulate Matter	D052638		Particulate Matter results in increased expression of COX8A mRNA	increases^expression	29703138
COX8A	1351	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of COX8A mRNA	increases^expression	18175754
COX8A	1351	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of COX8A mRNA	decreases^expression	22378314
COX8A	1351	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of COX8A mRNA	affects^expression	25979313
COX8A	1351	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of COX8A mRNA	increases^expression	23179753|27188386
COX8A	1351	XCT790	C488234		XCT790 results in decreased expression of COX8A mRNA	decreases^expression	30818834
CPOX	1371	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of CPOX protein	increases^expression	26194647
CPOX	1371	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPOX mRNA	affects^cotreatment|increases^expression	27188386
CPOX	1371	abrine	C496492		abrine results in decreased expression of CPOX mRNA	decreases^expression	31054353
CPOX	1371	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of CPOX mRNA	increases^expression	25704631
CPOX	1371	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of CPOX mRNA	decreases^expression	27153756
CPOX	1371	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of CPOX gene	decreases^methylation	27153756
CPOX	1371	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of CPOX promoter	affects^methylation	27901495
CPOX	1371	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of CPOX mRNA	decreases^expression	21632981
CPOX	1371	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of CPOX mRNA	affects^expression	30903817
CPOX	1371	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of CPOX mRNA	affects^cotreatment|increases^expression	27392435
CPOX	1371	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of CPOX mRNA	increases^expression	27392435
CPOX	1371	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of CPOX mRNA	decreases^expression	19549813
CPOX	1371	coproporphyrinogen III	C028026	2624-63-7	CPOX protein results in decreased carboxylation of coproporphyrinogen III	decreases^carboxylation	19339664
CPOX	1371	coproporphyrinogen III	C028026	2624-63-7	Mercury inhibits the reaction [CPOX protein results in decreased carboxylation of coproporphyrinogen III]	decreases^carboxylation|decreases^reaction	19339664
CPOX	1371	Coproporphyrins	D003306		[Mercury results in decreased activity of CPOX protein] which results in increased abundance of Coproporphyrins	decreases^activity|increases^abundance	16214298
CPOX	1371	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of CPOX mRNA	decreases^expression	25562108
CPOX	1371	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPOX mRNA	affects^cotreatment|increases^expression	27188386
CPOX	1371	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of CPOX mRNA	decreases^expression	29803840
CPOX	1371	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CPOX protein	decreases^activity|increases^O-linked glycosylation	23301498
CPOX	1371	Heme	D006418	14875-96-8	CPOX protein results in increased chemical synthesis of Heme	increases^chemical synthesis	11248690
CPOX	1371	ICG 001	C492448		ICG 001 results in decreased expression of CPOX mRNA	decreases^expression	26191083
CPOX	1371	isocoproporphyrin	C005524	36548-09-1	CPOX polymorphism affects the abundance of isocoproporphyrin analog	affects^abundance	16214298
CPOX	1371	isocoproporphyrin	C005524	36548-09-1	CPOX polymorphism results in increased chemical synthesis of isocoproporphyrin analog	increases^chemical synthesis	15967199
CPOX	1371	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of CPOX mRNA	affects^cotreatment|increases^expression	27392435
CPOX	1371	K 7174	C410337		K 7174 results in decreased expression of CPOX mRNA	decreases^expression	24086573
CPOX	1371	Mercury	D008628	7439-97-6	CPOX polymorphism affects the susceptibility to Mercury	affects^response to substance	16343843
CPOX	1371	Mercury	D008628	7439-97-6	CPOX protein affects the susceptibility to Mercury	affects^response to substance	19339664
CPOX	1371	Mercury	D008628	7439-97-6	CPOX protein polymorphism affects the susceptibility to Mercury	affects^response to substance	19339664
CPOX	1371	Mercury	D008628	7439-97-6	Mercury inhibits the reaction [CPOX protein results in decreased carboxylation of coproporphyrinogen III]	decreases^carboxylation|decreases^reaction	19339664
CPOX	1371	Mercury	D008628	7439-97-6	Mercury inhibits the reaction [CPOX protein results in increased chemical synthesis of protoporphyrinogen]	decreases^reaction|increases^chemical synthesis	19339664
CPOX	1371	Mercury	D008628	7439-97-6	Mercury results in decreased activity of CPOX protein	decreases^activity	16214298|19339664
CPOX	1371	Mercury	D008628	7439-97-6	[Mercury results in decreased activity of CPOX protein] which results in increased abundance of Coproporphyrins	decreases^activity|increases^abundance	16214298
CPOX	1371	pentacarboxylic porphyrin	C034350	28100-78-9	CPOX polymorphism results in increased metabolism of pentacarboxylic porphyrin	increases^metabolic processing	15967199
CPOX	1371	protoporphyrinogen	C011539	7412-77-3	CPOX protein results in increased chemical synthesis of protoporphyrinogen	increases^chemical synthesis	19339664
CPOX	1371	protoporphyrinogen	C011539	7412-77-3	Mercury inhibits the reaction [CPOX protein results in increased chemical synthesis of protoporphyrinogen]	decreases^reaction|increases^chemical synthesis	19339664
CPOX	1371	protoporphyrinogen	C011539	7412-77-3	TGFB1 protein promotes the reaction [CPOX protein results in increased chemical synthesis of protoporphyrinogen]	increases^chemical synthesis|increases^reaction	11248690
CPOX	1371	Smoke	D012906		Smoke affects the methylation of CPOX gene	affects^methylation	24704585
CPOX	1371	Sunitinib	D000077210		Sunitinib results in increased expression of CPOX mRNA	increases^expression	31533062
CPOX	1371	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPOX mRNA	affects^cotreatment|increases^expression	27188386
CPOX	1371	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of CPOX mRNA	affects^expression	25979313
CPOX	1371	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of CPOX gene	decreases^methylation	29154799
CPOX	1371	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of CPOX mRNA	increases^expression	23179753|26272509|28001369
CPT1A	1374	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CPT1A mRNA	affects^cotreatment|decreases^expression	28628672
CPT1A	1374	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CPT1A mRNA	affects^cotreatment|decreases^expression	28628672
CPT1A	1374	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of CPT1A mRNA	increases^expression	24810058
CPT1A	1374	2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid	C000608800		2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid results in increased expression of CPT1A mRNA	increases^expression	31676336
CPT1A	1374	2-amino-14,16-dimethyloctadecan-3-ol	C507616		2-amino-14,16-dimethyloctadecan-3-ol results in increased expression of CPT1A protein	increases^expression	32044396
CPT1A	1374	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of CPT1A protein	increases^expression	26194647
CPT1A	1374	3-(3,4-dimethoxyphenyl)propenoic acid	C065784	2316-26-9	3-(3,4-dimethoxyphenyl)propenoic acid inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	29940154
CPT1A	1374	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide	C547957		4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide results in decreased expression of CPT1A	decreases^expression	20516370
CPT1A	1374	abrine	C496492		abrine results in decreased expression of CPT1A mRNA	decreases^expression	31054353
CPT1A	1374	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of CPT1A intron	increases^methylation	30157460
CPT1A	1374	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of CPT1A intron	increases^methylation	30157460
CPT1A	1374	AICA ribonucleotide	C031143	3031-94-5	AICA ribonucleotide results in increased expression of CPT1A mRNA	increases^expression	25743752
CPT1A	1374	AICA ribonucleotide	C031143	3031-94-5	AICA ribonucleotide results in increased expression of CPT1A protein	increases^expression	25743752
CPT1A	1374	alpha-Linolenic Acid	D017962	463-40-1	alpha-Linolenic Acid results in increased expression of CPT1A mRNA	increases^expression	15307955
CPT1A	1374	alpha-Tocopherol	D024502	59-02-9	alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	17936189
CPT1A	1374	alpha-Tocopherol	D024502	59-02-9	alpha-Tocopherol promotes the reaction [NR1I2 results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	17936189
CPT1A	1374	alpha-Tocopherol	D024502	59-02-9	alpha-Tocopherol results in increased expression of CPT1A mRNA	increases^expression	17936189
CPT1A	1374	Amiodarone	D000638	1951-25-3	Amiodarone affects the expression of CPT1A mRNA	affects^expression	29248575
CPT1A	1374	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of CPT1A mRNA	decreases^expression	24449571
CPT1A	1374	Arachidonic Acid	D016718		Arachidonic Acid results in increased expression of CPT1A mRNA	increases^expression	15307955
CPT1A	1374	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of CPT1A mRNA	increases^expression	22521957
CPT1A	1374	Aspirin	D001241	50-78-2	Aspirin results in increased expression of CPT1A mRNA	increases^expression	25743752
CPT1A	1374	Aspirin	D001241	50-78-2	Aspirin results in increased expression of CPT1A protein	increases^expression	25743752
CPT1A	1374	Benzamides	D001549		[Benzamides co-treated with PPARA protein] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	28242381
CPT1A	1374	Benzbromarone	D001553	3562-84-3	Benzbromarone results in increased expression of CPT1A mRNA	increases^expression	25108121
CPT1A	1374	Benzbromarone	D001553	3562-84-3	Benzbromarone results in increased expression of CPT1A protein	increases^expression	25108121
CPT1A	1374	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the expression of CPT1A mRNA	affects^expression	25690898
CPT1A	1374	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of CPT1A 5' UTR	affects^methylation	27901495
CPT1A	1374	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of CPT1A promoter	affects^methylation	27901495
CPT1A	1374	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of CPT1A mRNA	increases^expression	21632981|21871943|22316170
CPT1A	1374	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in increased methylation of CPT1A intron	increases^methylation	30157460
CPT1A	1374	Bezafibrate	D001629	41859-67-0	Bezafibrate promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24534255
CPT1A	1374	Bezafibrate	D001629	41859-67-0	Bezafibrate results in increased expression of CPT1A mRNA	increases^expression	19682441|21640707|21816645
CPT1A	1374	bifenthrin	C099952	82657-04-3	bifenthrin results in decreased expression of CPT1A mRNA	decreases^expression	29554630
CPT1A	1374	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CPT1A mRNA	affects^cotreatment|decreases^expression	28628672
CPT1A	1374	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of CPT1A mRNA	decreases^expression	27685785
CPT1A	1374	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of CPT1A mRNA	increases^expression	20678512
CPT1A	1374	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CPT1A mRNA	affects^cotreatment|decreases^expression	28628672
CPT1A	1374	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of CPT1A mRNA	decreases^expression	26472689
CPT1A	1374	Capsaicin	D002211	404-86-4	Capsaicin promotes the reaction [Palmitic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	21745629
CPT1A	1374	Capsaicin	D002211	404-86-4	Capsaicin results in increased expression of CPT1A mRNA	increases^expression	21745629
CPT1A	1374	Carnitine	D002331		[Doxorubicin co-treated with Carnitine] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	16283381
CPT1A	1374	Carnitine	D002331		[Genistein co-treated with Carnitine] results in increased expression of CPT1A protein	affects^cotreatment|increases^expression	16362726
CPT1A	1374	Clofibrate	D002994	637-07-0	Clofibrate results in increased expression of CPT1A mRNA	increases^expression	16362726
CPT1A	1374	Clofibric Acid	D002995	882-09-7	Clofibric Acid results in increased expression of CPT1A mRNA	increases^expression	21214675
CPT1A	1374	daidzein	C004742	486-66-8	daidzein results in increased expression of CPT1A mRNA	increases^expression	16362726
CPT1A	1374	daidzein	C004742	486-66-8	daidzein results in increased expression of CPT1A protein	increases^expression	16362726
CPT1A	1374	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CPT1A mRNA	affects^cotreatment|decreases^expression	28628672
CPT1A	1374	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CPT1A mRNA	affects^cotreatment|decreases^expression	28628672
CPT1A	1374	Dichlorodiphenyl Dichloroethylene	D003633	72-55-9	Dichlorodiphenyl Dichloroethylene results in decreased expression of CPT1A mRNA	decreases^expression	28397872
CPT1A	1374	Diclofenac	D004008	15307-86-5	Diclofenac results in increased expression of CPT1A mRNA	increases^expression	19022234
CPT1A	1374	dihydroartemisinin	C039060		[dihydroartemisinin co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]	affects^cotreatment|decreases^expression|decreases^reaction	27939985
CPT1A	1374	dihydroartemisinin	C039060		[dihydroartemisinin co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of CPT1A protein]	affects^cotreatment|decreases^expression|decreases^reaction	27939985
CPT1A	1374	dihydroartemisinin	C039060		dihydroartemisinin inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	27939985
CPT1A	1374	dihydroartemisinin	C039060		dihydroartemisinin inhibits the reaction [Ethanol results in decreased expression of CPT1A protein]	decreases^expression|decreases^reaction	27939985
CPT1A	1374	Docosahexaenoic Acids	D004281	25167-62-8	Docosahexaenoic Acids results in increased expression of CPT1A mRNA	increases^expression	15307955
CPT1A	1374	dorsomorphin	C516138		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	dorsomorphin	C516138		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	Doxorubicin	D004317	23214-92-8	[Doxorubicin co-treated with Carnitine] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	16283381
CPT1A	1374	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of CPT1A mRNA	increases^expression	29803840
CPT1A	1374	Dronabinol	D013759		Dronabinol results in decreased expression of CPT1A mRNA	decreases^expression	18454173
CPT1A	1374	entinostat	C118739		entinostat results in increased expression of CPT1A mRNA	increases^expression	26272509
CPT1A	1374	entinostat	C118739		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	Ethanol	D000431	64-17-5	3-(3,4-dimethoxyphenyl)propenoic acid inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	29940154
CPT1A	1374	Ethanol	D000431	64-17-5	[dihydroartemisinin co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]	affects^cotreatment|decreases^expression|decreases^reaction	27939985
CPT1A	1374	Ethanol	D000431	64-17-5	[dihydroartemisinin co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of CPT1A protein]	affects^cotreatment|decreases^expression|decreases^reaction	27939985
CPT1A	1374	Ethanol	D000431	64-17-5	dihydroartemisinin inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	27939985
CPT1A	1374	Ethanol	D000431	64-17-5	dihydroartemisinin inhibits the reaction [Ethanol results in decreased expression of CPT1A protein]	decreases^expression|decreases^reaction	27939985
CPT1A	1374	Ethanol	D000431	64-17-5	Ethanol results in decreased expression of CPT1A mRNA	decreases^expression	27939985|29940154
CPT1A	1374	Ethanol	D000431	64-17-5	Ethanol results in decreased expression of CPT1A protein	decreases^expression	27939985
CPT1A	1374	Ethanol	D000431	64-17-5	NR1H4 protein inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	27939985
CPT1A	1374	Ethanol	D000431	64-17-5	NR1H4 protein inhibits the reaction [Ethanol results in decreased expression of CPT1A protein]	decreases^expression|decreases^reaction	27939985
CPT1A	1374	Ethanol	D000431	64-17-5	obeticholic acid inhibits the reaction [Ethanol results in decreased expression of CPT1A protein]	decreases^expression|decreases^reaction	27939985
CPT1A	1374	Exenatide	D000077270	141732-76-5	Exenatide inhibits the reaction [Palmitates results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	30253173
CPT1A	1374	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	30611723
CPT1A	1374	Fatty Acids, Nonesterified	D005230		Fatty Acids, Nonesterified results in decreased expression of CPT1A protein	decreases^expression	24735863
CPT1A	1374	Fatty Acids, Nonesterified	D005230		Fatty Acids, Nonesterified results in increased expression of CPT1A mRNA	increases^expression	24735863
CPT1A	1374	Fatty Acids, Nonesterified	D005230		Fenofibrate inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of CPT1A protein]	decreases^expression|decreases^reaction	24735863
CPT1A	1374	Fatty Acids, Nonesterified	D005230		Fenofibrate promotes the reaction [Fatty Acids, Nonesterified results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24735863
CPT1A	1374	Fatty Acids, Nonesterified	D005230		hugan qingzhi inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of CPT1A protein]	decreases^expression|decreases^reaction	24735863
CPT1A	1374	Fatty Acids, Nonesterified	D005230		hugan qingzhi promotes the reaction [Fatty Acids, Nonesterified results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24735863
CPT1A	1374	Fenofibrate	D011345	49562-28-9	Fenofibrate inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of CPT1A protein]	decreases^expression|decreases^reaction	24735863
CPT1A	1374	Fenofibrate	D011345	49562-28-9	Fenofibrate promotes the reaction [Fatty Acids, Nonesterified results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24735863
CPT1A	1374	Fenofibrate	D011345	49562-28-9	Fenofibrate promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24534255
CPT1A	1374	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of CPT1A mRNA	increases^expression	17070643|25572481
CPT1A	1374	fenofibric acid	C006012	26129-32-8	[fenofibric acid binds to PPARA protein] which results in increased expression of CPT1A mRNA	affects^binding|increases^expression	16197558
CPT1A	1374	Flame Retardants	D005411		Flame Retardants results in increased expression of CPT1A mRNA	increases^expression	27219277
CPT1A	1374	Fluorouracil	D005472	51-21-8	CPT1A protein affects the susceptibility to Fluorouracil	affects^response to substance	15548681
CPT1A	1374	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of CPT1A mRNA	decreases^expression	23649840
CPT1A	1374	Galactosamine	D005688	7535-00-4	alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	17936189
CPT1A	1374	Galactosamine	D005688	7535-00-4	Galactosamine results in decreased expression of CPT1A mRNA	decreases^expression	17936189
CPT1A	1374	Genistein	D019833	446-72-0	[Genistein co-treated with Carnitine] results in increased expression of CPT1A protein	affects^cotreatment|increases^expression	16362726
CPT1A	1374	Genistein	D019833	446-72-0	Genistein results in increased expression of CPT1A mRNA	increases^expression	16362726
CPT1A	1374	Gold	D006046	7440-57-5	[Polyethyleneimine binds to Gold] which results in decreased expression of CPT1A mRNA	affects^binding|decreases^expression	28433809
CPT1A	1374	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of CPT1A mRNA	affects^cotreatment|decreases^expression	30611723
CPT1A	1374	GW 501516	C425931		[GW 501516 binds to PPARD protein] which results in increased expression of CPT1A mRNA	affects^binding|increases^expression	16197558
CPT1A	1374	GW 7647	C453899		[GW 7647 co-treated with Oleic Acid] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	30611723
CPT1A	1374	GW 7647	C453899		GW 7647 results in increased expression of CPT1A mRNA	increases^expression	27226639|30611723|31676336
CPT1A	1374	Halogenated Diphenyl Ethers	D055768		Halogenated Diphenyl Ethers results in increased expression of CPT1A mRNA	increases^expression	27219277
CPT1A	1374	hugan qingzhi	C000594496		hugan qingzhi inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of CPT1A protein]	decreases^expression|decreases^reaction	24735863
CPT1A	1374	hugan qingzhi	C000594496		hugan qingzhi promotes the reaction [Fatty Acids, Nonesterified results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24735863
CPT1A	1374	Hydrocortisone	D006854	50-23-7	Hydrocortisone results in decreased expression of CPT1A mRNA	decreases^expression	30776459
CPT1A	1374	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CPT1A mRNA	affects^cotreatment|decreases^expression	28628672
CPT1A	1374	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CPT1A mRNA	affects^cotreatment|decreases^expression	28628672
CPT1A	1374	Ivermectin	D007559	70288-86-7	Ivermectin inhibits the reaction [Palmitic Acid results in increased expression of CPT1A mRNA]	decreases^reaction|increases^expression	30738135
CPT1A	1374	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of CPT1A mRNA	decreases^expression	23086925
CPT1A	1374	Leflunomide	D000077339	75706-12-6	Leflunomide results in increased expression of CPT1A mRNA	increases^expression	28988120|29427785
CPT1A	1374	mercuric bromide	C042720	7789-47-1	mercuric bromide results in increased expression of CPT1A mRNA	increases^expression	26272509
CPT1A	1374	mercuric bromide	C042720	7789-47-1	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	Methapyrilene	D008701	91-80-5	Methapyrilene results in increased methylation of CPT1A intron	increases^methylation	30157460
CPT1A	1374	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of CPT1A mRNA	increases^expression	17400583
CPT1A	1374	muraglitazar	C500085		muraglitazar promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24534255
CPT1A	1374	obeticholic acid	C464660		obeticholic acid inhibits the reaction [Ethanol results in decreased expression of CPT1A protein]	decreases^expression|decreases^reaction	27939985
CPT1A	1374	obeticholic acid	C464660		obeticholic acid results in increased expression of CPT1A mRNA	increases^expression	27939613
CPT1A	1374	Oleic Acid	D019301	112-80-1	Bezafibrate promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24534255
CPT1A	1374	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	30611723
CPT1A	1374	Oleic Acid	D019301	112-80-1	Fenofibrate promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24534255
CPT1A	1374	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of CPT1A mRNA	affects^cotreatment|decreases^expression	30611723
CPT1A	1374	Oleic Acid	D019301	112-80-1	[GW 7647 co-treated with Oleic Acid] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	30611723
CPT1A	1374	Oleic Acid	D019301	112-80-1	muraglitazar promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24534255
CPT1A	1374	Oleic Acid	D019301	112-80-1	Oleic Acid results in increased expression of CPT1A mRNA	increases^expression	24534255
CPT1A	1374	Oleic Acid	D019301	112-80-1	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in decreased expression of CPT1A protein	affects^cotreatment|decreases^expression	30547786
CPT1A	1374	Oleic Acid	D019301	112-80-1	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	30547786
CPT1A	1374	Oleic Acid	D019301	112-80-1	[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of CPT1A protein	affects^cotreatment|decreases^expression	30547786
CPT1A	1374	Oleic Acid	D019301	112-80-1	[Palmitic Acid co-treated with Oleic Acid] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	30547786
CPT1A	1374	Oleic Acid	D019301	112-80-1	Rosiglitazone promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24534255
CPT1A	1374	Oleic Acid	D019301	112-80-1	tesaglitazar promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24534255
CPT1A	1374	Orlistat	D000077403	96829-58-2	Orlistat results in decreased expression of CPT1A protein	decreases^expression	30667213
CPT1A	1374	osthol	C046627	484-12-8	osthol results in increased expression of CPT1A mRNA	increases^expression	19682441
CPT1A	1374	Oxygen	D010100	7782-44-7	CPT1A protein results in increased metabolism of Oxygen	increases^metabolic processing	31040181
CPT1A	1374	Oxygen	D010100	7782-44-7	EPAS1 gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	24503013
CPT1A	1374	Oxygen	D010100	7782-44-7	HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	24503013
CPT1A	1374	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of CPT1A mRNA	decreases^expression	24503013
CPT1A	1374	Paclitaxel	D017239		Paclitaxel results in decreased expression of CPT1A protein	decreases^expression	30667213
CPT1A	1374	Palmitates	D010168		Exenatide inhibits the reaction [Palmitates results in decreased expression of CPT1A mRNA]	decreases^expression|decreases^reaction	30253173
CPT1A	1374	Palmitates	D010168		Palmitates results in decreased expression of CPT1A mRNA	decreases^expression	30253173
CPT1A	1374	Palmitic Acid	D019308	57-10-3	Capsaicin promotes the reaction [Palmitic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	21745629
CPT1A	1374	Palmitic Acid	D019308	57-10-3	Ivermectin inhibits the reaction [Palmitic Acid results in increased expression of CPT1A mRNA]	decreases^reaction|increases^expression	30738135
CPT1A	1374	Palmitic Acid	D019308	57-10-3	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in decreased expression of CPT1A protein	affects^cotreatment|decreases^expression	30547786
CPT1A	1374	Palmitic Acid	D019308	57-10-3	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	30547786
CPT1A	1374	Palmitic Acid	D019308	57-10-3	[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of CPT1A protein	affects^cotreatment|decreases^expression	30547786
CPT1A	1374	Palmitic Acid	D019308	57-10-3	[Palmitic Acid co-treated with Oleic Acid] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	30547786
CPT1A	1374	Palmitic Acid	D019308	57-10-3	Palmitic Acid results in increased expression of CPT1A mRNA	increases^expression	21745629|30738135
CPT1A	1374	Palmitic Acid	D019308	57-10-3	Permethrin inhibits the reaction [Palmitic Acid results in increased expression of CPT1A mRNA]	decreases^reaction|increases^expression	30738135
CPT1A	1374	paricalcitol	C084656		[Phosphorus co-treated with paricalcitol] affects the expression of CPT1A mRNA	affects^cotreatment|affects^expression	17715259
CPT1A	1374	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	p-Chloromercuribenzoic Acid	D020245	59-85-8	p-Chloromercuribenzoic Acid results in increased expression of CPT1A mRNA	increases^expression	26272509
CPT1A	1374	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether results in increased expression of CPT1A mRNA	increases^expression	26705709
CPT1A	1374	perfluorobutane	C108042		perfluorobutane results in increased expression of CPT1A mRNA	increases^expression	23567314
CPT1A	1374	perfluorobutyric acid	C033094	375-22-4	perfluorobutyric acid results in decreased expression of CPT1A mRNA	decreases^expression	23567314
CPT1A	1374	perfluorodecanoic acid	C036567	335-76-2	perfluorodecanoic acid affects the expression of CPT1A mRNA	affects^expression	23567314
CPT1A	1374	perfluorododecanoic acid	C522391		perfluorododecanoic acid affects the expression of CPT1A mRNA	affects^expression	23567314
CPT1A	1374	perfluorohexanesulfonic acid	C471071	355-46-4	perfluorohexanesulfonic acid affects the expression of CPT1A mRNA	affects^expression	23567314
CPT1A	1374	perfluorohexanoic acid	C479228		perfluorohexanoic acid results in increased expression of CPT1A mRNA	increases^expression	23567314
CPT1A	1374	perfluoro-n-heptanoic acid	C101815	375-85-9	perfluoro-n-heptanoic acid affects the expression of CPT1A mRNA	affects^expression	23567314
CPT1A	1374	perfluoro-n-nonanoic acid	C101816	375-95-1	perfluoro-n-nonanoic acid results in increased expression of CPT1A mRNA	increases^expression	23567314
CPT1A	1374	perfluorononanoic acid	C584865		perfluorononanoic acid results in increased expression of CPT1A mRNA	increases^expression	32588087
CPT1A	1374	perfluoro-n-undecanoic acid	C101814	2058-94-8	perfluoro-n-undecanoic acid results in increased expression of CPT1A mRNA	increases^expression	23567314
CPT1A	1374	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in increased expression of CPT1A mRNA	increases^expression	23567314|27153767
CPT1A	1374	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid affects the expression of CPT1A mRNA	affects^expression	23567314
CPT1A	1374	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of CPT1A mRNA	increases^expression	23978341|25868421|27153767|31676336|32588087
CPT1A	1374	periodate-oxidized adenosine	C027579	34240-05-6	periodate-oxidized adenosine affects the expression of CPT1A mRNA	affects^expression	17097637
CPT1A	1374	Permethrin	D026023	52645-53-1	Permethrin inhibits the reaction [Palmitic Acid results in increased expression of CPT1A mRNA]	decreases^reaction|increases^expression	30738135
CPT1A	1374	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of CPT1A mRNA	increases^expression	26272509
CPT1A	1374	Phosphorus	D010758	7723-14-0	[Phosphorus co-treated with paricalcitol] affects the expression of CPT1A mRNA	affects^cotreatment|affects^expression	17715259
CPT1A	1374	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CPT1A mRNA	affects^binding|increases^activity|increases^expression	19710929
CPT1A	1374	pirinixic acid	C006253	50892-23-4	[pirinixic acid co-treated with PPARA protein] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	28242381
CPT1A	1374	pirinixic acid	C006253	50892-23-4	pirinixic acid results in increased expression of CPT1A mRNA	increases^expression	25092180|31676336
CPT1A	1374	Polyethyleneimine	D011094	9002-98-6	[Polyethyleneimine binds to Gold] which results in decreased expression of CPT1A mRNA	affects^binding|decreases^expression	28433809
CPT1A	1374	puag-haad	C034912	07/07/4721	puag-haad results in increased expression of CPT1A mRNA	increases^expression	29702089
CPT1A	1374	Quercetin	D011794	117-39-5	Quercetin results in increased expression of CPT1A mRNA	increases^expression	21632981
CPT1A	1374	Resveratrol	D000077185		Resveratrol promotes the reaction [Triiodothyronine results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	23209300
CPT1A	1374	Resveratrol	D000077185		Resveratrol results in increased expression of CPT1A mRNA	increases^expression	23209300
CPT1A	1374	Resveratrol	D000077185		Resveratrol results in increased expression of CPT1A protein	increases^expression	25943029
CPT1A	1374	Rosiglitazone	D000077154		Rosiglitazone promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24534255
CPT1A	1374	Rosiglitazone	D000077154		Rosiglitazone results in increased expression of CPT1A mRNA	increases^expression	25572481
CPT1A	1374	Rotenone	D012402	83-79-4	Rotenone results in increased expression of CPT1A mRNA	increases^expression	29955902
CPT1A	1374	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide results in decreased expression of CPT1A mRNA	decreases^expression	25351596
CPT1A	1374	sodium arsenite	C017947	13768-07-5	EPAS1 protein affects the reaction [sodium arsenite results in decreased expression of CPT1A protein]	affects^reaction|decreases^expression	30334557
CPT1A	1374	sodium arsenite	C017947	13768-07-5	sodium arsenite affects the methylation of CPT1A gene	affects^methylation	28589171
CPT1A	1374	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of CPT1A mRNA	decreases^expression	30334557
CPT1A	1374	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of CPT1A protein	decreases^expression	30334557
CPT1A	1374	Sodium Dodecyl Sulfate	D012967	151-21-3	Sodium Dodecyl Sulfate results in increased expression of CPT1A mRNA	increases^expression	31734321
CPT1A	1374	tesaglitazar	C501413		tesaglitazar promotes the reaction [Oleic Acid results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	24534255
CPT1A	1374	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of CPT1A mRNA	affects^expression	22298810
CPT1A	1374	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of CPT1A mRNA	increases^expression	17555868|20106945|21632981
CPT1A	1374	tetradecylselenoacetic acid	C410666		tetradecylselenoacetic acid results in increased expression of CPT1A mRNA	increases^expression	17185614
CPT1A	1374	tetrahydropalmatine	C014215	10097-84-4	tetrahydropalmatine results in decreased expression of CPT1A protein	decreases^expression	20109541
CPT1A	1374	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of CPT1A mRNA	increases^expression	30610935
CPT1A	1374	tributyl phosphate	C009524	126-73-8	tributyl phosphate results in increased expression of CPT1A mRNA	increases^expression	30966736
CPT1A	1374	Triclosan	D014260	3380-34-5	Triclosan results in decreased expression of CPT1A mRNA	decreases^expression	30510588
CPT1A	1374	Triiodothyronine	D014284	03/02/6893	Resveratrol promotes the reaction [Triiodothyronine results in increased expression of CPT1A mRNA]	increases^expression|increases^reaction	23209300
CPT1A	1374	Triiodothyronine	D014284	03/02/6893	Triiodothyronine results in increased expression of CPT1A mRNA	increases^expression	23209300
CPT1A	1374	triparacresyl phosphate	C421642		triparacresyl phosphate results in decreased expression of CPT1A mRNA	decreases^expression	30966736
CPT1A	1374	triphenyl phosphate	C005445	115-86-6	triphenyl phosphate results in decreased expression of CPT1A mRNA	decreases^expression	30966736
CPT1A	1374	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of CPT1A mRNA	decreases^expression	30966736
CPT1A	1374	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of CPT1A mRNA	increases^expression	26179874
CPT1A	1374	tris(1-chloro-2-propyl)phosphate	C000610787		tris(1-chloro-2-propyl)phosphate results in decreased expression of CPT1A mRNA	decreases^expression	30966736
CPT1A	1374	tris(2-butoxyethyl) phosphate	C013320	78-51-3	tris(2-butoxyethyl) phosphate affects the expression of CPT1A mRNA	affects^expression	29024780
CPT1A	1374	tris(2-ethylhexyl)phosphate	C049232	78-42-2	tris(2-ethylhexyl)phosphate results in increased expression of CPT1A mRNA	increases^expression	30966736
CPT1A	1374	tris(chloroethyl)phosphate	C031324		tris(chloroethyl)phosphate results in decreased expression of CPT1A mRNA	decreases^expression	30966736
CPT1A	1374	Troglitazone	D000077288	97322-87-7	Troglitazone results in increased expression of CPT1A mRNA	increases^expression	19022234|25572481
CPT1A	1374	Urea	D014508	57-13-6	Urea analog results in increased expression of CPT1A mRNA	increases^expression	15798002
CPT1A	1374	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CPT1A mRNA	affects^cotreatment|increases^expression	27188386
CPT1A	1374	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of CPT1A mRNA	affects^expression	25979313
CPT1A	1374	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of CPT1A mRNA	decreases^expression	29501571
CPT1A	1374	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of CPT1A gene	decreases^methylation	29501571
CPT1A	1374	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of CPT1A mRNA	increases^expression	20371285|23179753|24935251|26272509|27188386|28001369|29154799
CPT1A	1374	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of CPT1A gene	increases^methylation	29154799
CPT1A	1374	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of CPT1A mRNA	decreases^expression	28871336
CPT1A	1374	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of CPT1A protein	decreases^expression	28871336
CPT1C	126129	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPT1C mRNA	affects^cotreatment|decreases^expression	27188386
CPT1C	126129	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of CPT1C intron	decreases^methylation	30157460
CPT1C	126129	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of CPT1C mRNA	decreases^expression	22378314
CPT1C	126129	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of CPT1C 5' UTR	decreases^methylation	27901495
CPT1C	126129	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of CPT1C promoter	increases^methylation	27901495
CPT1C	126129	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in decreased methylation of CPT1C exon	decreases^methylation	30157460
CPT1C	126129	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of CPT1C mRNA	increases^expression	29275510
CPT1C	126129	Bortezomib	D000069286		CPT1C gene SNP results in increased susceptibility to Bortezomib	increases^response to substance	20864405
CPT1C	126129	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPT1C mRNA	affects^cotreatment|decreases^expression	27188386
CPT1C	126129	Methapyrilene	D008701	91-80-5	Methapyrilene results in decreased methylation of CPT1C exon	decreases^methylation	30157460
CPT1C	126129	MRK 003	C523799		MRK 003 results in decreased expression of CPT1C mRNA	decreases^expression	21169257
CPT1C	126129	nickel sulfate	C029938	7786-81-4	nickel sulfate results in decreased expression of CPT1C mRNA	decreases^expression	22714537
CPT1C	126129	O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate	C009618	5598-15-2	PON1 gene polymorphism affects the susceptibility to [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate affects the expression of CPT1C mRNA]	affects^expression|affects^response to substance	21673326
CPT1C	126129	Plant Extracts	D010936		Plant Extracts results in decreased expression of CPT1C mRNA	decreases^expression	23557933
CPT1C	126129	propionaldehyde	C005556	123-38-6	propionaldehyde results in increased expression of CPT1C mRNA	increases^expression	26079696
CPT1C	126129	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of CPT1C mRNA	decreases^expression	22714537
CPT1C	126129	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of CPT1C mRNA	increases^expression	22378314
CPT1C	126129	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of CPT1C mRNA	decreases^expression	21934132
CPT1C	126129	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPT1C mRNA	affects^cotreatment|decreases^expression	27188386
CPT1C	126129	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of CPT1C mRNA	affects^expression	28542535
CPT1C	126129	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of CPT1C mRNA	decreases^expression	24935251|26272509
CPT1C	126129	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of CPT1C mRNA	increases^expression	22378314
CPT1C	126129	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of CPT1C gene	increases^methylation	29154799
CRAT	1384	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of CRAT mRNA	increases^expression	22378314
CRAT	1384	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of CRAT mRNA	decreases^expression	32234424
CRAT	1384	Carmustine	D002330	154-93-8	Carmustine results in decreased expression of CRAT mRNA	decreases^expression	15980968
CRAT	1384	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of CRAT mRNA	decreases^expression	19376846
CRAT	1384	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of CRAT mRNA	decreases^expression	19549813
CRAT	1384	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of CRAT mRNA	decreases^expression	20106945
CRAT	1384	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of CRAT gene	increases^methylation	22964155
CRAT	1384	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of CRAT mRNA	decreases^expression	20436886
CRAT	1384	Nickel	D009532	7440-02-0	Nickel results in decreased expression of CRAT mRNA	decreases^expression	24768652
CRAT	1384	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of CRAT mRNA	increases^expression	23978341|25868421
CRAT	1384	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of CRAT protein	increases^expression	26879310
CRAT	1384	Potassium Dichromate	D011192	7778-50-9	Potassium Dichromate results in increased expression of CRAT protein	increases^expression	23718831
CRAT	1384	Selenium	D012643	7782-49-2	Selenium results in increased expression of CRAT mRNA	increases^expression	19244175
CRAT	1384	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of CRAT mRNA	decreases^expression	15336504
CRAT	1384	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of CRAT mRNA	decreases^expression	21998131
CRAT	1384	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of CRAT mRNA	increases^expression	22378314
CRAT	1384	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of CRAT mRNA	increases^expression	22378314
CRAT	1384	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of CRAT mRNA	affects^expression	25979313
CRAT	1384	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of CRAT gene	increases^methylation	29154799
CYP26B1	56603	abrine	C496492		abrine results in decreased expression of CYP26B1 mRNA	decreases^expression	31054353
CYP26B1	56603	Arecoline	D001115	63-75-2	Arecoline results in decreased expression of CYP26B1 mRNA	decreases^expression	17682004
CYP26B1	56603	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of CYP26B1 gene	affects^methylation	25304211
CYP26B1	56603	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of CYP26B1 mRNA	increases^expression	32234424
CYP26B1	56603	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	bis(4-hydroxyphenyl)sulfone results in increased expression of CYP26B1 mRNA	increases^expression	27685785
CYP26B1	56603	Calcitriol	D002117	32222-06-3	Calcitriol results in increased expression of CYP26B1 mRNA	increases^expression	16002434|26485663
CYP26B1	56603	Camptothecin	D002166	04/03/7689	CYP26B1 mRNA results in decreased susceptibility to Camptothecin	decreases^response to substance	25269479
CYP26B1	56603	Cisplatin	D002945	15663-27-1	Cisplatin affects the expression of CYP26B1 mRNA	affects^expression	23300844
CYP26B1	56603	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of CYP26B1 mRNA	affects^cotreatment|decreases^expression	27392435
CYP26B1	56603	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of CYP26B1 mRNA	decreases^expression	27392435
CYP26B1	56603	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of CYP26B1 mRNA	increases^expression	19549813
CYP26B1	56603	Decitabine	D000077209	2353-33-5	Decitabine affects the expression of CYP26B1 mRNA	affects^expression	23300844
CYP26B1	56603	DEET	D003671	134-62-3	[fipronil co-treated with DEET] results in increased expression of CYP26B1 mRNA	affects^cotreatment|increases^expression	27091632
CYP26B1	56603	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of CYP26B1 mRNA	decreases^expression	29803840
CYP26B1	56603	Estradiol	D004958	50-28-2	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP26B1 mRNA	affects^cotreatment|decreases^expression	19619570
CYP26B1	56603	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in increased expression of CYP26B1 mRNA	affects^cotreatment|increases^expression	30165855
CYP26B1	56603	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of CYP26B1 mRNA	decreases^expression	19619570
CYP26B1	56603	Ethinyl Estradiol	D004997	57-63-6	Ethinyl Estradiol results in decreased expression of CYP26B1 mRNA	decreases^expression	18936297
CYP26B1	56603	fipronil	C082360	120068-37-3	[fipronil co-treated with DEET] results in increased expression of CYP26B1 mRNA	affects^cotreatment|increases^expression	27091632
CYP26B1	56603	fipronil	C082360	120068-37-3	fipronil results in increased expression of CYP26B1 mRNA	increases^expression	27091632
CYP26B1	56603	Isotretinoin	D015474	4759-48-2	Isotretinoin results in increased expression of CYP26B1 mRNA	increases^expression	17486130|18769122
CYP26B1	56603	Isotretinoin	D015474	4759-48-2	R116010 promotes the reaction [Isotretinoin results in increased expression of CYP26B1 mRNA]	increases^expression|increases^reaction	17486130
CYP26B1	56603	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of CYP26B1 mRNA	affects^cotreatment|decreases^expression	27392435
CYP26B1	56603	Ketoconazole	D007654	65277-42-1	Ketoconazole inhibits the reaction [CYP26B1 protein results in increased metabolism of Tretinoin]	decreases^reaction|increases^metabolic processing	21906690
CYP26B1	56603	Ketoconazole	D007654	65277-42-1	Ketoconazole inhibits the reaction [CYP26B1 results in increased metabolism of Tretinoin]	decreases^reaction|increases^metabolic processing	14532297
CYP26B1	56603	Ketoconazole	D007654	65277-42-1	Ketoconazole results in decreased activity of CYP26B1	decreases^activity	14532297
CYP26B1	56603	kojic acid	C011890	501-30-4	kojic acid results in increased expression of CYP26B1 mRNA	increases^expression	16595896
CYP26B1	56603	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of CYP26B1 mRNA	decreases^expression	30851411
CYP26B1	56603	Oleic Acid	D019301	112-80-1	[Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26B1 mRNA	affects^cotreatment|increases^expression	30547786
CYP26B1	56603	Palmitic Acid	D019308	57-10-3	[Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26B1 mRNA	affects^cotreatment|increases^expression	30547786
CYP26B1	56603	Phenobarbital	D010634	50-06-6	Phenobarbital results in increased expression of CYP26B1 mRNA	increases^expression	22258563
CYP26B1	56603	quercitrin	C012526	522-12-3	quercitrin results in increased expression of CYP26B1 mRNA	increases^expression	25193878
CYP26B1	56603	R 115866	C406527		[R 115866 results in decreased activity of CYP26B1 protein] which results in increased activity of Tretinoin	decreases^activity|increases^activity	20606468
CYP26B1	56603	R116010	C450682		R116010 promotes the reaction [Isotretinoin results in increased expression of CYP26B1 mRNA]	increases^expression|increases^reaction	17486130
CYP26B1	56603	R116010	C450682		R116010 promotes the reaction [Tretinoin results in increased expression of CYP26B1 mRNA]	increases^expression|increases^reaction	17486130
CYP26B1	56603	Raloxifene Hydrochloride	D020849		[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of CYP26B1 mRNA	affects^cotreatment|decreases^expression	19059307
CYP26B1	56603	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in decreased expression of CYP26B1 mRNA	decreases^expression	25895662
CYP26B1	56603	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in increased expression of CYP26B1 mRNA	increases^expression	23806026
CYP26B1	56603	Sunitinib	D000077210		Sunitinib results in decreased expression of CYP26B1 mRNA	decreases^expression	31533062
CYP26B1	56603	Tamoxifen	D013629	10540-29-1	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of CYP26B1 mRNA	affects^cotreatment|decreases^expression	19059307
CYP26B1	56603	Tetrachlorodibenzodioxin	D013749	1746-01-6	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP26B1 mRNA	affects^cotreatment|decreases^expression	19619570
CYP26B1	56603	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of CYP26B1 mRNA	decreases^expression	19619570
CYP26B1	56603	Tretinoin	D014212	302-79-4	CYP26B1 gene SNP results in decreased abundance of Tretinoin	decreases^abundance	29379198
CYP26B1	56603	Tretinoin	D014212	302-79-4	CYP26B1 protein affects the degradation of Tretinoin	affects^degradation	16574820
CYP26B1	56603	Tretinoin	D014212	302-79-4	CYP26B1 protein binds to and results in increased metabolism of Tretinoin	affects^binding|increases^metabolic processing	21906690
CYP26B1	56603	Tretinoin	D014212	302-79-4	CYP26B1 protein results in decreased activity of Tretinoin	decreases^activity	20606468
CYP26B1	56603	Tretinoin	D014212	302-79-4	CYP26B1 protein results in increased metabolism of and results in decreased abundance of Tretinoin	decreases^abundance|increases^metabolic processing	29379198
CYP26B1	56603	Tretinoin	D014212	302-79-4	CYP26B1 protein results in increased metabolism of Tretinoin	increases^metabolic processing	17486130
CYP26B1	56603	Tretinoin	D014212	302-79-4	CYP26B1 results in increased metabolism of Tretinoin	increases^metabolic processing	14532297
CYP26B1	56603	Tretinoin	D014212	302-79-4	Ketoconazole inhibits the reaction [CYP26B1 protein results in increased metabolism of Tretinoin]	decreases^reaction|increases^metabolic processing	21906690
CYP26B1	56603	Tretinoin	D014212	302-79-4	Ketoconazole inhibits the reaction [CYP26B1 results in increased metabolism of Tretinoin]	decreases^reaction|increases^metabolic processing	14532297
CYP26B1	56603	Tretinoin	D014212	302-79-4	[R 115866 results in decreased activity of CYP26B1 protein] which results in increased activity of Tretinoin	decreases^activity|increases^activity	20606468
CYP26B1	56603	Tretinoin	D014212	302-79-4	R116010 promotes the reaction [Tretinoin results in increased expression of CYP26B1 mRNA]	increases^expression|increases^reaction	17486130
CYP26B1	56603	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of CYP26B1 mRNA	increases^expression	17431108|17486130|20606468|21934132|23724009|23830798
CYP26B1	56603	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of CYP26B1 mRNA	increases^expression	24935251
CYP26B1	56603	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of CYP26B1 mRNA	increases^expression	24383497|28001369
CYP26B1	56603	walrycin A	C574123		walrycin A results in increased expression of CYP26B1 mRNA	increases^expression	22314385
CYP4V2	285440	12-hydroxydodecanoic acid	C031263	505-95-3	2-chloro-5-nitrobenzanilide inhibits the reaction [CYP4V2 protein results in increased chemical synthesis of 12-hydroxydodecanoic acid]	decreases^reaction|increases^chemical synthesis	28729181
CYP4V2	285440	12-hydroxydodecanoic acid	C031263	505-95-3	CYP4V2 protein results in increased chemical synthesis of 12-hydroxydodecanoic acid	increases^chemical synthesis	28729181
CYP4V2	285440	2-chloro-5-nitrobenzanilide	C457499		2-chloro-5-nitrobenzanilide inhibits the reaction [CYP4V2 protein results in increased chemical synthesis of 12-hydroxydodecanoic acid]	decreases^reaction|increases^chemical synthesis	28729181
CYP4V2	285440	2-chloro-5-nitrobenzanilide	C457499		2-chloro-5-nitrobenzanilide results in decreased expression of CYP4V2 mRNA	decreases^expression	28729181
CYP4V2	285440	2-chloro-5-nitrobenzanilide	C457499		2-chloro-5-nitrobenzanilide results in decreased expression of CYP4V2 protein	decreases^expression	28729181
CYP4V2	285440	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYP4V2 mRNA	affects^cotreatment|decreases^expression	27188386
CYP4V2	285440	abrine	C496492		abrine results in decreased expression of CYP4V2 mRNA	decreases^expression	31054353
CYP4V2	285440	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of CYP4V2 protein	affects^expression	20106945
CYP4V2	285440	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of CYP4V2 mRNA	decreases^expression	27153756
CYP4V2	285440	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of CYP4V2 mRNA	decreases^expression	22378314
CYP4V2	285440	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of CYP4V2 mRNA	decreases^expression	32234424
CYP4V2	285440	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of CYP4V2 mRNA	affects^expression	21179406
CYP4V2	285440	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of CYP4V2 mRNA	increases^expression	27685785|29275510|31715268
CYP4V2	285440	butyraldehyde	C018475	123-72-8	butyraldehyde results in decreased expression of CYP4V2 mRNA	decreases^expression	26079696
CYP4V2	285440	C646 compound	C584509		C646 compound results in increased expression of CYP4V2 mRNA	increases^expression	26191083
CYP4V2	285440	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of CYP4V2 mRNA	decreases^expression	19549813
CYP4V2	285440	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of CYP4V2 mRNA	decreases^expression	20106945|25562108
CYP4V2	285440	DEET	D003671	134-62-3	[fipronil co-treated with DEET] results in decreased expression of CYP4V2 mRNA	affects^cotreatment|decreases^expression	27091632
CYP4V2	285440	Demecolcine	D003703	477-30-5	Demecolcine results in decreased expression of CYP4V2 mRNA	decreases^expression	23649840
CYP4V2	285440	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in decreased expression of CYP4V2 mRNA	decreases^expression	31163220
CYP4V2	285440	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYP4V2 mRNA	affects^cotreatment|decreases^expression	27188386
CYP4V2	285440	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of CYP4V2 mRNA	decreases^expression	29803840
CYP4V2	285440	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in increased expression of CYP4V2 mRNA	affects^cotreatment|increases^expression	30165855
CYP4V2	285440	fipronil	C082360	120068-37-3	[fipronil co-treated with DEET] results in decreased expression of CYP4V2 mRNA	affects^cotreatment|decreases^expression	27091632
CYP4V2	285440	fipronil	C082360	120068-37-3	fipronil results in decreased expression of CYP4V2 mRNA	decreases^expression	27091632
CYP4V2	285440	GSK-J4	C000593030		GSK-J4 results in decreased expression of CYP4V2 mRNA	decreases^expression	29301935
CYP4V2	285440	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of CYP4V2 mRNA	increases^expression	17400583
CYP4V2	285440	polyhexamethyleneguanidine	C060540	31961-54-3	polyhexamethyleneguanidine affects the expression of CYP4V2 mRNA	affects^expression	29337256
CYP4V2	285440	Sunitinib	D000077210		Sunitinib results in increased expression of CYP4V2 mRNA	increases^expression	31533062
CYP4V2	285440	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of CYP4V2 mRNA	increases^expression	20106945
CYP4V2	285440	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of CYP4V2 mRNA	increases^expression	22378314
CYP4V2	285440	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of CYP4V2 mRNA	decreases^expression	24935251
CYP4V2	285440	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of CYP4V2 mRNA	increases^expression	26179874
CYP4V2	285440	tris(2-butoxyethyl) phosphate	C013320	78-51-3	tris(2-butoxyethyl) phosphate affects the expression of CYP4V2 mRNA	affects^expression	29024780
CYP4V2	285440	Urethane	D014520	51-79-6	Urethane results in decreased expression of CYP4V2 mRNA	decreases^expression	28818685
CYP4V2	285440	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYP4V2 mRNA	affects^cotreatment|decreases^expression	27188386
CYP4V2	285440	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of CYP4V2 mRNA	decreases^expression	23179753|24383497|26272509|29154799
CYP4V2	285440	Vincristine	D014750		Vincristine results in decreased expression of CYP4V2 mRNA	decreases^expression	23649840
DAGLA	747	1-stearoyl-2-arachidonoylglycerol	C075809	65914-84-3	DAGLA protein results in increased metabolism of 1-stearoyl-2-arachidonoylglycerol	increases^metabolic processing	18657971
DAGLA	747	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of DAGLA 3' UTR	increases^methylation	30157460
DAGLA	747	arachidonyl-2-chloroethylamide	C119325		arachidonyl-2-chloroethylamide results in increased expression of DAGLA mRNA	increases^expression	31912162
DAGLA	747	arachidonyl-2-chloroethylamide	C119325		ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLA mRNA]	affects^reaction|increases^expression	31912162
DAGLA	747	arachidonyl-2-chloroethylamide	C119325		GSK5182 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLA mRNA]	decreases^reaction|increases^expression	31912162
DAGLA	747	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of DAGLA mRNA	decreases^expression	22378314
DAGLA	747	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of DAGLA 5' UTR	affects^methylation	27901495
DAGLA	747	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of DAGLA promoter	affects^methylation	27901495
DAGLA	747	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of DAGLA mRNA	increases^expression	19549813
DAGLA	747	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of DAGLA mRNA	increases^expression	25562108
DAGLA	747	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of DAGLA mRNA	increases^expression	28302478
DAGLA	747	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in decreased expression of DAGLA mRNA	affects^cotreatment|decreases^expression	30165855
DAGLA	747	GSK5182	C583041		GSK5182 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLA mRNA]	decreases^reaction|increases^expression	31912162
DAGLA	747	kojic acid	C011890	501-30-4	kojic acid results in increased expression of DAGLA mRNA	increases^expression	16595896
DAGLA	747	Lead	D007854	7439-92-1	Lead affects the expression of DAGLA mRNA	affects^expression	28903495
DAGLA	747	methyl arachidonylfluorophosphonate	C104810		methyl arachidonylfluorophosphonate analog results in decreased activity of DAGLA protein	decreases^activity	16466961
DAGLA	747	methyl arachidonylfluorophosphonate	C104810		methyl arachidonylfluorophosphonate results in decreased activity of DAGLA protein	decreases^activity	16466961
DAGLA	747	Orlistat	D000077403	96829-58-2	Orlistat results in decreased activity of DAGLA protein	decreases^activity	16466961
DAGLA	747	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of DAGLA mRNA	affects^expression	19159669
DAGLA	747	Sunitinib	D000077210		Sunitinib results in decreased expression of DAGLA mRNA	decreases^expression	31533062
DAGLA	747	tamibarotene	C061133	94497-51-5	tamibarotene affects the expression of DAGLA mRNA	affects^expression	15498508
DAGLA	747	Tretinoin	D014212	302-79-4	Tretinoin affects the expression of DAGLA mRNA	affects^expression	15498508
DAGLA	747	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of DAGLA mRNA	increases^expression	26179874
DAGLA	747	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of DAGLA gene	increases^methylation	29154799
DAGLB	221955	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DAGLB mRNA	affects^cotreatment|increases^expression	28628672
DAGLB	221955	1-stearoyl-2-arachidonoylglycerol	C075809	65914-84-3	DAGLB protein results in increased metabolism of 1-stearoyl-2-arachidonoylglycerol	increases^metabolic processing	18657971
DAGLB	221955	(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	C517041		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of DAGLB mRNA	increases^expression	19561079
DAGLB	221955	abrine	C496492		abrine results in increased expression of DAGLB mRNA	increases^expression	31054353
DAGLB	221955	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of DAGLB mRNA	increases^expression	29067470
DAGLB	221955	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of DAGLB intron	increases^methylation	30157460
DAGLB	221955	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of DAGLB mRNA	decreases^expression	24449571
DAGLB	221955	arachidonyl-2-chloroethylamide	C119325		arachidonyl-2-chloroethylamide results in increased expression of DAGLB mRNA	increases^expression	31912162
DAGLB	221955	arachidonyl-2-chloroethylamide	C119325		ESRRG protein affects the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLB mRNA]	affects^reaction|increases^expression	31912162
DAGLB	221955	arachidonyl-2-chloroethylamide	C119325		GSK5182 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLB mRNA]	decreases^reaction|increases^expression	31912162
DAGLB	221955	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of DAGLB promoter	increases^methylation	27901495
DAGLB	221955	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of DAGLB mRNA	affects^expression	21179406
DAGLB	221955	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DAGLB mRNA	affects^cotreatment|increases^expression	28628672
DAGLB	221955	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of DAGLB mRNA	affects^expression	25979313
DAGLB	221955	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of DAGLB mRNA	affects^cotreatment|decreases^expression	27392435
DAGLB	221955	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of DAGLB mRNA	increases^expression	19549813
DAGLB	221955	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of DAGLB mRNA	increases^expression	20106945
DAGLB	221955	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DAGLB mRNA	affects^cotreatment|increases^expression	28628672
DAGLB	221955	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in increased expression of DAGLB protein	increases^expression	31163220
DAGLB	221955	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of DAGLB mRNA	increases^expression	29803840
DAGLB	221955	GSK5182	C583041		GSK5182 inhibits the reaction [arachidonyl-2-chloroethylamide results in increased expression of DAGLB mRNA]	decreases^reaction|increases^expression	31912162
DAGLB	221955	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DAGLB mRNA	affects^cotreatment|increases^expression	28628672
DAGLB	221955	Irinotecan	D000077146		Irinotecan analog results in decreased expression of DAGLB mRNA	decreases^expression	18927307
DAGLB	221955	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of DAGLB mRNA	affects^cotreatment|decreases^expression	27392435
DAGLB	221955	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of DAGLB mRNA	decreases^expression	30851411
DAGLB	221955	oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine	C472349		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of DAGLB mRNA	affects^expression	17655762
DAGLB	221955	oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine	C472349		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Particulate Matter affects the expression of DAGLB mRNA]	affects^expression|increases^reaction	17655762
DAGLB	221955	oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine	C472349		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Vehicle Emissions affects the expression of DAGLB mRNA]	affects^expression|increases^reaction	17655762
DAGLB	221955	oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine	C472349		Particulate Matter promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of DAGLB mRNA]	affects^expression|increases^reaction	17655762
DAGLB	221955	oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine	C472349		Vehicle Emissions promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of DAGLB mRNA]	affects^expression|increases^reaction	17655762
DAGLB	221955	Particulate Matter	D052638		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Particulate Matter affects the expression of DAGLB mRNA]	affects^expression|increases^reaction	17655762
DAGLB	221955	Particulate Matter	D052638		Particulate Matter affects the expression of DAGLB mRNA	affects^expression	17655762
DAGLB	221955	Particulate Matter	D052638		Particulate Matter promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of DAGLB mRNA]	affects^expression|increases^reaction	17655762
DAGLB	221955	PCI 5002	C568608		[PCI 5002 co-treated with Zinc] results in increased expression of DAGLB mRNA	affects^cotreatment|increases^expression	18593933
DAGLB	221955	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of DAGLB mRNA	increases^expression	18175754
DAGLB	221955	Sunitinib	D000077210		Sunitinib results in increased expression of DAGLB mRNA	increases^expression	31533062
DAGLB	221955	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of DAGLB mRNA	affects^expression	22574217
DAGLB	221955	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of DAGLB mRNA	increases^expression	28065790
DAGLB	221955	Urethane	D014520	51-79-6	Urethane results in increased expression of DAGLB mRNA	increases^expression	28818685
DAGLB	221955	Vehicle Emissions	D001335		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Vehicle Emissions affects the expression of DAGLB mRNA]	affects^expression|increases^reaction	17655762
DAGLB	221955	Vehicle Emissions	D001335		Vehicle Emissions affects the expression of DAGLB mRNA	affects^expression	17655762
DAGLB	221955	Vehicle Emissions	D001335		Vehicle Emissions promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of DAGLB mRNA]	affects^expression|increases^reaction	17655762
DAGLB	221955	Zinc	D015032	7440-66-6	[PCI 5002 co-treated with Zinc] results in increased expression of DAGLB mRNA	affects^cotreatment|increases^expression	18593933
DARS1	1615	4-aminophenylarsenoxide	C032642	1122-90-3	4-aminophenylarsenoxide binds to DARS1 protein	affects^binding	26598702
DARS1	1615	4-aminophenylarsenoxide	C032642	1122-90-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DARS1 protein]	affects^binding|decreases^reaction	26598702
DARS1	1615	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of DARS1 mRNA	decreases^expression	21420995|29067470
DARS1	1615	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DARS1 protein]	affects^binding|decreases^reaction	26598702
DARS1	1615	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of DARS1 protein	increases^expression	25419056
DARS1	1615	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of DARS1 protein	increases^expression	24527689
DARS1	1615	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of DARS1 mRNA	affects^expression	25979313
DARS1	1615	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of DARS1 mRNA	increases^expression	26352163
DARS1	1615	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of DARS1 mRNA	decreases^expression	19549813
DARS1	1615	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of DARS1 mRNA	decreases^expression	28302478
DARS1	1615	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of DARS1 mRNA	decreases^expression	29803840
DARS1	1615	Fluorouracil	D005472	51-21-8	Fluorouracil affects the expression of DARS1 mRNA	affects^expression	16584549
DARS1	1615	Folic Acid	D005492	59-30-3	Folic Acid results in decreased expression of DARS1 mRNA	decreases^expression	21867686
DARS1	1615	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of DARS1 mRNA	affects^expression	20044591
DARS1	1615	K 7174	C410337		K 7174 results in decreased expression of DARS1 mRNA	decreases^expression	24086573
DARS1	1615	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of DARS1 mRNA	decreases^expression	30851411
DARS1	1615	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of DARS1 mRNA	decreases^expression	28001369
DARS1	1615	Metribolone	D015741	965-93-5	Metribolone promotes the reaction [NDRG1 protein binds to DARS1 protein]	affects^binding|increases^reaction	17220478
DARS1	1615	Plant Extracts	D010936		Plant Extracts results in increased expression of DARS1 mRNA	increases^expression	23557933
DARS1	1615	Quercetin	D011794	117-39-5	Quercetin results in increased expression of DARS1 mRNA	increases^expression	19729006
DARS1	1615	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of DARS1 protein	increases^expression	21925251
DARS1	1615	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of DARS1 mRNA	increases^expression	18175754
DARS1	1615	Sunitinib	D000077210		Sunitinib results in increased expression of DARS1 mRNA	increases^expression	31533062
DARS1	1615	tanespimycin	C112765		[tanespimycin co-treated with VER 155008] results in increased expression of DARS1 protein	affects^cotreatment|increases^expression	31370342
DARS1	1615	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in increased expression of DARS1 mRNA	increases^expression	15336504
DARS1	1615	Urethane	D014520	51-79-6	Urethane results in decreased expression of DARS1 mRNA	decreases^expression	28818685
DARS1	1615	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of DARS1 mRNA	decreases^expression	23179753
DARS1	1615	VER 155008	C550733		[tanespimycin co-treated with VER 155008] results in increased expression of DARS1 protein	affects^cotreatment|increases^expression	31370342
DDX19B	11269	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DDX19B mRNA	affects^cotreatment|decreases^expression	28628672
DDX19B	11269	abrine	C496492		abrine results in increased expression of DDX19B mRNA	increases^expression	31054353
DDX19B	11269	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of DDX19B gene	affects^methylation	25304211
DDX19B	11269	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of DDX19B mRNA	decreases^expression	22378314
DDX19B	11269	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of DDX19B promoter	affects^methylation	27901495
DDX19B	11269	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DDX19B mRNA	affects^cotreatment|decreases^expression	28628672
DDX19B	11269	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DDX19B mRNA	affects^cotreatment|decreases^expression	28628672
DDX19B	11269	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DDX19B mRNA	affects^cotreatment|decreases^expression	28628672
DDX19B	11269	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of DDX19B mRNA	decreases^expression	30851411
DDX19B	11269	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of DDX19B mRNA	decreases^expression	28001369
DDX19B	11269	Potassium Dichromate	D011192	7778-50-9	Potassium Dichromate results in increased expression of DDX19B protein	increases^expression	23718831
DDX19B	11269	quercitrin	C012526	522-12-3	quercitrin results in decreased expression of DDX19B mRNA	decreases^expression	25193878
DDX19B	11269	tetrahydropalmatine	C014215	10097-84-4	tetrahydropalmatine results in decreased expression of DDX19B protein	decreases^expression	20109541
DGUOK	1716	abrine	C496492		abrine results in increased expression of DGUOK mRNA	increases^expression	31054353
DGUOK	1716	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of DGUOK mRNA	decreases^expression	21420995|25704631
DGUOK	1716	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of DGUOK mRNA	increases^expression	27153756
DGUOK	1716	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of DGUOK promoter	affects^methylation	27901495
DGUOK	1716	Genistein	D019833	446-72-0	Genistein results in decreased expression of DGUOK mRNA	decreases^expression	22228119
DGUOK	1716	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of DGUOK mRNA	decreases^expression	30851411
DGUOK	1716	Lead	D007854	7439-92-1	Lead affects the splicing of DGUOK mRNA	affects^splicing	28903495
DGUOK	1716	Sarin	D012524	107-44-8	Sarin results in decreased expression of DGUOK mRNA	decreases^expression	19522546
DGUOK	1716	Sarin	D012524	107-44-8	Sarin results in increased expression of DGUOK mRNA	increases^expression	19522546
DGUOK	1716	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of DGUOK mRNA	decreases^expression	21934132
DGUOK	1716	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of DGUOK mRNA	affects^expression	25979313
DGUOK	1716	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of DGUOK mRNA	decreases^expression	23179753
ECHS1	1892	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ECHS1 protein	increases^expression	25670856
ECHS1	1892	8-Bromo Cyclic Adenosine Monophosphate	D015124	23583-48-4	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ECHS1 mRNA	increases^expression	22079614
ECHS1	1892	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of ECHS1 mRNA	decreases^expression	29067470
ECHS1	1892	acryloyl-coenzyme A	C047011	5776-58-9	ECHS1 gene mutant form results in increased abundance of acryloyl-coenzyme A	increases^abundance	25125611
ECHS1	1892	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of ECHS1 protein	affects^expression	20106945
ECHS1	1892	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of ECHS1 gene	affects^methylation	25304211
ECHS1	1892	Arsenic	D001151	7440-38-2	Arsenic results in decreased expression of ECHS1 protein	decreases^expression	25110733
ECHS1	1892	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of ECHS1 protein	increases^expression	19364129|25419056
ECHS1	1892	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of ECHS1 mRNA	decreases^expression	22378314
ECHS1	1892	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of ECHS1 mRNA	decreases^expression	32234424
ECHS1	1892	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of ECHS1 3' UTR	decreases^methylation	27901495
ECHS1	1892	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of ECHS1 mRNA	affects^expression	30903817
ECHS1	1892	C646 compound	C584509		C646 compound results in increased expression of ECHS1 mRNA	increases^expression	26191083
ECHS1	1892	Catechin	D002392	154-23-4	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ECHS1 mRNA	affects^cotreatment|increases^expression	24763279
ECHS1	1892	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of ECHS1 mRNA	decreases^expression	19549813
ECHS1	1892	cupric oxide	C030973	1317-38-0	cupric oxide results in decreased expression of ECHS1 protein	decreases^expression	25470785
ECHS1	1892	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of ECHS1 mRNA	decreases^expression	20106945|23830897|25562108
ECHS1	1892	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of ECHS1 mRNA	increases^expression	29803840
ECHS1	1892	Doxorubicin	D004317	23214-92-8	ECHS1 affects the susceptibility to Doxorubicin	affects^response to substance	15492826
ECHS1	1892	Drugs, Chinese Herbal	D004365		Drugs, Chinese Herbal results in decreased expression of ECHS1 protein	decreases^expression	18422750
ECHS1	1892	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of ECHS1 mRNA	increases^expression	24752549
ECHS1	1892	Fluorouracil	D005472	51-21-8	Fluorouracil results in increased expression of ECHS1 mRNA	increases^expression	15152939
ECHS1	1892	gossypol acetic acid	C028178	12542-36-8	gossypol acetic acid results in decreased expression of ECHS1 protein	decreases^expression	29938581
ECHS1	1892	Grape Seed Proanthocyanidins	C511402		[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ECHS1 mRNA	affects^cotreatment|increases^expression	24763279
ECHS1	1892	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of ECHS1 mRNA	affects^cotreatment|decreases^expression	30611723
ECHS1	1892	GW 7647	C453899		GW 7647 results in increased expression of ECHS1 mRNA	increases^expression	30611723
ECHS1	1892	K 7174	C410337		K 7174 results in decreased expression of ECHS1 mRNA	decreases^expression	24086573
ECHS1	1892	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of ECHS1 mRNA	decreases^expression	30851411
ECHS1	1892	Lead	D007854	7439-92-1	Lead results in decreased expression of ECHS1 mRNA	decreases^expression	19921347
ECHS1	1892	linalool	C018584	78-70-6	linalool results in increased expression of ECHS1 mRNA	increases^expression	24752549
ECHS1	1892	methacrylyl-coenzyme A	C035909	6008-91-9	ECHS1 gene mutant form results in increased abundance of methacrylyl-coenzyme A	increases^abundance	25125611
ECHS1	1892	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of ECHS1 mRNA	increases^expression	17400583
ECHS1	1892	microcystin RR	C063855		microcystin RR results in decreased expression of ECHS1 protein	decreases^expression	19111056
ECHS1	1892	Niclosamide	D009534	50-65-7	Niclosamide results in decreased expression of ECHS1 mRNA	decreases^expression	22576131
ECHS1	1892	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of ECHS1 mRNA	affects^cotreatment|decreases^expression	30611723
ECHS1	1892	Ouabain	D010042	630-60-4	Ouabain affects the expression of ECHS1 protein	affects^expression	17268060
ECHS1	1892	Sunitinib	D000077210		Sunitinib results in decreased expression of ECHS1 mRNA	decreases^expression	31533062
ECHS1	1892	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of ECHS1 mRNA	decreases^expression	26179874
ECHS1	1892	Triterpenes	D014315		Triterpenes results in decreased expression of ECHS1 protein	decreases^expression	18422750
ECHS1	1892	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of ECHS1 mRNA	increases^expression	23179753
ECHS1	1892	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of ECHS1 gene	increases^methylation	29154799
EPRS1	2058	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EPRS1 mRNA	decreases^expression	19150397|20018196|26238291
EPRS1	2058	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in decreased methylation of EPRS1 intron	decreases^methylation	30157460
EPRS1	2058	Ascorbic Acid	D001205	50-81-7	Ascorbic Acid results in decreased expression of EPRS1 mRNA	decreases^expression	19197388
EPRS1	2058	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of EPRS1 mRNA	decreases^expression	20678512
EPRS1	2058	C646 compound	C584509		C646 compound results in increased expression of EPRS1 mRNA	increases^expression	26191083
EPRS1	2058	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of EPRS1 mRNA	decreases^expression	25596134
EPRS1	2058	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of EPRS1 mRNA	increases^expression	26472689
EPRS1	2058	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde results in decreased expression of EPRS1 mRNA	decreases^expression	25596134
EPRS1	2058	chloropicrin	C100187	76-06-2	chloropicrin affects the expression of EPRS1 mRNA	affects^expression	26352163
EPRS1	2058	Cidofovir	D000077404	113852-37-2	Cidofovir results in decreased expression of EPRS1 mRNA	decreases^expression	25596134
EPRS1	2058	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of EPRS1 mRNA	decreases^expression	25596134
EPRS1	2058	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in decreased expression of EPRS1 mRNA	decreases^expression	25596134
EPRS1	2058	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of EPRS1 mRNA	increases^expression	20106945|21632981|25562108|25596134|27989131
EPRS1	2058	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EPRS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
EPRS1	2058	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of EPRS1 mRNA	increases^expression	25596134
EPRS1	2058	Fluorouracil	D005472	51-21-8	Fluorouracil results in decreased expression of EPRS1 mRNA	decreases^expression	16709241
EPRS1	2058	geldanamycin	C001277	30562-34-6	geldanamycin results in increased expression of EPRS1 mRNA	increases^expression	26705709
EPRS1	2058	Hydralazine	D006830	86-54-4	[Hydralazine co-treated with Valproic Acid] results in increased expression of EPRS1 mRNA	affects^cotreatment|increases^expression	17183730
EPRS1	2058	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of EPRS1 mRNA	affects^expression	20044591
EPRS1	2058	Ibuprofen	D007052	15687-27-1	Ibuprofen results in increased expression of EPRS1 mRNA	increases^expression	25596134
EPRS1	2058	ICG 001	C492448		ICG 001 results in increased expression of EPRS1 mRNA	increases^expression	26191083
EPRS1	2058	jinfukang	C544151		jinfukang results in decreased expression of EPRS1 mRNA	decreases^expression	27392435
EPRS1	2058	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of EPRS1 mRNA	decreases^expression	30851411
EPRS1	2058	Levonorgestrel	D016912	797-63-7	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of EPRS1 mRNA	affects^cotreatment|increases^expression	19074003
EPRS1	2058	Methotrexate	D008727	59-05-2	EPRS1 protein affects the susceptibility to Methotrexate	affects^response to substance	16217747
EPRS1	2058	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of EPRS1 mRNA	decreases^expression	30559759
EPRS1	2058	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of EPRS1 mRNA	decreases^expression	25596134
EPRS1	2058	perfluorononanoic acid	C584865		perfluorononanoic acid results in increased expression of EPRS1 mRNA	increases^expression	32588087
EPRS1	2058	Plant Extracts	D010936		Plant Extracts results in increased expression of EPRS1 mRNA	increases^expression	23557933
EPRS1	2058	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide results in decreased expression of EPRS1 mRNA	decreases^expression	25351596
EPRS1	2058	Sunitinib	D000077210		Sunitinib results in increased expression of EPRS1 mRNA	increases^expression	31533062
EPRS1	2058	testosterone enanthate	C004648		testosterone enanthate affects the expression of EPRS1 mRNA	affects^expression	17440010
EPRS1	2058	testosterone undecanoate	C010792		[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of EPRS1 mRNA	affects^cotreatment|increases^expression	19074003
EPRS1	2058	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of EPRS1 mRNA	increases^expression	22378314
EPRS1	2058	Thimerosal	D013849	54-64-8	Thimerosal results in decreased expression of EPRS1 mRNA	decreases^expression	27188386
EPRS1	2058	titanium dioxide	C009495	13463-67-7	titanium dioxide results in increased expression of EPRS1 protein	increases^expression	30910687
EPRS1	2058	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of EPRS1 protein	affects^expression	30291989
EPRS1	2058	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of EPRS1 mRNA	increases^expression	22378314|29453283
EPRS1	2058	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of EPRS1 protein	increases^expression	29453283
EPRS1	2058	Valproic Acid	D014635	99-66-1	[Hydralazine co-treated with Valproic Acid] results in increased expression of EPRS1 mRNA	affects^cotreatment|increases^expression	17183730
EPRS1	2058	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of EPRS1 mRNA	decreases^expression	23179753|27188386
EPRS1	2058	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of EPRS1 mRNA	affects^expression	20044591
EPRS1	2058	Vorinostat	D000077337		Vorinostat results in decreased expression of EPRS1 mRNA	decreases^expression	27188386
EPRS1	2058	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of EPRS1 mRNA	decreases^expression	25596134
FARSA	2193	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FARSA mRNA	affects^cotreatment|decreases^expression	28628672
FARSA	2193	2-amino-14,16-dimethyloctadecan-3-ol	C507616		2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of FARSA protein	decreases^expression	32044396
FARSA	2193	abrine	C496492		abrine results in increased expression of FARSA mRNA	increases^expression	31054353
FARSA	2193	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of FARSA intron	decreases^methylation	30157460
FARSA	2193	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of FARSA gene	increases^methylation	28458013
FARSA	2193	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of FARSA promoter	affects^methylation	27901495
FARSA	2193	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FARSA mRNA	affects^cotreatment|decreases^expression	28628672
FARSA	2193	Bortezomib	D000069286		Bortezomib results in decreased expression of FARSA mRNA	decreases^expression	20977926
FARSA	2193	Caffeine	D002110	58-08-2	Caffeine results in increased expression of FARSA protein	increases^expression	31195006
FARSA	2193	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of FARSA mRNA	decreases^expression	27594783
FARSA	2193	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of FARSA mRNA	decreases^expression	19376846
FARSA	2193	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of FARSA mRNA	decreases^expression	19549813
FARSA	2193	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of FARSA mRNA	increases^expression	20106945|22147139
FARSA	2193	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FARSA mRNA	affects^cotreatment|decreases^expression	28628672
FARSA	2193	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of FARSA mRNA	decreases^expression	29803840
FARSA	2193	Estradiol	D004958	50-28-2	Estradiol affects the expression of FARSA mRNA	affects^expression	22574217
FARSA	2193	Estradiol	D004958	50-28-2	Estradiol results in increased expression of FARSA mRNA	increases^expression	19167446
FARSA	2193	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of FARSA mRNA	decreases^expression	23649840
FARSA	2193	ICG 001	C492448		ICG 001 results in decreased expression of FARSA mRNA	decreases^expression	26191083
FARSA	2193	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FARSA mRNA	affects^cotreatment|decreases^expression	28628672
FARSA	2193	K 7174	C410337		K 7174 results in decreased expression of FARSA mRNA	decreases^expression	24086573
FARSA	2193	MLN7243	C000622638		MLN7243 results in increased sumoylation of FARSA protein	increases^sumoylation	31285264
FARSA	2193	Nickel	D009532	7440-02-0	Nickel results in increased expression of FARSA mRNA	increases^expression	25583101
FARSA	2193	Selenium	D012643	7782-49-2	[Selenium co-treated with Vitamin E] results in increased expression of FARSA mRNA	affects^cotreatment|increases^expression	19244175
FARSA	2193	Selenium	D012643	7782-49-2	Selenium results in increased expression of FARSA mRNA	increases^expression	19244175
FARSA	2193	Sunitinib	D000077210		Sunitinib results in increased expression of FARSA mRNA	increases^expression	31533062
FARSA	2193	Urethane	D014520	51-79-6	Urethane results in decreased expression of FARSA mRNA	decreases^expression	28818685
FARSA	2193	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of FARSA mRNA	increases^expression	23179753
FARSA	2193	Vitamin E	D014810	1406-18-4	[Selenium co-treated with Vitamin E] results in increased expression of FARSA mRNA	affects^cotreatment|increases^expression	19244175
FARSA	2193	Vitamin E	D014810	1406-18-4	Vitamin E results in increased expression of FARSA mRNA	increases^expression	19244175
FARSB	10056	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FARSB mRNA	affects^cotreatment|increases^expression	27188386
FARSB	10056	4-phenylbutyric acid	C075773	1821-12-1	4-phenylbutyric acid results in decreased expression of FARSB mRNA	decreases^expression	14583596
FARSB	10056	5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide	C528044		5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide results in increased expression of FARSB protein	increases^expression	31370342
FARSB	10056	afuresertib	C000593263		afuresertib results in decreased expression of FARSB mRNA	decreases^expression	28960945
FARSB	10056	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of FARSB mRNA	decreases^expression	20064835
FARSB	10056	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of FARSB promoter	decreases^methylation	27901495
FARSB	10056	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of FARSB mRNA	affects^expression	30903817
FARSB	10056	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of FARSB mRNA	increases^expression	26352163
FARSB	10056	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of FARSB mRNA	affects^cotreatment|decreases^expression	27392435
FARSB	10056	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of FARSB mRNA	decreases^expression	19320972
FARSB	10056	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of FARSB mRNA	decreases^expression	19549813
FARSB	10056	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of FARSB mRNA	increases^expression	19167446
FARSB	10056	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of FARSB mRNA	increases^expression	20106945|25562108
FARSB	10056	cylindrospermopsin	C089595	143545-90-8	cylindrospermopsin results in increased expression of FARSB mRNA	increases^expression	24921660
FARSB	10056	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FARSB mRNA	affects^cotreatment|increases^expression	27188386
FARSB	10056	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of FARSB mRNA	decreases^expression	29803840
FARSB	10056	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FARSB protein	decreases^activity|increases^O-linked glycosylation	23301498
FARSB	10056	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of FARSB mRNA	decreases^expression	20655997
FARSB	10056	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of FARSB mRNA	affects^expression	20044591
FARSB	10056	Irinotecan	D000077146		Irinotecan analog results in decreased expression of FARSB mRNA	decreases^expression	18927307
FARSB	10056	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of FARSB mRNA	affects^cotreatment|decreases^expression	27392435
FARSB	10056	jinfukang	C544151		jinfukang results in decreased expression of FARSB mRNA	decreases^expression	27392435
FARSB	10056	Lead	D007854	7439-92-1	Lead results in decreased expression of FARSB mRNA	decreases^expression	19921347
FARSB	10056	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of FARSB mRNA	decreases^expression	28001369
FARSB	10056	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of FARSB mRNA	decreases^expression	23649840
FARSB	10056	Nickel	D009532	7440-02-0	Nickel results in increased expression of FARSB mRNA	increases^expression	24768652
FARSB	10056	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of FARSB mRNA	decreases^expression	26516004
FARSB	10056	perfluorononanoic acid	C584865		perfluorononanoic acid results in increased expression of FARSB mRNA	increases^expression	32588087
FARSB	10056	Plant Extracts	D010936		Plant Extracts results in decreased expression of FARSB mRNA	decreases^expression	24677778
FARSB	10056	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of FARSB mRNA	increases^expression	18175754
FARSB	10056	STA 9090	C533237		STA 9090 results in increased expression of FARSB protein	increases^expression	31370342
FARSB	10056	Sunitinib	D000077210		Sunitinib results in increased expression of FARSB mRNA	increases^expression	31533062
FARSB	10056	tanespimycin	C112765		tanespimycin analog results in increased expression of FARSB protein	increases^expression	31370342
FARSB	10056	tanespimycin	C112765		[tanespimycin co-treated with VER 155008] results in increased expression of FARSB protein	affects^cotreatment|increases^expression	31370342
FARSB	10056	tanespimycin	C112765		tanespimycin results in increased expression of FARSB protein	increases^expression	31370342
FARSB	10056	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of FARSB mRNA	increases^expression	24935251
FARSB	10056	Urethane	D014520	51-79-6	Urethane results in decreased expression of FARSB mRNA	decreases^expression	28818685
FARSB	10056	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FARSB mRNA	affects^cotreatment|increases^expression	27188386
FARSB	10056	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of FARSB mRNA	affects^expression	25979313
FARSB	10056	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of FARSB mRNA	increases^expression	23179753|26272509|28001369|29154799
FARSB	10056	VER 155008	C550733		[tanespimycin co-treated with VER 155008] results in increased expression of FARSB protein	affects^cotreatment|increases^expression	31370342
FARSB	10056	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of FARSB mRNA	affects^expression	20044591
FARSB	10056	Vorinostat	D000077337		Vorinostat results in increased expression of FARSB mRNA	increases^expression	27188386
FASN	2194	1,2,5,6-dibenzanthracene	C026486	53-70-3	[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FASN mRNA	affects^cotreatment|affects^expression	17690111
FASN	2194	1,3-dichloro-2-propanol	C033489	96-23-1	1,3-dichloro-2-propanol results in increased expression of FASN mRNA	increases^expression	29305303
FASN	2194	1,3-dichloro-2-propanol	C033489	96-23-1	1,3-dichloro-2-propanol results in increased expression of FASN protein	increases^expression	29305303
FASN	2194	1,3-dichloro-2-propanol	C033489	96-23-1	alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	29305303
FASN	2194	1,3-dichloro-2-propanol	C033489	96-23-1	alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of FASN protein]	decreases^reaction|increases^expression	29305303
FASN	2194	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	26200599
FASN	2194	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FASN mRNA]	affects^cotreatment|increases^expression|increases^reaction	26200599
FASN	2194	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	FASN protein results in decreased susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]	affects^cotreatment|decreases^response to substance	26670611
FASN	2194	1-Naphthylisothiocyanate	D015058	551-06-4	[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FASN mRNA	affects^cotreatment|affects^expression	27344345
FASN	2194	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [kahweol results in decreased expression of FASN mRNA]	decreases^expression|increases^reaction	30205135
FASN	2194	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [kahweol results in decreased expression of FASN protein]	decreases^expression|increases^reaction	30205135
FASN	2194	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FASN mRNA	decreases^expression	30205135
FASN	2194	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FASN protein	decreases^expression	30205135
FASN	2194	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	kahweol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FASN mRNA]	decreases^expression|increases^reaction	30205135
FASN	2194	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	kahweol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FASN protein]	decreases^expression|increases^reaction	30205135
FASN	2194	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of FASN protein	increases^expression	26194647
FASN	2194	4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid	C524106		4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid results in decreased expression of FASN mRNA	decreases^expression	23305094
FASN	2194	4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid	C524106		4-(4-(3-adamantan-1-ylureido)cyclohexyloxy)benzoic acid results in decreased expression of FASN protein	decreases^expression	23305094
FASN	2194	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FASN mRNA	affects^cotreatment|decreases^expression	27188386
FASN	2194	4-methylene-2-octyl-5-oxofuran-3-carboxylic acid	C406734		4-methylene-2-octyl-5-oxofuran-3-carboxylic acid binds to and results in decreased activity of FASN protein	affects^binding|decreases^activity	17847090
FASN	2194	4-methylene-2-octyl-5-oxofuran-3-carboxylic acid	C406734		[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in decreased expression of FASN protein	affects^cotreatment|decreases^expression	21442130
FASN	2194	4-methylene-2-octyl-5-oxofuran-3-carboxylic acid	C406734		4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein	decreases^activity	21442130
FASN	2194	4-methylene-2-octyl-5-oxofuran-3-carboxylic acid	C406734		[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein] which results in increased susceptibility to Cisplatin	decreases^activity|increases^response to substance	21442130
FASN	2194	4-oxoretinoic acid	C002202	38030-57-8	4-oxoretinoic acid results in increased expression of FASN mRNA	increases^expression	15982314
FASN	2194	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	C080669		5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Ethanol results in increased expression of FASN protein]	decreases^reaction|increases^expression	29476730
FASN	2194	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	C080669		HIF1A protein inhibits the reaction [5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Ethanol results in increased expression of FASN protein]]	decreases^reaction|increases^expression	29476730
FASN	2194	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime affects the expression of FASN mRNA	affects^expression	31312845
FASN	2194	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in decreased expression of FASN mRNA	decreases^expression	30364229
FASN	2194	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		[Colforsin co-treated with 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30364229
FASN	2194	abrine	C496492		abrine results in decreased expression of FASN mRNA	decreases^expression	31054353
FASN	2194	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of FASN mRNA	decreases^expression	29067470
FASN	2194	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of FASN mRNA	increases^expression	21420995
FASN	2194	Adenosine Triphosphate	D000255	56-65-5	FASN protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]]	decreases^abundance|increases^reaction	26670611
FASN	2194	Adenosine Triphosphate	D000255	56-65-5	FASN protein results in decreased abundance of Adenosine Triphosphate	decreases^abundance	26670611
FASN	2194	Adenosine Triphosphate	D000255	56-65-5	Protein Kinase Inhibitors inhibits the reaction [FASN protein results in decreased abundance of Adenosine Triphosphate]	decreases^abundance|decreases^reaction	26670611
FASN	2194	Alitretinoin	D000077556	08/03/5300	Alitretinoin results in decreased expression of FASN mRNA	decreases^expression	15982314
FASN	2194	alliin	C006453		alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	29305303
FASN	2194	alliin	C006453		alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of FASN protein]	decreases^reaction|increases^expression	29305303
FASN	2194	Allopurinol	D000493	315-30-0	Allopurinol inhibits the reaction [Glucose results in increased expression of FASN protein]	decreases^reaction|increases^expression	23647015
FASN	2194	Amiodarone	D000638	1951-25-3	Amiodarone affects the expression of FASN mRNA	affects^expression	29248575
FASN	2194	apocarotenal	C004984	1107-26-2	apocarotenal results in decreased expression of FASN mRNA	decreases^expression	17034753
FASN	2194	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of FASN gene	affects^methylation	25304211
FASN	2194	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of FASN protein	increases^expression	25419056
FASN	2194	atheronal-A	C512174		atheronal-A inhibits the reaction [TO-901317 results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	27703007
FASN	2194	Atorvastatin	D000069059		Atorvastatin results in increased expression of FASN mRNA	increases^expression	11728391
FASN	2194	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of FASN mRNA	increases^expression	22378314
FASN	2194	avobenzone	C049935		avobenzone results in increased expression of FASN mRNA	increases^expression	31016361
FASN	2194	bathocuproine sulfonate	C028559	73348-75-1	bathocuproine sulfonate inhibits the reaction [copper histidine results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	24170205
FASN	2194	Benzene	D001554	71-43-2	Benzene results in increased expression of FASN mRNA	increases^expression	19162166
FASN	2194	Benzo(a)pyrene	D001564	50-32-8	[Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of FASN mRNA	affects^cotreatment|affects^expression	17690111
FASN	2194	Benzo(a)pyrene	D001564	50-32-8	[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FASN mRNA	affects^cotreatment|affects^expression	17690111
FASN	2194	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of FASN mRNA	decreases^expression	16269432|32234424
FASN	2194	benzo(b)fluoranthene	C006703	205-99-2	[Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of FASN mRNA	affects^cotreatment|affects^expression	17690111
FASN	2194	benzylparaben	C057775	94-18-8	benzylparaben results in increased expression of FASN mRNA	increases^expression	22956630
FASN	2194	beta-conglycinin protein, Glycine max	C013894		beta-conglycinin protein, Glycine max binds to and results in decreased activity of FASN protein	affects^binding|decreases^activity	20148945
FASN	2194	beta-hexachlorocyclohexane	C023888		beta-hexachlorocyclohexane results in increased expression of FASN protein	increases^expression	27203212
FASN	2194	beta-Naphthoflavone	D019324	6051-87-2	beta-Naphthoflavone results in decreased expression of FASN mRNA	decreases^expression	31225620
FASN	2194	betulin	C002503	473-98-3	betulin results in decreased expression of FASN mRNA	decreases^expression	27378817
FASN	2194	betulin	C002503	473-98-3	betulin results in decreased expression of FASN protein	decreases^expression	27447558
FASN	2194	Bexarotene	D000077610		[Bexarotene co-treated with GW 3965] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	Bexarotene	D000077610		[Bexarotene co-treated with paxilline] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	Bexarotene	D000077610		[Bexarotene co-treated with TO-901317] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	Bezafibrate	D001629	41859-67-0	[Oleic Acid co-treated with Bezafibrate] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	24534255
FASN	2194	bifenthrin	C099952	82657-04-3	bifenthrin results in increased expression of FASN mRNA	increases^expression	29554630
FASN	2194	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of FASN mRNA	affects^expression	24793377|30903817
FASN	2194	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of FASN protein	decreases^expression	27522653
FASN	2194	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of FASN mRNA	increases^expression	27014939|28483554|29721103
FASN	2194	bisphenol A	C006780	80-05-7	MIR192 mRNA inhibits the reaction [bisphenol A results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	28483554
FASN	2194	bisphenol A	C006780	80-05-7	N-piperidinyl-(8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydrobenzo(6,7)cyclohepta(1,2-c)pyrazole-3-carboxamide) inhibits the reaction [bisphenol A results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	27014939
FASN	2194	bisphenol A	C006780	80-05-7	SREBF1 protein affects the reaction [bisphenol A results in increased expression of FASN mRNA]	affects^reaction|increases^expression	28483554
FASN	2194	butylparaben	C038091	94-26-8	butylparaben results in increased expression of FASN mRNA	increases^expression	22956630
FASN	2194	caffeic acid	C040048	331-39-5	[Metformin co-treated with caffeic acid] results in decreased expression of FASN protein	affects^cotreatment|decreases^expression	28576465
FASN	2194	Calcitriol	D002117	32222-06-3	Calcitriol results in decreased expression of FASN mRNA	decreases^expression	12798352
FASN	2194	Calcitriol	D002117	32222-06-3	Cycloheximide inhibits the reaction [Calcitriol results in decreased expression of FASN mRNA]	decreases^expression|decreases^reaction	12798352
FASN	2194	CD 3254	C525130		[CD 3254 co-treated with GW 3965] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	CD 3254	C525130		[CD 3254 co-treated with paxilline] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	CD 3254	C525130		[CD 3254 co-treated with TO-901317] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	Ceramides	D002518		FASN protein results in increased abundance of Ceramides	increases^abundance	26670611
FASN	2194	Cerulenin	D002569	17397-89-6	Cerulenin results in decreased activity of FASN protein	decreases^activity	12798352
FASN	2194	Cerulenin	D002569	17397-89-6	[Cerulenin results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine	decreases^abundance|decreases^activity	18723500
FASN	2194	chloropicrin	C100187	76-06-2	chloropicrin results in decreased expression of FASN mRNA	decreases^expression	26352163
FASN	2194	Cholic Acids	D002793		[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FASN mRNA	affects^cotreatment|affects^expression	27344345
FASN	2194	Cholic Acids	D002793		[Cyclosporine co-treated with Cholic Acids] affects the expression of FASN mRNA	affects^cotreatment|affects^expression	27344345
FASN	2194	Cisplatin	D002945	15663-27-1	[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in decreased expression of FASN protein	affects^cotreatment|decreases^expression	21442130
FASN	2194	Cisplatin	D002945	15663-27-1	[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein] which results in increased susceptibility to Cisplatin	decreases^activity|increases^response to substance	21442130
FASN	2194	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	27392435
FASN	2194	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of FASN mRNA	decreases^expression	27594783
FASN	2194	Clozapine	D003024	5786-21-0	Clozapine results in increased expression of FASN mRNA	increases^expression	16027736|17052361
FASN	2194	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of FASN mRNA	decreases^expression	19320972
FASN	2194	Colforsin	D005576	138605-00-2	[Colforsin co-treated with 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30364229
FASN	2194	Colforsin	D005576	138605-00-2	[Colforsin co-treated with Leflunomide] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30364229
FASN	2194	Colforsin	D005576	138605-00-2	[Colforsin co-treated with teriflunomide] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30364229
FASN	2194	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of FASN mRNA	affects^binding|decreases^expression	20971185
FASN	2194	Copper	D003300	7440-50-8	[Thiosemicarbazones binds to Copper] which results in increased expression of FASN protein	affects^binding|increases^expression	20931265
FASN	2194	copper histidine	C098468		bathocuproine sulfonate inhibits the reaction [copper histidine results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	24170205
FASN	2194	copper histidine	C098468		copper histidine results in increased expression of FASN mRNA	increases^expression	24170205
FASN	2194	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of FASN mRNA	decreases^expression	19549813
FASN	2194	Crizotinib	D000077547		Crizotinib results in increased expression of FASN mRNA	increases^expression	23707608
FASN	2194	Cycloheximide	D003513	66-81-9	Cycloheximide inhibits the reaction [Calcitriol results in decreased expression of FASN mRNA]	decreases^expression|decreases^reaction	12798352
FASN	2194	Cyclosporine	D016572	59865-13-3	[Cyclosporine co-treated with Cholic Acids] affects the expression of FASN mRNA	affects^cotreatment|affects^expression	27344345
FASN	2194	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of FASN mRNA	decreases^expression	20106945|28903485
FASN	2194	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of FASN protein	increases^expression	28903485
FASN	2194	cyproconazole	C093628		cyproconazole results in decreased expression of FASN mRNA	decreases^expression	29995386
FASN	2194	cyproconazole	C093628		cyproconazole results in decreased expression of FASN protein	decreases^expression	29995386
FASN	2194	deoxypodophyllotoxin	C014451	69222-20-4	deoxypodophyllotoxin inhibits the reaction [TO-901317 results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	30148990
FASN	2194	Dexamethasone	D003907	50-02-2	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	26200599
FASN	2194	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of FASN mRNA	increases^expression	25047013
FASN	2194	Dexamethasone	D003907	50-02-2	Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FASN mRNA]	affects^cotreatment|increases^expression|increases^reaction	26200599
FASN	2194	Dexamethasone	D003907	50-02-2	FASN protein results in decreased susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]	affects^cotreatment|decreases^response to substance	26670611
FASN	2194	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of FASN gene	increases^methylation	22964155
FASN	2194	dibenzo(a,l)pyrene	C041517	191-30-0	dibenzo(a,l)pyrene results in decreased expression of FASN mRNA	decreases^expression	16269432
FASN	2194	Dichlorodiphenyl Dichloroethylene	D003633	72-55-9	Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FASN mRNA]	affects^cotreatment|increases^expression|increases^reaction	26200599
FASN	2194	Dichlorodiphenyl Dichloroethylene	D003633	72-55-9	Dichlorodiphenyl Dichloroethylene results in increased expression of FASN mRNA	increases^expression	27203212
FASN	2194	Dichlorodiphenyl Dichloroethylene	D003633	72-55-9	Dichlorodiphenyl Dichloroethylene results in increased expression of FASN protein	increases^expression	27203212
FASN	2194	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of FASN mRNA	increases^expression	28302478
FASN	2194	Diglycerides	D004075		FASN protein results in increased abundance of Diglycerides	increases^abundance	26670611
FASN	2194	dihydroartemisinin	C039060		[dihydroartemisinin co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of FASN mRNA]	affects^cotreatment|decreases^reaction|increases^expression	27939985
FASN	2194	dihydroartemisinin	C039060		[dihydroartemisinin co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of FASN protein]	affects^cotreatment|decreases^reaction|increases^expression	27939985
FASN	2194	dihydroartemisinin	C039060		dihydroartemisinin inhibits the reaction [Ethanol results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	27939985
FASN	2194	dihydroartemisinin	C039060		dihydroartemisinin inhibits the reaction [Ethanol results in increased expression of FASN protein]	decreases^reaction|increases^expression	27939985
FASN	2194	Dihydrotestosterone	D013196	521-18-6	Dihydrotestosterone results in increased expression of FASN mRNA	increases^expression	29581250
FASN	2194	Docetaxel	D000077143		[Docetaxel co-treated with fatostatin] results in decreased expression of FASN protein	affects^cotreatment|decreases^expression	26512780
FASN	2194	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FASN mRNA	affects^cotreatment|decreases^expression	27188386
FASN	2194	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of FASN mRNA	increases^expression	17089011
FASN	2194	Doxorubicin	D004317	23214-92-8	FASN protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein]	decreases^reaction|increases^cleavage	18281512
FASN	2194	Doxorubicin	D004317	23214-92-8	FASN protein results in decreased susceptibility to Doxorubicin	decreases^response to substance	18281512
FASN	2194	Doxorubicin	D004317	23214-92-8	Orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Doxorubicin]	decreases^reaction|decreases^response to substance	18281512
FASN	2194	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FASN protein	decreases^activity|increases^O-linked glycosylation	23301498
FASN	2194	epigallocatechin gallate	C045651	989-51-5	epigallocatechin gallate results in decreased expression of FASN mRNA	decreases^expression	20816778
FASN	2194	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of FASN mRNA	decreases^expression	20106945
FASN	2194	Estradiol	D004958	50-28-2	Estradiol results in increased expression of FASN mRNA	increases^expression	23019147
FASN	2194	Ethanol	D000431	64-17-5	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Ethanol results in increased expression of FASN protein]	decreases^reaction|increases^expression	29476730
FASN	2194	Ethanol	D000431	64-17-5	[dihydroartemisinin co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of FASN mRNA]	affects^cotreatment|decreases^reaction|increases^expression	27939985
FASN	2194	Ethanol	D000431	64-17-5	[dihydroartemisinin co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of FASN protein]	affects^cotreatment|decreases^reaction|increases^expression	27939985
FASN	2194	Ethanol	D000431	64-17-5	dihydroartemisinin inhibits the reaction [Ethanol results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	27939985
FASN	2194	Ethanol	D000431	64-17-5	dihydroartemisinin inhibits the reaction [Ethanol results in increased expression of FASN protein]	decreases^reaction|increases^expression	27939985
FASN	2194	Ethanol	D000431	64-17-5	Ethanol results in increased expression of FASN mRNA	increases^expression	24144995|27939985
FASN	2194	Ethanol	D000431	64-17-5	Ethanol results in increased expression of FASN protein	increases^expression	27939985|29476730
FASN	2194	Ethanol	D000431	64-17-5	HIF1A protein inhibits the reaction [5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [Ethanol results in increased expression of FASN protein]]	decreases^reaction|increases^expression	29476730
FASN	2194	Ethanol	D000431	64-17-5	NR1H4 protein inhibits the reaction [Ethanol results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	27939985
FASN	2194	Ethanol	D000431	64-17-5	NR1H4 protein inhibits the reaction [Ethanol results in increased expression of FASN protein]	decreases^reaction|increases^expression	27939985
FASN	2194	Ethanol	D000431	64-17-5	obeticholic acid inhibits the reaction [Ethanol results in increased expression of FASN protein]	decreases^reaction|increases^expression	27939985
FASN	2194	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of FASN mRNA	decreases^expression	23649840
FASN	2194	Etoposide	D005047	33419-42-0	Etoposide results in increased expression of FASN mRNA	increases^expression	17089011
FASN	2194	Exenatide	D000077270	141732-76-5	Exenatide inhibits the reaction [Palmitates results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	30253173
FASN	2194	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30611723
FASN	2194	fatostatin	C545733		[Docetaxel co-treated with fatostatin] results in decreased expression of FASN protein	affects^cotreatment|decreases^expression	26512780
FASN	2194	fatostatin	C545733		fatostatin results in decreased expression of FASN mRNA	decreases^expression	19716478|24493696|26512780|27378817|29436682
FASN	2194	fatostatin	C545733		fatostatin results in decreased expression of FASN protein	decreases^expression	24493696|26512780|27447558|28483521|29436682
FASN	2194	fatostatin	C545733		[Lipids deficiency results in increased susceptibility to fatostatin] which results in decreased expression of FASN mRNA	decreases^expression|increases^response to substance	30140005
FASN	2194	fatostatin	C545733		[TP53 protein mutant form results in increased susceptibility to fatostatin] promotes the reaction [fatostatin results in decreased expression of FASN mRNA]	decreases^expression|increases^reaction|increases^response to substance	26512780
FASN	2194	fatostatin	C545733		[TP53 protein mutant form results in increased susceptibility to fatostatin] which results in decreased expression of FASN protein	decreases^expression|increases^response to substance	26512780
FASN	2194	Fatty Acids	D005227		FASN protein results in increased chemical synthesis of Fatty Acids	increases^chemical synthesis	18723500
FASN	2194	Fatty Acids	D005227		[Fatty Acids co-treated with INS protein] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	24648896
FASN	2194	Fatty Acids	D005227		[Fatty Acids co-treated with INS protein] results in increased expression of FASN protein	affects^cotreatment|increases^expression	24648896
FASN	2194	Fatty Acids	D005227		[Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Fatty Acids	decreases^abundance|decreases^activity	18723500
FASN	2194	Fatty Acids	D005227		[Orlistat results in decreased activity of FASN protein] which results in decreased chemical synthesis of Fatty Acids	decreases^activity|decreases^chemical synthesis	17012255
FASN	2194	Fatty Acids	D005227		Quercetin inhibits the reaction [[Fatty Acids co-treated with INS protein] results in increased expression of FASN mRNA]	affects^cotreatment|decreases^reaction|increases^expression	24648896
FASN	2194	Fatty Acids	D005227		Quercetin inhibits the reaction [[Fatty Acids co-treated with INS protein] results in increased expression of FASN protein]	affects^cotreatment|decreases^reaction|increases^expression	24648896
FASN	2194	Fatty Acids, Nonesterified	D005230		FASN protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]]	increases^abundance|increases^reaction	26670611
FASN	2194	Fatty Acids, Nonesterified	D005230		FASN protein results in increased abundance of Fatty Acids, Nonesterified	increases^abundance	26670611
FASN	2194	Fatty Acids, Nonesterified	D005230		Fatty Acids, Nonesterified affects the expression of FASN mRNA	affects^expression	30402207
FASN	2194	Fatty Acids, Nonesterified	D005230		Fatty Acids, Nonesterified results in increased expression of FASN mRNA	increases^expression	23465592
FASN	2194	Fatty Acids, Nonesterified	D005230		MIR26A1 mRNA inhibits the reaction [Fatty Acids, Nonesterified affects the expression of FASN mRNA]	affects^expression|decreases^reaction	30402207
FASN	2194	Fatty Acids, Nonesterified	D005230		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased abundance of Fatty Acids, Nonesterified]	decreases^reaction|increases^abundance	26670611
FASN	2194	Fatty Acids, Nonesterified	D005230		S-allylcysteine inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	23465592
FASN	2194	Fenofibrate	D011345	49562-28-9	[Oleic Acid co-treated with Fenofibrate] affects the expression of FASN mRNA	affects^cotreatment|affects^expression	24534255
FASN	2194	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of FASN mRNA	decreases^expression	23649840
FASN	2194	Fulvestrant	D000077267	129453-61-8	Fulvestrant inhibits the reaction [Norethynodrel results in increased activity of FASN protein]	decreases^reaction|increases^activity	15870863
FASN	2194	ganoderic acid A	C515005		ganoderic acid A results in decreased expression of FASN mRNA	decreases^expression	29852127
FASN	2194	Genistein	D019833	446-72-0	Genistein results in increased expression of FASN mRNA	increases^expression	22228119
FASN	2194	Glucosamine	D005944	3416-24-8	Glucosamine results in increased expression of FASN mRNA	increases^expression	22096489
FASN	2194	Glucose	D005947	50-99-7	Allopurinol inhibits the reaction [Glucose results in increased expression of FASN protein]	decreases^reaction|increases^expression	23647015
FASN	2194	Glucose	D005947	50-99-7	Glucose results in increased expression of FASN protein	increases^expression	18482975|23647015
FASN	2194	Glucose	D005947	50-99-7	[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides	increases^abundance|increases^expression	18482975
FASN	2194	Glucose	D005947	50-99-7	[INS protein co-treated with Glucose] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	19724016
FASN	2194	Glucose	D005947	50-99-7	PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]]	decreases^reaction|increases^expression|increases^reaction	18482975
FASN	2194	Glucose	D005947	50-99-7	Quercetin inhibits the reaction [Glucose results in increased expression of FASN protein]	decreases^reaction|increases^expression	23647015
FASN	2194	Glucose	D005947	50-99-7	[Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides]	decreases^reaction|increases^abundance|increases^activity|increases^expression	18482975
FASN	2194	Glucose	D005947	50-99-7	SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]	decreases^reaction|increases^expression	18482975
FASN	2194	Glucose	D005947	50-99-7	SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of FASN mRNA]	affects^cotreatment|decreases^reaction|increases^expression	19724016
FASN	2194	GW 3965	C473027		[Bexarotene co-treated with GW 3965] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	GW 3965	C473027		[CD 3254 co-treated with GW 3965] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	GW 3965	C473027		GW 3965 results in increased expression of FASN mRNA	increases^expression	31437187|32123961
FASN	2194	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of FASN mRNA	affects^cotreatment|decreases^expression	30611723
FASN	2194	GW 7647	C453899		[GW 7647 co-treated with Oleic Acid] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30611723
FASN	2194	GW 7647	C453899		GW 7647 results in increased expression of FASN mRNA	increases^expression	31437187
FASN	2194	Haloperidol	D006220	52-86-8	Haloperidol results in increased expression of FASN mRNA	increases^expression	16027736
FASN	2194	Hydrocarbons, Chlorinated	D006843		Hydrocarbons, Chlorinated results in increased expression of FASN mRNA	increases^expression	27203212
FASN	2194	Hydrocarbons, Chlorinated	D006843		Hydrocarbons, Chlorinated results in increased expression of FASN protein	increases^expression	27203212
FASN	2194	Hydrocortisone	D006854	50-23-7	CEBPA protein affects the reaction [Hydrocortisone results in increased expression of FASN mRNA]	affects^reaction|increases^expression	30776459
FASN	2194	Hydrocortisone	D006854	50-23-7	Hydrocortisone results in increased expression of FASN mRNA	increases^expression	30776459
FASN	2194	Hydrocortisone	D006854	50-23-7	NR3C1 protein affects the reaction [Hydrocortisone results in increased expression of FASN mRNA]	affects^reaction|increases^expression	30776459
FASN	2194	Hydrocortisone	D006854	50-23-7	Resveratrol inhibits the reaction [Hydrocortisone results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	30776459
FASN	2194	Ibuprofen	D007052	15687-27-1	Ibuprofen affects the expression of FASN protein	affects^expression	18351690
FASN	2194	Ibuprofen	D007052	15687-27-1	Ibuprofen results in decreased expression of FASN mRNA	decreases^expression	18351690
FASN	2194	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of FASN mRNA	decreases^expression	15982314|20436886
FASN	2194	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	27392435
FASN	2194	kahweol	C053401	6894-43-5	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [kahweol results in decreased expression of FASN mRNA]	decreases^expression|increases^reaction	30205135
FASN	2194	kahweol	C053401	6894-43-5	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [kahweol results in decreased expression of FASN protein]	decreases^expression|increases^reaction	30205135
FASN	2194	kahweol	C053401	6894-43-5	kahweol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FASN mRNA]	decreases^expression|increases^reaction	30205135
FASN	2194	kahweol	C053401	6894-43-5	kahweol promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FASN protein]	decreases^expression|increases^reaction	30205135
FASN	2194	kahweol	C053401	6894-43-5	kahweol results in decreased expression of FASN mRNA	decreases^expression	30205135
FASN	2194	kahweol	C053401	6894-43-5	kahweol results in decreased expression of FASN protein	decreases^expression	30205135
FASN	2194	Lactic Acid	D019344	50-21-5	Lactic Acid results in increased expression of FASN mRNA	increases^expression	30851411
FASN	2194	Lead	D007854	7439-92-1	Lead results in increased expression of FASN mRNA	increases^expression	19921347
FASN	2194	Leflunomide	D000077339	75706-12-6	[Colforsin co-treated with Leflunomide] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30364229
FASN	2194	Lipids	D008055		[Lipids deficiency results in increased susceptibility to fatostatin] which results in decreased expression of FASN mRNA	decreases^expression|increases^response to substance	30140005
FASN	2194	lipstatin	C054164	96829-59-3	lipstatin analog binds to FASN protein	affects^binding	20577697
FASN	2194	Lovastatin	D008148	75330-75-5	Lovastatin results in increased expression of FASN mRNA	increases^expression	11728391
FASN	2194	Metformin	D008687	657-24-9	[Metformin co-treated with caffeic acid] results in decreased expression of FASN protein	affects^cotreatment|decreases^expression	28576465
FASN	2194	Metformin	D008687	657-24-9	Metformin results in decreased expression of FASN mRNA	decreases^expression	20956498
FASN	2194	Methimazole	D008713	60-56-0	Methimazole inhibits the reaction [IGF1 protein results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	29990518
FASN	2194	Methimazole	D008713	60-56-0	Methimazole results in decreased expression of FASN mRNA	decreases^expression	29990518
FASN	2194	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	C445068		methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in decreased expression of FASN mRNA	decreases^expression	20372807
FASN	2194	methyleugenol	C005223	93-15-2	methyleugenol results in decreased expression of FASN mRNA	decreases^expression	32234424
FASN	2194	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of FASN mRNA	decreases^expression	23649840
FASN	2194	Methylnitronitrosoguanidine	D008769	70-25-7	Methylnitronitrosoguanidine results in increased expression of FASN mRNA	increases^expression	12634122
FASN	2194	Metribolone	D015741	965-93-5	Metribolone promotes the reaction [NDRG1 protein binds to FASN protein]	affects^binding|increases^reaction	17220478
FASN	2194	Metribolone	D015741	965-93-5	Metribolone results in increased expression of FASN protein	increases^expression	17152098
FASN	2194	Mifepristone	D015735	84371-65-3	Mifepristone inhibits the reaction [Norethynodrel results in increased activity of FASN protein]	decreases^reaction|increases^activity	15870863
FASN	2194	Mitotane	D008939	53-19-0	Mitotane results in decreased expression of FASN mRNA	decreases^expression	31312845
FASN	2194	Mitoxantrone	D008942	65271-80-9	FASN protein results in decreased susceptibility to Mitoxantrone	decreases^response to substance	18281512
FASN	2194	Mitoxantrone	D008942	65271-80-9	Orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Mitoxantrone]	decreases^reaction|decreases^response to substance	18281512
FASN	2194	mono-(2-ethylhexyl)phthalate	C016599	4376-20-9	mono-(2-ethylhexyl)phthalate results in increased expression of FASN mRNA	increases^expression	23118965
FASN	2194	motexafin gadolinium	C437683		motexafin gadolinium results in decreased expression of FASN mRNA	decreases^expression	16357179
FASN	2194	MT19c compound	C568376		MT19c compound results in decreased expression of FASN mRNA	decreases^expression	21781307
FASN	2194	NADP	D009249	53-59-8	NADP binds to and results in increased activity of FASN protein	affects^binding|increases^activity	25526675
FASN	2194	Nanotubes, Carbon	D037742		Nanotubes, Carbon results in increased expression of FASN mRNA	increases^expression	24389112
FASN	2194	Nanotubes, Carbon	D037742		Nanotubes, Carbon results in increased expression of FASN protein	increases^expression	31047983
FASN	2194	Nelfinavir	D019888	159989-64-7	Nelfinavir results in decreased expression of FASN mRNA	decreases^expression	21355074
FASN	2194	Nelfinavir	D019888	159989-64-7	Nelfinavir results in decreased expression of FASN protein	decreases^expression	21355074
FASN	2194	Niacin	D009525		Niacin results in decreased expression of FASN mRNA	decreases^expression	19131065
FASN	2194	Nickel	D009532	7440-02-0	Nickel results in decreased expression of FASN mRNA	decreases^expression	24768652
FASN	2194	nickel acetate	C119536		nickel acetate affects the expression of FASN mRNA	affects^expression	23828170
FASN	2194	nickel acetate	C119536		nickel acetate affects the expression of FASN protein	affects^expression	23828170
FASN	2194	nickel chloride	C022838	7718-54-9	nickel chloride results in decreased expression of FASN mRNA	decreases^expression	17312168
FASN	2194	nickel sulfate	C029938	7786-81-4	nickel sulfate results in increased expression of FASN mRNA	increases^expression	16780908
FASN	2194	Norethindrone	D009640	68-22-4	Norethindrone results in increased activity of FASN protein	increases^activity	15870863
FASN	2194	Norethynodrel	D009641	68-23-5	Fulvestrant inhibits the reaction [Norethynodrel results in increased activity of FASN protein]	decreases^reaction|increases^activity	15870863
FASN	2194	Norethynodrel	D009641	68-23-5	Mifepristone inhibits the reaction [Norethynodrel results in increased activity of FASN protein]	decreases^reaction|increases^activity	15870863
FASN	2194	Norethynodrel	D009641	68-23-5	Norethynodrel results in increased activity of and results in increased expression of FASN protein	increases^activity|increases^expression	15870863
FASN	2194	N-phenylmaleimide	C028525	941-69-5	N-phenylmaleimide analog results in decreased expression of FASN mRNA	decreases^expression	27507602
FASN	2194	N-phenylmaleimide	C028525	941-69-5	N-phenylmaleimide results in decreased expression of FASN mRNA	decreases^expression	27507602
FASN	2194	N-piperidinyl-(8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydrobenzo(6,7)cyclohepta(1,2-c)pyrazole-3-carboxamide)	C475771		N-piperidinyl-(8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydrobenzo(6,7)cyclohepta(1,2-c)pyrazole-3-carboxamide) inhibits the reaction [bisphenol A results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	27014939
FASN	2194	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of FASN mRNA	affects^binding|decreases^expression	20971185
FASN	2194	obeticholic acid	C464660		obeticholic acid inhibits the reaction [Ethanol results in increased expression of FASN protein]	decreases^reaction|increases^expression	27939985
FASN	2194	obeticholic acid	C464660		obeticholic acid results in decreased expression of FASN mRNA	decreases^expression	27939613
FASN	2194	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30611723
FASN	2194	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of FASN mRNA	affects^cotreatment|decreases^expression	30611723
FASN	2194	Oleic Acid	D019301	112-80-1	[GW 7647 co-treated with Oleic Acid] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30611723
FASN	2194	Oleic Acid	D019301	112-80-1	[Oleic Acid co-treated with Bezafibrate] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	24534255
FASN	2194	Oleic Acid	D019301	112-80-1	[Oleic Acid co-treated with Fenofibrate] affects the expression of FASN mRNA	affects^cotreatment|affects^expression	24534255
FASN	2194	Orlistat	D000077403	96829-58-2	FASN protein affects the susceptibility to Orlistat	affects^response to substance	15870086
FASN	2194	Orlistat	D000077403	96829-58-2	Orlistat analog binds to FASN protein	affects^binding	20577697
FASN	2194	Orlistat	D000077403	96829-58-2	Orlistat analog results in decreased activity of FASN protein	decreases^activity	18710210
FASN	2194	Orlistat	D000077403	96829-58-2	Orlistat binds to and results in decreased activity of FASN protein	affects^binding|decreases^activity	17618296|17847090|20148945
FASN	2194	Orlistat	D000077403	96829-58-2	Orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Doxorubicin]	decreases^reaction|decreases^response to substance	18281512
FASN	2194	Orlistat	D000077403	96829-58-2	Orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Mitoxantrone]	decreases^reaction|decreases^response to substance	18281512
FASN	2194	Orlistat	D000077403	96829-58-2	Orlistat results in decreased activity of FASN protein	decreases^activity	15026345|15138278|15870086|17012255|18710210|18723500
FASN	2194	Orlistat	D000077403	96829-58-2	[Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Fatty Acids	decreases^abundance|decreases^activity	18723500
FASN	2194	Orlistat	D000077403	96829-58-2	[Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphatidylcholines	decreases^abundance|decreases^activity	18723500
FASN	2194	Orlistat	D000077403	96829-58-2	[Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine	decreases^abundance|decreases^activity	18723500
FASN	2194	Orlistat	D000077403	96829-58-2	[Orlistat results in decreased activity of FASN protein] which results in decreased chemical synthesis of Fatty Acids	decreases^activity|decreases^chemical synthesis	17012255
FASN	2194	Orlistat	D000077403	96829-58-2	[Orlistat results in decreased activity of FASN protein] which results in decreased expression of SKP2 protein	decreases^activity|decreases^expression	15138278
FASN	2194	Orlistat	D000077403	96829-58-2	Orlistat results in decreased expression of FASN protein	decreases^expression	30667213
FASN	2194	Oxygen	D010100	7782-44-7	EPAS1 gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of FASN mRNA]	decreases^expression|decreases^reaction	24503013
FASN	2194	Oxygen	D010100	7782-44-7	HIF1A gene mutant form inhibits the reaction [Oxygen deficiency results in decreased expression of FASN mRNA]	decreases^expression|decreases^reaction	24503013
FASN	2194	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of FASN mRNA	decreases^expression	24503013|26516004
FASN	2194	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of FASN protein	decreases^expression	26087400
FASN	2194	Paclitaxel	D017239		Paclitaxel results in decreased expression of FASN protein	decreases^expression	30667213
FASN	2194	Palmitates	D010168		Exenatide inhibits the reaction [Palmitates results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	30253173
FASN	2194	Palmitates	D010168		Palmitates binds to FASN protein	affects^binding	17847090
FASN	2194	Palmitates	D010168		Palmitates results in increased expression of FASN mRNA	increases^expression	30253173
FASN	2194	Palmitic Acid	D019308	57-10-3	Palmitic Acid results in increased phosphorylation of FASN protein	increases^phosphorylation	28073184
FASN	2194	Particulate Matter	D052638		Particulate Matter results in increased expression of FASN mRNA	increases^expression	29703138
FASN	2194	paxilline	C048220	57186-25-1	[Bexarotene co-treated with paxilline] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	paxilline	C048220	57186-25-1	[CD 3254 co-treated with paxilline] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	paxilline	C048220	57186-25-1	paxilline results in increased expression of FASN mRNA	increases^expression	32123961
FASN	2194	PD 0325901	C506614		PD 0325901 inhibits the reaction [Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased expression of UCP1 protein]]	decreases^reaction|increases^expression	26670611
FASN	2194	perfluorononanoic acid	C584865		perfluorononanoic acid results in decreased expression of FASN mRNA	decreases^expression	32588087
FASN	2194	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in decreased expression of FASN mRNA	decreases^expression	32588087
FASN	2194	Pesticides	D010575		Pesticides results in increased expression of FASN mRNA	increases^expression	27203212
FASN	2194	Pesticides	D010575		Pesticides results in increased expression of FASN protein	increases^expression	27203212
FASN	2194	PF-429242	C570314		PF-429242 results in decreased expression of FASN mRNA	decreases^expression	27378817
FASN	2194	PF-429242	C570314		PF-429242 results in decreased expression of FASN protein	decreases^expression	28483521
FASN	2194	Phosphatidylcholines	D010713		[Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphatidylcholines	decreases^abundance|decreases^activity	18723500
FASN	2194	Phosphorylcholine	D010767	107-73-3	[Cerulenin results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine	decreases^abundance|decreases^activity	18723500
FASN	2194	Phosphorylcholine	D010767	107-73-3	[Orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine	decreases^abundance|decreases^activity	18723500
FASN	2194	pimecrolimus	C117268		pimecrolimus inhibits the reaction [Rifampin results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	29356861
FASN	2194	Potassium Dichromate	D011192	7778-50-9	Potassium Dichromate results in increased expression of FASN protein	increases^expression	23718831
FASN	2194	propiconazole	C045950	60207-90-1	[propiconazole co-treated with tebuconazole] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30989312
FASN	2194	Protein Kinase Inhibitors	D047428		PD 0325901 inhibits the reaction [Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased expression of UCP1 protein]]	decreases^reaction|increases^expression	26670611
FASN	2194	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [FASN protein affects the localization of ARRB1 protein]	affects^localization|decreases^reaction	26670611
FASN	2194	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in decreased abundance of Adenosine Triphosphate]	decreases^abundance|decreases^reaction	26670611
FASN	2194	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased abundance of Fatty Acids, Nonesterified]	decreases^reaction|increases^abundance	26670611
FASN	2194	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased abundance of Triglycerides]	decreases^reaction|increases^abundance	26670611
FASN	2194	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased expression of ACACA mRNA]	decreases^reaction|increases^expression	26670611
FASN	2194	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased expression of ADIPOQ mRNA]	decreases^reaction|increases^expression	26670611
FASN	2194	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased expression of FASN protein]	decreases^reaction|increases^expression	26670611
FASN	2194	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased expression of RETN mRNA]	decreases^reaction|increases^expression	26670611
FASN	2194	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased expression of UCP1 mRNA]	decreases^reaction|increases^expression	26670611
FASN	2194	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased expression of UCP1 protein]	decreases^reaction|increases^expression	26670611
FASN	2194	puag-haad	C034912	07/07/4721	puag-haad inhibits the reaction [TO-901317 results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	29702089
FASN	2194	Quercetin	D011794	117-39-5	Quercetin inhibits the reaction [[Fatty Acids co-treated with INS protein] results in increased expression of FASN mRNA]	affects^cotreatment|decreases^reaction|increases^expression	24648896
FASN	2194	Quercetin	D011794	117-39-5	Quercetin inhibits the reaction [[Fatty Acids co-treated with INS protein] results in increased expression of FASN protein]	affects^cotreatment|decreases^reaction|increases^expression	24648896
FASN	2194	Quercetin	D011794	117-39-5	Quercetin inhibits the reaction [Glucose results in increased expression of FASN protein]	decreases^reaction|increases^expression	23647015
FASN	2194	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of FASN mRNA	decreases^expression	19729006|20596804
FASN	2194	Quercetin	D011794	117-39-5	Quercetin results in increased expression of FASN protein	increases^expression	19207037
FASN	2194	quinocetone	C502851		quinocetone results in increased expression of FASN mRNA	increases^expression	27046791
FASN	2194	Raffinose	D011887	512-69-6	Raffinose results in decreased expression of FASN mRNA	decreases^expression	29458019
FASN	2194	Resveratrol	D000077185		Resveratrol inhibits the reaction [Hydrocortisone results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	30776459
FASN	2194	Resveratrol	D000077185		Resveratrol inhibits the reaction [TO-901317 results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	23651738
FASN	2194	Resveratrol	D000077185		Resveratrol results in decreased expression of FASN mRNA	decreases^expression	20878097|30776459
FASN	2194	Resveratrol	D000077185		Resveratrol results in decreased expression of FASN protein	decreases^expression	25448084
FASN	2194	Resveratrol	D000077185		[Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides]	decreases^reaction|increases^abundance|increases^activity|increases^expression	18482975
FASN	2194	Rifampin	D012293	13292-46-1	pimecrolimus inhibits the reaction [Rifampin results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	29356861
FASN	2194	Rifampin	D012293	13292-46-1	Rifampin results in increased expression of FASN mRNA	increases^expression	29356861
FASN	2194	Rosiglitazone	D000077154		FASN protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]]	decreases^abundance|increases^reaction	26670611
FASN	2194	Rosiglitazone	D000077154		FASN protein promotes the reaction [Rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]]	increases^abundance|increases^reaction	26670611
FASN	2194	Rosiglitazone	D000077154		FASN protein results in increased susceptibility to Rosiglitazone	increases^response to substance	26670611
FASN	2194	Rosiglitazone	D000077154		Rosiglitazone promotes the reaction [PPARG protein results in increased expression of FASN protein]	increases^expression|increases^reaction	26670611
FASN	2194	Rosiglitazone	D000077154		Rosiglitazone results in increased expression of FASN mRNA	increases^expression	16806087|17148569
FASN	2194	S-allylcysteine	C065299	21593-77-1	S-allylcysteine inhibits the reaction [Fatty Acids, Nonesterified results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	23465592
FASN	2194	Selenium	D012643	7782-49-2	Selenium results in increased expression of FASN mRNA	increases^expression	19244175
FASN	2194	SGA 360	C551534		SGA 360 results in decreased expression of FASN mRNA	decreases^expression	31225620
FASN	2194	SGA 360	C551534		SGA 360 results in decreased expression of FASN protein	decreases^expression	31225620
FASN	2194	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog affects the secretion of FASN protein	affects^secretion	25895662
FASN	2194	Silybin	D000077385	22888-70-6	Silybin results in decreased expression of FASN protein	decreases^expression	25294820
FASN	2194	Simvastatin	D019821	79902-63-9	Simvastatin results in increased expression of FASN mRNA	increases^expression	11728391
FASN	2194	SRT1720	C525422		SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of FASN mRNA]	affects^cotreatment|decreases^reaction|increases^expression	19724016
FASN	2194	sulconazole	C033308	61318-90-9	sulconazole results in decreased expression of FASN mRNA	decreases^expression	31312845
FASN	2194	Sunitinib	D000077210		Sunitinib results in increased expression of FASN mRNA	increases^expression	31533062
FASN	2194	tebuconazole	C087114		[propiconazole co-treated with tebuconazole] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30989312
FASN	2194	tebuconazole	C087114		tebuconazole results in increased expression of FASN mRNA	increases^expression	30989312
FASN	2194	teriflunomide	C527525		[Colforsin co-treated with teriflunomide] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	30364229
FASN	2194	teriflunomide	C527525		teriflunomide results in decreased expression of FASN mRNA	decreases^expression	30364229
FASN	2194	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of FASN protein	decreases^expression	31225620
FASN	2194	Thimerosal	D013849	54-64-8	Thimerosal results in decreased expression of FASN mRNA	decreases^expression	27188386
FASN	2194	Thiosemicarbazones	D013882		[Thiosemicarbazones binds to Copper] which results in increased expression of FASN protein	affects^binding|increases^expression	20931265
FASN	2194	titanium dioxide	C009495	13463-67-7	titanium dioxide results in increased expression of FASN protein	increases^expression	30910687
FASN	2194	TO-901317	C423915		atheronal-A inhibits the reaction [TO-901317 results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	27703007
FASN	2194	TO-901317	C423915		[Bexarotene co-treated with TO-901317] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	TO-901317	C423915		[CD 3254 co-treated with TO-901317] results in increased expression of FASN mRNA	affects^cotreatment|increases^expression	32123961
FASN	2194	TO-901317	C423915		deoxypodophyllotoxin inhibits the reaction [TO-901317 results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	30148990
FASN	2194	TO-901317	C423915		puag-haad inhibits the reaction [TO-901317 results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	29702089
FASN	2194	TO-901317	C423915		Resveratrol inhibits the reaction [TO-901317 results in increased expression of FASN mRNA]	decreases^reaction|increases^expression	23651738
FASN	2194	TO-901317	C423915		TO-901317 results in decreased expression of FASN mRNA	decreases^expression	28903485
FASN	2194	TO-901317	C423915		TO-901317 results in increased expression of FASN mRNA	increases^expression	15548517|23651738|27703007|29702089|30003287|30148990|32123961
FASN	2194	TO-901317	C423915		TO-901317 results in increased expression of FASN protein	increases^expression	28903485
FASN	2194	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of FASN protein	affects^expression	30291989
FASN	2194	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of FASN mRNA	decreases^expression	28065790
FASN	2194	trametinib	C560077		trametinib affects the reaction [[BRAF protein affects the susceptibility to Vemurafenib] which affects the expression of FASN mRNA]	affects^expression|affects^reaction|affects^response to substance	29950559
FASN	2194	Tretinoin	D014212	302-79-4	Tretinoin metabolite results in increased expression of FASN mRNA	increases^expression	15982314
FASN	2194	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of FASN mRNA	decreases^expression	15982314|23724009
FASN	2194	tributyltin	C011559	688-73-3	tributyltin results in increased expression of FASN mRNA	increases^expression	28011154
FASN	2194	Triclosan	D014260	3380-34-5	Triclosan affects the expression of FASN mRNA	affects^expression	31714634
FASN	2194	Triclosan	D014260	3380-34-5	Triclosan affects the expression of FASN protein	affects^expression	31714634
FASN	2194	Triglycerides	D014280		FASN protein results in increased abundance of Triglycerides	increases^abundance	26670611
FASN	2194	Triglycerides	D014280		[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides	increases^abundance|increases^expression	18482975
FASN	2194	Triglycerides	D014280		Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased abundance of Triglycerides]	decreases^reaction|increases^abundance	26670611
FASN	2194	Triglycerides	D014280		[Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides]	decreases^reaction|increases^abundance|increases^activity|increases^expression	18482975
FASN	2194	triphenyl phosphate	C005445	115-86-6	triphenyl phosphate results in increased expression of FASN mRNA	increases^expression	28934090
FASN	2194	Troglitazone	D000077288	97322-87-7	Troglitazone results in increased expression of FASN mRNA	increases^expression	19022234
FASN	2194	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of FASN mRNA	decreases^expression	22378314
FASN	2194	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of FASN mRNA	increases^expression	22414386
FASN	2194	Ursodeoxycholic Acid	D014580	128-13-2	Ursodeoxycholic Acid results in decreased expression of FASN mRNA	decreases^expression	24312631
FASN	2194	valilactone	C054478	113276-96-3	valilactone results in decreased activity of FASN protein	decreases^activity	18710210
FASN	2194	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FASN mRNA	affects^cotreatment|decreases^expression	27188386
FASN	2194	Valproic Acid	D014635	99-66-1	NR1H3 protein affects the reaction [Valproic Acid results in increased expression of FASN mRNA]	affects^reaction|increases^expression	30003287
FASN	2194	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of FASN mRNA	decreases^expression	23179753|26272509|28001369|29501571
FASN	2194	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of FASN mRNA	increases^expression	30003287
FASN	2194	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of FASN protein	increases^expression	25716160|30003287
FASN	2194	Vemurafenib	D000077484		[BRAF protein affects the susceptibility to Vemurafenib] which affects the expression of FASN mRNA	affects^expression|affects^response to substance	29950559
FASN	2194	Vemurafenib	D000077484		trametinib affects the reaction [[BRAF protein affects the susceptibility to Vemurafenib] which affects the expression of FASN mRNA]	affects^expression|affects^reaction|affects^response to substance	29950559
FASN	2194	Vorinostat	D000077337		Vorinostat results in decreased expression of FASN mRNA	decreases^expression	27188386
FASN	2194	Zidovudine	D015215	30516-87-1	Zidovudine affects the expression of FASN mRNA	affects^expression	20032539
FASN	2194	Zinc Acetate	D019345	5970-45-6	Zinc Acetate results in decreased expression of FASN mRNA	decreases^expression	16357179
FASN	2194	zinc chloride	C016837	7646-85-7	zinc chloride results in decreased expression of FASN mRNA	decreases^expression	21540303
GALE	2582	2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine	C532162		[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased expression of GALE mRNA	decreases^expression|increases^response to substance	20453058
GALE	2582	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALE mRNA	affects^cotreatment|increases^expression	27188386
GALE	2582	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALE mRNA	affects^cotreatment|increases^expression	27188386
GALE	2582	4-aminophenylarsenoxide	C032642	1122-90-3	4-aminophenylarsenoxide binds to GALE protein	affects^binding	26598702
GALE	2582	4-aminophenylarsenoxide	C032642	1122-90-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GALE protein]	affects^binding|decreases^reaction	26598702
GALE	2582	abrine	C496492		abrine results in increased expression of GALE mRNA	increases^expression	31054353
GALE	2582	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of GALE mRNA	increases^expression	22230336
GALE	2582	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GALE protein]	affects^binding|decreases^reaction	26598702
GALE	2582	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of GALE protein	increases^expression	19364129
GALE	2582	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of GALE 5' UTR	decreases^methylation	27901495
GALE	2582	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of GALE promoter	decreases^methylation	27901495
GALE	2582	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of GALE mRNA	affects^cotreatment|increases^expression	27392435
GALE	2582	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of GALE mRNA	increases^expression	27392435
GALE	2582	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of GALE mRNA	decreases^expression	19376846
GALE	2582	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of GALE mRNA	decreases^expression	19549813
GALE	2582	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of GALE mRNA	increases^expression	25562108
GALE	2582	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALE mRNA	affects^cotreatment|increases^expression	27188386
GALE	2582	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALE mRNA	affects^cotreatment|increases^expression	27188386
GALE	2582	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of GALE mRNA	affects^cotreatment|increases^expression	27392435
GALE	2582	jinfukang	C544151		jinfukang results in increased expression of GALE mRNA	increases^expression	27392435
GALE	2582	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of GALE mRNA	decreases^expression	30851411
GALE	2582	lariciresinol	C060282		lariciresinol results in increased expression of GALE protein	increases^expression	27417256
GALE	2582	NAD	D009243	53-84-9	NAD binds to and results in increased activity of GALE protein	affects^binding|increases^activity	25526675
GALE	2582	Nickel	D009532	7440-02-0	Nickel results in increased expression of GALE mRNA	increases^expression	24768652
GALE	2582	Nicotine	D009538		Nicotine results in decreased expression of GALE mRNA	decreases^expression	16949557
GALE	2582	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALE mRNA	affects^cotreatment|increases^expression	27188386
GALE	2582	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of GALE mRNA	increases^expression	26272509
GALE	2582	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in increased expression of GALE mRNA	increases^expression	25895662
GALE	2582	thymidine 5'-diphosphate	C027923	491-97-4	thymidine 5'-diphosphate binds to GALE protein	affects^binding	25526675
GALE	2582	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of GALE mRNA	increases^expression	24935251
GALE	2582	Urethane	D014520	51-79-6	Urethane results in decreased expression of GALE mRNA	decreases^expression	28818685
GALE	2582	Uridine Diphosphate Galactose	D014531	2956-16-3	Uridine Diphosphate Galactose binds to GALE protein	affects^binding	25526675
GALE	2582	Uridine Diphosphate Glucose	D014532	133-89-1	Uridine Diphosphate Glucose binds to GALE protein	affects^binding	25526675
GALE	2582	Uridine Diphosphate Glucuronic Acid	D014535	2616-64-0	Uridine Diphosphate Glucuronic Acid binds to GALE protein	affects^binding	25526675
GALE	2582	Uridine Diphosphate N-Acetylgalactosamine	D014536	7277-98-7	Uridine Diphosphate N-Acetylgalactosamine binds to GALE protein	affects^binding	25526675
GALE	2582	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALE mRNA	affects^cotreatment|increases^expression	27188386
GALE	2582	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of GALE mRNA	affects^expression	25979313
GALE	2582	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of GALE mRNA	decreases^expression	29501571
GALE	2582	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of GALE protein	decreases^expression	29501571
GALE	2582	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of GALE mRNA	increases^expression	19101580|23179753|24383497|24935251|26272509|28001369|29154799
GAPDH	2597	1,10-phenanthroline	C025205	66-71-7	1,10-phenanthroline results in increased expression of GAPDH mRNA	increases^expression	19502547
GAPDH	2597	1,2-naphthoquinone	C040756	524-42-5	1,2-naphthoquinone binds to GAPDH protein	affects^binding	21827172
GAPDH	2597	1,2-naphthoquinone	C040756	524-42-5	1,2-naphthoquinone results in decreased activity of GAPDH protein	decreases^activity	21827172
GAPDH	2597	1,2-naphthoquinone	C040756	524-42-5	[Buthionine Sulfoximine results in decreased abundance of Glutathione] promotes the reaction [1,2-naphthoquinone binds to GAPDH protein]	affects^binding|decreases^abundance|increases^reaction	21827172
GAPDH	2597	1,2-naphthoquinone	C040756	524-42-5	[Buthionine Sulfoximine results in decreased abundance of Glutathione] promotes the reaction [1,2-naphthoquinone results in decreased activity of GAPDH protein]	decreases^abundance|decreases^activity|increases^reaction	21827172
GAPDH	2597	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	28628672
GAPDH	2597	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	28628672
GAPDH	2597	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of GAPDH mRNA	increases^expression	14724376
GAPDH	2597	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of GAPDH protein	increases^expression	24675778
GAPDH	2597	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	Selegiline inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of GAPDH mRNA]	decreases^reaction|increases^expression	14724376
GAPDH	2597	2,3,5-(triglutathion-S-yl)hydroquinone	C078765	119212-33-8	2,3,5-(triglutathion-S-yl)hydroquinone results in increased ADP-ribosylation of GAPDH protein	increases^ADP-ribosylation	31165168
GAPDH	2597	2,6-dichloro-4-nitrophenol	C015802	618-80-4	2,6-dichloro-4-nitrophenol results in increased expression of GAPDH mRNA	increases^expression	11227219
GAPDH	2597	2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one	C533410		[2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one co-treated with Cisplatin] inhibits the reaction [Oxygen deficiency results in increased expression of GAPDH mRNA]	affects^cotreatment|decreases^reaction|increases^expression	29690507
GAPDH	2597	2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one	C533410		[2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one co-treated with Cisplatin] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	29690507
GAPDH	2597	3-buten-2-one	C057920	78-94-4	3-buten-2-one binds to and results in decreased activity of GAPDH protein	affects^binding|decreases^activity	22084934
GAPDH	2597	4-aminophenylarsenoxide	C032642	1122-90-3	4-aminophenylarsenoxide binds to GAPDH protein	affects^binding	26598702
GAPDH	2597	4-aminophenylarsenoxide	C032642	1122-90-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GAPDH protein]	affects^binding|decreases^reaction	26598702
GAPDH	2597	9,10-Dimethyl-1,2-benzanthracene	D015127	57-97-6	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GAPDH mRNA	decreases^expression	19502547
GAPDH	2597	Acetaldehyde	D000079	75-07-0	[MPO protein co-treated with XDH protein co-treated with Acetaldehyde co-treated with Serotonin] affects the metabolism of and binds to GAPDH protein	affects^binding|affects^cotreatment|affects^metabolic processing	23009681
GAPDH	2597	Acrolein	D000171	107-02-8	Acrolein binds to and results in decreased activity of GAPDH protein	affects^binding|decreases^activity	22084934
GAPDH	2597	Acrylamide	D020106	79-06-1	Acrylamide binds to and results in decreased activity of GAPDH protein	affects^binding|decreases^activity	22084934
GAPDH	2597	Adenosine Diphosphate	D000244	58-64-0	Adenosine Diphosphate inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Adenosine Triphosphate	D000255	56-65-5	Adenosine Triphosphate inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Alitretinoin	D000077556	08/03/5300	Alitretinoin results in decreased expression of GAPDH protein	decreases^expression	28886987
GAPDH	2597	Antimony Potassium Tartrate	D000966	28300-74-5	Antimony Potassium Tartrate results in increased expression of GAPDH mRNA	increases^expression	28713220
GAPDH	2597	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GAPDH protein]	affects^binding|decreases^reaction	26598702
GAPDH	2597	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in increased expression of GAPDH protein	increases^expression	29553831
GAPDH	2597	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of GAPDH protein	increases^expression	17292933
GAPDH	2597	bis-N,N-dimethylamino-2-(N-methylpyrrolyl)methyl cyclopentadienyl titanium (IV)	C551172		bis-N,N-dimethylamino-2-(N-methylpyrrolyl)methyl cyclopentadienyl titanium (IV) results in decreased expression of GAPDH mRNA	decreases^expression	20162321
GAPDH	2597	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of GAPDH mRNA	affects^expression	30903817
GAPDH	2597	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	28628672
GAPDH	2597	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	28628672
GAPDH	2597	bromovanin	C515564		bromovanin results in decreased expression of GAPDH protein	decreases^expression	21419150
GAPDH	2597	Buthionine Sulfoximine	D019328	5072-26-4	[Buthionine Sulfoximine results in decreased abundance of Glutathione] promotes the reaction [1,2-naphthoquinone binds to GAPDH protein]	affects^binding|decreases^abundance|increases^reaction	21827172
GAPDH	2597	Buthionine Sulfoximine	D019328	5072-26-4	[Buthionine Sulfoximine results in decreased abundance of Glutathione] promotes the reaction [1,2-naphthoquinone results in decreased activity of GAPDH protein]	decreases^abundance|decreases^activity|increases^reaction	21827172
GAPDH	2597	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of GAPDH protein	increases^expression	24527689
GAPDH	2597	Capsaicin	D002211	404-86-4	Capsaicin results in increased expression of GAPDH protein	increases^expression	18991268
GAPDH	2597	cerous chloride	C026690	7790-86-5	[cerous chloride co-treated with lanthanum chloride] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	28954213
GAPDH	2597	cerous chloride	C026690	7790-86-5	cerous chloride results in decreased expression of GAPDH mRNA	decreases^expression	28954213
GAPDH	2597	Chlorodiphenyl (54% Chlorine)	D020111	11097-69-1	Chlorodiphenyl (54% Chlorine) results in increased expression of GAPDH mRNA	increases^expression	17851650
GAPDH	2597	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of GAPDH mRNA	increases^expression	26352163
GAPDH	2597	chromium histidinate	C499843		chromium histidinate inhibits the reaction [Hydrogen Peroxide results in increased expression of GAPDH mRNA]	decreases^reaction|increases^expression	19902159
GAPDH	2597	chromium histidinate	C499843		chromium histidinate results in increased expression of GAPDH mRNA	increases^expression	19902159
GAPDH	2597	Cisplatin	D002945	15663-27-1	[2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one co-treated with Cisplatin] inhibits the reaction [Oxygen deficiency results in increased expression of GAPDH mRNA]	affects^cotreatment|decreases^reaction|increases^expression	29690507
GAPDH	2597	Cisplatin	D002945	15663-27-1	[2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one co-treated with Cisplatin] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	29690507
GAPDH	2597	Cisplatin	D002945	15663-27-1	Cisplatin inhibits the reaction [Oxygen deficiency results in increased expression of GAPDH mRNA]	decreases^reaction|increases^expression	29690507
GAPDH	2597	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of GAPDH mRNA	decreases^expression	29690507
GAPDH	2597	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of GAPDH protein	increases^expression	21924258
GAPDH	2597	Coal Tar	D003033	8007-45-2	Coal Tar results in increased expression of GAPDH protein	increases^expression	18495319
GAPDH	2597	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of GAPDH mRNA	increases^expression	10646848|17553155|25100165
GAPDH	2597	cobaltous chloride	C018021	7646-79-9	tetraethylenepentamine inhibits the reaction [cobaltous chloride results in increased expression of GAPDH mRNA]	decreases^reaction|increases^expression	25100165
GAPDH	2597	cobalt sulfate	C026305	10124-43-3	cobalt sulfate results in increased expression of GAPDH mRNA	increases^expression	19502547
GAPDH	2597	Copper	D003300	7440-50-8	GAPDH protein binds to Copper	affects^binding	14534351|15359738
GAPDH	2597	cumene hydroperoxide	C007164	80-15-9	cumene hydroperoxide results in increased expression of GAPDH protein	increases^expression	11295360
GAPDH	2597	Cytarabine	D003561	147-94-4	Cytarabine affects the localization of GAPDH protein	affects^localization	19628630
GAPDH	2597	Cytarabine	D003561	147-94-4	Cytarabine results in decreased activity of GAPDH protein	decreases^activity	19628630
GAPDH	2597	Cytarabine	D003561	147-94-4	GAPDH protein results in increased susceptibility to Cytarabine	increases^response to substance	19628630
GAPDH	2597	Dactinomycin	D003609	50-76-0	Dactinomycin results in increased expression of GAPDH mRNA	increases^expression	16001973
GAPDH	2597	Decitabine	D000077209	2353-33-5	Decitabine results in decreased expression of GAPDH protein	decreases^expression	19294695
GAPDH	2597	Decitabine	D000077209	2353-33-5	Decitabine results in increased expression of GAPDH mRNA	increases^expression	17908484
GAPDH	2597	Deferoxamine	D003676	70-51-9	Deferoxamine results in decreased expression of GAPDH protein	decreases^expression	19515424
GAPDH	2597	Deferoxamine	D003676	70-51-9	ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of GAPDH protein]	decreases^reaction|increases^expression	19515424
GAPDH	2597	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	28628672
GAPDH	2597	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	28628672
GAPDH	2597	diallyl trisulfide	C042577	2050-87-5	diallyl trisulfide results in decreased expression of GAPDH protein	decreases^expression	16344271
GAPDH	2597	dihydroartemisinin	C039060		dihydroartemisinin analog binds to GAPDH protein	affects^binding	26340163
GAPDH	2597	Dimethyl Sulfoxide	D004121	67-68-5	Dimethyl Sulfoxide affects the expression of GAPDH mRNA	affects^expression	12843640
GAPDH	2597	Dopamine	D004298	51-61-6	Dopamine results in increased expression of GAPDH protein	increases^expression	24675778
GAPDH	2597	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of GAPDH mRNA	increases^expression	29803840
GAPDH	2597	Dronabinol	D013759		Dronabinol results in increased expression of GAPDH protein	increases^expression	18163980
GAPDH	2597	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GAPDH protein	decreases^activity|increases^O-linked glycosylation	23301498
GAPDH	2597	fenbuconazole	C504383		fenbuconazole results in increased expression of GAPDH mRNA	increases^expression	15942997
GAPDH	2597	ferric ammonium citrate	C013531	1185-57-5	ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of GAPDH protein]	decreases^reaction|increases^expression	19515424
GAPDH	2597	Fluorouracil	D005472	51-21-8	Fluorouracil affects the splicing of GAPDH mRNA	affects^splicing	17169984
GAPDH	2597	Glucose	D005947	50-99-7	Glucose results in increased expression of GAPDH mRNA	increases^expression	7826318
GAPDH	2597	Glucose	D005947	50-99-7	SOD2 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]	decreases^activity|decreases^reaction|increases^ADP-ribosylation	14523042
GAPDH	2597	Glucose	D005947	50-99-7	SOD2 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]	decreases^activity|decreases^reaction|increases^chemical synthesis	11050244
GAPDH	2597	Glutathione	D005978	70-18-8	Adenosine Diphosphate inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Glutathione	D005978	70-18-8	Adenosine Triphosphate inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Glutathione	D005978	70-18-8	[Buthionine Sulfoximine results in decreased abundance of Glutathione] promotes the reaction [1,2-naphthoquinone binds to GAPDH protein]	affects^binding|decreases^abundance|increases^reaction	21827172
GAPDH	2597	Glutathione	D005978	70-18-8	[Buthionine Sulfoximine results in decreased abundance of Glutathione] promotes the reaction [1,2-naphthoquinone results in decreased activity of GAPDH protein]	decreases^abundance|decreases^activity|increases^reaction	21827172
GAPDH	2597	Glutathione	D005978	70-18-8	[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog	affects^cotreatment|increases^reduction	15788719
GAPDH	2597	Glutathione	D005978	70-18-8	Glutathione results in increased metabolism of and results in increased activity of GAPDH protein modified form	increases^activity|increases^metabolic processing	21827172
GAPDH	2597	Glutathione	D005978	70-18-8	NAD analog inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Glutathione	D005978	70-18-8	NADP inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Glyceraldehyde 3-Phosphate	D005986	142-10-9	Adenosine Diphosphate inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Glyceraldehyde 3-Phosphate	D005986	142-10-9	Adenosine Triphosphate inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Glyceraldehyde 3-Phosphate	D005986	142-10-9	[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog	affects^cotreatment|increases^reduction	15788719
GAPDH	2597	Glyceraldehyde 3-Phosphate	D005986	142-10-9	NAD analog inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Glyceraldehyde 3-Phosphate	D005986	142-10-9	NADP inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Graphite	D006108	7782-42-5	Graphite results in decreased expression of GAPDH protein	decreases^expression	22157353
GAPDH	2597	GSK-J4	C000593030		GSK-J4 results in increased expression of GAPDH mRNA	increases^expression	29301935
GAPDH	2597	Hydrogen Peroxide	D006861	7722-84-1	chromium histidinate inhibits the reaction [Hydrogen Peroxide results in increased expression of GAPDH mRNA]	decreases^reaction|increases^expression	19902159
GAPDH	2597	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in decreased expression of GAPDH mRNA	decreases^expression	12419474
GAPDH	2597	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased expression of GAPDH mRNA	increases^expression	19902159|21751221
GAPDH	2597	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased expression of GAPDH protein	increases^expression	11295360
GAPDH	2597	indioside D	C428264		indioside D results in decreased expression of GAPDH protein	decreases^expression	18376857
GAPDH	2597	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	28628672
GAPDH	2597	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	28628672
GAPDH	2597	jinfukang	C544151		jinfukang results in increased expression of GAPDH mRNA	increases^expression	27392435
GAPDH	2597	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of GAPDH mRNA	decreases^expression	25961927
GAPDH	2597	K 7174	C410337		K 7174 results in decreased expression of GAPDH mRNA	decreases^expression	24086573
GAPDH	2597	lanthanum chloride	C028521	10099-58-8	[cerous chloride co-treated with lanthanum chloride] results in decreased expression of GAPDH mRNA	affects^cotreatment|decreases^expression	28954213
GAPDH	2597	Lead	D007854	7439-92-1	GAPDH protein binds to Lead	affects^binding	23896426
GAPDH	2597	Menthol	D008610	1490-04-6	Menthol results in increased expression of GAPDH mRNA	increases^expression	26760959
GAPDH	2597	Mercaptopurine	D015122		Mercaptopurine affects the localization of GAPDH protein	affects^localization	19628630
GAPDH	2597	Methylmercury Compounds	D008767		Methylmercury Compounds results in decreased expression of GAPDH mRNA	decreases^expression	19150642
GAPDH	2597	MLN7243	C000622638		MLN7243 results in increased sumoylation of GAPDH protein	increases^sumoylation	31285264
GAPDH	2597	Mustard Gas	D009151	505-60-2	Mustard Gas affects the localization of GAPDH protein	affects^localization	23827652
GAPDH	2597	Mustard Gas	D009151	505-60-2	Mustard Gas results in increased expression of GAPDH protein	increases^expression	23827652
GAPDH	2597	NAD	D009243	53-84-9	Adenosine Diphosphate inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	NAD	D009243	53-84-9	Adenosine Triphosphate inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	NAD	D009243	53-84-9	[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog	affects^cotreatment|increases^reduction	15788719
GAPDH	2597	NAD	D009243	53-84-9	NAD analog inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	NAD	D009243	53-84-9	NADP inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	NADP	D009249	53-59-8	NADP inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	Nanotubes, Carbon	D037742		Nanotubes, Carbon affects the expression of GAPDH protein	affects^expression	22001959
GAPDH	2597	Nanotubes, Carbon	D037742		Nanotubes, Carbon results in increased expression of GAPDH protein	increases^expression	22157353
GAPDH	2597	nickel chloride	C022838	7718-54-9	nickel chloride results in increased expression of GAPDH mRNA	increases^expression	10646848|23566959
GAPDH	2597	nordy	C510003		nordy results in increased expression of GAPDH protein	increases^expression	18232056
GAPDH	2597	obeticholic acid	C464660		obeticholic acid results in decreased expression of GAPDH mRNA	decreases^expression	27939613
GAPDH	2597	Okadaic Acid	D019319	78111-17-8	Okadaic Acid affects the expression of GAPDH mRNA	affects^expression	22788371
GAPDH	2597	Oxygen	D010100	7782-44-7	[2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one co-treated with Cisplatin] inhibits the reaction [Oxygen deficiency results in increased expression of GAPDH mRNA]	affects^cotreatment|decreases^reaction|increases^expression	29690507
GAPDH	2597	Oxygen	D010100	7782-44-7	Cisplatin inhibits the reaction [Oxygen deficiency results in increased expression of GAPDH mRNA]	decreases^reaction|increases^expression	29690507
GAPDH	2597	Oxygen	D010100	7782-44-7	Oxygen deficiency promotes the reaction [HIF1A protein binds to GAPDH promoter]	affects^binding|increases^reaction	23880069
GAPDH	2597	Oxygen	D010100	7782-44-7	Oxygen deficiency results in increased expression of GAPDH mRNA	increases^expression	10646848|19502547|29690507
GAPDH	2597	Particulate Matter	D052638		Particulate Matter results in decreased expression of GAPDH mRNA	decreases^expression	24769257
GAPDH	2597	perfluorohexanesulfonic acid	C471071	355-46-4	perfluorohexanesulfonic acid results in increased expression of GAPDH mRNA	increases^expression	23567314
GAPDH	2597	Pesticides	D010575		Pesticides results in decreased methylation of GAPDH gene	decreases^methylation	28396702
GAPDH	2597	Quercetin	D011794	117-39-5	Quercetin results in increased expression of GAPDH protein	increases^expression	19207037
GAPDH	2597	Rosiglitazone	D000077154		Rosiglitazone affects the expression of GAPDH protein	affects^expression	19556978
GAPDH	2597	Rotenone	D012402	83-79-4	[GAPDH protein polymorphism co-treated with Rotenone] results in decreased expression of BCL2 protein	affects^cotreatment|decreases^expression	29886133
GAPDH	2597	Rotenone	D012402	83-79-4	GAPDH protein polymorphism promotes the reaction [Rotenone promotes the reaction [GAPDH protein binds to GAPDH protein]]	affects^binding|increases^reaction	29886133
GAPDH	2597	Rotenone	D012402	83-79-4	GAPDH protein polymorphism promotes the reaction [Rotenone results in increased expression of and results in decreased activity of GAPDH protein]	decreases^activity|increases^expression|increases^reaction	29886133
GAPDH	2597	Rotenone	D012402	83-79-4	GAPDH protein polymorphism promotes the reaction [Rotenone results in increased expression of BAX protein]	increases^expression|increases^reaction	29886133
GAPDH	2597	Rotenone	D012402	83-79-4	GAPDH protein polymorphism promotes the reaction [Rotenone results in increased expression of TP53 protein]	increases^expression|increases^reaction	29886133
GAPDH	2597	Rotenone	D012402	83-79-4	Rotenone promotes the reaction [GAPDH protein binds to GAPDH protein]	affects^binding|increases^reaction	29886133
GAPDH	2597	Rotenone	D012402	83-79-4	Rotenone results in increased expression of and results in decreased activity of GAPDH protein	decreases^activity|increases^expression	29886133
GAPDH	2597	salinomycin	C010327	53003-10-4	salinomycin results in decreased expression of GAPDH mRNA	decreases^expression	19682730
GAPDH	2597	Selegiline	D012642		Selegiline inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of GAPDH mRNA]	decreases^reaction|increases^expression	14724376
GAPDH	2597	Selenium	D012643	7782-49-2	Selenium results in increased expression of GAPDH mRNA	increases^expression	19244175
GAPDH	2597	Serotonin	D012701	50-67-9	[MPO protein co-treated with XDH protein co-treated with Acetaldehyde co-treated with Serotonin] affects the metabolism of and binds to GAPDH protein	affects^binding|affects^cotreatment|affects^metabolic processing	23009681
GAPDH	2597	Serotonin	D012701	50-67-9	[tryptamine-4,5-dione co-treated with Serotonin] affects the metabolism of and binds to GAPDH protein	affects^binding|affects^cotreatment|affects^metabolic processing	23009681
GAPDH	2597	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in increased secretion of GAPDH protein	increases^secretion	25895662
GAPDH	2597	sodium arsenite	C017947	13768-07-5	Adenosine Diphosphate inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	sodium arsenite	C017947	13768-07-5	Adenosine Triphosphate inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	sodium arsenite	C017947	13768-07-5	[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog	affects^cotreatment|increases^reduction	15788719
GAPDH	2597	sodium arsenite	C017947	13768-07-5	NAD analog inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	sodium arsenite	C017947	13768-07-5	NADP inhibits the reaction [[GAPDH protein co-treated with NAD co-treated with Glyceraldehyde 3-Phosphate co-treated with Glutathione] results in increased reduction of sodium arsenite analog]	affects^cotreatment|decreases^reaction|increases^reduction	15788719
GAPDH	2597	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of GAPDH mRNA	increases^expression	28713220
GAPDH	2597	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of GAPDH protein	increases^expression	15899475
GAPDH	2597	Sunitinib	D000077210		Sunitinib results in increased expression of GAPDH mRNA	increases^expression	31533062
GAPDH	2597	Superoxides	D013481	11062-77-4	SOD2 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]	decreases^activity|decreases^reaction|increases^chemical synthesis	11050244
GAPDH	2597	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in increased expression of GAPDH protein	increases^expression	11295360
GAPDH	2597	tetrabromobisphenol A	C020806	79-94-7	tetrabromobisphenol A affects the expression of GAPDH protein	affects^expression	30098271
GAPDH	2597	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of GAPDH mRNA	decreases^expression	23152189
GAPDH	2597	tetraethylenepentamine	C034269	112-57-2	tetraethylenepentamine inhibits the reaction [cobaltous chloride results in increased expression of GAPDH mRNA]	decreases^reaction|increases^expression	25100165
GAPDH	2597	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of GAPDH protein	affects^expression	30291989
GAPDH	2597	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased metabolism of GAPDH protein	increases^metabolic processing	23396223
GAPDH	2597	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of GAPDH protein	decreases^expression	28886987|30806631
GAPDH	2597	Tretinoin	D014212	302-79-4	tributyltin promotes the reaction [Tretinoin results in decreased expression of GAPDH protein]	decreases^expression|increases^reaction	30806631
GAPDH	2597	Tretinoin	D014212	302-79-4	triphenyltin chloride promotes the reaction [Tretinoin results in decreased expression of GAPDH protein]	decreases^expression|increases^reaction	30806631
GAPDH	2597	tributyltin	C011559	688-73-3	tributyltin analog results in decreased expression of GAPDH protein	decreases^expression	31634547
GAPDH	2597	tributyltin	C011559	688-73-3	tributyltin promotes the reaction [Tretinoin results in decreased expression of GAPDH protein]	decreases^expression|increases^reaction	30806631
GAPDH	2597	tributyltin	C011559	688-73-3	tributyltin results in decreased expression of GAPDH protein	decreases^expression	30806631
GAPDH	2597	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of GAPDH protein	decreases^expression	19294695
GAPDH	2597	triphenyltin	C030665		triphenyltin analog results in decreased expression of GAPDH protein	decreases^expression	31634547
GAPDH	2597	triphenyltin chloride	C012594	639-58-7	triphenyltin chloride promotes the reaction [Tretinoin results in decreased expression of GAPDH protein]	decreases^expression|increases^reaction	30806631
GAPDH	2597	triphenyltin chloride	C012594	639-58-7	triphenyltin chloride results in decreased expression of GAPDH protein	decreases^expression	30806631
GAPDH	2597	tryptamine-4,5-dione	C060213	108560-71-0	[tryptamine-4,5-dione co-treated with Serotonin] affects the metabolism of and binds to GAPDH protein	affects^binding|affects^cotreatment|affects^metabolic processing	23009681
GAPDH	2597	Vitamin E	D014810	1406-18-4	Vitamin E results in increased expression of GAPDH mRNA	increases^expression	19244175
GAPDH	2597	Zinc	D015032	7440-66-6	GAPDH protein binds to Zinc	affects^binding	14534351
GARS1	2617	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of GARS1 mRNA	increases^expression	24810058
GARS1	2617	1-nitropyrene	C032668	5522-43-0	1-nitropyrene results in increased expression of GARS1 mRNA	increases^expression	19041380
GARS1	2617	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of GARS1 protein	increases^expression	26194647
GARS1	2617	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GARS1 mRNA	affects^cotreatment|increases^expression	27188386
GARS1	2617	(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	C517041		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of GARS1 mRNA	increases^expression	19561079
GARS1	2617	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GARS1 mRNA	decreases^expression	20018196
GARS1	2617	Acetaminophen	D000082	103-90-2	Acetaminophen affects the expression of GARS1 mRNA	affects^expression	25704631
GARS1	2617	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of GARS1 mRNA	increases^expression	29067470
GARS1	2617	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of GARS1 protein	affects^expression	20106945
GARS1	2617	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of GARS1 mRNA	decreases^expression	21632981
GARS1	2617	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of GARS1 mRNA	increases^expression	20458559
GARS1	2617	Ascorbic Acid	D001205	50-81-7	Ascorbic Acid results in decreased expression of GARS1 mRNA	decreases^expression	19197388
GARS1	2617	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of GARS1 mRNA	decreases^expression	20106945
GARS1	2617	Bexarotene	D000077610		Bexarotene results in decreased expression of GARS1 mRNA	decreases^expression	17178900
GARS1	2617	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of GARS1 mRNA	increases^expression	29275510
GARS1	2617	Bucladesine	D003994	362-74-3	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GARS1 mRNA	affects^cotreatment|decreases^expression	20823114
GARS1	2617	C646 compound	C584509		C646 compound results in increased expression of GARS1 mRNA	increases^expression	26191083
GARS1	2617	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of GARS1 mRNA	decreases^expression	25596134
GARS1	2617	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of GARS1 mRNA	affects^expression	24752500|25979313
GARS1	2617	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde affects the expression of GARS1 mRNA	affects^expression	25596134
GARS1	2617	chloropicrin	C100187	76-06-2	chloropicrin affects the expression of GARS1 mRNA	affects^expression	26352163
GARS1	2617	Cidofovir	D000077404	113852-37-2	Cidofovir results in increased expression of GARS1 mRNA	increases^expression	25596134
GARS1	2617	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of GARS1 mRNA	increases^expression	25596134
GARS1	2617	Cisplatin	D002945	15663-27-1	GARS1 protein affects the susceptibility to Cisplatin	affects^response to substance	16217747
GARS1	2617	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in increased expression of GARS1 mRNA	increases^expression	25596134
GARS1	2617	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of GARS1 mRNA	increases^expression	19549813
GARS1	2617	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of GARS1 mRNA	increases^expression	20106945|21163907|21632981|22147139|25562108|25596134|27989131
GARS1	2617	Diclofenac	D004008	15307-86-5	Diclofenac affects the expression of GARS1 mRNA	affects^expression	24752500
GARS1	2617	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GARS1 mRNA	affects^cotreatment|increases^expression	27188386
GARS1	2617	Dronabinol	D013759		Dronabinol affects the expression of GARS1 mRNA	affects^expression	18454173
GARS1	2617	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
GARS1	2617	Estradiol	D004958	50-28-2	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GARS1 mRNA	affects^cotreatment|decreases^expression	20823114
GARS1	2617	Estradiol	D004958	50-28-2	Estradiol results in increased expression of GARS1 mRNA	increases^expression	20106945
GARS1	2617	Fatty Acids, Omega-3	D015525		Fatty Acids, Omega-3 results in decreased expression of GARS1 mRNA	decreases^expression	16823509
GARS1	2617	Fatty Acids, Omega-6	D043371		Fatty Acids, Omega-6 results in decreased expression of GARS1 mRNA	decreases^expression	16823509
GARS1	2617	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of GARS1 mRNA	increases^expression	25596134
GARS1	2617	Gasoline	D005742		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
GARS1	2617	Gefitinib	D000077156		Gefitinib results in increased expression of GARS1 mRNA	increases^expression	16685379
GARS1	2617	ICG 001	C492448		ICG 001 results in increased expression of GARS1 mRNA	increases^expression	26191083
GARS1	2617	Ifosfamide	D007069	3778-73-2	Ifosfamide results in increased expression of GARS1 mRNA	increases^expression	25596134
GARS1	2617	K 7174	C410337		K 7174 results in increased expression of GARS1 mRNA	increases^expression	24086573
GARS1	2617	Lamivudine	D019259	134678-17-4	[Zidovudine co-treated with Lamivudine] results in increased expression of GARS1 mRNA	affects^cotreatment|increases^expression	15784690
GARS1	2617	Leflunomide	D000077339	75706-12-6	Leflunomide results in increased expression of GARS1 mRNA	increases^expression	28988120
GARS1	2617	Medroxyprogesterone Acetate	D017258	71-58-9	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GARS1 mRNA	affects^cotreatment|decreases^expression	20823114
GARS1	2617	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of GARS1 mRNA	increases^expression	28001369
GARS1	2617	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of GARS1 mRNA	decreases^expression	30559759
GARS1	2617	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of GARS1 mRNA	decreases^expression	25596134
GARS1	2617	Particulate Matter	D052638		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
GARS1	2617	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GARS1 mRNA	affects^cotreatment|increases^expression	27188386
GARS1	2617	p-Chloromercuribenzoic Acid	D020245	59-85-8	p-Chloromercuribenzoic Acid results in increased expression of GARS1 mRNA	increases^expression	26272509
GARS1	2617	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of GARS1 protein	increases^expression	26879310
GARS1	2617	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of GARS1 mRNA	affects^expression	19159669
GARS1	2617	Phenobarbital	D010634	50-06-6	Phenobarbital results in increased expression of GARS1 mRNA	increases^expression	19084549
GARS1	2617	Plant Extracts	D010936		Plant Extracts results in increased expression of GARS1 mRNA	increases^expression	23557933
GARS1	2617	Polycyclic Aromatic Hydrocarbons	D011084		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
GARS1	2617	polyhexamethyleneguanidine	C060540	31961-54-3	polyhexamethyleneguanidine affects the expression of GARS1 mRNA	affects^expression	29337256
GARS1	2617	Progesterone	D011374	57-83-0	Progesterone results in increased expression of GARS1 mRNA	increases^expression	18037150
GARS1	2617	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of GARS1 mRNA	increases^expression	18175754
GARS1	2617	sulforafan	C016766	4478-93-7	sulforafan results in increased expression of GARS1 mRNA	increases^expression	31838189
GARS1	2617	sulindac sulfide	C025462	32004-67-4	sulindac sulfide results in increased expression of GARS1 mRNA	increases^expression	12734198
GARS1	2617	Sunitinib	D000077210		Sunitinib results in increased expression of GARS1 mRNA	increases^expression	31533062
GARS1	2617	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of GARS1 mRNA	decreases^expression	20106945|21632981
GARS1	2617	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of GARS1 mRNA	increases^expression	22378314|29453283
GARS1	2617	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of GARS1 protein	increases^expression	29453283
GARS1	2617	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of GARS1 protein	affects^expression	30291989
GARS1	2617	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of GARS1 mRNA	decreases^expression	16140955
GARS1	2617	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of GARS1 mRNA	increases^expression	26179874
GARS1	2617	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of GARS1 mRNA	increases^expression	22378314|29453283
GARS1	2617	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of GARS1 protein	increases^expression	29453283
GARS1	2617	Urethane	D014520	51-79-6	Urethane results in increased expression of GARS1 mRNA	increases^expression	28818685
GARS1	2617	Ursodeoxycholic Acid	D014580	128-13-2	Ursodeoxycholic Acid affects the expression of GARS1 mRNA	affects^expression	18422935
GARS1	2617	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of GARS1 mRNA	affects^expression	25979313
GARS1	2617	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of GARS1 mRNA	increases^expression	23179753|29154799
GARS1	2617	Zidovudine	D015215	30516-87-1	[Zidovudine co-treated with Lamivudine] results in increased expression of GARS1 mRNA	affects^cotreatment|increases^expression	15784690
GLE1	2733	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GLE1 mRNA	affects^cotreatment|increases^expression	19167446
GLE1	2733	abrine	C496492		abrine results in decreased expression of GLE1 mRNA	decreases^expression	31054353
GLE1	2733	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of GLE1 mRNA	decreases^expression	21420995
GLE1	2733	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of GLE1 mRNA	decreases^expression	24449571
GLE1	2733	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of GLE1 gene	affects^methylation	25304211
GLE1	2733	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of GLE1 mRNA	affects^expression	21179406
GLE1	2733	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of GLE1 mRNA	affects^cotreatment|increases^expression	27392435
GLE1	2733	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of GLE1 mRNA	increases^expression	27392435
GLE1	2733	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GLE1 mRNA	affects^cotreatment|increases^expression	19167446
GLE1	2733	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of GLE1 mRNA	increases^expression	19167446
GLE1	2733	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of GLE1 mRNA	decreases^expression	25562108
GLE1	2733	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of GLE1 mRNA	increases^expression	29803840
GLE1	2733	Estradiol	D004958	50-28-2	Estradiol results in increased expression of GLE1 mRNA	increases^expression	19167446
GLE1	2733	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of GLE1 mRNA	increases^expression	23649840
GLE1	2733	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of GLE1 mRNA	affects^cotreatment|increases^expression	27392435
GLE1	2733	kojic acid	C011890	501-30-4	kojic acid results in decreased expression of GLE1 mRNA	decreases^expression	16595896
GLE1	2733	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of GLE1 mRNA	decreases^expression	30851411
GLE1	2733	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of GLE1 mRNA	increases^expression	23649840
GPAM	57678	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GPAM mRNA	affects^cotreatment|increases^expression	28628672
GPAM	57678	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of GPAM mRNA	affects^expression	26238291
GPAM	57678	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GPAM mRNA	decreases^expression	20382639
GPAM	57678	abrine	C496492		abrine results in decreased expression of GPAM mRNA	decreases^expression	31054353
GPAM	57678	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of GPAM mRNA	decreases^expression	21420995|25704631|29067470
GPAM	57678	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of GPAM mRNA	decreases^expression	22100608|27153756
GPAM	57678	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of GPAM gene	decreases^methylation	27153756
GPAM	57678	Air Pollutants	D000393		Air Pollutants analog results in increased expression of GPAM mRNA	increases^expression	21757418
GPAM	57678	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational affects the expression of GPAM mRNA	affects^expression	27809917
GPAM	57678	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in decreased expression of GPAM mRNA	decreases^expression	24160326
GPAM	57678	Asbestos, Serpentine	D017632		Asbestos, Serpentine results in decreased expression of GPAM mRNA	decreases^expression	24160326
GPAM	57678	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of GPAM mRNA	decreases^expression	22378314
GPAM	57678	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of GPAM mRNA	decreases^expression	26238291|32234424
GPAM	57678	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of GPAM promoter	increases^methylation	27901495
GPAM	57678	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of GPAM mRNA	affects^expression	21179406
GPAM	57678	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of GPAM mRNA	affects^expression	30903817
GPAM	57678	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of GPAM mRNA	increases^expression	25619500|28483554
GPAM	57678	bisphenol A	C006780	80-05-7	MIR192 mRNA inhibits the reaction [bisphenol A results in increased expression of GPAM mRNA]	decreases^reaction|increases^expression	28483554
GPAM	57678	Copper Sulfate	D019327	7758-98-7	Copper Sulfate affects the expression of GPAM mRNA	affects^expression	19549813
GPAM	57678	Cyclosporine	D016572	59865-13-3	Cyclosporine affects the expression of GPAM mRNA	affects^expression	25562108
GPAM	57678	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of GPAM mRNA	decreases^expression	20106945|21632981|27989131
GPAM	57678	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of GPAM mRNA	increases^expression	25047013
GPAM	57678	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GPAM mRNA	affects^cotreatment|increases^expression	28628672
GPAM	57678	entacapone	C071192	116314-67-1	entacapone results in decreased expression of GPAM protein	decreases^expression	29688484
GPAM	57678	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of GPAM mRNA	decreases^expression	20106945
GPAM	57678	Ethanol	D000431	64-17-5	Ethanol results in decreased expression of GPAM mRNA	decreases^expression	23378141
GPAM	57678	Exenatide	D000077270	141732-76-5	Exenatide inhibits the reaction [Palmitates results in increased expression of GPAM mRNA]	decreases^reaction|increases^expression	30253173
GPAM	57678	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of GPAM mRNA	affects^expression	21179406
GPAM	57678	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GPAM mRNA	affects^cotreatment|increases^expression	28628672
GPAM	57678	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of GPAM mRNA	increases^expression	17400583
GPAM	57678	methyleugenol	C005223	93-15-2	methyleugenol results in decreased expression of GPAM mRNA	decreases^expression	32234424
GPAM	57678	Nickel	D009532	7440-02-0	Nickel results in decreased expression of GPAM mRNA	decreases^expression	24768652|25583101
GPAM	57678	obeticholic acid	C464660		obeticholic acid results in decreased expression of GPAM mRNA	decreases^expression	27939613
GPAM	57678	Palmitates	D010168		Exenatide inhibits the reaction [Palmitates results in increased expression of GPAM mRNA]	decreases^reaction|increases^expression	30253173
GPAM	57678	Palmitates	D010168		Palmitates results in increased expression of GPAM mRNA	increases^expression	30253173
GPAM	57678	Particulate Matter	D052638		Particulate Matter results in increased expression of GPAM mRNA	increases^expression	24769257
GPAM	57678	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in decreased expression of GPAM mRNA	decreases^expression	32588087
GPAM	57678	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of GPAM mRNA	decreases^expression	21632981
GPAM	57678	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of GPAM mRNA	decreases^expression	29301061
GPAM	57678	Sunitinib	D000077210		Sunitinib results in increased expression of GPAM mRNA	increases^expression	31533062
GPAM	57678	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of GPAM mRNA	affects^expression	22298810
GPAM	57678	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of GPAM mRNA	increases^expression	30096437
GPAM	57678	Troglitazone	D000077288	97322-87-7	Troglitazone results in decreased expression of GPAM mRNA	decreases^expression	25572481
GPAM	57678	Urethane	D014520	51-79-6	Urethane results in decreased expression of GPAM mRNA	decreases^expression	28818685
GPAM	57678	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of GPAM mRNA	affects^expression	25979313
GPAM	57678	Valproic Acid	D014635	99-66-1	Valproic Acid affects the methylation of GPAM gene	affects^methylation	29501571
GPAM	57678	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of GPAM mRNA	decreases^expression	23179753|29501571
GPAT4	137964	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GPAT4 mRNA	affects^cotreatment|increases^expression	28628672
GPAT4	137964	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAT4 mRNA	affects^cotreatment|increases^expression	19167446
GPAT4	137964	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of GPAT4 mRNA	increases^expression	22230336
GPAT4	137964	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of GPAT4 mRNA	increases^expression	22100608
GPAT4	137964	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of GPAT4 mRNA	decreases^expression	24449571
GPAT4	137964	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of GPAT4 gene	affects^methylation	25304211
GPAT4	137964	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of GPAT4 3' UTR	decreases^methylation	27901495
GPAT4	137964	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of GPAT4 promoter	decreases^methylation	27901495
GPAT4	137964	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in increased methylation of GPAT4 intron	increases^methylation	30157460
GPAT4	137964	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GPAT4 mRNA	affects^cotreatment|increases^expression	28628672
GPAT4	137964	Chlorpyrifos	D004390	2921-88-2	GPAT4 gene mutant form results in decreased susceptibility to Chlorpyrifos	decreases^response to substance	26299976
GPAT4	137964	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAT4 mRNA	affects^cotreatment|increases^expression	19167446
GPAT4	137964	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of GPAT4 mRNA	affects^cotreatment|increases^expression	19167446
GPAT4	137964	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GPAT4 mRNA	affects^cotreatment|increases^expression	28628672
GPAT4	137964	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of GPAT4 mRNA	affects^cotreatment|increases^expression	30611723
GPAT4	137964	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of GPAT4 mRNA	affects^cotreatment|decreases^expression	30611723
GPAT4	137964	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of GPAT4 mRNA	affects^cotreatment|increases^expression	28628672
GPAT4	137964	K 7174	C410337		K 7174 results in increased expression of GPAT4 mRNA	increases^expression	24086573
GPAT4	137964	Methapyrilene	D008701	91-80-5	Methapyrilene results in increased methylation of GPAT4 intron	increases^methylation	30157460
GPAT4	137964	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of GPAT4 mRNA	affects^cotreatment|increases^expression	30611723
GPAT4	137964	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of GPAT4 mRNA	affects^cotreatment|decreases^expression	30611723
GPAT4	137964	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of GPAT4 mRNA	affects^cotreatment|increases^expression	19167446
GPAT4	137964	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of GPAT4 mRNA	affects^expression	22298810
GPAT4	137964	Urethane	D014520	51-79-6	Urethane results in increased expression of GPAT4 mRNA	increases^expression	28818685
GUK1	2987	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of GUK1 gene	affects^methylation	25304211
GUK1	2987	arsenite	C015001	15502-74-6	arsenite results in increased methylation of GUK1 promoter	increases^methylation	23974009
GUK1	2987	Aspirin	D001241	50-78-2	Aspirin results in decreased expression of GUK1 mRNA	decreases^expression	15928584
GUK1	2987	Azacitidine	D001374	320-67-2	Azacitidine results in increased expression of GUK1 mRNA	increases^expression	20823114
GUK1	2987	chloropicrin	C100187	76-06-2	chloropicrin affects the expression of GUK1 mRNA	affects^expression	26352163
GUK1	2987	chloropicrin	C100187	76-06-2	chloropicrin results in decreased expression of GUK1 mRNA	decreases^expression	28476498
GUK1	2987	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of GUK1 mRNA	increases^expression	27594783
GUK1	2987	Cisplatin	D002945	15663-27-1	Folic Acid affects the reaction [Cisplatin affects the expression of GUK1 mRNA]	affects^expression|affects^reaction	16898872
GUK1	2987	Ethanol	D000431	64-17-5	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GUK1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
GUK1	2987	Folic Acid	D005492	59-30-3	Folic Acid affects the reaction [Cisplatin affects the expression of GUK1 mRNA]	affects^expression|affects^reaction	16898872
GUK1	2987	Gasoline	D005742		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GUK1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
GUK1	2987	Hydralazine	D006830	86-54-4	[Hydralazine co-treated with Valproic Acid] results in increased expression of GUK1 mRNA	affects^cotreatment|increases^expression	17183730
GUK1	2987	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of GUK1 mRNA	decreases^expression	23086925
GUK1	2987	Lead	D007854	7439-92-1	Lead affects the expression of GUK1 mRNA	affects^expression	28903495
GUK1	2987	nickel sulfate	C029938	7786-81-4	nickel sulfate results in increased expression of GUK1 mRNA	increases^expression	18651567
GUK1	2987	Particulate Matter	D052638		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GUK1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
GUK1	2987	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GUK1 mRNA	affects^binding|decreases^expression|increases^activity	19710929
GUK1	2987	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GUK1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
GUK1	2987	Potassium Dichromate	D011192	7778-50-9	Potassium Dichromate results in increased expression of GUK1 protein	increases^expression	23718831
GUK1	2987	Urethane	D014520	51-79-6	Urethane results in increased expression of GUK1 mRNA	increases^expression	28818685
GUK1	2987	Valproic Acid	D014635	99-66-1	[Hydralazine co-treated with Valproic Acid] results in increased expression of GUK1 mRNA	affects^cotreatment|increases^expression	17183730
GUSB	2990	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GUSB mRNA	affects^cotreatment|increases^expression	28628672
GUSB	2990	6-((2-(4-imidazolyl)ethyl)amino)heptanoic acid 4-toluidide	C081972	103827-15-2	6-((2-(4-imidazolyl)ethyl)amino)heptanoic acid 4-toluidide results in increased expression of GUSB protein	increases^expression	11238657
GUSB	2990	6-((2-(4-imidazolyl)ethyl)amino)heptanoic acid 4-toluidide	C081972	103827-15-2	HRH1 protein promotes the reaction [6-((2-(4-imidazolyl)ethyl)amino)heptanoic acid 4-toluidide results in increased expression of GUSB protein]	increases^expression|increases^reaction	11238657
GUSB	2990	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of GUSB mRNA	increases^expression	22230336
GUSB	2990	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of GUSB protein	increases^expression	17642144
GUSB	2990	Am 580	C068073	102121-60-8	Am 580 results in increased expression of GUSB mRNA	increases^expression	16982809
GUSB	2990	benoxaprofen	C011677		benoxaprofen results in increased secretion of GUSB protein	increases^secretion	6737371
GUSB	2990	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of GUSB promoter	decreases^methylation	27901495
GUSB	2990	Benzo(a)pyrene	D001564	50-32-8	GUSB protein affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]	affects^reaction|increases^expression	26438400
GUSB	2990	Benzo(a)pyrene	D001564	50-32-8	GUSB protein affects the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]	affects^reaction|increases^expression	26438400
GUSB	2990	Benzo(a)pyrene	D001564	50-32-8	GUSB protein promotes the reaction [Benzo(a)pyrene results in increased expression of UGT1A6 mRNA]	increases^expression|increases^reaction	26438400
GUSB	2990	Benzo(a)pyrene	D001564	50-32-8	mannose-6-phosphate affects the reaction [GUSB protein affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]]	affects^reaction|increases^expression	26438400
GUSB	2990	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GUSB mRNA	affects^cotreatment|increases^expression	28628672
GUSB	2990	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of GUSB mRNA	affects^expression	25979313
GUSB	2990	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GUSB mRNA	affects^cotreatment|increases^expression	28628672
GUSB	2990	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of GUSB mRNA	decreases^expression	29803840
GUSB	2990	Doxorubicin	D004317	23214-92-8	GUSB protein affects the susceptibility to Doxorubicin	affects^response to substance	16217747
GUSB	2990	epigallocatechin gallate	C045651	989-51-5	epigallocatechin gallate inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of GUSB protein]	decreases^reaction|increases^secretion	11944907
GUSB	2990	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of GUSB mRNA	affects^cotreatment|increases^expression	22079256
GUSB	2990	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of GUSB mRNA	increases^expression	23649840
GUSB	2990	fexofenadine	C093230		fexofenadine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of GUSB protein]	affects^binding|decreases^reaction|increases^activity|increases^expression	11238657
GUSB	2990	fexofenadine	C093230		fexofenadine inhibits the reaction [Histamine results in increased expression of GUSB protein]	decreases^reaction|increases^expression	11238657
GUSB	2990	Histamine	D006632	51-45-6	fexofenadine inhibits the reaction [[Histamine binds to and results in increased activity of HRH1 protein] which results in increased expression of GUSB protein]	affects^binding|decreases^reaction|increases^activity|increases^expression	11238657
GUSB	2990	Histamine	D006632	51-45-6	fexofenadine inhibits the reaction [Histamine results in increased expression of GUSB protein]	decreases^reaction|increases^expression	11238657
GUSB	2990	Histamine	D006632	51-45-6	Histamine results in increased expression of GUSB protein	increases^expression	11238657
GUSB	2990	Histamine	D006632	51-45-6	HRH1 protein promotes the reaction [Histamine results in increased expression of GUSB protein]	increases^expression|increases^reaction	11238657
GUSB	2990	ICG 001	C492448		ICG 001 results in increased expression of GUSB mRNA	increases^expression	26191083
GUSB	2990	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of GUSB mRNA	affects^cotreatment|increases^expression	28628672
GUSB	2990	jinfukang	C544151		jinfukang results in increased expression of GUSB mRNA	increases^expression	27392435
GUSB	2990	mannose-6-phosphate	C027693	3672-15-9	mannose-6-phosphate affects the reaction [GUSB protein affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]]	affects^reaction|increases^expression	26438400
GUSB	2990	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of GUSB mRNA	increases^expression	23649840
GUSB	2990	N-Formylmethionine Leucyl-Phenylalanine	D009240	59880-97-6	epigallocatechin gallate inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of GUSB protein]	decreases^reaction|increases^secretion	11944907
GUSB	2990	N-Formylmethionine Leucyl-Phenylalanine	D009240	59880-97-6	N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of GUSB protein	increases^secretion	11944907
GUSB	2990	Paclitaxel	D017239		GUSB protein affects the susceptibility to Paclitaxel	affects^response to substance	16217747
GUSB	2990	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of GUSB mRNA	affects^cotreatment|increases^expression	22079256
GUSB	2990	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in increased expression of GUSB mRNA	increases^expression	22079256
GUSB	2990	Rosiglitazone	D000077154		Rosiglitazone results in increased expression of GUSB mRNA	increases^expression	16982809
GUSB	2990	Sunitinib	D000077210		Sunitinib results in decreased expression of GUSB mRNA	decreases^expression	31533062
GUSB	2990	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of GUSB mRNA	decreases^expression	15336504
GUSB	2990	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of GUSB mRNA	increases^expression	19101580|23179753
GUSB	2990	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of GUSB gene	increases^methylation	29154799
GUSB	2990	Vinblastine	D014747	865-21-4	GUSB protein affects the susceptibility to Vinblastine	affects^response to substance	16217747
GUSB	2990	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of GUSB mRNA	affects^expression	20044591
HADH	3033	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	28628672
HADH	3033	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	19167446
HADH	3033	2-Propanol	D019840	67-63-0	HADH protein results in increased metabolism of 2-Propanol	increases^metabolic processing	10600649
HADH	3033	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	27188386
HADH	3033	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	30611723
HADH	3033	abrine	C496492		abrine results in decreased expression of HADH mRNA	decreases^expression	31054353
HADH	3033	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of HADH mRNA	decreases^expression	29067470
HADH	3033	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of HADH protein	affects^expression	20106945
HADH	3033	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of HADH mRNA	decreases^expression	27153756
HADH	3033	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational affects the expression of HADH mRNA	affects^expression	27809917
HADH	3033	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of HADH mRNA	decreases^expression	22378314
HADH	3033	Azathioprine	D001379	446-86-6	Azathioprine results in decreased expression of HADH mRNA	decreases^expression	22623647
HADH	3033	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of HADH mRNA	decreases^expression	32234424
HADH	3033	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of HADH mRNA	affects^expression	21179406
HADH	3033	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of HADH mRNA	affects^expression	30903817
HADH	3033	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of HADH mRNA	increases^expression	16474171
HADH	3033	C646 compound	C584509		C646 compound results in increased expression of HADH mRNA	increases^expression	26191083
HADH	3033	Carmustine	D002330	154-93-8	Carmustine results in decreased expression of HADH mRNA	decreases^expression	15980968
HADH	3033	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	27392435
HADH	3033	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of HADH mRNA	increases^expression	19376846
HADH	3033	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of HADH mRNA	affects^binding|decreases^expression	20971185
HADH	3033	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of HADH mRNA	decreases^expression	19549813
HADH	3033	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	19167446
HADH	3033	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	19167446
HADH	3033	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of HADH mRNA	increases^expression	19167446
HADH	3033	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of HADH mRNA	decreases^expression	20106945|23830897|25562108
HADH	3033	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of HADH mRNA	increases^expression	27989131
HADH	3033	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of HADH mRNA	increases^expression	25047013
HADH	3033	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	28628672
HADH	3033	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	27188386
HADH	3033	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of HADH mRNA	decreases^expression	29803840
HADH	3033	Doxorubicin	D004317	23214-92-8	HADH protein affects the susceptibility to Doxorubicin	affects^response to substance	16217747
HADH	3033	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HADH protein	decreases^activity|increases^O-linked glycosylation	23301498
HADH	3033	erucylphospho-N,N,N-trimethylpropylammonium	C472787		erucylphospho-N,N,N-trimethylpropylammonium results in decreased expression of HADH mRNA	decreases^expression	29464035
HADH	3033	Estradiol	D004958	50-28-2	[Estradiol co-treated with Progesterone] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	20660070
HADH	3033	Estradiol	D004958	50-28-2	Estradiol results in increased expression of HADH mRNA	increases^expression	16474171|19167446
HADH	3033	Estradiol	D004958	50-28-2	HADH protein results in increased oxidation of Estradiol	increases^oxidation	10600649
HADH	3033	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of HADH mRNA	increases^expression	24752549
HADH	3033	Genistein	D019833	446-72-0	Genistein results in decreased expression of HADH mRNA	decreases^expression	26865667
HADH	3033	Genistein	D019833	446-72-0	Genistein results in increased expression of HADH mRNA	increases^expression	16474171
HADH	3033	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of HADH mRNA	affects^cotreatment|decreases^expression	30611723
HADH	3033	GW 7647	C453899		GW 7647 results in increased expression of HADH mRNA	increases^expression	30611723
HADH	3033	ICG 001	C492448		ICG 001 results in decreased expression of HADH mRNA	decreases^expression	26191083
HADH	3033	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	28628672
HADH	3033	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of HADH mRNA	decreases^expression	20436886
HADH	3033	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	27392435
HADH	3033	K 7174	C410337		K 7174 results in decreased expression of HADH mRNA	decreases^expression	24086573
HADH	3033	NAD	D009243	53-84-9	HADH protein results in increased metabolism of NAD	increases^metabolic processing	10600649
HADH	3033	Nickel	D009532	7440-02-0	Nickel results in decreased expression of HADH mRNA	decreases^expression	25583101
HADH	3033	Niclosamide	D009534	50-65-7	Niclosamide results in decreased expression of HADH mRNA	decreases^expression	22576131
HADH	3033	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of HADH mRNA	affects^binding|decreases^expression	20971185
HADH	3033	Oleic Acid	D019301	112-80-1	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	30611723
HADH	3033	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of HADH mRNA	affects^cotreatment|decreases^expression	30611723
HADH	3033	periodate-oxidized adenosine	C027579	34240-05-6	periodate-oxidized adenosine affects the expression of HADH mRNA	affects^expression	17097637
HADH	3033	Polychlorinated Biphenyls	D011078		Polychlorinated Biphenyls analog results in increased expression of HADH mRNA	increases^expression	16474171
HADH	3033	Progesterone	D011374	57-83-0	[Estradiol co-treated with Progesterone] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	20660070
HADH	3033	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	19167446
HADH	3033	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of HADH mRNA	decreases^expression	15336504
HADH	3033	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of HADH mRNA	increases^expression	20106945|21632981
HADH	3033	Theophylline	D013806	58-55-9	Theophylline results in decreased expression of HADH mRNA	decreases^expression	16083514
HADH	3033	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of HADH mRNA	decreases^expression	28065790
HADH	3033	Topotecan	D019772	123948-87-8	HADH protein affects the susceptibility to Topotecan	affects^response to substance	16217747
HADH	3033	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of HADH mRNA	decreases^expression	26179874
HADH	3033	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of HADH mRNA	decreases^expression	22378314
HADH	3033	Uranium	D014501	7440-61-1	Uranium affects the expression of HADH mRNA	affects^expression	15672453
HADH	3033	uranyl acetate	C005460	541-09-3	uranyl acetate affects the expression of HADH mRNA	affects^expression	15672453
HADH	3033	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HADH mRNA	affects^cotreatment|increases^expression	27188386
HADH	3033	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of HADH mRNA	affects^expression	25979313
HADH	3033	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of HADH mRNA	increases^expression	23179753|26272509
HADH	3033	Vinblastine	D014747	865-21-4	HADH protein affects the susceptibility to Vinblastine	affects^response to substance	16217747
HADH	3033	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of HADH mRNA	affects^expression	20044591
HADHA	3030	2,3,5-(triglutathion-S-yl)hydroquinone	C078765	119212-33-8	2,3,5-(triglutathion-S-yl)hydroquinone results in increased ADP-ribosylation of HADHA protein	increases^ADP-ribosylation	31165168
HADHA	3030	2-amino-14,16-dimethyloctadecan-3-ol	C507616		2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of HADHA protein	decreases^expression	32044396
HADHA	3030	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of HADHA protein	increases^expression	25670856
HADHA	3030	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of HADHA mRNA	affects^cotreatment|increases^expression	30611723
HADHA	3030	abrine	C496492		abrine results in increased expression of HADHA protein	increases^expression	31054353
HADHA	3030	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of HADHA gene	decreases^methylation	27153756
HADHA	3030	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of HADHA mRNA	decreases^expression	22378314
HADHA	3030	bathocuproine sulfonate	C028559	73348-75-1	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA]	affects^cotreatment|decreases^reaction|increases^expression	15477007
HADHA	3030	Bortezomib	D000069286		Bortezomib results in increased expression of HADHA mRNA	increases^expression	20977926
HADHA	3030	CD 437	C099555		CD 437 results in decreased expression of HADHA mRNA	decreases^expression	12958071
HADHA	3030	ciglitazone	C039671	74772-77-3	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of HADHA mRNA	affects^binding|increases^expression	16197558
HADHA	3030	ciglitazone	C039671	74772-77-3	[ciglitazone binds to PPARG protein] which results in increased expression of HADHA mRNA	affects^binding|increases^expression	16197558
HADHA	3030	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of HADHA mRNA	decreases^expression	20106945|23830897
HADHA	3030	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HADHA protein	decreases^activity|increases^O-linked glycosylation	23301498
HADHA	3030	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of HADHA mRNA	affects^cotreatment|increases^expression	30611723
HADHA	3030	Farnesol	D005204	4602-84-0	Farnesol analog results in increased expression of HADHA mRNA	increases^expression	30611723
HADHA	3030	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of HADHA mRNA	increases^expression	25572481
HADHA	3030	fenofibric acid	C006012	26129-32-8	[fenofibric acid binds to PPARA protein] which results in increased expression of HADHA mRNA	affects^binding|increases^expression	16197558
HADHA	3030	gossypol acetic acid	C028178	12542-36-8	gossypol acetic acid results in decreased expression of HADHA protein	decreases^expression	29938581
HADHA	3030	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of HADHA mRNA	affects^cotreatment|decreases^expression	30611723
HADHA	3030	GW 501516	C425931		[GW 501516 binds to PPARD protein] which results in increased expression of HADHA mRNA	affects^binding|increases^expression	16197558
HADHA	3030	GW 7647	C453899		[GW 7647 co-treated with Oleic Acid] results in increased expression of HADHA mRNA	affects^cotreatment|increases^expression	30611723
HADHA	3030	GW 7647	C453899		GW 7647 promotes the reaction [Oleic Acid results in increased expression of HADHA mRNA]	increases^expression|increases^reaction	30611723
HADHA	3030	GW 7647	C453899		GW 7647 results in increased expression of HADHA mRNA	increases^expression	30611723
HADHA	3030	Ionomycin	D015759	56092-81-0	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA]	affects^cotreatment|decreases^reaction|increases^expression	15477007
HADHA	3030	Ionomycin	D015759	56092-81-0	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA	affects^cotreatment|increases^expression	15477007
HADHA	3030	Lead	D007854	7439-92-1	Lead results in decreased expression of HADHA mRNA	decreases^expression	19921347
HADHA	3030	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of HADHA mRNA	increases^expression	17400583
HADHA	3030	Oleic Acid	D019301	112-80-1	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of HADHA mRNA	affects^cotreatment|increases^expression	30611723
HADHA	3030	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of HADHA mRNA	affects^cotreatment|increases^expression	30611723
HADHA	3030	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of HADHA mRNA	affects^cotreatment|decreases^expression	30611723
HADHA	3030	Oleic Acid	D019301	112-80-1	[GW 7647 co-treated with Oleic Acid] results in increased expression of HADHA mRNA	affects^cotreatment|increases^expression	30611723
HADHA	3030	Oleic Acid	D019301	112-80-1	GW 7647 promotes the reaction [Oleic Acid results in increased expression of HADHA mRNA]	increases^expression|increases^reaction	30611723
HADHA	3030	Oleic Acid	D019301	112-80-1	Oleic Acid results in increased expression of HADHA mRNA	increases^expression	30611723
HADHA	3030	perfluorobutane	C108042		perfluorobutane affects the expression of HADHA mRNA	affects^expression	23567314
HADHA	3030	perfluorodecanoic acid	C036567	335-76-2	perfluorodecanoic acid affects the expression of HADHA mRNA	affects^expression	23567314
HADHA	3030	perfluorododecanoic acid	C522391		perfluorododecanoic acid affects the expression of HADHA mRNA	affects^expression	23567314
HADHA	3030	perfluorohexanesulfonic acid	C471071	355-46-4	perfluorohexanesulfonic acid affects the expression of HADHA mRNA	affects^expression	23567314
HADHA	3030	perfluorohexanoic acid	C479228		perfluorohexanoic acid results in increased expression of HADHA mRNA	increases^expression	23567314
HADHA	3030	perfluoro-n-heptanoic acid	C101815	375-85-9	perfluoro-n-heptanoic acid results in increased expression of HADHA mRNA	increases^expression	23567314
HADHA	3030	perfluoro-n-nonanoic acid	C101816	375-95-1	perfluoro-n-nonanoic acid results in increased expression of HADHA mRNA	increases^expression	23567314
HADHA	3030	perfluoro-n-undecanoic acid	C101814	2058-94-8	perfluoro-n-undecanoic acid affects the expression of HADHA mRNA	affects^expression	23567314
HADHA	3030	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in increased expression of HADHA mRNA	increases^expression	23567314
HADHA	3030	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of HADHA mRNA	increases^expression	23567314|32588087
HADHA	3030	pyrrolidine dithiocarbamic acid	C020972	25769-03-3	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA]	affects^cotreatment|decreases^reaction|increases^expression	15477007
HADHA	3030	Sarin	D012524	107-44-8	Sarin results in decreased expression of HADHA mRNA	decreases^expression	19522546
HADHA	3030	Selenium	D012643	7782-49-2	Selenium results in decreased expression of HADHA mRNA	decreases^expression	19244175
HADHA	3030	Silver Compounds	D018030		Silver Compounds results in decreased expression of HADHA mRNA	decreases^expression	29703973
HADHA	3030	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of HADHA mRNA	increases^expression	18175754
HADHA	3030	testosterone enanthate	C004648		testosterone enanthate affects the expression of HADHA mRNA	affects^expression	17440010
HADHA	3030	Tetradecanoylphorbol Acetate	D013755	16561-29-8	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA]	affects^cotreatment|decreases^reaction|increases^expression	15477007
HADHA	3030	Tetradecanoylphorbol Acetate	D013755	16561-29-8	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA	affects^cotreatment|increases^expression	15477007
HADHA	3030	Thimerosal	D013849	54-64-8	Thimerosal results in decreased expression of HADHA mRNA	decreases^expression	27188386
HADHA	3030	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of HADHA mRNA	affects^expression	25979313
HADHA	3030	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of HADHA gene	decreases^methylation	29154799
HADHA	3030	Vitamin E	D014810	1406-18-4	Vitamin E results in decreased expression of HADHA mRNA	decreases^expression	19244175
HADHB	3032	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of HADHB protein	increases^expression	25670856
HADHB	3032	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of HADHB mRNA	affects^cotreatment|increases^expression	30611723
HADHB	3032	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of HADHB mRNA	decreases^expression	22230336
HADHB	3032	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of HADHB 5' UTR	affects^methylation	27901495
HADHB	3032	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of HADHB mRNA	decreases^expression	28302478
HADHB	3032	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of HADHB mRNA	decreases^expression	29803840
HADHB	3032	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in decreased expression of HADHB mRNA	affects^cotreatment|decreases^expression	30165855
HADHB	3032	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of HADHB mRNA	affects^cotreatment|increases^expression	30611723
HADHB	3032	Farnesol	D005204	4602-84-0	Farnesol analog results in increased expression of HADHB mRNA	increases^expression	30611723
HADHB	3032	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of HADHB mRNA	increases^expression	24752549|25572481
HADHB	3032	fenofibric acid	C006012	26129-32-8	[fenofibric acid binds to PPARA protein] which results in increased expression of HADHB mRNA	affects^binding|increases^expression	16197558
HADHB	3032	GW 7647	C453899		[GW 7647 co-treated with Oleic Acid] results in increased expression of HADHB mRNA	affects^cotreatment|increases^expression	30611723
HADHB	3032	GW 7647	C453899		GW 7647 promotes the reaction [Oleic Acid results in increased expression of HADHB mRNA]	increases^expression|increases^reaction	30611723
HADHB	3032	GW 7647	C453899		GW 7647 results in increased expression of HADHB mRNA	increases^expression	30611723
HADHB	3032	GW 7647	C453899		Oleic Acid promotes the reaction [GW 7647 results in increased expression of HADHB mRNA]	increases^expression|increases^reaction	30611723
HADHB	3032	ICG 001	C492448		ICG 001 results in increased expression of HADHB mRNA	increases^expression	26191083
HADHB	3032	Lead	D007854	7439-92-1	Lead results in decreased expression of HADHB mRNA	decreases^expression	19921347
HADHB	3032	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of HADHB mRNA	increases^expression	17400583
HADHB	3032	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of HADHB protein	decreases^expression	26861962
HADHB	3032	Oleic Acid	D019301	112-80-1	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of HADHB mRNA	affects^cotreatment|increases^expression	30611723
HADHB	3032	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of HADHB mRNA	affects^cotreatment|increases^expression	30611723
HADHB	3032	Oleic Acid	D019301	112-80-1	[GW 7647 co-treated with Oleic Acid] results in increased expression of HADHB mRNA	affects^cotreatment|increases^expression	30611723
HADHB	3032	Oleic Acid	D019301	112-80-1	GW 7647 promotes the reaction [Oleic Acid results in increased expression of HADHB mRNA]	increases^expression|increases^reaction	30611723
HADHB	3032	Oleic Acid	D019301	112-80-1	Oleic Acid promotes the reaction [GW 7647 results in increased expression of HADHB mRNA]	increases^expression|increases^reaction	30611723
HADHB	3032	Oleic Acid	D019301	112-80-1	Oleic Acid results in increased expression of HADHB mRNA	increases^expression	30611723
HADHB	3032	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of HADHB mRNA	increases^expression	32588087
HADHB	3032	Rosiglitazone	D000077154		Rosiglitazone results in increased expression of HADHB mRNA	increases^expression	25572481
HADHB	3032	titanium dioxide	C009495	13463-67-7	titanium dioxide results in decreased expression of HADHB protein	decreases^expression	30910687
HADHB	3032	Uranium Compounds	D017974		Uranium Compounds results in increased expression of HADHB mRNA	increases^expression	19654044
HADHB	3032	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of HADHB gene	decreases^methylation	29154799
HADHB	3032	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of HADHB mRNA	increases^expression	29501571
HARS1	3035	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of HARS1 protein	increases^expression	26194647
HARS1	3035	4-aminophenylarsenoxide	C032642	1122-90-3	4-aminophenylarsenoxide binds to HARS1 protein	affects^binding	26598702
HARS1	3035	4-aminophenylarsenoxide	C032642	1122-90-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HARS1 protein]	affects^binding|decreases^reaction	26598702
HARS1	3035	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HARS1 protein]	affects^binding|decreases^reaction	26598702
HARS1	3035	calfactant	C117342		[Nanotubes, Carbon co-treated with calfactant] results in increased expression of HARS1 protein	affects^cotreatment|increases^expression	23026733
HARS1	3035	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of HARS1 mRNA	increases^expression	26352163
HARS1	3035	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of HARS1 mRNA	increases^expression	19549813
HARS1	3035	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of HARS1 mRNA	increases^expression	25562108
HARS1	3035	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of HARS1 mRNA	increases^expression	29803840
HARS1	3035	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
HARS1	3035	Ionomycin	D015759	56092-81-0	pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of HARS1 mRNA]	affects^cotreatment|decreases^expression|decreases^reaction	15477007
HARS1	3035	Ionomycin	D015759	56092-81-0	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of HARS1 mRNA	affects^cotreatment|decreases^expression	15477007
HARS1	3035	Nanotubes, Carbon	D037742		[Nanotubes, Carbon co-treated with calfactant] results in increased expression of HARS1 protein	affects^cotreatment|increases^expression	23026733
HARS1	3035	pyrrolidine dithiocarbamic acid	C020972	25769-03-3	pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of HARS1 mRNA]	affects^cotreatment|decreases^expression|decreases^reaction	15477007
HARS1	3035	Selenium	D012643	7782-49-2	Selenium results in increased expression of HARS1 mRNA	increases^expression	19244175
HARS1	3035	Tetradecanoylphorbol Acetate	D013755	16561-29-8	pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of HARS1 mRNA]	affects^cotreatment|decreases^expression|decreases^reaction	15477007
HARS1	3035	Tetradecanoylphorbol Acetate	D013755	16561-29-8	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of HARS1 mRNA	affects^cotreatment|decreases^expression	15477007
HARS1	3035	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of HARS1 protein	affects^expression	30291989
HARS1	3035	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of HARS1 mRNA	affects^expression	25979313
HARS1	3035	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of HARS1 mRNA	increases^expression	23179753
HARS1	3035	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of HARS1 gene	increases^methylation	29154799
HARS1	3035	Vitamin E	D014810	1406-18-4	Vitamin E results in increased expression of HARS1 mRNA	increases^expression	19244175
HMOX2	3163	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	28628672
HMOX2	3163	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	28628672
HMOX2	3163	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of HMOX2 protein	increases^expression	25670856
HMOX2	3163	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	27188386
HMOX2	3163	abexinostat	C512352		abexinostat promotes the reaction [Bortezomib results in decreased expression of HMOX2 mRNA]	decreases^expression|increases^reaction	19417023
HMOX2	3163	abexinostat	C512352		abexinostat results in decreased expression of HMOX2 mRNA	decreases^expression	19417023
HMOX2	3163	Aerosols	D000336		Aerosols results in increased expression of HMOX2 mRNA	increases^expression	29505817
HMOX2	3163	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of HMOX2 gene	increases^methylation	28458013
HMOX2	3163	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in decreased methylation of HMOX2 intron	decreases^methylation	30157460
HMOX2	3163	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of HMOX2 mRNA	increases^expression	20458559
HMOX2	3163	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of HMOX2 5' UTR	affects^methylation	27901495
HMOX2	3163	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of HMOX2 promoter	affects^methylation	27901495
HMOX2	3163	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in decreased methylation of HMOX2 intron	decreases^methylation	30157460
HMOX2	3163	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of HMOX2 mRNA	affects^expression	21826169
HMOX2	3163	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	28628672
HMOX2	3163	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	28628672
HMOX2	3163	Bortezomib	D000069286		abexinostat promotes the reaction [Bortezomib results in decreased expression of HMOX2 mRNA]	decreases^expression|increases^reaction	19417023
HMOX2	3163	C646 compound	C584509		C646 compound results in decreased expression of HMOX2 mRNA	decreases^expression	26191083
HMOX2	3163	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone	D002259	370-86-5	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of HMOX2 mRNA	decreases^expression	16039398
HMOX2	3163	chromium histidinate	C499843		chromium histidinate results in increased expression of HMOX2 mRNA	increases^expression	19902159
HMOX2	3163	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of HMOX2 mRNA	decreases^expression	19549813
HMOX2	3163	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	28628672
HMOX2	3163	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	28628672
HMOX2	3163	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in increased expression of HMOX2 mRNA	increases^expression	31163220
HMOX2	3163	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	27188386
HMOX2	3163	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HMOX2 protein	decreases^activity|increases^O-linked glycosylation	23301498
HMOX2	3163	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of HMOX2 mRNA	affects^cotreatment|decreases^expression	22079256
HMOX2	3163	Estradiol	D004958	50-28-2	Estradiol affects the expression of HMOX2 mRNA	affects^expression	21826169
HMOX2	3163	Hemin	D006427	16009-13-5	HMOX2 protein results in decreased susceptibility to Hemin	decreases^response to substance	15589375
HMOX2	3163	Hydrogen Peroxide	D006861	7722-84-1	HMOX2 protein results in decreased susceptibility to Hydrogen Peroxide	decreases^response to substance	15589375
HMOX2	3163	Hydrogen Peroxide	D006861	7722-84-1	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	21751221
HMOX2	3163	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased expression of HMOX2 mRNA	increases^expression	21751221
HMOX2	3163	ICG 001	C492448		ICG 001 results in decreased expression of HMOX2 mRNA	decreases^expression	26191083
HMOX2	3163	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	28628672
HMOX2	3163	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	28628672
HMOX2	3163	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of HMOX2 mRNA	decreases^expression	30851411
HMOX2	3163	Methapyrilene	D008701	91-80-5	Methapyrilene results in decreased methylation of HMOX2 intron	decreases^methylation	30157460
HMOX2	3163	Methylmercury Compounds	D008767		HMOX2 protein results in decreased susceptibility to Methylmercury Compounds	decreases^response to substance	20807546
HMOX2	3163	Nanotubes, Carbon	D037742		Nanotubes, Carbon results in decreased expression of HMOX2 mRNA	decreases^expression	15585362
HMOX2	3163	Nanotubes, Carbon	D037742		Nanotubes, Carbon results in increased expression of HMOX2 mRNA	increases^expression	17450800
HMOX2	3163	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	C044387	16858-02-9	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of HMOX2 mRNA	decreases^expression	12888634
HMOX2	3163	Particulate Matter	D052638		Particulate Matter results in increased expression of HMOX2 mRNA	increases^expression	30081072
HMOX2	3163	pinosylvin	C049032	102-61-4	pinosylvin results in increased expression of HMOX2 mRNA	increases^expression	23333577
HMOX2	3163	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of HMOX2 mRNA	affects^cotreatment|decreases^expression	22079256
HMOX2	3163	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of HMOX2 mRNA	decreases^expression	22079256
HMOX2	3163	Quinic Acid	D011801	77-95-2	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	21751221
HMOX2	3163	Reactive Oxygen Species	D017382		Reactive Oxygen Species results in increased expression of HMOX2 mRNA	increases^expression	25800948
HMOX2	3163	Sodium Dodecyl Sulfate	D012967	151-21-3	Sodium Dodecyl Sulfate results in increased expression of HMOX2 mRNA	increases^expression	31734321
HMOX2	3163	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of HMOX2 mRNA	increases^expression	18175754
HMOX2	3163	tert-Butylhydroperoxide	D020122	75-91-2	HMOX2 protein results in decreased susceptibility to tert-Butylhydroperoxide	decreases^response to substance	15589375
HMOX2	3163	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of HMOX2 mRNA	decreases^expression	27509014
HMOX2	3163	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in increased methylation of HMOX2 gene	increases^methylation	27509014
HMOX2	3163	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of HMOX2 mRNA	decreases^expression	16039398
HMOX2	3163	titanium dioxide	C009495	13463-67-7	titanium dioxide results in increased expression of HMOX2 mRNA	increases^expression	19695317
HMOX2	3163	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of HMOX2 mRNA	increases^expression	29505817
HMOX2	3163	Tretinoin	D014212	302-79-4	[Tretinoin co-treated with Zoledronic Acid] results in increased expression of HMOX2 protein	affects^cotreatment|increases^expression	20349282
HMOX2	3163	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of HMOX2 mRNA	increases^expression	24935251
HMOX2	3163	Urethane	D014520	51-79-6	Urethane results in increased expression of HMOX2 mRNA	increases^expression	28818685
HMOX2	3163	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMOX2 mRNA	affects^cotreatment|increases^expression	27188386
HMOX2	3163	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of HMOX2 mRNA	affects^expression	25979313
HMOX2	3163	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of HMOX2 mRNA	increases^expression	23179753|26272509|28001369
HMOX2	3163	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of HMOX2 gene	increases^methylation	29154799
HMOX2	3163	Vanadates	D014638		Vanadates results in increased expression of HMOX2 mRNA	increases^expression	22714537
HMOX2	3163	Vehicle Emissions	D001335		Vehicle Emissions results in increased expression of HMOX2 mRNA	increases^expression	30081072
HMOX2	3163	Zoledronic Acid	D000077211		[Tretinoin co-treated with Zoledronic Acid] results in increased expression of HMOX2 protein	affects^cotreatment|increases^expression	20349282
HSD17B10	3028	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in decreased expression of HSD17B10 protein	decreases^expression	24806433
HSD17B10	3028	20-hydroxycholesterol	C025813	516-72-3	[20-hydroxycholesterol co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of HSD17B10 protein	increases^expression	25670856
HSD17B10	3028	5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide	C528044		5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide results in decreased expression of HSD17B10 protein	decreases^expression	31370342
HSD17B10	3028	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of HSD17B10 mRNA	decreases^expression	25704631|26690555
HSD17B10	3028	Aminoglutethimide	D000616	125-84-8	Aminoglutethimide results in decreased expression of HSD17B10 protein	decreases^expression	26102013
HSD17B10	3028	Androstane-3,17-diol	D015113	25126-76-5	[Androstane-3,17-diol co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	Arsenic	D001151	7440-38-2	Arsenic results in increased methylation of HSD17B10 promoter	increases^methylation	21291286
HSD17B10	3028	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of HSD17B10 mRNA	decreases^expression	22378314
HSD17B10	3028	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of HSD17B10 exon	affects^methylation	27901495
HSD17B10	3028	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of HSD17B10 promoter	affects^methylation	27901495
HSD17B10	3028	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of HSD17B10 mRNA	decreases^expression	25047013|29275510
HSD17B10	3028	cholest-5-en-3 beta,7 alpha-diol	C011724	566-26-7	[cholest-5-en-3 beta,7 alpha-diol co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	Cholestanol	D004083	80-97-7	[Cholestanol co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of HSD17B10 mRNA	decreases^expression	20106945
HSD17B10	3028	dibutyldi(4-chlorobenzohydroxamato)tin(IV)	C542282		dibutyldi(4-chlorobenzohydroxamato)tin(IV) results in decreased expression of HSD17B10 protein	decreases^expression	22732634
HSD17B10	3028	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HSD17B10 protein	decreases^activity|increases^O-linked glycosylation	23301498
HSD17B10	3028	Estradiol	D004958	50-28-2	Estradiol promotes the reaction [HSD17B10 protein binds to ESR1 protein]	affects^binding|increases^reaction	27156127
HSD17B10	3028	Genistein	D019833	446-72-0	Genistein results in decreased expression of HSD17B10 mRNA	decreases^expression	22228119
HSD17B10	3028	K 7174	C410337		K 7174 results in decreased expression of HSD17B10 mRNA	decreases^expression	24086573
HSD17B10	3028	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of HSD17B10 mRNA	decreases^expression	30851411
HSD17B10	3028	Lead	D007854	7439-92-1	Lead affects the expression of HSD17B10 mRNA	affects^expression	28903495
HSD17B10	3028	NAD	D009243	53-84-9	[20-hydroxycholesterol co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	NAD	D009243	53-84-9	[Androstane-3,17-diol co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	NAD	D009243	53-84-9	[cholest-5-en-3 beta,7 alpha-diol co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	NAD	D009243	53-84-9	[Cholestanol co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	NAD	D009243	53-84-9	NAD binds to and results in increased activity of HSD17B10 protein	affects^binding|increases^activity	25526675
HSD17B10	3028	NAD	D009243	53-84-9	[Pregnanolone co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	NAD	D009243	53-84-9	[Progesterone co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in increased expression of HSD17B10 mRNA	increases^expression	27153767
HSD17B10	3028	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of HSD17B10 protein	increases^expression	26879310
HSD17B10	3028	Pregnanolone	D011280	128-20-1	[Pregnanolone co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	Progesterone	D011374	57-83-0	[Progesterone co-treated with NAD] binds to HSD17B10 protein	affects^binding|affects^cotreatment	25526675
HSD17B10	3028	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of HSD17B10 protein	increases^expression	20050688
HSD17B10	3028	STA 9090	C533237		STA 9090 results in decreased expression of HSD17B10 protein	decreases^expression	31370342
HSD17B10	3028	Sunitinib	D000077210		Sunitinib results in decreased expression of HSD17B10 mRNA	decreases^expression	31533062
HSD17B10	3028	tanespimycin	C112765		tanespimycin analog results in decreased expression of HSD17B10 protein	decreases^expression	31370342
HSD17B10	3028	tanespimycin	C112765		[tanespimycin co-treated with VER 155008] results in decreased expression of HSD17B10 protein	affects^cotreatment|decreases^expression	31370342
HSD17B10	3028	tanespimycin	C112765		tanespimycin results in decreased expression of HSD17B10 protein	decreases^expression	31370342
HSD17B10	3028	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of HSD17B10 mRNA	decreases^expression	22378314
HSD17B10	3028	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of HSD17B10 mRNA	decreases^expression	23724009
HSD17B10	3028	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of HSD17B10 mRNA	increases^expression	23179753
HSD17B10	3028	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of HSD17B10 gene	increases^methylation	29154799
HSD17B10	3028	VER 155008	C550733		[tanespimycin co-treated with VER 155008] results in decreased expression of HSD17B10 protein	affects^cotreatment|decreases^expression	31370342
HSD17B4	3295	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether metabolite results in decreased expression of HSD17B4 mRNA	decreases^expression	18248924
HSD17B4	3295	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether metabolite results in increased expression of HSD17B4 mRNA	increases^expression	18248924
HSD17B4	3295	2,2-bis(4-glycidyloxyphenyl)propane	C019273	1675-54-3	HSD17B4 gene SNP affects the susceptibility to 2,2-bis(4-glycidyloxyphenyl)propane	affects^response to substance	25622337
HSD17B4	3295	2,3,7,8-tetrabromodibenzo-4-dioxin	C066841	50585-41-6	2,3,7,8-tetrabromodibenzo-4-dioxin results in decreased expression of HSD17B4 mRNA	decreases^expression	17447562
HSD17B4	3295	2,4,6-trichlorophenol	C024564	88-06-2	2,4,6-trichlorophenol results in decreased expression of HSD17B4 mRNA	decreases^expression	21296122
HSD17B4	3295	2,4-dibromophenol	C013930	615-58-7	2,4-dibromophenol results in increased expression of HSD17B4 mRNA	increases^expression	17447562
HSD17B4	3295	2,6-dibromophenol	C038964	608-33-3	2,6-dibromophenol results in decreased expression of HSD17B4 mRNA	decreases^expression	17447562
HSD17B4	3295	2-bromophenol	C032038	95-56-7	2-bromophenol results in increased expression of HSD17B4 mRNA	increases^expression	17447562
HSD17B4	3295	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	C511621		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in increased expression of HSD17B4 mRNA]	decreases^reaction|increases^expression	28655636
HSD17B4	3295	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	C511621		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in increased expression of HSD17B4 mRNA]	decreases^reaction|increases^expression	28655636
HSD17B4	3295	3,3',4,4',5,5'-hexabromobiphenyl	C032790	60044-26-0	3,3',4,4',5,5'-hexabromobiphenyl results in increased expression of HSD17B4 mRNA	increases^expression	17447562
HSD17B4	3295	3,3',4,4'-tetrabromobiphenyl	C036685	77102-82-0	3,3',4,4'-tetrabromobiphenyl results in increased expression of HSD17B4 mRNA	increases^expression	17447562
HSD17B4	3295	4-nitro-3-cresol	C008636		[4-nitro-3-cresol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD17B4 protein	affects^cotreatment|increases^expression	18336853
HSD17B4	3295	8-Bromo Cyclic Adenosine Monophosphate	D015124	23583-48-4	[4-nitro-3-cresol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD17B4 protein	affects^cotreatment|increases^expression	18336853
HSD17B4	3295	abrine	C496492		abrine results in decreased expression of HSD17B4 mRNA	decreases^expression	31054353
HSD17B4	3295	abrine	C496492		abrine results in increased expression of HSD17B4 protein	increases^expression	31054353
HSD17B4	3295	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of HSD17B4 mRNA	decreases^expression	25704631|29067470
HSD17B4	3295	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of HSD17B4 gene	decreases^methylation	27153756
HSD17B4	3295	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational results in decreased expression of HSD17B4 mRNA	decreases^expression	23195993
HSD17B4	3295	Aminoglutethimide	D000616	125-84-8	Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of HSD17B4 mRNA]	decreases^reaction|increases^expression	16935330
HSD17B4	3295	Aminoglutethimide	D000616	125-84-8	Aminoglutethimide results in decreased expression of HSD17B4 mRNA	decreases^expression	16935330
HSD17B4	3295	Androstenediol	D015114	521-17-5	HSD17B4 protein affects the metabolism of Androstenediol	affects^metabolic processing	16054388
HSD17B4	3295	Androstenediol	D015114	521-17-5	HSD17B4 protein results in increased chemical synthesis of Androstenediol	increases^chemical synthesis	16054388
HSD17B4	3295	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of HSD17B4 gene	affects^methylation	25304211
HSD17B4	3295	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of HSD17B4 protein	increases^expression	25419056
HSD17B4	3295	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of HSD17B4 mRNA	increases^expression	22378314
HSD17B4	3295	Benzofurans	D001572		Benzofurans results in increased expression of HSD17B4 mRNA	increases^expression	17447562
HSD17B4	3295	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of HSD17B4 mRNA	affects^expression	21179406
HSD17B4	3295	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of HSD17B4 mRNA	affects^expression	25979313
HSD17B4	3295	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of HSD17B4 mRNA	affects^cotreatment|increases^expression	27392435
HSD17B4	3295	Colforsin	D005576	138605-00-2	Aminoglutethimide inhibits the reaction [Colforsin results in increased expression of HSD17B4 mRNA]	decreases^reaction|increases^expression	16935330
HSD17B4	3295	Colforsin	D005576	138605-00-2	Colforsin affects the expression of HSD17B4 mRNA	affects^expression	20726872
HSD17B4	3295	Colforsin	D005576	138605-00-2	Colforsin results in increased expression of HSD17B4 mRNA	increases^expression	16935330|22446829
HSD17B4	3295	Colforsin	D005576	138605-00-2	Ketoconazole promotes the reaction [Colforsin results in increased expression of HSD17B4 mRNA]	increases^expression|increases^reaction	16935330
HSD17B4	3295	Colforsin	D005576	138605-00-2	Valproic Acid affects the reaction [Colforsin affects the expression of HSD17B4 mRNA]	affects^expression|affects^reaction	20726872
HSD17B4	3295	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of HSD17B4 mRNA	decreases^expression	19549813
HSD17B4	3295	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of HSD17B4 mRNA	decreases^expression	20106945|23830897
HSD17B4	3295	Dehydroepiandrosterone	D003687	53-43-0	HSD17B4 protein affects the metabolism of Dehydroepiandrosterone	affects^metabolic processing	16054388
HSD17B4	3295	Dehydroepiandrosterone	D003687	53-43-0	HSD17B4 protein results in increased chemical synthesis of Dehydroepiandrosterone	increases^chemical synthesis	16054388
HSD17B4	3295	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of HSD17B4 mRNA	decreases^expression	28302478
HSD17B4	3295	Estradiol	D004958	50-28-2	HSD17B4 protein affects the metabolism of Estradiol	affects^metabolic processing	16054388
HSD17B4	3295	Estradiol	D004958	50-28-2	HSD17B4 protein results in increased chemical synthesis of Estradiol	increases^chemical synthesis	16054388
HSD17B4	3295	Estrone	D004970	53-16-7	HSD17B4 protein affects the metabolism of Estrone	affects^metabolic processing	16054388
HSD17B4	3295	Estrone	D004970	53-16-7	HSD17B4 protein results in increased chemical synthesis of Estrone	increases^chemical synthesis	16054388
HSD17B4	3295	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of HSD17B4 mRNA	increases^expression	25572481
HSD17B4	3295	Flame Retardants	D005411		Flame Retardants metabolite results in decreased expression of HSD17B4 mRNA	decreases^expression	18248924
HSD17B4	3295	Flame Retardants	D005411		Flame Retardants metabolite results in increased expression of HSD17B4 mRNA	increases^expression	18248924
HSD17B4	3295	Flame Retardants	D005411		Flame Retardants results in decreased expression of HSD17B4 mRNA	decreases^expression	17447562
HSD17B4	3295	Flame Retardants	D005411		Flame Retardants results in increased expression of HSD17B4 mRNA	increases^expression	17447562
HSD17B4	3295	Halogenated Diphenyl Ethers	D055768		Halogenated Diphenyl Ethers metabolite results in increased expression of HSD17B4 mRNA	increases^expression	18313098
HSD17B4	3295	ICG 001	C492448		ICG 001 results in decreased expression of HSD17B4 mRNA	decreases^expression	26191083
HSD17B4	3295	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of HSD17B4 mRNA	affects^cotreatment|increases^expression	27392435
HSD17B4	3295	Ketoconazole	D007654	65277-42-1	Ketoconazole promotes the reaction [Colforsin results in increased expression of HSD17B4 mRNA]	increases^expression|increases^reaction	16935330
HSD17B4	3295	Ketoconazole	D007654	65277-42-1	Ketoconazole results in increased expression of HSD17B4 mRNA	increases^expression	16935330
HSD17B4	3295	Lead	D007854	7439-92-1	Lead results in decreased expression of HSD17B4 mRNA	decreases^expression	19921347
HSD17B4	3295	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of HSD17B4 mRNA	increases^expression	17400583
HSD17B4	3295	Metribolone	D015741	965-93-5	Metribolone promotes the reaction [NDRG1 protein binds to HSD17B4 protein]	affects^binding|increases^reaction	17220478
HSD17B4	3295	NAD	D009243	53-84-9	NAD binds to and results in increased activity of HSD17B4 protein	affects^binding|increases^activity	25526675
HSD17B4	3295	Nickel	D009532	7440-02-0	Nickel results in decreased expression of HSD17B4 mRNA	decreases^expression	23195993
HSD17B4	3295	Oils, Volatile	D009822		Oils, Volatile results in increased expression of HSD17B4 mRNA	increases^expression	31425786
HSD17B4	3295	Paclitaxel	D017239		HSD17B4 protein affects the susceptibility to Paclitaxel	affects^response to substance	16217747
HSD17B4	3295	Particulate Matter	D052638		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in increased expression of HSD17B4 mRNA]	decreases^reaction|increases^expression	28655636
HSD17B4	3295	Particulate Matter	D052638		Particulate Matter results in increased expression of HSD17B4 mRNA	increases^expression	28655636
HSD17B4	3295	Pentachlorophenol	D010416	87-86-5	Pentachlorophenol results in decreased expression of HSD17B4 mRNA	decreases^expression	21296122
HSD17B4	3295	perfluorohexanesulfonic acid	C471071	355-46-4	perfluorohexanesulfonic acid results in increased expression of HSD17B4 mRNA	increases^expression	23567314
HSD17B4	3295	perfluoro-n-heptanoic acid	C101815	375-85-9	perfluoro-n-heptanoic acid results in increased expression of HSD17B4 mRNA	increases^expression	23567314
HSD17B4	3295	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in decreased expression of HSD17B4 mRNA	decreases^expression	23074026
HSD17B4	3295	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in increased expression of HSD17B4 mRNA	increases^expression	23567314
HSD17B4	3295	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of HSD17B4 mRNA	increases^expression	23567314
HSD17B4	3295	periodate-oxidized adenosine	C027579	34240-05-6	periodate-oxidized adenosine affects the expression of HSD17B4 mRNA	affects^expression	17097637
HSD17B4	3295	Plant Extracts	D010936		Plant Extracts results in increased expression of HSD17B4 mRNA	increases^expression	23557933
HSD17B4	3295	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of HSD17B4 mRNA	decreases^expression	21632981
HSD17B4	3295	Sunitinib	D000077210		Sunitinib results in decreased expression of HSD17B4 mRNA	decreases^expression	31533062
HSD17B4	3295	tribromodiphenyl ether 28	C533760		tribromodiphenyl ether 28 metabolite results in increased expression of HSD17B4 mRNA	increases^expression	18248924
HSD17B4	3295	Urethane	D014520	51-79-6	Urethane results in decreased expression of HSD17B4 mRNA	decreases^expression	28818685
HSD17B4	3295	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of HSD17B4 mRNA	affects^expression	25979313
HSD17B4	3295	Valproic Acid	D014635	99-66-1	Valproic Acid affects the reaction [Colforsin affects the expression of HSD17B4 mRNA]	affects^expression|affects^reaction	20726872
HSD17B4	3295	Vehicle Emissions	D001335		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in increased expression of HSD17B4 mRNA]	decreases^reaction|increases^expression	28655636
HSD17B4	3295	Vehicle Emissions	D001335		Vehicle Emissions results in increased expression of HSD17B4 mRNA	increases^expression	28655636
HSD17B4	3295	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of HSD17B4 mRNA	affects^expression	20044591
IARS1	3376	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of IARS1 mRNA	increases^expression	24810058
IARS1	3376	1-nitropyrene	C032668	5522-43-0	1-nitropyrene results in increased expression of IARS1 mRNA	increases^expression	19041380
IARS1	3376	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of IARS1 mRNA	increases^expression	29067470
IARS1	3376	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of IARS1 mRNA	increases^expression	27153756
IARS1	3376	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased expression of IARS1 mRNA	decreases^expression	19128835
IARS1	3376	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of IARS1 mRNA	increases^expression	20458559
IARS1	3376	arsenite	C015001	15502-74-6	arsenite results in decreased methylation of IARS1 promoter	decreases^methylation	23974009
IARS1	3376	Ascorbic Acid	D001205	50-81-7	Ascorbic Acid results in decreased expression of IARS1 mRNA	decreases^expression	19197388
IARS1	3376	Aspirin	D001241	50-78-2	Aspirin results in decreased expression of IARS1 mRNA	decreases^expression	11906190
IARS1	3376	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of IARS1 intron	affects^methylation	30157460
IARS1	3376	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of IARS1 mRNA	increases^expression	29275510
IARS1	3376	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of IARS1 mRNA	increases^expression	25596134|26472689
IARS1	3376	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde affects the expression of IARS1 mRNA	affects^expression	25596134
IARS1	3376	Cidofovir	D000077404	113852-37-2	Cidofovir results in increased expression of IARS1 mRNA	increases^expression	25596134
IARS1	3376	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of IARS1 mRNA	increases^expression	25596134
IARS1	3376	Clodronic Acid	D004002	10596-23-3	Clodronic Acid affects the expression of IARS1 mRNA	affects^expression	25596134
IARS1	3376	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of IARS1 mRNA	decreases^expression	19320972
IARS1	3376	Cyclosporine	D016572	59865-13-3	Cyclosporine affects the expression of IARS1 mRNA	affects^expression	25562108
IARS1	3376	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of IARS1 mRNA	increases^expression	20106945|25596134|27989131
IARS1	3376	Dronabinol	D013759		Dronabinol results in increased expression of IARS1 mRNA	increases^expression	18454173
IARS1	3376	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of IARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
IARS1	3376	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of IARS1 mRNA	increases^expression	25596134
IARS1	3376	Ibuprofen	D007052	15687-27-1	Ibuprofen results in increased expression of IARS1 mRNA	increases^expression	25596134
IARS1	3376	ICG 001	C492448		ICG 001 results in increased expression of IARS1 mRNA	increases^expression	26191083
IARS1	3376	Ifosfamide	D007069	3778-73-2	Ifosfamide results in increased expression of IARS1 mRNA	increases^expression	25596134
IARS1	3376	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of IARS1 mRNA	decreases^expression	22904298
IARS1	3376	Lead	D007854	7439-92-1	Lead affects the splicing of IARS1 mRNA	affects^splicing	28903495
IARS1	3376	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of IARS1 mRNA	decreases^expression	23649840
IARS1	3376	methylparaben	C015358	99-76-3	methylparaben results in increased expression of IARS1 mRNA	increases^expression	31745603
IARS1	3376	Nanotubes, Carbon	D037742		Nanotubes, Carbon results in increased expression of IARS1 protein	increases^expression	23026733
IARS1	3376	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of IARS1 mRNA	decreases^expression	25596134
IARS1	3376	perfluorononanoic acid	C584865		perfluorononanoic acid results in increased expression of IARS1 mRNA	increases^expression	32588087
IARS1	3376	Plant Extracts	D010936		Plant Extracts results in increased expression of IARS1 mRNA	increases^expression	23557933
IARS1	3376	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of IARS1 mRNA	decreases^expression	21632981
IARS1	3376	Rosiglitazone	D000077154		Rosiglitazone results in increased expression of IARS1 mRNA	increases^expression	25572481
IARS1	3376	Selenium	D012643	7782-49-2	[Selenium co-treated with Vitamin E] results in increased expression of IARS1 mRNA	affects^cotreatment|increases^expression	19244175
IARS1	3376	Selenium	D012643	7782-49-2	Selenium results in decreased expression of IARS1 mRNA	decreases^expression	19244175
IARS1	3376	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of IARS1 mRNA	decreases^expression	28595984
IARS1	3376	Sunitinib	D000077210		Sunitinib results in increased expression of IARS1 mRNA	increases^expression	31533062
IARS1	3376	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of IARS1 mRNA	decreases^expression	20106945
IARS1	3376	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of IARS1 mRNA	decreases^expression	28065790
IARS1	3376	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of IARS1 mRNA	increases^expression	29453283
IARS1	3376	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of IARS1 protein	increases^expression	29453283
IARS1	3376	Urethane	D014520	51-79-6	Urethane results in decreased expression of IARS1 mRNA	decreases^expression	28818685
IARS1	3376	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of IARS1 mRNA	increases^expression	29154799
IARS1	3376	Vitamin E	D014810	1406-18-4	[Selenium co-treated with Vitamin E] results in increased expression of IARS1 mRNA	affects^cotreatment|increases^expression	19244175
IARS1	3376	Vitamin E	D014810	1406-18-4	Vitamin E results in decreased expression of IARS1 mRNA	decreases^expression	19244175
IARS1	3376	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of IARS1 mRNA	affects^expression	20044591
KARS1	3735	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in decreased expression of KARS1 protein	decreases^expression	24806433
KARS1	3735	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	C472791		3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of KARS1 mRNA	decreases^expression	12958071
KARS1	3735	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of KARS1 mRNA	decreases^expression	21420995|25704631
KARS1	3735	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of KARS1 mRNA	increases^expression	22378314
KARS1	3735	CD 437	C099555		CD 437 results in decreased expression of KARS1 mRNA	decreases^expression	12958071
KARS1	3735	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of KARS1 mRNA	decreases^expression	19549813
KARS1	3735	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of KARS1 mRNA	decreases^expression	29803840
KARS1	3735	Estradiol	D004958	50-28-2	Estradiol promotes the reaction [KARS1 protein binds to ESR1 protein]	affects^binding|increases^reaction	27156127
KARS1	3735	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of KARS1 mRNA	decreases^expression	23086925
KARS1	3735	kojic acid	C011890	501-30-4	kojic acid results in decreased expression of KARS1 mRNA	decreases^expression	16595896
KARS1	3735	Lead	D007854	7439-92-1	Lead results in decreased expression of KARS1 mRNA	decreases^expression	19921347
KARS1	3735	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of KARS1 mRNA	affects^expression	25979313
LARS1	51520	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	affects^cotreatment|decreases^expression	27188386
LARS1	51520	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	affects^cotreatment|decreases^expression	27188386
LARS1	51520	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LARS1 mRNA	decreases^expression	20018196
LARS1	51520	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of LARS1 intron	increases^methylation	30157460
LARS1	51520	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in increased expression of LARS1 mRNA	increases^expression	29523930
LARS1	51520	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of LARS1 mRNA	affects^expression	30903817
LARS1	51520	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of LARS1 mRNA	increases^expression	25596134
LARS1	51520	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of LARS1 mRNA	affects^expression	25979313
LARS1	51520	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde results in decreased expression of LARS1 mRNA	decreases^expression	25596134
LARS1	51520	Cidofovir	D000077404	113852-37-2	Cidofovir results in decreased expression of LARS1 mRNA	decreases^expression	25596134
LARS1	51520	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of LARS1 mRNA	decreases^expression	25596134
LARS1	51520	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of LARS1 mRNA	increases^expression	20106945|25562108|25596134|27989131
LARS1	51520	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	affects^cotreatment|decreases^expression	27188386
LARS1	51520	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	affects^cotreatment|decreases^expression	27188386
LARS1	51520	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
LARS1	51520	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of LARS1 mRNA	increases^expression	25596134
LARS1	51520	geldanamycin	C001277	30562-34-6	geldanamycin results in increased expression of LARS1 mRNA	increases^expression	26705709
LARS1	51520	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of LARS1 mRNA	affects^expression	21179406
LARS1	51520	Ibuprofen	D007052	15687-27-1	Ibuprofen results in increased expression of LARS1 mRNA	increases^expression	25596134
LARS1	51520	ICG 001	C492448		ICG 001 results in increased expression of LARS1 mRNA	increases^expression	26191083
LARS1	51520	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of LARS1 mRNA	decreases^expression	28001369
LARS1	51520	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of LARS1 mRNA	decreases^expression	23649840
LARS1	51520	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of LARS1 mRNA	decreases^expression	30559759
LARS1	51520	Plant Extracts	D010936		Plant Extracts results in increased expression of LARS1 mRNA	increases^expression	23557933
LARS1	51520	Sunitinib	D000077210		Sunitinib results in increased expression of LARS1 mRNA	increases^expression	31533062
LARS1	51520	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of LARS1 mRNA	decreases^expression	20106945|21632981
LARS1	51520	Thimerosal	D013849	54-64-8	Thimerosal results in decreased expression of LARS1 mRNA	decreases^expression	27188386
LARS1	51520	torcetrapib	C483909		torcetrapib results in increased expression of LARS1 mRNA	increases^expression	23228038
LARS1	51520	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of LARS1 mRNA	decreases^expression	23724009
LARS1	51520	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	affects^cotreatment|decreases^expression	27188386
LARS1	51520	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of LARS1 mRNA	decreases^expression	26272509
LARS1	51520	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	affects^cotreatment|decreases^expression	27188386
LARS1	51520	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of LARS1 mRNA	affects^expression	25979313
LARS1	51520	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of LARS1 mRNA	decreases^expression	23179753|26272509
LARS1	51520	Vorinostat	D000077337		Vorinostat results in decreased expression of LARS1 mRNA	decreases^expression	27188386
LCLAT1	253558	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LCLAT1 mRNA	decreases^expression	19150397
LCLAT1	253558	abrine	C496492		abrine results in decreased expression of LCLAT1 mRNA	decreases^expression	31054353
LCLAT1	253558	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of LCLAT1 mRNA	decreases^expression	21420995
LCLAT1	253558	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of LCLAT1 mRNA	decreases^expression	27153756
LCLAT1	253558	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of LCLAT1 mRNA	decreases^expression	20064835
LCLAT1	253558	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of LCLAT1 promoter	increases^methylation	27901495
LCLAT1	253558	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of LCLAT1 mRNA	affects^cotreatment|decreases^expression	27392435
LCLAT1	253558	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of LCLAT1 mRNA	decreases^expression	27392435
LCLAT1	253558	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of LCLAT1 mRNA	decreases^expression	25562108
LCLAT1	253558	ICG 001	C492448		ICG 001 results in decreased expression of LCLAT1 mRNA	decreases^expression	26191083
LCLAT1	253558	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of LCLAT1 mRNA	affects^cotreatment|decreases^expression	27392435
LCLAT1	253558	jinfukang	C544151		jinfukang results in decreased expression of LCLAT1 mRNA	decreases^expression	27392435
LCLAT1	253558	Particulate Matter	D052638		Particulate Matter results in increased expression of LCLAT1 mRNA	increases^expression	24769257
LCLAT1	253558	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of LCLAT1 mRNA	affects^expression	28542535
LIPE	3991	Adenosine Triphosphate	D000255	56-65-5	Adenosine Triphosphate results in increased activity of LIPE protein	increases^activity	7155675
LIPE	3991	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	bis(4-hydroxyphenyl)sulfone results in increased expression of LIPE mRNA	increases^expression	27685785|30616060
LIPE	3991	chiglitazar	C515629		chiglitazar results in increased expression of LIPE mRNA	increases^expression	23150725
LIPE	3991	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of LIPE mRNA	affects^cotreatment|increases^expression	27392435
LIPE	3991	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of LIPE mRNA	increases^expression	27392435
LIPE	3991	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of LIPE mRNA	decreases^expression	12032628|22917661
LIPE	3991	Cyclic AMP	D000242	60-92-4	Cyclic AMP results in increased activity of LIPE protein	increases^activity	7155675
LIPE	3991	Deferoxamine	D003676	70-51-9	Deferoxamine results in decreased expression of LIPE mRNA	decreases^expression	12032628
LIPE	3991	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of LIPE mRNA	increases^expression	25047013
LIPE	3991	Dietary Carbohydrates	D004040		Dietary Carbohydrates results in decreased expression of LIPE mRNA	decreases^expression	17490981
LIPE	3991	Dietary Carbohydrates	D004040		[Dietary Fats co-treated with Dietary Carbohydrates] affects the expression of LIPE protein	affects^cotreatment|affects^expression	22551950
LIPE	3991	Dietary Fats	D004041		[Dietary Fats co-treated with Dietary Carbohydrates] affects the expression of LIPE protein	affects^cotreatment|affects^expression	22551950
LIPE	3991	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of LIPE mRNA	decreases^expression	29803840
LIPE	3991	Epinephrine	D004837	51-43-4	Epinephrine results in increased activity of LIPE protein	increases^activity	7155675
LIPE	3991	Epinephrine	D004837	51-43-4	Theophylline inhibits the reaction [Epinephrine results in increased activity of LIPE protein]	decreases^reaction|increases^activity	7155675
LIPE	3991	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in decreased expression of LIPE mRNA	affects^cotreatment|decreases^expression	30165855
LIPE	3991	Fatty Acids, Nonesterified	D005230		Fatty Acids, Nonesterified affects the activity of LIPE protein	affects^activity	14749208
LIPE	3991	GSK-J4	C000593030		GSK-J4 results in decreased expression of LIPE mRNA	decreases^expression	29301935
LIPE	3991	Hormones	D006728		Hormones affects the activity of LIPE protein	affects^activity	3420405
LIPE	3991	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of LIPE mRNA	affects^cotreatment|increases^expression	27392435
LIPE	3991	Niacin	D009525		Niacin results in decreased activity of LIPE protein	decreases^activity	14749208
LIPE	3991	Niacin	D009525		Niacin results in decreased expression of LIPE mRNA	decreases^expression	19131065
LIPE	3991	Nickel	D009532	7440-02-0	Nickel results in decreased expression of LIPE mRNA	decreases^expression	25583101
LIPE	3991	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of LIPE mRNA	decreases^expression	12032628
LIPE	3991	retinol palmitate	C014794	79-81-2	LIPE protein results in increased hydrolysis of retinol palmitate	increases^hydrolysis	16741517
LIPE	3991	retinol palmitate	C014794	79-81-2	PLIN3 protein inhibits the reaction [LIPE protein results in increased hydrolysis of retinol palmitate]	decreases^reaction|increases^hydrolysis	16741517
LIPE	3991	Rosiglitazone	D000077154		Rosiglitazone results in increased expression of LIPE mRNA	increases^expression	23150725
LIPE	3991	Sunitinib	D000077210		Sunitinib results in decreased expression of LIPE mRNA	decreases^expression	31533062
LIPE	3991	Tenofovir	D000068698		Tenofovir affects the expression of LIPE mRNA	affects^expression	20032539
LIPE	3991	Theophylline	D013806	58-55-9	Theophylline inhibits the reaction [Epinephrine results in increased activity of LIPE protein]	decreases^reaction|increases^activity	7155675
LIPE	3991	Theophylline	D013806	58-55-9	Theophylline results in increased activity of LIPE protein	increases^activity	7155675
LIPE	3991	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of LIPE mRNA	increases^expression	29501571
LIPE	3991	Zidovudine	D015215	30516-87-1	Zidovudine affects the expression of LIPE mRNA	affects^expression	20032539
LPIN1	23175	1-Butanol	D020001	71-36-3	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression	27188386
LPIN1	23175	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of LPIN1 mRNA	decreases^expression	29067470
LPIN1	23175	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the methylation of LPIN1 intron	affects^methylation	30157460
LPIN1	23175	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of LPIN1 mRNA	decreases^expression	27153756
LPIN1	23175	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of LPIN1 intron	increases^methylation	30157460
LPIN1	23175	afuresertib	C000593263		afuresertib results in increased expression of LPIN1 mRNA	increases^expression	28960945
LPIN1	23175	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational affects the expression of LPIN1 mRNA	affects^expression	27809917
LPIN1	23175	Air Pollutants, Occupational	D000395		[Air Pollutants, Occupational results in increased abundance of Vehicle Emissions] which results in increased expression of LPIN1 mRNA	increases^abundance|increases^expression	27809917
LPIN1	23175	Aldehydes	D000447		Aldehydes results in decreased expression of LPIN1 mRNA	decreases^expression	25014914
LPIN1	23175	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in decreased methylation of LPIN1 gene	decreases^methylation	29523930
LPIN1	23175	avobenzone	C049935		avobenzone results in increased expression of LPIN1 mRNA	increases^expression	31016361
LPIN1	23175	azaspiracid	C406592		azaspiracid results in increased expression of LPIN1 mRNA	increases^expression	28939011
LPIN1	23175	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of LPIN1 5' UTR	affects^methylation	27901495
LPIN1	23175	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of LPIN1 promoter	affects^methylation	27901495
LPIN1	23175	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of LPIN1 mRNA	decreases^expression	20064835
LPIN1	23175	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	C072553		benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TGFB1 protein results in decreased expression of LPIN1 protein]	decreases^expression|decreases^reaction	27345520
LPIN1	23175	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	C072553		benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of LPIN1 protein	increases^expression	27345520
LPIN1	23175	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	bis(4-hydroxyphenyl)sulfone results in increased expression of LPIN1 mRNA	increases^expression	27685785
LPIN1	23175	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of LPIN1 mRNA	increases^expression	27685785
LPIN1	23175	C646 compound	C584509		C646 compound affects the expression of LPIN1 mRNA	affects^expression	26191083
LPIN1	23175	Cadmium	D002104	7440-43-9	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LPIN1 mRNA	decreases^expression|increases^abundance	29741670
LPIN1	23175	Cadmium Chloride	D019256	10108-64-2	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LPIN1 mRNA	decreases^expression|increases^abundance	29741670
LPIN1	23175	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of LPIN1 mRNA	increases^expression	27594783
LPIN1	23175	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of LPIN1 mRNA	increases^expression	19376846
LPIN1	23175	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of LPIN1 mRNA	increases^expression	19549813
LPIN1	23175	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of LPIN1 mRNA	decreases^expression	20106945
LPIN1	23175	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of LPIN1 mRNA	increases^expression	25562108|27989131
LPIN1	23175	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of LPIN1 mRNA	increases^expression	19853017
LPIN1	23175	Dietary Fats	D004041		ANGPTL4 protein modified form affects the reaction [Dietary Fats affects the expression of LPIN1 mRNA]	affects^expression|affects^reaction	28842503
LPIN1	23175	dorsomorphin	C516138		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression	27188386
LPIN1	23175	entinostat	C118739		entinostat results in decreased expression of LPIN1 mRNA	decreases^expression	26272509
LPIN1	23175	entinostat	C118739		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression	27188386
LPIN1	23175	epigallocatechin gallate	C045651	989-51-5	epigallocatechin gallate results in increased expression of LPIN1 mRNA	increases^expression	32512070
LPIN1	23175	Ethanol	D000431	64-17-5	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of LPIN1 mRNA	affects^cotreatment|increases^expression	30611723
LPIN1	23175	Gasoline	D005742		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Gasoline	D005742		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Gasoline	D005742		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Gasoline	D005742		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	gedunin	C106014	2753-30-2	gedunin results in increased expression of LPIN1 mRNA	increases^expression	17010675
LPIN1	23175	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression	30611723
LPIN1	23175	GW 4064	C412815		GW 4064 results in decreased expression of LPIN1 mRNA	decreases^expression	30611723
LPIN1	23175	ICG 001	C492448		ICG 001 results in decreased expression of LPIN1 mRNA	decreases^expression	26191083
LPIN1	23175	isobutyl alcohol	C040507	78-83-1	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of LPIN1 mRNA	decreases^expression	20436886
LPIN1	23175	MLN7243	C000622638		MLN7243 results in increased sumoylation of LPIN1 protein	increases^sumoylation	31285264
LPIN1	23175	obeticholic acid	C464660		obeticholic acid results in decreased expression of LPIN1 mRNA	decreases^expression	27939613
LPIN1	23175	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of LPIN1 mRNA	affects^cotreatment|increases^expression	30611723
LPIN1	23175	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression	30611723
LPIN1	23175	Particulate Matter	D052638		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Particulate Matter	D052638		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Particulate Matter	D052638		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Particulate Matter	D052638		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Phenytoin	D010672	57-41-0	Phenytoin results in increased expression of LPIN1 mRNA	increases^expression	14741686
LPIN1	23175	Plant Extracts	D010936		Plant Extracts results in increased expression of LPIN1 mRNA	increases^expression	23557933
LPIN1	23175	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	Polycyclic Aromatic Hydrocarbons	D011084		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LPIN1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
LPIN1	23175	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of LPIN1 mRNA	decreases^expression	22714537
LPIN1	23175	Progesterone	D011374	57-83-0	Progesterone results in increased expression of LPIN1 mRNA	increases^expression	18070364
LPIN1	23175	Resveratrol	D000077185		LPIN1 affects the reaction [Resveratrol inhibits the reaction [TGFB1 protein results in increased expression of SERPINE1 protein]]	affects^reaction|decreases^reaction|increases^expression	27345520
LPIN1	23175	Resveratrol	D000077185		Resveratrol inhibits the reaction [TGFB1 protein results in decreased expression of LPIN1 mRNA]	decreases^expression|decreases^reaction	27345520
LPIN1	23175	Resveratrol	D000077185		Resveratrol inhibits the reaction [TGFB1 protein results in decreased expression of LPIN1 protein]	decreases^expression|decreases^reaction	27345520
LPIN1	23175	Resveratrol	D000077185		Resveratrol results in decreased ubiquitination of and results in decreased degradation of and results in increased expression of LPIN1 protein	decreases^degradation|decreases^ubiquitination|increases^expression	27345520
LPIN1	23175	Resveratrol	D000077185		Resveratrol results in increased expression of LPIN1 mRNA	increases^expression	27345520
LPIN1	23175	Resveratrol	D000077185		Resveratrol results in increased expression of LPIN1 protein	increases^expression	27345520
LPIN1	23175	Rosiglitazone	D000077154		LPIN1 gene SNP results in increased susceptibility to Rosiglitazone	increases^response to substance	18693052
LPIN1	23175	Selenium	D012643	7782-49-2	Selenium results in decreased expression of LPIN1 mRNA	decreases^expression	19244175
LPIN1	23175	sodium arsenite	C017947	13768-07-5	sodium arsenite affects the methylation of LPIN1 gene	affects^methylation	28589171
LPIN1	23175	Sunitinib	D000077210		Sunitinib results in increased expression of LPIN1 mRNA	increases^expression	31533062
LPIN1	23175	tamibarotene	C061133	94497-51-5	tamibarotene results in decreased expression of LPIN1 mRNA	decreases^expression	15498508
LPIN1	23175	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of LPIN1 mRNA	decreases^expression	20106945
LPIN1	23175	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of LPIN1 mRNA	increases^expression	29453283
LPIN1	23175	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of LPIN1 mRNA	decreases^expression	28065790
LPIN1	23175	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of LPIN1 mRNA	decreases^expression	15498508
LPIN1	23175	Triclosan	D014260	3380-34-5	Triclosan affects the expression of LPIN1 mRNA	affects^expression	31714634
LPIN1	23175	tripterine	C050414	34157-83-0	tripterine results in increased expression of LPIN1 mRNA	increases^expression	17010675
LPIN1	23175	Troglitazone	D000077288	97322-87-7	Troglitazone results in decreased expression of LPIN1 mRNA	decreases^expression	25572481
LPIN1	23175	Uranium	D014501	7440-61-1	Uranium affects the expression of LPIN1 mRNA	affects^expression	15672453
LPIN1	23175	uranyl acetate	C005460	541-09-3	uranyl acetate affects the expression of LPIN1 mRNA	affects^expression	15672453
LPIN1	23175	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of LPIN1 mRNA	affects^expression	25979313
LPIN1	23175	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of LPIN1 mRNA	decreases^expression	24935251|28001369
LPIN1	23175	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of LPIN1 gene	decreases^methylation	29154799
LPIN1	23175	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of LPIN1 mRNA	increases^expression	25716160
LPIN1	23175	Vehicle Emissions	D001335		[Air Pollutants, Occupational results in increased abundance of Vehicle Emissions] which results in increased expression of LPIN1 mRNA	increases^abundance|increases^expression	27809917
LPIN1	23175	Vitamin E	D014810	1406-18-4	Vitamin E results in decreased expression of LPIN1 mRNA	decreases^expression	19244175
LPIN1	23175	Zoledronic Acid	D000077211		Zoledronic Acid results in increased expression of LPIN1 mRNA	increases^expression	20977926
LPIN2	9663	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA	affects^cotreatment|decreases^expression	30611723
LPIN2	9663	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of LPIN2 mRNA	decreases^expression	21420995
LPIN2	9663	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of LPIN2 gene	increases^methylation	27153756
LPIN2	9663	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of LPIN2 intron	increases^methylation	30157460
LPIN2	9663	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of LPIN2 mRNA	decreases^expression	32234424
LPIN2	9663	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of LPIN2 promoter	increases^methylation	27901495
LPIN2	9663	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of LPIN2 mRNA	affects^expression	30903817
LPIN2	9663	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of LPIN2 mRNA	affects^expression	25979313
LPIN2	9663	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of LPIN2 mRNA	increases^expression	27594783
LPIN2	9663	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of LPIN2 mRNA	decreases^expression	20106945
LPIN2	9663	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased methylation of LPIN2 promoter	decreases^methylation	27989131
LPIN2	9663	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of LPIN2 mRNA	increases^expression	25562108
LPIN2	9663	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of LPIN2 gene	increases^methylation	22964155
LPIN2	9663	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of LPIN2 mRNA	decreases^expression	29803840
LPIN2	9663	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA	affects^cotreatment|decreases^expression	30611723
LPIN2	9663	GW 4064	C412815		GW 4064 results in decreased expression of LPIN2 mRNA	decreases^expression	30611723
LPIN2	9663	K 7174	C410337		K 7174 results in increased expression of LPIN2 mRNA	increases^expression	24086573
LPIN2	9663	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of LPIN2 mRNA	decreases^expression	30851411
LPIN2	9663	Lovastatin	D008148	75330-75-5	LPIN2 SNP results in decreased susceptibility to Lovastatin	decreases^response to substance	21483694
LPIN2	9663	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of LPIN2 mRNA	increases^expression	23649840
LPIN2	9663	obeticholic acid	C464660		obeticholic acid results in decreased expression of LPIN2 mRNA	decreases^expression	27939613
LPIN2	9663	Oleic Acid	D019301	112-80-1	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA	affects^cotreatment|decreases^expression	30611723
LPIN2	9663	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA	affects^cotreatment|decreases^expression	30611723
LPIN2	9663	potassium perchlorate	C009006		potassium perchlorate results in decreased expression of LPIN2 mRNA	decreases^expression	29673971
LPIN2	9663	salinomycin	C010327	53003-10-4	salinomycin results in decreased expression of LPIN2 mRNA	decreases^expression	19682730
LPIN2	9663	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in increased expression of LPIN2 mRNA	increases^expression	23806026
LPIN2	9663	Sunitinib	D000077210		Sunitinib results in increased expression of LPIN2 mRNA	increases^expression	31533062
LPIN2	9663	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of LPIN2 mRNA	decreases^expression	15336504
LPIN2	9663	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of LPIN2 mRNA	increases^expression	26179874
LPIN2	9663	Zinc Sulfate	D019287	7733-02-0	Zinc Sulfate results in decreased expression of LPIN2 mRNA	decreases^expression	16330358
MARS1	4141	1-Butanol	D020001	71-36-3	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
MARS1	4141	1-nitropyrene	C032668	5522-43-0	1-nitropyrene results in increased expression of MARS1 mRNA	increases^expression	19041380
MARS1	4141	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of MARS1 mRNA	increases^expression	19095052
MARS1	4141	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARS1 mRNA	affects^cotreatment|increases^expression	27188386
MARS1	4141	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of MARS1 mRNA	increases^expression	29067470
MARS1	4141	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of MARS1 promoter	increases^methylation	30157460
MARS1	4141	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of MARS1 mRNA	decreases^expression	24449571
MARS1	4141	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in increased expression of MARS1 mRNA	increases^expression	29523930
MARS1	4141	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of MARS1 mRNA	decreases^expression	22378314
MARS1	4141	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of MARS1 mRNA	affects^expression	30903817
MARS1	4141	C646 compound	C584509		C646 compound results in increased expression of MARS1 mRNA	increases^expression	26191083
MARS1	4141	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of MARS1 mRNA	affects^expression	25979313
MARS1	4141	chloropicrin	C100187	76-06-2	chloropicrin results in decreased expression of MARS1 mRNA	decreases^expression	26352163
MARS1	4141	Cisplatin	D002945	15663-27-1	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MARS1 mRNA]	decreases^expression|decreases^reaction	21858171
MARS1	4141	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of MARS1 mRNA	increases^expression	19549813
MARS1	4141	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of MARS1 mRNA	increases^expression	20106945|21632981|25562108|27989131
MARS1	4141	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARS1 mRNA	affects^cotreatment|increases^expression	27188386
MARS1	4141	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of MARS1 mRNA	decreases^expression	29803840
MARS1	4141	Drugs, Chinese Herbal	D004365		Drugs, Chinese Herbal results in increased expression of MARS1 mRNA	increases^expression	29667321
MARS1	4141	Fluorouracil	D005472	51-21-8	TP53 protein affects the reaction [Fluorouracil results in decreased expression of MARS1 mRNA]	affects^reaction|decreases^expression	15016801
MARS1	4141	Gasoline	D005742		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
MARS1	4141	gemcitabine	C056507	103882-84-4	gemcitabine results in increased expression of MARS1 mRNA	increases^expression	17039268
MARS1	4141	ICG 001	C492448		ICG 001 results in increased expression of MARS1 mRNA	increases^expression	26191083
MARS1	4141	K 7174	C410337		K 7174 results in increased expression of MARS1 mRNA	increases^expression	24086573
MARS1	4141	Lamivudine	D019259	134678-17-4	[Zidovudine co-treated with Lamivudine] results in increased expression of MARS1 mRNA	affects^cotreatment|increases^expression	15784690
MARS1	4141	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of MARS1 mRNA	increases^expression	28001369
MARS1	4141	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of MARS1 mRNA	decreases^expression	23649840
MARS1	4141	mono-(2-ethylhexyl)phthalate	C016599	4376-20-9	mono-(2-ethylhexyl)phthalate results in increased expression of MARS1 mRNA	increases^expression	22321834
MARS1	4141	Nickel	D009532	7440-02-0	Nickel results in increased expression of MARS1 mRNA	increases^expression	25583101
MARS1	4141	nickel chloride	C022838	7718-54-9	nickel chloride results in increased expression of MARS1 mRNA	increases^expression	17312168
MARS1	4141	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of MARS1 mRNA	decreases^expression	30559759
MARS1	4141	Particulate Matter	D052638		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
MARS1	4141	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARS1 mRNA	affects^cotreatment|increases^expression	27188386
MARS1	4141	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether analog results in increased expression of MARS1 mRNA	increases^expression	19095052
MARS1	4141	Piroxicam	D010894	36322-90-4	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MARS1 mRNA]	decreases^expression|decreases^reaction	21858171
MARS1	4141	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of MARS1 mRNA	decreases^expression	21858171
MARS1	4141	Plant Extracts	D010936		Plant Extracts results in increased expression of MARS1 mRNA	increases^expression	23557933
MARS1	4141	Plant Oils	D010938		Plant Oils results in decreased expression of MARS1 mRNA	decreases^expression	23370395
MARS1	4141	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
MARS1	4141	Progesterone	D011374	57-83-0	Progesterone results in increased expression of MARS1 mRNA	increases^expression	18037150
MARS1	4141	salinomycin	C010327	53003-10-4	salinomycin results in decreased expression of MARS1 mRNA	decreases^expression	19682730
MARS1	4141	Silver	D012834	7440-22-4	Silver results in increased expression of MARS1 mRNA	increases^expression	26014281
MARS1	4141	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of MARS1 mRNA	decreases^expression	20106945|21632981
MARS1	4141	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of MARS1 mRNA	increases^expression	22378314
MARS1	4141	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of MARS1 mRNA	increases^expression	22378314|29453283
MARS1	4141	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of MARS1 mRNA	increases^expression	23179753
MARS1	4141	Vincristine	D014750		Vincristine results in decreased expression of MARS1 mRNA	decreases^expression	23649840
MARS1	4141	Vorinostat	D000077337		Vorinostat results in decreased expression of MARS1 mRNA	decreases^expression	27188386
MARS1	4141	Zidovudine	D015215	30516-87-1	[Zidovudine co-treated with Lamivudine] results in increased expression of MARS1 mRNA	affects^cotreatment|increases^expression	15784690
MBOAT2	129642	abrine	C496492		abrine results in decreased expression of MBOAT2 mRNA	decreases^expression	31054353
MBOAT2	129642	afimoxifene	C016601	68392-35-8	afimoxifene inhibits the reaction [Estrogens results in decreased expression of MBOAT2 mRNA]	decreases^expression|decreases^reaction	21233418
MBOAT2	129642	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of MBOAT2 gene	decreases^methylation	27153756
MBOAT2	129642	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of MBOAT2 intron	increases^methylation	30157460
MBOAT2	129642	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of MBOAT2 promoter	decreases^methylation	27901495
MBOAT2	129642	Dihydrotestosterone	D013196	521-18-6	Dihydrotestosterone results in increased expression of MBOAT2 mRNA	increases^expression	29581250
MBOAT2	129642	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of MBOAT2 mRNA	decreases^expression	29803840
MBOAT2	129642	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in increased expression of MBOAT2 mRNA	affects^cotreatment|increases^expression	30165855
MBOAT2	129642	Estrogens	D004967		afimoxifene inhibits the reaction [Estrogens results in decreased expression of MBOAT2 mRNA]	decreases^expression|decreases^reaction	21233418
MBOAT2	129642	Estrogens	D004967		Estrogens results in decreased expression of MBOAT2 mRNA	decreases^expression	21233418
MBOAT2	129642	hydroquinone	C031927	123-31-9	hydroquinone results in increased expression of MBOAT2 mRNA	increases^expression	31256213
MBOAT2	129642	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of MBOAT2 mRNA	decreases^expression	20436886
MBOAT2	129642	methylparaben	C015358	99-76-3	methylparaben results in increased expression of MBOAT2 mRNA	increases^expression	31745603
MBOAT2	129642	Nickel	D009532	7440-02-0	Nickel results in decreased expression of MBOAT2 mRNA	decreases^expression	24768652
MBOAT2	129642	Sunitinib	D000077210		Sunitinib results in increased expression of MBOAT2 mRNA	increases^expression	31533062
MBOAT2	129642	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of MBOAT2 mRNA	decreases^expression	23179753
MBOAT2	129642	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of MBOAT2 mRNA	increases^expression	29154799
MGLL	11343	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MGLL mRNA	increases^expression	23146750
MGLL	11343	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGLL mRNA	affects^cotreatment|decreases^expression	19167446
MGLL	11343	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MGLL mRNA	affects^cotreatment|increases^expression	27188386
MGLL	11343	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MGLL mRNA	decreases^expression	19150397
MGLL	11343	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of MGLL mRNA	decreases^expression	21420995
MGLL	11343	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of MGLL mRNA	increases^expression	21641981
MGLL	11343	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of MGLL intron	increases^methylation	30157460
MGLL	11343	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of MGLL mRNA	decreases^expression	20064835
MGLL	11343	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of MGLL 5' UTR	decreases^methylation	27901495
MGLL	11343	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of MGLL promoter	decreases^methylation	27901495
MGLL	11343	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of MGLL mRNA	increases^expression	32234424
MGLL	11343	Cadmium	D002104	7440-43-9	Cadmium results in increased expression of MGLL mRNA	increases^expression	24376830
MGLL	11343	Calcitriol	D002117	32222-06-3	Calcitriol results in increased expression of MGLL mRNA	increases^expression	21592394
MGLL	11343	Calcitriol	D002117	32222-06-3	[Testosterone co-treated with Calcitriol] results in increased expression of MGLL mRNA	affects^cotreatment|increases^expression	21592394
MGLL	11343	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of MGLL mRNA	affects^expression	25979313
MGLL	11343	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of MGLL mRNA	decreases^expression	27594783
MGLL	11343	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of MGLL mRNA	decreases^expression	19320972
MGLL	11343	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of MGLL mRNA	decreases^expression	12860252
MGLL	11343	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGLL mRNA	affects^cotreatment|decreases^expression	19167446
MGLL	11343	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in decreased expression of MGLL mRNA	affects^cotreatment|decreases^expression	19167446
MGLL	11343	Coumestrol	D003375	479-13-0	Coumestrol results in decreased expression of MGLL mRNA	decreases^expression	19167446
MGLL	11343	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of MGLL mRNA	increases^expression	20106945
MGLL	11343	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of MGLL mRNA	increases^expression	25047013
MGLL	11343	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in increased expression of MGLL mRNA	increases^expression	31163220
MGLL	11343	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MGLL mRNA	affects^cotreatment|increases^expression	27188386
MGLL	11343	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of MGLL mRNA	decreases^expression	29803840
MGLL	11343	erucylphospho-N,N,N-trimethylpropylammonium	C472787		erucylphospho-N,N,N-trimethylpropylammonium results in increased expression of MGLL mRNA	increases^expression	29464035
MGLL	11343	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in increased expression of MGLL mRNA	affects^cotreatment|increases^expression	30165855
MGLL	11343	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of MGLL mRNA	decreases^expression	23649840
MGLL	11343	Folic Acid	D005492	59-30-3	Folic Acid affects the expression of MGLL mRNA	affects^expression	17320366
MGLL	11343	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of MGLL mRNA	decreases^expression	23649840|28937961
MGLL	11343	(+)-JQ1 compound	C561695		[(+)-JQ1 compound co-treated with PD 0325901] results in decreased expression of MGLL mRNA	affects^cotreatment|decreases^expression	25119042
MGLL	11343	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of MGLL mRNA	decreases^expression	24796395|25119042|26752646
MGLL	11343	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of MGLL mRNA	decreases^expression	23649840
MGLL	11343	nickel sulfate	C029938	7786-81-4	nickel sulfate results in increased expression of MGLL mRNA	increases^expression	16780908
MGLL	11343	Particulate Matter	D052638		Particulate Matter results in decreased expression of MGLL mRNA	decreases^expression	24769257
MGLL	11343	Particulate Matter	D052638		Particulate Matter results in increased expression of MGLL mRNA	increases^expression	29703138
MGLL	11343	PD 0325901	C506614		[(+)-JQ1 compound co-treated with PD 0325901] results in decreased expression of MGLL mRNA	affects^cotreatment|decreases^expression	25119042
MGLL	11343	PD 0325901	C506614		PD 0325901 results in decreased expression of MGLL mRNA	decreases^expression	25119042
MGLL	11343	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MGLL mRNA	affects^cotreatment|increases^expression	27188386
MGLL	11343	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of MGLL mRNA	increases^expression	26272509
MGLL	11343	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in decreased expression of MGLL mRNA	affects^cotreatment|decreases^expression	19167446
MGLL	11343	Smoke	D012906		Smoke results in increased expression of MGLL mRNA	increases^expression	21095227
MGLL	11343	sodium arsenite	C017947	13768-07-5	sodium arsenite affects the methylation of MGLL gene	affects^methylation	28589171
MGLL	11343	sulforafan	C016766	4478-93-7	sulforafan results in decreased expression of MGLL mRNA	decreases^expression	31838189
MGLL	11343	Sunitinib	D000077210		Sunitinib results in increased expression of MGLL mRNA	increases^expression	31533062
MGLL	11343	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in increased expression of MGLL mRNA	increases^expression	15336504
MGLL	11343	Testosterone	D013739	58-22-0	[Testosterone co-treated with Calcitriol] results in increased expression of MGLL mRNA	affects^cotreatment|increases^expression	21592394
MGLL	11343	Testosterone	D013739	58-22-0	Testosterone results in increased expression of MGLL mRNA	increases^expression	21592394
MGLL	11343	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of MGLL mRNA	decreases^expression	23724009
MGLL	11343	triadimefon	C032910	43121-43-3	triadimefon results in decreased expression of MGLL mRNA	decreases^expression	26705709
MGLL	11343	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of MGLL mRNA	decreases^expression	29501571
MGLL	11343	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of MGLL protein	increases^expression	29501571
MGLL	11343	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of MGLL gene	increases^methylation	29154799|29501571
MMAA	166785	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAA mRNA	affects^cotreatment|decreases^expression	27188386
MMAA	166785	abrine	C496492		abrine results in decreased expression of MMAA mRNA	decreases^expression	31054353
MMAA	166785	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of MMAA mRNA	decreases^expression	21420995
MMAA	166785	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of MMAA gene	decreases^methylation	27153756
MMAA	166785	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of MMAA 5' UTR	increases^methylation	27901495
MMAA	166785	butyraldehyde	C018475	123-72-8	butyraldehyde results in decreased expression of MMAA mRNA	decreases^expression	26079696
MMAA	166785	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of MMAA mRNA	decreases^expression	27594783
MMAA	166785	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of MMAA mRNA	increases^expression	27392435
MMAA	166785	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of MMAA mRNA	decreases^expression	19549813
MMAA	166785	dorsomorphin	C516138		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAA mRNA	affects^cotreatment|decreases^expression	27188386
MMAA	166785	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of MMAA mRNA	decreases^expression	29803840
MMAA	166785	entinostat	C118739		entinostat results in decreased expression of MMAA mRNA	decreases^expression	26272509
MMAA	166785	entinostat	C118739		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAA mRNA	affects^cotreatment|decreases^expression	27188386
MMAA	166785	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of MMAA mRNA	decreases^expression	23649840
MMAA	166785	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of MMAA mRNA	decreases^expression	20655997
MMAA	166785	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of MMAA mRNA	decreases^expression	30851411
MMAA	166785	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of MMAA mRNA	decreases^expression	28001369
MMAA	166785	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of MMAA mRNA	decreases^expression	23649840
MMAA	166785	Nickel	D009532	7440-02-0	Nickel results in increased expression of MMAA mRNA	increases^expression	24768652|25583101
MMAA	166785	Sodium Dodecyl Sulfate	D012967	151-21-3	Sodium Dodecyl Sulfate results in increased expression of MMAA mRNA	increases^expression	31734321
MMAA	166785	Sunitinib	D000077210		Sunitinib results in increased expression of MMAA mRNA	increases^expression	31533062
MMAA	166785	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of MMAA mRNA	decreases^expression	24935251
MMAA	166785	Urethane	D014520	51-79-6	Urethane results in decreased expression of MMAA mRNA	decreases^expression	28818685
MMAA	166785	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of MMAA mRNA	affects^expression	25979313
MMAA	166785	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of MMAA mRNA	decreases^expression	23179753|24935251
MMAA	166785	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of MMAA mRNA	increases^expression	28001369
MMAB	326625	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA	affects^cotreatment|decreases^expression	27188386
MMAB	326625	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA	affects^cotreatment|decreases^expression	27188386
MMAB	326625	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA	affects^cotreatment|decreases^expression	27188386
MMAB	326625	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of MMAB mRNA	decreases^expression	29067470
MMAB	326625	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of MMAB protein	affects^expression	20106945
MMAB	326625	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of MMAB mRNA	decreases^expression	27153756
MMAB	326625	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of MMAB gene	decreases^methylation	27153756
MMAB	326625	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of MMAB intron	increases^methylation	30157460
MMAB	326625	afuresertib	C000593263		afuresertib results in increased expression of MMAB mRNA	increases^expression	28960945
MMAB	326625	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of MMAB mRNA	decreases^expression	22378314
MMAB	326625	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of MMAB mRNA	decreases^expression	21871943|26238291|32234424
MMAB	326625	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of MMAB 3' UTR	increases^methylation	27901495
MMAB	326625	butyraldehyde	C018475	123-72-8	butyraldehyde results in decreased expression of MMAB mRNA	decreases^expression	26079696
MMAB	326625	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of MMAB mRNA	affects^expression	25979313
MMAB	326625	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of MMAB mRNA	affects^cotreatment|increases^expression	27392435
MMAB	326625	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of MMAB mRNA	decreases^expression	19549813
MMAB	326625	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of MMAB mRNA	increases^expression	19167446
MMAB	326625	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of MMAB mRNA	decreases^expression	20106945|25562108
MMAB	326625	dorsomorphin	C516138		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA	affects^cotreatment|decreases^expression	27188386
MMAB	326625	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA	affects^cotreatment|decreases^expression	27188386
MMAB	326625	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA	affects^cotreatment|decreases^expression	27188386
MMAB	326625	Doxorubicin	D004317	23214-92-8	Doxorubicin affects the expression of MMAB mRNA	affects^expression	29803840
MMAB	326625	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MMAB protein	decreases^activity|increases^O-linked glycosylation	23301498
MMAB	326625	Estradiol	D004958	50-28-2	Estradiol affects the expression of MMAB mRNA	affects^expression	22574217
MMAB	326625	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of MMAB mRNA	decreases^expression	23649840
MMAB	326625	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of MMAB mRNA	decreases^expression	23649840
MMAB	326625	Hydralazine	D006830	86-54-4	[Hydralazine co-treated with Valproic Acid] results in increased expression of MMAB mRNA	affects^cotreatment|increases^expression	17183730
MMAB	326625	Hydrogen Peroxide	D006861	7722-84-1	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of MMAB protein	affects^cotreatment|decreases^expression	18951874
MMAB	326625	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased expression of MMAB mRNA	increases^expression	18951874
MMAB	326625	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of MMAB mRNA	affects^cotreatment|increases^expression	27392435
MMAB	326625	jinfukang	C544151		jinfukang results in increased expression of MMAB mRNA	increases^expression	27392435
MMAB	326625	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of MMAB mRNA	decreases^expression	28988120|29427785
MMAB	326625	Lithium Chloride	D018021	7447-41-8	Lithium Chloride results in decreased expression of MMAB mRNA	decreases^expression	23527032
MMAB	326625	mercuric bromide	C042720	7789-47-1	mercuric bromide results in decreased expression of MMAB mRNA	decreases^expression	26272509
MMAB	326625	mercuric bromide	C042720	7789-47-1	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA	affects^cotreatment|decreases^expression	27188386
MMAB	326625	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of MMAB mRNA	decreases^expression	28001369
MMAB	326625	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of MMAB mRNA	decreases^expression	23649840
MMAB	326625	MRK 003	C523799		MRK 003 results in decreased expression of MMAB mRNA	decreases^expression	21169257
MMAB	326625	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA	affects^cotreatment|decreases^expression	27188386
MMAB	326625	p-Chloromercuribenzoic Acid	D020245	59-85-8	p-Chloromercuribenzoic Acid results in decreased expression of MMAB mRNA	decreases^expression	26272509
MMAB	326625	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAB mRNA	affects^cotreatment|decreases^expression	27188386
MMAB	326625	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in decreased expression of MMAB mRNA	decreases^expression	26272509
MMAB	326625	Potassium Dichromate	D011192	7778-50-9	Potassium Dichromate results in increased expression of MMAB protein	increases^expression	23718831
MMAB	326625	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of MMAB mRNA	decreases^expression	21632981
MMAB	326625	Sunitinib	D000077210		Sunitinib results in increased expression of MMAB mRNA	increases^expression	31533062
MMAB	326625	Theophylline	D013806	58-55-9	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of MMAB protein	affects^cotreatment|decreases^expression	18951874
MMAB	326625	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of MMAB mRNA	decreases^expression	28065790
MMAB	326625	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of MMAB mRNA	decreases^expression	23724009
MMAB	326625	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of MMAB mRNA	decreases^expression	22378314
MMAB	326625	Valproic Acid	D014635	99-66-1	[Hydralazine co-treated with Valproic Acid] results in increased expression of MMAB mRNA	affects^cotreatment|increases^expression	17183730
MMAB	326625	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of MMAB mRNA	affects^expression	25979313
MMAB	326625	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of MMAB mRNA	decreases^expression	23179753|27188386|28001369|29154799
MRI1	84245	abrine	C496492		abrine results in decreased expression of MRI1 mRNA	decreases^expression	31054353
MRI1	84245	Antirheumatic Agents	D018501		Antirheumatic Agents results in increased expression of MRI1 mRNA	increases^expression	24449571
MRI1	84245	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of MRI1 mRNA	increases^expression	26472689
MRI1	84245	Cisplatin	D002945	15663-27-1	Cisplatin affects the expression of MRI1 mRNA	affects^expression	23300844
MRI1	84245	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of MRI1 mRNA	affects^cotreatment|increases^expression	27392435
MRI1	84245	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of MRI1 mRNA	increases^expression	27392435
MRI1	84245	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of MRI1 mRNA	affects^binding|decreases^expression	20971185
MRI1	84245	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of MRI1 mRNA	decreases^expression	19549813
MRI1	84245	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of MRI1 mRNA	decreases^expression	25562108
MRI1	84245	Decitabine	D000077209	2353-33-5	Decitabine affects the expression of MRI1 mRNA	affects^expression	23300844
MRI1	84245	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of MRI1 mRNA	decreases^expression	29803840
MRI1	84245	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of MRI1 mRNA	affects^cotreatment|increases^expression	27392435
MRI1	84245	nickel sulfate	C029938	7786-81-4	nickel sulfate results in increased expression of MRI1 mRNA	increases^expression	22714537
MRI1	84245	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of MRI1 mRNA	affects^binding|decreases^expression	20971185
MRI1	84245	Quercetin	D011794	117-39-5	Quercetin results in increased expression of MRI1 mRNA	increases^expression	21632981
MRI1	84245	Sunitinib	D000077210		Sunitinib results in decreased expression of MRI1 mRNA	decreases^expression	31533062
MRI1	84245	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of MRI1 mRNA	decreases^expression	26179874
MRI1	84245	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of MRI1 mRNA	affects^expression	25979313
MRI1	84245	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of MRI1 gene	increases^methylation	29154799
MYBBP1A	10514	abrine	C496492		abrine results in increased expression of MYBBP1A protein	increases^expression	31054353
MYBBP1A	10514	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of MYBBP1A polyA tail	increases^methylation	30157460
MYBBP1A	10514	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased expression of MYBBP1A protein	decreases^expression	25419056
MYBBP1A	10514	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of MYBBP1A mRNA	decreases^expression	22378314
MYBBP1A	10514	C646 compound	C584509		C646 compound results in decreased expression of MYBBP1A mRNA	decreases^expression	26191083
MYBBP1A	10514	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of MYBBP1A mRNA	decreases^expression	27594783
MYBBP1A	10514	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of MYBBP1A mRNA	decreases^expression	19320972
MYBBP1A	10514	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of MYBBP1A mRNA	affects^binding|decreases^expression	20971185
MYBBP1A	10514	cupric oxide	C030973	1317-38-0	cupric oxide results in decreased expression of MYBBP1A mRNA	decreases^expression	22077320
MYBBP1A	10514	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of MYBBP1A mRNA	increases^expression	20106945
MYBBP1A	10514	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of MYBBP1A mRNA	increases^expression	28302478
MYBBP1A	10514	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of MYBBP1A mRNA	decreases^expression	29803840
MYBBP1A	10514	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MYBBP1A protein	decreases^activity|increases^O-linked glycosylation	23301498
MYBBP1A	10514	epigallocatechin gallate	C045651	989-51-5	epigallocatechin gallate results in decreased expression of MYBBP1A protein	decreases^expression	31195006
MYBBP1A	10514	Estradiol	D004958	50-28-2	Estradiol results in increased expression of MYBBP1A mRNA	increases^expression	23019147
MYBBP1A	10514	Genistein	D019833	446-72-0	Genistein results in increased expression of MYBBP1A mRNA	increases^expression	23019147
MYBBP1A	10514	GSK-J4	C000593030		GSK-J4 results in decreased expression of MYBBP1A mRNA	decreases^expression	29301935
MYBBP1A	10514	ICG 001	C492448		ICG 001 results in decreased expression of MYBBP1A mRNA	decreases^expression	26191083
MYBBP1A	10514	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of MYBBP1A mRNA	decreases^expression	23649840
MYBBP1A	10514	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of MYBBP1A mRNA	affects^binding|decreases^expression	20971185
MYBBP1A	10514	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of MYBBP1A mRNA	decreases^expression	26516004
MYBBP1A	10514	perfluorononanoic acid	C584865		perfluorononanoic acid results in increased expression of MYBBP1A mRNA	increases^expression	32588087
MYBBP1A	10514	Plant Extracts	D010936		Plant Extracts results in decreased expression of MYBBP1A mRNA	decreases^expression	24677778
MYBBP1A	10514	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in increased expression of MYBBP1A mRNA	increases^expression	22714537
MYBBP1A	10514	Resveratrol	D000077185		Resveratrol results in decreased expression of MYBBP1A protein	decreases^expression	18089832
MYBBP1A	10514	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in increased expression of MYBBP1A mRNA	increases^expression	25895662
MYBBP1A	10514	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of MYBBP1A mRNA	increases^expression	28595984
MYBBP1A	10514	Sunitinib	D000077210		Sunitinib results in increased expression of MYBBP1A mRNA	increases^expression	31533062
MYBBP1A	10514	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of MYBBP1A mRNA	increases^expression	22903824
MYBBP1A	10514	titanium dioxide	C009495	13463-67-7	titanium dioxide results in decreased expression of MYBBP1A protein	decreases^expression	30910687
MYBBP1A	10514	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of MYBBP1A mRNA	affects^expression	28542535
MYBBP1A	10514	Urethane	D014520	51-79-6	Urethane results in decreased expression of MYBBP1A mRNA	decreases^expression	28818685
MYBBP1A	10514	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of MYBBP1A mRNA	affects^expression	25979313
MYBBP1A	10514	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of MYBBP1A gene	increases^methylation	29154799
NARS1	4677	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	C472791		3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of NARS1 mRNA	decreases^expression	12958071
NARS1	4677	afimoxifene	C016601	68392-35-8	afimoxifene results in decreased expression of NARS1 mRNA	decreases^expression	16514628
NARS1	4677	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational results in decreased expression of NARS1 mRNA	decreases^expression	23195993
NARS1	4677	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of NARS1 mRNA	decreases^expression	24449571
NARS1	4677	Ascorbic Acid	D001205	50-81-7	Ascorbic Acid results in decreased expression of NARS1 mRNA	decreases^expression	19197388
NARS1	4677	beauvericin	C004456	26048-05-5	[beauvericin co-treated with enniatins] results in increased expression of NARS1 protein	affects^cotreatment|increases^expression	32407736
NARS1	4677	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of NARS1 mRNA	increases^expression	29275510
NARS1	4677	C646 compound	C584509		C646 compound results in increased expression of NARS1 mRNA	increases^expression	26191083
NARS1	4677	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride affects the localization of NARS1 protein	affects^localization	18261755
NARS1	4677	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of NARS1 mRNA	affects^expression	25979313
NARS1	4677	CD 437	C099555		CD 437 results in decreased expression of NARS1 mRNA	decreases^expression	12958071
NARS1	4677	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde results in decreased expression of NARS1 mRNA	decreases^expression	25596134
NARS1	4677	chloropicrin	C100187	76-06-2	chloropicrin affects the expression of NARS1 mRNA	affects^expression	26352163
NARS1	4677	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of NARS1 mRNA	increases^expression	28476498
NARS1	4677	Cidofovir	D000077404	113852-37-2	Cidofovir results in decreased expression of NARS1 mRNA	decreases^expression	25596134
NARS1	4677	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of NARS1 mRNA	decreases^expression	25596134
NARS1	4677	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in decreased expression of NARS1 mRNA	decreases^expression	25596134
NARS1	4677	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of NARS1 mRNA	decreases^expression	19320972
NARS1	4677	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of NARS1 mRNA	increases^expression	19549813
NARS1	4677	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NARS1 mRNA	increases^expression	20106945
NARS1	4677	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of NARS1 mRNA	decreases^expression	28302478
NARS1	4677	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NARS1 mRNA	decreases^expression	29803840
NARS1	4677	enniatins	C100264		[beauvericin co-treated with enniatins] results in increased expression of NARS1 protein	affects^cotreatment|increases^expression	32407736
NARS1	4677	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
NARS1	4677	Estradiol	D004958	50-28-2	Estradiol results in increased expression of NARS1 mRNA	increases^expression	16514628
NARS1	4677	Fulvestrant	D000077267	129453-61-8	Fulvestrant results in decreased expression of NARS1 mRNA	decreases^expression	16514628
NARS1	4677	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of NARS1 mRNA	affects^expression	20044591|21179406
NARS1	4677	ICG 001	C492448		ICG 001 results in increased expression of NARS1 mRNA	increases^expression	26191083
NARS1	4677	Nickel	D009532	7440-02-0	Nickel results in decreased expression of NARS1 mRNA	decreases^expression	23195993
NARS1	4677	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of NARS1 mRNA	decreases^expression	25596134
NARS1	4677	Raloxifene Hydrochloride	D020849		Raloxifene Hydrochloride results in decreased expression of NARS1 mRNA	decreases^expression	16514628
NARS1	4677	Sunitinib	D000077210		Sunitinib results in increased expression of NARS1 mRNA	increases^expression	31533062
NARS1	4677	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of NARS1 mRNA	increases^expression	22378314
NARS1	4677	Tretinoin	D014212	302-79-4	Tretinoin results in increased acetylation of NARS1 protein	increases^acetylation	28053092
NARS1	4677	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of NARS1 mRNA	increases^expression	22378314
NARS1	4677	Uranium	D014501	7440-61-1	Uranium affects the expression of NARS1 mRNA	affects^expression	15672453
NARS1	4677	Uranium Compounds	D017974		Uranium Compounds results in decreased expression of NARS1 mRNA	decreases^expression	19654044
NARS1	4677	uranyl acetate	C005460	541-09-3	uranyl acetate affects the expression of NARS1 mRNA	affects^expression	15672453
NARS1	4677	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of NARS1 mRNA	decreases^expression	25596134
NDC1	55706	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDC1 mRNA	affects^cotreatment|increases^expression	19167446
NDC1	55706	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDC1 mRNA	affects^cotreatment|increases^expression	27188386
NDC1	55706	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NDC1 mRNA	decreases^expression	19150397|20382639
NDC1	55706	abrine	C496492		abrine results in decreased expression of NDC1 mRNA	decreases^expression	31054353
NDC1	55706	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NDC1 mRNA	decreases^expression	21420995|29067470
NDC1	55706	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of NDC1 mRNA	decreases^expression	24449571
NDC1	55706	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of NDC1 mRNA	decreases^expression	20064835
NDC1	55706	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of NDC1 mRNA	decreases^expression	29275510
NDC1	55706	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of NDC1 mRNA	affects^binding|decreases^expression	20971185
NDC1	55706	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDC1 mRNA	affects^cotreatment|increases^expression	19167446
NDC1	55706	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of NDC1 mRNA	affects^cotreatment|increases^expression	19167446
NDC1	55706	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of NDC1 mRNA	increases^expression	19167446
NDC1	55706	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of NDC1 mRNA	decreases^expression	20106945
NDC1	55706	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NDC1 mRNA	increases^expression	25562108
NDC1	55706	Dasatinib	D000069439		Dasatinib results in decreased expression of NDC1 mRNA	decreases^expression	20579391
NDC1	55706	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDC1 mRNA	affects^cotreatment|increases^expression	27188386
NDC1	55706	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NDC1 mRNA	decreases^expression	29803840
NDC1	55706	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of NDC1 mRNA	decreases^expression	23649840
NDC1	55706	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of NDC1 mRNA	decreases^expression	23649840
NDC1	55706	ICG 001	C492448		ICG 001 results in decreased expression of NDC1 mRNA	decreases^expression	26191083
NDC1	55706	incobotulinumtoxinA	C545476		incobotulinumtoxinA results in decreased expression of NDC1 mRNA	decreases^expression	29522793
NDC1	55706	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of NDC1 mRNA	decreases^expression	24297863|24796395
NDC1	55706	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of NDC1 mRNA	decreases^expression	23649840
NDC1	55706	Nickel	D009532	7440-02-0	Nickel results in increased expression of NDC1 mRNA	increases^expression	25583101
NDC1	55706	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of NDC1 mRNA	affects^binding|decreases^expression	20971185
NDC1	55706	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of NDC1 mRNA	decreases^expression	26516004
NDC1	55706	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of NDC1 mRNA	affects^cotreatment|increases^expression	19167446
NDC1	55706	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of NDC1 mRNA	affects^expression	28542535
NDC1	55706	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDC1 mRNA	affects^cotreatment|increases^expression	27188386
NDC1	55706	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of NDC1 mRNA	increases^expression	23179753|26272509|29154799
NDC1	55706	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of NDC1 mRNA	affects^expression	20044591
NME1	4830	11,12-epoxy-5,8,14-eicosatrienoic acid	C046783		11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Terfenadine analog results in increased expression of NME1 protein]	decreases^reaction|increases^expression	19289568
NME1	4830	1-Butanol	D020001	71-36-3	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NME1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
NME1	4830	2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid	C488288		2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid inhibits the reaction [VEGFA protein results in decreased expression of NME1 protein]	decreases^expression|decreases^reaction	25447407
NME1	4830	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	C472791		3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of NME1 mRNA	decreases^expression	12958071
NME1	4830	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27188386
NME1	4830	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27188386
NME1	4830	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27188386
NME1	4830	7,3'-dihydroxy-4'-methoxyisoflavone	C121707		7,3'-dihydroxy-4'-methoxyisoflavone results in increased expression of NME1 protein	increases^expression	24455688
NME1	4830	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of NME1 protein	affects^expression	20106945
NME1	4830	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of NME1 mRNA	increases^expression	22100608|27153756
NME1	4830	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of NME1 mRNA	increases^expression	12478894
NME1	4830	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of NME1 protein	increases^expression	12452020
NME1	4830	Ascorbic Acid	D001205	50-81-7	[Tretinoin co-treated with Ascorbic Acid] results in decreased expression of NME1 mRNA	affects^cotreatment|decreases^expression	16443354
NME1	4830	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of NME1 mRNA	decreases^expression	22378314|25275270
NME1	4830	Atrazine	D001280	1912-24-9	Atrazine results in decreased phosphorylation of NME1 protein	decreases^phosphorylation	25275270
NME1	4830	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of NME1 mRNA	increases^expression	20106945|21632981|32234424
NME1	4830	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of NME1 protein	increases^expression	20097212
NME1	4830	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of NME1 5' UTR	increases^methylation	27901495
NME1	4830	bisphenol A	C006780	80-05-7	bisphenol A promotes the reaction [NME1 protein binds to ESR1 protein]	affects^binding|increases^reaction	27156127
NME1	4830	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of NME1 mRNA	decreases^expression	29275510
NME1	4830	butylidenephthalide	C026105	551-08-6	butylidenephthalide results in increased expression of NME1 protein	increases^expression	23770345
NME1	4830	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of NME1 protein	decreases^expression	24419708
NME1	4830	CD 437	C099555		CD 437 results in decreased expression of NME1 mRNA	decreases^expression	12958071
NME1	4830	chlorophyllin	C007020	15611-43-5	chlorophyllin analog results in decreased expression of NME1 protein	decreases^expression	22852132
NME1	4830	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27392435
NME1	4830	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of NME1 mRNA	increases^expression	27392435
NME1	4830	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of NME1 protein	increases^expression	20540955|21924258
NME1	4830	Coal Tar	D003033	8007-45-2	Coal Tar results in increased expression of NME1 protein	increases^expression	18495319
NME1	4830	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of NME1 mRNA	decreases^expression	19376846
NME1	4830	Copper	D003300	7440-50-8	NME1 protein binds to Copper	affects^binding	14534351|15359738
NME1	4830	Curcumin	D003474	458-37-7	Curcumin results in increased expression of NME1 mRNA	increases^expression	17198877
NME1	4830	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NME1 mRNA	increases^expression	20106945
NME1	4830	dibenzo(a,l)pyrene	C041517	191-30-0	dibenzo(a,l)pyrene results in increased expression of NME1 protein	increases^expression	18495319
NME1	4830	Diethylstilbestrol	D004054	56-53-1	Diethylstilbestrol results in increased expression of NME1 mRNA	increases^expression	15766595
NME1	4830	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27188386
NME1	4830	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27188386
NME1	4830	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27188386
NME1	4830	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NME1 mRNA	decreases^expression	29803840
NME1	4830	Doxorubicin	D004317	23214-92-8	NME1 protein results in decreased susceptibility to Doxorubicin	decreases^response to substance	24675091
NME1	4830	Dronabinol	D013759		Dronabinol results in decreased expression of NME1 mRNA	decreases^expression	18454173
NME1	4830	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NME1 protein	decreases^activity|increases^O-linked glycosylation	23301498
NME1	4830	erucylphospho-N,N,N-trimethylpropylammonium	C472787		erucylphospho-N,N,N-trimethylpropylammonium results in decreased expression of NME1 mRNA	decreases^expression	29464035
NME1	4830	Estradiol	D004958	50-28-2	Estradiol results in increased expression of NME1 mRNA	increases^expression	14605097|22609851
NME1	4830	Ethanol	D000431	64-17-5	Ethanol results in increased expression of NME1 protein	increases^expression	20621659
NME1	4830	Fluorouracil	D005472	51-21-8	NME1 protein affects the susceptibility to Fluorouracil	affects^response to substance	15548681
NME1	4830	Fulvestrant	D000077267	129453-61-8	[Fulvestrant co-treated with Sirolimus] results in decreased expression of NME1 mRNA	affects^cotreatment|decreases^expression	19016759
NME1	4830	Fulvestrant	D000077267	129453-61-8	Fulvestrant results in decreased expression of NME1 mRNA	decreases^expression	19016759
NME1	4830	gambierol	C435770		[Okadaic Acid co-treated with gambierol] results in decreased expression of NME1 protein	affects^cotreatment|decreases^expression	19397276
NME1	4830	Gasoline	D005742		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NME1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
NME1	4830	Graphite	D006108	7782-42-5	Graphite results in decreased expression of NME1 protein	decreases^expression	22157353
NME1	4830	Hydralazine	D006830	86-54-4	[Hydralazine co-treated with Valproic Acid] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	17183730
NME1	4830	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased expression of NME1 mRNA	increases^expression	18951874
NME1	4830	Indomethacin	D007213	53-86-1	Indomethacin results in increased expression of NME1 mRNA	increases^expression	12192599
NME1	4830	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27392435
NME1	4830	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of NME1 mRNA	decreases^expression	21889194|22904298|23086925|23430699|24297863
NME1	4830	methylselenic acid	C008493		methylselenic acid results in decreased expression of NME1 mRNA	decreases^expression	18548127
NME1	4830	MK2i peptide	C540575		[TGFB1 protein co-treated with MK2i peptide] results in decreased expression of NME1 protein	affects^cotreatment|decreases^expression	20864298
NME1	4830	myricetin	C040015	529-44-2	myricetin results in increased expression of NME1 protein	increases^expression	29698783
NME1	4830	Nanotubes, Carbon	D037742		Nanotubes, Carbon results in increased expression of NME1 protein	increases^expression	22157353
NME1	4830	naringenin	C005273	480-41-1	naringenin results in increased expression of NME1 mRNA	increases^expression	27838343
NME1	4830	naringenin	C005273	480-41-1	naringenin results in increased expression of NME1 protein	increases^expression	27838343
NME1	4830	Nickel	D009532	7440-02-0	Nickel results in increased expression of NME1 mRNA	increases^expression	25583101
NME1	4830	Okadaic Acid	D019319	78111-17-8	[Okadaic Acid co-treated with gambierol] results in decreased expression of NME1 protein	affects^cotreatment|decreases^expression	19397276
NME1	4830	Okadaic Acid	D019319	78111-17-8	Okadaic Acid results in decreased expression of NME1 protein	decreases^expression	19397276
NME1	4830	ON 01910	C507134		ON 01910 results in decreased expression of NME1 mRNA	decreases^expression	22351695
NME1	4830	o,p'-DDT	C016340	789-02-6	o,p'-DDT results in increased expression of NME1 mRNA	increases^expression	22609851
NME1	4830	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of NME1 mRNA	decreases^expression	26516004
NME1	4830	Particulate Matter	D052638		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NME1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
NME1	4830	Particulate Matter	D052638		Particulate Matter results in decreased expression of NME1 mRNA	decreases^expression	29703138
NME1	4830	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27188386
NME1	4830	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of NME1 mRNA	increases^expression	26272509
NME1	4830	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NME1 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
NME1	4830	Quercetin	D011794	117-39-5	Quercetin results in increased expression of NME1 mRNA	increases^expression	20596804
NME1	4830	quinocetone	C502851		quinocetone results in decreased expression of NME1 protein	decreases^expression	27046791
NME1	4830	Sirolimus	D020123	53123-88-9	[Fulvestrant co-treated with Sirolimus] results in decreased expression of NME1 mRNA	affects^cotreatment|decreases^expression	19016759
NME1	4830	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of NME1 mRNA	decreases^expression	12016162
NME1	4830	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of NME1 protein	increases^expression	21925251
NME1	4830	sulforafan	C016766	4478-93-7	NME1 protein binds to sulforafan	affects^binding	21838287
NME1	4830	Terfenadine	D016593	50679-08-8	11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Terfenadine analog results in increased expression of NME1 protein]	decreases^reaction|increases^expression	19289568
NME1	4830	Terfenadine	D016593	50679-08-8	Terfenadine analog results in increased expression of NME1 protein	increases^expression	19289568
NME1	4830	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of NME1 protein	affects^expression	30291989
NME1	4830	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased metabolism of NME1 protein	increases^metabolic processing	23396223
NME1	4830	Tretinoin	D014212	302-79-4	[Tretinoin co-treated with Ascorbic Acid] results in decreased expression of NME1 mRNA	affects^cotreatment|decreases^expression	16443354
NME1	4830	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of NME1 mRNA	decreases^expression	16054129|23724009
NME1	4830	tributyltin	C011559	688-73-3	tributyltin analog results in decreased expression of NME1 protein	decreases^expression	31634547
NME1	4830	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27188386
NME1	4830	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of NME1 mRNA	increases^expression	24935251|26272509
NME1	4830	triphenyltin	C030665		triphenyltin analog results in decreased expression of NME1 protein	decreases^expression	31634547
NME1	4830	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of NME1 mRNA	decreases^expression	22378314
NME1	4830	Urethane	D014520	51-79-6	Urethane results in decreased expression of NME1 mRNA	decreases^expression	28818685
NME1	4830	Valproic Acid	D014635	99-66-1	[Hydralazine co-treated with Valproic Acid] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	17183730
NME1	4830	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NME1 mRNA	affects^cotreatment|increases^expression	27188386
NME1	4830	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NME1 mRNA	affects^expression	25979313
NME1	4830	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of NME1 mRNA	increases^expression	23179753|24383497|24935251|25192806|26272509|28001369
NME1	4830	Vehicle Emissions	D001335		Vehicle Emissions results in increased expression of NME1 protein	increases^expression	18495319
NME1	4830	Vitallium	D014800	12629-02-6	Vitallium analog results in decreased expression of NME1 mRNA	decreases^expression	23825117
NME1	4830	Vorinostat	D000077337		Vorinostat results in increased expression of NME1 mRNA	increases^expression	27188386
NME1	4830	Zearalenone	D015025	17924-92-4	Zearalenone results in increased expression of NME1 mRNA	increases^expression	28965971
NME1	4830	Zinc	D015032	7440-66-6	NME1 protein binds to Zinc	affects^binding	14534351
NME1	4830	Zinc	D015032	7440-66-6	Zinc deficiency results in decreased expression of NME1 mRNA	decreases^expression	12888634
NME2	4831	4-hydroxy-2-nonenal	C027576	29343-52-0	4-hydroxy-2-nonenal results in decreased expression of NME2 mRNA	decreases^expression	12419474
NME2	4831	abrine	C496492		abrine results in decreased expression of NME2 mRNA	decreases^expression	31054353
NME2	4831	Alitretinoin	D000077556	08/03/5300	Alitretinoin results in decreased expression of NME2 protein	decreases^expression	28886987
NME2	4831	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of NME2 promoter	increases^methylation	27901495
NME2	4831	Calcitriol	D002117	32222-06-3	Calcitriol results in decreased expression of NME2 mRNA	decreases^expression	15951637|16847355
NME2	4831	Capsaicin	D002211	404-86-4	Capsaicin results in increased expression of NME2 mRNA	increases^expression	21310942
NME2	4831	Catechin	D002392	154-23-4	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of NME2 mRNA	affects^cotreatment|decreases^expression	24763279
NME2	4831	Cocaine	D003042	50-36-2	Cocaine affects the expression of NME2 protein	affects^expression	19393250
NME2	4831	Decitabine	D000077209	2353-33-5	Decitabine affects the methylation of NME2 gene	affects^methylation	17630775
NME2	4831	Diethylstilbestrol	D004054	56-53-1	Diethylstilbestrol results in increased expression of NME2 mRNA	increases^expression	15766595
NME2	4831	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NME2 mRNA	decreases^expression	29803840
NME2	4831	Grape Seed Proanthocyanidins	C511402		[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of NME2 mRNA	affects^cotreatment|decreases^expression	24763279
NME2	4831	JP8 aviation fuel	C098607		JP8 aviation fuel results in increased expression of NME2 mRNA	increases^expression	12832151
NME2	4831	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of NME2 mRNA	decreases^expression	23086925
NME2	4831	Mifepristone	D015735	84371-65-3	Mifepristone inhibits the reaction [Progesterone results in increased expression of NME2 mRNA]	decreases^reaction|increases^expression	15674352
NME2	4831	N'-(10H-indolo(3,2-b)quinolin-11-yl)-N,N-dimethylpropane-1,3-diamine	C521094		N'-(10H-indolo(3,2-b)quinolin-11-yl)-N,N-dimethylpropane-1,3-diamine inhibits the reaction [NME2 protein binds to MYC promoter]	affects^binding|decreases^reaction	21774525
NME2	4831	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of NME2 protein	decreases^expression	26861962
NME2	4831	Plant Extracts	D010936		Plant Extracts results in decreased expression of NME2 mRNA	decreases^expression	21920417
NME2	4831	Progesterone	D011374	57-83-0	Mifepristone inhibits the reaction [Progesterone results in increased expression of NME2 mRNA]	decreases^reaction|increases^expression	15674352
NME2	4831	Progesterone	D011374	57-83-0	Progesterone results in increased expression of NME2 mRNA	increases^expression	15674352
NME2	4831	quinoline	C037219	91-22-5	quinoline analog results in increased expression of NME2 protein	increases^expression	18645022
NME2	4831	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog affects the secretion of NME2 protein	affects^secretion	25895662
NME2	4831	Sodium Dodecyl Sulfate	D012967	151-21-3	Sodium Dodecyl Sulfate results in decreased expression of NME2 protein	decreases^expression	21469165
NME2	4831	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in decreased expression of NME2 mRNA	decreases^expression	16705456
NME2	4831	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of NME2 mRNA	decreases^expression	12419474
NME2	4831	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of NME2 protein	affects^expression	30291989
NME2	4831	Tretinoin	D014212	302-79-4	Tretinoin promotes the reaction [tributyltin results in decreased expression of NME2 protein]	decreases^expression|increases^reaction	30806631
NME2	4831	Tretinoin	D014212	302-79-4	Tretinoin promotes the reaction [triphenyltin chloride results in decreased expression of NME2 protein]	decreases^expression|increases^reaction	30806631
NME2	4831	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of NME2 protein	decreases^expression	28886987|30806631
NME2	4831	tributyltin	C011559	688-73-3	Tretinoin promotes the reaction [tributyltin results in decreased expression of NME2 protein]	decreases^expression|increases^reaction	30806631
NME2	4831	tributyltin	C011559	688-73-3	tributyltin analog results in decreased expression of NME2 protein	decreases^expression	31634547
NME2	4831	tributyltin	C011559	688-73-3	tributyltin results in decreased expression of NME2 protein	decreases^expression	30806631
NME2	4831	triphenyltin	C030665		triphenyltin analog results in decreased expression of NME2 protein	decreases^expression	31634547
NME2	4831	triphenyltin chloride	C012594	639-58-7	Tretinoin promotes the reaction [triphenyltin chloride results in decreased expression of NME2 protein]	decreases^expression|increases^reaction	30806631
NME2	4831	triphenyltin chloride	C012594	639-58-7	triphenyltin chloride results in decreased expression of NME2 protein	decreases^expression	30806631
NME3	4832	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NME3 mRNA	affects^cotreatment|increases^expression	28628672
NME3	4832	2-Naphthylamine	D015081	91-59-8	2-Naphthylamine results in decreased expression of NME3 mRNA	decreases^expression	18247414
NME3	4832	afimoxifene	C016601	68392-35-8	NME3 results in decreased susceptibility to afimoxifene	decreases^response to substance	21233418
NME3	4832	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of NME3 polyA tail	increases^methylation	30157460
NME3	4832	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of NME3 mRNA	decreases^expression	18247414
NME3	4832	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of NME3 promoter	increases^methylation	27901495
NME3	4832	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NME3 mRNA	affects^cotreatment|increases^expression	28628672
NME3	4832	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of NME3 mRNA	affects^expression	25979313
NME3	4832	Catechin	D002392	154-23-4	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of NME3 mRNA	affects^cotreatment|decreases^expression	24763279
NME3	4832	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of NME3 mRNA	affects^cotreatment|increases^expression	27392435
NME3	4832	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of NME3 mRNA	decreases^expression	20106945
NME3	4832	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NME3 mRNA	affects^cotreatment|increases^expression	28628672
NME3	4832	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NME3 mRNA	decreases^expression	29803840
NME3	4832	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NME3 protein	decreases^activity|increases^O-linked glycosylation	23301498
NME3	4832	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in decreased expression of NME3 mRNA	affects^cotreatment|decreases^expression	30165855
NME3	4832	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of NME3 mRNA	decreases^expression	23373633
NME3	4832	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of NME3 mRNA	decreases^expression	23649840
NME3	4832	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of NME3 mRNA	decreases^expression	23649840
NME3	4832	Grape Seed Proanthocyanidins	C511402		[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of NME3 mRNA	affects^cotreatment|decreases^expression	24763279
NME3	4832	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NME3 mRNA	affects^cotreatment|increases^expression	28628672
NME3	4832	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of NME3 mRNA	affects^cotreatment|increases^expression	27392435
NME3	4832	jinfukang	C544151		jinfukang results in increased expression of NME3 mRNA	increases^expression	27392435
NME3	4832	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of NME3 mRNA	decreases^expression	23086925
NME3	4832	K 7174	C410337		K 7174 results in decreased expression of NME3 mRNA	decreases^expression	24086573
NME3	4832	Menthol	D008610	1490-04-6	Menthol results in decreased expression of NME3 mRNA	decreases^expression	26760959
NME3	4832	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of NME3 mRNA	decreases^expression	23649840
NME3	4832	Nickel	D009532	7440-02-0	Nickel results in decreased expression of NME3 mRNA	decreases^expression	25583101
NME3	4832	Nicotine	D009538		Nicotine results in decreased expression of NME3 mRNA	decreases^expression	18247414
NME3	4832	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NME3 mRNA	affects^binding|decreases^expression|increases^activity	19710929
NME3	4832	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of NME3 mRNA	increases^expression	18175754
NME3	4832	Sunitinib	D000077210		Sunitinib results in decreased expression of NME3 mRNA	decreases^expression	31533062
NME3	4832	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of NME3 mRNA	decreases^expression	29453283
NME3	4832	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of NME3 mRNA	increases^expression	22378314
NME3	4832	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of NME3 mRNA	decreases^expression	22363418
NME3	4832	Urethane	D014520	51-79-6	Urethane results in decreased expression of NME3 mRNA	decreases^expression	28818685
NME3	4832	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NME3 mRNA	affects^expression	25979313
NME3	4832	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NME3 mRNA	decreases^expression	23179753
NME3	4832	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of NME3 gene	increases^methylation	29154799
NME4	4833	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NME4 mRNA	affects^cotreatment|decreases^expression	27188386
NME4	4833	abrine	C496492		abrine results in decreased expression of NME4 mRNA	decreases^expression	31054353
NME4	4833	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NME4 mRNA	decreases^expression	22230336
NME4	4833	afimoxifene	C016601	68392-35-8	NME4 results in decreased susceptibility to afimoxifene	decreases^response to substance	21233418
NME4	4833	Antirheumatic Agents	D018501		Antirheumatic Agents results in increased expression of NME4 mRNA	increases^expression	24449571
NME4	4833	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of NME4 mRNA	decreases^expression	22378314
NME4	4833	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of NME4 promoter	increases^methylation	27901495
NME4	4833	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of NME4 mRNA	affects^expression	30903817
NME4	4833	Cadmium	D002104	7440-43-9	Cadmium results in increased expression of NME4 mRNA	increases^expression	24376830
NME4	4833	chloropicrin	C100187	76-06-2	chloropicrin results in decreased expression of NME4 mRNA	decreases^expression	26352163
NME4	4833	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of NME4 mRNA	decreases^expression	19320972|19376846|22941251
NME4	4833	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of NME4 mRNA	affects^binding|decreases^expression	20971185
NME4	4833	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of NME4 mRNA	decreases^expression	20106945|25562108|27989131
NME4	4833	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NME4 mRNA	affects^cotreatment|decreases^expression	27188386
NME4	4833	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NME4 mRNA	decreases^expression	29803840|30031762
NME4	4833	Dust	D004391		Dust results in decreased expression of NME4 mRNA	decreases^expression	17805423
NME4	4833	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in increased expression of NME4 mRNA	affects^cotreatment|increases^expression	30165855
NME4	4833	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of NME4 mRNA	decreases^expression	23649840
NME4	4833	Fluorouracil	D005472	51-21-8	NME4 protein affects the susceptibility to Fluorouracil	affects^response to substance	16217747
NME4	4833	Folic Acid	D005492	59-30-3	Folic Acid affects the expression of NME4 mRNA	affects^expression	16361273
NME4	4833	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of NME4 mRNA	decreases^expression	23649840
NME4	4833	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of NME4 mRNA	decreases^expression	23086925
NME4	4833	K 7174	C410337		K 7174 results in decreased expression of NME4 mRNA	decreases^expression	24086573
NME4	4833	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of NME4 mRNA	decreases^expression	23179753|27188386
NME4	4833	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of NME4 mRNA	decreases^expression	23649840
NME4	4833	methylselenic acid	C008493		methylselenic acid results in decreased expression of NME4 mRNA	decreases^expression	18548127
NME4	4833	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of NME4 mRNA	affects^binding|decreases^expression	20971185
NME4	4833	Paclitaxel	D017239		Paclitaxel results in decreased expression of NME4 protein	decreases^expression	15907983
NME4	4833	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NME4 mRNA	affects^cotreatment|decreases^expression	27188386
NME4	4833	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in decreased expression of NME4 mRNA	decreases^expression	26272509
NME4	4833	Plant Extracts	D010936		Plant Extracts results in decreased expression of NME4 mRNA	decreases^expression	23557933
NME4	4833	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of NME4 mRNA	decreases^expression	15309432
NME4	4833	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of NME4 protein	decreases^expression	15221776
NME4	4833	Smoke	D012906		Smoke results in increased expression of NME4 mRNA	increases^expression	21095227
NME4	4833	Sunitinib	D000077210		Sunitinib results in decreased expression of NME4 mRNA	decreases^expression	31533062
NME4	4833	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of NME4 mRNA	decreases^expression	22378314
NME4	4833	Thimerosal	D013849	54-64-8	Thimerosal results in decreased expression of NME4 mRNA	decreases^expression	27188386
NME4	4833	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of NME4 mRNA	decreases^expression	26179874
NME4	4833	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of NME4 mRNA	decreases^expression	22378314
NME4	4833	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NME4 mRNA	affects^expression	25979313
NME4	4833	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NME4 mRNA	decreases^expression	23179753|24935251|28001369|29154799
NME4	4833	Vanadates	D014638		Vanadates results in increased expression of NME4 mRNA	increases^expression	22714537
NME6	10201	1,4-phenylenebis(methylene)selenocyanate	C074153	85539-83-9	1,4-phenylenebis(methylene)selenocyanate affects the expression of NME6 protein	affects^expression	18444160
NME6	10201	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of NME6 protein	increases^expression	26194647
NME6	10201	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NME6 mRNA	decreases^expression	21420995
NME6	10201	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of NME6 gene	decreases^methylation	27153756
NME6	10201	Aspirin	D001241	50-78-2	Aspirin results in increased expression of NME6 mRNA	increases^expression	15456535
NME6	10201	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of NME6 3' UTR	decreases^methylation	27901495
NME6	10201	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of NME6 mRNA	decreases^expression	19549813
NME6	10201	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NME6 mRNA	increases^expression	20106945
NME6	10201	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of NME6 mRNA	affects^expression	21179406
NME6	10201	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of NME6 mRNA	decreases^expression	25307878
NME6	10201	Menthol	D008610	1490-04-6	Menthol results in decreased expression of NME6 mRNA	decreases^expression	26760959
NME6	10201	Plant Extracts	D010936		Plant Extracts results in increased expression of NME6 mRNA	increases^expression	23557933
NME6	10201	Selenomethionine	D012645	1464-42-2	Selenomethionine affects the expression of NME6 protein	affects^expression	18444160
NME6	10201	Urethane	D014520	51-79-6	Urethane results in decreased expression of NME6 mRNA	decreases^expression	28818685
NME6	10201	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NME6 mRNA	affects^expression	25979313
NME6	10201	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NME6 mRNA	decreases^expression	29154799
NME7	29922	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NME7 mRNA	decreases^expression	26238291
NME7	29922	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NME7 mRNA	decreases^expression	21420995
NME7	29922	afimoxifene	C016601	68392-35-8	NME7 results in decreased susceptibility to afimoxifene	decreases^response to substance	21233418
NME7	29922	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of NME7 protein	affects^expression	20106945
NME7	29922	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of NME7 mRNA	decreases^expression	22100608
NME7	29922	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of NME7 gene	decreases^methylation	27153756
NME7	29922	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of NME7 intron	increases^methylation	30157460
NME7	29922	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of NME7 mRNA	decreases^expression	22378314
NME7	29922	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of NME7 mRNA	decreases^expression	20064835|20106945|21632981|22316170|26238291
NME7	29922	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of NME7 mRNA	affects^expression	21179406
NME7	29922	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of NME7 mRNA	affects^cotreatment|decreases^expression	27392435
NME7	29922	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of NME7 mRNA	decreases^expression	27392435
NME7	29922	Cisplatin	D002945	15663-27-1	[Piroxicam co-treated with Cisplatin] results in increased expression of NME7 mRNA	affects^cotreatment|increases^expression	21858171
NME7	29922	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of NME7 mRNA	decreases^expression	19549813
NME7	29922	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NME7 mRNA	increases^expression	20106945
NME7	29922	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of NME7 mRNA	decreases^expression	28302478
NME7	29922	doxifluridine	C025034	05/09/3094	NME7 protein results in decreased susceptibility to doxifluridine	decreases^response to substance	16734730
NME7	29922	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NME7 mRNA	affects^cotreatment|decreases^expression	22079256
NME7	29922	Estradiol	D004958	50-28-2	EGF protein inhibits the reaction [Estradiol results in decreased expression of NME7 mRNA]	decreases^expression|decreases^reaction	24758408
NME7	29922	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of NME7 mRNA	decreases^expression	24758408
NME7	29922	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of NME7 mRNA	increases^expression	23649840
NME7	29922	ICG 001	C492448		ICG 001 results in decreased expression of NME7 mRNA	decreases^expression	26191083
NME7	29922	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of NME7 mRNA	affects^cotreatment|decreases^expression	27392435
NME7	29922	jinfukang	C544151		jinfukang results in decreased expression of NME7 mRNA	decreases^expression	27392435
NME7	29922	K 7174	C410337		K 7174 results in increased expression of NME7 mRNA	increases^expression	24086573
NME7	29922	Lactic Acid	D019344	50-21-5	Lactic Acid results in increased expression of NME7 mRNA	increases^expression	30851411
NME7	29922	Piroxicam	D010894	36322-90-4	[Piroxicam co-treated with Cisplatin] results in increased expression of NME7 mRNA	affects^cotreatment|increases^expression	21858171
NME7	29922	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NME7 mRNA	affects^cotreatment|decreases^expression	22079256
NME7	29922	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of NME7 mRNA	decreases^expression	22079256
NME7	29922	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of NME7 mRNA	decreases^expression	21632981
NME7	29922	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide results in increased expression of NME7 mRNA	increases^expression	25351596
NME7	29922	Sunitinib	D000077210		Sunitinib results in decreased expression of NME7 mRNA	decreases^expression	31533062
NME7	29922	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NME7 mRNA	affects^expression	25979313
NME7	29922	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of NME7 gene	decreases^methylation	29154799
NME7	29922	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of NME7 mRNA	increases^expression	23179753|25716160|27188386|29154799
NME7	29922	Vorinostat	D000077337		Vorinostat results in increased expression of NME7 mRNA	increases^expression	27188386
NUP107	57122	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP107 mRNA	affects^cotreatment|increases^expression	19167446
NUP107	57122	2,3-dimethoxy-1,4-naphthoquinone	C063002	6956-96-3	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of NUP107 mRNA	increases^expression	17547211
NUP107	57122	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP107 mRNA	decreases^expression	26238291
NUP107	57122	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NUP107 mRNA	decreases^expression	21420995
NUP107	57122	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of NUP107 gene	increases^methylation	27153756
NUP107	57122	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of NUP107 mRNA	increases^expression	17547211
NUP107	57122	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of NUP107 mRNA	affects^expression	21179406
NUP107	57122	Calcitriol	D002117	32222-06-3	Calcitriol results in decreased expression of NUP107 mRNA	decreases^expression	21592394
NUP107	57122	Calcitriol	D002117	32222-06-3	[Testosterone co-treated with Calcitriol] results in decreased expression of NUP107 mRNA	affects^cotreatment|decreases^expression	21592394
NUP107	57122	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP107 mRNA	affects^cotreatment|increases^expression	19167446
NUP107	57122	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of NUP107 mRNA	affects^cotreatment|increases^expression	19167446
NUP107	57122	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of NUP107 mRNA	increases^expression	19167446
NUP107	57122	cupric chloride	C029892	7447-39-4	cupric chloride results in increased expression of NUP107 mRNA	increases^expression	17211630
NUP107	57122	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of NUP107 mRNA	decreases^expression	20106945|21632981
NUP107	57122	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of NUP107 mRNA	decreases^expression	28302478
NUP107	57122	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP107 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP107	57122	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NUP107 mRNA	affects^cotreatment|decreases^expression	22079256
NUP107	57122	Estradiol	D004958	50-28-2	Estradiol results in increased expression of NUP107 mRNA	increases^expression	19167446
NUP107	57122	ICG 001	C492448		ICG 001 results in decreased expression of NUP107 mRNA	decreases^expression	26191083
NUP107	57122	incobotulinumtoxinA	C545476		incobotulinumtoxinA results in decreased expression of NUP107 mRNA	decreases^expression	29522793
NUP107	57122	Mercury	D008628	7439-97-6	Mercury results in increased expression of NUP107 mRNA	increases^expression	17547211
NUP107	57122	Plant Extracts	D010936		Plant Extracts results in increased expression of NUP107 mRNA	increases^expression	23557933
NUP107	57122	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NUP107 mRNA	affects^cotreatment|decreases^expression	22079256
NUP107	57122	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of NUP107 mRNA	decreases^expression	22079256
NUP107	57122	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of NUP107 mRNA	affects^cotreatment|increases^expression	19167446
NUP107	57122	Testosterone	D013739	58-22-0	[Testosterone co-treated with Calcitriol] results in decreased expression of NUP107 mRNA	affects^cotreatment|decreases^expression	21592394
NUP107	57122	Testosterone	D013739	58-22-0	Testosterone results in decreased expression of NUP107 mRNA	decreases^expression	21592394
NUP107	57122	Troglitazone	D000077288	97322-87-7	Troglitazone results in decreased expression of NUP107 mRNA	decreases^expression	19140230
NUP107	57122	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of NUP107 mRNA	decreases^expression	29453283
NUP107	57122	Urethane	D014520	51-79-6	Urethane results in decreased expression of NUP107 mRNA	decreases^expression	28818685
NUP107	57122	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NUP107 mRNA	affects^expression	25979313
NUP107	57122	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of NUP107 mRNA	affects^expression	20044591
NUP133	55746	3,3'-diindolylmethane	C016392	04/05/1968	3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of NUP133 mRNA]	decreases^expression|decreases^reaction	11179685
NUP133	55746	abrine	C496492		abrine results in decreased expression of NUP133 mRNA	decreases^expression	31054353
NUP133	55746	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NUP133 mRNA	decreases^expression	21420995
NUP133	55746	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of NUP133 gene	increases^methylation	27153756
NUP133	55746	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational affects the expression of NUP133 mRNA	affects^expression	27809917
NUP133	55746	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of NUP133 mRNA	decreases^expression	24449571
NUP133	55746	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of NUP133 mRNA	affects^expression	21179406
NUP133	55746	Calcitriol	D002117	32222-06-3	Calcitriol results in increased expression of NUP133 mRNA	increases^expression	16002434
NUP133	55746	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of NUP133 mRNA	decreases^expression	19549813
NUP133	55746	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP133 mRNA	decreases^expression	29803840
NUP133	55746	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NUP133 mRNA	affects^cotreatment|decreases^expression	22079256
NUP133	55746	Estradiol	D004958	50-28-2	3,3'-diindolylmethane inhibits the reaction [Estradiol results in decreased expression of NUP133 mRNA]	decreases^expression|decreases^reaction	11179685
NUP133	55746	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of NUP133 mRNA	decreases^expression	11179685
NUP133	55746	Estradiol	D004958	50-28-2	Tetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of NUP133 mRNA]	decreases^expression|increases^reaction	11179685
NUP133	55746	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased acetylation of NUP133 promoter	decreases^acetylation	29098329
NUP133	55746	ochratoxin A	C025589	303-47-9	[ochratoxin A results in decreased acetylation of NUP133 promoter] which results in decreased expression of NUP133 mRNA	decreases^acetylation|decreases^expression	29098329
NUP133	55746	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of NUP133 mRNA	decreases^expression	29098329
NUP133	55746	Plant Extracts	D010936		Plant Extracts results in increased expression of NUP133 mRNA	increases^expression	23557933
NUP133	55746	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NUP133 mRNA	affects^cotreatment|decreases^expression	22079256
NUP133	55746	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of NUP133 mRNA	decreases^expression	22079256
NUP133	55746	sulindac sulfide	C025462	32004-67-4	sulindac sulfide results in increased expression of NUP133 mRNA	increases^expression	12734198
NUP133	55746	Sunitinib	D000077210		Sunitinib results in increased expression of NUP133 mRNA	increases^expression	31533062
NUP133	55746	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of NUP133 mRNA]	decreases^expression|increases^reaction	11179685
NUP153	9972	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	C093973		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP153 protein]	affects^localization|affects^reaction	20041180
NUP153	9972	2,3,5-(triglutathion-S-yl)hydroquinone	C078765	119212-33-8	2,3,5-(triglutathion-S-yl)hydroquinone results in increased ADP-ribosylation of NUP153 protein	increases^ADP-ribosylation	31165168
NUP153	9972	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the localization of NUP153 protein	affects^localization	20041180
NUP153	9972	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP153 protein]	affects^localization|affects^reaction	20041180
NUP153	9972	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of NUP153 mRNA	affects^expression	20382639
NUP153	9972	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP153 mRNA	decreases^expression	19150397
NUP153	9972	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NUP153 mRNA	increases^expression	26238291
NUP153	9972	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of NUP153 mRNA	increases^expression	22230336
NUP153	9972	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of NUP153 intron	increases^methylation	30157460
NUP153	9972	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in decreased methylation of NUP153 intron	decreases^methylation	30157460
NUP153	9972	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased expression of NUP153 mRNA	decreases^expression	21461292
NUP153	9972	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of NUP153 mRNA	increases^expression	22378314
NUP153	9972	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of NUP153 intron	affects^methylation	30157460
NUP153	9972	C646 compound	C584509		C646 compound results in decreased expression of NUP153 mRNA	decreases^expression	26191083
NUP153	9972	Calcitriol	D002117	32222-06-3	Calcitriol results in decreased expression of NUP153 mRNA	decreases^expression	16002434
NUP153	9972	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of NUP153 mRNA	increases^expression	19549813
NUP153	9972	Demecolcine	D003703	477-30-5	Demecolcine results in increased expression of NUP153 mRNA	increases^expression	23649840
NUP153	9972	diethyl maleate	C014476	141-05-9	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP153 protein]	affects^localization|affects^reaction	20041180
NUP153	9972	diethyl maleate	C014476	141-05-9	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP153 protein]	affects^localization|affects^reaction	20041180
NUP153	9972	diethyl maleate	C014476	141-05-9	diethyl maleate affects the localization of NUP153 protein	affects^localization	20041180
NUP153	9972	diethyl maleate	C014476	141-05-9	diethyl maleate results in increased phosphorylation of and results in increased O-linked glycosylation of NUP153 protein	increases^O-linked glycosylation|increases^phosphorylation	20041180
NUP153	9972	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP153 mRNA	decreases^expression	29803840
NUP153	9972	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP153 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP153	9972	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of NUP153 mRNA	decreases^expression	20655997
NUP153	9972	Hydralazine	D006830	86-54-4	[Hydralazine co-treated with Valproic Acid] results in increased expression of NUP153 mRNA	affects^cotreatment|increases^expression	17183730
NUP153	9972	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of NUP153 mRNA	affects^expression	20044591
NUP153	9972	ICG 001	C492448		ICG 001 results in decreased expression of NUP153 mRNA	decreases^expression	26191083
NUP153	9972	Irinotecan	D000077146		Irinotecan analog results in decreased expression of NUP153 mRNA	decreases^expression	18927307
NUP153	9972	jinfukang	C544151		jinfukang results in decreased expression of NUP153 mRNA	decreases^expression	27392435
NUP153	9972	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of NUP153 mRNA	increases^expression	28001369
NUP153	9972	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of NUP153 mRNA	increases^expression	23649840
NUP153	9972	MLN7243	C000622638		MLN7243 results in decreased sumoylation of NUP153 protein	decreases^sumoylation	31285264
NUP153	9972	Palmitic Acid	D019308	57-10-3	Palmitic Acid affects the phosphorylation of NUP153 protein	affects^phosphorylation	28073184
NUP153	9972	seocalcitol	C078903	134404-52-7	seocalcitol results in decreased expression of NUP153 mRNA	decreases^expression	12040012
NUP153	9972	Silver	D012834	7440-22-4	Silver results in increased expression of NUP153 mRNA	increases^expression	26014281
NUP153	9972	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of NUP153 mRNA	decreases^expression	24935251
NUP153	9972	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of NUP153 mRNA	increases^expression	24935251
NUP153	9972	Valproic Acid	D014635	99-66-1	[Hydralazine co-treated with Valproic Acid] results in increased expression of NUP153 mRNA	affects^cotreatment|increases^expression	17183730
NUP153	9972	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NUP153 mRNA	decreases^expression	24935251
NUP153	9972	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of NUP153 gene	decreases^methylation	29154799
NUP153	9972	Vincristine	D014750		Vincristine results in increased expression of NUP153 mRNA	increases^expression	23649840
NUP155	9631	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	28628672
NUP155	9631	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	28628672
NUP155	9631	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	19167446
NUP155	9631	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP155 mRNA	decreases^expression	20382639
NUP155	9631	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in decreased methylation of NUP155 intron	decreases^methylation	30157460
NUP155	9631	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of NUP155 promoter	decreases^methylation	27901495
NUP155	9631	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	28628672
NUP155	9631	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	28628672
NUP155	9631	Bucladesine	D003994	362-74-3	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NUP155 mRNA	affects^cotreatment|decreases^expression	20823114
NUP155	9631	Calcitriol	D002117	32222-06-3	Calcitriol results in decreased expression of NUP155 mRNA	decreases^expression	21592394
NUP155	9631	Calcitriol	D002117	32222-06-3	[Testosterone co-treated with Calcitriol] results in decreased expression of NUP155 mRNA	affects^cotreatment|decreases^expression	21592394
NUP155	9631	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of NUP155 mRNA	decreases^expression	19320972
NUP155	9631	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	19167446
NUP155	9631	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	19167446
NUP155	9631	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of NUP155 mRNA	increases^expression	19167446
NUP155	9631	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NUP155 mRNA	increases^expression	25562108
NUP155	9631	Demecolcine	D003703	477-30-5	Demecolcine results in decreased expression of NUP155 mRNA	decreases^expression	23649840
NUP155	9631	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	28628672
NUP155	9631	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	28628672
NUP155	9631	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP155 mRNA	decreases^expression	29803840
NUP155	9631	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP155 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP155	9631	Estradiol	D004958	50-28-2	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NUP155 mRNA	affects^cotreatment|decreases^expression	20823114
NUP155	9631	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	28628672
NUP155	9631	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	28628672
NUP155	9631	jinfukang	C544151		jinfukang results in decreased expression of NUP155 mRNA	decreases^expression	27392435
NUP155	9631	K 7174	C410337		K 7174 results in decreased expression of NUP155 mRNA	decreases^expression	24086573
NUP155	9631	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of NUP155 mRNA	decreases^expression	30851411
NUP155	9631	Medroxyprogesterone Acetate	D017258	71-58-9	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of NUP155 mRNA	affects^cotreatment|decreases^expression	20823114
NUP155	9631	MLN7243	C000622638		MLN7243 results in increased sumoylation of NUP155 protein	increases^sumoylation	31285264
NUP155	9631	Plant Extracts	D010936		Plant Extracts results in increased expression of NUP155 mRNA	increases^expression	23557933
NUP155	9631	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of NUP155 mRNA	affects^cotreatment|increases^expression	19167446
NUP155	9631	sodium arsenite	C017947	13768-07-5	sodium arsenite affects the methylation of NUP155 gene	affects^methylation	28589171
NUP155	9631	Testosterone	D013739	58-22-0	[Testosterone co-treated with Calcitriol] results in decreased expression of NUP155 mRNA	affects^cotreatment|decreases^expression	21592394
NUP155	9631	Testosterone	D013739	58-22-0	Testosterone results in decreased expression of NUP155 mRNA	decreases^expression	21592394
NUP155	9631	tetrahydropalmatine	C014215	10097-84-4	tetrahydropalmatine results in decreased expression of NUP155 protein	decreases^expression	20109541
NUP155	9631	Urethane	D014520	51-79-6	Urethane results in decreased expression of NUP155 mRNA	decreases^expression	28818685
NUP155	9631	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NUP155 mRNA	affects^expression	25979313
NUP155	9631	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NUP155 mRNA	decreases^expression	23179753|27188386
NUP160	23279	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP160 mRNA	affects^cotreatment|decreases^expression	27188386
NUP160	23279	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NUP160 mRNA	affects^cotreatment|increases^expression	27188386
NUP160	23279	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NUP160 mRNA	increases^expression	26238291
NUP160	23279	Arsenic	D001151	7440-38-2	NUP160 mRNA results in increased susceptibility to Arsenic	increases^response to substance	17976673
NUP160	23279	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of NUP160 protein	increases^expression	24527689
NUP160	23279	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of NUP160 mRNA	affects^cotreatment|decreases^expression	27392435
NUP160	23279	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP160 mRNA	affects^cotreatment|decreases^expression	27188386
NUP160	23279	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NUP160 mRNA	affects^cotreatment|increases^expression	27188386
NUP160	23279	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP160 mRNA	decreases^expression	29803840
NUP160	23279	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NUP160 mRNA	affects^cotreatment|decreases^expression	22079256
NUP160	23279	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in decreased expression of NUP160 mRNA	decreases^expression	18951874
NUP160	23279	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased expression of NUP160 mRNA	increases^expression	18951874
NUP160	23279	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of NUP160 mRNA	affects^cotreatment|decreases^expression	27392435
NUP160	23279	jinfukang	C544151		jinfukang results in decreased expression of NUP160 mRNA	decreases^expression	27392435
NUP160	23279	Nickel	D009532	7440-02-0	Nickel results in increased expression of NUP160 mRNA	increases^expression	24768652|25583101
NUP160	23279	NSC 689534	C558013		NSC 689534 results in decreased expression of NUP160 mRNA	decreases^expression	20971185
NUP160	23279	Particulate Matter	D052638		Particulate Matter results in increased methylation of NUP160 gene	increases^methylation	30081103
NUP160	23279	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP160 mRNA	affects^cotreatment|decreases^expression	27188386
NUP160	23279	p-Chloromercuribenzoic Acid	D020245	59-85-8	p-Chloromercuribenzoic Acid results in decreased expression of NUP160 mRNA	decreases^expression	26272509
NUP160	23279	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of NUP160 mRNA	decreases^expression	21858171
NUP160	23279	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NUP160 mRNA	affects^cotreatment|decreases^expression	22079256
NUP160	23279	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of NUP160 mRNA	decreases^expression	22079256
NUP160	23279	Progesterone	D011374	57-83-0	Progesterone results in increased expression of NUP160 mRNA	increases^expression	18070364
NUP160	23279	Raloxifene Hydrochloride	D020849		Raloxifene Hydrochloride results in increased expression of NUP160 mRNA	increases^expression	16497877
NUP160	23279	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide results in increased expression of NUP160 mRNA	increases^expression	25351596
NUP160	23279	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NUP160 mRNA	affects^cotreatment|increases^expression	27188386
NUP160	23279	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NUP160 mRNA	decreases^expression	27188386
NUP160	23279	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of NUP160 mRNA	increases^expression	23179753|24383497|24935251|25192806|26272509|28001369
NUP160	23279	Vitamin E	D014810	1406-18-4	Vitamin E results in decreased expression of NUP160 mRNA	decreases^expression	19244175
NUP160	23279	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of NUP160 mRNA	affects^expression	20044591
NUP160	23279	Vorinostat	D000077337		Vorinostat results in increased expression of NUP160 mRNA	increases^expression	27188386
NUP188	23511	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of NUP188 mRNA	increases^expression	22230336
NUP188	23511	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of NUP188 mRNA	increases^expression	22100608
NUP188	23511	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of NUP188 gene	increases^methylation	27153756
NUP188	23511	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of NUP188 mRNA	increases^expression	32234424
NUP188	23511	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of NUP188 promoter	increases^methylation	27901495
NUP188	23511	C646 compound	C584509		C646 compound results in decreased expression of NUP188 mRNA	decreases^expression	26191083
NUP188	23511	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of NUP188 protein	decreases^expression	24527689
NUP188	23511	Diazinon	D003976	333-41-5	Diazinon results in decreased methylation of NUP188 gene	decreases^methylation	22964155
NUP188	23511	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of NUP188 mRNA	increases^expression	28302478
NUP188	23511	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP188 mRNA	decreases^expression	29803840
NUP188	23511	Estradiol	D004958	50-28-2	Estradiol results in increased expression of NUP188 mRNA	increases^expression	23019147
NUP188	23511	ICG 001	C492448		ICG 001 results in decreased expression of NUP188 mRNA	decreases^expression	26191083
NUP188	23511	K 7174	C410337		K 7174 results in decreased expression of NUP188 mRNA	decreases^expression	24086573
NUP188	23511	Sunitinib	D000077210		Sunitinib results in decreased expression of NUP188 mRNA	decreases^expression	31533062
NUP188	23511	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of NUP188 mRNA	decreases^expression	15336504
NUP188	23511	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NUP188 mRNA	affects^expression	25979313
NUP205	23165	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NUP205 mRNA	increases^expression	26238291
NUP205	23165	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of NUP205 mRNA	increases^expression	22230336
NUP205	23165	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of NUP205 gene	increases^methylation	27153756
NUP205	23165	Benzene	D001554	71-43-2	Benzene results in increased expression of NUP205 mRNA	increases^expression	19162166
NUP205	23165	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of NUP205 mRNA	increases^expression	32234424
NUP205	23165	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of NUP205 mRNA	increases^expression	19167446
NUP205	23165	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP205 mRNA	decreases^expression	29803840
NUP205	23165	incobotulinumtoxinA	C545476		incobotulinumtoxinA results in decreased expression of NUP205 mRNA	decreases^expression	29522793
NUP205	23165	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of NUP205 mRNA	decreases^expression	23430699
NUP205	23165	Lead	D007854	7439-92-1	Lead affects the expression of NUP205 mRNA	affects^expression	28903495
NUP205	23165	Plant Extracts	D010936		Plant Extracts results in increased expression of NUP205 mRNA	increases^expression	23557933
NUP205	23165	Sunitinib	D000077210		Sunitinib results in decreased expression of NUP205 mRNA	decreases^expression	31533062
NUP205	23165	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of NUP205 mRNA	decreases^expression	15336504
NUP205	23165	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of NUP205 mRNA	affects^expression	22574217
NUP205	23165	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of NUP205 mRNA	decreases^expression	22378314
NUP205	23165	Urethane	D014520	51-79-6	Urethane results in decreased expression of NUP205 mRNA	decreases^expression	28818685
NUP205	23165	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NUP205 mRNA	affects^expression	25979313
NUP205	23165	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NUP205 mRNA	decreases^expression	23179753
NUP210	23225	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP210 mRNA	affects^cotreatment|increases^expression	19167446
NUP210	23225	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP210 mRNA	affects^cotreatment|decreases^expression	27188386
NUP210	23225	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP210 mRNA	affects^cotreatment|decreases^expression	27188386
NUP210	23225	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP210 mRNA	decreases^expression	19150397
NUP210	23225	abrine	C496492		abrine results in decreased expression of NUP210 mRNA	decreases^expression	31054353
NUP210	23225	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of NUP210 mRNA	increases^expression	22230336
NUP210	23225	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of NUP210 gene	decreases^methylation	27153756
NUP210	23225	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of NUP210 intron	increases^methylation	30157460
NUP210	23225	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of NUP210 intron	increases^methylation	30157460
NUP210	23225	Aminoglutethimide	D000616	125-84-8	Aminoglutethimide results in decreased expression of NUP210 protein	decreases^expression	26102013
NUP210	23225	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of NUP210 mRNA	decreases^expression	24449571
NUP210	23225	Arsenic	D001151	7440-38-2	Arsenic affects the expression of NUP210 mRNA	affects^expression	18414638
NUP210	23225	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of NUP210 promoter	affects^methylation	27901495
NUP210	23225	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of NUP210 mRNA	decreases^expression	20064835
NUP210	23225	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in increased methylation of NUP210 exon	increases^methylation	30157460
NUP210	23225	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of NUP210 mRNA	affects^expression	30903817
NUP210	23225	butyraldehyde	C018475	123-72-8	butyraldehyde results in decreased expression of NUP210 mRNA	decreases^expression	26079696
NUP210	23225	C646 compound	C584509		C646 compound results in decreased expression of NUP210 mRNA	decreases^expression	26191083
NUP210	23225	Catechin	D002392	154-23-4	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of NUP210 mRNA	affects^cotreatment|decreases^expression	24763279
NUP210	23225	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of NUP210 mRNA	decreases^expression	27594783
NUP210	23225	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of NUP210 mRNA	decreases^expression	19549813
NUP210	23225	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP210 mRNA	affects^cotreatment|increases^expression	19167446
NUP210	23225	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of NUP210 mRNA	affects^cotreatment|increases^expression	19167446
NUP210	23225	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of NUP210 mRNA	increases^expression	19167446
NUP210	23225	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of NUP210 mRNA	decreases^expression	25562108
NUP210	23225	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of NUP210 mRNA	increases^expression	28302478
NUP210	23225	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP210 mRNA	affects^cotreatment|decreases^expression	27188386
NUP210	23225	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP210 mRNA	affects^cotreatment|decreases^expression	27188386
NUP210	23225	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in decreased expression of NUP210 mRNA	affects^cotreatment|decreases^expression	30165855
NUP210	23225	Gold	D006046	7440-57-5	[Polyethyleneimine binds to Gold] which results in decreased expression of NUP210 mRNA	affects^binding|decreases^expression	28433809
NUP210	23225	Grape Seed Proanthocyanidins	C511402		[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of NUP210 mRNA	affects^cotreatment|decreases^expression	24763279
NUP210	23225	K 7174	C410337		K 7174 results in decreased expression of NUP210 mRNA	decreases^expression	24086573
NUP210	23225	Methapyrilene	D008701	91-80-5	Methapyrilene results in increased methylation of NUP210 exon	increases^methylation	30157460
NUP210	23225	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of NUP210 mRNA	decreases^expression	28001369
NUP210	23225	Nickel	D009532	7440-02-0	Nickel results in increased expression of NUP210 mRNA	increases^expression	24768652|25583101
NUP210	23225	nickel sulfate	C029938	7786-81-4	nickel sulfate results in decreased expression of NUP210 mRNA	decreases^expression	22714537
NUP210	23225	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP210 mRNA	affects^cotreatment|decreases^expression	27188386
NUP210	23225	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in decreased expression of NUP210 mRNA	decreases^expression	26272509
NUP210	23225	Polyethyleneimine	D011094	9002-98-6	[Polyethyleneimine binds to Gold] which results in decreased expression of NUP210 mRNA	affects^binding|decreases^expression	28433809
NUP210	23225	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in increased expression of NUP210 mRNA	increases^expression	22714537
NUP210	23225	Quercetin	D011794	117-39-5	Quercetin results in increased expression of NUP210 mRNA	increases^expression	21632981
NUP210	23225	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of NUP210 mRNA	affects^cotreatment|increases^expression	19167446
NUP210	23225	Smoke	D012906		Smoke results in decreased expression of NUP210 mRNA	decreases^expression	21095227
NUP210	23225	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of NUP210 mRNA	decreases^expression	22714537
NUP210	23225	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of NUP210 mRNA	increases^expression	29301061
NUP210	23225	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of NUP210 protein	affects^expression	30291989
NUP210	23225	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP210 mRNA	affects^cotreatment|decreases^expression	27188386
NUP210	23225	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of NUP210 mRNA	decreases^expression	24935251|26272509
NUP210	23225	Triclosan	D014260	3380-34-5	Triclosan results in decreased expression of NUP210 mRNA	decreases^expression	30510588
NUP210	23225	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of NUP210 mRNA	decreases^expression	26179874
NUP210	23225	Urethane	D014520	51-79-6	Urethane results in decreased expression of NUP210 mRNA	decreases^expression	28818685
NUP210	23225	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NUP210 mRNA	affects^expression	25979313
NUP210	23225	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of NUP210 mRNA	increases^expression	23179753
NUP210	23225	Vanadates	D014638		Vanadates results in decreased expression of NUP210 mRNA	decreases^expression	22714537
NUP214	8021	2,3,5-(triglutathion-S-yl)hydroquinone	C078765	119212-33-8	2,3,5-(triglutathion-S-yl)hydroquinone results in decreased ADP-ribosylation of NUP214 protein	decreases^ADP-ribosylation	31165168
NUP214	8021	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP214 mRNA	decreases^expression	19150397
NUP214	8021	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of NUP214 mRNA	increases^expression	22230336
NUP214	8021	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of NUP214 intron	increases^methylation	30157460
NUP214	8021	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of NUP214 3' UTR	affects^methylation	30157460
NUP214	8021	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of NUP214 promoter	affects^methylation	27901495
NUP214	8021	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of NUP214 protein	decreases^expression	24527689
NUP214	8021	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of NUP214 mRNA	affects^expression	25979313
NUP214	8021	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of NUP214 mRNA	affects^binding|decreases^expression	20971185
NUP214	8021	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NUP214 mRNA	increases^expression	25562108
NUP214	8021	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of NUP214 mRNA	increases^expression	28302478
NUP214	8021	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP214 mRNA	decreases^expression	29803840
NUP214	8021	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP214 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP214	8021	Flavonoids	D005419		Flavonoids results in increased expression of NUP214 mRNA	increases^expression	15465739
NUP214	8021	gardiquimod	C546771		gardiquimod results in decreased expression of NUP214 mRNA	decreases^expression	28003376
NUP214	8021	gardiquimod	C546771		Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of NUP214 mRNA]	decreases^expression|decreases^reaction	28003376
NUP214	8021	Lycopene	D000077276	502-65-8	Lycopene results in decreased expression of NUP214 mRNA	decreases^expression	16886892
NUP214	8021	MLN7243	C000622638		MLN7243 results in decreased sumoylation of NUP214 protein	decreases^sumoylation	31285264
NUP214	8021	Nickel	D009532	7440-02-0	Nickel results in increased expression of NUP214 mRNA	increases^expression	24768652|25583101
NUP214	8021	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of NUP214 mRNA	affects^binding|decreases^expression	20971185
NUP214	8021	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NUP214 mRNA	affects^binding|increases^activity|increases^expression	19710929
NUP214	8021	Plant Extracts	D010936		Plant Extracts results in increased expression of NUP214 mRNA	increases^expression	15465739
NUP214	8021	Polyphenols	D059808		Polyphenols results in increased expression of NUP214 mRNA	increases^expression	15465739
NUP214	8021	Protein Kinase Inhibitors	D047428		Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of NUP214 mRNA]	decreases^expression|decreases^reaction	28003376
NUP214	8021	Tetrachlorodibenzodioxin	D013749	1746-01-6	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of NUP214 mRNA	affects^cotreatment|decreases^expression	14761676
NUP214	8021	Triiodothyronine	D014284	03/02/6893	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of NUP214 mRNA	affects^cotreatment|decreases^expression	14761676
NUP35	129401	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP35 mRNA	decreases^expression	19150397|20382639
NUP35	129401	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NUP35 mRNA	decreases^expression	21420995
NUP35	129401	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of NUP35 mRNA	decreases^expression	22378314
NUP35	129401	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of NUP35 mRNA	decreases^expression	29275510
NUP35	129401	Cadmium	D002104	7440-43-9	Cadmium results in decreased expression of NUP35 mRNA	decreases^expression	24376830
NUP35	129401	Calcitriol	D002117	32222-06-3	Calcitriol results in decreased expression of NUP35 mRNA	decreases^expression	21592394
NUP35	129401	Calcitriol	D002117	32222-06-3	[Testosterone co-treated with Calcitriol] results in decreased expression of NUP35 mRNA	affects^cotreatment|decreases^expression	21592394
NUP35	129401	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of NUP35 mRNA	affects^cotreatment|decreases^expression	27392435
NUP35	129401	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of NUP35 mRNA	increases^expression	19167446
NUP35	129401	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of NUP35 mRNA	decreases^expression	28302478
NUP35	129401	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP35 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP35	129401	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of NUP35 mRNA	decreases^expression	23649840
NUP35	129401	Gasoline	D005742		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NUP35 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
NUP35	129401	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of NUP35 mRNA	affects^cotreatment|decreases^expression	27392435
NUP35	129401	jinfukang	C544151		jinfukang results in decreased expression of NUP35 mRNA	decreases^expression	27392435
NUP35	129401	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of NUP35 mRNA	decreases^expression	23649840
NUP35	129401	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of NUP35 mRNA	decreases^expression	26516004
NUP35	129401	Particulate Matter	D052638		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NUP35 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
NUP35	129401	pinosylvin	C049032	102-61-4	pinosylvin results in decreased expression of NUP35 mRNA	decreases^expression	23333577
NUP35	129401	Polycyclic Aromatic Hydrocarbons	D011084		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NUP35 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
NUP35	129401	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of NUP35 mRNA	decreases^expression	21632981
NUP35	129401	Testosterone	D013739	58-22-0	[Testosterone co-treated with Calcitriol] results in decreased expression of NUP35 mRNA	affects^cotreatment|decreases^expression	21592394
NUP35	129401	Testosterone	D013739	58-22-0	Testosterone results in decreased expression of NUP35 mRNA	decreases^expression	21592394
NUP35	129401	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of NUP35 mRNA	affects^expression	22574217
NUP35	129401	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of NUP35 mRNA	decreases^expression	21632981
NUP35	129401	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of NUP35 mRNA	increases^expression	17555868
NUP35	129401	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of NUP35 mRNA	decreases^expression	26179874
NUP42	11097	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of NUP42 mRNA	decreases^expression	22378314
NUP42	11097	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of NUP42 mRNA	affects^expression	21179406
NUP42	11097	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of NUP42 mRNA	decreases^expression	19549813
NUP42	11097	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of NUP42 mRNA	decreases^expression	28302478
NUP42	11097	ICG 001	C492448		ICG 001 results in increased expression of NUP42 mRNA	increases^expression	26191083
NUP42	11097	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of NUP42 mRNA	decreases^expression	28988120
NUP43	348995	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NUP43 mRNA	affects^cotreatment|increases^expression	28628672
NUP43	348995	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational results in decreased expression of NUP43 mRNA	decreases^expression	23195993
NUP43	348995	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of NUP43 promoter	increases^methylation	27901495
NUP43	348995	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of NUP43 mRNA	affects^expression	21179406
NUP43	348995	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NUP43 mRNA	affects^cotreatment|increases^expression	28628672
NUP43	348995	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NUP43 mRNA	affects^cotreatment|increases^expression	28628672
NUP43	348995	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP43 mRNA	decreases^expression	29803840
NUP43	348995	Estradiol	D004958	50-28-2	Estradiol affects the expression of NUP43 mRNA	affects^expression	22574217
NUP43	348995	ICG 001	C492448		ICG 001 results in increased expression of NUP43 mRNA	increases^expression	26191083
NUP43	348995	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NUP43 mRNA	affects^cotreatment|increases^expression	28628672
NUP43	348995	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of NUP43 mRNA	decreases^expression	30851411
NUP43	348995	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of NUP43 mRNA	decreases^expression	28988120
NUP43	348995	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of NUP43 mRNA	decreases^expression	28001369
NUP43	348995	Nickel	D009532	7440-02-0	Nickel results in decreased expression of NUP43 mRNA	decreases^expression	23195993
NUP43	348995	nickel chloride	C022838	7718-54-9	nickel chloride results in decreased expression of NUP43 mRNA	decreases^expression	17312168
NUP43	348995	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of NUP43 gene	increases^methylation	29154799
NUP50	10762	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NUP50 mRNA	affects^cotreatment|increases^expression	28628672
NUP50	10762	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NUP50 mRNA	decreases^expression	21420995
NUP50	10762	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of NUP50 gene	increases^methylation	27153756
NUP50	10762	Asbestos, Serpentine	D017632		Asbestos, Serpentine results in increased methylation of NUP50 5' UTR	increases^methylation	29523930
NUP50	10762	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of NUP50 mRNA	decreases^expression	29275510
NUP50	10762	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NUP50 mRNA	affects^cotreatment|increases^expression	28628672
NUP50	10762	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of NUP50 mRNA	increases^expression	19376846
NUP50	10762	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of NUP50 mRNA	increases^expression	19549813
NUP50	10762	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of NUP50 mRNA	increases^expression	19167446
NUP50	10762	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NUP50 mRNA	increases^expression	25562108
NUP50	10762	cylindrospermopsin	C089595	143545-90-8	cylindrospermopsin results in increased expression of NUP50 mRNA	increases^expression	24921660
NUP50	10762	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NUP50 mRNA	affects^cotreatment|increases^expression	28628672
NUP50	10762	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP50 mRNA	decreases^expression	29803840
NUP50	10762	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP50 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP50	10762	Hydrogen Peroxide	D006861	7722-84-1	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of NUP50 protein	affects^cotreatment|increases^expression	18951874
NUP50	10762	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NUP50 mRNA	affects^cotreatment|increases^expression	28628672
NUP50	10762	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of NUP50 mRNA	decreases^expression	24449571
NUP50	10762	MLN7243	C000622638		MLN7243 affects the sumoylation of NUP50 protein	affects^sumoylation	31285264
NUP50	10762	Nickel	D009532	7440-02-0	Nickel results in increased expression of NUP50 mRNA	increases^expression	25583101
NUP50	10762	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	C044387	16858-02-9	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of NUP50 mRNA	increases^expression	12756304
NUP50	10762	Palmitic Acid	D019308	57-10-3	Palmitic Acid results in decreased phosphorylation of NUP50 protein	decreases^phosphorylation	28073184
NUP50	10762	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of NUP50 mRNA	decreases^expression	21858171
NUP50	10762	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of NUP50 mRNA	affects^expression	22574217
NUP50	10762	Theophylline	D013806	58-55-9	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of NUP50 protein	affects^cotreatment|increases^expression	18951874
NUP50	10762	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of NUP50 mRNA	increases^expression	28065790
NUP50	10762	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of NUP50 mRNA	affects^expression	28542535
NUP50	10762	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NUP50 mRNA	affects^expression	25979313
NUP50	10762	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of NUP50 gene	increases^methylation	29154799
NUP54	53371	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NUP54 mRNA	increases^expression	26238291
NUP54	53371	Aflatoxin M1	D016607	6795-23-9	Aflatoxin M1 results in decreased expression of NUP54 mRNA	decreases^expression	30928695
NUP54	53371	Antirheumatic Agents	D018501		Antirheumatic Agents results in increased expression of NUP54 mRNA	increases^expression	24449571
NUP54	53371	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of NUP54 mRNA	decreases^expression	22378314
NUP54	53371	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of NUP54 promoter	increases^methylation	27901495
NUP54	53371	Calcitriol	D002117	32222-06-3	Calcitriol results in decreased expression of NUP54 mRNA	decreases^expression	21592394
NUP54	53371	Calcitriol	D002117	32222-06-3	[Testosterone co-treated with Calcitriol] results in decreased expression of NUP54 mRNA	affects^cotreatment|decreases^expression	21592394
NUP54	53371	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NUP54 mRNA	increases^expression	25562108
NUP54	53371	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of NUP54 mRNA	decreases^expression	28302478
NUP54	53371	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP54 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP54	53371	jinfukang	C544151		jinfukang results in decreased expression of NUP54 mRNA	decreases^expression	27392435
NUP54	53371	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of NUP54 mRNA	decreases^expression	24449571
NUP54	53371	Plant Extracts	D010936		Plant Extracts results in increased expression of NUP54 mRNA	increases^expression	23557933
NUP54	53371	Testosterone	D013739	58-22-0	[Testosterone co-treated with Calcitriol] results in decreased expression of NUP54 mRNA	affects^cotreatment|decreases^expression	21592394
NUP54	53371	Testosterone	D013739	58-22-0	Testosterone results in decreased expression of NUP54 mRNA	decreases^expression	21592394
NUP54	53371	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of NUP54 mRNA	decreases^expression	21934132
NUP58	9818	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of NUP58 mRNA	increases^expression	19095052
NUP58	9818	(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	C517041		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of NUP58 mRNA	increases^expression	19561079
NUP58	9818	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP58 mRNA	decreases^expression	20018196
NUP58	9818	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NUP58 mRNA	increases^expression	19150397
NUP58	9818	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of NUP58 mRNA	increases^expression	21420995|22230336
NUP58	9818	Arsenic	D001151	7440-38-2	Arsenic affects the expression of NUP58 mRNA	affects^expression	18414638
NUP58	9818	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in increased expression of NUP58 mRNA	increases^expression	18687144
NUP58	9818	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of NUP58 mRNA	increases^expression	19376846
NUP58	9818	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in increased expression of NUP58 mRNA	affects^binding|increases^expression	20971185
NUP58	9818	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NUP58 mRNA	increases^expression	20106945
NUP58	9818	Endosulfan	D004726	115-29-7	Endosulfan results in increased expression of NUP58 mRNA	increases^expression	26615145
NUP58	9818	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in decreased expression of NUP58 mRNA	decreases^expression	18951874
NUP58	9818	K 7174	C410337		K 7174 results in increased expression of NUP58 mRNA	increases^expression	24086573
NUP58	9818	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of NUP58 mRNA	increases^expression	23179753
NUP58	9818	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of NUP58 mRNA	increases^expression	23649840
NUP58	9818	methylparaben	C015358	99-76-3	methylparaben results in increased expression of NUP58 mRNA	increases^expression	31745603
NUP58	9818	N(6)-(delta(2)-isopentenyl)adenine	C001478	2365-40-4	N(6)-(delta(2)-isopentenyl)adenine results in increased expression of NUP58 mRNA	increases^expression	16129123
NUP58	9818	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in increased expression of NUP58 mRNA	affects^binding|increases^expression	20971185
NUP58	9818	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether analog results in increased expression of NUP58 mRNA	increases^expression	19095052
NUP58	9818	Plant Extracts	D010936		Plant Extracts results in increased expression of NUP58 mRNA	increases^expression	23557933
NUP58	9818	Sunitinib	D000077210		Sunitinib results in increased expression of NUP58 mRNA	increases^expression	31533062
NUP58	9818	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of NUP58 mRNA	affects^expression	22574217
NUP58	9818	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of NUP58 mRNA	increases^expression	24935251
NUP58	9818	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NUP58 mRNA	decreases^expression	23179753|25192806
NUP62	23636	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP62 mRNA	decreases^expression	19150397|20382639
NUP62	23636	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NUP62 mRNA	decreases^expression	21420995
NUP62	23636	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of NUP62 mRNA	decreases^expression	24449571
NUP62	23636	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite affects the expression of NUP62 mRNA	affects^expression	17331233
NUP62	23636	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in decreased expression of NUP62 mRNA	decreases^expression	29523930
NUP62	23636	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of NUP62 mRNA	decreases^expression	22378314
NUP62	23636	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of NUP62 promoter	affects^methylation	27901495
NUP62	23636	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of NUP62 5' UTR	increases^methylation	27901495
NUP62	23636	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in decreased methylation of NUP62 intron	decreases^methylation	30157460
NUP62	23636	Benzophenoneidum	D001576	2465-27-2	Benzophenoneidum results in increased expression of NUP62 protein	increases^expression	28722353
NUP62	23636	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of NUP62 mRNA	decreases^expression	25562108|27989131
NUP62	23636	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of NUP62 mRNA	increases^expression	28302478
NUP62	23636	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP62 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP62	23636	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of NUP62 mRNA	decreases^expression	28988120
NUP62	23636	Menthol	D008610	1490-04-6	Menthol results in decreased expression of NUP62 mRNA	decreases^expression	26760959
NUP62	23636	Methapyrilene	D008701	91-80-5	Methapyrilene results in decreased methylation of NUP62 intron	decreases^methylation	30157460
NUP62	23636	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of NUP62 mRNA	increases^expression	28001369
NUP62	23636	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of NUP62 mRNA	decreases^expression	23649840
NUP62	23636	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NUP62 mRNA	affects^binding|decreases^expression|increases^activity	19710929
NUP62	23636	salinomycin	C010327	53003-10-4	salinomycin results in decreased expression of NUP62 mRNA	decreases^expression	19682730
NUP62	23636	sodium arsenite	C017947	13768-07-5	sodium arsenite affects the expression of NUP62 mRNA	affects^expression	20816728
NUP62	23636	Sunitinib	D000077210		Sunitinib results in increased expression of NUP62 mRNA	increases^expression	31533062
NUP62	23636	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of NUP62 protein	affects^expression	30291989
NUP62	23636	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of NUP62 mRNA	affects^expression	28542535
NUP62	23636	urushiol	C003747	53237-59-5	urushiol results in decreased expression of NUP62 mRNA	decreases^expression	31734321
NUP62	23636	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NUP62 mRNA	decreases^expression	22083351|28001369
NUP62	23636	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of NUP62 gene	increases^methylation	29154799
NUP62	23636	Vorinostat	D000077337		Vorinostat results in decreased expression of NUP62 mRNA	decreases^expression	22083351
NUP85	79902	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP85 mRNA	decreases^expression	19150397|20382639
NUP85	79902	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NUP85 mRNA	decreases^expression	21420995
NUP85	79902	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in increased methylation of NUP85 intron	increases^methylation	30157460
NUP85	79902	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of NUP85 mRNA	decreases^expression	29275510
NUP85	79902	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of NUP85 mRNA	decreases^expression	19549813
NUP85	79902	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of NUP85 mRNA	increases^expression	19167446
NUP85	79902	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP85 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP85	79902	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NUP85 mRNA	affects^cotreatment|decreases^expression	22079256
NUP85	79902	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of NUP85 mRNA	decreases^expression	24297863
NUP85	79902	K 7174	C410337		K 7174 results in decreased expression of NUP85 mRNA	decreases^expression	24086573
NUP85	79902	Methapyrilene	D008701	91-80-5	Methapyrilene results in increased methylation of NUP85 intron	increases^methylation	30157460
NUP85	79902	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of NUP85 mRNA	decreases^expression	21858171
NUP85	79902	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NUP85 mRNA	affects^cotreatment|decreases^expression	22079256
NUP85	79902	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of NUP85 mRNA	decreases^expression	22079256
NUP85	79902	propionaldehyde	C005556	123-38-6	propionaldehyde results in decreased expression of NUP85 mRNA	decreases^expression	26079696
NUP85	79902	Quercetin	D011794	117-39-5	Quercetin results in increased expression of NUP85 mRNA	increases^expression	21632981
NUP85	79902	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of NUP85 mRNA	increases^expression	28595984
NUP85	79902	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of NUP85 mRNA	decreases^expression	26179874
NUP85	79902	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NUP85 mRNA	affects^expression	25979313
NUP85	79902	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NUP85 mRNA	decreases^expression	23179753
NUP88	4927	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	C093973		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the localization of NUP88 protein	affects^localization	20041180
NUP88	4927	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	C093973		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP88 protein]	affects^localization|affects^reaction	20041180
NUP88	4927	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	C093973		[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] affects the reaction [diethyl maleate affects the localization of NUP88 protein]	affects^cotreatment|affects^localization|affects^reaction	20041180
NUP88	4927	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the localization of NUP88 protein	affects^localization	20041180
NUP88	4927	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP88 protein]	affects^localization|affects^reaction	20041180
NUP88	4927	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] affects the reaction [diethyl maleate affects the localization of NUP88 protein]	affects^cotreatment|affects^localization|affects^reaction	20041180
NUP88	4927	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP88 mRNA	affects^cotreatment|decreases^expression	27188386
NUP88	4927	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP88 mRNA	decreases^expression	20382639
NUP88	4927	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of NUP88 mRNA	decreases^expression	21420995
NUP88	4927	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of NUP88 mRNA	increases^expression	22378314
NUP88	4927	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of NUP88 intron	affects^methylation	30157460
NUP88	4927	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased mutagenesis of NUP88 gene	increases^mutagenesis	25435355
NUP88	4927	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of NUP88 mRNA	decreases^expression	29275510
NUP88	4927	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of NUP88 mRNA	decreases^expression	19376846
NUP88	4927	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NUP88 mRNA	increases^expression	20106945|27989131
NUP88	4927	diethyl maleate	C014476	141-05-9	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP88 protein]	affects^localization|affects^reaction	20041180
NUP88	4927	diethyl maleate	C014476	141-05-9	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [diethyl maleate affects the localization of NUP88 protein]	affects^localization|affects^reaction	20041180
NUP88	4927	diethyl maleate	C014476	141-05-9	[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] affects the reaction [diethyl maleate affects the localization of NUP88 protein]	affects^cotreatment|affects^localization|affects^reaction	20041180
NUP88	4927	diethyl maleate	C014476	141-05-9	diethyl maleate affects the localization of NUP88 protein	affects^localization	20041180
NUP88	4927	diethyl maleate	C014476	141-05-9	diethyl maleate results in increased phosphorylation of and results in increased glycosylation of NUP88 protein	increases^glycosylation|increases^phosphorylation	20041180
NUP88	4927	dimethylarsinous acid	C472511		dimethylarsinous acid results in decreased expression of NUP88 mRNA	decreases^expression	16507463
NUP88	4927	Dinitrochlorobenzene	D004137	97-00-7	Dinitrochlorobenzene results in increased expression of NUP88 mRNA	increases^expression	17374397
NUP88	4927	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP88 mRNA	affects^cotreatment|decreases^expression	27188386
NUP88	4927	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP88 mRNA	decreases^expression	29803840
NUP88	4927	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP88 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP88	4927	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of NUP88 mRNA	decreases^expression	23649840
NUP88	4927	Eugenol	D005054	97-53-0	Eugenol results in increased expression of NUP88 mRNA	increases^expression	17374397
NUP88	4927	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of NUP88 mRNA	decreases^expression	23649840
NUP88	4927	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of NUP88 mRNA	decreases^expression	30851411
NUP88	4927	Methotrexate	D008727	59-05-2	NUP88 protein affects the susceptibility to Methotrexate	affects^response to substance	16217747
NUP88	4927	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of NUP88 mRNA	decreases^expression	23649840
NUP88	4927	monomethylarsonous acid	C406082		monomethylarsonous acid results in decreased expression of NUP88 mRNA	decreases^expression	16507463
NUP88	4927	nickel sulfate	C029938	7786-81-4	nickel sulfate results in increased expression of NUP88 mRNA	increases^expression	16780908|17374397
NUP88	4927	Oxazolone	D010081	15646-46-5	Oxazolone results in increased expression of NUP88 mRNA	increases^expression	17374397
NUP88	4927	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NUP88 mRNA	affects^binding|increases^activity|increases^expression	19710929
NUP88	4927	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of NUP88 mRNA	decreases^expression	21858171
NUP88	4927	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of NUP88 mRNA	decreases^expression	16507463
NUP88	4927	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of NUP88 mRNA	decreases^expression	28542535
NUP88	4927	Urethane	D014520	51-79-6	Urethane results in decreased expression of NUP88 mRNA	decreases^expression	28818685
NUP88	4927	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUP88 mRNA	affects^cotreatment|decreases^expression	27188386
NUP88	4927	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NUP88 mRNA	affects^expression	25979313
NUP88	4927	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of NUP88 mRNA	decreases^expression	23179753|26272509|27188386
NUP88	4927	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of NUP88 mRNA	increases^expression	29154799
NUP93	9688	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP93 mRNA	decreases^expression	20382639
NUP93	9688	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of NUP93 mRNA	decreases^expression	24449571
NUP93	9688	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of NUP93 gene	affects^methylation	25304211
NUP93	9688	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of NUP93 5' UTR	affects^methylation	27901495
NUP93	9688	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of NUP93 promoter	affects^methylation	27901495
NUP93	9688	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of NUP93 mRNA	decreases^expression	20064835
NUP93	9688	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of NUP93 mRNA	increases^expression	32234424
NUP93	9688	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of NUP93 mRNA	decreases^expression	19320972
NUP93	9688	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of NUP93 mRNA	affects^binding|decreases^expression	20971185
NUP93	9688	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of NUP93 mRNA	increases^expression	25562108
NUP93	9688	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of NUP93 mRNA	increases^expression	28302478
NUP93	9688	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP93 mRNA	decreases^expression	29803840
NUP93	9688	ICG 001	C492448		ICG 001 results in decreased expression of NUP93 mRNA	decreases^expression	26191083
NUP93	9688	K 7174	C410337		K 7174 results in decreased expression of NUP93 mRNA	decreases^expression	24086573
NUP93	9688	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of NUP93 mRNA	affects^binding|decreases^expression	20971185
NUP93	9688	Plant Extracts	D010936		Plant Extracts results in increased expression of NUP93 mRNA	increases^expression	23557933
NUP93	9688	Selenium	D012643	7782-49-2	Selenium results in increased expression of NUP93 mRNA	increases^expression	19244175
NUP93	9688	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of NUP93 mRNA	increases^expression	28595984
NUP93	9688	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of NUP93 mRNA	increases^expression	30610935
NUP93	9688	Vitamin E	D014810	1406-18-4	Vitamin E results in increased expression of NUP93 mRNA	increases^expression	19244175
NUP93	9688	Zoledronic Acid	D000077211		Zoledronic Acid results in increased expression of NUP93 mRNA	increases^expression	24714768
NUP98	4928	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NUP98 mRNA	affects^cotreatment|increases^expression	28628672
NUP98	4928	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of NUP98 mRNA	decreases^expression	19095052
NUP98	4928	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUP98 mRNA	decreases^expression	19150397
NUP98	4928	abrine	C496492		abrine results in increased expression of NUP98 mRNA	increases^expression	31054353
NUP98	4928	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of NUP98 mRNA	increases^expression	22230336
NUP98	4928	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of NUP98 intron	decreases^methylation	30157460
NUP98	4928	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of NUP98 mRNA	decreases^expression	24449571
NUP98	4928	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of NUP98 5' UTR	decreases^methylation	27901495
NUP98	4928	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in increased methylation of NUP98 intron	increases^methylation	30157460
NUP98	4928	bisphenol A	C006780	80-05-7	bisphenol A results in decreased methylation of NUP98 gene	decreases^methylation	22576693
NUP98	4928	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of NUP98 mRNA	increases^expression	22576693
NUP98	4928	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NUP98 mRNA	affects^cotreatment|increases^expression	28628672
NUP98	4928	C646 compound	C584509		C646 compound results in decreased expression of NUP98 mRNA	decreases^expression	26191083
NUP98	4928	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of NUP98 mRNA	decreases^expression	21457566
NUP98	4928	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of NUP98 mRNA	decreases^expression	19376846
NUP98	4928	Curcumin	D003474	458-37-7	Curcumin results in increased expression of NUP98 mRNA	increases^expression	17198877
NUP98	4928	deguelin	C107676	522-17-8	deguelin results in decreased expression of NUP98 mRNA	decreases^expression	17490514
NUP98	4928	deguelin	C107676	522-17-8	deguelin results in decreased expression of NUP98 protein	decreases^expression	17490514
NUP98	4928	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NUP98 mRNA	affects^cotreatment|increases^expression	28628672
NUP98	4928	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of NUP98 mRNA	decreases^expression	29803840
NUP98	4928	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NUP98 protein	decreases^activity|increases^O-linked glycosylation	23301498
NUP98	4928	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NUP98 mRNA	affects^cotreatment|decreases^expression	22079256
NUP98	4928	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of NUP98 mRNA	decreases^expression	23649840
NUP98	4928	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NUP98 mRNA	affects^cotreatment|increases^expression	28628672
NUP98	4928	Lead	D007854	7439-92-1	Lead affects the expression of NUP98 mRNA	affects^expression	28903495
NUP98	4928	Methapyrilene	D008701	91-80-5	Methapyrilene results in increased methylation of NUP98 intron	increases^methylation	30157460
NUP98	4928	MLN7243	C000622638		MLN7243 results in increased sumoylation of NUP98 protein	increases^sumoylation	31285264
NUP98	4928	Nickel	D009532	7440-02-0	Nickel results in increased expression of NUP98 mRNA	increases^expression	24768652|25583101
NUP98	4928	nickel sulfate	C029938	7786-81-4	nickel sulfate results in increased expression of NUP98 mRNA	increases^expression	18651567
NUP98	4928	PCI 5002	C568608		[PCI 5002 co-treated with Zinc] results in increased expression of NUP98 mRNA	affects^cotreatment|increases^expression	18593933
NUP98	4928	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NUP98 mRNA	affects^cotreatment|decreases^expression	22079256
NUP98	4928	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of NUP98 mRNA	decreases^expression	22079256
NUP98	4928	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of NUP98 mRNA	increases^expression	18175754
NUP98	4928	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of NUP98 mRNA	increases^expression	28065790
NUP98	4928	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of NUP98 mRNA	decreases^expression	26179874
NUP98	4928	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of NUP98 mRNA	affects^expression	25979313
NUP98	4928	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of NUP98 mRNA	increases^expression	23179753|24383497
NUP98	4928	Valsartan	D000068756		Valsartan inhibits the reaction [AGT protein results in increased expression of NUP98 mRNA]	decreases^reaction|increases^expression	19225232
NUP98	4928	Zinc	D015032	7440-66-6	[PCI 5002 co-treated with Zinc] results in increased expression of NUP98 mRNA	affects^cotreatment|increases^expression	18593933
NUP98	4928	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of NUP98 mRNA	decreases^expression	24714768
PKM	5315	14-deoxy-11,12-didehydroandrographolide	C495626		14-deoxy-11,12-didehydroandrographolide results in decreased expression of PKM mRNA	decreases^expression	22101062
PKM	5315	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PKM mRNA	affects^cotreatment|decreases^expression	28628672
PKM	5315	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	28628672
PKM	5315	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in decreased expression of PKM protein	decreases^expression	24675778
PKM	5315	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	C093973		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [DDT results in increased expression of and affects the localization of PKM protein alternative form]	affects^localization|decreases^reaction|increases^expression	31724279
PKM	5315	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	C093973		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [DDT results in increased expression of PKM mRNA alternative form]	decreases^reaction|increases^expression	31724279
PKM	5315	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	C093973		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased phosphorylation of and affects the localization of PKM protein]	affects^localization|decreases^reaction|increases^phosphorylation	32078667
PKM	5315	2,3',4,4',5-pentachlorobiphenyl	C070055		2,3',4,4',5-pentachlorobiphenyl results in increased expression of and affects the localization of PKM protein	affects^localization|increases^expression	31251971
PKM	5315	2,3',4,4',5-pentachlorobiphenyl	C070055		2,3',4,4',5-pentachlorobiphenyl results in increased expression of PKM mRNA	increases^expression	31251971
PKM	5315	2,3',4,4',5-pentachlorobiphenyl	C070055		2,3',4,4',5-pentachlorobiphenyl results in increased expression of PKM protein	increases^expression	31251971
PKM	5315	2,3',4,4',5-pentachlorobiphenyl	C070055		Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PKM mRNA]	decreases^reaction|increases^expression	31251971
PKM	5315	2,3',4,4',5-pentachlorobiphenyl	C070055		AHR protein affects the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PKM mRNA]	affects^reaction|increases^expression	31251971
PKM	5315	2,3',4,4',5-pentachlorobiphenyl	C070055		AHR protein affects the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PKM protein]	affects^reaction|increases^expression	31251971
PKM	5315	2,3',4,4',5-pentachlorobiphenyl	C070055		PKM protein affects the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of LDHA mRNA]	affects^reaction|increases^expression	31251971
PKM	5315	2,3',4,4',5-pentachlorobiphenyl	C070055		PKM protein affects the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PDK1 mRNA]	affects^reaction|increases^expression	31251971
PKM	5315	2,3',4,4',5-pentachlorobiphenyl	C070055		PKM protein affects the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of SLC2A1 mRNA]	affects^reaction|increases^expression	31251971
PKM	5315	2,3,5-(triglutathion-S-yl)hydroquinone	C078765	119212-33-8	2,3,5-(triglutathion-S-yl)hydroquinone results in increased ADP-ribosylation of PKM protein	increases^ADP-ribosylation	31165168
PKM	5315	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	19167446
PKM	5315	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	C511621		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PKM mRNA]	decreases^expression|decreases^reaction	23152189
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM mRNA	increases^expression	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM protein	increases^expression	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM mRNA]	decreases^reaction|increases^expression	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM protein]	decreases^reaction|increases^expression	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	AHR mRNA promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM mRNA]	increases^expression|increases^reaction	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	AHR mRNA promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM protein]	increases^expression|increases^reaction	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	Fulvestrant inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM mRNA]	decreases^reaction|increases^expression	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	Fulvestrant inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM protein]	decreases^reaction|increases^expression	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	PKM protein promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CDH1 mRNA]	decreases^expression|increases^reaction	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	PKM protein promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CDH2 mRNA]	increases^expression|increases^reaction	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	PKM protein promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SNAI1 mRNA]	increases^expression|increases^reaction	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	PKM protein promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of STAT3 protein]	increases^expression|increases^reaction	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	PKM protein promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of STAT3 protein modified form]	increases^expression|increases^reaction	28284859
PKM	5315	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	PKM protein promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VIM mRNA]	increases^expression|increases^reaction	28284859
PKM	5315	3-hydroxyflavone	C041477	577-85-5	3-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	4-(4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1H,4H,5H,6H-pyrrolo(3,4-c)pyrazol-5-yl)benzoic acid	C583126		4-(4-(3-hydroxyphenyl)-3-(4-methylphenyl)-6-oxo-1H,4H,5H,6H-pyrrolo(3,4-c)pyrazol-5-yl)benzoic acid results in decreased expression of PKM protein	decreases^expression	27423937
PKM	5315	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	4-chlorobiphenyl	C006983	2051-62-9	4-chlorobiphenyl metabolite results in increased expression of PKM mRNA	increases^expression	25417049
PKM	5315	4-hydroxy-2-nonenal	C027576	29343-52-0	4-hydroxy-2-nonenal analog binds to PKM protein	affects^binding	27978618
PKM	5315	4-hydroxy-2-nonenal	C027576	29343-52-0	4-hydroxy-2-nonenal binds to and results in decreased activity of PKM protein	affects^binding|decreases^activity	27978618
PKM	5315	4-hydroxy-2-nonenal	C027576	29343-52-0	4-hydroxy-2-nonenal promotes the reaction [PKM protein binds to PKM protein]	affects^binding|increases^reaction	27978618
PKM	5315	4'-methoxy-1-naphthylfenoterol	C000603500		4'-methoxy-1-naphthylfenoterol results in decreased expression of PKM protein	decreases^expression	27423937
PKM	5315	4-oxo-2-nonenal	C403894		4-oxo-2-nonenal analog binds to PKM protein	affects^binding	27978618
PKM	5315	4-oxo-2-nonenal	C403894		4-oxo-2-nonenal binds to and results in decreased activity of PKM protein	affects^binding|decreases^activity	27978618
PKM	5315	4-oxo-2-nonenal	C403894		4-oxo-2-nonenal promotes the reaction [PKM protein binds to PKM protein]	affects^binding|increases^reaction	27978618
PKM	5315	5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide	C528044		5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide results in decreased expression of PKM protein	decreases^expression	31370342
PKM	5315	5-chloro-2-methyl-4-isothiazolin-3-one	C011421	26172-55-4	5-chloro-2-methyl-4-isothiazolin-3-one results in increased metabolism of PKM protein	increases^metabolic processing	29267982
PKM	5315	5-hydroxyflavone	C062711	491-78-1	5-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	6-hydroxyflavone	C529356		6-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PKM mRNA	decreases^expression	20018196
PKM	5315	7-hydroxyflavone	C429845		7-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	abrine	C496492		abrine results in increased expression of PKM protein	increases^expression	31054353
PKM	5315	Acetylcysteine	D000111	616-91-1	Acetylcysteine inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of PKM mRNA]	decreases^reaction|increases^expression	31251971
PKM	5315	Acetylcysteine	D000111	616-91-1	Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM mRNA]	decreases^reaction|increases^expression	28284859
PKM	5315	Acetylcysteine	D000111	616-91-1	Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM protein]	decreases^reaction|increases^expression	28284859
PKM	5315	Acetylcysteine	D000111	616-91-1	Acetylcysteine inhibits the reaction [DDT results in increased expression of and affects the localization of PKM protein alternative form]	affects^localization|decreases^reaction|increases^expression	31724279
PKM	5315	Acetylcysteine	D000111	616-91-1	Acetylcysteine inhibits the reaction [DDT results in increased expression of PKM mRNA alternative form]	decreases^reaction|increases^expression	31724279
PKM	5315	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of PKM mRNA	decreases^expression	22100608
PKM	5315	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of PKM mRNA	increases^expression	27153756
PKM	5315	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of PKM gene	increases^methylation	27153756
PKM	5315	Alitretinoin	D000077556	08/03/5300	Alitretinoin results in decreased expression of PKM protein	decreases^expression	28886987
PKM	5315	alpha-naphthoflavone	C011512	604-59-1	alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PKM mRNA]	decreases^expression|decreases^reaction	23152189
PKM	5315	Ampicillin	D000667	69-53-4	Ampicillin results in increased expression of PKM mRNA	increases^expression	21632981
PKM	5315	Apigenin	D047310	520-36-5	Apigenin inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	Arsenic	D001151	7440-38-2	Arsenic binds to PKM protein	affects^binding	17499915
PKM	5315	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of PKM protein	increases^expression	25419056
PKM	5315	Arsenic Trioxide	D000077237	1327-53-3	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	15894607
PKM	5315	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in increased expression of PKM protein	increases^expression	29553831
PKM	5315	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of PKM mRNA	increases^expression	22378314
PKM	5315	Azacitidine	D001374	320-67-2	Azacitidine results in increased expression of PKM mRNA	increases^expression	20823114
PKM	5315	baicalein	C006680	491-67-8	baicalein results in increased activity of PKM protein	increases^activity	25388478
PKM	5315	baicalin	C038044	21967-41-9	baicalin results in increased activity of PKM protein	increases^activity	25388478
PKM	5315	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of PKM mRNA	increases^expression	32234424
PKM	5315	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased mutagenesis of PKM gene	increases^mutagenesis	25435355
PKM	5315	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of PKM mRNA	affects^expression	30903817
PKM	5315	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of PKM mRNA	increases^expression	19371625
PKM	5315	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PKM mRNA	affects^cotreatment|decreases^expression	28628672
PKM	5315	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	28628672
PKM	5315	bromovanin	C515564		bromovanin results in decreased expression of PKM protein	decreases^expression	21419150
PKM	5315	Butyrates	D002087		Butyrates results in decreased expression of PKM mRNA	decreases^expression	22009386
PKM	5315	C646 compound	C584509		C646 compound results in decreased expression of PKM mRNA	decreases^expression	26191083
PKM	5315	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of and results in increased secretion of PKM protein	increases^expression|increases^secretion	24980261
PKM	5315	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of PKM protein	increases^expression	24527689
PKM	5315	cinnamic aldehyde	C012843	104-55-2	cinnamic aldehyde results in increased metabolism of PKM protein	increases^metabolic processing	29267982
PKM	5315	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of and results in increased secretion of PKM protein	increases^expression|increases^secretion	24980261
PKM	5315	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of PKM mRNA	decreases^expression	19376846
PKM	5315	Copper	D003300	7440-50-8	PKM protein binds to Copper	affects^binding	15359738
PKM	5315	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	19167446
PKM	5315	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of PKM mRNA	decreases^expression	21163907|21632981|25562108
PKM	5315	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of and results in increased secretion of PKM protein	increases^expression|increases^secretion	24980261
PKM	5315	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of PKM mRNA	increases^expression	27989131
PKM	5315	DDT	D003634	50-29-3	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [DDT results in increased expression of and affects the localization of PKM protein alternative form]	affects^localization|decreases^reaction|increases^expression	31724279
PKM	5315	DDT	D003634	50-29-3	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [DDT results in increased expression of PKM mRNA alternative form]	decreases^reaction|increases^expression	31724279
PKM	5315	DDT	D003634	50-29-3	Acetylcysteine inhibits the reaction [DDT results in increased expression of and affects the localization of PKM protein alternative form]	affects^localization|decreases^reaction|increases^expression	31724279
PKM	5315	DDT	D003634	50-29-3	Acetylcysteine inhibits the reaction [DDT results in increased expression of PKM mRNA alternative form]	decreases^reaction|increases^expression	31724279
PKM	5315	DDT	D003634	50-29-3	DDT results in increased expression of and affects the localization of PKM protein alternative form	affects^localization|increases^expression	31724279
PKM	5315	DDT	D003634	50-29-3	DDT results in increased expression of PKM mRNA alternative form	increases^expression	31724279
PKM	5315	DDT	D003634	50-29-3	PKM protein alternative form affects the reaction [DDT results in increased expression of LDHA mRNA]	affects^reaction|increases^expression	31724279
PKM	5315	DDT	D003634	50-29-3	PKM protein alternative form affects the reaction [DDT results in increased expression of PDK1 mRNA]	affects^reaction|increases^expression	31724279
PKM	5315	DDT	D003634	50-29-3	PKM protein alternative form affects the reaction [DDT results in increased expression of SLC2A1 mRNA]	affects^reaction|increases^expression	31724279
PKM	5315	Decitabine	D000077209	2353-33-5	Decitabine affects the methylation of PKM gene	affects^methylation	17630775
PKM	5315	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PKM mRNA	affects^cotreatment|decreases^expression	28628672
PKM	5315	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	28628672
PKM	5315	Dichloroacetic Acid	D003999	79-43-6	Dichloroacetic Acid results in decreased expression of PKM protein	decreases^expression	31654802
PKM	5315	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of PKM mRNA	increases^expression	28302478
PKM	5315	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in increased expression of PKM mRNA	increases^expression	31163220
PKM	5315	dihydroartemisinin	C039060		dihydroartemisinin analog binds to PKM protein	affects^binding	26340163
PKM	5315	Dinitrochlorobenzene	D004137	97-00-7	Dinitrochlorobenzene results in increased metabolism of PKM protein	increases^metabolic processing	29267982
PKM	5315	diosmetin	C039602	520-34-3	diosmetin results in increased activity of PKM protein	increases^activity	25388478
PKM	5315	Dopamine	D004298	51-61-6	Dopamine results in increased expression of PKM protein	increases^expression	24675778
PKM	5315	dorsomorphin	C516138		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	dorsomorphin	C516138		[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of PKM mRNA	decreases^expression	29803840
PKM	5315	Dronabinol	D013759		Dronabinol results in increased expression of PKM protein	increases^expression	18163980
PKM	5315	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PKM protein	decreases^activity|increases^O-linked glycosylation	23301498
PKM	5315	erucylphospho-N,N,N-trimethylpropylammonium	C472787		erucylphospho-N,N,N-trimethylpropylammonium results in decreased expression of PKM mRNA	decreases^expression	29464035
PKM	5315	Estradiol	D004958	50-28-2	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased phosphorylation of and affects the localization of PKM protein]	affects^localization|decreases^reaction|increases^phosphorylation	32078667
PKM	5315	Estradiol	D004958	50-28-2	Estradiol results in increased phosphorylation of and affects the localization of PKM protein	affects^localization|increases^phosphorylation	32078667
PKM	5315	Estradiol	D004958	50-28-2	Fulvestrant inhibits the reaction [Estradiol results in increased phosphorylation of and affects the localization of PKM protein]	affects^localization|decreases^reaction|increases^phosphorylation	32078667
PKM	5315	Estradiol	D004958	50-28-2	Fulvestrant inhibits the reaction [Glucose promotes the reaction [Estradiol results in increased phosphorylation of PKM protein]]	decreases^reaction|increases^phosphorylation|increases^reaction	32078667
PKM	5315	Estradiol	D004958	50-28-2	Glucose promotes the reaction [Estradiol results in increased phosphorylation of PKM protein]	increases^phosphorylation|increases^reaction	32078667
PKM	5315	Estradiol	D004958	50-28-2	TSC2 inhibits the reaction [Estradiol results in increased phosphorylation of PKM protein]	decreases^reaction|increases^phosphorylation	32078667
PKM	5315	flavone	C043562	525-82-6	flavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	Fulvestrant	D000077267	129453-61-8	Fulvestrant inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM mRNA]	decreases^reaction|increases^expression	28284859
PKM	5315	Fulvestrant	D000077267	129453-61-8	Fulvestrant inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PKM protein]	decreases^reaction|increases^expression	28284859
PKM	5315	Fulvestrant	D000077267	129453-61-8	Fulvestrant inhibits the reaction [Estradiol results in increased phosphorylation of and affects the localization of PKM protein]	affects^localization|decreases^reaction|increases^phosphorylation	32078667
PKM	5315	Fulvestrant	D000077267	129453-61-8	Fulvestrant inhibits the reaction [Glucose promotes the reaction [Estradiol results in increased phosphorylation of PKM protein]]	decreases^reaction|increases^phosphorylation|increases^reaction	32078667
PKM	5315	Fusaric Acid	D005669	536-69-6	Fusaric Acid results in increased expression of PKM mRNA	increases^expression	31654802
PKM	5315	Fusaric Acid	D005669	536-69-6	Fusaric Acid results in increased expression of PKM protein	increases^expression	31654802
PKM	5315	Fusaric Acid	D005669	536-69-6	Galactose affects the reaction [Fusaric Acid results in increased expression of PKM mRNA]	affects^reaction|increases^expression	31654802
PKM	5315	Fusaric Acid	D005669	536-69-6	Glucose affects the reaction [Fusaric Acid results in increased expression of PKM mRNA]	affects^reaction|increases^expression	31654802
PKM	5315	Fusaric Acid	D005669	536-69-6	Glucose affects the reaction [Fusaric Acid results in increased expression of PKM protein]	affects^reaction|increases^expression	31654802
PKM	5315	Galactose	D005690	26566-61-0	Galactose affects the reaction [Fusaric Acid results in increased expression of PKM mRNA]	affects^reaction|increases^expression	31654802
PKM	5315	Glucose	D005947	50-99-7	Fulvestrant inhibits the reaction [Glucose promotes the reaction [Estradiol results in increased phosphorylation of PKM protein]]	decreases^reaction|increases^phosphorylation|increases^reaction	32078667
PKM	5315	Glucose	D005947	50-99-7	Glucose affects the reaction [Fusaric Acid results in increased expression of PKM mRNA]	affects^reaction|increases^expression	31654802
PKM	5315	Glucose	D005947	50-99-7	Glucose affects the reaction [Fusaric Acid results in increased expression of PKM protein]	affects^reaction|increases^expression	31654802
PKM	5315	Glucose	D005947	50-99-7	Glucose deficiency promotes the reaction [SAICAR binds to and results in increased activity of PKM protein]	affects^binding|increases^activity|increases^reaction	23086999
PKM	5315	Glucose	D005947	50-99-7	Glucose promotes the reaction [Estradiol results in increased phosphorylation of PKM protein]	increases^phosphorylation|increases^reaction	32078667
PKM	5315	Glucose	D005947	50-99-7	PKM protein results in increased uptake of Glucose	increases^uptake	22574221
PKM	5315	ICG 001	C492448		ICG 001 results in decreased expression of PKM mRNA	decreases^expression	26191083
PKM	5315	indioside D	C428264		indioside D results in decreased expression of PKM protein	decreases^expression	18376857
PKM	5315	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PKM mRNA	affects^cotreatment|decreases^expression	28628672
PKM	5315	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	28628672
PKM	5315	K 7174	C410337		K 7174 results in decreased expression of PKM mRNA	decreases^expression	24086573
PKM	5315	Lactic Acid	D019344	50-21-5	PKM protein results in increased abundance of Lactic Acid	increases^abundance	22574221
PKM	5315	Luteolin	D047311	491-70-3	Luteolin results in increased activity of PKM protein	increases^activity	25388478
PKM	5315	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride results in increased expression of and results in increased secretion of PKM protein	increases^expression|increases^secretion	24980261
PKM	5315	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of PKM mRNA	increases^expression	28001369
PKM	5315	Metribolone	D015741	965-93-5	Metribolone promotes the reaction [NDRG1 protein binds to PKM protein]	affects^binding|increases^reaction	17220478
PKM	5315	MLN7243	C000622638		MLN7243 results in increased sumoylation of PKM protein	increases^sumoylation	31285264
PKM	5315	Niclosamide	D009534	50-65-7	Niclosamide results in increased expression of PKM mRNA	increases^expression	22576131
PKM	5315	o,p'-DDT	C016340	789-02-6	o,p'-DDT results in increased expression of PKM mRNA	increases^expression	19371625
PKM	5315	Oxygen	D010100	7782-44-7	[IL15 protein co-treated with Oxygen deficiency] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27129235
PKM	5315	Oxygen	D010100	7782-44-7	Oxygen deficiency results in increased expression of PKM protein	increases^expression	26087400
PKM	5315	Paclitaxel	D017239		PKM protein affects the susceptibility to Paclitaxel	affects^response to substance	16217747
PKM	5315	Panobinostat	D000077767		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	Panobinostat	D000077767		Panobinostat results in increased expression of PKM mRNA	increases^expression	26272509
PKM	5315	Particulate Matter	D052638		Particulate Matter results in increased expression of PKM protein	increases^expression	20658469
PKM	5315	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in increased expression of PKM mRNA	increases^expression	27153767
PKM	5315	Pesticides	D010575		Pesticides results in increased methylation of PKM gene	increases^methylation	28396702
PKM	5315	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of PKM mRNA	increases^expression	26272509
PKM	5315	Phosphoenolpyruvate	D010728	73-89-2	3-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	Phosphoenolpyruvate	D010728	73-89-2	5-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	Phosphoenolpyruvate	D010728	73-89-2	6-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	Phosphoenolpyruvate	D010728	73-89-2	7-hydroxyflavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	Phosphoenolpyruvate	D010728	73-89-2	Apigenin inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	Phosphoenolpyruvate	D010728	73-89-2	flavone inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	Phosphoenolpyruvate	D010728	73-89-2	PKM protein results in increased metabolism of Phosphoenolpyruvate	increases^metabolic processing	25388478
PKM	5315	Phosphoenolpyruvate	D010728	73-89-2	wogonin inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	Polychlorinated Biphenyls	D011078		Polychlorinated Biphenyls affects the expression of PKM mRNA	affects^expression	21334430
PKM	5315	Potassium Dichromate	D011192	7778-50-9	Potassium Dichromate results in increased expression of PKM protein	increases^expression	20332019
PKM	5315	PP242	C572919		PP242 results in decreased expression of PKM mRNA	decreases^expression	30679557
PKM	5315	Quartz	D011791	14808-60-7	Quartz affects the expression of PKM protein	affects^expression	27917503
PKM	5315	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of PKM protein	decreases^expression	15221776
PKM	5315	Quercetin	D011794	117-39-5	Quercetin results in increased expression of PKM mRNA	increases^expression	21632981
PKM	5315	Quercetin	D011794	117-39-5	Quercetin results in increased expression of PKM protein	increases^expression	14750173
PKM	5315	quinone	C004532	106-51-4	[HIF1A protein co-treated with quinone] results in increased expression of PKM protein	affects^cotreatment|increases^expression	30448556
PKM	5315	quinone	C004532	106-51-4	quinone results in increased expression of PKM protein	increases^expression	30448556
PKM	5315	Resveratrol	D000077185		PKM protein results in decreased susceptibility to Resveratrol	decreases^response to substance	22574221
PKM	5315	Resveratrol	D000077185		[Resveratrol results in decreased activity of MTOR protein] which results in decreased expression of PKM mRNA	decreases^activity|decreases^expression	22574221
PKM	5315	Resveratrol	D000077185		[Resveratrol results in decreased activity of MTOR protein] which results in decreased expression of PKM protein	decreases^activity|decreases^expression	22574221
PKM	5315	SAICAR	C020635	3031-95-6	Glucose deficiency promotes the reaction [SAICAR binds to and results in increased activity of PKM protein]	affects^binding|increases^activity|increases^reaction	23086999
PKM	5315	scutellarin	C484876		scutellarin results in increased activity of PKM protein	increases^activity	25388478
PKM	5315	Selenium	D012643	7782-49-2	Selenium results in increased expression of PKM mRNA	increases^expression	19244175
PKM	5315	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide affects the expression of PKM protein	affects^expression	27917503
PKM	5315	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in increased secretion of PKM protein	increases^secretion	25895662
PKM	5315	Sirolimus	D020123	53123-88-9	[Sirolimus results in decreased activity of MTOR protein] which results in decreased expression of PKM protein	decreases^activity|decreases^expression	22574221
PKM	5315	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of PKM mRNA	increases^expression	28595984
PKM	5315	STA 9090	C533237		STA 9090 results in increased expression of PKM protein	increases^expression	31370342
PKM	5315	sulindac sulfide	C025462	32004-67-4	sulindac sulfide results in decreased expression of PKM mRNA	decreases^expression	16184548
PKM	5315	Sunitinib	D000077210		Sunitinib results in increased expression of PKM mRNA	increases^expression	31533062
PKM	5315	tanespimycin	C112765		tanespimycin results in decreased expression of PKM protein	decreases^expression	31370342
PKM	5315	tangeretin	C059006	481-53-8	tangeretin results in increased activity of PKM protein	increases^activity	25388478
PKM	5315	testosterone-3-carboxymethyloxime-bovine serum albumin conjugate	C045037		testosterone-3-carboxymethyloxime-bovine serum albumin conjugate results in increased expression of PKM mRNA	increases^expression	20189893
PKM	5315	Tetrachlorodibenzodioxin	D013749	1746-01-6	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PKM mRNA]	decreases^expression|decreases^reaction	23152189
PKM	5315	Tetrachlorodibenzodioxin	D013749	1746-01-6	alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PKM mRNA]	decreases^expression|decreases^reaction	23152189
PKM	5315	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of PKM mRNA	decreases^expression	23152189
PKM	5315	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of PKM mRNA	decreases^expression	22378314
PKM	5315	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of PKM protein	affects^expression	30291989
PKM	5315	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of PKM mRNA	decreases^expression	28065790|30291989
PKM	5315	Tretinoin	D014212	302-79-4	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	15894607
PKM	5315	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of PKM protein	decreases^expression	28886987
PKM	5315	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of PKM mRNA	increases^expression	15894607|17218384
PKM	5315	tributyltin	C011559	688-73-3	tributyltin analog results in decreased expression of PKM protein	decreases^expression	31634547
PKM	5315	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of PKM mRNA	increases^expression	24935251|26272509
PKM	5315	Triclosan	D014260	3380-34-5	Triclosan results in decreased expression of PKM mRNA	decreases^expression	30510588
PKM	5315	triphenyltin	C030665		triphenyltin analog results in decreased expression of PKM protein	decreases^expression	31634547
PKM	5315	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of PKM mRNA	decreases^expression	26179874
PKM	5315	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of PKM mRNA	decreases^expression	22378314
PKM	5315	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of PKM mRNA	increases^expression	23179753|24383497|24935251|26272509|28001369
PKM	5315	Vitamin E	D014810	1406-18-4	Vitamin E results in increased expression of PKM mRNA	increases^expression	19244175
PKM	5315	Vorinostat	D000077337		[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKM mRNA	affects^cotreatment|increases^expression	27188386
PKM	5315	Vorinostat	D000077337		Vorinostat results in increased expression of PKM mRNA	increases^expression	26272509
PKM	5315	wogonin	C085514	632-85-9	wogonin inhibits the reaction [PKM protein results in increased metabolism of Phosphoenolpyruvate]	decreases^reaction|increases^metabolic processing	25388478
PKM	5315	yessotoxin	C066632		yessotoxin analog results in increased expression of PKM mRNA	increases^expression	30679557
PKM	5315	Zinc	D015032	7440-66-6	Zinc results in decreased expression of PKM protein	decreases^expression	15984569
PLPP1	8611	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PLPP1 mRNA	decreases^expression	20018196
PLPP1	8611	acyline	C109238		acyline results in decreased expression of PLPP1 mRNA	decreases^expression	17510436
PLPP1	8611	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of PLPP1 mRNA	increases^expression	22521957
PLPP1	8611	Azacitidine	D001374	320-67-2	Azacitidine results in increased expression of PLPP1 mRNA	increases^expression	19194470
PLPP1	8611	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLPP1 mRNA	affects^cotreatment|decreases^expression	22079256
PLPP1	8611	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of PLPP1 mRNA	affects^expression	20044591
PLPP1	8611	Irinotecan	D000077146		PLPP1 protein results in decreased susceptibility to Irinotecan	decreases^response to substance	16734730
PLPP1	8611	Iron	D007501	7439-89-6	Iron deficiency results in increased expression of PLPP1 mRNA	increases^expression	20368581
PLPP1	8611	Isoflavones	D007529		Isoflavones results in decreased expression of PLPP1 mRNA	decreases^expression	17374662
PLPP1	8611	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of PLPP1 mRNA	decreases^expression	28988120
PLPP1	8611	Methotrexate	D008727	59-05-2	PLPP1 protein affects the susceptibility to Methotrexate	affects^response to substance	16217747
PLPP1	8611	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of PLPP1 mRNA	increases^expression	23649840
PLPP1	8611	Paclitaxel	D017239		PLPP1 protein results in decreased susceptibility to Paclitaxel	decreases^response to substance	16734730
PLPP1	8611	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLPP1 mRNA	affects^cotreatment|decreases^expression	22079256
PLPP1	8611	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of PLPP1 mRNA	decreases^expression	22079256
PLPP1	8611	Rosiglitazone	D000077154		Rosiglitazone results in increased expression of PLPP1 mRNA	increases^expression	25572481
PLPP1	8611	sulforafan	C016766	4478-93-7	sulforafan results in decreased expression of PLPP1 mRNA	decreases^expression	31838189
PLPP1	8611	Sunitinib	D000077210		Sunitinib results in increased expression of PLPP1 mRNA	increases^expression	31533062
PLPP1	8611	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of PLPP1 mRNA	affects^expression	22298810
PLPP1	8611	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of PLPP1 mRNA	increases^expression	23724009
PLPP1	8611	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of PLPP1 mRNA	affects^expression	25979313
PLPP1	8611	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of PLPP1 mRNA	affects^expression	20044591
PLPP3	8613	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLPP3 mRNA	affects^cotreatment|increases^expression	28628672
PLPP3	8613	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PLPP3 mRNA	increases^expression	23146750
PLPP3	8613	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PLPP3 mRNA	decreases^expression	29947894
PLPP3	8613	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PLPP3 mRNA	decreases^expression	19150397|20018196
PLPP3	8613	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of PLPP3 mRNA	decreases^expression	21420995
PLPP3	8613	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of PLPP3 gene	decreases^methylation	27153756
PLPP3	8613	Am 580	C068073	102121-60-8	Am 580 results in increased expression of PLPP3 mRNA	increases^expression	16982809
PLPP3	8613	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of PLPP3 gene	affects^methylation	25304211
PLPP3	8613	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of PLPP3 mRNA	increases^expression	19128835
PLPP3	8613	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite affects the expression of PLPP3 mRNA	affects^expression	24160326
PLPP3	8613	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in increased expression of PLPP3 mRNA	increases^expression	18687144|25757056
PLPP3	8613	Asbestos, Serpentine	D017632		Asbestos, Serpentine affects the expression of PLPP3 mRNA	affects^expression	24160326
PLPP3	8613	Azathioprine	D001379	446-86-6	Azathioprine results in decreased expression of PLPP3 mRNA	decreases^expression	19192274
PLPP3	8613	Benzene	D001554	71-43-2	Benzene results in increased expression of PLPP3 mRNA	increases^expression	19162166
PLPP3	8613	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of PLPP3 mRNA	decreases^expression	20064835|20106945|21632981|22316170|26238291
PLPP3	8613	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of PLPP3 mRNA	decreases^expression	16474171
PLPP3	8613	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of PLPP3 mRNA	increases^expression	29275510
PLPP3	8613	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLPP3 mRNA	affects^cotreatment|increases^expression	28628672
PLPP3	8613	chloroquine diphosphate	C023676	50-63-5	chloroquine diphosphate results in decreased expression of PLPP3 mRNA	decreases^expression	19192274
PLPP3	8613	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of PLPP3 mRNA	affects^cotreatment|decreases^expression	27392435
PLPP3	8613	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of PLPP3 mRNA	decreases^expression	27392435
PLPP3	8613	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of PLPP3 mRNA	decreases^expression	19549813
PLPP3	8613	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of PLPP3 mRNA	decreases^expression	20106945|25562108|27989131
PLPP3	8613	Demecolcine	D003703	477-30-5	Demecolcine results in increased expression of PLPP3 mRNA	increases^expression	23649840
PLPP3	8613	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLPP3 mRNA	affects^cotreatment|increases^expression	28628672
PLPP3	8613	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of PLPP3 mRNA	decreases^expression	29803840
PLPP3	8613	entinostat	C118739		entinostat results in increased expression of PLPP3 mRNA	increases^expression	27188386
PLPP3	8613	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLPP3 mRNA	affects^cotreatment|decreases^expression	22079256
PLPP3	8613	Estradiol	D004958	50-28-2	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PLPP3 mRNA	affects^cotreatment|decreases^expression	19619570
PLPP3	8613	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PLPP3 mRNA	affects^cotreatment|decreases^expression	30165855
PLPP3	8613	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of PLPP3 mRNA	decreases^expression	16474171|19619570
PLPP3	8613	Estradiol	D004958	50-28-2	Estradiol results in increased expression of PLPP3 mRNA	increases^expression	23019147
PLPP3	8613	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of PLPP3 mRNA	increases^expression	23649840
PLPP3	8613	Genistein	D019833	446-72-0	Genistein results in decreased expression of PLPP3 mRNA	decreases^expression	16474171
PLPP3	8613	Genistein	D019833	446-72-0	Genistein results in increased expression of PLPP3 mRNA	increases^expression	23019147
PLPP3	8613	Gold Sodium Thiomalate	D006052	12244-57-4	Gold Sodium Thiomalate results in decreased expression of PLPP3 mRNA	decreases^expression	19192274
PLPP3	8613	Hydrochloric Acid	D006851	7647-01-0	Hydrochloric Acid results in decreased expression of PLPP3 mRNA	decreases^expression	15046208
PLPP3	8613	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of PLPP3 mRNA	affects^expression	20044591
PLPP3	8613	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLPP3 mRNA	affects^cotreatment|increases^expression	28628672
PLPP3	8613	Isoflavones	D007529		Isoflavones affects the expression of PLPP3 mRNA	affects^expression	16365062
PLPP3	8613	Isotretinoin	D015474	4759-48-2	Isotretinoin results in increased expression of PLPP3 mRNA	increases^expression	20436886
PLPP3	8613	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of PLPP3 mRNA	affects^cotreatment|decreases^expression	27392435
PLPP3	8613	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in increased expression of PLPP3 mRNA	increases^expression	26752646
PLPP3	8613	K 7174	C410337		K 7174 results in decreased expression of PLPP3 mRNA	decreases^expression	24086573
PLPP3	8613	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of PLPP3 mRNA	decreases^expression	19192274
PLPP3	8613	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of PLPP3 mRNA	increases^expression	17400583
PLPP3	8613	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of PLPP3 mRNA	decreases^expression	28001369
PLPP3	8613	Methylprednisolone	D008775	83-43-2	Methylprednisolone results in decreased expression of PLPP3 mRNA	decreases^expression	19192274
PLPP3	8613	nickel chloride	C022838	7718-54-9	nickel chloride results in increased expression of PLPP3 mRNA	increases^expression	17312168
PLPP3	8613	PCI 5002	C568608		[PCI 5002 co-treated with Zinc] results in increased expression of PLPP3 mRNA	affects^cotreatment|increases^expression	18593933
PLPP3	8613	periodate-oxidized adenosine	C027579	34240-05-6	periodate-oxidized adenosine affects the expression of PLPP3 mRNA	affects^expression	17097637
PLPP3	8613	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of PLPP3 mRNA	decreases^expression	19192274
PLPP3	8613	Polychlorinated Biphenyls	D011078		Polychlorinated Biphenyls analog results in decreased expression of PLPP3 mRNA	decreases^expression	16474171
PLPP3	8613	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLPP3 mRNA	affects^cotreatment|decreases^expression	22079256
PLPP3	8613	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of PLPP3 mRNA	decreases^expression	22079256
PLPP3	8613	Prednisolone	D011239	50-24-8	Prednisolone results in decreased expression of PLPP3 mRNA	decreases^expression	19192274
PLPP3	8613	Progesterone	D011374	57-83-0	Progesterone results in increased expression of PLPP3 mRNA	increases^expression	20864642
PLPP3	8613	Raloxifene Hydrochloride	D020849		ESR1 protein affects the reaction [Raloxifene Hydrochloride results in increased expression of PLPP3 mRNA]	affects^reaction|increases^expression	14699072
PLPP3	8613	Raloxifene Hydrochloride	D020849		Raloxifene Hydrochloride affects the expression of PLPP3 mRNA	affects^expression	14699072
PLPP3	8613	Rosiglitazone	D000077154		Rosiglitazone results in increased expression of PLPP3 mRNA	increases^expression	16982809
PLPP3	8613	Selenium	D012643	7782-49-2	Selenium results in decreased expression of PLPP3 mRNA	decreases^expression	19244175
PLPP3	8613	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide results in increased expression of PLPP3 mRNA	increases^expression	25351596
PLPP3	8613	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of PLPP3 mRNA	increases^expression	28595984
PLPP3	8613	Sodium Dodecyl Sulfate	D012967	151-21-3	Sodium Dodecyl Sulfate results in increased expression of PLPP3 mRNA	increases^expression	31734321
PLPP3	8613	testosterone enanthate	C004648		testosterone enanthate affects the expression of PLPP3 mRNA	affects^expression	17440010
PLPP3	8613	Tetrachlorodibenzodioxin	D013749	1746-01-6	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PLPP3 mRNA	affects^cotreatment|decreases^expression	19619570
PLPP3	8613	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of PLPP3 mRNA	decreases^expression	11007951|19619570|20106945
PLPP3	8613	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of PLPP3 mRNA	decreases^expression	30291989
PLPP3	8613	tobacco tar	C024746		tobacco tar results in decreased expression of PLPP3 mRNA	decreases^expression	19559774
PLPP3	8613	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of PLPP3 mRNA	decreases^expression	23724009
PLPP3	8613	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of PLPP3 mRNA	decreases^expression	22378314
PLPP3	8613	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of PLPP3 mRNA	affects^expression	25979313
PLPP3	8613	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of PLPP3 mRNA	decreases^expression	24935251|28001369
PLPP3	8613	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of PLPP3 mRNA	increases^expression	24935251
PLPP3	8613	Vincristine	D014750		Vincristine results in increased expression of PLPP3 mRNA	increases^expression	23649840
PLPP3	8613	Vitamin E	D014810	1406-18-4	Vitamin E results in increased expression of PLPP3 mRNA	increases^expression	19244175
PLPP3	8613	Zinc	D015032	7440-66-6	[PCI 5002 co-treated with Zinc] results in increased expression of PLPP3 mRNA	affects^cotreatment|increases^expression	18593933
PLPP3	8613	Zoledronic Acid	D000077211		Zoledronic Acid results in increased expression of PLPP3 mRNA	increases^expression	24714768
PLPP5	84513	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of PLPP5 mRNA	increases^expression	19095052
PLPP5	84513	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP5 mRNA	affects^cotreatment|decreases^expression	27188386
PLPP5	84513	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP5 mRNA	affects^cotreatment|decreases^expression	27188386
PLPP5	84513	(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	C517041		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of PLPP5 mRNA	increases^expression	19561079
PLPP5	84513	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PLPP5 mRNA	increases^expression	19150397
PLPP5	84513	arsenite	C015001	15502-74-6	arsenite results in increased methylation of PLPP5 promoter	increases^methylation	23974009
PLPP5	84513	belinostat	C487081		belinostat results in decreased expression of PLPP5 mRNA	decreases^expression	27188386
PLPP5	84513	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of PLPP5 mRNA	affects^expression	30903817
PLPP5	84513	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of PLPP5 mRNA	affects^expression	25979313
PLPP5	84513	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of PLPP5 mRNA	affects^cotreatment|increases^expression	27392435
PLPP5	84513	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in increased expression of PLPP5 mRNA	affects^binding|increases^expression	20971185
PLPP5	84513	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of PLPP5 mRNA	increases^expression	19549813
PLPP5	84513	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of PLPP5 mRNA	increases^expression	20106945|21632981|25562108|27989131
PLPP5	84513	decabromobiphenyl ether	C010902	1163-19-5	decabromobiphenyl ether affects the expression of PLPP5 mRNA	affects^expression	24834073
PLPP5	84513	deoxynivalenol	C007262	51481-10-8	deoxynivalenol results in decreased expression of PLPP5 mRNA	decreases^expression	31863870
PLPP5	84513	Dexamethasone	D003907	50-02-2	Dexamethasone results in decreased expression of PLPP5 mRNA	decreases^expression	25047013
PLPP5	84513	Dihydrotestosterone	D013196	521-18-6	Dihydrotestosterone results in increased expression of PLPP5 mRNA	increases^expression	29581250
PLPP5	84513	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP5 mRNA	affects^cotreatment|decreases^expression	27188386
PLPP5	84513	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP5 mRNA	affects^cotreatment|decreases^expression	27188386
PLPP5	84513	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of PLPP5 mRNA	decreases^expression	29803840
PLPP5	84513	entinostat	C118739		entinostat results in decreased expression of PLPP5 mRNA	decreases^expression	27188386
PLPP5	84513	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of PLPP5 mRNA	decreases^expression	23019147
PLPP5	84513	Estradiol	D004958	50-28-2	Estradiol results in increased expression of PLPP5 mRNA	increases^expression	20106945
PLPP5	84513	Genistein	D019833	446-72-0	Genistein results in increased expression of PLPP5 mRNA	increases^expression	26865667
PLPP5	84513	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of PLPP5 mRNA	affects^cotreatment|increases^expression	27392435
PLPP5	84513	jinfukang	C544151		jinfukang results in increased expression of PLPP5 mRNA	increases^expression	27392435
PLPP5	84513	NSC668394	C570897		NSC668394 results in increased expression of PLPP5 mRNA	increases^expression	27137931
PLPP5	84513	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in increased expression of PLPP5 mRNA	affects^binding|increases^expression	20971185
PLPP5	84513	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of PLPP5 mRNA	decreases^expression	28595984
PLPP5	84513	Sunitinib	D000077210		Sunitinib results in increased expression of PLPP5 mRNA	increases^expression	31533062
PLPP5	84513	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of PLPP5 mRNA	increases^expression	22378314|29453283
PLPP5	84513	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of PLPP5 mRNA	increases^expression	28065790
PLPP5	84513	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP5 mRNA	affects^cotreatment|decreases^expression	27188386
PLPP5	84513	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of PLPP5 mRNA	decreases^expression	24935251|26272509|27188386
PLPP5	84513	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of PLPP5 mRNA	increases^expression	22378314|29453283
PLPP5	84513	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP5 mRNA	affects^cotreatment|decreases^expression	27188386
PLPP5	84513	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of PLPP5 mRNA	affects^expression	25979313
PLPP5	84513	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of PLPP5 mRNA	decreases^expression	23179753|24383497|24935251|26272509|28001369
PLPP5	84513	Vorinostat	D000077337		Vorinostat results in decreased expression of PLPP5 mRNA	decreases^expression	27188386
PLPPR2	64748	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PLPPR2 mRNA	affects^cotreatment|increases^expression	28628672
PLPPR2	64748	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of PLPPR2 mRNA	increases^expression	22230336
PLPPR2	64748	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of PLPPR2 exon	decreases^methylation	30157460
PLPPR2	64748	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of PLPPR2 intron	increases^methylation	30157460
PLPPR2	64748	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of PLPPR2 intron	increases^methylation	30157460
PLPPR2	64748	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of PLPPR2 mRNA	increases^expression	22378314
PLPPR2	64748	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in increased methylation of PLPPR2 intron	increases^methylation	30157460
PLPPR2	64748	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of PLPPR2 mRNA	increases^expression	19371625
PLPPR2	64748	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PLPPR2 mRNA	affects^cotreatment|increases^expression	28628672
PLPPR2	64748	C646 compound	C584509		C646 compound results in decreased expression of PLPPR2 mRNA	decreases^expression	26191083
PLPPR2	64748	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PLPPR2 mRNA	affects^cotreatment|increases^expression	28628672
PLPPR2	64748	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of PLPPR2 gene	increases^methylation	22964155
PLPPR2	64748	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of PLPPR2 mRNA	decreases^expression	29803840
PLPPR2	64748	Genistein	D019833	446-72-0	Genistein results in increased expression of PLPPR2 mRNA	increases^expression	19371625
PLPPR2	64748	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PLPPR2 mRNA	affects^cotreatment|increases^expression	28628672
PLPPR2	64748	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in increased expression of PLPPR2 mRNA	increases^expression	24796395
PLPPR2	64748	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of PLPPR2 mRNA	decreases^expression	30851411
PLPPR2	64748	Methapyrilene	D008701	91-80-5	Methapyrilene results in increased methylation of PLPPR2 intron	increases^methylation	30157460
PLPPR2	64748	o,p'-DDT	C016340	789-02-6	o,p'-DDT results in increased expression of PLPPR2 mRNA	increases^expression	19371625
PLPPR2	64748	Resveratrol	D000077185		Resveratrol results in increased expression of PLPPR2 mRNA	increases^expression	19371625
PLPPR2	64748	Sunitinib	D000077210		Sunitinib results in decreased expression of PLPPR2 mRNA	decreases^expression	31533062
PLPPR2	64748	Urethane	D014520	51-79-6	Urethane results in increased expression of PLPPR2 mRNA	increases^expression	28818685
PLPPR2	64748	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of PLPPR2 mRNA	increases^expression	28001369
PLPPR2	64748	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of PLPPR2 gene	increases^methylation	29154799
PLPPR2	64748	Zearalenone	D015025	17924-92-4	Zearalenone results in increased expression of PLPPR2 mRNA	increases^expression	19371625
PLPPR4	9890	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPPR4 mRNA	affects^cotreatment|decreases^expression	27188386
PLPPR4	9890	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PLPPR4 mRNA	increases^expression	20382639
PLPPR4	9890	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of PLPPR4 3' UTR	affects^methylation	27901495
PLPPR4	9890	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of PLPPR4 promoter	affects^methylation	27901495
PLPPR4	9890	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of PLPPR4 exon	increases^methylation	27901495
PLPPR4	9890	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of PLPPR4 mRNA	increases^expression	29275510
PLPPR4	9890	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in decreased expression of PLPPR4 mRNA	decreases^expression	31163220
PLPPR4	9890	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPPR4 mRNA	affects^cotreatment|decreases^expression	27188386
PLPPR4	9890	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of PLPPR4 mRNA	decreases^expression	29803840
PLPPR4	9890	geldanamycin	C001277	30562-34-6	geldanamycin results in increased expression of PLPPR4 mRNA	increases^expression	26705709
PLPPR4	9890	incobotulinumtoxinA	C545476		incobotulinumtoxinA results in increased expression of PLPPR4 mRNA	increases^expression	29522793
PLPPR4	9890	Lead	D007854	7439-92-1	Lead affects the expression of PLPPR4 mRNA	affects^expression	28903495
PLPPR4	9890	Mercury	D008628	7439-97-6	Mercury results in increased expression of PLPPR4 mRNA	increases^expression	16823088
PLPPR4	9890	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of PLPPR4 mRNA	decreases^expression	17400583
PLPPR4	9890	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of PLPPR4 mRNA	decreases^expression	28001369
PLPPR4	9890	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPPR4 mRNA	affects^cotreatment|decreases^expression	27188386
PLPPR4	9890	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in decreased expression of PLPPR4 mRNA	decreases^expression	26272509
PLPPR4	9890	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of PLPPR4 mRNA	decreases^expression	25879800
PLPPR4	9890	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased methylation of PLPPR4 gene	decreases^methylation	24570342
PLPPR4	9890	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of PLPPR4 mRNA	increases^expression	22714537
PLPPR4	9890	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of PLPPR4 mRNA	decreases^expression	23724009
PLPPR4	9890	triadimefon	C032910	43121-43-3	triadimefon results in decreased expression of PLPPR4 mRNA	decreases^expression	26705709
PLPPR4	9890	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of PLPPR4 mRNA	decreases^expression	24935251
PLPPR4	9890	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of PLPPR4 mRNA	increases^expression	24935251|26705709
PLPPR4	9890	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of PLPPR4 gene	decreases^methylation	29154799
PLPPR4	9890	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of PLPPR4 mRNA	increases^expression	24935251|26705709
PNPLA2	57104	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PNPLA2 mRNA	affects^cotreatment|increases^expression	28628672
PNPLA2	57104	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PNPLA2 mRNA	increases^expression	19150397
PNPLA2	57104	abrine	C496492		abrine results in increased expression of PNPLA2 mRNA	increases^expression	31054353
PNPLA2	57104	afuresertib	C000593263		afuresertib results in increased expression of PNPLA2 mRNA	increases^expression	28960945
PNPLA2	57104	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of PNPLA2 mRNA	increases^expression	22378314
PNPLA2	57104	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of PNPLA2 mRNA	decreases^expression	20106945
PNPLA2	57104	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of PNPLA2 exon	decreases^methylation	27901495
PNPLA2	57104	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of PNPLA2 promoter	decreases^methylation	27901495
PNPLA2	57104	C646 compound	C584509		C646 compound results in decreased expression of PNPLA2 mRNA	decreases^expression	26191083
PNPLA2	57104	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of PNPLA2 mRNA	decreases^expression	22917661
PNPLA2	57104	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of PNPLA2 mRNA	increases^expression	25047013
PNPLA2	57104	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PNPLA2 mRNA	affects^cotreatment|increases^expression	28628672
PNPLA2	57104	Dietary Carbohydrates	D004040		[Dietary Fats co-treated with Dietary Carbohydrates] affects the expression of PNPLA2 protein	affects^cotreatment|affects^expression	22551950
PNPLA2	57104	Dietary Fats	D004041		[Dietary Fats co-treated with Dietary Carbohydrates] affects the expression of PNPLA2 protein	affects^cotreatment|affects^expression	22551950
PNPLA2	57104	Drugs, Chinese Herbal	D004365		Drugs, Chinese Herbal results in increased expression of PNPLA2 mRNA	increases^expression	23811387
PNPLA2	57104	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PNPLA2 mRNA	affects^cotreatment|increases^expression	22079256
PNPLA2	57104	Estradiol	D004958	50-28-2	Estradiol affects the expression of PNPLA2 mRNA	affects^expression	22574217
PNPLA2	57104	Glucose	D005947	50-99-7	Glucose deficiency results in decreased expression of PNPLA2 protein	decreases^expression	24802182
PNPLA2	57104	Hydrocortisone	D006854	50-23-7	Hydrocortisone results in decreased expression of PNPLA2 mRNA	decreases^expression	30776459
PNPLA2	57104	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PNPLA2 mRNA	affects^cotreatment|increases^expression	28628672
PNPLA2	57104	jinfukang	C544151		jinfukang results in decreased expression of PNPLA2 mRNA	decreases^expression	27392435
PNPLA2	57104	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in increased expression of PNPLA2 mRNA	increases^expression	24796395
PNPLA2	57104	MK 2206	C548887		MK 2206 inhibits the reaction [PNPLA2 protein results in increased phosphorylation of AKT1 protein]	decreases^reaction|increases^phosphorylation	31476254
PNPLA2	57104	Naphthoquinones	D009285		Naphthoquinones results in increased expression of PNPLA2 mRNA	increases^expression	23811387
PNPLA2	57104	nickel acetate	C119536		nickel acetate affects the expression of PNPLA2 mRNA	affects^expression	12915101
PNPLA2	57104	Plant Extracts	D010936		Plant Extracts results in decreased expression of PNPLA2 mRNA	decreases^expression	23557933
PNPLA2	57104	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PNPLA2 mRNA	affects^cotreatment|increases^expression	22079256
PNPLA2	57104	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in increased expression of PNPLA2 mRNA	increases^expression	22079256
PNPLA2	57104	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in decreased expression of PNPLA2 mRNA	decreases^expression	25895662
PNPLA2	57104	Urethane	D014520	51-79-6	Urethane results in increased expression of PNPLA2 mRNA	increases^expression	28818685
PNPLA2	57104	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of PNPLA2 gene	increases^methylation	29154799
POLA1	5422	14-deoxy-11,12-didehydroandrographolide	C495626		14-deoxy-11,12-didehydroandrographolide results in decreased expression of POLA1 mRNA	decreases^expression	22101062
POLA1	5422	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POLA1 mRNA	affects^cotreatment|increases^expression	28628672
POLA1	5422	1-nitropyrene	C032668	5522-43-0	1-nitropyrene results in increased expression of POLA1 mRNA	increases^expression	19041380
POLA1	5422	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA1 mRNA	affects^cotreatment|increases^expression	19167446
POLA1	5422	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of POLA1 mRNA	decreases^expression	20382639
POLA1	5422	abrine	C496492		abrine results in decreased expression of POLA1 mRNA	decreases^expression	31054353
POLA1	5422	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of POLA1 protein	affects^expression	20106945
POLA1	5422	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of POLA1 gene	decreases^methylation	27153756
POLA1	5422	Antirheumatic Agents	D018501		Antirheumatic Agents results in increased expression of POLA1 mRNA	increases^expression	24449571
POLA1	5422	Aphidicolin	D016590	38966-21-1	Aphidicolin results in decreased activity of POLA1 protein	decreases^activity	224865
POLA1	5422	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of POLA1 mRNA	increases^expression	22378314
POLA1	5422	Azathioprine	D001379	446-86-6	Azathioprine results in decreased expression of POLA1 mRNA	decreases^expression	22623647
POLA1	5422	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of POLA1 intron	affects^methylation	30157460
POLA1	5422	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of POLA1 promoter	affects^methylation	27901495
POLA1	5422	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of POLA1 mRNA	decreases^expression	20064835|20106945|21632981|26238291
POLA1	5422	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of POLA1 3' UTR	decreases^methylation	27901495
POLA1	5422	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of POLA1 mRNA	increases^expression	32234424
POLA1	5422	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of POLA1 exon	increases^methylation	27901495
POLA1	5422	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of POLA1 mRNA	affects^expression	21179406
POLA1	5422	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of POLA1 mRNA	decreases^expression	29275510
POLA1	5422	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POLA1 mRNA	affects^cotreatment|increases^expression	28628672
POLA1	5422	cadmium acetate	C028031	543-90-8	cadmium acetate results in decreased expression of POLA1 mRNA	decreases^expression	20839231
POLA1	5422	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of POLA1 mRNA	affects^expression	25979313
POLA1	5422	Chlorpromazine	D002746	50-53-3	Chlorpromazine analog results in decreased expression of POLA1 mRNA	decreases^expression	15924885
POLA1	5422	chromium hexavalent ion	C074702	18540-29-9	chromium hexavalent ion results in increased expression of POLA1 mRNA	increases^expression	30690063
POLA1	5422	Cisplatin	D002945	15663-27-1	Cisplatin promotes the reaction [jinfukang results in decreased expression of POLA1 mRNA]	decreases^expression|increases^reaction	27392435
POLA1	5422	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of POLA1 mRNA	decreases^expression	27392435
POLA1	5422	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of POLA1 mRNA	increases^expression	27594783
POLA1	5422	Cisplatin	D002945	15663-27-1	jinfukang promotes the reaction [Cisplatin results in decreased expression of POLA1 mRNA]	decreases^expression|increases^reaction	27392435
POLA1	5422	Cisplatin	D002945	15663-27-1	POLA1 protein results in increased susceptibility to Cisplatin	increases^response to substance	16734730
POLA1	5422	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of POLA1 mRNA	decreases^expression	19320972
POLA1	5422	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of POLA1 mRNA	affects^binding|decreases^expression	20971185
POLA1	5422	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA1 mRNA	affects^cotreatment|increases^expression	19167446
POLA1	5422	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of POLA1 mRNA	affects^cotreatment|increases^expression	19167446
POLA1	5422	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of POLA1 mRNA	increases^expression	19167446
POLA1	5422	CPG-oligonucleotide	C408982		CPG-oligonucleotide results in decreased expression of POLA1 mRNA	decreases^expression	21878529
POLA1	5422	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of POLA1 mRNA	decreases^expression	20106945|25562108
POLA1	5422	Dasatinib	D000069439		Dasatinib results in decreased expression of POLA1 mRNA	decreases^expression	20579391
POLA1	5422	Decitabine	D000077209	2353-33-5	Decitabine affects the methylation of POLA1 gene	affects^methylation	17630775
POLA1	5422	Demecolcine	D003703	477-30-5	Demecolcine results in decreased expression of POLA1 mRNA	decreases^expression	23649840
POLA1	5422	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POLA1 mRNA	affects^cotreatment|increases^expression	28628672
POLA1	5422	Diethylstilbestrol	D004054	56-53-1	Diethylstilbestrol results in increased expression of POLA1 mRNA	increases^expression	15766595
POLA1	5422	Drugs, Chinese Herbal	D004365		Drugs, Chinese Herbal results in decreased expression of POLA1 mRNA	decreases^expression	29667321
POLA1	5422	Estradiol	D004958	50-28-2	Estradiol results in increased expression of POLA1 mRNA	increases^expression	19167446
POLA1	5422	Fluorouracil	D005472	51-21-8	Fluorouracil results in decreased expression of POLA1 mRNA	decreases^expression	19219653
POLA1	5422	geraniol	C007836	624-15-7	geraniol results in decreased expression of POLA1 mRNA	decreases^expression	27683099
POLA1	5422	GSK-J4	C000593030		GSK-J4 results in decreased expression of POLA1 mRNA	decreases^expression	29301935
POLA1	5422	incobotulinumtoxinA	C545476		incobotulinumtoxinA results in decreased expression of POLA1 mRNA	decreases^expression	29522793
POLA1	5422	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POLA1 mRNA	affects^cotreatment|increases^expression	28628672
POLA1	5422	Irinotecan	D000077146		POLA1 protein results in increased susceptibility to Irinotecan	increases^response to substance	16734730
POLA1	5422	jinfukang	C544151		Cisplatin promotes the reaction [jinfukang results in decreased expression of POLA1 mRNA]	decreases^expression|increases^reaction	27392435
POLA1	5422	jinfukang	C544151		jinfukang promotes the reaction [Cisplatin results in decreased expression of POLA1 mRNA]	decreases^expression|increases^reaction	27392435
POLA1	5422	methylselenic acid	C008493		methylselenic acid results in decreased expression of POLA1 mRNA	decreases^expression	12517777
POLA1	5422	N-Nitrosopyrrolidine	D009242	930-55-2	N-Nitrosopyrrolidine results in decreased expression of POLA1 mRNA	decreases^expression	32234424
POLA1	5422	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of POLA1 mRNA	affects^binding|decreases^expression	20971185
POLA1	5422	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of POLA1 mRNA	decreases^expression	26516004
POLA1	5422	phenethyl isothiocyanate	C058305	02/09/2257	phenethyl isothiocyanate results in decreased expression of POLA1 mRNA	decreases^expression	26678675
POLA1	5422	Plant Extracts	D010936		Plant Extracts results in increased expression of POLA1 mRNA	increases^expression	23557933
POLA1	5422	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in increased expression of POLA1 mRNA	increases^expression	22714537
POLA1	5422	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of POLA1 mRNA	decreases^expression	15309432
POLA1	5422	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of POLA1 mRNA	affects^cotreatment|increases^expression	19167446
POLA1	5422	Resveratrol	D000077185		Resveratrol results in decreased expression of POLA1 mRNA	decreases^expression	15767336
POLA1	5422	Rotenone	D012402	83-79-4	Rotenone results in decreased expression of POLA1 mRNA	decreases^expression	29955902
POLA1	5422	Rotenone	D012402	83-79-4	Rotenone results in increased expression of POLA1 mRNA	increases^expression	18191903
POLA1	5422	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of POLA1 mRNA	decreases^expression	26179874
POLA1	5422	Urethane	D014520	51-79-6	Urethane results in decreased expression of POLA1 mRNA	decreases^expression	28818685
POLA1	5422	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of POLA1 mRNA	affects^expression	25979313
POLA1	5422	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of POLA1 gene	decreases^methylation	29154799
POLA1	5422	Vincristine	D014750		Vincristine results in decreased expression of POLA1 mRNA	decreases^expression	23649840
POLA2	23649	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA2 mRNA	affects^cotreatment|increases^expression	19167446
POLA2	23649	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of POLA2 mRNA	increases^expression	22230336
POLA2	23649	afuresertib	C000593263		afuresertib results in decreased expression of POLA2 mRNA	decreases^expression	28960945
POLA2	23649	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of POLA2 mRNA	decreases^expression	22378314
POLA2	23649	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of POLA2 mRNA	increases^expression	32234424
POLA2	23649	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of POLA2 mRNA	decreases^expression	29275510
POLA2	23649	Calcitriol	D002117	32222-06-3	Calcitriol results in decreased expression of POLA2 mRNA	decreases^expression	21592394
POLA2	23649	Calcitriol	D002117	32222-06-3	[Testosterone co-treated with Calcitriol] results in decreased expression of POLA2 mRNA	affects^cotreatment|decreases^expression	21592394
POLA2	23649	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of POLA2 mRNA	affects^cotreatment|increases^expression	27392435
POLA2	23649	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of POLA2 mRNA	increases^expression	27392435|27594783
POLA2	23649	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of POLA2 mRNA	decreases^expression	19320972
POLA2	23649	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of POLA2 mRNA	affects^binding|decreases^expression	20971185
POLA2	23649	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of POLA2 mRNA	decreases^expression	19549813
POLA2	23649	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA2 mRNA	affects^cotreatment|increases^expression	19167446
POLA2	23649	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of POLA2 mRNA	affects^cotreatment|increases^expression	19167446
POLA2	23649	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of POLA2 mRNA	increases^expression	19167446
POLA2	23649	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of POLA2 mRNA	decreases^expression	20106945|21632981|25562108
POLA2	23649	Dasatinib	D000069439		Dasatinib results in decreased expression of POLA2 mRNA	decreases^expression	20579391
POLA2	23649	Demecolcine	D003703	477-30-5	Demecolcine results in decreased expression of POLA2 mRNA	decreases^expression	23649840
POLA2	23649	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of POLA2 mRNA	decreases^expression	29803840
POLA2	23649	Dronabinol	D013759		Dronabinol results in decreased expression of POLA2 mRNA	decreases^expression	18454173
POLA2	23649	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of POLA2 protein	decreases^activity|increases^O-linked glycosylation	23301498
POLA2	23649	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of POLA2 mRNA	affects^cotreatment|decreases^expression	22079256
POLA2	23649	erucylphospho-N,N,N-trimethylpropylammonium	C472787		erucylphospho-N,N,N-trimethylpropylammonium results in decreased expression of POLA2 mRNA	decreases^expression	29464035
POLA2	23649	Fluorouracil	D005472	51-21-8	POLA2 protein affects the susceptibility to Fluorouracil	affects^response to substance	15548681
POLA2	23649	GSK-J4	C000593030		GSK-J4 results in decreased expression of POLA2 mRNA	decreases^expression	29301935
POLA2	23649	incobotulinumtoxinA	C545476		incobotulinumtoxinA results in decreased expression of POLA2 mRNA	decreases^expression	29522793
POLA2	23649	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of POLA2 mRNA	affects^cotreatment|increases^expression	27392435
POLA2	23649	jinfukang	C544151		jinfukang results in increased expression of POLA2 mRNA	increases^expression	27392435
POLA2	23649	Lactic Acid	D019344	50-21-5	Lactic Acid results in increased expression of POLA2 mRNA	increases^expression	30851411
POLA2	23649	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of POLA2 mRNA	decreases^expression	28988120
POLA2	23649	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of POLA2 mRNA	increases^expression	23649840
POLA2	23649	MLN7243	C000622638		MLN7243 results in increased sumoylation of POLA2 protein	increases^sumoylation	31285264
POLA2	23649	Nickel	D009532	7440-02-0	Nickel results in increased expression of POLA2 mRNA	increases^expression	24768652|25583101
POLA2	23649	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of POLA2 mRNA	affects^binding|decreases^expression	20971185
POLA2	23649	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of POLA2 mRNA	decreases^expression	26516004
POLA2	23649	palbociclib	C500026		palbociclib results in decreased expression of POLA2 mRNA	decreases^expression	22869556
POLA2	23649	perfluorononanoic acid	C584865		perfluorononanoic acid results in decreased expression of POLA2 mRNA	decreases^expression	32588087
POLA2	23649	phenethyl isothiocyanate	C058305	02/09/2257	phenethyl isothiocyanate results in decreased expression of POLA2 mRNA	decreases^expression	26678675
POLA2	23649	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of POLA2 mRNA	affects^expression	19159669
POLA2	23649	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of POLA2 mRNA	affects^binding|decreases^expression|increases^activity	19710929
POLA2	23649	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of POLA2 mRNA	affects^cotreatment|decreases^expression	22079256
POLA2	23649	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of POLA2 mRNA	decreases^expression	22079256
POLA2	23649	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of POLA2 mRNA	affects^cotreatment|increases^expression	19167446
POLA2	23649	Selenium	D012643	7782-49-2	Selenium results in increased expression of POLA2 mRNA	increases^expression	19244175
POLA2	23649	Sunitinib	D000077210		Sunitinib results in decreased expression of POLA2 mRNA	decreases^expression	31533062
POLA2	23649	Testosterone	D013739	58-22-0	[Testosterone co-treated with Calcitriol] results in decreased expression of POLA2 mRNA	affects^cotreatment|decreases^expression	21592394
POLA2	23649	Testosterone	D013739	58-22-0	Testosterone results in decreased expression of POLA2 mRNA	decreases^expression	21592394
POLA2	23649	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of POLA2 mRNA	decreases^expression	22378314
POLA2	23649	trans-10,cis-12-conjugated linoleic acid	C496197		trans-10,cis-12-conjugated linoleic acid results in decreased expression of POLA2 mRNA	decreases^expression	17951470
POLA2	23649	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of POLA2 mRNA	decreases^expression	26179874
POLA2	23649	Troglitazone	D000077288	97322-87-7	Troglitazone results in decreased expression of POLA2 mRNA	decreases^expression	19140230
POLA2	23649	Urethane	D014520	51-79-6	Urethane results in decreased expression of POLA2 mRNA	decreases^expression	28818685
POLB	5423	1,12-benzoperylene	C006718	191-24-2	1,12-benzoperylene results in increased expression of POLB mRNA	increases^expression	31518672
POLB	5423	2'-deoxyadenosine	C058118	958-09-8	[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLB protein	affects^binding|decreases^activity	26098310
POLB	5423	4-hydroxy-2-nonenal	C027576	29343-52-0	4-hydroxy-2-nonenal results in decreased expression of POLB mRNA	decreases^expression	12419474
POLB	5423	5-chlorouracil	C010889	1820-81-1	POLB protein affects the metabolism of 5-chlorouracil	affects^metabolic processing	20104909
POLB	5423	5-formyl-2'-deoxyuridine 5'-triphosphate	C105691		POLB protein binds to and results in increased metabolism of 5-formyl-2'-deoxyuridine 5'-triphosphate	affects^binding|increases^metabolic processing	28862449
POLB	5423	5-formyldeoxycytosine-5'-triphosphate	C000625642		POLB protein binds to and results in increased metabolism of 5-formyldeoxycytosine-5'-triphosphate	affects^binding|increases^metabolic processing	28862449
POLB	5423	6-thio-2'-deoxyguanosine-5'-triphosphate	C000625641		POLB protein binds to and results in increased metabolism of 6-thio-2'-deoxyguanosine-5'-triphosphate	affects^binding|increases^metabolic processing	28862449
POLB	5423	abrine	C496492		abrine results in increased expression of POLB mRNA	increases^expression	31054353
POLB	5423	Arsenic	D001151	7440-38-2	Arsenic results in decreased expression of POLB mRNA	decreases^expression	21332098
POLB	5423	Arsenic	D001151	7440-38-2	Arsenic results in decreased expression of POLB protein	decreases^expression	21332098
POLB	5423	Arsenic	D001151	7440-38-2	Curcumin inhibits the reaction [Arsenic results in decreased expression of POLB mRNA]	decreases^expression|decreases^reaction	21332098
POLB	5423	Arsenic	D001151	7440-38-2	Curcumin inhibits the reaction [Arsenic results in decreased expression of POLB protein]	decreases^expression|decreases^reaction	21332098
POLB	5423	arsenite	C015001	15502-74-6	arsenite affects the expression of POLB mRNA	affects^expression	18252256
POLB	5423	arsenite	C015001	15502-74-6	arsenite results in increased expression of POLB protein	increases^expression	15996700
POLB	5423	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of POLB mRNA	affects^expression	21179406
POLB	5423	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of POLB mRNA	decreases^expression	29275510
POLB	5423	C646 compound	C584509		C646 compound results in increased expression of POLB mRNA	increases^expression	26191083
POLB	5423	Chlorpyrifos	D004390	2921-88-2	Chlorpyrifos results in increased expression of POLB protein	increases^expression	28887667
POLB	5423	Chromium	D002857	7440-47-3	Chromium results in increased activity of POLB protein	increases^activity	9649318
POLB	5423	Curcumin	D003474	458-37-7	Curcumin inhibits the reaction [Arsenic results in decreased expression of POLB mRNA]	decreases^expression|decreases^reaction	21332098
POLB	5423	Curcumin	D003474	458-37-7	Curcumin inhibits the reaction [Arsenic results in decreased expression of POLB protein]	decreases^expression|decreases^reaction	21332098
POLB	5423	Curcumin	D003474	458-37-7	Curcumin results in decreased expression of POLB protein	decreases^expression	19401701
POLB	5423	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of POLB mRNA	decreases^expression	27989131
POLB	5423	cylindrospermopsin	C089595	143545-90-8	cylindrospermopsin results in decreased expression of POLB mRNA	decreases^expression	23726867
POLB	5423	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of POLB mRNA	decreases^expression	28302478
POLB	5423	diepoxybutane	C007366		[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLB protein	affects^binding|decreases^activity	26098310
POLB	5423	fluorodeoxyuridine triphosphate	C522804		POLB protein binds to and results in increased metabolism of fluorodeoxyuridine triphosphate	affects^binding|increases^metabolic processing	28862449
POLB	5423	honokiol	C005499	35354-74-6	honokiol results in decreased activity of POLB protein	decreases^activity	28067485
POLB	5423	Iron	D007501	7439-89-6	Iron binds to and inhibits the reaction [NEIL1 protein binds to POLB protein]	affects^binding|decreases^reaction	20622253
POLB	5423	methoxyamine	C005214	67-62-9	POLB protein inhibits the reaction [MPG protein promotes the reaction [methoxyamine results in increased susceptibility to Temozolomide]]	decreases^reaction|increases^reaction|increases^response to substance	21377995
POLB	5423	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of POLB mRNA	increases^expression	21527772|23649840
POLB	5423	N6-(2-hydroxy-3-buten-1-yl)-2'-deoxyadenosine	C000598755		N6-(2-hydroxy-3-buten-1-yl)-2'-deoxyadenosine results in decreased activity of POLB protein	decreases^activity	26098310
POLB	5423	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of POLB protein	decreases^expression	25030372
POLB	5423	Paraquat	D010269	4685-14-7	Paraquat results in increased expression of POLB protein	increases^expression	28428137
POLB	5423	Quercetin	D011794	117-39-5	Quercetin results in increased expression of POLB protein	increases^expression	19207037
POLB	5423	sodium arsenite	C017947	13768-07-5	[HAX1 protein affects the susceptibility to sodium arsenite] which affects the expression of POLB mRNA	affects^expression|affects^response to substance	23164465
POLB	5423	sodium arsenite	C017947	13768-07-5	[sodium arsenite results in increased activity of [MAPK3 protein co-treated with MAPK1 protein]] which results in decreased expression of POLB	affects^cotreatment|decreases^expression|increases^activity	22634503
POLB	5423	Taurine	D013654	107-35-7	Taurine results in increased expression of POLB mRNA	increases^expression	16579726
POLB	5423	Temozolomide	D000077204	85622-93-1	POLB protein inhibits the reaction [MPG protein promotes the reaction [methoxyamine results in increased susceptibility to Temozolomide]]	decreases^reaction|increases^reaction|increases^response to substance	21377995
POLB	5423	Temozolomide	D000077204	85622-93-1	POLB protein results in decreased susceptibility to Temozolomide	decreases^response to substance	16024643
POLB	5423	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of POLB mRNA	affects^expression	28542535
POLB	5423	Uranium Compounds	D017974		Uranium Compounds results in increased expression of POLB mRNA	increases^expression	19654044
POLB	5423	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of POLB mRNA	affects^expression	25979313
POLB	5423	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of POLB mRNA	decreases^expression	23179753|27188386
POLB	5423	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of POLB mRNA	increases^expression	29154799
POLD2	5425	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA	affects^cotreatment|increases^expression	19167446
POLD2	5425	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of POLD2 promoter	increases^methylation	27901495
POLD2	5425	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in increased methylation of POLD2 exon	increases^methylation	30157460
POLD2	5425	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of POLD2 mRNA	decreases^expression	29275510
POLD2	5425	chromium histidinate	C499843		chromium histidinate inhibits the reaction [Hydrogen Peroxide results in increased expression of POLD2 mRNA]	decreases^reaction|increases^expression	19902159
POLD2	5425	chromium histidinate	C499843		chromium histidinate results in increased expression of POLD2 mRNA	increases^expression	19902159
POLD2	5425	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of POLD2 mRNA	decreases^expression	19320972|19376846
POLD2	5425	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA	affects^cotreatment|increases^expression	19167446
POLD2	5425	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of POLD2 mRNA	affects^cotreatment|increases^expression	19167446
POLD2	5425	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of POLD2 mRNA	increases^expression	19167446
POLD2	5425	Estradiol	D004958	50-28-2	Estradiol results in increased expression of POLD2 mRNA	increases^expression	19167446
POLD2	5425	Guanine	D006147	73-40-5	Guanine metabolite results in decreased activity of [POLD1 protein binds to POLD2 protein binds to POLD3 protein binds to POLD4 protein]	affects^binding|decreases^activity	26010525
POLD2	5425	Guanine	D006147	73-40-5	Guanine metabolite results in decreased activity of [POLD1 protein binds to POLD2 protein binds to POLD4 protein]	affects^binding|decreases^activity	26010525
POLD2	5425	Hydrogen Peroxide	D006861	7722-84-1	chromium histidinate inhibits the reaction [Hydrogen Peroxide results in increased expression of POLD2 mRNA]	decreases^reaction|increases^expression	19902159
POLD2	5425	Hydrogen Peroxide	D006861	7722-84-1	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of POLD2 mRNA	affects^cotreatment|increases^expression	21751221
POLD2	5425	K 7174	C410337		K 7174 results in decreased expression of POLD2 mRNA	decreases^expression	24086573
POLD2	5425	Mercury	D008628	7439-97-6	Mercury affects the expression of POLD2 mRNA	affects^expression	16823088
POLD2	5425	Methapyrilene	D008701	91-80-5	Methapyrilene results in increased methylation of POLD2 exon	increases^methylation	30157460
POLD2	5425	Mifepristone	D015735	84371-65-3	Mifepristone results in decreased expression of POLD2 mRNA	decreases^expression	17584828
POLD2	5425	MLN7243	C000622638		MLN7243 results in increased sumoylation of POLD2 protein	increases^sumoylation	31285264
POLD2	5425	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of POLD2 mRNA	decreases^expression	26516004
POLD2	5425	Quercetin	D011794	117-39-5	Quercetin results in decreased expression of POLD2 mRNA	decreases^expression	15309432
POLD2	5425	Quinic Acid	D011801	77-95-2	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of POLD2 mRNA	affects^cotreatment|increases^expression	21751221
POLD2	5425	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of POLD2 mRNA	affects^cotreatment|increases^expression	19167446
POLD2	5425	Vitallium	D014800	12629-02-6	Vitallium analog results in decreased expression of POLD2 mRNA	decreases^expression	23825117
POLD3	10714	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	28628672
POLD3	10714	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	19167446
POLD3	10714	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLD3 mRNA	affects^cotreatment|decreases^expression	27188386
POLD3	10714	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	27188386
POLD3	10714	abrine	C496492		abrine results in decreased expression of POLD3 mRNA	decreases^expression	31054353
POLD3	10714	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of POLD3 mRNA	increases^expression	22230336
POLD3	10714	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of POLD3 protein	affects^expression	20106945
POLD3	10714	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of POLD3 mRNA	increases^expression	20458559
POLD3	10714	Azathioprine	D001379	446-86-6	Azathioprine results in decreased expression of POLD3 mRNA	decreases^expression	22623647
POLD3	10714	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of POLD3 mRNA	increases^expression	32234424
POLD3	10714	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of POLD3 mRNA	decreases^expression	29275510
POLD3	10714	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	28628672
POLD3	10714	Cadmium	D002104	7440-43-9	Cadmium results in decreased expression of POLD3 mRNA	decreases^expression	21120746
POLD3	10714	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of POLD3 mRNA	increases^expression	26472689
POLD3	10714	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of POLD3 mRNA	affects^expression	25979313
POLD3	10714	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of POLD3 mRNA	increases^expression	27594783
POLD3	10714	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of POLD3 mRNA	affects^binding|decreases^expression	20971185
POLD3	10714	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	19167446
POLD3	10714	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	19167446
POLD3	10714	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of POLD3 mRNA	increases^expression	19167446
POLD3	10714	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of POLD3 mRNA	decreases^expression	25562108
POLD3	10714	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of POLD3 mRNA	increases^expression	20106945
POLD3	10714	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	28628672
POLD3	10714	Diethylhexyl Phthalate	D004051	117-81-7	Diethylhexyl Phthalate results in increased expression of POLD3 protein	increases^expression	31163220
POLD3	10714	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLD3 mRNA	affects^cotreatment|decreases^expression	27188386
POLD3	10714	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	27188386
POLD3	10714	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of POLD3 mRNA	decreases^expression	29803840
POLD3	10714	Guanine	D006147	73-40-5	Guanine metabolite results in decreased activity of [POLD1 protein binds to POLD2 protein binds to POLD3 protein binds to POLD4 protein]	affects^binding|decreases^activity	26010525
POLD3	10714	incobotulinumtoxinA	C545476		incobotulinumtoxinA results in decreased expression of POLD3 mRNA	decreases^expression	29522793
POLD3	10714	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	28628672
POLD3	10714	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of POLD3 mRNA	decreases^expression	30851411
POLD3	10714	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of POLD3 mRNA	increases^expression	23649840
POLD3	10714	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of POLD3 mRNA	affects^binding|decreases^expression	20971185
POLD3	10714	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of POLD3 mRNA	decreases^expression	24236059
POLD3	10714	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLD3 mRNA	affects^cotreatment|decreases^expression	27188386
POLD3	10714	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in decreased expression of POLD3 mRNA	decreases^expression	26272509
POLD3	10714	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of POLD3 mRNA	decreases^expression	21858171
POLD3	10714	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	19167446
POLD3	10714	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of POLD3 mRNA	increases^expression	28595984
POLD3	10714	sulindac sulfide	C025462	32004-67-4	sulindac sulfide results in decreased expression of POLD3 mRNA	decreases^expression	16184548
POLD3	10714	Sunitinib	D000077210		Sunitinib results in decreased expression of POLD3 mRNA	decreases^expression	31533062
POLD3	10714	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of POLD3 mRNA	affects^expression	22574217
POLD3	10714	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of POLD3 mRNA	increases^expression	21496263
POLD3	10714	trans-10,cis-12-conjugated linoleic acid	C496197		trans-10,cis-12-conjugated linoleic acid results in decreased expression of POLD3 mRNA	decreases^expression	17951470
POLD3	10714	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of POLD3 mRNA	decreases^expression	16054129
POLD3	10714	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of POLD3 mRNA	affects^expression	28542535
POLD3	10714	Triiodothyronine	D014284	03/02/6893	Triiodothyronine analog inhibits the reaction [POLD3 protein binds to PCNA protein]	affects^binding|decreases^reaction	22383522
POLD3	10714	Troglitazone	D000077288	97322-87-7	Troglitazone results in decreased expression of POLD3 mRNA	decreases^expression	19140230
POLD3	10714	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLD3 mRNA	affects^cotreatment|increases^expression	27188386
POLD3	10714	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of POLD3 mRNA	increases^expression	23179753|26272509
POLD3	10714	Vincristine	D014750		Vincristine results in decreased expression of POLD3 mRNA	decreases^expression	23649840
POLD4	57804	abrine	C496492		abrine results in increased expression of POLD4 mRNA	increases^expression	31054353
POLD4	57804	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of POLD4 mRNA	increases^expression	21641981|27153756
POLD4	57804	afuresertib	C000593263		afuresertib results in increased expression of POLD4 mRNA	increases^expression	28960945
POLD4	57804	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of POLD4 mRNA	decreases^expression	24449571
POLD4	57804	Arsenic	D001151	7440-38-2	Arsenic results in increased methylation of POLD4 promoter	increases^methylation	21291286
POLD4	57804	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of POLD4 mRNA	increases^expression	22521957
POLD4	57804	Azathioprine	D001379	446-86-6	Azathioprine results in increased expression of POLD4 mRNA	increases^expression	22623647
POLD4	57804	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the expression of POLD4 mRNA	affects^expression	20106945|20624995
POLD4	57804	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of POLD4 mRNA	increases^expression	21632981|22316170
POLD4	57804	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of POLD4 mRNA	decreases^expression	16474171
POLD4	57804	Chlorpromazine	D002746	50-53-3	Chlorpromazine analog results in increased expression of POLD4 mRNA	increases^expression	15924885
POLD4	57804	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of POLD4 mRNA	decreases^expression	19376846
POLD4	57804	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of POLD4 mRNA	increases^expression	19549813
POLD4	57804	CPG-oligonucleotide	C408982		CPG-oligonucleotide results in decreased expression of POLD4 mRNA	decreases^expression	21878529
POLD4	57804	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of POLD4 mRNA	decreases^expression	20106945
POLD4	57804	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased methylation of POLD4 promoter	decreases^methylation	27989131
POLD4	57804	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of POLD4 mRNA	increases^expression	25562108
POLD4	57804	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of POLD4 gene	increases^methylation	22964155
POLD4	57804	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of POLD4 mRNA	decreases^expression	28302478
POLD4	57804	Dietary Carbohydrates	D004040		Dietary Carbohydrates results in decreased expression of POLD4 mRNA	decreases^expression	17490981
POLD4	57804	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of POLD4 mRNA	increases^expression	16404146
POLD4	57804	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of POLD4 mRNA	decreases^expression	16474171|23019147
POLD4	57804	Genistein	D019833	446-72-0	Genistein results in decreased expression of POLD4 mRNA	decreases^expression	16474171
POLD4	57804	Guanine	D006147	73-40-5	Guanine metabolite results in decreased activity of [POLD1 protein binds to POLD2 protein binds to POLD3 protein binds to POLD4 protein]	affects^binding|decreases^activity	26010525
POLD4	57804	Guanine	D006147	73-40-5	Guanine metabolite results in decreased activity of [POLD1 protein binds to POLD2 protein binds to POLD4 protein]	affects^binding|decreases^activity	26010525
POLD4	57804	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of POLD4 mRNA	affects^expression	23410634
POLD4	57804	K 7174	C410337		K 7174 results in increased expression of POLD4 mRNA	increases^expression	24086573
POLD4	57804	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of POLD4 mRNA	affects^expression	19159669
POLD4	57804	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of POLD4 mRNA	affects^binding|decreases^expression|increases^activity	19710929
POLD4	57804	Polychlorinated Biphenyls	D011078		Polychlorinated Biphenyls analog results in decreased expression of POLD4 mRNA	decreases^expression	16474171
POLD4	57804	Quercetin	D011794	117-39-5	Quercetin results in increased expression of POLD4 mRNA	increases^expression	21632981
POLD4	57804	tamibarotene	C061133	94497-51-5	tamibarotene results in increased expression of POLD4 mRNA	increases^expression	15498508
POLD4	57804	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide affects the expression of POLD4 mRNA	affects^expression	23410634
POLD4	57804	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of POLD4 mRNA	increases^expression	20106945|21632981
POLD4	57804	trans-10,cis-12-conjugated linoleic acid	C496197		trans-10,cis-12-conjugated linoleic acid results in increased expression of POLD4 mRNA	increases^expression	17951470
POLD4	57804	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of POLD4 mRNA	increases^expression	15498508|16054129
POLD4	57804	Vanadates	D014638		Vanadates results in increased expression of POLD4 mRNA	increases^expression	22714537
POLD4	57804	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of POLD4 mRNA	affects^expression	23410634
POLE	5426	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE mRNA	affects^cotreatment|increases^expression	19167446
POLE	5426	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of POLE mRNA	increases^expression	22230336
POLE	5426	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of POLE intron	decreases^methylation	30157460
POLE	5426	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of POLE 3' UTR	increases^methylation	30157460
POLE	5426	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of POLE intron	increases^methylation	30157460
POLE	5426	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of POLE mRNA	decreases^expression	22378314
POLE	5426	C646 compound	C584509		C646 compound results in decreased expression of POLE mRNA	decreases^expression	26191083
POLE	5426	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE mRNA	affects^cotreatment|increases^expression	19167446
POLE	5426	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of POLE mRNA	increases^expression	19167446
POLE	5426	Demecolcine	D003703	477-30-5	Demecolcine results in decreased expression of POLE mRNA	decreases^expression	23649840
POLE	5426	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of POLE gene	increases^methylation	22964155
POLE	5426	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of POLE mRNA	increases^expression	28302478
POLE	5426	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of POLE mRNA	decreases^expression	29803840
POLE	5426	Ethanol	D000431	64-17-5	Ethanol results in decreased expression of POLE protein	decreases^expression	20621659
POLE	5426	geraniol	C007836	624-15-7	geraniol results in decreased expression of POLE mRNA	decreases^expression	27683099
POLE	5426	jinfukang	C544151		jinfukang results in increased expression of POLE mRNA	increases^expression	27392435
POLE	5426	phenethyl isothiocyanate	C058305	02/09/2257	phenethyl isothiocyanate results in decreased expression of POLE mRNA	decreases^expression	26678675
POLE	5426	Polychlorinated Biphenyls	D011078		Polychlorinated Biphenyls affects the expression of POLE mRNA	affects^expression	21334430
POLE	5426	Quercetin	D011794	117-39-5	Quercetin results in increased expression of POLE mRNA	increases^expression	21632981
POLE	5426	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of POLE mRNA	decreases^expression	12377979
POLE	5426	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of POLE mRNA	increases^expression	28595984
POLE	5426	Sunitinib	D000077210		Sunitinib results in decreased expression of POLE mRNA	decreases^expression	31533062
POLE	5426	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of POLE mRNA	affects^expression	22574217
POLE	5426	Troglitazone	D000077288	97322-87-7	Troglitazone results in decreased expression of POLE mRNA	decreases^expression	19140230
POLE	5426	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of POLE gene	increases^methylation	29154799
POLE	5426	Xylitol	D014993	87-99-0	Xylitol results in increased expression of POLE mRNA	increases^expression	32275922
POLE3	54107	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE3 mRNA	affects^cotreatment|increases^expression	19167446
POLE3	54107	abrine	C496492		abrine results in decreased expression of POLE3 protein	decreases^expression	31054353
POLE3	54107	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of POLE3 mRNA	increases^expression	22100608
POLE3	54107	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of POLE3 gene	increases^methylation	27153756
POLE3	54107	arsenite	C015001	15502-74-6	arsenite affects the expression of POLE3 mRNA	affects^expression	22959463
POLE3	54107	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of POLE3 mRNA	decreases^expression	22378314
POLE3	54107	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of POLE3 mRNA	decreases^expression	21632981
POLE3	54107	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of POLE3 mRNA	decreases^expression	29275510
POLE3	54107	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of POLE3 protein	decreases^expression	24527689
POLE3	54107	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of POLE3 mRNA	increases^expression	26472689
POLE3	54107	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of POLE3 mRNA	affects^expression	24752500
POLE3	54107	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of POLE3 mRNA	decreases^expression	19549813
POLE3	54107	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE3 mRNA	affects^cotreatment|increases^expression	19167446
POLE3	54107	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of POLE3 mRNA	decreases^expression	21632981|25562108
POLE3	54107	Diclofenac	D004008	15307-86-5	Diclofenac affects the expression of POLE3 mRNA	affects^expression	24752500
POLE3	54107	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of POLE3 mRNA	decreases^expression	29803840
POLE3	54107	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of POLE3 mRNA	affects^cotreatment|increases^expression	22079256
POLE3	54107	erucylphospho-N,N,N-trimethylpropylammonium	C472787		erucylphospho-N,N,N-trimethylpropylammonium results in decreased expression of POLE3 mRNA	decreases^expression	29464035
POLE3	54107	K 7174	C410337		K 7174 results in decreased expression of POLE3 mRNA	decreases^expression	24086573
POLE3	54107	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of POLE3 mRNA	decreases^expression	28988120
POLE3	54107	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of POLE3 mRNA	decreases^expression	21858171
POLE3	54107	Plant Extracts	D010936		Plant Extracts results in decreased expression of POLE3 mRNA	decreases^expression	24677778
POLE3	54107	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of POLE3 mRNA	affects^cotreatment|increases^expression	22079256
POLE3	54107	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in increased expression of POLE3 mRNA	increases^expression	22079256
POLE3	54107	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of POLE3 mRNA	increases^expression	18175754
POLE3	54107	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of POLE3 mRNA	affects^expression	22574217
POLE3	54107	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of POLE3 mRNA	decreases^expression	21632981
POLE3	54107	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of POLE3 mRNA	decreases^expression	26179874
POLE3	54107	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of POLE3 mRNA	decreases^expression	23527032
POLE4	56655	4-phenylbutyric acid	C075773	1821-12-1	4-phenylbutyric acid results in decreased expression of POLE4 mRNA	decreases^expression	14583596
POLE4	56655	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of POLE4 mRNA	increases^expression	29067470
POLE4	56655	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of POLE4 gene	increases^methylation	27153756
POLE4	56655	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of POLE4 mRNA	increases^expression	20458559
POLE4	56655	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of POLE4 mRNA	affects^expression	24752500
POLE4	56655	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of POLE4 mRNA	decreases^expression	19320972
POLE4	56655	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of POLE4 mRNA	decreases^expression	19549813
POLE4	56655	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of POLE4 mRNA	increases^expression	25562108
POLE4	56655	Diclofenac	D004008	15307-86-5	Diclofenac affects the expression of POLE4 mRNA	affects^expression	24752500
POLE4	56655	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of POLE4 mRNA	decreases^expression	28302478
POLE4	56655	entinostat	C118739		entinostat results in decreased expression of POLE4 mRNA	decreases^expression	27188386
POLE4	56655	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of POLE4 protein	decreases^activity|increases^O-linked glycosylation	23301498
POLE4	56655	Hydralazine	D006830	86-54-4	[Hydralazine co-treated with Valproic Acid] results in increased expression of POLE4 mRNA	affects^cotreatment|increases^expression	17183730
POLE4	56655	Progesterone	D011374	57-83-0	Progesterone results in decreased expression of POLE4 mRNA	decreases^expression	18037150
POLE4	56655	Thimerosal	D013849	54-64-8	Thimerosal results in increased expression of POLE4 mRNA	increases^expression	27188386
POLE4	56655	Valproic Acid	D014635	99-66-1	[Hydralazine co-treated with Valproic Acid] results in increased expression of POLE4 mRNA	affects^cotreatment|increases^expression	17183730
POLE4	56655	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of POLE4 mRNA	affects^expression	25979313
POLE4	56655	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of POLE4 mRNA	decreases^expression	23179753|24935251|27188386|29154799
POLE4	56655	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of POLE4 gene	decreases^methylation	29154799
POLG	5428	1,12-benzoperylene	C006718	191-24-2	1,12-benzoperylene results in increased expression of POLG mRNA	increases^expression	31518672
POLG	5428	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of POLG mRNA	increases^expression	22230336|25704631|29067470
POLG	5428	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of POLG gene	affects^methylation	25304211
POLG	5428	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of POLG mRNA	increases^expression	22378314
POLG	5428	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of POLG promoter	decreases^methylation	27901495
POLG	5428	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased mutagenesis of POLG gene	increases^mutagenesis	25435355
POLG	5428	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of POLG mRNA	affects^expression	24752500
POLG	5428	Chloramphenicol	D002701	56-75-7	Chloramphenicol results in increased expression of POLG mRNA	increases^expression	22712077
POLG	5428	CPG-oligonucleotide	C408982		CPG-oligonucleotide results in decreased expression of POLG mRNA	decreases^expression	21878529
POLG	5428	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of POLG gene	increases^methylation	22964155
POLG	5428	Diclofenac	D004008	15307-86-5	Diclofenac affects the expression of POLG mRNA	affects^expression	24752500
POLG	5428	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of POLG mRNA	increases^expression	29803840
POLG	5428	Fluorouracil	D005472	51-21-8	POLG protein affects the susceptibility to Fluorouracil	affects^response to substance	15548681
POLG	5428	ICG 001	C492448		ICG 001 results in decreased expression of POLG mRNA	decreases^expression	26191083
POLG	5428	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in increased expression of POLG mRNA	increases^expression	23430699
POLG	5428	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of POLG mRNA	decreases^expression	28988120|29427785
POLG	5428	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of POLG mRNA	decreases^expression	12760830
POLG	5428	Sunitinib	D000077210		POLG affects the susceptibility to Sunitinib	affects^response to substance	26385865
POLG	5428	Sunitinib	D000077210		Sunitinib results in decreased expression of POLG mRNA	decreases^expression	26385865
POLG	5428	Sunitinib	D000077210		Sunitinib results in decreased expression of POLG protein	decreases^expression	26385865
POLG	5428	Sunitinib	D000077210		Sunitinib results in increased expression of POLG mRNA	increases^expression	31533062
POLG	5428	Tetrachlorodibenzodioxin	D013749	1746-01-6	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of POLG mRNA	affects^cotreatment|decreases^expression	14761676
POLG	5428	Triiodothyronine	D014284	03/02/6893	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of POLG mRNA	affects^cotreatment|decreases^expression	14761676
POLG	5428	Urethane	D014520	51-79-6	Urethane results in increased expression of POLG mRNA	increases^expression	28818685
POLG	5428	Valproic Acid	D014635	99-66-1	POLG gene SNP results in increased susceptibility to Valproic Acid	increases^response to substance	18716558
POLG	5428	Valproic Acid	D014635	99-66-1	POLG protein mutant form results in increased susceptibility to Valproic Acid	increases^response to substance	20138553
POLG2	11232	2-methyl-4-isothiazolin-3-one	C011506	2682-20-4	2-methyl-4-isothiazolin-3-one results in increased expression of POLG2 mRNA	increases^expression	31629900
POLG2	11232	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of POLG2 mRNA	increases^expression	20382639
POLG2	11232	Acetaminophen	D000082	103-90-2	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of POLG2 mRNA	affects^cotreatment|increases^expression	31059760
POLG2	11232	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of POLG2 mRNA	increases^expression	22230336|31059760
POLG2	11232	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of POLG2 intron	increases^methylation	30157460
POLG2	11232	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of POLG2 intron	increases^methylation	30157460
POLG2	11232	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased expression of POLG2 mRNA	decreases^expression	27829220
POLG2	11232	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of POLG2 mRNA	decreases^expression	22378314
POLG2	11232	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of POLG2 intron	affects^methylation	30157460
POLG2	11232	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of POLG2 promoter	increases^methylation	27901495
POLG2	11232	Carmustine	D002330	154-93-8	POLG2 mRNA affects the susceptibility to Carmustine	affects^response to substance	16365179
POLG2	11232	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of POLG2 mRNA	decreases^expression	19376846
POLG2	11232	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of POLG2 mRNA	decreases^expression	19549813
POLG2	11232	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of POLG2 mRNA	decreases^expression	28302478
POLG2	11232	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of POLG2 mRNA	increases^expression	29803840
POLG2	11232	Lipopolysaccharides	D008070		[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of POLG2 mRNA	affects^cotreatment|increases^expression	31059760
POLG2	11232	methylparaben	C015358	99-76-3	methylparaben results in increased expression of POLG2 mRNA	increases^expression	31745603
POLG2	11232	Plant Extracts	D010936		Plant Extracts results in increased expression of POLG2 mRNA	increases^expression	23557933
POLG2	11232	Temozolomide	D000077204	85622-93-1	POLG2 mRNA affects the susceptibility to Temozolomide	affects^response to substance	16365179
POLG2	11232	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of POLG2 mRNA	increases^expression	22378314
POLG2	11232	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of POLG2 mRNA	decreases^expression	23179753
POLG2	11232	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of POLG2 mRNA	increases^expression	29154799
POLH	5429	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POLH mRNA	affects^cotreatment|decreases^expression	28628672
POLH	5429	2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct	C502239		2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct affects the activity of POLH protein	affects^activity	19628463
POLH	5429	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	C049584	105650-23-5	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the activity of POLH protein	affects^activity	19628463
POLH	5429	3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene	C026832	64551-89-9	3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene results in increased expression of POLH mRNA	increases^expression	22236718
POLH	5429	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLH mRNA	affects^cotreatment|increases^expression	27188386
POLH	5429	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLH mRNA	affects^cotreatment|increases^expression	27188386
POLH	5429	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	POLH mutant form inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased mutagenesis of HPRT1 gene]	decreases^reaction|increases^mutagenesis	22745795
POLH	5429	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	POLH results in increased susceptibility to 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	increases^response to substance	22745795
POLH	5429	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of POLH mRNA	increases^expression	22230336
POLH	5429	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of POLH protein	affects^expression	20106945
POLH	5429	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of POLH mRNA	increases^expression	21632981|21641981|22100608|27153756
POLH	5429	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational results in decreased expression of POLH mRNA	decreases^expression	23195993
POLH	5429	benz(a)anthracene	C030935	56-55-3	benz(a)anthracene results in increased expression of POLH mRNA	increases^expression	22236718
POLH	5429	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of POLH mRNA	increases^expression	20106945|21632981|26238291|27694624|32234424
POLH	5429	benzo(a)pyrene diolepoxide I	C072019	60268-85-1	benzo(a)pyrene diolepoxide I promotes the reaction [TP53 protein binds to POLH promoter]	affects^binding|increases^reaction	27694624
POLH	5429	benzo(a)pyrene diolepoxide I	C072019	60268-85-1	benzo(a)pyrene diolepoxide I results in decreased expression of POLH mRNA	decreases^expression	27694624
POLH	5429	benzo(a)pyrene diolepoxide I	C072019	60268-85-1	benzo(a)pyrene diolepoxide I results in decreased expression of POLH protein	decreases^expression	27694624
POLH	5429	benzo(a)pyrene diolepoxide I	C072019	60268-85-1	benzo(a)pyrene diolepoxide I results in increased expression of POLH mRNA	increases^expression	27694624
POLH	5429	benzo(a)pyrene diolepoxide I	C072019	60268-85-1	benzo(a)pyrene diolepoxide I results in increased expression of POLH protein	increases^expression	27694624
POLH	5429	benzo(a)pyrene diolepoxide I	C072019	60268-85-1	pifithrin inhibits the reaction [benzo(a)pyrene diolepoxide I results in increased expression of POLH mRNA]	decreases^reaction|increases^expression	27694624
POLH	5429	benzo(a)pyrene diolepoxide I	C072019	60268-85-1	POLH protein results in decreased susceptibility to benzo(a)pyrene diolepoxide I	decreases^response to substance	27694624
POLH	5429	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POLH mRNA	affects^cotreatment|decreases^expression	28628672
POLH	5429	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of POLH mRNA	affects^expression	24752500
POLH	5429	Carmustine	D002330	154-93-8	[Carmustine co-treated with MDM4 protein] results in increased expression of POLH protein	affects^cotreatment|increases^expression	20472715
POLH	5429	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of POLH mRNA	affects^cotreatment|increases^expression	27392435
POLH	5429	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of POLH mRNA	increases^expression	27392435
POLH	5429	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of POLH mRNA	increases^expression	19549813
POLH	5429	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of POLH mRNA	decreases^expression	21632981|25562108
POLH	5429	Dactinomycin	D003609	50-76-0	Dactinomycin inhibits the reaction [fotemustine results in increased expression of POLH mRNA]	decreases^reaction|increases^expression	25125662
POLH	5429	Demecolcine	D003703	477-30-5	Demecolcine results in increased expression of POLH mRNA	increases^expression	23649840
POLH	5429	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POLH mRNA	affects^cotreatment|decreases^expression	28628672
POLH	5429	Diclofenac	D004008	15307-86-5	Diclofenac affects the expression of POLH mRNA	affects^expression	24752500
POLH	5429	dorsomorphin	C516138		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLH mRNA	affects^cotreatment|increases^expression	27188386
POLH	5429	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLH mRNA	affects^cotreatment|increases^expression	27188386
POLH	5429	Dronabinol	D013759		Dronabinol results in increased expression of POLH mRNA	increases^expression	16597638
POLH	5429	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of POLH mRNA	increases^expression	23649840
POLH	5429	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of POLH mRNA	increases^expression	23649840
POLH	5429	fotemustine	C054368		Dactinomycin inhibits the reaction [fotemustine results in increased expression of POLH mRNA]	decreases^reaction|increases^expression	25125662
POLH	5429	fotemustine	C054368		fotemustine promotes the reaction [TP53 protein binds to POLH promoter]	affects^binding|increases^reaction	25125662
POLH	5429	fotemustine	C054368		fotemustine results in increased expression of POLH mRNA	increases^expression	25125662
POLH	5429	fotemustine	C054368		fotemustine results in increased expression of POLH protein	increases^expression	25125662
POLH	5429	fotemustine	C054368		pifithrin inhibits the reaction [fotemustine results in increased expression of POLH mRNA]	decreases^reaction|increases^expression	25125662
POLH	5429	fotemustine	C054368		pifithrin inhibits the reaction [fotemustine results in increased expression of POLH protein]	decreases^reaction|increases^expression	25125662
POLH	5429	fotemustine	C054368		POLH protein results in decreased susceptibility to fotemustine	decreases^response to substance	25125662
POLH	5429	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in decreased expression of POLH mRNA	decreases^expression	18951874
POLH	5429	hydroquinone	C031927	123-31-9	POLH mutant form results in increased susceptibility to hydroquinone	increases^response to substance	22981619
POLH	5429	hydroquinone	C031927	123-31-9	[POLH mutant form results in increased susceptibility to hydroquinone] which results in increased expression of H2AX protein	increases^expression|increases^response to substance	22981619
POLH	5429	Hydroxyurea	D006918	127-07-1	Hydroxyurea results in increased expression of POLH mRNA	increases^expression	25125662
POLH	5429	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POLH mRNA	affects^cotreatment|decreases^expression	28628672
POLH	5429	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of POLH mRNA	affects^cotreatment|increases^expression	27392435
POLH	5429	Leflunomide	D000077339	75706-12-6	Leflunomide results in decreased expression of POLH mRNA	decreases^expression	28988120
POLH	5429	Lomustine	D008130	13010-47-4	Lomustine results in increased expression of POLH mRNA	increases^expression	25125662
POLH	5429	Lomustine	D008130	13010-47-4	Lomustine results in increased expression of POLH protein	increases^expression	25125662
POLH	5429	Lomustine	D008130	13010-47-4	pifithrin inhibits the reaction [Lomustine results in increased expression of POLH protein]	decreases^reaction|increases^expression	25125662
POLH	5429	Lomustine	D008130	13010-47-4	POLH protein results in decreased susceptibility to Lomustine	decreases^response to substance	25125662
POLH	5429	mafosfamide	C048341	88859-04-5	mafosfamide results in increased expression of POLH mRNA	increases^expression	25125662
POLH	5429	mafosfamide	C048341	88859-04-5	POLH protein results in decreased susceptibility to mafosfamide	decreases^response to substance	25125662
POLH	5429	mercuric bromide	C042720	7789-47-1	mercuric bromide results in increased expression of POLH mRNA	increases^expression	26272509
POLH	5429	mercuric bromide	C042720	7789-47-1	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLH mRNA	affects^cotreatment|increases^expression	27188386
POLH	5429	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of POLH mRNA	increases^expression	23649840
POLH	5429	N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	C078255	142784-25-6	N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the activity of POLH protein	affects^activity	19628463
POLH	5429	Nickel	D009532	7440-02-0	Nickel results in decreased expression of POLH mRNA	decreases^expression	23195993
POLH	5429	Paraquat	D010269	4685-14-7	Paraquat results in increased expression of POLH mRNA	increases^expression	23613995
POLH	5429	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POLH mRNA	affects^cotreatment|increases^expression	27188386
POLH	5429	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of POLH mRNA	increases^expression	26272509
POLH	5429	pifithrin	C121565		pifithrin inhibits the reaction [benzo(a)pyrene diolepoxide I results in increased expression of POLH mRNA]	decreases^reaction|increases^expression	27694624
POLH	5429	pifithrin	C121565		pifithrin inhibits the reaction [fotemustine results in increased expression of POLH mRNA]	decreases^reaction|increases^expression	25125662
POLH	5429	pifithrin	C121565		pifithrin inhibits the reaction [fotemustine results in increased expression of POLH protein]	decreases^reaction|increases^expression	25125662
POLH	5429	pifithrin	C121565		pifithrin inhibits the reaction [Lomustine results in increased expression of POLH protein]	decreases^reaction|increases^expression	25125662
POLH	5429	polyhexamethyleneguanidine	C060540	31961-54-3	polyhexamethyleneguanidine affects the expression of POLH mRNA	affects^expression	29337256
POLH	5429	Quercetin	D011794	117-39-5	Quercetin results in increased expression of POLH mRNA	increases^expression	21632981
POLH	5429	quercitrin	C012526	522-12-3	quercitrin results in increased expression of POLH mRNA	increases^expression	25193878
POLH	5429	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of POLH mRNA	decreases^expression	29301061
POLH	5429	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of POLH mRNA	increases^expression	27694624
POLH	5429	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of POLH mRNA	decreases^expression	26179874
POLH	5429	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of POLH mRNA	decreases^expression	28001369
POLI	11201	2'-deoxyadenosine	C058118	958-09-8	[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein	affects^binding|decreases^activity	26098310
POLI	11201	2'-deoxyadenosine	C058118	958-09-8	POLN protein inhibits the reaction [[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein]	affects^binding|decreases^activity|decreases^reaction	26098310
POLI	11201	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	affects^cotreatment|decreases^expression	27188386
POLI	11201	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	affects^cotreatment|decreases^expression	27188386
POLI	11201	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of POLI mRNA	increases^expression	26238291
POLI	11201	Aflatoxin M1	D016607	6795-23-9	Aflatoxin M1 results in decreased expression of POLI mRNA	decreases^expression	30928695
POLI	11201	Antirheumatic Agents	D018501		Antirheumatic Agents results in increased expression of POLI mRNA	increases^expression	24449571
POLI	11201	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of POLI mRNA	decreases^expression	19549813
POLI	11201	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in decreased expression of POLI mRNA	affects^cotreatment|decreases^expression	19167446
POLI	11201	cupric oxide	C030973	1317-38-0	cupric oxide results in decreased expression of POLI mRNA	decreases^expression	22077320
POLI	11201	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of POLI mRNA	decreases^expression	28302478
POLI	11201	diepoxybutane	C007366		[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein	affects^binding|decreases^activity	26098310
POLI	11201	diepoxybutane	C007366		POLN protein inhibits the reaction [[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein]	affects^binding|decreases^activity|decreases^reaction	26098310
POLI	11201	dorsomorphin	C516138		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	affects^cotreatment|decreases^expression	27188386
POLI	11201	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	affects^cotreatment|decreases^expression	27188386
POLI	11201	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of POLI mRNA	decreases^expression	29803840
POLI	11201	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of POLI mRNA	affects^cotreatment|decreases^expression	22079256
POLI	11201	Genistein	D019833	446-72-0	Genistein results in decreased expression of POLI mRNA	decreases^expression	22228119
POLI	11201	Guanine	D006147	73-40-5	Guanine metabolite results in decreased activity of POLI protein	decreases^activity	26010525
POLI	11201	jinfukang	C544151		jinfukang results in decreased expression of POLI mRNA	decreases^expression	27392435
POLI	11201	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of POLI mRNA	decreases^expression	28001369
POLI	11201	methylparaben	C015358	99-76-3	methylparaben results in increased expression of POLI mRNA	increases^expression	31745603
POLI	11201	MK-886	C060893	118414-82-7	MK-886 results in decreased activity of POLI protein	decreases^activity	23305233
POLI	11201	N6-(2-hydroxy-3-buten-1-yl)-2'-deoxyadenosine	C000598755		N6-(2-hydroxy-3-buten-1-yl)-2'-deoxyadenosine results in decreased activity of POLI protein	decreases^activity	26098310
POLI	11201	Panobinostat	D000077767		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	affects^cotreatment|decreases^expression	27188386
POLI	11201	Panobinostat	D000077767		Panobinostat results in decreased expression of POLI mRNA	decreases^expression	26272509
POLI	11201	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in decreased expression of POLI mRNA	decreases^expression	27153767
POLI	11201	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	affects^cotreatment|decreases^expression	27188386
POLI	11201	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in decreased expression of POLI mRNA	decreases^expression	26272509
POLI	11201	Plant Extracts	D010936		Plant Extracts results in increased expression of POLI mRNA	increases^expression	23557933
POLI	11201	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of POLI mRNA	affects^cotreatment|decreases^expression	22079256
POLI	11201	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of POLI mRNA	decreases^expression	22079256
POLI	11201	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in decreased expression of POLI mRNA	affects^cotreatment|decreases^expression	19167446
POLI	11201	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of POLI mRNA	decreases^expression	28065790
POLI	11201	Urethane	D014520	51-79-6	Urethane results in decreased expression of POLI mRNA	decreases^expression	28818685
POLI	11201	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of POLI mRNA	affects^expression	25979313
POLI	11201	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of POLI mRNA	decreases^expression	23179753
POLI	11201	Vitamin E	D014810	1406-18-4	Vitamin E results in decreased expression of POLI mRNA	decreases^expression	19244175
POLK	51426	2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct	C502239		2-amino-1-methyl-6-phenolimidazo(4,5-b)pyridine-DNA adduct affects the activity of POLK protein	affects^activity	19628463
POLK	51426	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	C049584	105650-23-5	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the activity of POLK protein	affects^activity	19628463
POLK	51426	2'-deoxyadenosine	C058118	958-09-8	[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLK protein	affects^binding|decreases^activity	26098310
POLK	51426	2'-deoxycytidine 5'-triphosphate	C024107	2056-98-6	2'-deoxycytidine 5'-triphosphate promotes the reaction [N(2)-furfuryl-deoxyguanosine results in increased stability of POLK protein]	increases^reaction|increases^stability	28823149
POLK	51426	2'-deoxycytidine 5'-triphosphate	C024107	2056-98-6	N-(2'-deoxyguanosin-8-yl)-3-aminobenzanthrone inhibits the reaction [POLK protein binds to 2'-deoxycytidine 5'-triphosphate]	affects^binding|decreases^reaction	31286773
POLK	51426	2'-deoxycytidine 5'-triphosphate	C024107	2056-98-6	POLK protein binds to 2'-deoxycytidine 5'-triphosphate	affects^binding	31286773
POLK	51426	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	C511621		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in decreased expression of POLK protein	decreases^expression	26651356
POLK	51426	680C91	C093792		680C91 results in decreased expression of POLK protein	decreases^expression	26651356
POLK	51426	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide analog affects the expression of POLK mRNA	affects^expression	22227292
POLK	51426	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	POLK protein inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased mutagenesis of TK1 gene]	decreases^reaction|increases^mutagenesis	28077981
POLK	51426	abrine	C496492		abrine results in increased expression of POLK mRNA	increases^expression	31054353
POLK	51426	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of POLK gene	decreases^methylation	27153756
POLK	51426	Benzene	D001554	71-43-2	Benzene affects the expression of POLK mRNA	affects^expression	16188086
POLK	51426	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of POLK mRNA	affects^cotreatment|decreases^expression	27392435
POLK	51426	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of POLK mRNA	decreases^expression	27392435
POLK	51426	Clorgyline	D003010	17780-72-2	Clorgyline results in increased expression of POLK mRNA	increases^expression	19691856
POLK	51426	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of POLK mRNA	increases^expression	19549813
POLK	51426	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of POLK mRNA	increases^expression	25562108
POLK	51426	Deoxyadenosines	D003839		Deoxyadenosines analog results in decreased activity of POLK protein	decreases^activity	28823149
POLK	51426	diepoxybutane	C007366		[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLK protein	affects^binding|decreases^activity	26098310
POLK	51426	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of POLK mRNA	decreases^expression	29803840
POLK	51426	Gold	D006046	7440-57-5	Gold results in decreased expression of POLK mRNA	decreases^expression	25523186
POLK	51426	Guanine	D006147	73-40-5	Guanine metabolite results in decreased activity of POLK protein	decreases^activity	26010525
POLK	51426	Irinotecan	D000077146		Irinotecan analog results in decreased expression of POLK mRNA	decreases^expression	18927307
POLK	51426	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of POLK mRNA	affects^cotreatment|decreases^expression	27392435
POLK	51426	jinfukang	C544151		jinfukang results in decreased expression of POLK mRNA	decreases^expression	27392435
POLK	51426	Methylcholanthrene	D008748	56-49-5	Methylcholanthrene results in increased expression of POLK mRNA	increases^expression	26651356
POLK	51426	Methylcholanthrene	D008748	56-49-5	Methylcholanthrene results in increased expression of POLK protein	increases^expression	26651356
POLK	51426	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of POLK mRNA	increases^expression	23649840
POLK	51426	Mitomycin	D016685	50-07-7	POLK protein inhibits the reaction [Mitomycin results in increased mutagenesis of TK1 gene]	decreases^reaction|increases^mutagenesis	28077981
POLK	51426	MK-886	C060893	118414-82-7	MK-886 results in decreased activity of POLK protein	decreases^activity	23305233
POLK	51426	MLN7243	C000622638		MLN7243 results in increased sumoylation of POLK protein	increases^sumoylation	31285264
POLK	51426	N-(2'-deoxyguanosin-8-yl)-3-aminobenzanthrone	C000622103		N-(2'-deoxyguanosin-8-yl)-3-aminobenzanthrone inhibits the reaction [POLK protein binds to 2'-deoxycytidine 5'-triphosphate]	affects^binding|decreases^reaction	31286773
POLK	51426	N(2)-furfuryl-deoxyguanosine	C000608473		2'-deoxycytidine 5'-triphosphate promotes the reaction [N(2)-furfuryl-deoxyguanosine results in increased stability of POLK protein]	increases^reaction|increases^stability	28823149
POLK	51426	N(2)-furfuryl-deoxyguanosine	C000608473		N(2)-furfuryl-deoxyguanosine results in increased stability of POLK protein	increases^stability	28823149
POLK	51426	N6-(2-hydroxy-3-buten-1-yl)-2'-deoxyadenosine	C000598755		N6-(2-hydroxy-3-buten-1-yl)-2'-deoxyadenosine results in decreased activity of POLK protein	decreases^activity	26098310
POLK	51426	N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	C078255	142784-25-6	N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the activity of POLK protein	affects^activity	19628463
POLK	51426	Nickel	D009532	7440-02-0	Nickel affects the expression of POLK mRNA	affects^expression	14575637
POLK	51426	Nickel	D009532	7440-02-0	trichostatin A inhibits the reaction [Nickel affects the expression of POLK mRNA]	affects^expression|decreases^reaction	14575637
POLK	51426	Paclitaxel	D017239		Paclitaxel results in decreased expression of POLK mRNA	decreases^expression	15000894
POLK	51426	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in decreased expression of POLK mRNA	decreases^expression	27153767
POLK	51426	Plant Extracts	D010936		Plant Extracts results in increased expression of POLK mRNA	increases^expression	23557933
POLK	51426	trichostatin A	C012589	58880-19-6	trichostatin A inhibits the reaction [Nickel affects the expression of POLK mRNA]	affects^expression|decreases^reaction	14575637
POLK	51426	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of POLK mRNA	increases^expression	26179874
POLL	27343	abrine	C496492		abrine results in increased expression of POLL mRNA	increases^expression	31054353
POLL	27343	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of POLL mRNA	decreases^expression	28458013
POLL	27343	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of POLL gene	increases^methylation	28458013
POLL	27343	Aflatoxin B1	D016604	1162-65-8	Decitabine inhibits the reaction [Aflatoxin B1 results in decreased expression of POLL mRNA]	decreases^expression|decreases^reaction	28458013
POLL	27343	Amiodarone	D000638	1951-25-3	Amiodarone results in increased expression of POLL mRNA	increases^expression	19774075
POLL	27343	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of POLL mRNA	increases^expression	27694624
POLL	27343	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of POLL promoter	increases^methylation	27901495
POLL	27343	benzo(a)pyrene diolepoxide I	C072019	60268-85-1	benzo(a)pyrene diolepoxide I results in increased expression of POLL mRNA	increases^expression	27694624
POLL	27343	Decitabine	D000077209	2353-33-5	Decitabine inhibits the reaction [Aflatoxin B1 results in decreased expression of POLL mRNA]	decreases^expression|decreases^reaction	28458013
POLL	27343	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of POLL mRNA	decreases^expression	29803840
POLL	27343	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of POLL mRNA	decreases^expression	19167446
POLL	27343	honokiol	C005499	35354-74-6	honokiol results in decreased activity of POLL protein	decreases^activity	28067485
POLL	27343	Selenium	D012643	7782-49-2	[Selenium co-treated with Vitamin E] results in increased expression of POLL mRNA	affects^cotreatment|increases^expression	19244175
POLL	27343	Selenium	D012643	7782-49-2	Selenium results in increased expression of POLL mRNA	increases^expression	19244175
POLL	27343	Selenomethionine	D012645	1464-42-2	Selenomethionine affects the expression of POLL mRNA	affects^expression	17222674
POLL	27343	Vitamin E	D014810	1406-18-4	[Selenium co-treated with Vitamin E] results in increased expression of POLL mRNA	affects^cotreatment|increases^expression	19244175
POLM	27434	abrine	C496492		abrine results in increased expression of POLM mRNA	increases^expression	31054353
POLM	27434	Amphotericin B	D000666	1397-89-3	Amphotericin B results in increased expression of POLM mRNA	increases^expression	20849824
POLM	27434	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of POLM 3' UTR	decreases^methylation	27901495
POLM	27434	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of POLM mRNA	affects^expression	21179406
POLM	27434	Bortezomib	D000069286		Bortezomib results in decreased expression of POLM mRNA	decreases^expression	20977926
POLM	27434	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of POLM mRNA	increases^expression	20849824
POLM	27434	Cyclophosphamide	D003520	50-18-0	Cyclophosphamide results in increased expression of POLM mRNA	increases^expression	20849824
POLM	27434	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of POLM mRNA	decreases^expression	29803840
POLM	27434	Estradiol	D004958	50-28-2	Estradiol affects the expression of POLM mRNA	affects^expression	22574217
POLM	27434	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in increased expression of POLM mRNA	affects^cotreatment|increases^expression	30165855
POLM	27434	Gentamicins	D005839		Gentamicins results in increased expression of POLM mRNA	increases^expression	20849824
POLM	27434	MK-886	C060893	118414-82-7	MK-886 results in decreased activity of POLM protein	decreases^activity	23305233
POLM	27434	Raloxifene Hydrochloride	D020849		Raloxifene Hydrochloride results in increased expression of POLM mRNA	increases^expression	16497877
POLM	27434	Taurine	D013654	107-35-7	Taurine results in increased expression of POLM mRNA	increases^expression	16579726
POM121	9883	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of POM121 gene	affects^methylation	25304211
POM121	9883	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of POM121 mRNA	decreases^expression	22378314
POM121	9883	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of POM121 mRNA	increases^expression	26472689
POM121	9883	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of POM121 mRNA	decreases^expression	27594783
POM121	9883	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of POM121 mRNA	increases^expression	28302478
POM121	9883	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of POM121 mRNA	decreases^expression	29803840
POM121	9883	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of POM121 protein	decreases^activity|increases^O-linked glycosylation	23301498
POM121	9883	Estradiol	D004958	50-28-2	Estradiol results in increased expression of POM121 mRNA	increases^expression	23019147
POM121	9883	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of POM121 mRNA	affects^cotreatment|decreases^expression	28628672
POM121	9883	Plant Extracts	D010936		Plant Extracts results in decreased expression of POM121 mRNA	decreases^expression	23557933
POM121	9883	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased methylation of POM121 intron	decreases^methylation	31039056
POM121	9883	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of POM121 gene	decreases^methylation	29154799
QARS1	5859	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in decreased methylation of QARS1 promoter	decreases^methylation	30157460
QARS1	5859	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in decreased methylation of QARS1 promoter	decreases^methylation	30157460
QARS1	5859	C646 compound	C584509		C646 compound results in increased expression of QARS1 mRNA	increases^expression	26191083
QARS1	5859	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of QARS1 mRNA	increases^expression	26352163
QARS1	5859	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of QARS1 mRNA	affects^cotreatment|increases^expression	27392435
QARS1	5859	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of QARS1 mRNA	increases^expression	27392435
QARS1	5859	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of QARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
QARS1	5859	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of QARS1 mRNA	affects^cotreatment|increases^expression	27392435
QARS1	5859	jinfukang	C544151		jinfukang results in increased expression of QARS1 mRNA	increases^expression	27392435
QARS1	5859	Lead	D007854	7439-92-1	Lead affects the expression of QARS1 mRNA	affects^expression	28903495
QARS1	5859	Methapyrilene	D008701	91-80-5	Methapyrilene results in decreased methylation of QARS1 promoter	decreases^methylation	30157460
QARS1	5859	Okadaic Acid	D019319	78111-17-8	Okadaic Acid affects the expression of QARS1 mRNA	affects^expression	22788371
QARS1	5859	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of QARS1 mRNA	increases^expression	11489354
QARS1	5859	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of QARS1 protein	affects^expression	30291989
QARS1	5859	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of QARS1 mRNA	increases^expression	17218384
QARS1	5859	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of QARS1 mRNA	affects^expression	25979313
QARS1	5859	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of QARS1 mRNA	decreases^expression	23179753|29154799
QARS1	5859	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of QARS1 gene	increases^methylation	29154799
RAE1	8480	(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	C517041		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of RAE1 mRNA	increases^expression	19561079
RAE1	8480	abrine	C496492		abrine results in increased expression of RAE1 mRNA	increases^expression	31054353
RAE1	8480	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of RAE1 mRNA	affects^expression	21179406
RAE1	8480	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of RAE1 mRNA	increases^expression	19549813
RAE1	8480	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of RAE1 mRNA	increases^expression	19167446
RAE1	8480	deoxynivalenol	C007262	51481-10-8	deoxynivalenol results in increased expression of RAE1 mRNA	increases^expression	31863870
RAE1	8480	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of RAE1 mRNA	increases^expression	29803840
RAE1	8480	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RAE1 protein	decreases^activity|increases^O-linked glycosylation	23301498
RAE1	8480	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of RAE1 mRNA	increases^expression	24449571
RAE1	8480	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of RAE1 mRNA	increases^expression	23649840
RAE1	8480	MLN7243	C000622638		MLN7243 results in increased sumoylation of RAE1 protein	increases^sumoylation	31285264
RAE1	8480	Plant Extracts	D010936		Plant Extracts results in increased expression of RAE1 mRNA	increases^expression	23557933
RAE1	8480	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of RAE1 mRNA	increases^expression	28065790
RAE1	8480	Urethane	D014520	51-79-6	Urethane results in increased expression of RAE1 mRNA	increases^expression	28818685
RAE1	8480	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of RAE1 mRNA	affects^expression	25979313
RANBP2	5903	2,3,5-(triglutathion-S-yl)hydroquinone	C078765	119212-33-8	2,3,5-(triglutathion-S-yl)hydroquinone results in increased ADP-ribosylation of RANBP2 protein	increases^ADP-ribosylation	31165168
RANBP2	5903	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RANBP2 mRNA	decreases^expression	19150397|20018196
RANBP2	5903	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of RANBP2 mRNA	decreases^expression	21420995
RANBP2	5903	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of RANBP2 intron	increases^methylation	30157460
RANBP2	5903	Arsenic	D001151	7440-38-2	RANBP2 mRNA results in increased susceptibility to Arsenic	increases^response to substance	17976673
RANBP2	5903	Azacitidine	D001374	320-67-2	Azacitidine results in increased expression of RANBP2 mRNA	increases^expression	19194470
RANBP2	5903	Cisplatin	D002945	15663-27-1	[Piroxicam co-treated with Cisplatin] results in decreased expression of RANBP2 mRNA	affects^cotreatment|decreases^expression	21858171
RANBP2	5903	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of RANBP2 mRNA	increases^expression	19376846
RANBP2	5903	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of RANBP2 mRNA	decreases^expression	25562108
RANBP2	5903	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RANBP2 protein	decreases^activity|increases^O-linked glycosylation	23301498
RANBP2	5903	jinfukang	C544151		jinfukang results in decreased expression of RANBP2 mRNA	decreases^expression	27392435
RANBP2	5903	Methylcholanthrene	D008748	56-49-5	Methylcholanthrene promotes the reaction [AHR protein binds to RANBP2 promoter]	affects^binding|increases^reaction	20348232
RANBP2	5903	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of RANBP2 mRNA	decreases^expression	28001369
RANBP2	5903	MLN7243	C000622638		MLN7243 results in decreased sumoylation of RANBP2 protein	decreases^sumoylation	31285264
RANBP2	5903	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in decreased expression of RANBP2 mRNA	decreases^expression	27153767
RANBP2	5903	Pioglitazone	D000077205	111025-46-8	Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]	decreases^reaction|increases^expression	20847119
RANBP2	5903	Piroxicam	D010894	36322-90-4	[Piroxicam co-treated with Cisplatin] results in decreased expression of RANBP2 mRNA	affects^cotreatment|decreases^expression	21858171
RANBP2	5903	Plant Extracts	D010936		Plant Extracts results in increased expression of RANBP2 mRNA	increases^expression	23557933
RANBP2	5903	Rosiglitazone	D000077154		Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]	decreases^reaction|increases^expression	20847119
RANBP2	5903	Selenium	D012643	7782-49-2	[Selenium co-treated with Vitamin E] results in decreased expression of RANBP2 mRNA	affects^cotreatment|decreases^expression	19244175
RANBP2	5903	Selenium	D012643	7782-49-2	Selenium results in decreased expression of RANBP2 mRNA	decreases^expression	19244175
RANBP2	5903	tert-Butylhydroperoxide	D020122	75-91-2	Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]	decreases^reaction|increases^expression	20847119
RANBP2	5903	tert-Butylhydroperoxide	D020122	75-91-2	Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]	decreases^reaction|increases^expression	20847119
RANBP2	5903	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA	increases^expression	20847119
RANBP2	5903	tert-Butylhydroperoxide	D020122	75-91-2	Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]	decreases^reaction|increases^expression	20847119
RANBP2	5903	testosterone enanthate	C004648		testosterone enanthate affects the expression of RANBP2 mRNA	affects^expression	17440010
RANBP2	5903	tetrahydropalmatine	C014215	10097-84-4	tetrahydropalmatine results in decreased expression of RANBP2 protein	decreases^expression	20109541
RANBP2	5903	Troglitazone	D000077288	97322-87-7	Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]	decreases^reaction|increases^expression	20847119
RANBP2	5903	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of RANBP2 mRNA	affects^expression	23179753|25979313
RANBP2	5903	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of RANBP2 mRNA	increases^expression	29154799
RANBP2	5903	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of RANBP2 gene	increases^methylation	29154799
RANBP2	5903	Vitamin E	D014810	1406-18-4	[Selenium co-treated with Vitamin E] results in decreased expression of RANBP2 mRNA	affects^cotreatment|decreases^expression	19244175
RANBP2	5903	Vitamin E	D014810	1406-18-4	Vitamin E results in decreased expression of RANBP2 mRNA	decreases^expression	19244175
RANBP2	5903	Vorinostat	D000077337		Vorinostat results in increased expression of RANBP2 mRNA	increases^expression	27188386
RARS1	5917	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of RARS1 protein	increases^expression	25419056
RARS1	5917	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of RARS1 protein	increases^expression	24527689
RARS1	5917	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of RARS1 mRNA	increases^expression	26352163
RARS1	5917	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of RARS1 mRNA	decreases^expression	28302478
RARS1	5917	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of RARS1 mRNA	increases^expression	29803840
RARS1	5917	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
RARS1	5917	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RARS1 mRNA	affects^cotreatment|decreases^expression	22079256
RARS1	5917	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of RARS1 mRNA	affects^expression	20044591
RARS1	5917	jinfukang	C544151		jinfukang results in decreased expression of RARS1 mRNA	decreases^expression	27392435
RARS1	5917	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of RARS1 mRNA	decreases^expression	30851411
RARS1	5917	Lead	D007854	7439-92-1	Lead affects the expression of RARS1 mRNA	affects^expression	28903495
RARS1	5917	methylparaben	C015358	99-76-3	methylparaben results in increased expression of RARS1 mRNA	increases^expression	31745603
RARS1	5917	Plant Extracts	D010936		Plant Extracts results in increased expression of RARS1 mRNA	increases^expression	23557933
RARS1	5917	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RARS1 mRNA	affects^cotreatment|decreases^expression	22079256
RARS1	5917	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of RARS1 mRNA	decreases^expression	22079256
RARS1	5917	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of RARS1 protein	affects^expression	30291989
RARS1	5917	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of RARS1 mRNA	decreases^expression	16054129
REV3L	5980	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	28628672
REV3L	5980	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	27188386
REV3L	5980	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	27188386
REV3L	5980	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	27188386
REV3L	5980	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of REV3L mRNA	decreases^expression	19150397
REV3L	5980	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of REV3L mRNA	decreases^expression	21420995
REV3L	5980	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of REV3L gene	decreases^methylation	27153756
REV3L	5980	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of REV3L mRNA	increases^expression	20106945
REV3L	5980	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of REV3L mRNA	increases^expression	29275510
REV3L	5980	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	28628672
REV3L	5980	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of REV3L mRNA	affects^expression	24752500
REV3L	5980	Clorgyline	D003010	17780-72-2	Clorgyline results in increased expression of REV3L mRNA	increases^expression	19691856
REV3L	5980	Curcumin	D003474	458-37-7	Curcumin results in increased expression of REV3L protein	increases^expression	19137819
REV3L	5980	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of REV3L mRNA	decreases^expression	25562108
REV3L	5980	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of REV3L mRNA	increases^expression	25047013
REV3L	5980	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	28628672
REV3L	5980	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of REV3L gene	increases^methylation	22964155
REV3L	5980	Diclofenac	D004008	15307-86-5	Diclofenac affects the expression of REV3L mRNA	affects^expression	24752500
REV3L	5980	dorsomorphin	C516138		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	27188386
REV3L	5980	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	27188386
REV3L	5980	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	27188386
REV3L	5980	Doxorubicin	D004317	23214-92-8	REV3L protein affects the susceptibility to Doxorubicin	affects^response to substance	16217747
REV3L	5980	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of REV3L mRNA	affects^cotreatment|decreases^expression	22079256
REV3L	5980	Estradiol	D004958	50-28-2	[Estradiol co-treated with Progesterone] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	20660070
REV3L	5980	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of REV3L mRNA	increases^expression	23649840
REV3L	5980	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of REV3L mRNA	increases^expression	20655997|23649840
REV3L	5980	Genistein	D019833	446-72-0	Genistein results in decreased expression of REV3L mRNA	decreases^expression	22228119
REV3L	5980	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	28628672
REV3L	5980	jinfukang	C544151		jinfukang results in decreased expression of REV3L mRNA	decreases^expression	27392435
REV3L	5980	Lead	D007854	7439-92-1	Lead affects the expression of REV3L mRNA	affects^expression	28903495
REV3L	5980	Melphalan	D008558	148-82-3	Melphalan results in decreased expression of REV3L mRNA	decreases^expression	22363485
REV3L	5980	mercuric bromide	C042720	7789-47-1	mercuric bromide results in increased expression of REV3L mRNA	increases^expression	26272509
REV3L	5980	mercuric bromide	C042720	7789-47-1	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	27188386
REV3L	5980	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of REV3L mRNA	increases^expression	23179753|27188386|28001369
REV3L	5980	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of REV3L mRNA	increases^expression	23649840
REV3L	5980	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	27188386
REV3L	5980	p-Chloromercuribenzoic Acid	D020245	59-85-8	p-Chloromercuribenzoic Acid results in increased expression of REV3L mRNA	increases^expression	26272509
REV3L	5980	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in decreased expression of REV3L mRNA	decreases^expression	27153767
REV3L	5980	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	27188386
REV3L	5980	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of REV3L mRNA	increases^expression	26272509
REV3L	5980	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of REV3L mRNA	affects^cotreatment|decreases^expression	22079256
REV3L	5980	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of REV3L mRNA	decreases^expression	22079256
REV3L	5980	Progesterone	D011374	57-83-0	[Estradiol co-treated with Progesterone] results in increased expression of REV3L mRNA	affects^cotreatment|increases^expression	20660070
REV3L	5980	Quercetin	D011794	117-39-5	Quercetin results in increased expression of REV3L mRNA	increases^expression	21632981
REV3L	5980	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of REV3L mRNA	decreases^expression	12377979
REV3L	5980	tamibarotene	C061133	94497-51-5	tamibarotene results in decreased expression of REV3L mRNA	decreases^expression	15498508
REV3L	5980	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of REV3L mRNA	affects^expression	22574217
REV3L	5980	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of REV3L mRNA	decreases^expression	15498508
REV3L	5980	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of REV3L mRNA	increases^expression	21934132
REV3L	5980	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of REV3L mRNA	increases^expression	24935251
REV3L	5980	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of REV3L mRNA	increases^expression	28001369
REV3L	5980	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of REV3L gene	increases^methylation	29154799
REV3L	5980	Vinblastine	D014747	865-21-4	REV3L protein affects the susceptibility to Vinblastine	affects^response to substance	16217747
RFC5	5985	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC5 mRNA	affects^cotreatment|increases^expression	19167446
RFC5	5985	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RFC5 mRNA	decreases^expression	20382639
RFC5	5985	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of RFC5 mRNA	increases^expression	22230336
RFC5	5985	AM 251	C103505		AM 251 results in decreased expression of RFC5 mRNA	decreases^expression	16500647
RFC5	5985	Azathioprine	D001379	446-86-6	Azathioprine results in decreased expression of RFC5 mRNA	decreases^expression	22623647
RFC5	5985	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of RFC5 mRNA	decreases^expression	21802500
RFC5	5985	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of RFC5 mRNA	increases^expression	21714911|32234424
RFC5	5985	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of RFC5 promoter	increases^methylation	27901495
RFC5	5985	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of RFC5 mRNA	affects^expression	30903817
RFC5	5985	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of RFC5 mRNA	decreases^expression	29275510
RFC5	5985	Cisplatin	D002945	15663-27-1	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of RFC5 mRNA]	decreases^expression|decreases^reaction	21858171
RFC5	5985	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of RFC5 protein	decreases^expression	20540955
RFC5	5985	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of RFC5 mRNA	increases^expression	27594783
RFC5	5985	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of RFC5 mRNA	decreases^expression	19376846
RFC5	5985	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of RFC5 mRNA	affects^binding|decreases^expression	20971185
RFC5	5985	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of RFC5 mRNA	decreases^expression	19549813
RFC5	5985	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC5 mRNA	affects^cotreatment|increases^expression	19167446
RFC5	5985	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of RFC5 mRNA	affects^cotreatment|increases^expression	19167446
RFC5	5985	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of RFC5 mRNA	increases^expression	19167446
RFC5	5985	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of RFC5 mRNA	decreases^expression	20106945|21632981|25562108
RFC5	5985	Dasatinib	D000069439		Dasatinib results in decreased expression of RFC5 mRNA	decreases^expression	20579391
RFC5	5985	Diethylstilbestrol	D004054	56-53-1	Diethylstilbestrol results in increased expression of RFC5 mRNA	increases^expression	15766595
RFC5	5985	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of RFC5 mRNA	decreases^expression	29803840
RFC5	5985	Doxorubicin	D004317	23214-92-8	RFC5 protein affects the susceptibility to Doxorubicin	affects^response to substance	16217747
RFC5	5985	erucylphospho-N,N,N-trimethylpropylammonium	C472787		erucylphospho-N,N,N-trimethylpropylammonium results in decreased expression of RFC5 mRNA	decreases^expression	29464035
RFC5	5985	incobotulinumtoxinA	C545476		incobotulinumtoxinA results in decreased expression of RFC5 mRNA	decreases^expression	29522793
RFC5	5985	jinfukang	C544151		jinfukang results in increased expression of RFC5 mRNA	increases^expression	27392435
RFC5	5985	K 7174	C410337		K 7174 results in decreased expression of RFC5 mRNA	decreases^expression	24086573
RFC5	5985	Manganese	D008345	7439-96-5	Manganese results in decreased expression of RFC5 mRNA	decreases^expression	17175027
RFC5	5985	manganese chloride	C025340	05/01/7773	manganese chloride results in decreased expression of RFC5 mRNA	decreases^expression	17175027
RFC5	5985	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of RFC5 mRNA	increases^expression	23649840
RFC5	5985	methylselenic acid	C008493		methylselenic acid results in decreased expression of RFC5 mRNA	decreases^expression	11830524
RFC5	5985	microcystin RR	C063855		microcystin RR results in increased expression of RFC5 protein	increases^expression	19111056
RFC5	5985	Mustard Gas	D009151	505-60-2	Mustard Gas results in decreased expression of RFC5 mRNA	decreases^expression	25102026
RFC5	5985	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of RFC5 mRNA	affects^binding|decreases^expression	20971185
RFC5	5985	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of RFC5 mRNA	decreases^expression	26516004
RFC5	5985	Paclitaxel	D017239		Paclitaxel results in decreased expression of RFC5 protein	decreases^expression	15907983
RFC5	5985	palbociclib	C500026		palbociclib results in decreased expression of RFC5 mRNA	decreases^expression	22869556
RFC5	5985	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in decreased expression of RFC5 protein	decreases^expression	26879310
RFC5	5985	Piroxicam	D010894	36322-90-4	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of RFC5 mRNA]	decreases^expression|decreases^reaction	21858171
RFC5	5985	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of RFC5 mRNA	decreases^expression	21858171
RFC5	5985	Plant Extracts	D010936		Plant Extracts results in increased expression of RFC5 mRNA	increases^expression	23557933
RFC5	5985	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of RFC5 mRNA	affects^cotreatment|increases^expression	19167446
RFC5	5985	Rotenone	D012402	83-79-4	Rotenone results in increased expression of RFC5 mRNA	increases^expression	18191903
RFC5	5985	Simvastatin	D019821	79902-63-9	Simvastatin results in decreased expression of RFC5 mRNA	decreases^expression	17428261
RFC5	5985	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of RFC5 mRNA	increases^expression	12016162
RFC5	5985	tamibarotene	C061133	94497-51-5	tamibarotene affects the expression of RFC5 mRNA	affects^expression	15498508
RFC5	5985	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in decreased expression of RFC5 mRNA	decreases^expression	21802500
RFC5	5985	Tetradecanoylphorbol Acetate	D013755	16561-29-8	Tetradecanoylphorbol Acetate results in increased expression of RFC5 mRNA	increases^expression	19031421
RFC5	5985	trans-10,cis-12-conjugated linoleic acid	C496197		trans-10,cis-12-conjugated linoleic acid results in decreased expression of RFC5 mRNA	decreases^expression	17951470
RFC5	5985	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of RFC5 mRNA	decreases^expression	15498508
RFC5	5985	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of RFC5 mRNA	decreases^expression	26179874
RFC5	5985	Troglitazone	D000077288	97322-87-7	Troglitazone results in decreased expression of RFC5 mRNA	decreases^expression	19140230
RFC5	5985	Vinblastine	D014747	865-21-4	RFC5 protein affects the susceptibility to Vinblastine	affects^response to substance	16217747
RRM1	6240	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM1 mRNA	affects^cotreatment|increases^expression	19167446
RRM1	6240	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RRM1 mRNA	affects^cotreatment|decreases^expression	27188386
RRM1	6240	4-aminophenylarsenoxide	C032642	1122-90-3	4-aminophenylarsenoxide binds to RRM1 protein	affects^binding	26598702
RRM1	6240	4-aminophenylarsenoxide	C032642	1122-90-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RRM1 protein]	affects^binding|decreases^reaction	26598702
RRM1	6240	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RRM1 mRNA	decreases^expression	20382639
RRM1	6240	abrine	C496492		abrine results in decreased expression of RRM1 mRNA	decreases^expression	31054353
RRM1	6240	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of RRM1 mRNA	decreases^expression	21420995|29067470
RRM1	6240	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of RRM1 mRNA	increases^expression	22230336
RRM1	6240	afimoxifene	C016601	68392-35-8	afimoxifene results in decreased expression of RRM1 mRNA	decreases^expression	16514628
RRM1	6240	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of RRM1 protein	affects^expression	20106945
RRM1	6240	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RRM1 protein]	affects^binding|decreases^reaction	26598702
RRM1	6240	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased expression of RRM1 protein	decreases^expression	25174355|25335113
RRM1	6240	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of RRM1 protein	increases^expression	25419056
RRM1	6240	Azathioprine	D001379	446-86-6	Azathioprine results in decreased expression of RRM1 mRNA	decreases^expression	22623647
RRM1	6240	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of RRM1 mRNA	increases^expression	32234424
RRM1	6240	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of RRM1 promoter	increases^methylation	27901495
RRM1	6240	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of RRM1 mRNA	affects^expression	30903817
RRM1	6240	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of RRM1 mRNA	decreases^expression	29275510
RRM1	6240	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of RRM1 mRNA	increases^expression	27392435|27594783
RRM1	6240	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of RRM1 mRNA	decreases^expression	19376846
RRM1	6240	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of RRM1 mRNA	affects^binding|decreases^expression	20971185
RRM1	6240	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM1 mRNA	affects^cotreatment|increases^expression	19167446
RRM1	6240	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with Resveratrol] results in increased expression of RRM1 mRNA	affects^cotreatment|increases^expression	19167446
RRM1	6240	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of RRM1 mRNA	increases^expression	19167446
RRM1	6240	Cyclosporine	D016572	59865-13-3	Cyclosporine affects the expression of RRM1 mRNA	affects^expression	25562108
RRM1	6240	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of RRM1 mRNA	decreases^expression	20106945|21632981
RRM1	6240	Dasatinib	D000069439		Dasatinib results in decreased expression of RRM1 mRNA	decreases^expression	20579391
RRM1	6240	Diazinon	D003976	333-41-5	Diazinon results in decreased expression of RRM1 mRNA	decreases^expression	16539210
RRM1	6240	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of RRM1 mRNA	decreases^expression	28302478
RRM1	6240	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RRM1 mRNA	affects^cotreatment|decreases^expression	27188386
RRM1	6240	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of RRM1 mRNA	decreases^expression	29803840
RRM1	6240	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RRM1 protein	decreases^activity|increases^O-linked glycosylation	23301498
RRM1	6240	erucylphospho-N,N,N-trimethylpropylammonium	C472787		erucylphospho-N,N,N-trimethylpropylammonium results in decreased expression of RRM1 mRNA	decreases^expression	29464035
RRM1	6240	Estradiol	D004958	50-28-2	Estradiol results in increased expression of RRM1 mRNA	increases^expression	16514628|19167446
RRM1	6240	fialuridine	C043457	69123-98-4	RRM1 affects the susceptibility to fialuridine	affects^response to substance	31505000
RRM1	6240	Fluorouracil	D005472	51-21-8	Fluorouracil results in increased expression of RRM1 protein	increases^expression	15331170
RRM1	6240	Fulvestrant	D000077267	129453-61-8	Fulvestrant results in decreased expression of RRM1 mRNA	decreases^expression	16514628
RRM1	6240	Gefitinib	D000077156		RRM1 gene polymorphism affects the susceptibility to Gefitinib	affects^response to substance	21264830
RRM1	6240	gemcitabine	C056507	103882-84-4	[gemcitabine results in decreased susceptibility to gemcitabine] which results in increased expression of RRM1 mRNA	decreases^response to substance|increases^expression	25189999
RRM1	6240	gemcitabine	C056507	103882-84-4	[gemcitabine results in decreased susceptibility to gemcitabine] which results in increased expression of RRM1 protein	decreases^response to substance|increases^expression	25189999
RRM1	6240	gemcitabine	C056507	103882-84-4	RRM1 protein affects the susceptibility to gemcitabine	affects^response to substance	26894857
RRM1	6240	gossypol acetic acid	C028178	12542-36-8	gossypol acetic acid results in decreased expression of RRM1 protein	decreases^expression	29938581
RRM1	6240	Graphite	D006108	7782-42-5	Graphite results in decreased expression of RRM1 protein	decreases^expression	22157353
RRM1	6240	Hydrazones	D006835		Hydrazones results in decreased expression of RRM1 protein	decreases^expression	28716444
RRM1	6240	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of RRM1 mRNA	affects^expression	20044591|23410634
RRM1	6240	ICG 001	C492448		ICG 001 results in decreased expression of RRM1 mRNA	decreases^expression	26191083
RRM1	6240	incobotulinumtoxinA	C545476		incobotulinumtoxinA results in decreased expression of RRM1 mRNA	decreases^expression	29522793
RRM1	6240	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of RRM1 mRNA	decreases^expression	25961927
RRM1	6240	K 7174	C410337		K 7174 results in decreased expression of RRM1 mRNA	decreases^expression	24086573
RRM1	6240	Lead	D007854	7439-92-1	Lead results in decreased expression of RRM1 mRNA	decreases^expression	19921347
RRM1	6240	methylselenic acid	C008493		methylselenic acid affects the expression of RRM1 mRNA	affects^expression	14617803
RRM1	6240	Mitotane	D008939	53-19-0	Mitotane results in increased expression of RRM1 mRNA	increases^expression	22547773
RRM1	6240	Mitotane	D008939	53-19-0	RRM1 protein results in decreased susceptibility to Mitotane	decreases^response to substance	22547773
RRM1	6240	Mustard Gas	D009151	505-60-2	Mustard Gas results in decreased expression of RRM1 mRNA	decreases^expression	25102026
RRM1	6240	Nanotubes, Carbon	D037742		Nanotubes, Carbon results in increased expression of RRM1 protein	increases^expression	22157353
RRM1	6240	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of RRM1 mRNA	affects^binding|decreases^expression	20971185
RRM1	6240	palbociclib	C500026		palbociclib results in decreased expression of RRM1 mRNA	decreases^expression	22869556
RRM1	6240	perfluorononanoic acid	C584865		perfluorononanoic acid results in decreased expression of RRM1 mRNA	decreases^expression	32588087
RRM1	6240	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in decreased expression of RRM1 protein	decreases^expression	26879310
RRM1	6240	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of RRM1 mRNA	affects^expression	19159669
RRM1	6240	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RRM1 mRNA	affects^cotreatment|decreases^expression	27188386
RRM1	6240	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in decreased expression of RRM1 mRNA	decreases^expression	26272509
RRM1	6240	Plant Extracts	D010936		Plant Extracts results in increased expression of RRM1 mRNA	increases^expression	23557933
RRM1	6240	Quercetin	D011794	117-39-5	Quercetin results in increased expression of RRM1 mRNA	increases^expression	21632981
RRM1	6240	quinoline	C037219	91-22-5	quinoline analog results in decreased expression of RRM1 protein	decreases^expression	18645022
RRM1	6240	Raloxifene Hydrochloride	D020849		Raloxifene Hydrochloride results in decreased expression of RRM1 mRNA	decreases^expression	16514628
RRM1	6240	Resveratrol	D000077185		[Coumestrol co-treated with Resveratrol] results in increased expression of RRM1 mRNA	affects^cotreatment|increases^expression	19167446
RRM1	6240	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased methylation of RRM1 gene	decreases^methylation	25199682
RRM1	6240	Sunitinib	D000077210		Sunitinib results in decreased expression of RRM1 mRNA	decreases^expression	31533062
RRM1	6240	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide affects the expression of RRM1 mRNA	affects^expression	23410634
RRM1	6240	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of RRM1 mRNA	decreases^expression	15336504
RRM1	6240	Thapsigargin	D019284	67526-95-8	Thapsigargin results in decreased expression of RRM1 mRNA	decreases^expression	22378314
RRM1	6240	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased methylation of RRM1 intron	increases^methylation	31039056
RRM1	6240	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of RRM1 mRNA	decreases^expression	26179874
RRM1	6240	Troglitazone	D000077288	97322-87-7	Troglitazone results in decreased expression of RRM1 mRNA	decreases^expression	19140230
RRM1	6240	Urethane	D014520	51-79-6	Urethane results in decreased expression of RRM1 mRNA	decreases^expression	28818685
RRM1	6240	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of RRM1 mRNA	decreases^expression	23179753|28001369
RRM1	6240	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of RRM1 mRNA	affects^expression	20044591|23410634
RRM1	6240	Vorinostat	D000077337		Vorinostat results in increased expression of RRM1 mRNA	increases^expression	27188386
RRM2B	50484	2,4-diaminotoluene	C010914	95-80-7	2,4-diaminotoluene results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	2-Acetylaminofluorene	D015073	53-96-3	2-Acetylaminofluorene results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	C049584	105650-23-5	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	2-amino-3-methylimidazo(4,5-f)quinoline	C029216	76180-96-6	2-amino-3-methylimidazo(4,5-f)quinoline results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of RRM2B protein	increases^expression	26194647
RRM2B	50484	3-aminopyridine-2-carboxaldehyde thiosemicarbazone	C078157	143621-35-6	[Cisplatin co-treated with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone] results in increased expression of RRM2B protein	affects^cotreatment|increases^expression	20954859
RRM2B	50484	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRM2B mRNA	affects^cotreatment|increases^expression	27188386
RRM2B	50484	6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine	C000595015		6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine results in increased expression of RRM2B mRNA	increases^expression	28073004
RRM2B	50484	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RRM2B mRNA	increases^expression	20382639|28593498
RRM2B	50484	9,10-Dimethyl-1,2-benzanthracene	D015127	57-97-6	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of RRM2B mRNA	increases^expression	22230336
RRM2B	50484	adefovir dipivoxil	C106812	142340-99-6	adefovir dipivoxil results in increased expression of RRM2B mRNA	increases^expression	25596134
RRM2B	50484	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of RRM2B protein	affects^expression	20106945
RRM2B	50484	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of RRM2B mRNA	increases^expression	21632981|21641981|21704725|22100608|27153756
RRM2B	50484	Azacitidine	D001374	320-67-2	Azacitidine results in increased expression of RRM2B mRNA	increases^expression	19010910
RRM2B	50484	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the expression of RRM2B mRNA	affects^expression	21873647
RRM2B	50484	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene metabolite results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of RRM2B mRNA	increases^expression	20064835|20106945|21632981|22316170|30453624|32234424
RRM2B	50484	Bortezomib	D000069286		Bortezomib results in increased expression of RRM2B mRNA	increases^expression	20977926
RRM2B	50484	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of RRM2B mRNA	increases^expression	25596134
RRM2B	50484	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of RRM2B mRNA	affects^expression	25979313
RRM2B	50484	Chloramphenicol	D002701	56-75-7	Chloramphenicol results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde affects the expression of RRM2B mRNA	affects^expression	25596134
RRM2B	50484	Cidofovir	D000077404	113852-37-2	Cidofovir results in decreased expression of RRM2B mRNA	decreases^expression	25596134
RRM2B	50484	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone] results in increased expression of RRM2B protein	affects^cotreatment|increases^expression	20954859
RRM2B	50484	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of RRM2B mRNA	decreases^expression	25596134
RRM2B	50484	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of RRM2B mRNA	increases^expression	21704725|25450742|27392435|27594783
RRM2B	50484	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of RRM2B protein	increases^expression	21875941
RRM2B	50484	Cisplatin	D002945	15663-27-1	TP53 affects the reaction [Cisplatin results in increased expression of RRM2B protein]	affects^reaction|increases^expression	21875941
RRM2B	50484	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in decreased expression of RRM2B mRNA	decreases^expression	25596134
RRM2B	50484	CPG-oligonucleotide	C408982		CPG-oligonucleotide results in increased expression of RRM2B mRNA	increases^expression	21878529
RRM2B	50484	Cyclophosphamide	D003520	50-18-0	Cyclophosphamide metabolite results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of RRM2B mRNA	increases^expression	20106945|25596134
RRM2B	50484	Decitabine	D000077209	2353-33-5	Decitabine results in increased expression of RRM2B mRNA	increases^expression	19010910
RRM2B	50484	Decitabine	D000077209	2353-33-5	Decitabine results in increased expression of RRM2B protein	increases^expression	19010910
RRM2B	50484	Decitabine	D000077209	2353-33-5	TP53 protein affects the reaction [Decitabine results in increased expression of RRM2B mRNA]	affects^reaction|increases^expression	19010910
RRM2B	50484	Demecolcine	D003703	477-30-5	Demecolcine results in increased expression of RRM2B mRNA	increases^expression	23649840
RRM2B	50484	deoxynivalenol	C007262	51481-10-8	deoxynivalenol results in increased expression of RRM2B mRNA	increases^expression	31863870
RRM2B	50484	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of RRM2B mRNA	decreases^expression	28302478
RRM2B	50484	diethanolamine	C020283	111-42-2	diethanolamine results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	dimethylarsinous acid	C472511		dimethylarsinous acid results in increased expression of RRM2B mRNA	increases^expression	20886546
RRM2B	50484	Dimethylnitrosamine	D004128	62-75-9	Dimethylnitrosamine metabolite results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRM2B mRNA	affects^cotreatment|increases^expression	27188386
RRM2B	50484	Doxorubicin	D004317	23214-92-8	Doxorubicin affects the expression of RRM2B mRNA	affects^expression	25529476
RRM2B	50484	Doxorubicin	D004317	23214-92-8	Doxorubicin inhibits the reaction [KDM8 protein binds to RRM2B promoter]	affects^binding|decreases^reaction	26025680
RRM2B	50484	Doxorubicin	D004317	23214-92-8	Doxorubicin promotes the reaction [TP53 protein binds to RRM2B promoter]	affects^binding|increases^reaction	26025680
RRM2B	50484	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of RRM2B mRNA	increases^expression	21704725|30031762
RRM2B	50484	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of RRM2B protein	increases^expression	26025680
RRM2B	50484	Doxorubicin	D004317	23214-92-8	KDM8 protein affects the reaction [Doxorubicin results in increased expression of RRM2B protein]	affects^reaction|increases^expression	26025680
RRM2B	50484	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of RRM2B mRNA	increases^expression	23649840
RRM2B	50484	Ethylnitrosourea	D005038	759-73-9	Ethylnitrosourea results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	Etoposide	D005047	33419-42-0	Etoposide results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	Eugenol	D005054	97-53-0	Eugenol results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	Fluorouracil	D005472	51-21-8	Fluorouracil results in increased expression of RRM2B mRNA	increases^expression	16557594|21704725
RRM2B	50484	Fluorouracil	D005472	51-21-8	RRM2B protein results in decreased susceptibility to Fluorouracil	decreases^response to substance	15890238
RRM2B	50484	Fluorouracil	D005472	51-21-8	TP53 protein affects the reaction [Fluorouracil results in increased expression of RRM2B mRNA]	affects^reaction|increases^expression	15016801
RRM2B	50484	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of RRM2B mRNA	increases^expression	23649840
RRM2B	50484	Genistein	D019833	446-72-0	Genistein results in increased expression of RRM2B mRNA	increases^expression	18847459
RRM2B	50484	Hydroxyurea	D006918	127-07-1	Hydroxyurea results in increased expression of RRM2B mRNA	increases^expression	18647660
RRM2B	50484	Ifosfamide	D007069	3778-73-2	Ifosfamide results in decreased expression of RRM2B mRNA	decreases^expression	25596134
RRM2B	50484	isobutyraldehyde	C017439	78-84-2	isobutyraldehyde results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	jinfukang	C544151		jinfukang results in decreased expression of RRM2B mRNA	decreases^expression	27392435
RRM2B	50484	Lactic Acid	D019344	50-21-5	Lactic Acid results in increased expression of RRM2B mRNA	increases^expression	30851411
RRM2B	50484	Lead	D007854	7439-92-1	Lead affects the expression of RRM2B mRNA	affects^expression	28903495
RRM2B	50484	Magnetite Nanoparticles	D058185		[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RRM2B mRNA	affects^cotreatment|increases^expression	26378955
RRM2B	50484	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of RRM2B mRNA	increases^expression	21678067
RRM2B	50484	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of RRM2B mRNA	increases^expression	28001369
RRM2B	50484	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of RRM2B mRNA	increases^expression	21704725|23649840
RRM2B	50484	Methylnitronitrosoguanidine	D008769	70-25-7	ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]	increases^expression|increases^reaction	26921499
RRM2B	50484	Methylnitronitrosoguanidine	D008769	70-25-7	CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]	increases^expression|increases^reaction	26921499
RRM2B	50484	Methylnitronitrosoguanidine	D008769	70-25-7	E2F1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]	increases^expression|increases^reaction	26921499
RRM2B	50484	Methylnitronitrosoguanidine	D008769	70-25-7	E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]	increases^expression|increases^reaction	26921499
RRM2B	50484	Methylnitronitrosoguanidine	D008769	70-25-7	Methylnitronitrosoguanidine affects the expression of RRM2B mRNA	affects^expression	26921499
RRM2B	50484	Methylnitronitrosoguanidine	D008769	70-25-7	Methylnitronitrosoguanidine results in increased expression of and affects the localization of RRM2B protein	affects^localization|increases^expression	26921499
RRM2B	50484	Methylnitronitrosoguanidine	D008769	70-25-7	Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	Methylnitronitrosoguanidine	D008769	70-25-7	TP53 protein mutant form inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]	decreases^reaction|increases^expression	26921499
RRM2B	50484	Mustard Gas	D009151	505-60-2	Mustard Gas results in increased expression of RRM2B mRNA	increases^expression	25102026
RRM2B	50484	ochratoxin A	C025589	303-47-9	ochratoxin A results in increased expression of RRM2B mRNA	increases^expression	30559759
RRM2B	50484	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of RRM2B mRNA	decreases^expression	25596134
RRM2B	50484	Paclitaxel	D017239		Paclitaxel results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRM2B mRNA	affects^cotreatment|increases^expression	27188386
RRM2B	50484	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of RRM2B mRNA	increases^expression	26272509
RRM2B	50484	Plant Extracts	D010936		Plant Extracts results in increased expression of RRM2B mRNA	increases^expression	23557933
RRM2B	50484	potassium bromate	C019536	02/01/7758	potassium bromate results in increased expression of RRM2B mRNA	increases^expression	30559759
RRM2B	50484	Potassium Dichromate	D011192	7778-50-9	Potassium Dichromate results in increased expression of RRM2B protein	increases^expression	23718831
RRM2B	50484	propionaldehyde	C005556	123-38-6	propionaldehyde results in increased expression of RRM2B mRNA	increases^expression	26079696
RRM2B	50484	pyrimidin-2-one beta-ribofuranoside	C009131		pyrimidin-2-one beta-ribofuranoside results in increased expression of RRM2B mRNA	increases^expression	19010910
RRM2B	50484	Quercetin	D011794	117-39-5	Quercetin results in increased expression of RRM2B mRNA	increases^expression	21632981
RRM2B	50484	Resveratrol	D000077185		Resveratrol results in increased expression of RRM2B mRNA	increases^expression	15767336|26341291
RRM2B	50484	Silver Compounds	D018030		[ERCC4 gene mutant form results in increased susceptibility to Silver Compounds] which results in increased expression of RRM2B protein	increases^expression|increases^response to substance	29462690
RRM2B	50484	sodium arsenite	C017947	13768-07-5	sodium arsenite affects the expression of RRM2B mRNA	affects^expression	29319823
RRM2B	50484	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of RRM2B mRNA	increases^expression	21704725
RRM2B	50484	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of RRM2B mRNA	increases^expression	24383545
RRM2B	50484	Succimer	D004113	304-55-2	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RRM2B mRNA	affects^cotreatment|increases^expression	26378955
RRM2B	50484	Sunitinib	D000077210		Sunitinib results in increased expression of RRM2B mRNA	increases^expression	31533062
RRM2B	50484	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of RRM2B mRNA	increases^expression	22378314
RRM2B	50484	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of RRM2B mRNA	affects^expression	25979313
RRM2B	50484	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of RRM2B mRNA	increases^expression	19101580
RRM2B	50484	Vorinostat	D000077337		Vorinostat results in increased expression of RRM2B mRNA	increases^expression	27188386
RRM2B	50484	Zidovudine	D015215	30516-87-1	Zidovudine results in increased expression of RRM2B mRNA	increases^expression	21704725
SARS1	6301	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of SARS1 mRNA	increases^expression	24810058
SARS1	6301	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of SARS1 mRNA	increases^expression	19095052
SARS1	6301	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SARS1 mRNA	affects^cotreatment|increases^expression	27188386
SARS1	6301	(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	C517041		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of SARS1 mRNA	increases^expression	19561079
SARS1	6301	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of SARS1 mRNA	increases^expression	29067470
SARS1	6301	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of SARS1 gene	decreases^methylation	27153756
SARS1	6301	AM 251	C103505		AM 251 results in increased expression of SARS1 mRNA	increases^expression	16500647
SARS1	6301	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of SARS1 mRNA	affects^expression	20170705
SARS1	6301	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of SARS1 mRNA	increases^expression	29275510
SARS1	6301	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride affects the localization of SARS1 protein	affects^localization	18261755
SARS1	6301	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in decreased expression of SARS1 mRNA	decreases^expression	25596134
SARS1	6301	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of SARS1 mRNA	affects^expression	24752500|25979313
SARS1	6301	chloropicrin	C100187	76-06-2	chloropicrin results in decreased expression of SARS1 mRNA	decreases^expression	26352163
SARS1	6301	Cidofovir	D000077404	113852-37-2	Cidofovir results in increased expression of SARS1 mRNA	increases^expression	25596134
SARS1	6301	Cisplatin	D002945	15663-27-1	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SARS1 mRNA]	decreases^expression|decreases^reaction	21858171
SARS1	6301	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of SARS1 mRNA	increases^expression	25596134
SARS1	6301	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of SARS1 mRNA	increases^expression	19549813
SARS1	6301	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of SARS1 mRNA	increases^expression	20106945|21632981|25562108|25596134|27989131
SARS1	6301	Diclofenac	D004008	15307-86-5	Diclofenac affects the expression of SARS1 mRNA	affects^expression	24752500
SARS1	6301	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SARS1 mRNA	affects^cotreatment|increases^expression	27188386
SARS1	6301	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of SARS1 mRNA	increases^expression	29803840
SARS1	6301	Ethinyl Estradiol	D004997	57-63-6	Ethinyl Estradiol affects the expression of SARS1 mRNA	affects^expression	20170705|26865667
SARS1	6301	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of SARS1 mRNA	increases^expression	23649840
SARS1	6301	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of SARS1 mRNA	increases^expression	23649840
SARS1	6301	Gasoline	D005742		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
SARS1	6301	Genistein	D019833	446-72-0	Genistein results in increased expression of SARS1 mRNA	increases^expression	26865667
SARS1	6301	Ifosfamide	D007069	3778-73-2	Ifosfamide results in increased expression of SARS1 mRNA	increases^expression	25596134
SARS1	6301	Indomethacin	D007213	53-86-1	Indomethacin results in increased expression of SARS1 mRNA	increases^expression	17401462
SARS1	6301	K 7174	C410337		K 7174 results in increased expression of SARS1 mRNA	increases^expression	24086573
SARS1	6301	Leflunomide	D000077339	75706-12-6	Leflunomide results in increased expression of SARS1 mRNA	increases^expression	28988120
SARS1	6301	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of SARS1 mRNA	increases^expression	28001369
SARS1	6301	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of SARS1 mRNA	increases^expression	23649840
SARS1	6301	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of SARS1 mRNA	decreases^expression	30559759
SARS1	6301	Oxygen	D010100	7782-44-7	Oxygen deficiency results in increased expression of SARS1 mRNA	increases^expression	25596134
SARS1	6301	Particulate Matter	D052638		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
SARS1	6301	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SARS1 mRNA	affects^cotreatment|increases^expression	27188386
SARS1	6301	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether analog results in increased expression of SARS1 mRNA	increases^expression	19095052
SARS1	6301	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether results in increased expression of SARS1 mRNA	increases^expression	26705709
SARS1	6301	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of SARS1 mRNA	increases^expression	25868421
SARS1	6301	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of SARS1 protein	increases^expression	26879310
SARS1	6301	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of SARS1 mRNA	affects^expression	19159669
SARS1	6301	Piroxicam	D010894	36322-90-4	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SARS1 mRNA]	decreases^expression|decreases^reaction	21858171
SARS1	6301	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of SARS1 mRNA	decreases^expression	21858171
SARS1	6301	Polycyclic Aromatic Hydrocarbons	D011084		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
SARS1	6301	Progesterone	D011374	57-83-0	Progesterone results in increased expression of SARS1 mRNA	increases^expression	18037150
SARS1	6301	pterostilbene	C107773		pterostilbene results in increased expression of SARS1 mRNA	increases^expression	22450950
SARS1	6301	Resveratrol	D000077185		Resveratrol results in increased expression of SARS1 mRNA	increases^expression	12569576
SARS1	6301	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of SARS1 mRNA	decreases^expression	28595984
SARS1	6301	Sunitinib	D000077210		Sunitinib results in increased expression of SARS1 mRNA	increases^expression	31533062
SARS1	6301	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of SARS1 mRNA	increases^expression	22378314|29453283
SARS1	6301	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of SARS1 protein	increases^expression	29453283
SARS1	6301	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of SARS1 protein	affects^expression	30291989
SARS1	6301	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of SARS1 mRNA	increases^expression	22378314|29453283
SARS1	6301	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of SARS1 protein	increases^expression	29453283
SARS1	6301	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of SARS1 mRNA	affects^expression	25979313
SARS1	6301	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of SARS1 mRNA	increases^expression	23179753|29154799
SARS1	6301	Vorinostat	D000077337		Vorinostat results in decreased expression of SARS1 mRNA	decreases^expression	27188386
SEC13	6396	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of SEC13 mRNA	decreases^expression	11793227|22230336
SEC13	6396	Aspirin	D001241	50-78-2	Aspirin results in decreased expression of SEC13 mRNA	decreases^expression	15928584
SEC13	6396	beauvericin	C004456	26048-05-5	beauvericin results in decreased expression of SEC13 mRNA	decreases^expression	29203277
SEC13	6396	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of SEC13 promoter	decreases^methylation	27901495
SEC13	6396	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of SEC13 mRNA	affects^expression	30903817
SEC13	6396	Caffeine	D002110	58-08-2	Caffeine results in decreased expression of SEC13 mRNA	decreases^expression	11793227
SEC13	6396	Catechin	D002392	154-23-4	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of SEC13 mRNA	affects^cotreatment|decreases^expression	24763279
SEC13	6396	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of SEC13 protein	decreases^expression	16622835
SEC13	6396	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of SEC13 mRNA	decreases^expression	19549813
SEC13	6396	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of SEC13 mRNA	decreases^expression	25562108
SEC13	6396	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of SEC13 mRNA	increases^expression	20106945
SEC13	6396	Doxorubicin	D004317	23214-92-8	Doxorubicin affects the expression of SEC13 mRNA	affects^expression	29803840
SEC13	6396	Gasoline	D005742		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SEC13 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
SEC13	6396	Glucose	D005947	50-99-7	Glucose deficiency results in decreased expression of SEC13 protein	decreases^expression	22314686
SEC13	6396	Grape Seed Proanthocyanidins	C511402		[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of SEC13 mRNA	affects^cotreatment|decreases^expression	24763279
SEC13	6396	isobutyl alcohol	C040507	78-83-1	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SEC13 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
SEC13	6396	MLN7243	C000622638		MLN7243 results in increased sumoylation of SEC13 protein	increases^sumoylation	31285264
SEC13	6396	Particulate Matter	D052638		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SEC13 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
SEC13	6396	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in decreased expression of SEC13 protein	decreases^expression	26879310
SEC13	6396	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SEC13 mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
SEC13	6396	Quartz	D011791	14808-60-7	Quartz affects the expression of SEC13 protein	affects^expression	27917503
SEC13	6396	Selenium	D012643	7782-49-2	Selenium results in increased expression of SEC13 mRNA	increases^expression	19244175
SEC13	6396	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide affects the expression of SEC13 protein	affects^expression	27917503
SEC13	6396	sodium arsenite	C017947	13768-07-5	sodium arsenite affects the expression of SEC13 mRNA	affects^expression	29301061
SEC13	6396	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of SEC13 mRNA	increases^expression	22378314
SEC13	6396	Thioacetamide	D013853	62-55-5	Thioacetamide results in decreased expression of SEC13 mRNA	decreases^expression	11793227
SEC13	6396	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of SEC13 mRNA	increases^expression	28065790
SEC13	6396	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of SEC13 mRNA	increases^expression	22378314|29453283
SEC13	6396	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of SEC13 gene	increases^methylation	29154799
SEC13	6396	Vitamin E	D014810	1406-18-4	Vitamin E results in increased expression of SEC13 mRNA	increases^expression	19244175
SEC13	6396	Zinc	D015032	7440-66-6	Zinc deficiency results in increased expression of SEC13 mRNA	increases^expression	22171008
SEH1L	81929	abrine	C496492		abrine results in decreased expression of SEH1L mRNA	decreases^expression	31054353
SEH1L	81929	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of SEH1L mRNA	decreases^expression	21420995
SEH1L	81929	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational results in decreased expression of SEH1L mRNA	decreases^expression	23195993
SEH1L	81929	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of SEH1L mRNA	decreases^expression	24449571
SEH1L	81929	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of SEH1L mRNA	decreases^expression	29275510
SEH1L	81929	Catechin	D002392	154-23-4	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of SEH1L mRNA	affects^cotreatment|increases^expression	24763279
SEH1L	81929	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of SEH1L mRNA	decreases^expression	27594783
SEH1L	81929	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of SEH1L mRNA	decreases^expression	19320972|19376846
SEH1L	81929	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of SEH1L mRNA	increases^expression	19549813
SEH1L	81929	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of SEH1L mRNA	decreases^expression	23649840
SEH1L	81929	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of SEH1L mRNA	decreases^expression	23649840
SEH1L	81929	Grape Seed Proanthocyanidins	C511402		[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of SEH1L mRNA	affects^cotreatment|increases^expression	24763279
SEH1L	81929	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of SEH1L mRNA	affects^expression	20044591
SEH1L	81929	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of SEH1L mRNA	decreases^expression	30851411
SEH1L	81929	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of SEH1L mRNA	increases^expression	28001369
SEH1L	81929	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of SEH1L mRNA	decreases^expression	23649840
SEH1L	81929	Nickel	D009532	7440-02-0	Nickel results in decreased expression of SEH1L mRNA	decreases^expression	23195993
SEH1L	81929	Nickel	D009532	7440-02-0	Nickel results in increased expression of SEH1L mRNA	increases^expression	24768652|25583101
SEH1L	81929	Plant Extracts	D010936		Plant Extracts results in increased expression of SEH1L mRNA	increases^expression	23557933
SEH1L	81929	Progesterone	D011374	57-83-0	Progesterone results in decreased expression of SEH1L mRNA	decreases^expression	18037150
SEH1L	81929	Sunitinib	D000077210		Sunitinib results in increased expression of SEH1L mRNA	increases^expression	31533062
SEH1L	81929	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of SEH1L mRNA	decreases^expression	21934132
SEH1L	81929	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of SEH1L mRNA	affects^expression	25979313
SEH1L	81929	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of SEH1L mRNA	decreases^expression	23179753|27188386
SEH1L	81929	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of SEH1L gene	decreases^methylation	29154799
SEH1L	81929	Vanadates	D014638		Vanadates results in decreased expression of SEH1L mRNA	decreases^expression	22714537
SEH1L	81929	Vitamin K 3	D024483	58-27-5	Vitamin K 3 affects the expression of SEH1L mRNA	affects^expression	20044591
SLC27A1	376497	3-iodothyronamine	C487948		SLC27A1 mRNA affects the uptake of 3-iodothyronamine	affects^uptake	19074582
SLC27A1	376497	6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	C475093		[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in decreased expression of SLC27A1 mRNA	affects^cotreatment|decreases^expression	30611723
SLC27A1	376497	abrine	C496492		abrine results in decreased expression of SLC27A1 mRNA	decreases^expression	31054353
SLC27A1	376497	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of SLC27A1 intron	increases^methylation	30157460
SLC27A1	376497	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of SLC27A1 intron	increases^methylation	30157460
SLC27A1	376497	afuresertib	C000593263		afuresertib results in increased expression of SLC27A1 mRNA	increases^expression	28960945
SLC27A1	376497	Alitretinoin	D000077556	08/03/5300	Alitretinoin results in increased expression of SLC27A1 mRNA	increases^expression	10777552
SLC27A1	376497	arsenite	C015001	15502-74-6	arsenite results in increased methylation of SLC27A1 promoter	increases^methylation	23974009
SLC27A1	376497	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of SLC27A1 mRNA	increases^expression	29275510
SLC27A1	376497	Calcitriol	D002117	32222-06-3	Calcitriol results in increased expression of SLC27A1 mRNA	increases^expression	21592394
SLC27A1	376497	Calcitriol	D002117	32222-06-3	[Testosterone co-treated with Calcitriol] results in increased expression of SLC27A1 mRNA	affects^cotreatment|increases^expression	21592394
SLC27A1	376497	Cisplatin	D002945	15663-27-1	Cisplatin affects the expression of SLC27A1 mRNA	affects^expression	23300844
SLC27A1	376497	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of SLC27A1 mRNA	affects^cotreatment|increases^expression	27392435
SLC27A1	376497	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of SLC27A1 mRNA	increases^expression	19549813
SLC27A1	376497	Decitabine	D000077209	2353-33-5	Decitabine affects the expression of SLC27A1 mRNA	affects^expression	23300844
SLC27A1	376497	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of SLC27A1 mRNA	decreases^expression	29803840
SLC27A1	376497	Farnesol	D005204	4602-84-0	[Farnesol analog co-treated with Oleic Acid] results in increased expression of SLC27A1 mRNA	affects^cotreatment|increases^expression	30611723
SLC27A1	376497	GW 4064	C412815		[GW 4064 co-treated with Oleic Acid] results in decreased expression of SLC27A1 mRNA	affects^cotreatment|decreases^expression	30611723
SLC27A1	376497	GW 7647	C453899		[GW 7647 co-treated with Oleic Acid] results in decreased expression of SLC27A1 mRNA	affects^cotreatment|decreases^expression	30611723
SLC27A1	376497	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of SLC27A1 mRNA	affects^cotreatment|increases^expression	27392435
SLC27A1	376497	jinfukang	C544151		jinfukang results in increased expression of SLC27A1 mRNA	increases^expression	27392435
SLC27A1	376497	Lead	D007854	7439-92-1	Lead affects the expression of SLC27A1 mRNA	affects^expression	28903495
SLC27A1	376497	Lead	D007854	7439-92-1	Lead results in decreased expression of SLC27A1 mRNA	decreases^expression	19921347
SLC27A1	376497	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of SLC27A1 mRNA	decreases^expression	17400583
SLC27A1	376497	MT19c compound	C568376		MT19c compound results in decreased expression of SLC27A1 mRNA	decreases^expression	21781307
SLC27A1	376497	Nickel	D009532	7440-02-0	Nickel results in decreased expression of SLC27A1 mRNA	decreases^expression	24768652|25583101
SLC27A1	376497	Oleic Acid	D019301	112-80-1	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in decreased expression of SLC27A1 mRNA	affects^cotreatment|decreases^expression	30611723
SLC27A1	376497	Oleic Acid	D019301	112-80-1	[Farnesol analog co-treated with Oleic Acid] results in increased expression of SLC27A1 mRNA	affects^cotreatment|increases^expression	30611723
SLC27A1	376497	Oleic Acid	D019301	112-80-1	[GW 4064 co-treated with Oleic Acid] results in decreased expression of SLC27A1 mRNA	affects^cotreatment|decreases^expression	30611723
SLC27A1	376497	Oleic Acid	D019301	112-80-1	[GW 7647 co-treated with Oleic Acid] results in decreased expression of SLC27A1 mRNA	affects^cotreatment|decreases^expression	30611723
SLC27A1	376497	Plant Oils	D010938		Plant Oils results in decreased expression of SLC27A1 mRNA	decreases^expression	23370395
SLC27A1	376497	Rosiglitazone	D000077154		Rosiglitazone results in decreased expression of SLC27A1 mRNA	decreases^expression	15619071|17148569
SLC27A1	376497	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in decreased expression of SLC27A1 mRNA	decreases^expression	25895662
SLC27A1	376497	Sodium Dodecyl Sulfate	D012967	151-21-3	Sodium Dodecyl Sulfate results in increased expression of SLC27A1 mRNA	increases^expression	31734321
SLC27A1	376497	Testosterone	D013739	58-22-0	[Testosterone co-treated with Calcitriol] results in increased expression of SLC27A1 mRNA	affects^cotreatment|increases^expression	21592394
SLC27A1	376497	Testosterone	D013739	58-22-0	Testosterone results in increased expression of SLC27A1 mRNA	increases^expression	21592394
SLC27A1	376497	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of SLC27A1 mRNA	affects^expression	22574217
SLC27A1	376497	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of SLC27A1 mRNA	decreases^expression	28065790
SLC27A1	376497	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of SLC27A1 mRNA	affects^expression	28542535
SLC27A1	376497	Urethane	D014520	51-79-6	Urethane results in increased expression of SLC27A1 mRNA	increases^expression	28818685
SLC27A1	376497	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of SLC27A1 mRNA	affects^expression	25979313
SLC27A1	376497	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of SLC27A1 mRNA	increases^expression	29154799|29501571
SLC27A1	376497	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of SLC27A1 gene	increases^methylation	29154799
SLC27A1	376497	Zoledronic Acid	D000077211		Zoledronic Acid results in increased expression of SLC27A1 mRNA	increases^expression	20977926
SLC27A4	10999	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of SLC27A4 mRNA	increases^expression	24767308
SLC27A4	10999	2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine	C532162		[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased expression of SLC27A4 mRNA	decreases^expression|increases^response to substance	20453058
SLC27A4	10999	2,2',3',4,4',5-hexachlorobiphenyl	C029790	35065-28-2	2,2',3',4,4',5-hexachlorobiphenyl affects the expression of SLC27A4 mRNA	affects^expression	21703328
SLC27A4	10999	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of SLC27A4 mRNA	decreases^expression	19095052
SLC27A4	10999	3,4,5,3',4'-pentachlorobiphenyl	C023035	57465-28-8	3,4,5,3',4'-pentachlorobiphenyl affects the expression of SLC27A4 mRNA	affects^expression	21703328
SLC27A4	10999	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC27A4 mRNA	affects^cotreatment|increases^expression	27188386
SLC27A4	10999	8-Bromo Cyclic Adenosine Monophosphate	D015124	23583-48-4	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC27A4 mRNA	decreases^expression	22079614
SLC27A4	10999	abrine	C496492		abrine results in decreased expression of SLC27A4 mRNA	decreases^expression	31054353
SLC27A4	10999	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of SLC27A4 mRNA	decreases^expression	21420995
SLC27A4	10999	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of SLC27A4 mRNA	increases^expression	29067470
SLC27A4	10999	Arbutin	D001104	497-76-7	Arbutin results in decreased expression of SLC27A4 mRNA	decreases^expression	17103032
SLC27A4	10999	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of SLC27A4 mRNA	affects^expression	30903817
SLC27A4	10999	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of SLC27A4 mRNA	decreases^expression	27594783
SLC27A4	10999	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of SLC27A4 mRNA	decreases^expression	19320972
SLC27A4	10999	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of SLC27A4 mRNA	increases^expression	28302478
SLC27A4	10999	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC27A4 mRNA	affects^cotreatment|increases^expression	27188386
SLC27A4	10999	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC27A4 mRNA	affects^cotreatment|decreases^expression	22079256
SLC27A4	10999	Estradiol	D004958	50-28-2	Estradiol affects the expression of SLC27A4 mRNA	affects^expression	22574217
SLC27A4	10999	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of SLC27A4 mRNA	increases^expression	24752549
SLC27A4	10999	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of SLC27A4 protein	increases^expression	24752549
SLC27A4	10999	Fenofibrate	D011345	49562-28-9	PPARA protein promotes the reaction [Fenofibrate results in increased expression of SLC27A4 protein]	increases^expression|increases^reaction	24752549
SLC27A4	10999	jinfukang	C544151		jinfukang results in increased expression of SLC27A4 mRNA	increases^expression	27392435
SLC27A4	10999	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in increased expression of SLC27A4 mRNA	increases^expression	24796395
SLC27A4	10999	Lactic Acid	D019344	50-21-5	Lactic Acid results in decreased expression of SLC27A4 mRNA	decreases^expression	30851411
SLC27A4	10999	linalool	C018584	78-70-6	linalool results in increased expression of SLC27A4 mRNA	increases^expression	24752549
SLC27A4	10999	linalool	C018584	78-70-6	linalool results in increased expression of SLC27A4 protein	increases^expression	24752549
SLC27A4	10999	linalool	C018584	78-70-6	PPARA protein promotes the reaction [linalool results in increased expression of SLC27A4 protein]	increases^expression|increases^reaction	24752549
SLC27A4	10999	Niacin	D009525		Niacin results in increased expression of SLC27A4 mRNA	increases^expression	24767308
SLC27A4	10999	Nickel	D009532	7440-02-0	Nickel results in increased expression of SLC27A4 mRNA	increases^expression	25583101
SLC27A4	10999	N-Nitrosopyrrolidine	D009242	930-55-2	N-Nitrosopyrrolidine results in increased expression of SLC27A4 mRNA	increases^expression	32234424
SLC27A4	10999	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of SLC27A4 mRNA	decreases^expression	26516004
SLC27A4	10999	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether analog results in decreased expression of SLC27A4 mRNA	decreases^expression	19095052
SLC27A4	10999	Polychlorinated Biphenyls	D011078		Polychlorinated Biphenyls affects the expression of SLC27A4 mRNA	affects^expression	21334430
SLC27A4	10999	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC27A4 mRNA	affects^cotreatment|decreases^expression	22079256
SLC27A4	10999	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of SLC27A4 mRNA	decreases^expression	22079256
SLC27A4	10999	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of SLC27A4 mRNA	increases^expression	23152189
SLC27A4	10999	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC27A4 mRNA	affects^cotreatment|increases^expression	27188386
SLC27A4	10999	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of SLC27A4 mRNA	affects^expression	25979313
SLC27A4	10999	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of SLC27A4 mRNA	increases^expression	23179753|24383497|26272509|28001369
SLC29A1	2030	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of SLC29A1 mRNA	increases^expression	24810058
SLC29A1	2030	2,3-bis(3'-hydroxybenzyl)butyrolactone	C029497	76543-15-2	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC29A1 mRNA	affects^cotreatment|increases^expression	19167446
SLC29A1	2030	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	C511621		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in decreased expression of SLC29A1 mRNA]	decreases^expression|decreases^reaction	28655636
SLC29A1	2030	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	C511621		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in decreased expression of SLC29A1 mRNA]	decreases^expression|decreases^reaction	28655636
SLC29A1	2030	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC29A1 mRNA	affects^cotreatment|decreases^expression	27188386
SLC29A1	2030	4-nitrobenzylthioinosine	C001789	38048-32-7	4-nitrobenzylthioinosine binds to SLC29A1 protein	affects^binding	28041785
SLC29A1	2030	4-nitrobenzylthioinosine	C001789	38048-32-7	4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]	affects^cotreatment|decreases^reaction|increases^uptake	10366666
SLC29A1	2030	4-nitrobenzylthioinosine	C001789	38048-32-7	4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in decreased susceptibility to Fluorouracil]	decreases^reaction|decreases^response to substance	17695509
SLC29A1	2030	4-nitrobenzylthioinosine	C001789	38048-32-7	4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of gemcitabine]	decreases^reaction|increases^uptake	17695509
SLC29A1	2030	4-nitrobenzylthioinosine	C001789	38048-32-7	4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]	decreases^reaction|increases^uptake	9353301|9396714
SLC29A1	2030	4-nitrobenzylthioinosine	C001789	38048-32-7	Cilostazol inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]	affects^binding|decreases^reaction	28041785
SLC29A1	2030	4-nitrobenzylthioinosine	C001789	38048-32-7	Dipyridamole inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]	affects^binding|decreases^reaction	28041785
SLC29A1	2030	4-nitrobenzylthioinosine	C001789	38048-32-7	Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]]	affects^cotreatment|decreases^reaction|increases^reaction|increases^uptake	10366666
SLC29A1	2030	4-nitrobenzylthioinosine	C001789	38048-32-7	draflazine inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]	affects^binding|decreases^reaction	28041785
SLC29A1	2030	4-nitrobenzylthioinosine	C001789	38048-32-7	Ticagrelor inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]	affects^binding|decreases^reaction	28041785
SLC29A1	2030	abrine	C496492		abrine results in decreased expression of SLC29A1 mRNA	decreases^expression	31054353
SLC29A1	2030	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of SLC29A1 mRNA	increases^expression	22230336
SLC29A1	2030	Adenosine	D000241	58-61-7	Cilostazol inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]	decreases^reaction|increases^uptake	28041785
SLC29A1	2030	Adenosine	D000241	58-61-7	Dipyridamole inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]	decreases^reaction|increases^uptake	28041785
SLC29A1	2030	Adenosine	D000241	58-61-7	draflazine inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]	decreases^reaction|increases^uptake	28041785
SLC29A1	2030	Adenosine	D000241	58-61-7	Ethanol promotes the reaction [SLC29A1 protein alternative form results in increased uptake of Adenosine]	increases^reaction|increases^uptake	21283641
SLC29A1	2030	Adenosine	D000241	58-61-7	Ethanol promotes the reaction [SLC29A1 protein results in increased uptake of Adenosine]	increases^reaction|increases^uptake	21283641
SLC29A1	2030	Adenosine	D000241	58-61-7	SLC29A1 protein alternative form results in increased uptake of Adenosine	increases^uptake	21283641
SLC29A1	2030	Adenosine	D000241	58-61-7	SLC29A1 protein results in increased uptake of Adenosine	increases^uptake	21283641|28041785|9396714
SLC29A1	2030	Adenosine	D000241	58-61-7	Ticagrelor inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]	decreases^reaction|increases^uptake	28041785
SLC29A1	2030	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of SLC29A1 protein	affects^expression	20106945
SLC29A1	2030	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of SLC29A1 gene	decreases^methylation	27153756
SLC29A1	2030	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of SLC29A1 mRNA	increases^expression	22100608|32234424
SLC29A1	2030	afuresertib	C000593263		afuresertib results in decreased expression of SLC29A1 mRNA	decreases^expression	28960945
SLC29A1	2030	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of SLC29A1 gene	affects^methylation	25304211
SLC29A1	2030	Arsenic Trioxide	D000077237	1327-53-3	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SLC29A1 mRNA	affects^cotreatment|increases^expression	15894607
SLC29A1	2030	Atrazine	D001280	1912-24-9	Atrazine results in increased expression of SLC29A1 mRNA	increases^expression	22378314
SLC29A1	2030	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of SLC29A1 5' UTR	affects^methylation	27901495
SLC29A1	2030	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of SLC29A1 mRNA	increases^expression	32234424
SLC29A1	2030	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of SLC29A1 promoter	increases^methylation	27901495
SLC29A1	2030	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of SLC29A1 mRNA	affects^expression	30903817
SLC29A1	2030	C646 compound	C584509		C646 compound results in decreased expression of SLC29A1 mRNA	decreases^expression	26191083
SLC29A1	2030	Cadmium	D002104	7440-43-9	Cadmium results in decreased expression of SLC29A1 mRNA	decreases^expression	23369406
SLC29A1	2030	Calcitriol	D002117	32222-06-3	Calcitriol results in decreased expression of SLC29A1 mRNA	decreases^expression	21592394
SLC29A1	2030	Calcitriol	D002117	32222-06-3	[Testosterone co-treated with Calcitriol] results in decreased expression of SLC29A1 mRNA	affects^cotreatment|decreases^expression	21592394
SLC29A1	2030	Cilostazol	D000077407	73963-72-1	Cilostazol inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]	affects^binding|decreases^reaction	28041785
SLC29A1	2030	Cilostazol	D000077407	73963-72-1	Cilostazol inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]	decreases^reaction|increases^uptake	28041785
SLC29A1	2030	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of SLC29A1 mRNA	affects^cotreatment|increases^expression	27392435
SLC29A1	2030	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of SLC29A1 mRNA	decreases^expression	27594783
SLC29A1	2030	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of SLC29A1 mRNA	increases^expression	27392435
SLC29A1	2030	Cisplatin	D002945	15663-27-1	SLC29A1 protein affects the susceptibility to Cisplatin	affects^response to substance	18728667
SLC29A1	2030	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of SLC29A1 mRNA	decreases^expression	19320972
SLC29A1	2030	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of SLC29A1 mRNA	affects^binding|decreases^expression	20971185
SLC29A1	2030	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of SLC29A1 mRNA	decreases^expression	19549813
SLC29A1	2030	Coumestrol	D003375	479-13-0	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC29A1 mRNA	affects^cotreatment|increases^expression	19167446
SLC29A1	2030	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of SLC29A1 mRNA	increases^expression	19167446
SLC29A1	2030	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of SLC29A1 mRNA	decreases^expression	21632981|25562108
SLC29A1	2030	Cytarabine	D003561	147-94-4	SLC29A1 gene polymorphism results in decreased susceptibility to Cytarabine	decreases^response to substance	18381442
SLC29A1	2030	Demecolcine	D003703	477-30-5	Demecolcine results in decreased expression of SLC29A1 mRNA	decreases^expression	23649840
SLC29A1	2030	Dilazep	D004109	35898-87-4	Dilazep inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]	decreases^reaction|increases^uptake	9353301|9396714
SLC29A1	2030	Dipyridamole	D004176	58-32-2	Dipyridamole inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]	affects^binding|decreases^reaction	28041785
SLC29A1	2030	Dipyridamole	D004176	58-32-2	Dipyridamole inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]	decreases^reaction|increases^uptake	28041785
SLC29A1	2030	Dipyridamole	D004176	58-32-2	Dipyridamole inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]	decreases^reaction|increases^uptake	9353301|9396714
SLC29A1	2030	Dipyridamole	D004176	58-32-2	Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]]	affects^cotreatment|decreases^reaction|increases^reaction|increases^uptake	10366666
SLC29A1	2030	Dipyridamole	D004176	58-32-2	Dipyridamole results in decreased activity of SLC29A1 protein	decreases^activity	21678404
SLC29A1	2030	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC29A1 mRNA	affects^cotreatment|decreases^expression	27188386
SLC29A1	2030	Doxorubicin	D004317	23214-92-8	Doxorubicin affects the expression of SLC29A1 mRNA	affects^expression	29803840
SLC29A1	2030	Doxorubicin	D004317	23214-92-8	SLC29A1 protein affects the susceptibility to Doxorubicin	affects^response to substance	18452103
SLC29A1	2030	draflazine	C072040		draflazine inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]	affects^binding|decreases^reaction	28041785
SLC29A1	2030	draflazine	C072040		draflazine inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]	decreases^reaction|increases^uptake	28041785
SLC29A1	2030	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in increased expression of SLC29A1 mRNA	affects^cotreatment|increases^expression	30165855
SLC29A1	2030	Estradiol	D004958	50-28-2	Estradiol results in increased expression of SLC29A1 mRNA	increases^expression	19167446
SLC29A1	2030	Ethanol	D000431	64-17-5	Ethanol promotes the reaction [SLC29A1 protein alternative form results in increased uptake of Adenosine]	increases^reaction|increases^uptake	21283641
SLC29A1	2030	Ethanol	D000431	64-17-5	Ethanol promotes the reaction [SLC29A1 protein results in increased uptake of Adenosine]	increases^reaction|increases^uptake	21283641
SLC29A1	2030	fialuridine	C043457	69123-98-4	SLC29A1 affects the susceptibility to fialuridine	affects^response to substance	31505000
SLC29A1	2030	Fluorouracil	D005472	51-21-8	4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in decreased susceptibility to Fluorouracil]	decreases^reaction|decreases^response to substance	17695509
SLC29A1	2030	Fluorouracil	D005472	51-21-8	Fluorouracil promotes the reaction [SLC29A1 protein results in increased uptake of gemcitabine]	increases^reaction|increases^uptake	16868479
SLC29A1	2030	Fluorouracil	D005472	51-21-8	Fluorouracil results in increased expression of SLC29A1	increases^expression	18383843
SLC29A1	2030	Fluorouracil	D005472	51-21-8	Fluorouracil results in increased expression of SLC29A1 mRNA	increases^expression	16868479
SLC29A1	2030	Fluorouracil	D005472	51-21-8	SLC29A1 protein affects the susceptibility to Fluorouracil	affects^response to substance	16217747
SLC29A1	2030	Fluorouracil	D005472	51-21-8	SLC29A1 protein results in decreased susceptibility to Fluorouracil	decreases^response to substance	17695509
SLC29A1	2030	gemcitabine	C056507	103882-84-4	4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of gemcitabine]	decreases^reaction|increases^uptake	17695509
SLC29A1	2030	gemcitabine	C056507	103882-84-4	Fluorouracil promotes the reaction [SLC29A1 protein results in increased uptake of gemcitabine]	increases^reaction|increases^uptake	16868479
SLC29A1	2030	gemcitabine	C056507	103882-84-4	[S 1 (combination) results in increased expression of SLC29A1 mRNA] which results in increased uptake of gemcitabine	increases^expression|increases^uptake	18383843
SLC29A1	2030	gemcitabine	C056507	103882-84-4	SLC29A1 mRNA results in increased susceptibility to gemcitabine	increases^response to substance	18490900
SLC29A1	2030	gemcitabine	C056507	103882-84-4	SLC29A1 protein affects the susceptibility to gemcitabine	affects^response to substance	18452103|18728667|26894857
SLC29A1	2030	gemcitabine	C056507	103882-84-4	SLC29A1 protein results in decreased susceptibility to gemcitabine	decreases^response to substance	17695509
SLC29A1	2030	gemcitabine	C056507	103882-84-4	SLC29A1 protein results in increased susceptibility to gemcitabine	increases^response to substance	15501974|18992248
SLC29A1	2030	gemcitabine	C056507	103882-84-4	SLC29A1 protein results in increased uptake of gemcitabine	increases^uptake	16868479|17695509|18383843|18992248
SLC29A1	2030	GSK-J4	C000593030		GSK-J4 results in decreased expression of SLC29A1 mRNA	decreases^expression	29301935
SLC29A1	2030	ICG 001	C492448		ICG 001 results in decreased expression of SLC29A1 mRNA	decreases^expression	26191083
SLC29A1	2030	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of SLC29A1 mRNA	affects^cotreatment|increases^expression	27392435
SLC29A1	2030	jinfukang	C544151		jinfukang results in increased expression of SLC29A1 mRNA	increases^expression	27392435
SLC29A1	2030	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of SLC29A1 mRNA	decreases^expression	24796395
SLC29A1	2030	Lidoflazine	D008013	3416-26-0	Lidoflazine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]	decreases^reaction|increases^uptake	9396714
SLC29A1	2030	methyleugenol	C005223	93-15-2	methyleugenol results in increased expression of SLC29A1 mRNA	increases^expression	32234424
SLC29A1	2030	Methylthioinosine	D008778	342-69-8	SLC29A1 mRNA affects the transport of Methylthioinosine	affects^transport	16859645
SLC29A1	2030	Mustard Gas	D009151	505-60-2	Mustard Gas results in decreased expression of SLC29A1 mRNA	decreases^expression	25102026
SLC29A1	2030	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of SLC29A1 mRNA	affects^binding|decreases^expression	20971185
SLC29A1	2030	Particulate Matter	D052638		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in decreased expression of SLC29A1 mRNA]	decreases^expression|decreases^reaction	28655636
SLC29A1	2030	Particulate Matter	D052638		Particulate Matter results in decreased expression of SLC29A1 mRNA	decreases^expression	28655636
SLC29A1	2030	Plant Extracts	D010936		Plant Extracts results in decreased expression of SLC29A1 mRNA	decreases^expression	24677778
SLC29A1	2030	Quercetin	D011794	117-39-5	Quercetin results in increased expression of SLC29A1 mRNA	increases^expression	21632981
SLC29A1	2030	Ribavirin	D012254	36791-04-5	SLC29A1 protein results in increased uptake of Ribavirin	increases^uptake	20185188
SLC29A1	2030	Rifampin	D012293	13292-46-1	Rifampin results in increased expression of SLC29A1 mRNA	increases^expression	27199754
SLC29A1	2030	Rotenone	D012402	83-79-4	Rotenone results in increased expression of SLC29A1 mRNA	increases^expression	29955902
SLC29A1	2030	S 1 (combination)	C079198	150863-82-4	S 1 (combination) results in increased expression of SLC29A1 mRNA	increases^expression	18383843
SLC29A1	2030	S 1 (combination)	C079198	150863-82-4	[S 1 (combination) results in increased expression of SLC29A1 mRNA] which results in increased uptake of gemcitabine	increases^expression|increases^uptake	18383843
SLC29A1	2030	Selenium	D012643	7782-49-2	[Selenium co-treated with Vitamin E] results in increased expression of SLC29A1 mRNA	affects^cotreatment|increases^expression	19244175
SLC29A1	2030	seocalcitol	C078903	134404-52-7	seocalcitol results in decreased expression of SLC29A1 mRNA	decreases^expression	12040012
SLC29A1	2030	Sunitinib	D000077210		Sunitinib results in increased expression of SLC29A1 mRNA	increases^expression	31533062
SLC29A1	2030	Testosterone	D013739	58-22-0	[Testosterone co-treated with Calcitriol] results in decreased expression of SLC29A1 mRNA	affects^cotreatment|decreases^expression	21592394
SLC29A1	2030	Testosterone	D013739	58-22-0	Testosterone results in decreased expression of SLC29A1 mRNA	decreases^expression	21592394
SLC29A1	2030	Ticagrelor	D000077486		Ticagrelor inhibits the reaction [4-nitrobenzylthioinosine binds to SLC29A1 protein]	affects^binding|decreases^reaction	28041785
SLC29A1	2030	Ticagrelor	D000077486		Ticagrelor inhibits the reaction [SLC29A1 protein results in increased uptake of Adenosine]	decreases^reaction|increases^uptake	28041785
SLC29A1	2030	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of SLC29A1 mRNA	decreases^expression	28065790
SLC29A1	2030	Tretinoin	D014212	302-79-4	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SLC29A1 mRNA	affects^cotreatment|increases^expression	15894607
SLC29A1	2030	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of SLC29A1 mRNA	decreases^expression	23724009
SLC29A1	2030	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of SLC29A1 mRNA	increases^expression	15894607
SLC29A1	2030	Triclosan	D014260	3380-34-5	Triclosan results in decreased expression of SLC29A1 mRNA	decreases^expression	30510588
SLC29A1	2030	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of SLC29A1 mRNA	decreases^expression	26179874
SLC29A1	2030	UFT(R) drug	C096910		UFT(R) drug results in increased expression of SLC29A1 mRNA	increases^expression	16868479
SLC29A1	2030	Urethane	D014520	51-79-6	Urethane results in increased expression of SLC29A1 mRNA	increases^expression	28818685
SLC29A1	2030	Uridine	D014529	58-96-8	4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]	affects^cotreatment|decreases^reaction|increases^uptake	10366666
SLC29A1	2030	Uridine	D014529	58-96-8	4-nitrobenzylthioinosine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]	decreases^reaction|increases^uptake	9353301|9396714
SLC29A1	2030	Uridine	D014529	58-96-8	Dilazep inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]	decreases^reaction|increases^uptake	9353301|9396714
SLC29A1	2030	Uridine	D014529	58-96-8	Dipyridamole inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]	decreases^reaction|increases^uptake	9353301|9396714
SLC29A1	2030	Uridine	D014529	58-96-8	Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]]	affects^cotreatment|decreases^reaction|increases^reaction|increases^uptake	10366666
SLC29A1	2030	Uridine	D014529	58-96-8	Lidoflazine inhibits the reaction [SLC29A1 protein results in increased uptake of Uridine]	decreases^reaction|increases^uptake	9396714
SLC29A1	2030	Uridine	D014529	58-96-8	[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine	affects^cotreatment|increases^uptake	10366666
SLC29A1	2030	Uridine	D014529	58-96-8	SLC29A1 protein results in increased uptake of Uridine	increases^uptake	10366666|18381442|9353301|9396714
SLC29A1	2030	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC29A1 mRNA	affects^cotreatment|decreases^expression	27188386
SLC29A1	2030	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of SLC29A1 mRNA	decreases^expression	26272509
SLC29A1	2030	Vehicle Emissions	D001335		2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in decreased expression of SLC29A1 mRNA]	decreases^expression|decreases^reaction	28655636
SLC29A1	2030	Vehicle Emissions	D001335		Vehicle Emissions results in decreased expression of SLC29A1 mRNA	decreases^expression	28655636
SLC29A1	2030	Vincristine	D014750		Vincristine results in decreased expression of SLC29A1 mRNA	decreases^expression	23649840
SLC29A1	2030	Vinorelbine	D000077235	71486-22-1	SLC29A1 protein affects the susceptibility to Vinorelbine	affects^response to substance	18452103
SLC29A1	2030	Vitamin E	D014810	1406-18-4	[Selenium co-treated with Vitamin E] results in increased expression of SLC29A1 mRNA	affects^cotreatment|increases^expression	19244175
SLC29A1	2030	Vitamin E	D014810	1406-18-4	Vitamin E results in increased expression of SLC29A1 mRNA	increases^expression	19244175
SLC29A1	2030	Zidovudine	D015215	30516-87-1	Zidovudine results in increased expression of SLC29A1 mRNA	increases^expression	24292225
SLC29A2	3177	3-iodothyronamine	C487948		SLC29A2 mRNA affects the uptake of 3-iodothyronamine	affects^uptake	19074582
SLC29A2	3177	4-nitrobenzylthioinosine	C001789	38048-32-7	4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]	affects^cotreatment|decreases^reaction|increases^uptake	10366666
SLC29A2	3177	4-nitrobenzylthioinosine	C001789	38048-32-7	Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]]	affects^cotreatment|decreases^reaction|increases^reaction|increases^uptake	10366666
SLC29A2	3177	abrine	C496492		abrine results in decreased expression of SLC29A2 mRNA	decreases^expression	31054353
SLC29A2	3177	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of SLC29A2 mRNA	decreases^expression	29067470
SLC29A2	3177	Adenosine	D000241	58-61-7	SLC29A2 protein results in increased uptake of Adenosine	increases^uptake	9396714
SLC29A2	3177	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of SLC29A2 gene	affects^methylation	25304211
SLC29A2	3177	Azacitidine	D001374	320-67-2	Azacitidine results in decreased expression of SLC29A2 mRNA	decreases^expression	19194470
SLC29A2	3177	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	bis(4-hydroxyphenyl)sulfone results in increased expression of SLC29A2 mRNA	increases^expression	27685785
SLC29A2	3177	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of SLC29A2 mRNA	increases^expression	27685785
SLC29A2	3177	Cadmium	D002104	7440-43-9	Cadmium results in increased expression of SLC29A2 mRNA	increases^expression	24376830
SLC29A2	3177	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of SLC29A2 mRNA	affects^cotreatment|increases^expression	27392435
SLC29A2	3177	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of SLC29A2 mRNA	decreases^expression	27594783
SLC29A2	3177	Copper	D003300	7440-50-8	[NSC 689534 binds to Copper] which results in decreased expression of SLC29A2 mRNA	affects^binding|decreases^expression	20971185
SLC29A2	3177	Decitabine	D000077209	2353-33-5	Decitabine results in decreased expression of SLC29A2 mRNA	decreases^expression	19194470
SLC29A2	3177	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of SLC29A2 mRNA	increases^expression	28302478
SLC29A2	3177	Dipyridamole	D004176	58-32-2	Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]]	affects^cotreatment|decreases^reaction|increases^reaction|increases^uptake	10366666
SLC29A2	3177	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of SLC29A2 mRNA	decreases^expression	29803840
SLC29A2	3177	Environmental Pollutants	D004785		Environmental Pollutants affects the expression of SLC29A2 mRNA	affects^expression	19118595
SLC29A2	3177	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC29A2 mRNA	affects^cotreatment|decreases^expression	30165855
SLC29A2	3177	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of SLC29A2 mRNA	decreases^expression	23649840
SLC29A2	3177	fatostatin	C545733		fatostatin results in decreased expression of SLC29A2 mRNA	decreases^expression	19716478
SLC29A2	3177	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of SLC29A2 mRNA	decreases^expression	23649840
SLC29A2	3177	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of SLC29A2 mRNA	affects^cotreatment|increases^expression	27392435
SLC29A2	3177	jinfukang	C544151		jinfukang results in increased expression of SLC29A2 mRNA	increases^expression	27392435
SLC29A2	3177	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of SLC29A2 mRNA	decreases^expression	23649840
SLC29A2	3177	NSC 689534	C558013		[NSC 689534 binds to Copper] which results in decreased expression of SLC29A2 mRNA	affects^binding|decreases^expression	20971185
SLC29A2	3177	Particulate Matter	D052638		Particulate Matter results in increased expression of SLC29A2 mRNA	increases^expression	31520698
SLC29A2	3177	Rotenone	D012402	83-79-4	Rotenone results in increased expression of SLC29A2 mRNA	increases^expression	29955902
SLC29A2	3177	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide results in decreased expression of SLC29A2 mRNA	decreases^expression	25351596
SLC29A2	3177	Sunitinib	D000077210		Sunitinib results in increased expression of SLC29A2 mRNA	increases^expression	31533062
SLC29A2	3177	Thimerosal	D013849	54-64-8	Thimerosal results in decreased expression of SLC29A2 mRNA	decreases^expression	27188386
SLC29A2	3177	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of SLC29A2 mRNA	decreases^expression	28065790
SLC29A2	3177	trans-10,cis-12-conjugated linoleic acid	C496197		trans-10,cis-12-conjugated linoleic acid results in increased expression of SLC29A2 mRNA	increases^expression	17951470
SLC29A2	3177	Triclosan	D014260	3380-34-5	Triclosan results in decreased expression of SLC29A2 mRNA	decreases^expression	30510588
SLC29A2	3177	Uridine	D014529	58-96-8	4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]	affects^cotreatment|decreases^reaction|increases^uptake	10366666
SLC29A2	3177	Uridine	D014529	58-96-8	Dipyridamole promotes the reaction [4-nitrobenzylthioinosine inhibits the reaction [[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine]]	affects^cotreatment|decreases^reaction|increases^reaction|increases^uptake	10366666
SLC29A2	3177	Uridine	D014529	58-96-8	[SLC29A1 protein co-treated with SLC29A2 protein] results in increased uptake of Uridine	affects^cotreatment|increases^uptake	10366666
SLC29A2	3177	Uridine	D014529	58-96-8	SLC29A2 protein results in increased uptake of Uridine	increases^uptake	10366666|9396714
SLC29A2	3177	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of SLC29A2 mRNA	affects^expression	25979313
SLC29A2	3177	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of SLC29A2 gene	increases^methylation	29154799
SLC29A2	3177	Vincristine	D014750		Vincristine results in decreased expression of SLC29A2 mRNA	decreases^expression	23649840
SLC29A2	3177	Zinc	D015032	7440-66-6	Zinc deficiency results in increased expression of SLC29A2 mRNA	increases^expression	18356318
SLC46A1	113235	3-iodothyronamine	C487948		SLC46A1 mRNA affects the uptake of 3-iodothyronamine	affects^uptake	19074582
SLC46A1	113235	4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid	D017878	53005-05-3	4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid	D017878	53005-05-3	4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of SLC46A1 protein	decreases^activity	17475902
SLC46A1	113235	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC46A1 mRNA	affects^cotreatment|increases^expression	27188386
SLC46A1	113235	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC46A1 mRNA	affects^cotreatment|increases^expression	27188386
SLC46A1	113235	5-methyltetrahydrofolate	C005984	134-35-0	5-methyltetrahydrofolate inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	5-methyltetrahydrofolate	C005984	134-35-0	5-methyltetrahydrofolate results in decreased activity of SLC46A1 protein	decreases^activity	17475902
SLC46A1	113235	abrine	C496492		abrine results in decreased expression of SLC46A1 mRNA	decreases^expression	31054353
SLC46A1	113235	Adenosine Triphosphate	D000255	56-65-5	[SLC46A1 protein results in increased susceptibility to N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid] which results in decreased chemical synthesis of Adenosine Triphosphate	decreases^chemical synthesis|increases^response to substance	21879757
SLC46A1	113235	AM 251	C103505		AM 251 results in increased expression of SLC46A1 mRNA	increases^expression	19145103
SLC46A1	113235	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of SLC46A1 mRNA	decreases^expression	24449571
SLC46A1	113235	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of SLC46A1 promoter	affects^methylation	27901495
SLC46A1	113235	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of SLC46A1 mRNA	decreases^expression	32234424
SLC46A1	113235	Cadmium	D002104	7440-43-9	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC46A1 mRNA	decreases^expression|increases^abundance	32645461
SLC46A1	113235	Cadmium	D002104	7440-43-9	Cadmium results in increased expression of SLC46A1 mRNA	increases^expression	17156779
SLC46A1	113235	Cadmium Chloride	D019256	10108-64-2	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC46A1 mRNA	decreases^expression|increases^abundance	32645461
SLC46A1	113235	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of SLC46A1 mRNA	increases^expression	17156779
SLC46A1	113235	Calcitriol	D002117	32222-06-3	Calcitriol results in increased expression of SLC46A1 mRNA	increases^expression	16002434|26485663|27107558
SLC46A1	113235	Cholecalciferol	D002762	67-97-0	Cholecalciferol results in increased expression of SLC46A1 mRNA	increases^expression	22474172
SLC46A1	113235	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of SLC46A1 mRNA	affects^cotreatment|increases^expression	27392435
SLC46A1	113235	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of SLC46A1 mRNA	increases^expression	27392435
SLC46A1	113235	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of SLC46A1 mRNA	decreases^expression	19549813
SLC46A1	113235	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of SLC46A1 mRNA	decreases^expression	20106945|25562108
SLC46A1	113235	Decitabine	D000077209	2353-33-5	[Decitabine affects the methylation of SLC46A1 promoter] which affects the expression of SLC46A1 mRNA	affects^expression|affects^methylation	18817749
SLC46A1	113235	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC46A1 mRNA	affects^cotreatment|increases^expression	27188386
SLC46A1	113235	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC46A1 mRNA	affects^cotreatment|increases^expression	27188386
SLC46A1	113235	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of SLC46A1 mRNA	decreases^expression	29803840
SLC46A1	113235	Dronabinol	D013759		Dronabinol results in decreased expression of SLC46A1 mRNA	decreases^expression	19145103
SLC46A1	113235	Estradiol	D004958	50-28-2	Estradiol results in increased expression of SLC46A1 mRNA	increases^expression	23019147
SLC46A1	113235	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of SLC46A1 mRNA	increases^expression	23649840
SLC46A1	113235	Folic Acid	D005492	59-30-3	4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	Folic Acid	D005492	59-30-3	5-methyltetrahydrofolate inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	Folic Acid	D005492	59-30-3	Folic Acid deficiency results in decreased expression of SLC46A1 mRNA	decreases^expression	20465997
SLC46A1	113235	Folic Acid	D005492	59-30-3	Folic Acid results in decreased expression of SLC46A1 mRNA	decreases^expression	17616776
SLC46A1	113235	Folic Acid	D005492	59-30-3	Leucovorin inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	Folic Acid	D005492	59-30-3	Methotrexate inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	Folic Acid	D005492	59-30-3	SLC46A1 protein results in increased transport of Folic Acid	increases^transport	17129779|17446347|17475902|19762432
SLC46A1	113235	Folic Acid	D005492	59-30-3	Sulfobromophthalein inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of SLC46A1 mRNA	increases^expression	23649840
SLC46A1	113235	Heme	D006418	14875-96-8	SLC46A1 protein promotes the reaction [Heme results in increased expression of HMOX1 mRNA]	increases^expression|increases^reaction	17156779
SLC46A1	113235	Heme	D006418	14875-96-8	SLC46A1 protein results in increased uptake of Heme	increases^uptake	17156779
SLC46A1	113235	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of SLC46A1 mRNA	affects^expression	20044591
SLC46A1	113235	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of SLC46A1 mRNA	affects^cotreatment|increases^expression	27392435
SLC46A1	113235	Leucovorin	D002955	58-05-9	Leucovorin inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	Leucovorin	D002955	58-05-9	Leucovorin results in decreased activity of SLC46A1 protein	decreases^activity	17475902
SLC46A1	113235	lometrexol	C045894	95693-76-8	SLC46A1 protein results in increased susceptibility to lometrexol	increases^response to substance	21879757
SLC46A1	113235	Methotrexate	D008727	59-05-2	Methotrexate inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	Methotrexate	D008727	59-05-2	Methotrexate results in decreased activity of SLC46A1 protein	decreases^activity	17475902
SLC46A1	113235	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of SLC46A1 mRNA	decreases^expression	24449571
SLC46A1	113235	Methotrexate	D008727	59-05-2	N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid inhibits the reaction [SLC46A1 protein results in increased uptake of Methotrexate]	decreases^reaction|increases^uptake	21879757
SLC46A1	113235	Methotrexate	D008727	59-05-2	Pemetrexed inhibits the reaction [SLC46A1 protein results in increased uptake of Methotrexate]	decreases^reaction|increases^uptake	21879757
SLC46A1	113235	Methotrexate	D008727	59-05-2	SLC46A1 gene SNP results in increased susceptibility to Methotrexate	increases^response to substance	25124723
SLC46A1	113235	Methotrexate	D008727	59-05-2	SLC46A1 protein results in increased susceptibility to Methotrexate	increases^response to substance	21879757
SLC46A1	113235	Methotrexate	D008727	59-05-2	SLC46A1 protein results in increased transport of Methotrexate	increases^transport	17475902|19762432
SLC46A1	113235	Methotrexate	D008727	59-05-2	SLC46A1 protein results in increased uptake of Methotrexate	increases^uptake	21879757
SLC46A1	113235	Methotrexate	D008727	59-05-2	Sulfasalazine inhibits the reaction [SLC46A1 protein results in increased transport of Methotrexate]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in increased expression of SLC46A1 mRNA	increases^expression	23649840
SLC46A1	113235	N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid	C568952		N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid inhibits the reaction [SLC46A1 protein results in increased uptake of Methotrexate]	decreases^reaction|increases^uptake	21879757
SLC46A1	113235	N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid	C568952		N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid results in increased activity of SLC46A1 protein	increases^activity	21879757
SLC46A1	113235	N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid	C568952		SLC46A1 protein results in increased susceptibility to N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid	increases^response to substance	21879757
SLC46A1	113235	N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid	C568952		[SLC46A1 protein results in increased susceptibility to N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid] which results in decreased activity of GART protein	decreases^activity|increases^response to substance	21879757
SLC46A1	113235	N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid	C568952		[SLC46A1 protein results in increased susceptibility to N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid] which results in decreased chemical synthesis of Adenosine Triphosphate	decreases^chemical synthesis|increases^response to substance	21879757
SLC46A1	113235	Pemetrexed	D000068437		Pemetrexed inhibits the reaction [SLC46A1 protein results in increased uptake of Methotrexate]	decreases^reaction|increases^uptake	21879757
SLC46A1	113235	Pemetrexed	D000068437		Pemetrexed results in increased activity of SLC46A1 protein	increases^activity	21879757
SLC46A1	113235	Pemetrexed	D000068437		SLC46A1 protein results in increased susceptibility to Pemetrexed	increases^response to substance	21879757
SLC46A1	113235	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC46A1 mRNA	affects^cotreatment|increases^expression	27188386
SLC46A1	113235	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of SLC46A1 mRNA	increases^expression	26272509
SLC46A1	113235	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in increased expression of SLC46A1 mRNA	increases^expression	22714537
SLC46A1	113235	Proton Pump Inhibitors	D054328		Proton Pump Inhibitors results in decreased expression of SLC46A1 mRNA	decreases^expression	19762432
SLC46A1	113235	Pyrimethamine	D011739	58-14-0	Pyrimethamine results in decreased activity of SLC46A1 protein	decreases^activity	19762432
SLC46A1	113235	raltitrexed	C068874		SLC46A1 protein results in increased susceptibility to raltitrexed	increases^response to substance	21879757
SLC46A1	113235	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of SLC46A1 mRNA	decreases^expression	28595984
SLC46A1	113235	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of SLC46A1 mRNA	increases^expression	22714537
SLC46A1	113235	Sulfasalazine	D012460	599-79-1	Sulfasalazine inhibits the reaction [SLC46A1 protein results in increased transport of Methotrexate]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	Sulfasalazine	D012460	599-79-1	Sulfasalazine results in decreased activity of SLC46A1 protein	decreases^activity	17475902|19762432
SLC46A1	113235	Sulfobromophthalein	D013448	297-83-6	Sulfobromophthalein inhibits the reaction [SLC46A1 protein results in increased transport of Folic Acid]	decreases^reaction|increases^transport	17475902
SLC46A1	113235	Sulfobromophthalein	D013448	297-83-6	Sulfobromophthalein results in decreased activity of SLC46A1 protein	decreases^activity	17475902
SLC46A1	113235	Sunitinib	D000077210		Sunitinib results in decreased expression of SLC46A1 mRNA	decreases^expression	31533062
SLC46A1	113235	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in decreased expression of SLC46A1 mRNA	decreases^expression	22956110
SLC46A1	113235	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of SLC46A1 mRNA	affects^expression	22574217
SLC46A1	113235	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of SLC46A1 mRNA	increases^expression	29453283
SLC46A1	113235	Urethane	D014520	51-79-6	Urethane results in decreased expression of SLC46A1 mRNA	decreases^expression	28818685
SLC46A1	113235	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC46A1 mRNA	affects^cotreatment|increases^expression	27188386
SLC46A1	113235	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of SLC46A1 gene	decreases^methylation	29154799
SLC46A1	113235	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of SLC46A1 mRNA	increases^expression	23179753|24383497|26272509|28001369|29223574
SLC5A6	8884	2,4-Dinitrophenol	D019297	51-28-5	2,4-Dinitrophenol inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	4-Chloromercuribenzenesulfonate	D002731	554-77-8	4-Chloromercuribenzenesulfonate inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of SLC5A6 mRNA	increases^expression	29067470
SLC5A6	8884	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of SLC5A6 gene	increases^methylation	27153756
SLC5A6	8884	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of SLC5A6 mRNA	increases^expression	20458559
SLC5A6	8884	Azides	D001386		Azides inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of SLC5A6 5' UTR	increases^methylation	27901495
SLC5A6	8884	Biotin	D001710	58-85-5	2,4-Dinitrophenol inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	4-Chloromercuribenzenesulfonate inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	Azides inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	Biotin affects the expression of SLC5A6 mRNA	affects^expression	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	Biotin affects the expression of SLC5A6 protein	affects^expression	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	calmidazolium inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	chelerythrine inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	Gramicidin inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	Iodoacetates inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	Ouabain inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	Probenecid inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	SLC5A6 protein results in increased transport of Biotin	increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	SLC5A6 results in increased transport of Biotin	increases^transport	10329687
SLC5A6	8884	Biotin	D001710	58-85-5	SLC5A6 results in increased uptake of Biotin	increases^uptake	12646417
SLC5A6	8884	Biotin	D001710	58-85-5	Sodium affects the reaction [SLC5A6 results in increased transport of Biotin]	affects^reaction|increases^transport	10329687
SLC5A6	8884	Biotin	D001710	58-85-5	Sodium promotes the reaction [SLC5A6 protein results in increased transport of Biotin]	increases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	Staurosporine inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	Tetradecanoylphorbol Acetate promotes the reaction [SLC5A6 protein results in increased transport of Biotin]	increases^reaction|increases^transport	15561972
SLC5A6	8884	Biotin	D001710	58-85-5	Trifluoperazine inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of SLC5A6 mRNA	affects^expression	30903817
SLC5A6	8884	butyraldehyde	C018475	123-72-8	butyraldehyde results in decreased expression of SLC5A6 mRNA	decreases^expression	26079696
SLC5A6	8884	C646 compound	C584509		C646 compound results in decreased expression of SLC5A6 mRNA	decreases^expression	26191083
SLC5A6	8884	calmidazolium	C031938		calmidazolium inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	chelerythrine	C016299	34316-15-9	chelerythrine inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of SLC5A6 mRNA	decreases^expression	19320972
SLC5A6	8884	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in decreased expression of SLC5A6 mRNA	decreases^expression	19549813
SLC5A6	8884	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of SLC5A6 mRNA	increases^expression	28302478
SLC5A6	8884	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC5A6 mRNA	affects^cotreatment|decreases^expression	22079256
SLC5A6	8884	Estradiol	D004958	50-28-2	Estradiol results in increased expression of SLC5A6 mRNA	increases^expression	23019147
SLC5A6	8884	Genistein	D019833	446-72-0	Genistein results in increased expression of SLC5A6 mRNA	increases^expression	23019147
SLC5A6	8884	Gramicidin	D006096	1405-97-6	Gramicidin inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of SLC5A6 mRNA	affects^expression	20044591
SLC5A6	8884	Iodoacetates	D007461		Iodoacetates inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Isotretinoin	D015474	4759-48-2	Isotretinoin results in decreased expression of SLC5A6 mRNA	decreases^expression	20436886
SLC5A6	8884	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of SLC5A6 mRNA	decreases^expression	23430699
SLC5A6	8884	K 7174	C410337		K 7174 results in decreased expression of SLC5A6 mRNA	decreases^expression	24086573
SLC5A6	8884	Ouabain	D010042	630-60-4	Ouabain inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of SLC5A6 mRNA	decreases^expression	26516004
SLC5A6	8884	Pantothenic Acid	D010205	79-83-4	SLC5A6 results in increased transport of Pantothenic Acid	increases^transport	10329687
SLC5A6	8884	Pantothenic Acid	D010205	79-83-4	Sodium affects the reaction [SLC5A6 results in increased transport of Pantothenic Acid]	affects^reaction|increases^transport	10329687
SLC5A6	8884	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC5A6 mRNA	affects^cotreatment|decreases^expression	22079256
SLC5A6	8884	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of SLC5A6 mRNA	decreases^expression	22079256
SLC5A6	8884	Probenecid	D011339	57-66-9	Probenecid inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in increased expression of SLC5A6 mRNA	increases^expression	25895662
SLC5A6	8884	Sodium	D012964	7440-23-5	Sodium affects the reaction [SLC5A6 results in increased transport of Biotin]	affects^reaction|increases^transport	10329687
SLC5A6	8884	Sodium	D012964	7440-23-5	Sodium affects the reaction [SLC5A6 results in increased transport of Pantothenic Acid]	affects^reaction|increases^transport	10329687
SLC5A6	8884	Sodium	D012964	7440-23-5	Sodium affects the reaction [SLC5A6 results in increased transport of Thioctic Acid]	affects^reaction|increases^transport	10329687
SLC5A6	8884	Sodium	D012964	7440-23-5	Sodium promotes the reaction [SLC5A6 protein results in increased transport of Biotin]	increases^reaction|increases^transport	15561972
SLC5A6	8884	Staurosporine	D019311	62996-74-1	Staurosporine inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of SLC5A6 mRNA	affects^expression	22298810
SLC5A6	8884	Tetradecanoylphorbol Acetate	D013755	16561-29-8	Tetradecanoylphorbol Acetate promotes the reaction [SLC5A6 protein results in increased transport of Biotin]	increases^reaction|increases^transport	15561972
SLC5A6	8884	Thioctic Acid	D008063	62-46-4	SLC5A6 results in increased transport of Thioctic Acid	increases^transport	10329687
SLC5A6	8884	Thioctic Acid	D008063	62-46-4	Sodium affects the reaction [SLC5A6 results in increased transport of Thioctic Acid]	affects^reaction|increases^transport	10329687
SLC5A6	8884	Trifluoperazine	D014268	117-89-5	Trifluoperazine inhibits the reaction [SLC5A6 protein results in increased transport of Biotin]	decreases^reaction|increases^transport	15561972
SLC5A6	8884	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of SLC5A6 mRNA	affects^expression	25979313
SLC5A6	8884	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of SLC5A6 gene	increases^methylation	29154799
TARS1	6897	1-nitropyrene	C032668	5522-43-0	1-nitropyrene results in increased expression of TARS1 mRNA	increases^expression	19041380
TARS1	6897	2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine	C532162		[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased expression of TARS1 mRNA	decreases^expression|increases^response to substance	20453058
TARS1	6897	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone	C016583	64091-91-4	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TARS1 mRNA	increases^expression	19038236
TARS1	6897	afimoxifene	C016601	68392-35-8	afimoxifene results in decreased expression of TARS1 mRNA	decreases^expression	16514628
TARS1	6897	Ascorbic Acid	D001205	50-81-7	Ascorbic Acid results in decreased expression of TARS1 mRNA	decreases^expression	19197388
TARS1	6897	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of TARS1 mRNA	decreases^expression	20678512
TARS1	6897	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of TARS1 mRNA	increases^expression	29275510
TARS1	6897	borrelidin	C005066	7184-60-3	borrelidin analog binds to and affects the folding of TARS1 protein	affects^binding|affects^folding	26271225
TARS1	6897	borrelidin	C005066	7184-60-3	borrelidin binds to and affects the folding of TARS1 protein	affects^binding|affects^folding	26271225
TARS1	6897	borrelidin	C005066	7184-60-3	borrelidin binds to and results in decreased activity of TARS1 protein	affects^binding|decreases^activity	25824639
TARS1	6897	borrelidin	C005066	7184-60-3	borrelidin results in decreased activity of TARS1 protein	decreases^activity	25489076
TARS1	6897	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of TARS1 mRNA	increases^expression	25596134
TARS1	6897	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde results in decreased expression of TARS1 mRNA	decreases^expression	25596134
TARS1	6897	chloropicrin	C100187	76-06-2	chloropicrin affects the expression of TARS1 mRNA	affects^expression	26352163
TARS1	6897	Cidofovir	D000077404	113852-37-2	Cidofovir results in decreased expression of TARS1 mRNA	decreases^expression	25596134
TARS1	6897	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of TARS1 mRNA	decreases^expression	24280081|25596134
TARS1	6897	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in decreased expression of TARS1 mRNA	decreases^expression	25596134
TARS1	6897	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of TARS1 mRNA	increases^expression	19549813
TARS1	6897	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of TARS1 mRNA	increases^expression	20106945|21632981|25562108
TARS1	6897	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of TARS1 mRNA	decreases^expression	28302478
TARS1	6897	dorsomorphin	C516138		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	dorsomorphin	C516138		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of TARS1 mRNA	increases^expression	29803840
TARS1	6897	entinostat	C118739		entinostat results in increased expression of TARS1 mRNA	increases^expression	26272509
TARS1	6897	entinostat	C118739		[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
TARS1	6897	Estradiol	D004958	50-28-2	Estradiol results in increased expression of TARS1 mRNA	increases^expression	16514628
TARS1	6897	Fulvestrant	D000077267	129453-61-8	Fulvestrant results in decreased expression of TARS1 mRNA	decreases^expression	16514628
TARS1	6897	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide affects the expression of TARS1 mRNA	affects^expression	20044591
TARS1	6897	Ifosfamide	D007069	3778-73-2	Ifosfamide results in decreased expression of TARS1 mRNA	decreases^expression	25596134
TARS1	6897	jinfukang	C544151		jinfukang results in decreased expression of TARS1 mRNA	decreases^expression	27392435
TARS1	6897	K 7174	C410337		K 7174 results in increased expression of TARS1 mRNA	increases^expression	24086573
TARS1	6897	Leflunomide	D000077339	75706-12-6	Leflunomide results in increased expression of TARS1 mRNA	increases^expression	28988120
TARS1	6897	Lithium Chloride	D018021	7447-41-8	Lithium Chloride results in increased expression of TARS1 mRNA	increases^expression	15711924
TARS1	6897	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of TARS1 mRNA	increases^expression	28001369
TARS1	6897	Metribolone	D015741	965-93-5	Metribolone promotes the reaction [NDRG1 protein binds to TARS1 protein]	affects^binding|increases^reaction	17220478
TARS1	6897	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of TARS1 mRNA	decreases^expression	30559759
TARS1	6897	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of TARS1 mRNA	decreases^expression	25596134
TARS1	6897	Panobinostat	D000077767		[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	Panobinostat	D000077767		Panobinostat results in increased expression of TARS1 mRNA	increases^expression	26272509
TARS1	6897	perfluorononanoic acid	C584865		perfluorononanoic acid results in increased expression of TARS1 mRNA	increases^expression	32588087
TARS1	6897	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of TARS1 protein	increases^expression	26879310
TARS1	6897	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of TARS1 mRNA	affects^expression	19159669
TARS1	6897	Plant Extracts	D010936		Plant Extracts results in increased expression of TARS1 mRNA	increases^expression	23557933
TARS1	6897	Potassium Dichromate	D011192	7778-50-9	Potassium Dichromate results in increased expression of TARS1 mRNA	increases^expression	11678601
TARS1	6897	Raloxifene Hydrochloride	D020849		Raloxifene Hydrochloride results in decreased expression of TARS1 mRNA	decreases^expression	16514628
TARS1	6897	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of TARS1 protein	decreases^expression	20050688
TARS1	6897	Sunitinib	D000077210		Sunitinib results in increased expression of TARS1 mRNA	increases^expression	31533062
TARS1	6897	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of TARS1 mRNA	increases^expression	22378314
TARS1	6897	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of TARS1 protein	affects^expression	30291989
TARS1	6897	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of TARS1 mRNA	increases^expression	22363418
TARS1	6897	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	trichostatin A	C012589	58880-19-6	trichostatin A results in increased expression of TARS1 mRNA	increases^expression	24935251|26272509
TARS1	6897	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of TARS1 mRNA	increases^expression	26179874
TARS1	6897	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of TARS1 mRNA	increases^expression	22378314
TARS1	6897	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TARS1 mRNA	affects^cotreatment|increases^expression	27188386
TARS1	6897	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of TARS1 mRNA	affects^expression	25979313
TARS1	6897	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of TARS1 mRNA	decreases^expression	23179753
TARS1	6897	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of TARS1 gene	decreases^methylation	29154799
TARS1	6897	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of TARS1 mRNA	increases^expression	23179753|26272509
TENT4A	11044	2-butenal	C012796	4170-30-3	2-butenal results in decreased expression of TENT4A mRNA	decreases^expression	20471460
TENT4A	11044	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TENT4A mRNA	decreases^expression	19150397
TENT4A	11044	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of TENT4A mRNA	increases^expression	21420995
TENT4A	11044	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of TENT4A gene	decreases^methylation	27153756
TENT4A	11044	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of TENT4A mRNA	decreases^expression	22378314
TENT4A	11044	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of TENT4A 5' UTR	increases^methylation	27901495
TENT4A	11044	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of TENT4A mRNA	decreases^expression	27594783
TENT4A	11044	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of TENT4A mRNA	increases^expression	19376846
TENT4A	11044	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of TENT4A mRNA	increases^expression	19167446
TENT4A	11044	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of TENT4A mRNA	increases^expression	20106945
TENT4A	11044	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of TENT4A mRNA	increases^expression	28302478
TENT4A	11044	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of TENT4A mRNA	decreases^expression	29803840
TENT4A	11044	Nickel	D009532	7440-02-0	Nickel results in increased expression of TENT4A mRNA	increases^expression	19031421
TENT4A	11044	Nicotine	D009538		Nicotine results in increased splicing of TENT4A mRNA alternative form	increases^splicing	23825647
TENT4A	11044	Sunitinib	D000077210		Sunitinib results in increased expression of TENT4A mRNA	increases^expression	31533062
TENT4A	11044	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of TENT4A gene	decreases^methylation	29154799
TENT4A	11044	Vitamin E	D014810	1406-18-4	Vitamin E results in decreased expression of TENT4A mRNA	decreases^expression	19244175
TPK1	27010	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TPK1 mRNA	affects^cotreatment|increases^expression	27188386
TPK1	27010	abrine	C496492		abrine results in increased expression of TPK1 mRNA	increases^expression	31054353
TPK1	27010	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of TPK1 protein	affects^expression	20106945
TPK1	27010	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of TPK1 mRNA	decreases^expression	22100608|32234424
TPK1	27010	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of TPK1 intron	increases^methylation	30157460
TPK1	27010	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of TPK1 mRNA	decreases^expression	24449571
TPK1	27010	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of TPK1 gene	affects^methylation	25304211
TPK1	27010	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of TPK1 mRNA	decreases^expression	20064835|20106945|21871943
TPK1	27010	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased methylation of TPK1 3' UTR	decreases^methylation	27901495
TPK1	27010	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in increased methylation of TPK1 intron	increases^methylation	30157460
TPK1	27010	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of TPK1 mRNA	affects^cotreatment|decreases^expression	27392435
TPK1	27010	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of TPK1 mRNA	decreases^expression	27392435|27594783
TPK1	27010	Cytarabine	D003561	147-94-4	Cytarabine results in decreased expression of TPK1 mRNA	decreases^expression	21198554
TPK1	27010	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TPK1 mRNA	affects^cotreatment|increases^expression	27188386
TPK1	27010	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of TPK1 mRNA	decreases^expression	29803840
TPK1	27010	Estradiol	D004958	50-28-2	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TPK1 mRNA	affects^cotreatment|increases^expression	19619570
TPK1	27010	Estradiol	D004958	50-28-2	Estradiol results in decreased expression of TPK1 mRNA	decreases^expression	23019147
TPK1	27010	Estradiol	D004958	50-28-2	Estradiol results in increased expression of TPK1 mRNA	increases^expression	19619570
TPK1	27010	Formaldehyde	D005557	50-00-0	Formaldehyde results in decreased expression of TPK1 mRNA	decreases^expression	23649840
TPK1	27010	Genistein	D019833	446-72-0	Genistein results in decreased expression of TPK1 mRNA	decreases^expression	23019147
TPK1	27010	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of TPK1 mRNA	affects^cotreatment|decreases^expression	27392435
TPK1	27010	Methapyrilene	D008701	91-80-5	Methapyrilene results in increased methylation of TPK1 intron	increases^methylation	30157460
TPK1	27010	methyleugenol	C005223	93-15-2	methyleugenol results in decreased expression of TPK1 mRNA	decreases^expression	32234424
TPK1	27010	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of TPK1 mRNA	decreases^expression	28001369
TPK1	27010	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of TPK1 mRNA	decreases^expression	23649840
TPK1	27010	Nickel	D009532	7440-02-0	Nickel results in increased expression of TPK1 mRNA	increases^expression	24768652|25583101
TPK1	27010	N-Nitrosopyrrolidine	D009242	930-55-2	N-Nitrosopyrrolidine results in decreased expression of TPK1 mRNA	decreases^expression	32234424
TPK1	27010	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of TPK1 mRNA	increases^expression	23978341
TPK1	27010	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TPK1 mRNA	affects^cotreatment|increases^expression	27188386
TPK1	27010	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of TPK1 mRNA	increases^expression	26272509
TPK1	27010	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in decreased expression of TPK1 mRNA	decreases^expression	22714537
TPK1	27010	Tetrachlorodibenzodioxin	D013749	1746-01-6	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TPK1 mRNA	affects^cotreatment|increases^expression	19619570
TPK1	27010	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of TPK1 mRNA	increases^expression	19619570
TPK1	27010	Topotecan	D019772	123948-87-8	TPK1 protein affects the susceptibility to Topotecan	affects^response to substance	16217747
TPK1	27010	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of TPK1 mRNA	increases^expression	28001369
TPR	7175	16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione	C020175	24320-06-7	16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in decreased expression of TPR mRNA	decreases^expression	20519331
TPR	7175	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	28628672
TPR	7175	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	27188386
TPR	7175	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	27188386
TPR	7175	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TPR mRNA	decreases^expression	20018196|26238291
TPR	7175	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of TPR mRNA	affects^expression	21179406
TPR	7175	Biotin	D001710	58-85-5	Biotin results in increased expression of TPR mRNA	increases^expression	15219929
TPR	7175	bis(4-hydroxyphenyl)sulfone	C543008	80-09-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	28628672
TPR	7175	Catechin	D002392	154-23-4	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	24763279
TPR	7175	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	28628672
TPR	7175	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	27188386
TPR	7175	dorsomorphin	C516138		[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	27188386
TPR	7175	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of TPR mRNA	decreases^expression	29803840
TPR	7175	Dronabinol	D013759		Dronabinol results in increased expression of TPR mRNA	increases^expression	16597638
TPR	7175	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TPR protein	decreases^activity|increases^O-linked glycosylation	23301498
TPR	7175	geldanamycin	C001277	30562-34-6	geldanamycin results in increased expression of TPR mRNA	increases^expression	26705709
TPR	7175	Genistein	D019833	446-72-0	ESR1 promotes the reaction [Genistein results in decreased expression of TPR protein]	decreases^expression|increases^reaction	20884965
TPR	7175	Genistein	D019833	446-72-0	Genistein results in decreased expression of TPR protein	decreases^expression	20884965
TPR	7175	Grape Seed Proanthocyanidins	C511402		[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	24763279
TPR	7175	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased expression of TPR mRNA	increases^expression	18951874
TPR	7175	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	28628672
TPR	7175	Malathion	D008294	121-75-5	Malathion results in increased expression of TPR mRNA	increases^expression	32069766
TPR	7175	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of TPR mRNA	decreases^expression	28001369
TPR	7175	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of TPR mRNA	increases^expression	26272509
TPR	7175	MLN7243	C000622638		MLN7243 affects the sumoylation of TPR protein	affects^sumoylation	31285264
TPR	7175	Nicotine	D009538		Nicotine results in increased expression of TPR mRNA	increases^expression	16949557
TPR	7175	penconazole	C087058		penconazole results in increased expression of TPR mRNA	increases^expression	23811263
TPR	7175	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	27188386
TPR	7175	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in decreased expression of TPR mRNA	decreases^expression	26272509
TPR	7175	Phosphorus	D010758	7723-14-0	Phosphorus results in increased expression of TPR mRNA	increases^expression	17715259
TPR	7175	poly(propyleneimine)	C443641		poly(propyleneimine) analog results in increased expression of TPR mRNA	increases^expression	16308212
TPR	7175	Rosiglitazone	D000077154		Rosiglitazone results in decreased expression of TPR mRNA	decreases^expression	25572481
TPR	7175	Selenium	D012643	7782-49-2	[Selenium co-treated with Vitamin E] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	19244175
TPR	7175	Selenium	D012643	7782-49-2	Selenium results in decreased expression of TPR mRNA	decreases^expression	19244175
TPR	7175	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of TPR mRNA	decreases^expression	12679051
TPR	7175	tamibarotene	C061133	94497-51-5	tamibarotene results in decreased expression of TPR mRNA	decreases^expression	15498508
TPR	7175	testosterone enanthate	C004648		testosterone enanthate affects the expression of TPR mRNA	affects^expression	17440010
TPR	7175	Thimerosal	D013849	54-64-8	Thimerosal results in decreased expression of TPR mRNA	decreases^expression	27188386
TPR	7175	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of TPR protein	affects^expression	30291989
TPR	7175	torcetrapib	C483909		torcetrapib results in increased expression of TPR mRNA	increases^expression	23228038
TPR	7175	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of TPR mRNA	decreases^expression	15498508|21934132
TPR	7175	trichostatin A	C012589	58880-19-6	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	27188386
TPR	7175	trichostatin A	C012589	58880-19-6	trichostatin A results in decreased expression of TPR mRNA	decreases^expression	24935251|26272509
TPR	7175	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of TPR mRNA	decreases^expression	23179753|24935251
TPR	7175	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of TPR gene	decreases^methylation	29154799
TPR	7175	Vitamin E	D014810	1406-18-4	[Selenium co-treated with Vitamin E] results in decreased expression of TPR mRNA	affects^cotreatment|decreases^expression	19244175
TPR	7175	Vitamin E	D014810	1406-18-4	Vitamin E results in decreased expression of TPR mRNA	decreases^expression	19244175
TPR	7175	Vorinostat	D000077337		Vorinostat results in decreased expression of TPR mRNA	decreases^expression	27188386
TXN	7295	1,25-dihydroxyvitamin D	C097949	66772-14-3	1,25-dihydroxyvitamin D affects the localization of TXN protein	affects^localization	16061374
TXN	7295	1,2-benzisothiazoline-3-one	C015699	2634-33-5	1,2-benzisothiazoline-3-one results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane	C478160		[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of and affects the localization of TXN protein	affects^cotreatment|affects^localization|decreases^expression	28757135
TXN	7295	(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane	C478160		[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression	28757135
TXN	7295	(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane	C478160		[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXN protein	affects^cotreatment|decreases^expression	28757135
TXN	7295	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression	28628672
TXN	7295	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	D015632	28289-54-5	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TXN protein	decreases^expression	24140863
TXN	7295	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	D015632	28289-54-5	TXN protein inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein]	decreases^expression|decreases^reaction	24140863
TXN	7295	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	D015632	28289-54-5	TXN protein inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased cleavage of CASP12 protein]	decreases^reaction|increases^cleavage	24140863
TXN	7295	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	D015632	28289-54-5	TXN protein inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of DDIT3 protein]	decreases^reaction|increases^expression	24140863
TXN	7295	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	D015632	28289-54-5	TXN protein inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of ERN1 protein]	decreases^reaction|increases^expression	24140863
TXN	7295	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	D015632	28289-54-5	TXN protein inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HSPA5 protein]	decreases^reaction|increases^expression	24140863
TXN	7295	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	D015632	28289-54-5	TXN protein inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TRAF2 protein]	decreases^reaction|increases^expression	24140863
TXN	7295	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	D015632	28289-54-5	TXN protein results in decreased susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases^response to substance	24140863
TXN	7295	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	TXN protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased cleavage of CASP12 protein]	decreases^reaction|increases^cleavage	24140863
TXN	7295	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	TXN protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of DDIT3 protein]	decreases^reaction|increases^expression	24140863
TXN	7295	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	TXN protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of ERN1 protein]	decreases^reaction|increases^expression	24140863
TXN	7295	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	TXN protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HSPA5 protein]	decreases^reaction|increases^expression	24140863
TXN	7295	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	TXN protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of TRAF2 protein]	decreases^reaction|increases^expression	24140863
TXN	7295	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	TXN protein results in decreased susceptibility to 1-Methyl-4-phenylpyridinium	decreases^response to substance	24140863
TXN	7295	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	C085911	154447-36-6	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TXN protein results in decreased susceptibility to Oxygen]	decreases^reaction|decreases^response to substance	20812253
TXN	7295	2-nonynoic acid methyl ester	C055802	111-80-8	2-nonynoic acid methyl ester results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	C472791		3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of TXN mRNA	decreases^expression	12958071
TXN	7295	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXN mRNA	affects^cotreatment|increases^expression	27188386
TXN	7295	4-hydroxy-2-nonenal	C027576	29343-52-0	4-hydroxy-2-nonenal affects the metabolism of TXN protein	affects^metabolic processing	17982132
TXN	7295	4-hydroxy-2-nonenal	C027576	29343-52-0	4-hydroxy-2-nonenal results in decreased activity of TXN protein	decreases^activity	17982132
TXN	7295	4-hydroxy-equilenin	C065250	81608-60-8	4-hydroxy-equilenin results in increased expression of TXN mRNA	increases^expression	15135645
TXN	7295	4-methylumbelliferyl acetate	C032078	09/05/2747	4-methylumbelliferyl acetate results in increased activity of TXN protein	increases^activity	24103856
TXN	7295	7,8-diacetoxy-4-methylcoumarin	C114369		7,8-diacetoxy-4-methylcoumarin results in increased activity of TXN protein	increases^activity	24103856
TXN	7295	7,8-diacetoxy-4-methylcoumarin	C114369		7,8-diacetoxy-4-methylcoumarin results in increased expression of TXN mRNA	increases^expression	24103856
TXN	7295	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TXN mRNA	increases^expression	19150397
TXN	7295	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of TXN mRNA	decreases^expression	22230336|26690555
TXN	7295	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of TXN mRNA	increases^expression	31059760
TXN	7295	Acetylcysteine	D000111	616-91-1	Acetylcysteine inhibits the reaction [Acrolein results in increased oxidation of TXN protein]	decreases^reaction|increases^oxidation	18023956
TXN	7295	Acetylcysteine	D000111	616-91-1	Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of TXN protein]	decreases^expression|decreases^reaction	17959236
TXN	7295	Acetylcysteine	D000111	616-91-1	Acetylcysteine results in decreased expression of TXN protein	decreases^expression	17959236
TXN	7295	Acrolein	D000171	107-02-8	Acetylcysteine inhibits the reaction [Acrolein results in increased oxidation of TXN protein]	decreases^reaction|increases^oxidation	18023956
TXN	7295	Acrolein	D000171	107-02-8	Acrolein affects the metabolism of TXN protein	affects^metabolic processing	17982132
TXN	7295	Acrolein	D000171	107-02-8	Acrolein results in decreased activity of TXN protein	decreases^activity	15388247|17982132
TXN	7295	Acrolein	D000171	107-02-8	Acrolein results in increased oxidation of TXN protein	increases^oxidation	18023956|19135121
TXN	7295	Adenosine Triphosphate	D000255	56-65-5	Adenosine Triphosphate results in increased expression of TXN protein	increases^expression	22129738
TXN	7295	Aerosols	D000336		Aerosols affects the expression of TXN mRNA	affects^expression	29505817
TXN	7295	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 affects the expression of TXN protein	affects^expression	20106945
TXN	7295	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of TXN gene	decreases^methylation	27153756
TXN	7295	Air Pollutants	D000393		Air Pollutants results in increased expression of TXN mRNA	increases^expression	18079490
TXN	7295	Arsenic	D001151	7440-38-2	TXN gene SNP affects the susceptibility to Arsenic	affects^response to substance	29751399
TXN	7295	Arsenic	D001151	7440-38-2	[TXN gene SNP affects the susceptibility to Arsenic] which affects the abundance of Arsenicals	affects^abundance|affects^response to substance	29751399
TXN	7295	Arsenicals	D001152		[TXN gene SNP affects the susceptibility to Arsenic] which affects the abundance of Arsenicals	affects^abundance|affects^response to substance	29751399
TXN	7295	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide affects the expression of TXN mRNA	affects^expression	25873331
TXN	7295	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased expression of TXN mRNA	increases^expression	25258189
TXN	7295	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased oxidation of TXN protein	increases^oxidation	17640917|26975474
TXN	7295	Arsenic Trioxide	D000077237	1327-53-3	TXN protein results in decreased susceptibility to Arsenic Trioxide	decreases^response to substance	20707922|22590507
TXN	7295	Asbestos	D001194	1332-21-4	Asbestos results in increased expression of TXN protein	increases^expression	27032653
TXN	7295	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in increased expression of TXN mRNA	increases^expression	24885895
TXN	7295	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in increased oxidation of TXN protein	increases^oxidation	24885895
TXN	7295	Asbestos, Crocidolite	D017638	12001-28-4	[Asbestos, Crocidolite results in increased oxidation of TXN protein] inhibits the reaction [TXN protein binds to TXNIP protein]	affects^binding|decreases^reaction|increases^oxidation	24885895
TXN	7295	Asbestos, Crocidolite	D017638	12001-28-4	TXN mRNA inhibits the reaction [Asbestos, Crocidolite results in increased oxidation of TXN protein]	decreases^reaction|increases^oxidation	24885895
TXN	7295	Atenolol	D001262	29122-68-7	Atenolol results in increased expression of TXN mRNA	increases^expression	19915711
TXN	7295	Auranofin	D001310	34031-32-8	Auranofin results in increased oxidation of TXN protein	increases^oxidation	26975474
TXN	7295	Benzene	D001554	71-43-2	TXN protein results in decreased susceptibility to Benzene	decreases^response to substance	17157166
TXN	7295	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of TXN mRNA	increases^expression	21632981|31255691
TXN	7295	Benzoic Acid	D019817		Benzoic Acid results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	benzyl cinnamate	C526327		benzyl cinnamate results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of TXN mRNA	affects^expression	30903817
TXN	7295	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of TXN mRNA	decreases^expression	20678512
TXN	7295	bisphenol A	C006780	80-05-7	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression	28628672
TXN	7295	Bucladesine	D003994	362-74-3	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of TXN mRNA	affects^cotreatment|increases^expression	20823114
TXN	7295	Cacodylic Acid	D002101	75-60-5	[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXN mRNA	affects^cotreatment|affects^expression	23192986
TXN	7295	Cadmium	D002104	7440-43-9	Cadmium results in increased expression of TXN protein	increases^expression	16440303
TXN	7295	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride affects the localization of TXN protein	affects^localization	18261755|22961094
TXN	7295	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of TXN mRNA	increases^expression	25596134|26525392
TXN	7295	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of TXN protein	increases^expression	16440303
TXN	7295	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased oxidation of TXN protein	increases^oxidation	16337887
TXN	7295	Cadmium Chloride	D019256	10108-64-2	Cytochalasin D inhibits the reaction [Cadmium Chloride affects the localization of TXN protein]	affects^localization|decreases^reaction	22961094
TXN	7295	CD 437	C099555		CD 437 results in decreased expression of TXN mRNA	decreases^expression	12958071
TXN	7295	cerous chloride	C026690	7790-86-5	cerous chloride results in increased expression of TXN mRNA	increases^expression	28954213
TXN	7295	Chenodeoxycholic Acid	D002635	474-25-9	[Chenodeoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of TXN mRNA	increases^activity|increases^expression	17724089
TXN	7295	Chenodeoxycholic Acid	D002635	474-25-9	Chenodeoxycholic Acid results in increased expression of TXN protein	increases^expression	17724089
TXN	7295	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde results in increased expression of TXN mRNA	increases^expression	25596134
TXN	7295	Chlorogenic Acid	D002726	327-97-9	Chlorogenic Acid results in increased expression of TXN mRNA	increases^expression	20706672
TXN	7295	chromium hexavalent ion	C074702	18540-29-9	chromium hexavalent ion inhibits the reaction [TXN protein binds to MAP3K5 protein]	affects^binding|decreases^reaction	19703554
TXN	7295	chromium hexavalent ion	C074702	18540-29-9	chromium hexavalent ion results in increased oxidation of TXN protein	increases^oxidation	19703554|21237240
TXN	7295	chromium hexavalent ion	C074702	18540-29-9	tris(2-carboxyethyl)phosphine inhibits the reaction [chromium hexavalent ion results in increased oxidation of TXN protein]	decreases^reaction|increases^oxidation	19703554
TXN	7295	Cidofovir	D000077404	113852-37-2	Cidofovir results in increased expression of TXN mRNA	increases^expression	25596134
TXN	7295	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in increased expression of TXN mRNA	affects^cotreatment|increases^expression	27392435
TXN	7295	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of TXN protein	decreases^expression	30396169
TXN	7295	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of TXN mRNA	increases^expression	25450742|25596134|27392435
TXN	7295	Cisplatin	D002945	15663-27-1	TXN protein results in decreased susceptibility to Cisplatin	decreases^response to substance	10754530
TXN	7295	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in increased expression of TXN mRNA	increases^expression	25596134
TXN	7295	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of TXN mRNA	increases^expression	19549813
TXN	7295	cupric chloride	C029892	7447-39-4	cupric chloride results in increased expression of TXN mRNA	increases^expression	17211630
TXN	7295	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of TXN mRNA	increases^expression	20106945|25596134
TXN	7295	Cytochalasin D	D015638	22144-77-0	Cytochalasin D inhibits the reaction [Cadmium Chloride affects the localization of TXN protein]	affects^localization|decreases^reaction	22961094
TXN	7295	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression	28628672
TXN	7295	diallyl trisulfide	C042577	2050-87-5	diallyl trisulfide results in decreased expression of TXN protein	decreases^expression	28574600|30396169
TXN	7295	diallyl trisulfide	C042577	2050-87-5	diallyl trisulfide results in decreased reduction of TXN protein	decreases^reduction	30396169
TXN	7295	diallyl trisulfide	C042577	2050-87-5	TXN protein promotes the reaction [diallyl trisulfide results in increased expression of TXNIP protein]	increases^expression|increases^reaction	30396169
TXN	7295	Diamide	D003958	10465-78-8	Diamide results in increased oxidation of TXN protein	increases^oxidation	26975474
TXN	7295	dibenzo(a,l)pyrene	C041517	191-30-0	dibenzo(a,l)pyrene results in decreased expression of TXN mRNA	decreases^expression	31255691
TXN	7295	dibutyldi(4-chlorobenzohydroxamato)tin(IV)	C542282		dibutyldi(4-chlorobenzohydroxamato)tin(IV) results in increased expression of TXN mRNA	increases^expression	22732634
TXN	7295	dibutyldi(4-chlorobenzohydroxamato)tin(IV)	C542282		dibutyldi(4-chlorobenzohydroxamato)tin(IV) results in increased expression of TXN protein	increases^expression	22732634
TXN	7295	Diclofenac	D004008	15307-86-5	Diclofenac results in increased expression of TXN mRNA	increases^expression	19022234
TXN	7295	dicrotophos	C000944	3735-78-2	dicrotophos results in decreased expression of TXN mRNA	decreases^expression	28302478
TXN	7295	diethyl maleate	C014476	141-05-9	diethyl maleate results in decreased activity of TXN protein	decreases^activity	15388247
TXN	7295	dimethoxycurcumin	C521105		dimethoxycurcumin results in decreased expression of TXN protein	decreases^expression	31513842
TXN	7295	dimethylarsine	C062856	593-57-7	[sodium arsenite co-treated with dimethylarsine analog co-treated with methylarsine analog] affects the expression of TXN mRNA	affects^cotreatment|affects^expression	25873331
TXN	7295	Dinitrochlorobenzene	D004137	97-00-7	Dinitrochlorobenzene inhibits the reaction [Selegiline results in increased expression of TXN]	decreases^reaction|increases^expression	16099847
TXN	7295	Dinitrochlorobenzene	D004137	97-00-7	Dinitrochlorobenzene inhibits the reaction [TXN protein affects the susceptibility to Selegiline]	affects^response to substance|decreases^reaction	16099847
TXN	7295	Dinitrochlorobenzene	D004137	97-00-7	Dinitrochlorobenzene results in increased oxidation of TXN protein	increases^oxidation	26975474
TXN	7295	diphenylcyclopropenone	C029402	886-38-4	diphenylcyclopropenone results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXN mRNA	affects^cotreatment|increases^expression	27188386
TXN	7295	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of TXN mRNA	increases^expression	29803840
TXN	7295	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TXN protein	decreases^activity|increases^O-linked glycosylation	23301498
TXN	7295	epigallocatechin gallate	C045651	989-51-5	epigallocatechin gallate results in increased expression of TXN mRNA	increases^expression	20706672
TXN	7295	Estradiol	D004958	50-28-2	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of TXN mRNA	affects^cotreatment|increases^expression	20823114
TXN	7295	Flame Retardants	D005411		Flame Retardants results in increased expression of TXN mRNA	increases^expression	19858236
TXN	7295	Fluorescein-5-isothiocyanate	D016650	3326-32-7	Fluorescein-5-isothiocyanate results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	Formaldehyde	D005557	50-00-0	Formaldehyde results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	gamma-Linolenic Acid	D017965		gamma-Linolenic Acid results in increased expression of TXN mRNA	increases^expression	20664735
TXN	7295	Gasoline	D005742		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
TXN	7295	Genistein	D019833	446-72-0	Genistein results in decreased expression of TXN mRNA	decreases^expression	20706672
TXN	7295	Glucose	D005947	50-99-7	Glucose deficiency results in increased secretion of TXN protein	increases^secretion	24802182
TXN	7295	glycidamide	C071834		glycidamide results in increased expression of TXN mRNA	increases^expression	17822822
TXN	7295	gossypol acetic acid	C028178	12542-36-8	gossypol acetic acid results in increased expression of TXN protein	increases^expression	29938581
TXN	7295	Hydrogen Peroxide	D006861	7722-84-1	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of TXN mRNA	affects^cotreatment|increases^expression	21751221
TXN	7295	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased oxidation of TXN protein	increases^oxidation	26975474
TXN	7295	Hydrogen Peroxide	D006861	7722-84-1	TXN protein results in decreased susceptibility to Hydrogen Peroxide	decreases^response to substance	10754530|16024017
TXN	7295	hydroquinone	C031927	123-31-9	hydroquinone results in increased expression of TXN mRNA	increases^expression	15452088
TXN	7295	hydroxycitronellal	C020755	107-75-5	hydroxycitronellal results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	Ifosfamide	D007069	3778-73-2	Ifosfamide results in increased expression of TXN mRNA	increases^expression	25596134
TXN	7295	imidazopyrazole	C026262	251-80-9	imidazopyrazole analog results in decreased expression of TXN mRNA	decreases^expression	30388846
TXN	7295	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression	28628672
TXN	7295	Indomethacin	D007213	53-86-1	TXN protein inhibits the reaction [Indomethacin results in decreased expression of AKT1 protein modified form]	decreases^expression|decreases^reaction	17654042
TXN	7295	Indomethacin	D007213	53-86-1	TXN protein inhibits the reaction [Indomethacin results in increased abundance of Reactive Oxygen Species]	decreases^reaction|increases^abundance	17654042
TXN	7295	isobutyl alcohol	C040507	78-83-1	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
TXN	7295	IV 2 compound	C412893		IV 2 compound results in decreased activity of and results in decreased expression of TXN protein	decreases^activity|decreases^expression	30396169
TXN	7295	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in increased expression of TXN mRNA	affects^cotreatment|increases^expression	27392435
TXN	7295	K 7174	C410337		K 7174 results in increased expression of TXN mRNA	increases^expression	24086573
TXN	7295	linalool	C018584	78-70-6	linalool results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	Lipopolysaccharides	D008070		Lipopolysaccharides results in decreased expression of TXN protein	decreases^expression	17959236
TXN	7295	Lipopolysaccharides	D008070		Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in decreased expression of TXN protein]	decreases^expression|decreases^reaction	17959236
TXN	7295	Lithocholic Acid	D008095	434-13-9	[Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of TXN mRNA	increases^activity|increases^expression	17724089
TXN	7295	Lithocholic Acid	D008095	434-13-9	Lithocholic Acid results in increased expression of TXN protein	increases^expression	17724089
TXN	7295	Magnetite Nanoparticles	D058185		[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression	26378955
TXN	7295	manumycin	C054474	52665-74-4	manumycin results in decreased expression of TXN	decreases^expression	19409983
TXN	7295	Mechlorethamine	D008466		Mechlorethamine results in decreased activity of TXN protein	decreases^activity	26451472
TXN	7295	Medroxyprogesterone Acetate	D017258	71-58-9	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of TXN mRNA	affects^cotreatment|increases^expression	20823114
TXN	7295	Mercuric Chloride	D008627	7487-94-7	Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of TXN protein]	decreases^expression|decreases^reaction	17959236
TXN	7295	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride inhibits the reaction [Lipopolysaccharides results in decreased expression of TXN protein]	decreases^expression|decreases^reaction	17959236
TXN	7295	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride results in decreased activity of and affects the metabolism of TXN protein	affects^metabolic processing|decreases^activity	18321861
TXN	7295	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride results in decreased expression of TXN protein	decreases^expression	17959236
TXN	7295	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride results in increased oxidation of TXN protein	increases^oxidation	16337887
TXN	7295	Mercuric Chloride	D008627	7487-94-7	sodium selenide inhibits the reaction [Mercuric Chloride results in decreased expression of TXN protein]	decreases^expression|decreases^reaction	17959236
TXN	7295	Mercury	D008628	7439-97-6	Mercury binds to TXN protein	affects^binding	18321861
TXN	7295	Methamphetamine	D008694	537-46-2	TXN protein inhibits the reaction [Methamphetamine results in decreased expression of CASP12 protein]	decreases^expression|decreases^reaction	32203791
TXN	7295	Methamphetamine	D008694	537-46-2	TXN protein inhibits the reaction [Methamphetamine results in decreased expression of CASP3 protein]	decreases^expression|decreases^reaction	32203791
TXN	7295	Methamphetamine	D008694	537-46-2	TXN protein inhibits the reaction [Methamphetamine results in increased expression of BAX protein]	decreases^reaction|increases^expression	32203791
TXN	7295	Methamphetamine	D008694	537-46-2	TXN protein inhibits the reaction [Methamphetamine results in increased expression of DDIT3 protein]	decreases^reaction|increases^expression	32203791
TXN	7295	Methamphetamine	D008694	537-46-2	TXN protein inhibits the reaction [Methamphetamine results in increased expression of HSPA5 protein]	decreases^reaction|increases^expression	32203791
TXN	7295	Methamphetamine	D008694	537-46-2	TXN protein results in decreased susceptibility to Methamphetamine	decreases^response to substance	32203791
TXN	7295	methylarsine	C543395		[sodium arsenite co-treated with dimethylarsine analog co-treated with methylarsine analog] affects the expression of TXN mRNA	affects^cotreatment|affects^expression	25873331
TXN	7295	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of TXN mRNA	increases^expression	28001369
TXN	7295	Methylmercury Compounds	D008767		Methylmercury Compounds results in decreased activity of and affects the metabolism of TXN protein	affects^metabolic processing|decreases^activity	18321861
TXN	7295	microcystin RR	C063855		microcystin RR results in decreased expression of TXN protein	decreases^expression	19111056
TXN	7295	MLN7243	C000622638		MLN7243 results in decreased sumoylation of TXN protein	decreases^sumoylation	31285264
TXN	7295	monomethylarsonic acid	C020300	124-58-3	[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXN mRNA	affects^cotreatment|affects^expression	23192986
TXN	7295	N-acetylsphingosine	C064769		N-acetylsphingosine results in decreased activity of TXN protein	decreases^activity	18270325
TXN	7295	N-acetylsphingosine	C064769		TXNIP affects the reaction [N-acetylsphingosine results in decreased activity of TXN protein]	affects^reaction|decreases^activity	18270325
TXN	7295	Nanotubes, Carbon	D037742		Nanotubes, Carbon affects the expression of TXN protein	affects^expression	22001959
TXN	7295	Nanotubes, Carbon	D037742		Nanotubes, Carbon results in increased expression of TXN protein	increases^expression	22157353
TXN	7295	N-methyl-4-aminophenol	C014112		N-methyl-4-aminophenol results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	Nonidet P-40	C010615	9036-19-5	Nonidet P-40 results in decreased expression of TXN mRNA	decreases^expression	26552463
TXN	7295	obeticholic acid	C464660		obeticholic acid results in decreased expression of TXN mRNA	decreases^expression	27939613
TXN	7295	Okadaic Acid	D019319	78111-17-8	Okadaic Acid results in decreased expression of TXN protein	decreases^expression	19397276
TXN	7295	osajin	C485800		osajin results in increased expression of TXN mRNA	increases^expression	20706672
TXN	7295	Ouabain	D010042	630-60-4	Ouabain affects the expression of TXN protein	affects^expression	17268060
TXN	7295	Oxygen	D010100	7782-44-7	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TXN protein results in decreased susceptibility to Oxygen]	decreases^reaction|decreases^response to substance	20812253
TXN	7295	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of TXN mRNA	decreases^expression	25596134
TXN	7295	Oxygen	D010100	7782-44-7	TXN protein inhibits the reaction [Oxygen results in increased chemical synthesis of Reactive Oxygen Species]	decreases^reaction|increases^chemical synthesis	20812253
TXN	7295	Oxygen	D010100	7782-44-7	TXN protein promotes the reaction [Oxygen results in increased activity of SOD2 protein]	increases^activity|increases^reaction	20812253
TXN	7295	Oxygen	D010100	7782-44-7	TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK1 protein]	increases^phosphorylation|increases^reaction	20812253
TXN	7295	Oxygen	D010100	7782-44-7	TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK3 protein]	increases^phosphorylation|increases^reaction	20812253
TXN	7295	Oxygen	D010100	7782-44-7	TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK8 protein]	increases^phosphorylation|increases^reaction	20812253
TXN	7295	Oxygen	D010100	7782-44-7	TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK9 protein]	increases^phosphorylation|increases^reaction	20812253
TXN	7295	Oxygen	D010100	7782-44-7	TXN protein results in decreased susceptibility to Oxygen	decreases^response to substance	20812253
TXN	7295	Oxygen	D010100	7782-44-7	U 0126 inhibits the reaction [TXN protein results in decreased susceptibility to Oxygen]	decreases^reaction|decreases^response to substance	20812253
TXN	7295	Paraquat	D010269	4685-14-7	TXN protein results in decreased susceptibility to Paraquat	decreases^response to substance	10754530|16024017|19735704
TXN	7295	Particulate Matter	D052638		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
TXN	7295	Particulate Matter	D052638		TXN protein promotes the reaction [Particulate Matter results in increased phosphorylation of AKT1 protein]	increases^phosphorylation|increases^reaction	16298680
TXN	7295	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether results in increased expression of TXN mRNA	increases^expression	19858236
TXN	7295	perillaldehyde	C033342	2111-75-3	KEAP1 protein inhibits the reaction [perillaldehyde results in increased expression of TXN mRNA]	decreases^reaction|increases^expression	19123792
TXN	7295	perillaldehyde	C033342	2111-75-3	perillaldehyde promotes the reaction [NFE2L2 protein binds to TXN enhancer]	affects^binding|increases^reaction	19123792
TXN	7295	perillaldehyde	C033342	2111-75-3	perillaldehyde results in increased expression of TXN mRNA	increases^expression	19123792
TXN	7295	perillaldehyde	C033342	2111-75-3	perillaldehyde results in increased expression of TXN protein	increases^expression	19123792
TXN	7295	phenethyl isothiocyanate	C058305	02/09/2257	phenethyl isothiocyanate results in increased expression of TXN mRNA	increases^expression	20442190
TXN	7295	phenethyl isothiocyanate	C058305	02/09/2257	TXN protein binds to phenethyl isothiocyanate	affects^binding	21838287
TXN	7295	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXN mRNA	affects^cotreatment|increases^expression	27188386
TXN	7295	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of TXN mRNA	increases^expression	26272509
TXN	7295	Phosphatidylcholines	D010713		[TXN protein binds to PTEN protein] inhibits the reaction [PTEN protein binds to Phosphatidylcholines]	affects^binding|decreases^reaction	15313215
TXN	7295	phosphatidylethanolamine	C483858	39382-08-6	[TXN protein binds to PTEN protein] inhibits the reaction [PTEN protein binds to phosphatidylethanolamine]	affects^binding|decreases^reaction	15313215
TXN	7295	Phosphatidylserines	D010718		[TXN protein binds to PTEN protein] inhibits the reaction [PTEN protein binds to Phosphatidylserines]	affects^binding|decreases^reaction	15313215
TXN	7295	Plant Extracts	D010936		Plant Extracts results in increased expression of TXN mRNA	increases^expression	19123792
TXN	7295	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression|increases^abundance	29432896
TXN	7295	pomiferin	C474837		pomiferin results in increased expression of TXN mRNA	increases^expression	20706672
TXN	7295	Propolis	D011429	9009-62-5	Propolis results in increased expression of TXN mRNA	increases^expression	20706672
TXN	7295	puerarin	C033607	3681-99-0	puerarin results in increased expression of TXN mRNA	increases^expression	20706672
TXN	7295	Quinic Acid	D011801	77-95-2	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of TXN mRNA	affects^cotreatment|increases^expression	21751221
TXN	7295	quinocetone	C502851		quinocetone results in increased expression of TXN protein	increases^expression	27046791
TXN	7295	Reactive Oxygen Species	D017382		TXN protein inhibits the reaction [Indomethacin results in increased abundance of Reactive Oxygen Species]	decreases^reaction|increases^abundance	17654042
TXN	7295	Reactive Oxygen Species	D017382		TXN protein inhibits the reaction [Oxygen results in increased chemical synthesis of Reactive Oxygen Species]	decreases^reaction|increases^chemical synthesis	20812253
TXN	7295	Resveratrol	D000077185		Resveratrol results in increased expression of TXN mRNA	increases^expression	20706672
TXN	7295	Resveratrol	D000077185		Resveratrol results in increased expression of TXN protein	increases^expression	16198371
TXN	7295	Ribavirin	D012254	36791-04-5	Ribavirin results in decreased expression of TXN protein	decreases^expression	16198661
TXN	7295	rosavin	C529148		rosavin results in increased expression of TXN mRNA	increases^expression	20706672
TXN	7295	Salicylic Acid	D020156	69-72-7	Salicylic Acid results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	Selegiline	D012642		Dinitrochlorobenzene inhibits the reaction [Selegiline results in increased expression of TXN]	decreases^reaction|increases^expression	16099847
TXN	7295	Selegiline	D012642		Dinitrochlorobenzene inhibits the reaction [TXN protein affects the susceptibility to Selegiline]	affects^response to substance|decreases^reaction	16099847
TXN	7295	Selegiline	D012642		MYC protein affects the reaction [Selegiline results in increased expression of TXN]	affects^reaction|increases^expression	16099847
TXN	7295	Selegiline	D012642		Selegiline results in increased expression of TXN protein	increases^expression	16099847
TXN	7295	Selegiline	D012642		TXN protein affects the susceptibility to Selegiline	affects^response to substance	16099847
TXN	7295	sodium arsenite	C017947	13768-07-5	[sodium arsenite co-treated with dimethylarsine analog co-treated with methylarsine analog] affects the expression of TXN mRNA	affects^cotreatment|affects^expression	25873331
TXN	7295	sodium arsenite	C017947	13768-07-5	[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXN mRNA	affects^cotreatment|affects^expression	23192986
TXN	7295	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of TXN mRNA	increases^expression	12076508|21281968|28229933|28512695
TXN	7295	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of TXN protein	increases^expression	28512695
TXN	7295	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased oxidation of TXN protein	increases^oxidation	16337887
TXN	7295	sodium chromate(VI)	C028982	03/11/7775	sodium chromate(VI) results in increased oxidation of TXN protein	increases^oxidation	18328613|19135121
TXN	7295	sodium chromate(VI)	C028982	03/11/7775	tris(2-carboxyethyl)phosphine inhibits the reaction [sodium chromate(VI) results in increased oxidation of TXN protein]	decreases^reaction|increases^oxidation	19135121
TXN	7295	Sodium Dodecyl Sulfate	D012967	151-21-3	Sodium Dodecyl Sulfate results in increased expression of TXN mRNA	increases^expression	20491607
TXN	7295	sodium selenide	C037341	1313-85-5	sodium selenide inhibits the reaction [Mercuric Chloride results in decreased expression of TXN protein]	decreases^expression|decreases^reaction	17959236
TXN	7295	sodium selenide	C037341	1313-85-5	sodium selenide results in decreased expression of TXN protein	decreases^expression	17959236
TXN	7295	Sodium Selenite	D018038	10102-18-8	[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of and affects the localization of TXN protein	affects^cotreatment|affects^localization|decreases^expression	28757135
TXN	7295	Sodium Selenite	D018038	10102-18-8	[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression	28757135
TXN	7295	Sodium Selenite	D018038	10102-18-8	[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXN protein	affects^cotreatment|decreases^expression	28757135
TXN	7295	Succimer	D004113	304-55-2	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TXN mRNA	affects^cotreatment|decreases^expression	26378955
TXN	7295	sulforafan	C016766	4478-93-7	sulforafan results in decreased methylation of TXN gene	decreases^methylation	31838189
TXN	7295	sulforafan	C016766	4478-93-7	sulforafan results in increased expression of TXN mRNA	increases^expression	19123792|20442190|31838189
TXN	7295	sulforafan	C016766	4478-93-7	sulforafan results in increased expression of TXN protein	increases^expression	25683455
TXN	7295	Sunitinib	D000077210		Sunitinib results in increased expression of TXN mRNA	increases^expression	31533062
TXN	7295	tert-Butylhydroperoxide	D020122	75-91-2	TXN protein results in decreased susceptibility to tert-Butylhydroperoxide	decreases^response to substance	10754530
TXN	7295	Tetrachlorodibenzodioxin	D013749	1746-01-6	TXN protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AHR mRNA]	decreases^reaction|increases^expression	11462148
TXN	7295	Tetrachlorodibenzodioxin	D013749	1746-01-6	TXN protein results in decreased susceptibility to Tetrachlorodibenzodioxin	decreases^response to substance	11462148
TXN	7295	Tetradecanoylphorbol Acetate	D013755	16561-29-8	Tetradecanoylphorbol Acetate results in increased expression of TXN mRNA	increases^expression	24632381
TXN	7295	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of TXN mRNA	affects^expression	29459183
TXN	7295	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of TXN protein	affects^expression	30291989
TXN	7295	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of TXN mRNA	increases^expression	22363418|29505817
TXN	7295	Tretinoin	D014212	302-79-4	Tretinoin results in decreased expression of TXN mRNA	decreases^expression	21934132
TXN	7295	triptolide	C001899	38748-32-2	NOTCH1 protein modified form inhibits the reaction [triptolide results in decreased expression of TXN protein]	decreases^expression|decreases^reaction	30394310
TXN	7295	triptolide	C001899	38748-32-2	triptolide results in decreased expression of TXN protein	decreases^expression	30394310
TXN	7295	tris(2-carboxyethyl)phosphine	C080938	5961-85-3	tris(2-carboxyethyl)phosphine inhibits the reaction [chromium hexavalent ion results in increased oxidation of TXN protein]	decreases^reaction|increases^oxidation	19703554
TXN	7295	tris(2-carboxyethyl)phosphine	C080938	5961-85-3	tris(2-carboxyethyl)phosphine inhibits the reaction [sodium chromate(VI) results in increased oxidation of TXN protein]	decreases^reaction|increases^oxidation	19135121
TXN	7295	Troglitazone	D000077288	97322-87-7	Troglitazone results in increased expression of TXN mRNA	increases^expression	19022234
TXN	7295	Tunicamycin	D014415	11089-65-9	Tunicamycin results in decreased expression of TXN mRNA	decreases^expression	22378314
TXN	7295	U 0126	C113580		U 0126 inhibits the reaction [TXN protein results in decreased susceptibility to Oxygen]	decreases^reaction|decreases^response to substance	20812253
TXN	7295	Vehicle Emissions	D001335		TXN protein promotes the reaction [Vehicle Emissions results in increased phosphorylation of AKT1 protein]	increases^phosphorylation|increases^reaction	16298680
TXN	7295	Vitallium	D014800	12629-02-6	Vitallium analog results in increased expression of TXN mRNA	increases^expression	23825117
TXN	7295	Vorinostat	D000077337		Vorinostat results in decreased expression of TXN protein	decreases^expression	20543569
TXN	7295	Vorinostat	D000077337		Vorinostat results in increased expression of TXN protein	increases^expression	17593366
TXN	7295	zinc chromate	C023616	13530-65-9	zinc chromate results in increased oxidation of TXN protein	increases^oxidation	18328613
TXN2	25828	10-(6'-ubiquinonyl)decyltriphenylphosphonium bromide	C476756		10-(6'-ubiquinonyl)decyltriphenylphosphonium bromide inhibits the reaction [SOD2 protein results in increased expression of TXN2 mRNA]	decreases^reaction|increases^expression	15683720
TXN2	25828	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased oxidation of TXN2 protein	increases^oxidation	17018646
TXN2	25828	3-aminopyridine-2-carboxaldehyde thiosemicarbazone	C078157	143621-35-6	[3-aminopyridine-2-carboxaldehyde thiosemicarbazone binds to Iron] which results in increased oxidation of TXN2 protein	affects^binding|increases^oxidation	21195754
TXN2	25828	3-aminopyridine-2-carboxaldehyde thiosemicarbazone	C078157	143621-35-6	3-aminopyridine-2-carboxaldehyde thiosemicarbazone results in increased oxidation of TXN2 protein	increases^oxidation	21195754
TXN2	25828	abexinostat	C512352		abexinostat promotes the reaction [Bortezomib results in decreased expression of TXN2 mRNA]	decreases^expression|increases^reaction	19417023
TXN2	25828	abexinostat	C512352		abexinostat results in decreased expression of TXN2 mRNA	decreases^expression	19417023
TXN2	25828	Acetaminophen	D000082	103-90-2	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of TXN2 mRNA	affects^cotreatment|decreases^expression	31059760
TXN2	25828	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of TXN2 mRNA	increases^expression	25704631
TXN2	25828	Acrolein	D000171	107-02-8	Acrolein results in increased oxidation of TXN2 protein	increases^oxidation	18023956|19135121
TXN2	25828	Air Pollutants, Occupational	D000395		Air Pollutants, Occupational affects the expression of TXN2 mRNA	affects^expression	27809917
TXN2	25828	Aluminum	D000535	7429-90-5	[aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of TXN2 protein	decreases^expression|increases^abundance	31945389
TXN2	25828	aluminum chlorhydrate	C016976	12042-91-0	[aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of TXN2 protein	decreases^expression|increases^abundance	31945389
TXN2	25828	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of TXN2 gene	affects^methylation	25304211
TXN2	25828	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in increased oxidation of TXN2 protein	increases^oxidation	26975474
TXN2	25828	Auranofin	D001310	34031-32-8	Auranofin results in increased oxidation of TXN2 protein	increases^oxidation	26975474
TXN2	25828	Bandrowski's base	C051597	20048-27-5	Bandrowski's base results in increased expression of TXN2 mRNA	increases^expression	20566472
TXN2	25828	Bortezomib	D000069286		abexinostat promotes the reaction [Bortezomib results in decreased expression of TXN2 mRNA]	decreases^expression|increases^reaction	19417023
TXN2	25828	Bosentan	D000077300	147536-97-8	Bosentan results in decreased expression of TXN2 mRNA	decreases^expression	29761207
TXN2	25828	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased oxidation of TXN2 protein	increases^oxidation	16337887
TXN2	25828	Calcium	D002118	7440-70-2	TXN2 protein results in decreased susceptibility to Calcium	decreases^response to substance	18550601
TXN2	25828	chromium hexavalent ion	C074702	18540-29-9	chromium hexavalent ion results in decreased expression of TXN2 mRNA	decreases^expression	29069462
TXN2	25828	chromium hexavalent ion	C074702	18540-29-9	chromium hexavalent ion results in decreased expression of TXN2 protein	decreases^expression	29069462
TXN2	25828	chromium hexavalent ion	C074702	18540-29-9	chromium hexavalent ion results in increased oxidation of TXN2 protein	increases^oxidation	19703554|20883776|21237240
TXN2	25828	chromium hexavalent ion	C074702	18540-29-9	tris(2-carboxyethyl)phosphine inhibits the reaction [chromium hexavalent ion results in increased oxidation of TXN2 protein]	decreases^reaction|increases^oxidation	19703554
TXN2	25828	cinnamyl alcohol	C020722	104-54-1	cinnamyl alcohol results in increased expression of TXN2 mRNA	increases^expression	20566472
TXN2	25828	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of TXN2 mRNA	increases^expression	27392435
TXN2	25828	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of TXN2 mRNA	decreases^expression	19376846
TXN2	25828	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of TXN2 mRNA	decreases^expression	20106945
TXN2	25828	Diamide	D003958	10465-78-8	Diamide results in increased oxidation of TXN2 protein	increases^oxidation	26975474
TXN2	25828	Dinitrochlorobenzene	D004137	97-00-7	Dinitrochlorobenzene results in increased expression of TXN2 mRNA	increases^expression	20566472
TXN2	25828	Dinitrochlorobenzene	D004137	97-00-7	Dinitrochlorobenzene results in increased oxidation of TXN2 protein	increases^oxidation	26975474
TXN2	25828	Disulfiram	D004221	97-77-8	Disulfiram results in increased expression of TXN2 mRNA	increases^expression	20566472
TXN2	25828	Doxorubicin	D004317	23214-92-8	Doxorubicin results in increased expression of TXN2 mRNA	increases^expression	29803840
TXN2	25828	Environmental Pollutants	D004785		Environmental Pollutants affects the expression of TXN2 mRNA	affects^expression	19118595
TXN2	25828	Etoposide	D005047	33419-42-0	TXN2 protein results in decreased susceptibility to Etoposide	decreases^response to substance	12080052
TXN2	25828	Eugenol	D005054	97-53-0	Eugenol results in increased expression of TXN2 mRNA	increases^expression	20566472
TXN2	25828	Flame Retardants	D005411		Flame Retardants results in decreased expression of TXN2 protein	decreases^expression	19858236
TXN2	25828	Flame Retardants	D005411		Flame Retardants results in increased expression of TXN2 mRNA	increases^expression	19858236
TXN2	25828	hexyl cinnamic aldehyde	C080043	101-86-0	hexyl cinnamic aldehyde results in increased expression of TXN2 mRNA	increases^expression	20566472
TXN2	25828	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased oxidation of TXN2 protein	increases^oxidation	16797630|17018646|26975474
TXN2	25828	Iron	D007501	7439-89-6	[3-aminopyridine-2-carboxaldehyde thiosemicarbazone binds to Iron] which results in increased oxidation of TXN2 protein	affects^binding|increases^oxidation	21195754
TXN2	25828	isoeugenol	C036643	97-54-1	isoeugenol results in increased expression of TXN2 mRNA	increases^expression	20566472
TXN2	25828	K 7174	C410337		K 7174 results in decreased expression of TXN2 mRNA	decreases^expression	24086573
TXN2	25828	Lipopolysaccharides	D008070		[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of TXN2 mRNA	affects^cotreatment|decreases^expression	31059760
TXN2	25828	Lipopolysaccharides	D008070		[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of TXN2 protein	affects^cotreatment|increases^expression	21355852
TXN2	25828	Lipopolysaccharides	D008070		Thiomalates promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of TXN2 protein]	affects^cotreatment|increases^expression|increases^reaction	21355852
TXN2	25828	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride results in increased oxidation of TXN2 protein	increases^oxidation	16337887
TXN2	25828	mito-carboxy proxyl	C571715		mito-carboxy proxyl inhibits the reaction [Troglitazone results in increased oxidation of TXN2 protein]	decreases^reaction|increases^oxidation	17975114
TXN2	25828	nickel sulfate	C029938	7786-81-4	nickel sulfate results in increased expression of TXN2 mRNA	increases^expression	20566472
TXN2	25828	ochratoxin A	C025589	303-47-9	ochratoxin A results in increased expression of TXN2 mRNA	increases^expression	17316727
TXN2	25828	Paraquat	D010269	4685-14-7	Paraquat results in increased oxidation of TXN2 protein	increases^oxidation	21402726
TXN2	25828	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether results in increased expression of TXN2 mRNA	increases^expression	19858236
TXN2	25828	Peptidoglycan	D010457		[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of TXN2 protein	affects^cotreatment|increases^expression	21355852
TXN2	25828	Peptidoglycan	D010457		Thiomalates promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of TXN2 protein]	affects^cotreatment|increases^expression|increases^reaction	21355852
TXN2	25828	Rotenone	D012402	83-79-4	Rotenone results in increased oxidation of TXN2 protein	increases^oxidation	17018646
TXN2	25828	Rotenone	D012402	83-79-4	TXN2 protein results in increased susceptibility to Rotenone	increases^response to substance	12080052
TXN2	25828	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased oxidation of TXN2 protein	increases^oxidation	16337887
TXN2	25828	sodium chromate(VI)	C028982	03/11/7775	sodium chromate(VI) results in increased oxidation of TXN2 protein	increases^oxidation	18328613
TXN2	25828	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in increased oxidation of TXN2 protein	increases^oxidation	16797630
TXN2	25828	tert-Butylhydroperoxide	D020122	75-91-2	TXN2 protein results in decreased susceptibility to tert-Butylhydroperoxide	decreases^response to substance	18550601
TXN2	25828	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of TXN2 mRNA	increases^expression	22378314
TXN2	25828	Thiomalates	D013870		Thiomalates promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of TXN2 protein]	affects^cotreatment|increases^expression|increases^reaction	21355852
TXN2	25828	trichostatin A	C012589	58880-19-6	trichostatin A affects the expression of TXN2 mRNA	affects^expression	28542535
TXN2	25828	tris(2-carboxyethyl)phosphine	C080938	5961-85-3	tris(2-carboxyethyl)phosphine inhibits the reaction [chromium hexavalent ion results in increased oxidation of TXN2 protein]	decreases^reaction|increases^oxidation	19703554
TXN2	25828	Troglitazone	D000077288	97322-87-7	mito-carboxy proxyl inhibits the reaction [Troglitazone results in increased oxidation of TXN2 protein]	decreases^reaction|increases^oxidation	17975114
TXN2	25828	Troglitazone	D000077288	97322-87-7	Troglitazone results in increased oxidation of TXN2 protein	increases^oxidation	17975114
TXN2	25828	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of TXN2 mRNA	increases^expression	22378314
TXN2	25828	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of TXN2 mRNA	affects^expression	25979313
TXN2	25828	zinc chromate	C023616	13530-65-9	zinc chromate results in increased oxidation of TXN2 protein	increases^oxidation	18328613
TXNRD1	7296	(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane	C478160		(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane results in decreased activity of TXNRD1 protein	decreases^activity	15982805
TXNRD1	7296	(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane	C478160		[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXNRD1 mRNA	affects^cotreatment|decreases^expression	28757135
TXNRD1	7296	(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane	C478160		[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXNRD1 protein	affects^cotreatment|decreases^expression	28757135
TXNRD1	7296	(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane	C478160		Sodium Selenite promotes the reaction [TXNRD1 protein results in increased susceptibility to (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane]	increases^reaction|increases^response to substance	28757135
TXNRD1	7296	(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane	C478160		TXNRD1 protein results in increased susceptibility to (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane	increases^response to substance	28757135
TXNRD1	7296	1,2-dithiol-3-thione	C049325		1,2-dithiol-3-thione results in increased expression of and results in increased activity of TXNRD1 protein	increases^activity|increases^expression	25179160
TXNRD1	7296	1-(5-isoquinolinylsulfonyl)-3-methylpiperazine	C080501	84477-73-6	1-(5-isoquinolinylsulfonyl)-3-methylpiperazine inhibits the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	12663510
TXNRD1	7296	1,6-hexamethylene diisocyanate	C015262	822-06-0	1,6-hexamethylene diisocyanate results in increased expression of TXNRD1 mRNA	increases^expression	24211530
TXNRD1	7296	1-Butanol	D020001	71-36-3	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	1-Naphthylisothiocyanate	D015058	551-06-4	[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	27344345
TXNRD1	7296	2,3-dimethoxy-1,4-naphthoquinone	C063002	6956-96-3	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of TXNRD1 mRNA	increases^expression	17547211
TXNRD1	7296	2-butenal	C012796	4170-30-3	2-butenal results in increased expression of TXNRD1 mRNA	increases^expression	20471460
TXNRD1	7296	2-chloroethyl ethyl sulfide	C031278	693-07-2	2-chloroethyl ethyl sulfide results in decreased activity of TXNRD1 protein	decreases^activity	20345183
TXNRD1	7296	2-chloroethyl ethyl sulfide	C031278	693-07-2	TXNRD1 protein affects the susceptibility to 2-chloroethyl ethyl sulfide	affects^response to substance	20345183
TXNRD1	7296	2-cyclohexylselenazolidine-4-carboxylic acid	C578079		2-cyclohexylselenazolidine-4-carboxylic acid results in increased expression of TXNRD1 mRNA	increases^expression	22807314
TXNRD1	7296	2-cyclohexylselenazolidine-4-carboxylic acid	C578079		2-cyclohexylselenazolidine-4-carboxylic acid results in increased expression of TXNRD1 protein	increases^expression	22807314
TXNRD1	7296	2-cyclohexylselenazolidine-4-carboxylic acid	C578079		NFE2L2 mutant form inhibits the reaction [2-cyclohexylselenazolidine-4-carboxylic acid results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	22807314
TXNRD1	7296	2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one	C533410		2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one results in decreased expression of TXNRD1 mRNA	decreases^expression	29416738
TXNRD1	7296	2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one	C533410		2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one results in decreased expression of TXNRD1 protein	decreases^expression	29416738
TXNRD1	7296	2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one	C533410		TXNRD1 protein inhibits the reaction [2-hydroxymethyl-2-methoxymethylazabicyclo(2.2.2)octan-3-one results in increased expression of H2AX protein modified form]	decreases^reaction|increases^expression	29416738
TXNRD1	7296	2-methyl-4-isothiazolin-3-one	C011506	2682-20-4	2-methyl-4-isothiazolin-3-one results in increased expression of TXNRD1 mRNA	increases^expression	30806763
TXNRD1	7296	2-Propanol	D019840	67-63-0	2-Propanol results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	2-tert-butylhydroquinone	C018855	1948-33-0	2-tert-butylhydroquinone results in increased expression of TXNRD1 mRNA	increases^expression	12949356|30806763
TXNRD1	7296	3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one	C000623021		3-(pyridin-3-ylsulfonyl)-5-(trifluoromethyl)-2H-chromen-2-one results in increased expression of TXNRD1 mRNA	increases^expression	28790194
TXNRD1	7296	4,4'-hexafluorisopropylidene diphenol	C583074		4,4'-hexafluorisopropylidene diphenol inhibits the reaction [ESR1 protein binds to TXNRD1 protein]	affects^binding|decreases^reaction	29389661
TXNRD1	7296	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	27188386
TXNRD1	7296	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	27188386
TXNRD1	7296	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	27188386
TXNRD1	7296	4-nitrososulfamethoxazole	C072956	131549-85-4	4-nitrososulfamethoxazole results in increased expression of TXNRD1 mRNA	increases^expression	28444390
TXNRD1	7296	7,8-diacetoxy-4-methylcoumarin	C114369		7,8-diacetoxy-4-methylcoumarin results in increased expression of TXNRD1 mRNA	increases^expression	24103856
TXNRD1	7296	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	D015123	55097-80-8	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TXNRD1 mRNA	decreases^expression	19150397
TXNRD1	7296	7-aminocephalosporanic acid	C030735	957-68-6	7-aminocephalosporanic acid results in increased expression of TXNRD1 mRNA	increases^expression	24211530
TXNRD1	7296	7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-one	C553817		7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-one results in increased expression of TXNRD1 mRNA	increases^expression	19936915
TXNRD1	7296	8-Hydroxy-2'-Deoxyguanosine	D000080242	88847-89-6	TXNRD1 gene SNP affects the abundance of 8-Hydroxy-2'-Deoxyguanosine	affects^abundance	19896490
TXNRD1	7296	9,10-dihydro-9,10-dihydroxybenzo(a)pyrene	C020738	24909-09-9	9,10-dihydro-9,10-dihydroxybenzo(a)pyrene results in increased expression of TXNRD1 mRNA	increases^expression	26238291
TXNRD1	7296	abrine	C496492		abrine results in decreased expression of TXNRD1 mRNA	decreases^expression	31054353
TXNRD1	7296	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of TXNRD1 mRNA	increases^expression	21420995
TXNRD1	7296	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of TXNRD1 protein	increases^expression	22230336
TXNRD1	7296	Acetylcysteine	D000111	616-91-1	Acetylcysteine inhibits the reaction [Acrolein results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	15652504
TXNRD1	7296	Acrolein	D000171	107-02-8	Acetylcysteine inhibits the reaction [Acrolein results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	15652504
TXNRD1	7296	Acrolein	D000171	107-02-8	Acrolein results in decreased activity of TXNRD1 protein	decreases^activity	15388247|15652504|19135121
TXNRD1	7296	Acrolein	D000171	107-02-8	Acrolein results in increased expression of TXNRD1 mRNA	increases^expression	15652504|24211530
TXNRD1	7296	Acrolein	D000171	107-02-8	Cycloheximide inhibits the reaction [Acrolein results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	15652504
TXNRD1	7296	Acrolein	D000171	107-02-8	Dactinomycin inhibits the reaction [Acrolein results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	15652504
TXNRD1	7296	Aerosols	D000336		Aerosols results in increased expression of TXNRD1 mRNA	increases^expression	29448087|29501877|29505817
TXNRD1	7296	Aerosols	D000336		Aerosols results in increased expression of TXNRD1 protein	increases^expression	29505817
TXNRD1	7296	afimoxifene	C016601	68392-35-8	afimoxifene results in decreased expression of TXNRD1 mRNA	decreases^expression	16514628
TXNRD1	7296	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of TXNRD1 gene	decreases^methylation	27153756
TXNRD1	7296	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased expression of TXNRD1 mRNA	increases^expression	27153756
TXNRD1	7296	Air Pollutants	D000393		Air Pollutants results in increased expression of TXNRD1 mRNA	increases^expression	23649983
TXNRD1	7296	allyl isothiocyanate	C004471	57-06-7	allyl isothiocyanate results in decreased activity of TXNRD1 protein	decreases^activity	17937621
TXNRD1	7296	allyl sulfide	C038491	592-88-1	allyl sulfide results in increased activity of TXNRD1 protein	increases^activity	17937621
TXNRD1	7296	ammonium hexachloroplatinate	C018453	16919-58-7	ammonium hexachloroplatinate results in increased expression of TXNRD1 mRNA	increases^expression	24211530
TXNRD1	7296	Antimony	D000965	7440-36-0	Antimony results in increased expression of TXNRD1 mRNA	increases^expression	17547211
TXNRD1	7296	Antimony Potassium Tartrate	D000966	28300-74-5	Antimony Potassium Tartrate results in increased expression of TXNRD1 mRNA	increases^expression	17547211|28713220
TXNRD1	7296	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of TXNRD1 gene	affects^methylation	25304211
TXNRD1	7296	Arsenic	D001151	7440-38-2	Arsenic results in increased expression of TXNRD1 mRNA	increases^expression	29247444
TXNRD1	7296	Arsenic	D001151	7440-38-2	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of TXNRD1 mRNA	increases^abundance|increases^expression	32525701
TXNRD1	7296	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide affects the expression of TXNRD1 mRNA	affects^expression	25873331
TXNRD1	7296	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased activity of TXNRD1 protein	decreases^activity	17640917
TXNRD1	7296	Arsenic Trioxide	D000077237	1327-53-3	[INCB018424 co-treated with Arsenic Trioxide] results in decreased expression of TXNRD1 mRNA	affects^cotreatment|decreases^expression	30012499
TXNRD1	7296	Arsenic Trioxide	D000077237	1327-53-3	TXNRD1 protein results in decreased susceptibility to Arsenic Trioxide	decreases^response to substance	20707922
TXNRD1	7296	arsenite	C015001	15502-74-6	arsenite results in increased expression of TXNRD1 mRNA	increases^expression	18550526
TXNRD1	7296	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in increased expression of TXNRD1 mRNA	increases^expression	18687144
TXNRD1	7296	Aspirin	D001241	50-78-2	Aspirin results in decreased expression of TXNRD1 mRNA	decreases^expression	11906190
TXNRD1	7296	Auranofin	D001310	34031-32-8	Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD1 protein]	decreases^reaction|increases^activity	19486940
TXNRD1	7296	Auranofin	D001310	34031-32-8	Auranofin promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]	increases^expression|increases^reaction	19486940
TXNRD1	7296	Auranofin	D001310	34031-32-8	Auranofin results in decreased activity of TXNRD1 protein	decreases^activity	18405881|18789312|21172426
TXNRD1	7296	Auranofin	D001310	34031-32-8	Auranofin results in increased expression of TXNRD1 mRNA	increases^expression	19486940
TXNRD1	7296	Auranofin	D001310	34031-32-8	Auranofin results in increased oxidation of TXNRD1 protein	increases^oxidation	19486940
TXNRD1	7296	Auranofin	D001310	34031-32-8	potassium tellurate(IV) promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein]	increases^oxidation|increases^reaction	19486940
TXNRD1	7296	Auranofin	D001310	34031-32-8	Sodium Selenite promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein]	increases^oxidation|increases^reaction	19486940
TXNRD1	7296	Aurothioglucose	D006051	12192-57-3	Aurothioglucose results in decreased activity of TXNRD1 protein	decreases^activity	21172426
TXNRD1	7296	avobenzone	C049935		avobenzone results in increased expression of TXNRD1 mRNA	increases^expression	31016361
TXNRD1	7296	Azathioprine	D001379	446-86-6	Azathioprine results in increased expression of TXNRD1 mRNA	increases^expression	22623647
TXNRD1	7296	Bandrowski's base	C051597	20048-27-5	Bandrowski's base results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of TXNRD1 promoter	affects^methylation	27901495
TXNRD1	7296	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased expression of TXNRD1 mRNA	increases^expression	20106945|21632981|22316170|26238291
TXNRD1	7296	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of TXNRD1 5' UTR	increases^methylation	27901495
TXNRD1	7296	Benzoic Acid	D019817		Benzoic Acid results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	benzyl isothiocyanate	C031403	622-78-6	benzyl isothiocyanate results in decreased activity of TXNRD1 protein	decreases^activity	17937621
TXNRD1	7296	benzyl isothiocyanate	C031403	622-78-6	NADP affects the reaction [benzyl isothiocyanate results in decreased activity of TXNRD1 protein]	affects^reaction|decreases^activity	17937621
TXNRD1	7296	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	C072553		benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TXNRD1 mRNA	increases^expression	18550526
TXNRD1	7296	beta-methylcholine	C044887	7562-87-0	beta-methylcholine affects the expression of TXNRD1 mRNA	affects^expression	21179406
TXNRD1	7296	beta-Naphthoflavone	D019324	6051-87-2	beta-Naphthoflavone results in increased expression of TXNRD1 mRNA	increases^expression	12949356|19737606
TXNRD1	7296	bisphenol A	C006780	80-05-7	bisphenol A affects the expression of TXNRD1 mRNA	affects^expression	30903817
TXNRD1	7296	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of TXNRD1 mRNA	increases^expression	29275510
TXNRD1	7296	Bosentan	D000077300	147536-97-8	Bosentan results in increased expression of TXNRD1 mRNA	increases^expression	29761207
TXNRD1	7296	Buthionine Sulfoximine	D019328	5072-26-4	Buthionine Sulfoximine inhibits the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	12663510
TXNRD1	7296	Buthionine Sulfoximine	D019328	5072-26-4	Buthionine Sulfoximine promotes the reaction [Sodium Selenite results in increased activity of TXNRD1 protein]	increases^activity|increases^reaction	12663510
TXNRD1	7296	Buthionine Sulfoximine	D019328	5072-26-4	Buthionine Sulfoximine results in increased expression of TXNRD1 mRNA	increases^expression	12663510
TXNRD1	7296	C646 compound	C584509		C646 compound results in decreased expression of TXNRD1 mRNA	decreases^expression	26191083
TXNRD1	7296	Cacodylic Acid	D002101	75-60-5	[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	23192986
TXNRD1	7296	Cadmium	D002104	7440-43-9	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNRD1 mRNA	increases^abundance|increases^expression	29741670
TXNRD1	7296	Cadmium	D002104	7440-43-9	Cadmium results in increased expression of TXNRD1 mRNA	increases^expression	17547211|21120746|21172416|24284285
TXNRD1	7296	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride promotes the reaction [NFE2L2 protein binds to TXNRD1 promoter]	affects^binding|increases^reaction	15521073
TXNRD1	7296	Cadmium Chloride	D019256	10108-64-2	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNRD1 mRNA	increases^abundance|increases^expression	29741670
TXNRD1	7296	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of TXNRD1 mRNA	increases^expression	15521073|17547211|25596134|26472689|26525392
TXNRD1	7296	cadmium sulfate	C037123	10124-36-4	cadmium sulfate results in increased expression of TXNRD1 mRNA	increases^expression	21783983
TXNRD1	7296	Caffeine	D002110	58-08-2	Caffeine results in decreased expression of TXNRD1 mRNA	decreases^expression	18444173
TXNRD1	7296	Calcitriol	D002117	32222-06-3	Calcitriol results in increased expression of TXNRD1 mRNA	increases^expression	16002434
TXNRD1	7296	captax	C005563	149-30-4	captax results in increased expression of TXNRD1 mRNA	increases^expression	24211530
TXNRD1	7296	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of TXNRD1 mRNA	affects^expression	24752500|25979313
TXNRD1	7296	cerous chloride	C026690	7790-86-5	cerous chloride results in increased expression of TXNRD1 mRNA	increases^expression	28954213
TXNRD1	7296	chlorite	C001599	1318-59-8	chlorite results in decreased activity of TXNRD1 protein	decreases^activity	27478981
TXNRD1	7296	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde affects the expression of TXNRD1 mRNA	affects^expression	25596134
TXNRD1	7296	chlorobenzene	C031294	108-90-7	chlorobenzene results in increased expression of TXNRD1 mRNA	increases^expression	19800902
TXNRD1	7296	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of TXNRD1 mRNA	increases^expression	24211530|26352163
TXNRD1	7296	Chlorpromazine	D002746	50-53-3	[Chlorpromazine co-treated with Cholic Acids] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	27344345
TXNRD1	7296	Cholic Acids	D002793		[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	27344345
TXNRD1	7296	Cholic Acids	D002793		[Chlorpromazine co-treated with Cholic Acids] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	27344345
TXNRD1	7296	Cholic Acids	D002793		[Cyclosporine co-treated with Cholic Acids] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	27344345
TXNRD1	7296	Cholic Acids	D002793		[Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	27344345
TXNRD1	7296	Cidofovir	D000077404	113852-37-2	Cidofovir results in increased expression of TXNRD1 mRNA	increases^expression	25596134
TXNRD1	7296	cinnamic aldehyde	C012843	104-55-2	cinnamic aldehyde results in increased expression of TXNRD1 mRNA	increases^expression	19000754|24211530|30806763
TXNRD1	7296	cinnamic aldehyde	C012843	104-55-2	cinnamic aldehyde results in increased expression of TXNRD1 protein	increases^expression	18304597
TXNRD1	7296	cinnamyl alcohol	C020722	104-54-1	cinnamyl alcohol results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	Cisplatin	D002945	15663-27-1	Cisplatin promotes the reaction [TXNRD1 protein binds to TXN1 protein]	affects^binding|increases^reaction	20851179
TXNRD1	7296	Cisplatin	D002945	15663-27-1	Cisplatin promotes the reaction [TXNRD1 protein binds to TXNDC17 protein]	affects^binding|increases^reaction	20851179
TXNRD1	7296	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased activity of TXNRD1 protein	decreases^activity	21172426
TXNRD1	7296	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of TXNRD1 mRNA	increases^expression	25450742|25596134
TXNRD1	7296	Cisplatin	D002945	15663-27-1	TXNRD1 protein results in decreased susceptibility to Cisplatin	decreases^response to substance	10490269
TXNRD1	7296	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in increased expression of TXNRD1 mRNA	increases^expression	25596134
TXNRD1	7296	Cobalt	D003035	7440-48-4	[tungsten carbide co-treated with Cobalt] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	23052192
TXNRD1	7296	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in increased expression of TXNRD1 mRNA	increases^expression	22941251
TXNRD1	7296	coniferaldehyde	C075384	458-36-6	coniferaldehyde results in increased expression of TXNRD1 mRNA	increases^expression	26275128
TXNRD1	7296	Copper	D003300	7440-50-8	Copper results in increased expression of TXNRD1 mRNA	increases^expression	20875833
TXNRD1	7296	Copper	D003300	7440-50-8	[Organoselenium Compounds binds to Copper] which results in increased expression of TXNRD1 mRNA	affects^binding|increases^expression	25167922
TXNRD1	7296	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of TXNRD1 mRNA	increases^expression	19549813
TXNRD1	7296	cupric chloride	C029892	7447-39-4	cupric chloride results in increased expression of TXNRD1 mRNA	increases^expression	17211630
TXNRD1	7296	Curcumin	D003474	458-37-7	Curcumin analog results in increased expression of TXNRD1 mRNA	increases^expression	26409325
TXNRD1	7296	Curcumin	D003474	458-37-7	Curcumin results in increased expression of TXNRD1 mRNA	increases^expression	17198877
TXNRD1	7296	Cycloheximide	D003513	66-81-9	Cycloheximide inhibits the reaction [Acrolein results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	15652504
TXNRD1	7296	Cycloheximide	D003513	66-81-9	Cycloheximide inhibits the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	12663510
TXNRD1	7296	Cyclosporine	D016572	59865-13-3	[Cyclosporine co-treated with Cholic Acids] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	27344345
TXNRD1	7296	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of TXNRD1 mRNA	increases^expression	20106945|25596134
TXNRD1	7296	cylindrospermopsin	C089595	143545-90-8	cylindrospermopsin results in increased expression of TXNRD1 mRNA	increases^expression	23726867
TXNRD1	7296	Cysteine	D003545	52-90-4	TXNRD1 gene mutant form inhibits the reaction [diphenyldiselenide results in increased abundance of Cysteine]	decreases^reaction|increases^abundance	23360449
TXNRD1	7296	Dactinomycin	D003609	50-76-0	Dactinomycin inhibits the reaction [Acrolein results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	15652504
TXNRD1	7296	Dactinomycin	D003609	50-76-0	Dactinomycin inhibits the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	12663510
TXNRD1	7296	darinaparsin	C515055		darinaparsin results in increased expression of TXNRD1 mRNA	increases^expression	23426167
TXNRD1	7296	Dexamethasone	D003907	50-02-2	Dexamethasone results in increased expression of TXNRD1 mRNA	increases^expression	25047013
TXNRD1	7296	Diclofenac	D004008	15307-86-5	Diclofenac affects the expression of TXNRD1 mRNA	affects^expression	24752500
TXNRD1	7296	diethyl maleate	C014476	141-05-9	diethyl maleate results in increased expression of TXNRD1 mRNA	increases^expression	15521073
TXNRD1	7296	dimethylarsine	C062856	593-57-7	[sodium arsenite co-treated with dimethylarsine analog co-treated with methylarsine analog] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	25873331
TXNRD1	7296	Dimethylnitrosamine	D004128	62-75-9	Dimethylnitrosamine results in increased expression of TXNRD1 mRNA	increases^expression	17547211
TXNRD1	7296	Dinitrochlorobenzene	D004137	97-00-7	Dinitrochlorobenzene results in increased expression of TXNRD1 mRNA	increases^expression	17374397|20146380|20566472
TXNRD1	7296	diphenyldiselenide	C061132	1666-13-3	TXNRD1 gene mutant form inhibits the reaction [diphenyldiselenide results in increased abundance of Cysteine]	decreases^reaction|increases^abundance	23360449
TXNRD1	7296	diphenyldiselenide	C061132	1666-13-3	TXNRD1 gene mutant form results in decreased susceptibility to diphenyldiselenide	decreases^response to substance	23360449
TXNRD1	7296	diphenyl disulfide	C053871	882-33-7	diphenyl disulfide inhibits the reaction [Methylmercury Compounds results in decreased activity of TXNRD1 protein]	decreases^activity|decreases^reaction	28383113
TXNRD1	7296	diphenyl disulfide	C053871	882-33-7	diphenyl disulfide results in increased expression of and results in increased activity of TXNRD1 protein	increases^activity|increases^expression	28383113
TXNRD1	7296	Diquat	D004178	2764-72-9	Diquat results in increased expression of TXNRD1 mRNA	increases^expression	21172416
TXNRD1	7296	Disulfiram	D004221	97-77-8	Disulfiram results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	Dithionitrobenzoic Acid	D004228	69-78-3	TXNRD1 protein results in increased reduction of Dithionitrobenzoic Acid	increases^reduction	21172426
TXNRD1	7296	dorsomorphin	C516138		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	27188386
TXNRD1	7296	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	27188386
TXNRD1	7296	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	27188386
TXNRD1	7296	Dronabinol	D013759		Dronabinol results in increased expression of TXNRD1 mRNA	increases^expression	18454173
TXNRD1	7296	Drugs, Chinese Herbal	D004365		Drugs, Chinese Herbal results in increased expression of TXNRD1 mRNA	increases^expression	23811387
TXNRD1	7296	ebselen	C042986	60940-34-3	ebselen results in increased expression of and results in increased activity of TXNRD1 protein	increases^activity|increases^expression	28383113
TXNRD1	7296	Edetic Acid	D004492	60-00-4	Edetic Acid results in increased activity of TXNRD1 protein	increases^activity	16774913
TXNRD1	7296	Edetic Acid	D004492	60-00-4	Zinc inhibits the reaction [Edetic Acid results in increased activity of TXNRD1 protein]	decreases^reaction|increases^activity	16774913
TXNRD1	7296	elesclomol	C512195		elesclomol results in increased expression of TXNRD1 mRNA	increases^expression	18723479
TXNRD1	7296	Emodin	D004642	518-82-1	Emodin results in decreased expression of TXNRD1 mRNA	decreases^expression	16045814
TXNRD1	7296	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TXNRD1 protein	decreases^activity|increases^O-linked glycosylation	23301498
TXNRD1	7296	Epichlorohydrin	D004811	106-89-8	Epichlorohydrin results in increased expression of TXNRD1 mRNA	increases^expression	24211530
TXNRD1	7296	erucin	C073539	4430-36-8	erucin results in increased expression of and results in increased activity of TXNRD1 protein	increases^activity|increases^expression	15740016
TXNRD1	7296	erucin	C073539	4430-36-8	erucin results in increased expression of TXNRD1 mRNA	increases^expression	15740016
TXNRD1	7296	erucin	C073539	4430-36-8	Selenium promotes the reaction [erucin results in increased expression of and results in increased activity of TXNRD1 protein]	increases^activity|increases^expression|increases^reaction	15740016
TXNRD1	7296	erucylphospho-N,N,N-trimethylpropylammonium	C472787		erucylphospho-N,N,N-trimethylpropylammonium results in increased expression of TXNRD1 mRNA	increases^expression	29464035
TXNRD1	7296	Estradiol	D004958	50-28-2	[Estradiol co-treated with TGFB1 protein] results in decreased expression of TXNRD1 mRNA	affects^cotreatment|decreases^expression	30165855
TXNRD1	7296	Estradiol	D004958	50-28-2	Estradiol promotes the reaction [ESR1 protein binds to TXNRD1 protein]	affects^binding|increases^reaction	23665804|29389661
TXNRD1	7296	Estradiol	D004958	50-28-2	Estradiol results in increased expression of TXNRD1 mRNA	increases^expression	16514628
TXNRD1	7296	Ethanol	D000431	64-17-5	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	Ethinyl Estradiol	D004997	57-63-6	[Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	27344345
TXNRD1	7296	Eugenol	D005054	97-53-0	Eugenol results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of TXNRD1 mRNA	increases^expression	25596134
TXNRD1	7296	ferric citrate	C025314	3522-50-7	ferric citrate results in increased expression of TXNRD1 mRNA	increases^expression	29959986
TXNRD1	7296	Flame Retardants	D005411		Flame Retardants results in increased expression of TXNRD1 mRNA	increases^expression	19858236
TXNRD1	7296	Floxacillin	D005436	5250-39-5	Floxacillin results in increased expression of TXNRD1 mRNA	increases^expression	28444390
TXNRD1	7296	Fluorouracil	D005472	51-21-8	Fluorouracil results in decreased expression of TXNRD1 mRNA	decreases^expression	19219653
TXNRD1	7296	Fulvestrant	D000077267	129453-61-8	Fulvestrant results in decreased expression of TXNRD1 mRNA	decreases^expression	16514628
TXNRD1	7296	Galactose	D005690	26566-61-0	Galactose results in decreased expression of TXNRD1 mRNA	decreases^expression	23274001
TXNRD1	7296	Galactose	D005690	26566-61-0	sodium bisulfide inhibits the reaction [Galactose results in decreased expression of TXNRD1 mRNA]	decreases^expression|decreases^reaction	23274001
TXNRD1	7296	gamma-Linolenic Acid	D017965		gamma-Linolenic Acid results in increased expression of TXNRD1 mRNA	increases^expression	20664735
TXNRD1	7296	Gasoline	D005742		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	Gasoline	D005742		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	Gasoline	D005742		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	gedunin	C106014	2753-30-2	gedunin results in increased expression of TXNRD1 mRNA	increases^expression	17010675
TXNRD1	7296	Genistein	D019833	446-72-0	Genistein results in increased expression of TXNRD1 mRNA	increases^expression	18444173
TXNRD1	7296	glycidamide	C071834		glycidamide results in increased expression of TXNRD1 mRNA	increases^expression	17822822
TXNRD1	7296	Gold	D006046	7440-57-5	Gold results in decreased activity of TXNRD1 protein	decreases^activity	20851179
TXNRD1	7296	Gold	D006046	7440-57-5	Gold results in increased expression of TXNRD1 mRNA	increases^expression	29705079
TXNRD1	7296	hexyl cinnamic aldehyde	C080043	101-86-0	hexyl cinnamic aldehyde results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	Hydrogen Peroxide	D006861	7722-84-1	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	21751221
TXNRD1	7296	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in decreased expression of TXNRD1 mRNA	decreases^expression	18951874
TXNRD1	7296	Hydrogen Peroxide	D006861	7722-84-1	Hydrogen Peroxide results in increased expression of TXNRD1 mRNA	increases^expression	12414654|15521073
TXNRD1	7296	hydroquinone	C031927	123-31-9	hydroquinone results in increased expression of TXNRD1 mRNA	increases^expression	15452088|31256213
TXNRD1	7296	hydroxyethyl methacrylate	C005044	868-77-9	hydroxyethyl methacrylate results in increased expression of TXNRD1 mRNA	increases^expression	30497689
TXNRD1	7296	hydroxyhydroquinone	C013038	533-73-3	hydroxyhydroquinone results in increased expression of TXNRD1 mRNA	increases^expression	17572062
TXNRD1	7296	Hypochlorous Acid	D006997	7790-92-3	Hypochlorous Acid results in increased expression of TXNRD1 mRNA	increases^expression	18156441
TXNRD1	7296	iberin	C082585	505-44-2	iberin results in increased expression of and results in increased activity of TXNRD1 protein	increases^activity|increases^expression	15740016
TXNRD1	7296	iberin	C082585	505-44-2	iberin results in increased expression of TXNRD1 mRNA	increases^expression	15740016
TXNRD1	7296	iberin	C082585	505-44-2	Selenium promotes the reaction [iberin results in increased expression of and results in increased activity of TXNRD1 protein]	increases^activity|increases^expression|increases^reaction	15740016
TXNRD1	7296	ICG 001	C492448		ICG 001 results in decreased expression of TXNRD1 mRNA	decreases^expression	26191083
TXNRD1	7296	Ifosfamide	D007069	3778-73-2	Ifosfamide results in increased expression of TXNRD1 mRNA	increases^expression	25596134
TXNRD1	7296	INCB018424	C540383		[INCB018424 co-treated with Arsenic Trioxide] results in decreased expression of TXNRD1 mRNA	affects^cotreatment|decreases^expression	30012499
TXNRD1	7296	isoeugenol	C036643	97-54-1	isoeugenol results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	Isoflavones	D007529		Isoflavones results in increased expression of TXNRD1 mRNA	increases^expression	17374662
TXNRD1	7296	Isoniazid	D007538	54-85-3	Isoniazid results in increased expression of TXNRD1 mRNA	increases^expression	28444390
TXNRD1	7296	(+)-JQ1 compound	C561695		(+)-JQ1 compound analog binds to TXNRD1 protein	affects^binding	24972113
TXNRD1	7296	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in increased expression of TXNRD1 mRNA	increases^expression	24796395
TXNRD1	7296	juglone	C005134	481-39-0	TXNRD1 protein results in increased reduction of juglone	increases^reduction	21172426
TXNRD1	7296	K 7174	C410337		K 7174 results in increased expression of TXNRD1 mRNA	increases^expression	24086573
TXNRD1	7296	Lactic Acid	D019344	50-21-5	Lactic Acid results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	lead acetate	C008261	301-04-2	lead acetate results in increased expression of TXNRD1 mRNA	increases^expression	27562236
TXNRD1	7296	Leflunomide	D000077339	75706-12-6	Leflunomide results in increased expression of TXNRD1 mRNA	increases^expression	28988120
TXNRD1	7296	lipoamide	C013091	940-69-2	TXNRD1 protein results in increased reduction of lipoamide	increases^reduction	21172426
TXNRD1	7296	Lithocholic Acid	D008095	434-13-9	[Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of TXNRD1 mRNA	increases^activity|increases^expression	17724089
TXNRD1	7296	Maleic Anhydrides	D008299		Maleic Anhydrides results in increased expression of TXNRD1 mRNA	increases^expression	24211530
TXNRD1	7296	Maneb	D008344	12427-38-2	[Maneb results in increased expression of NFE2L2 protein] which results in increased expression of TXNRD1 mRNA	increases^expression	21402726
TXNRD1	7296	manganese(III)-tetrakis(4-benzoic acid)porphyrin	C097284		[Plant Extracts co-treated with manganese(III)-tetrakis(4-benzoic acid)porphyrin] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	30243747
TXNRD1	7296	Mechlorethamine	D008466		[NADP co-treated with Mechlorethamine] results in decreased activity of TXNRD1 protein	affects^cotreatment|decreases^activity	24274902
TXNRD1	7296	mercuric bromide	C042720	7789-47-1	mercuric bromide results in increased expression of TXNRD1 mRNA	increases^expression	26272509
TXNRD1	7296	mercuric bromide	C042720	7789-47-1	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	27188386
TXNRD1	7296	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]	increases^expression|increases^reaction	24816296
TXNRD1	7296	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride results in decreased activity of TXNRD1 protein	decreases^activity	17959236|20810785
TXNRD1	7296	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride results in increased expression of TXNRD1 mRNA	increases^expression	24816296
TXNRD1	7296	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride results in increased expression of TXNRD1 protein	increases^expression	24816296
TXNRD1	7296	Mercuric Chloride	D008627	7487-94-7	Sodium Selenite inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein]	decreases^activity|decreases^reaction	20810785
TXNRD1	7296	Mercuric Chloride	D008627	7487-94-7	Sodium Selenite promotes the reaction [Mercuric Chloride results in increased expression of TXNRD1 mRNA]	increases^expression|increases^reaction	24816296
TXNRD1	7296	Mercuric Chloride	D008627	7487-94-7	Sodium Selenite promotes the reaction [Mercuric Chloride results in increased expression of TXNRD1 protein]	increases^expression|increases^reaction	24816296
TXNRD1	7296	Mercury	D008628	7439-97-6	Mercury results in increased expression of TXNRD1 mRNA	increases^expression	17547211
TXNRD1	7296	Methotrexate	D008727	59-05-2	Methotrexate results in increased expression of TXNRD1 mRNA	increases^expression	21678067
TXNRD1	7296	methylarsine	C543395		[sodium arsenite co-treated with dimethylarsine analog co-treated with methylarsine analog] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	25873331
TXNRD1	7296	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride inhibits the reaction [Sodium Selenite results in increased expression of TXNRD1 protein]	decreases^reaction|increases^expression	24816296
TXNRD1	7296	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased activity of TXNRD1 protein	decreases^activity	24816296
TXNRD1	7296	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of TXNRD1 mRNA	decreases^expression	29581082
TXNRD1	7296	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of TXNRD1 protein	decreases^expression	24816296
TXNRD1	7296	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of TXNRD1 mRNA	increases^expression	23179753|24816296|27188386|28001369
TXNRD1	7296	Methylmercury Compounds	D008767		diphenyl disulfide inhibits the reaction [Methylmercury Compounds results in decreased activity of TXNRD1 protein]	decreases^activity|decreases^reaction	28383113
TXNRD1	7296	Methylmercury Compounds	D008767		Methylmercury Compounds results in decreased activity of TXNRD1 protein	decreases^activity	28383113
TXNRD1	7296	methyl salicylate	C033069	119-36-8	methyl salicylate results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	methylselenic acid	C008493		TXNRD1 protein results in increased metabolism of methylselenic acid	increases^metabolic processing	11782468
TXNRD1	7296	Metribolone	D015741	965-93-5	Metribolone results in decreased expression of TXNRD1 protein	decreases^expression	17152098
TXNRD1	7296	MLN7243	C000622638		MLN7243 results in increased sumoylation of TXNRD1 protein	increases^sumoylation	31285264
TXNRD1	7296	mono-(2-ethylhexyl)phthalate	C016599	4376-20-9	mono-(2-ethylhexyl)phthalate results in increased expression of TXNRD1 mRNA	increases^expression	23360888
TXNRD1	7296	monomethylarsonic acid	C020300	124-58-3	[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	23192986
TXNRD1	7296	monomethylarsonous acid	C406082		monomethylarsonous acid results in increased expression of and results in decreased activity of TXNRD1 protein	decreases^activity|increases^expression	19095002
TXNRD1	7296	monomethylarsonous acid	C406082		monomethylarsonous acid results in increased expression of TXNRD1 mRNA	increases^expression	19095002|20886546|23876855
TXNRD1	7296	motexafin gadolinium	C437683		motexafin gadolinium results in increased expression of TXNRD1 mRNA	increases^expression	16357179
TXNRD1	7296	motexafin gadolinium	C437683		[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	16357179
TXNRD1	7296	N(6)-(delta(2)-isopentenyl)adenine	C001478	2365-40-4	N(6)-(delta(2)-isopentenyl)adenine results in increased expression of TXNRD1 mRNA	increases^expression	16129123
TXNRD1	7296	NADP	D009249	53-59-8	NADP affects the reaction [benzyl isothiocyanate results in decreased activity of TXNRD1 protein]	affects^reaction|decreases^activity	17937621
TXNRD1	7296	NADP	D009249	53-59-8	[NADP co-treated with Mechlorethamine] results in decreased activity of TXNRD1 protein	affects^cotreatment|decreases^activity	24274902
TXNRD1	7296	Naphthoquinones	D009285		Naphthoquinones results in increased expression of TXNRD1 mRNA	increases^expression	23811387
TXNRD1	7296	n-hexane	C026385	110-54-3	n-hexane results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	nickel chloride	C022838	7718-54-9	nickel chloride results in increased expression of TXNRD1 mRNA	increases^expression	17547211
TXNRD1	7296	nickel sulfate	C029938	7786-81-4	nickel sulfate results in increased expression of TXNRD1 mRNA	increases^expression	17374397|20566472
TXNRD1	7296	Nitrogen Dioxide	D009585	10102-44-0	Nitrogen Dioxide results in increased expression of TXNRD1 mRNA	increases^expression	27206323
TXNRD1	7296	Nonidet P-40	C010615	9036-19-5	Nonidet P-40 results in increased expression of TXNRD1 mRNA	increases^expression	26552463
TXNRD1	7296	NSC668394	C570897		NSC668394 results in increased expression of TXNRD1 mRNA	increases^expression	27137931
TXNRD1	7296	Organogold Compounds	D050607		Organogold Compounds results in decreased activity of TXNRD1 protein	decreases^activity	21172426
TXNRD1	7296	Organoselenium Compounds	D016566		[Organoselenium Compounds binds to Copper] which results in increased expression of TXNRD1 mRNA	affects^binding|increases^expression	25167922
TXNRD1	7296	Oxazolone	D010081	15646-46-5	Oxazolone results in increased expression of TXNRD1 mRNA	increases^expression	17374397
TXNRD1	7296	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of TXNRD1 mRNA	decreases^expression	25596134
TXNRD1	7296	Ozone	D010126	10028-15-6	Ozone results in increased expression of TXNRD1 mRNA	increases^expression	27206323
TXNRD1	7296	Palladium	D010165	03/05/7440	Palladium results in decreased activity of TXNRD1 protein	decreases^activity	20851179
TXNRD1	7296	Particulate Matter	D052638		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	Particulate Matter	D052638		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	Particulate Matter	D052638		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	Particulate Matter	D052638		Particulate Matter results in decreased expression of TXNRD1 protein	decreases^expression	20658469
TXNRD1	7296	Particulate Matter	D052638		Particulate Matter results in increased expression of TXNRD1 mRNA	increases^expression	28341207|29703138
TXNRD1	7296	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	27188386
TXNRD1	7296	p-Chloromercuribenzoic Acid	D020245	59-85-8	p-Chloromercuribenzoic Acid results in increased expression of TXNRD1 mRNA	increases^expression	26272509
TXNRD1	7296	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of TXNRD1 protein	increases^expression	26879310
TXNRD1	7296	phenanthridone	C040601		phenanthridone results in decreased expression of TXNRD1 mRNA	decreases^expression	29416738
TXNRD1	7296	phenanthridone	C040601		phenanthridone results in decreased expression of TXNRD1 protein	decreases^expression	29416738
TXNRD1	7296	phenanthridone	C040601		TXNRD1 protein inhibits the reaction [phenanthridone results in increased expression of H2AX protein modified form]	decreases^reaction|increases^expression	29416738
TXNRD1	7296	phenethyl isothiocyanate	C058305	02/09/2257	phenethyl isothiocyanate results in decreased activity of TXNRD1 protein	decreases^activity	17937621
TXNRD1	7296	phenethyl isothiocyanate	C058305	02/09/2257	phenethyl isothiocyanate results in increased expression of TXNRD1 mRNA	increases^expression	20442190
TXNRD1	7296	Phenol	D019800	108-95-2	Phenol results in increased expression of TXNRD1 mRNA	increases^expression	17547211
TXNRD1	7296	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	27188386
TXNRD1	7296	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of TXNRD1 mRNA	increases^expression	26272509
TXNRD1	7296	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TXNRD1 mRNA	affects^binding|increases^activity|increases^expression	19710929
TXNRD1	7296	Plant Extracts	D010936		[Plant Extracts co-treated with manganese(III)-tetrakis(4-benzoic acid)porphyrin] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	30243747
TXNRD1	7296	Plant Extracts	D010936		Plant Extracts results in increased expression of TXNRD1 mRNA	increases^expression	23557933
TXNRD1	7296	Plant Extracts	D010936		Plant Extracts results in increased expression of TXNRD1 protein	increases^expression	18304597
TXNRD1	7296	plumbagin	C014758	481-42-5	plumbagin results in increased expression of TXNRD1 mRNA	increases^expression	20028456
TXNRD1	7296	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	Polycyclic Aromatic Hydrocarbons	D011084		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
TXNRD1	7296	potassium tellurate(IV)	C026899	7790-58-1	potassium tellurate(IV) affects the oxidation of TXNRD1 protein	affects^oxidation	19486940
TXNRD1	7296	potassium tellurate(IV)	C026899	7790-58-1	potassium tellurate(IV) promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein]	increases^oxidation|increases^reaction	19486940
TXNRD1	7296	potassium tellurate(IV)	C026899	7790-58-1	potassium tellurate(IV) results in increased activity of TXNRD1 protein	increases^activity	19486940
TXNRD1	7296	potassium tellurate(IV)	C026899	7790-58-1	potassium tellurate(IV) results in increased expression of TXNRD1 mRNA	increases^expression	19486940
TXNRD1	7296	Quercetin	D011794	117-39-5	Quercetin results in increased expression of TXNRD1 mRNA	increases^expression	21632981
TXNRD1	7296	Quinic Acid	D011801	77-95-2	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	21751221
TXNRD1	7296	quinocetone	C502851		quinocetone results in decreased expression of TXNRD1 mRNA	decreases^expression	27046791
TXNRD1	7296	Raloxifene Hydrochloride	D020849		Raloxifene Hydrochloride results in decreased expression of TXNRD1 mRNA	decreases^expression	16514628
TXNRD1	7296	Reactive Oxygen Species	D017382		TXNRD1 protein results in decreased abundance of Reactive Oxygen Species	decreases^abundance	29416738
TXNRD1	7296	resorcinol	C031389	108-46-3	resorcinol results in increased expression of TXNRD1 mRNA	increases^expression	30806763
TXNRD1	7296	Resveratrol	D000077185		Resveratrol results in increased activity of TXNRD1 protein	increases^activity	17261084
TXNRD1	7296	selenaproline	C014811	63578-00-7	TXNRD1 protein results in decreased susceptibility to selenaproline analog	decreases^response to substance	20920480
TXNRD1	7296	Selenic Acid	D064586		Selenic Acid results in increased expression of TXNRD1 protein	increases^expression	31585128
TXNRD1	7296	Selenium	D012643	7782-49-2	Selenium promotes the reaction [erucin results in increased expression of and results in increased activity of TXNRD1 protein]	increases^activity|increases^expression|increases^reaction	15740016
TXNRD1	7296	Selenium	D012643	7782-49-2	Selenium promotes the reaction [iberin results in increased expression of and results in increased activity of TXNRD1 protein]	increases^activity|increases^expression|increases^reaction	15740016
TXNRD1	7296	Selenium	D012643	7782-49-2	Selenium promotes the reaction [Selenium results in increased expression of TXNRD1 protein]	increases^expression|increases^reaction	17150329
TXNRD1	7296	Selenium	D012643	7782-49-2	Selenium promotes the reaction [sulforafan results in increased expression of and results in increased activity of TXNRD1 protein]	increases^activity|increases^expression|increases^reaction	15740016
TXNRD1	7296	Selenium	D012643	7782-49-2	Selenium results in increased activity of TXNRD1 protein	increases^activity	12949356|15471857
TXNRD1	7296	Selenium	D012643	7782-49-2	Selenium results in increased expression of and results in increased activity of TXNRD1 protein	increases^activity|increases^expression	15740016
TXNRD1	7296	Selenium	D012643	7782-49-2	Selenium results in increased expression of TXNRD1 protein	increases^expression	17150329
TXNRD1	7296	Selenium	D012643	7782-49-2	[sulforafan co-treated with Selenium] results in increased activity of TXNRD1 protein	affects^cotreatment|increases^activity	12949356
TXNRD1	7296	selenocystine	C009226	1464-43-3	NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	22807314
TXNRD1	7296	selenocystine	C009226	1464-43-3	selenocystine results in increased expression of TXNRD1 mRNA	increases^expression	22807314
TXNRD1	7296	selenocystine	C009226	1464-43-3	selenocystine results in increased expression of TXNRD1 protein	increases^expression	22807314
TXNRD1	7296	selenocystine	C009226	1464-43-3	TXNRD1 protein results in decreased susceptibility to selenocystine	decreases^response to substance	20920480
TXNRD1	7296	Selenomethionine	D012645	1464-42-2	Selenomethionine results in increased expression of TXNRD1 mRNA	increases^expression	22807314
TXNRD1	7296	Selenomethionine	D012645	1464-42-2	Selenomethionine results in increased expression of TXNRD1 protein	increases^expression	22807314|31585128
TXNRD1	7296	seocalcitol	C078903	134404-52-7	seocalcitol results in increased expression of TXNRD1 mRNA	increases^expression	12040012
TXNRD1	7296	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in increased expression of TXNRD1 mRNA	increases^expression	22627296
TXNRD1	7296	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide analog results in increased secretion of TXNRD1 protein	increases^secretion	25895662
TXNRD1	7296	Silicon Dioxide	D012822	7631-86-9	Silicon Dioxide results in increased expression of TXNRD1 mRNA	increases^expression	25351596
TXNRD1	7296	Silver	D012834	7440-22-4	NFE2L2 protein promotes the reaction [Silver results in increased expression of TXNRD1 mRNA]	increases^expression|increases^reaction	22036727
TXNRD1	7296	Silver	D012834	7440-22-4	Silver results in increased expression of TXNRD1 mRNA	increases^expression	22036727|26014281|28959546
TXNRD1	7296	sodium arsenate	C009277		[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of TXNRD1 mRNA	increases^abundance|increases^expression	32525701
TXNRD1	7296	sodium arsenate	C009277		sodium arsenate results in increased expression of TXNRD1 mRNA	increases^expression	12727804
TXNRD1	7296	sodium arsenite	C017947	13768-07-5	[sodium arsenite co-treated with dimethylarsine analog co-treated with methylarsine analog] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	25873331
TXNRD1	7296	sodium arsenite	C017947	13768-07-5	[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of TXNRD1 mRNA	affects^cotreatment|affects^expression	23192986
TXNRD1	7296	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of TXNRD1 mRNA	increases^expression	12377979|12679051|12760830|15521073|20886546|23876855|25879800|26535918|28229933|28512695|28713220
TXNRD1	7296	sodium arsenite	C017947	13768-07-5	sodium arsenite results in increased expression of TXNRD1 protein	increases^expression	28512695
TXNRD1	7296	sodium bisulfide	C025451	16721-80-5	sodium bisulfide inhibits the reaction [Galactose results in decreased expression of TXNRD1 mRNA]	decreases^expression|decreases^reaction	23274001
TXNRD1	7296	Sodium Dodecyl Sulfate	D012967	151-21-3	Sodium Dodecyl Sulfate results in increased expression of TXNRD1 mRNA	increases^expression	20566472
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD1 protein]	decreases^reaction|increases^activity	19486940
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Auranofin promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]	increases^expression|increases^reaction	19486940
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Buthionine Sulfoximine promotes the reaction [Sodium Selenite results in increased activity of TXNRD1 protein]	increases^activity|increases^reaction	12663510
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Mercuric Chloride promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]	increases^expression|increases^reaction	24816296
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	methylmercuric chloride inhibits the reaction [Sodium Selenite results in increased expression of TXNRD1 protein]	decreases^reaction|increases^expression	24816296
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXNRD1 mRNA	affects^cotreatment|decreases^expression	28757135
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of TXNRD1 protein	affects^cotreatment|decreases^expression	28757135
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein]	decreases^activity|decreases^reaction	20810785
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein]	increases^oxidation|increases^reaction	19486940
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite promotes the reaction [Mercuric Chloride results in increased expression of TXNRD1 mRNA]	increases^expression|increases^reaction	24816296
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite promotes the reaction [Mercuric Chloride results in increased expression of TXNRD1 protein]	increases^expression|increases^reaction	24816296
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite promotes the reaction [sulforafan results in increased activity of TXNRD1 protein]	increases^activity|increases^reaction	12663510
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite promotes the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	increases^expression|increases^reaction	12663510
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite promotes the reaction [sulforafan results in increased expression of TXNRD1 protein]	increases^expression|increases^reaction	12663510
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite promotes the reaction [TXNRD1 protein results in increased susceptibility to (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane]	increases^reaction|increases^response to substance	28757135
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in decreased activity of TXNRD1 protein	decreases^activity	18405881
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in decreased expression of TXNRD1 protein	decreases^expression	18405881
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased activity of TXNRD1 protein	increases^activity	12663510|12949356|18405881|19486940|24816296
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of and results in increased activity of TXNRD1 protein	increases^activity|increases^expression	25179160
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of TXNRD1 mRNA	increases^expression	18405881|19486940|24383545|24816296
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of TXNRD1 mRNA alternative form	increases^expression	18405881
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of TXNRD1 protein	increases^expression	12663510|18405881|24816296|31585128
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased oxidation of TXNRD1 protein	increases^oxidation	19486940
TXNRD1	7296	Sodium Selenite	D018038	10102-18-8	[sulforafan co-treated with Sodium Selenite] results in increased activity of TXNRD1 protein	affects^cotreatment|increases^activity	12949356
TXNRD1	7296	Sorafenib	D000077157		Sorafenib results in increased expression of TXNRD1 mRNA	increases^expression	26409325
TXNRD1	7296	sulforafan	C016766	4478-93-7	1-(5-isoquinolinylsulfonyl)-3-methylpiperazine inhibits the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	12663510
TXNRD1	7296	sulforafan	C016766	4478-93-7	Buthionine Sulfoximine inhibits the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	12663510
TXNRD1	7296	sulforafan	C016766	4478-93-7	Cycloheximide inhibits the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	12663510
TXNRD1	7296	sulforafan	C016766	4478-93-7	Dactinomycin inhibits the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	12663510
TXNRD1	7296	sulforafan	C016766	4478-93-7	NFE2L2 mutant form inhibits the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	decreases^reaction|increases^expression	22807314
TXNRD1	7296	sulforafan	C016766	4478-93-7	NFE2L2 mutant form inhibits the reaction [sulforafan results in increased expression of TXNRD1 protein]	decreases^reaction|increases^expression	22807314
TXNRD1	7296	sulforafan	C016766	4478-93-7	Selenium promotes the reaction [sulforafan results in increased expression of and results in increased activity of TXNRD1 protein]	increases^activity|increases^expression|increases^reaction	15740016
TXNRD1	7296	sulforafan	C016766	4478-93-7	Sodium Selenite promotes the reaction [sulforafan results in increased activity of TXNRD1 protein]	increases^activity|increases^reaction	12663510
TXNRD1	7296	sulforafan	C016766	4478-93-7	Sodium Selenite promotes the reaction [sulforafan results in increased expression of TXNRD1 mRNA]	increases^expression|increases^reaction	12663510
TXNRD1	7296	sulforafan	C016766	4478-93-7	Sodium Selenite promotes the reaction [sulforafan results in increased expression of TXNRD1 protein]	increases^expression|increases^reaction	12663510
TXNRD1	7296	sulforafan	C016766	4478-93-7	[sulforafan co-treated with Selenium] results in increased activity of TXNRD1 protein	affects^cotreatment|increases^activity	12949356
TXNRD1	7296	sulforafan	C016766	4478-93-7	[sulforafan co-treated with Sodium Selenite] results in increased activity of TXNRD1 protein	affects^cotreatment|increases^activity	12949356
TXNRD1	7296	sulforafan	C016766	4478-93-7	sulforafan results in decreased activity of TXNRD1 protein	decreases^activity	17937621
TXNRD1	7296	sulforafan	C016766	4478-93-7	sulforafan results in increased activity of TXNRD1 protein	increases^activity	12663510|12949356
TXNRD1	7296	sulforafan	C016766	4478-93-7	sulforafan results in increased expression of and results in increased activity of TXNRD1 protein	increases^activity|increases^expression	15740016
TXNRD1	7296	sulforafan	C016766	4478-93-7	sulforafan results in increased expression of TXNRD1 mRNA	increases^expression	12663510|12949356|15740016|20442190|31838189
TXNRD1	7296	sulforafan	C016766	4478-93-7	sulforafan results in increased expression of TXNRD1 protein	increases^expression	12663510|17150329|22807314
TXNRD1	7296	sulindac sulfide	C025462	32004-67-4	sulindac sulfide results in increased expression of TXNRD1 mRNA	increases^expression	16184548
TXNRD1	7296	Tamoxifen	D013629	10540-29-1	[IFNB1 protein co-treated with Tamoxifen] results in increased expression of TXNRD1 protein	affects^cotreatment|increases^expression	10771088
TXNRD1	7296	Tamoxifen	D013629	10540-29-1	Tamoxifen inhibits the reaction [ESR1 protein binds to TXNRD1 protein]	affects^binding|decreases^reaction	23665804
TXNRD1	7296	taxifolin	C003377	480-18-2	taxifolin results in increased expression of TXNRD1 mRNA	increases^expression	17541156
TXNRD1	7296	tert-Butylhydroperoxide	D020122	75-91-2	MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNRD1 mRNA]	increases^expression|increases^reaction	16636651
TXNRD1	7296	tert-Butylhydroperoxide	D020122	75-91-2	tert-Butylhydroperoxide results in increased expression of TXNRD1 mRNA	increases^expression	12414654|16636651
TXNRD1	7296	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin affects the expression of TXNRD1 mRNA	affects^expression	22298810
TXNRD1	7296	Tetrachlorodibenzodioxin	D013749	1746-01-6	Tetrachlorodibenzodioxin results in increased expression of TXNRD1 mRNA	increases^expression	12377990|20106945|21632981|22903824
TXNRD1	7296	Tetradecanoylphorbol Acetate	D013755	16561-29-8	Tetradecanoylphorbol Acetate results in increased expression of TXNRD1 mRNA	increases^expression	12949356
TXNRD1	7296	tetrathiomolybdate	C020809	16330-92-0	tetrathiomolybdate analog results in increased expression of TXNRD1 mRNA	increases^expression	19323979
TXNRD1	7296	Thioctic Acid	D008063	62-46-4	TXNRD1 protein results in increased reduction of Thioctic Acid	increases^reduction	21172426
TXNRD1	7296	Thiram	D013893	137-26-8	Thiram results in increased expression of TXNRD1 mRNA	increases^expression	24211530
TXNRD1	7296	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of TXNRD1 protein	affects^expression	30291989
TXNRD1	7296	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of TXNRD1 mRNA	increases^expression	22363418|27404394|27865774|28065790|29448087|29501877|29505817|30610935
TXNRD1	7296	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in increased expression of TXNRD1 protein	increases^expression	29501877|29505817
TXNRD1	7296	tripterine	C050414	34157-83-0	tripterine results in increased expression of TXNRD1 mRNA	increases^expression	17010675
TXNRD1	7296	tungsten carbide	C002802	11130-73-7	[tungsten carbide co-treated with Cobalt] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	23052192
TXNRD1	7296	Uranium Compounds	D017974		Uranium Compounds results in increased expression of TXNRD1 mRNA	increases^expression	19654044
TXNRD1	7296	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of TXNRD1 mRNA	affects^expression	25979313
TXNRD1	7296	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of TXNRD1 mRNA	decreases^expression	29501571
TXNRD1	7296	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of TXNRD1 gene	decreases^methylation	29501571
TXNRD1	7296	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of TXNRD1 mRNA	increases^expression	23179753|28001369|29154799
TXNRD1	7296	Vitamin K 3	D024483	58-27-5	Vitamin K 3 results in increased expression of TXNRD1 mRNA	increases^expression	12414654
TXNRD1	7296	Zinc	D015032	7440-66-6	Zinc inhibits the reaction [Edetic Acid results in increased activity of TXNRD1 protein]	decreases^reaction|increases^activity	16774913
TXNRD1	7296	Zinc Acetate	D019345	5970-45-6	[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of TXNRD1 mRNA	affects^cotreatment|increases^expression	16357179
TXNRD1	7296	Zinc Acetate	D019345	5970-45-6	Zinc Acetate results in increased expression of TXNRD1 mRNA	increases^expression	16357179
TXNRD1	7296	Zinc Oxide	D015034	1314-13-2	Zinc Oxide results in increased expression of TXNRD1 mRNA	increases^expression	19755143
TXNRD2	10587	8-Hydroxy-2'-Deoxyguanosine	D000080242	88847-89-6	TXNRD2 gene SNP affects the abundance of 8-Hydroxy-2'-Deoxyguanosine	affects^abundance	19896490
TXNRD2	10587	abexinostat	C512352		abexinostat promotes the reaction [Bortezomib results in decreased expression of TXNRD2 mRNA]	decreases^expression|increases^reaction	19417023
TXNRD2	10587	abexinostat	C512352		abexinostat results in decreased expression of TXNRD2 mRNA	decreases^expression	19417023
TXNRD2	10587	Acetaminophen	D000082	103-90-2	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of TXNRD2 mRNA	affects^cotreatment|decreases^expression	31059760
TXNRD2	10587	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of TXNRD2 mRNA	decreases^expression	29067470|31059760
TXNRD2	10587	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased expression of TXNRD2 mRNA	decreases^expression	27153756
TXNRD2	10587	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of TXNRD2 gene	increases^methylation	27153756
TXNRD2	10587	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of TXNRD2 intron	increases^methylation	30157460
TXNRD2	10587	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in increased methylation of TXNRD2 promoter	increases^methylation	30157460
TXNRD2	10587	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in decreased methylation of TXNRD2 promoter	decreases^methylation	30157460
TXNRD2	10587	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in increased methylation of TXNRD2 intron	increases^methylation	30157460
TXNRD2	10587	Auranofin	D001310	34031-32-8	Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD2 protein]	decreases^reaction|increases^activity	19486940
TXNRD2	10587	Auranofin	D001310	34031-32-8	Auranofin promotes the reaction [Sodium Selenite results in decreased expression of TXNRD2 mRNA]	decreases^expression|increases^reaction	19486940
TXNRD2	10587	Auranofin	D001310	34031-32-8	Auranofin results in decreased activity of TXNRD2 protein	decreases^activity	21172426|21355852
TXNRD2	10587	Aurothioglucose	D006051	12192-57-3	Aurothioglucose results in decreased activity of TXNRD2 protein	decreases^activity	21172426
TXNRD2	10587	avobenzone	C049935		avobenzone results in increased expression of TXNRD2 mRNA	increases^expression	31016361
TXNRD2	10587	Bandrowski's base	C051597	20048-27-5	Bandrowski's base results in increased expression of TXNRD2 mRNA	increases^expression	20566472
TXNRD2	10587	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of TXNRD2 intron	affects^methylation	30157460
TXNRD2	10587	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in decreased expression of TXNRD2 mRNA	decreases^expression	22316170|32234424
TXNRD2	10587	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene results in increased methylation of TXNRD2 3' UTR	increases^methylation	27901495
TXNRD2	10587	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in increased methylation of TXNRD2 intron	increases^methylation	30157460
TXNRD2	10587	benzo(e)pyrene	C026487	192-97-2	benzo(e)pyrene results in increased methylation of TXNRD2 promoter	increases^methylation	30157460
TXNRD2	10587	Bortezomib	D000069286		abexinostat promotes the reaction [Bortezomib results in decreased expression of TXNRD2 mRNA]	decreases^expression|increases^reaction	19417023
TXNRD2	10587	cadmium sulfide	C034939	1306-23-6	cadmium sulfide results in decreased expression of TXNRD2 mRNA	decreases^expression	27866839
TXNRD2	10587	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of TXNRD2 mRNA	affects^expression	25979313
TXNRD2	10587	cerous chloride	C026690	7790-86-5	cerous chloride results in decreased expression of TXNRD2 mRNA	decreases^expression	28954213
TXNRD2	10587	cinnamyl alcohol	C020722	104-54-1	cinnamyl alcohol results in increased expression of TXNRD2 mRNA	increases^expression	20566472
TXNRD2	10587	Cisplatin	D002945	15663-27-1	[Cisplatin co-treated with jinfukang] results in decreased expression of TXNRD2 mRNA	affects^cotreatment|decreases^expression	27392435
TXNRD2	10587	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased activity of TXNRD2 protein	decreases^activity	21172426
TXNRD2	10587	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of TXNRD2 mRNA	decreases^expression	27392435
TXNRD2	10587	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of TXNRD2 mRNA	decreases^expression	19320972
TXNRD2	10587	Cyclosporine	D016572	59865-13-3	Cyclosporine results in decreased expression of TXNRD2 mRNA	decreases^expression	20106945
TXNRD2	10587	cylindrospermopsin	C089595	143545-90-8	cylindrospermopsin results in increased expression of TXNRD2 mRNA	increases^expression	24921660
TXNRD2	10587	Dinitrochlorobenzene	D004137	97-00-7	Dinitrochlorobenzene results in increased expression of TXNRD2 mRNA	increases^expression	20566472
TXNRD2	10587	Disulfiram	D004221	97-77-8	Disulfiram results in increased expression of TXNRD2 mRNA	increases^expression	20566472
TXNRD2	10587	Dithionitrobenzoic Acid	D004228	69-78-3	TXNRD2 protein results in increased reduction of Dithionitrobenzoic Acid	increases^reduction	21172426
TXNRD2	10587	Environmental Pollutants	D004785		Environmental Pollutants affects the expression of TXNRD2 mRNA	affects^expression	19118595
TXNRD2	10587	Eugenol	D005054	97-53-0	Eugenol results in increased expression of TXNRD2 mRNA	increases^expression	20566472
TXNRD2	10587	Flame Retardants	D005411		Flame Retardants results in decreased expression of TXNRD2 protein	decreases^expression	19858236
TXNRD2	10587	Flame Retardants	D005411		Flame Retardants results in increased expression of TXNRD2 mRNA	increases^expression	19858236
TXNRD2	10587	Gold	D006046	7440-57-5	[Polyethyleneimine binds to Gold] which results in decreased expression of TXNRD2 mRNA	affects^binding|decreases^expression	28433809
TXNRD2	10587	hexyl cinnamic aldehyde	C080043	101-86-0	hexyl cinnamic aldehyde results in increased expression of TXNRD2 mRNA	increases^expression	20566472
TXNRD2	10587	isoeugenol	C036643	97-54-1	isoeugenol results in increased expression of TXNRD2 mRNA	increases^expression	20566472
TXNRD2	10587	jinfukang	C544151		[Cisplatin co-treated with jinfukang] results in decreased expression of TXNRD2 mRNA	affects^cotreatment|decreases^expression	27392435
TXNRD2	10587	(+)-JQ1 compound	C561695		(+)-JQ1 compound results in decreased expression of TXNRD2 mRNA	decreases^expression	24796395
TXNRD2	10587	juglone	C005134	481-39-0	TXNRD2 protein results in increased reduction of juglone	increases^reduction	21172426
TXNRD2	10587	lipoamide	C013091	940-69-2	TXNRD2 protein results in increased reduction of lipoamide	increases^reduction	21172426
TXNRD2	10587	Lipopolysaccharides	D008070		[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of TXNRD2 mRNA	affects^cotreatment|decreases^expression	31059760
TXNRD2	10587	Mechlorethamine	D008466		Mechlorethamine results in decreased activity of TXNRD2 protein	decreases^activity	24274902
TXNRD2	10587	Mercuric Chloride	D008627	7487-94-7	Mercuric Chloride results in decreased activity of TXNRD2 protein	decreases^activity	24816296
TXNRD2	10587	Methapyrilene	D008701	91-80-5	Methapyrilene results in increased methylation of TXNRD2 intron	increases^methylation	30157460
TXNRD2	10587	Methapyrilene	D008701	91-80-5	Methapyrilene results in increased methylation of TXNRD2 promoter	increases^methylation	30157460
TXNRD2	10587	Methotrexate	D008727	59-05-2	Methotrexate results in decreased expression of TXNRD2 mRNA	decreases^expression	24449571
TXNRD2	10587	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in decreased expression of TXNRD2 mRNA	decreases^expression	29581082
TXNRD2	10587	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of TXNRD2 mRNA	increases^expression	28001369
TXNRD2	10587	nickel sulfate	C029938	7786-81-4	nickel sulfate results in increased expression of TXNRD2 mRNA	increases^expression	20566472
TXNRD2	10587	obeticholic acid	C464660		obeticholic acid results in decreased expression of TXNRD2 mRNA	decreases^expression	27939613
TXNRD2	10587	Omacor	C405603		Omacor results in increased expression of TXNRD2 protein	increases^expression	24597798
TXNRD2	10587	Organogold Compounds	D050607		Organogold Compounds results in decreased activity of TXNRD2 protein	decreases^activity	21172426
TXNRD2	10587	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether results in decreased expression of TXNRD2 protein	decreases^expression	19858236
TXNRD2	10587	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of TXNRD2 protein	increases^expression	26879310
TXNRD2	10587	Petroleum	D010578		TXNRD2 gene SNP affects the susceptibility to Petroleum	affects^response to substance	21716162
TXNRD2	10587	Polyethyleneimine	D011094	9002-98-6	[Polyethyleneimine binds to Gold] which results in decreased expression of TXNRD2 mRNA	affects^binding|decreases^expression	28433809
TXNRD2	10587	potassium tellurate(IV)	C026899	7790-58-1	potassium tellurate(IV) results in increased activity of TXNRD2 protein	increases^activity	19486940
TXNRD2	10587	Selenic Acid	D064586		Selenic Acid results in increased expression of TXNRD2 protein	increases^expression	31585128
TXNRD2	10587	Selenium	D012643	7782-49-2	Selenium results in increased activity of TXNRD2 protein	increases^activity	15471857
TXNRD2	10587	Selenomethionine	D012645	1464-42-2	Selenomethionine affects the expression of TXNRD2 mRNA	affects^expression	17222674
TXNRD2	10587	Selenomethionine	D012645	1464-42-2	Selenomethionine results in increased expression of TXNRD2 protein	increases^expression	31585128
TXNRD2	10587	Sodium Selenite	D018038	10102-18-8	Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD2 protein]	decreases^reaction|increases^activity	19486940
TXNRD2	10587	Sodium Selenite	D018038	10102-18-8	Auranofin promotes the reaction [Sodium Selenite results in decreased expression of TXNRD2 mRNA]	decreases^expression|increases^reaction	19486940
TXNRD2	10587	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in decreased expression of TXNRD2 mRNA	decreases^expression	19486940
TXNRD2	10587	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased activity of TXNRD2 protein	increases^activity	19486940
TXNRD2	10587	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of TXNRD2 protein	increases^expression	31585128
TXNRD2	10587	Sunitinib	D000077210		Sunitinib results in decreased expression of TXNRD2 mRNA	decreases^expression	31533062
TXNRD2	10587	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of TXNRD2 protein	affects^expression	30291989
TXNRD2	10587	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution results in decreased expression of TXNRD2 mRNA	decreases^expression	29505817
TXNRD2	10587	Triclosan	D014260	3380-34-5	Triclosan results in increased expression of TXNRD2 mRNA	increases^expression	30510588
TXNRD2	10587	Urethane	D014520	51-79-6	Urethane results in decreased expression of TXNRD2 mRNA	decreases^expression	28818685
TXNRD2	10587	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of TXNRD2 mRNA	affects^expression	25979313
TXNRD2	10587	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased expression of TXNRD2 mRNA	decreases^expression	29154799
TXNRD2	10587	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of TXNRD2 mRNA	increases^expression	28001369
TXNRD2	10587	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased methylation of TXNRD2 gene	increases^methylation	29154799
TXNRD2	10587	wogonin	C085514	632-85-9	wogonin results in decreased expression of TXNRD2 mRNA	decreases^expression	32671444
TXNRD2	10587	wogonin	C085514	632-85-9	wogonin results in decreased expression of TXNRD2 protein	decreases^expression	32671444
VARS1	7407	abrine	C496492		abrine results in increased expression of VARS1 protein	increases^expression	31054353
VARS1	7407	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of VARS1 mRNA	decreases^expression	21420995|25704631|29067470
VARS1	7407	aflatoxin B2	C029753	22040-96-6	aflatoxin B2 results in decreased methylation of VARS1 exon	decreases^methylation	30157460
VARS1	7407	Arsenic	D001151	7440-38-2	Arsenic affects the methylation of VARS1 gene	affects^methylation	25304211
VARS1	7407	Asbestos, Crocidolite	D017638	12001-28-4	Asbestos, Crocidolite results in decreased expression of VARS1 mRNA	decreases^expression	29523930
VARS1	7407	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of VARS1 mRNA	decreases^expression	25047013
VARS1	7407	calfactant	C117342		[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of VARS1 protein	affects^cotreatment|decreases^expression	23026733
VARS1	7407	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of VARS1 mRNA	affects^expression	25979313
VARS1	7407	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of VARS1 mRNA	decreases^expression	27594783
VARS1	7407	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of VARS1 mRNA	increases^expression	25596134
VARS1	7407	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in increased expression of VARS1 mRNA	increases^expression	25596134
VARS1	7407	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of VARS1 mRNA	decreases^expression	19320972
VARS1	7407	Coumestrol	D003375	479-13-0	Coumestrol results in increased expression of VARS1 mRNA	increases^expression	19167446
VARS1	7407	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of VARS1 mRNA	increases^expression	25562108
VARS1	7407	Diazinon	D003976	333-41-5	Diazinon results in increased methylation of VARS1 gene	increases^methylation	22964155
VARS1	7407	dicrotophos	C000944	3735-78-2	dicrotophos results in increased expression of VARS1 mRNA	increases^expression	28302478
VARS1	7407	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of VARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
VARS1	7407	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in decreased expression of VARS1 mRNA	decreases^expression	23649840
VARS1	7407	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of VARS1 mRNA	increases^expression	25596134
VARS1	7407	GSK-J4	C000593030		GSK-J4 results in decreased expression of VARS1 mRNA	decreases^expression	29301935
VARS1	7407	Ibuprofen	D007052	15687-27-1	Ibuprofen results in increased expression of VARS1 mRNA	increases^expression	25596134
VARS1	7407	Ifosfamide	D007069	3778-73-2	Ifosfamide results in increased expression of VARS1 mRNA	increases^expression	25596134
VARS1	7407	Methyl Methanesulfonate	D008741	66-27-3	Methyl Methanesulfonate results in decreased expression of VARS1 mRNA	decreases^expression	23649840
VARS1	7407	Nanotubes, Carbon	D037742		[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of VARS1 protein	affects^cotreatment|decreases^expression	23026733
VARS1	7407	Nickel	D009532	7440-02-0	Nickel results in increased expression of VARS1 mRNA	increases^expression	25583101
VARS1	7407	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of VARS1 mRNA	decreases^expression	30559759
VARS1	7407	pirinixic acid	C006253	50892-23-4	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of VARS1 mRNA	affects^binding|decreases^expression|increases^activity	19710929
VARS1	7407	Urethane	D014520	51-79-6	Urethane results in decreased expression of VARS1 mRNA	decreases^expression	28818685
VARS1	7407	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of VARS1 mRNA	affects^expression	25979313
VARS1	7407	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of VARS1 mRNA	increases^expression	23179753
VARS1	7407	Zoledronic Acid	D000077211		Zoledronic Acid results in increased expression of VARS1 mRNA	increases^expression	20977926
WARS1	7453	1-Butanol	D020001	71-36-3	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of WARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
WARS1	7453	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of WARS1 mRNA	increases^expression	24810058
WARS1	7453	1-nitropyrene	C032668	5522-43-0	1-nitropyrene results in increased expression of WARS1 mRNA	increases^expression	19041380
WARS1	7453	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of WARS1 mRNA	increases^expression	19095052
WARS1	7453	3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol	C572491		3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of WARS1 protein	increases^expression	26194647
WARS1	7453	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WARS1 mRNA	affects^cotreatment|increases^expression	27188386
WARS1	7453	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WARS1 mRNA	affects^cotreatment|increases^expression	27188386
WARS1	7453	(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	C517041		(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of WARS1 mRNA	increases^expression	19561079
WARS1	7453	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of WARS1 mRNA	increases^expression	29067470
WARS1	7453	AM 251	C103505		AM 251 results in increased expression of WARS1 mRNA	increases^expression	16500647
WARS1	7453	Antirheumatic Agents	D018501		Antirheumatic Agents results in decreased expression of WARS1 mRNA	decreases^expression	24449571
WARS1	7453	Arsenic Trioxide	D000077237	1327-53-3	Arsenic Trioxide results in decreased expression of WARS1 protein	decreases^expression	19364129
WARS1	7453	arsenite	C015001	15502-74-6	arsenite affects the expression of WARS1 mRNA	affects^expression	22959463
WARS1	7453	Ascorbic Acid	D001205	50-81-7	Ascorbic Acid results in decreased expression of WARS1 mRNA	decreases^expression	19197388
WARS1	7453	Aspirin	D001241	50-78-2	Aspirin results in decreased expression of WARS1 mRNA	decreases^expression	11906190|15928584
WARS1	7453	Atrazine	D001280	1912-24-9	Atrazine results in decreased expression of WARS1 mRNA	decreases^expression	22378314
WARS1	7453	bicalutamide	C053541		bicalutamide results in increased expression of WARS1 mRNA	increases^expression	15638997
WARS1	7453	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of WARS1 mRNA	decreases^expression	20678512
WARS1	7453	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of WARS1 mRNA	increases^expression	29275510
WARS1	7453	bromovanin	C515564		bromovanin results in decreased expression of WARS1 protein	decreases^expression	21419150
WARS1	7453	C646 compound	C584509		C646 compound results in increased expression of WARS1 mRNA	increases^expression	26191083
WARS1	7453	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride affects the localization of WARS1 protein	affects^localization	18261755
WARS1	7453	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of WARS1 mRNA	increases^expression	25596134
WARS1	7453	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of WARS1 mRNA	affects^expression	25979313
WARS1	7453	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde affects the expression of WARS1 mRNA	affects^expression	25596134
WARS1	7453	Cidofovir	D000077404	113852-37-2	Cidofovir results in increased expression of WARS1 mRNA	increases^expression	25596134
WARS1	7453	Cisplatin	D002945	15663-27-1	Cisplatin results in increased expression of WARS1 mRNA	increases^expression	25596134
WARS1	7453	Clodronic Acid	D004002	10596-23-3	Clodronic Acid affects the expression of WARS1 mRNA	affects^expression	25596134
WARS1	7453	cobaltous chloride	C018021	7646-79-9	cobaltous chloride results in decreased expression of WARS1 mRNA	decreases^expression	19320972
WARS1	7453	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of WARS1 mRNA	increases^expression	19549813
WARS1	7453	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of WARS1 mRNA	increases^expression	20106945|21632981|22147139|23830897|25562108|25596134|27989131
WARS1	7453	deoxynivalenol	C007262	51481-10-8	deoxynivalenol results in decreased expression of WARS1 mRNA	decreases^expression	31863870
WARS1	7453	Dexamethasone	D003907	50-02-2	Dexamethasone results in decreased expression of WARS1 mRNA	decreases^expression	25047013
WARS1	7453	Diethylstilbestrol	D004054	56-53-1	Diethylstilbestrol results in increased expression of WARS1 mRNA	increases^expression	15159206
WARS1	7453	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WARS1 mRNA	affects^cotreatment|increases^expression	27188386
WARS1	7453	dorsomorphin	C516138		[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WARS1 mRNA	affects^cotreatment|increases^expression	27188386
WARS1	7453	Doxorubicin	D004317	23214-92-8	Doxorubicin results in decreased expression of WARS1 mRNA	decreases^expression	29803840
WARS1	7453	Dronabinol	D013759		Dronabinol results in decreased expression of WARS1 mRNA	decreases^expression	18454173
WARS1	7453	Drugs, Chinese Herbal	D004365		Drugs, Chinese Herbal results in decreased expression of WARS1 protein	decreases^expression	18422750
WARS1	7453	Ellagic Acid	D004610	476-66-4	Ellagic Acid results in increased expression of WARS1 mRNA	increases^expression	12002526
WARS1	7453	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of WARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
WARS1	7453	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of WARS1 mRNA	affects^cotreatment|increases^expression	22079256
WARS1	7453	Estradiol	D004958	50-28-2	Estradiol results in increased expression of WARS1 mRNA	increases^expression	15159206|15757668|21185374
WARS1	7453	Estriol	D004964	50-27-1	Estriol results in increased expression of WARS1 mRNA	increases^expression	15159206
WARS1	7453	Estrone	D004970	53-16-7	Estrone results in increased expression of WARS1 mRNA	increases^expression	15159206
WARS1	7453	Ethyl Methanesulfonate	D005020	62-50-0	Ethyl Methanesulfonate results in increased expression of WARS1 mRNA	increases^expression	23649840
WARS1	7453	Fenretinide	D017313	65646-68-6	Fenretinide results in increased expression of WARS1 mRNA	increases^expression	16671099
WARS1	7453	Fluorouracil	D005472	51-21-8	TP53 protein affects the reaction [Fluorouracil results in decreased expression of WARS1 mRNA]	affects^reaction|decreases^expression	15016801
WARS1	7453	Gasoline	D005742		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of WARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
WARS1	7453	Genistein	D019833	446-72-0	Genistein results in increased expression of WARS1 mRNA	increases^expression	15159206|15757668|26865667
WARS1	7453	ICG 001	C492448		ICG 001 results in increased expression of WARS1 mRNA	increases^expression	26191083
WARS1	7453	Ifosfamide	D007069	3778-73-2	Ifosfamide results in increased expression of WARS1 mRNA	increases^expression	25596134
WARS1	7453	Lamivudine	D019259	134678-17-4	[Zidovudine co-treated with Lamivudine] results in increased expression of WARS1 mRNA	affects^cotreatment|increases^expression	15784690
WARS1	7453	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of WARS1 mRNA	increases^expression	28001369
WARS1	7453	Methylmercury Compounds	D008767		Methylmercury Compounds results in increased expression of WARS1 protein	increases^expression	18959786
WARS1	7453	Methylnitronitrosoguanidine	D008769	70-25-7	Methylnitronitrosoguanidine results in decreased expression of WARS1 mRNA	decreases^expression	12634122
WARS1	7453	Metribolone	D015741	965-93-5	Metribolone results in increased expression of WARS1 protein	increases^expression	17152098
WARS1	7453	Mitoxantrone	D008942	65271-80-9	WARS1 protein affects the susceptibility to Mitoxantrone	affects^response to substance	16217747
WARS1	7453	Nickel	D009532	7440-02-0	Nickel results in increased expression of WARS1 mRNA	increases^expression	24768652|25583101
WARS1	7453	nonylphenol	C025256	25154-52-3	nonylphenol results in increased expression of WARS1 mRNA	increases^expression	15159206
WARS1	7453	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of WARS1 mRNA	decreases^expression	25596134
WARS1	7453	Particulate Matter	D052638		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of WARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
WARS1	7453	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether results in increased expression of WARS1 mRNA	increases^expression	26705709
WARS1	7453	perfluorononanoic acid	C584865		perfluorononanoic acid results in increased expression of WARS1 mRNA	increases^expression	32588087
WARS1	7453	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of WARS1 protein	increases^expression	26879310
WARS1	7453	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WARS1 mRNA	affects^cotreatment|increases^expression	27188386
WARS1	7453	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of WARS1 mRNA	increases^expression	26272509
WARS1	7453	Piroxicam	D010894	36322-90-4	Piroxicam results in decreased expression of WARS1 mRNA	decreases^expression	21858171
WARS1	7453	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of WARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
WARS1	7453	potassium bromate	C019536	02/01/7758	potassium bromate results in decreased expression of WARS1 mRNA	decreases^expression	30559759
WARS1	7453	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of WARS1 mRNA	affects^cotreatment|increases^expression	22079256
WARS1	7453	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in increased expression of WARS1 mRNA	increases^expression	22079256
WARS1	7453	Resveratrol	D000077185		Resveratrol results in increased expression of WARS1 mRNA	increases^expression	12002526|12569576
WARS1	7453	sodium arsenite	C017947	13768-07-5	sodium arsenite results in decreased expression of WARS1 mRNA	decreases^expression	28595984
WARS1	7453	Sodium Selenite	D018038	10102-18-8	Sodium Selenite results in increased expression of WARS1 mRNA	increases^expression	24383545
WARS1	7453	Sunitinib	D000077210		Sunitinib results in increased expression of WARS1 mRNA	increases^expression	31533062
WARS1	7453	T-2 Toxin	D013605	21259-20-1	T-2 Toxin results in decreased expression of WARS1 mRNA	decreases^expression	31863870
WARS1	7453	tamibarotene	C061133	94497-51-5	tamibarotene results in increased expression of WARS1 mRNA	increases^expression	15498508
WARS1	7453	Tamoxifen	D013629	10540-29-1	Tamoxifen results in increased expression of WARS1 mRNA	increases^expression	19155303
WARS1	7453	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of WARS1 mRNA	increases^expression	22378314|29453283
WARS1	7453	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of WARS1 protein	increases^expression	29453283
WARS1	7453	Tobacco Smoke Pollution	D014028		Tobacco Smoke Pollution affects the expression of WARS1 protein	affects^expression	30291989
WARS1	7453	Tretinoin	D014212	302-79-4	Tretinoin results in increased expression of WARS1 mRNA	increases^expression	15498508|17218384
WARS1	7453	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of WARS1 mRNA	increases^expression	26179874
WARS1	7453	Triterpenes	D014315		Triterpenes results in decreased expression of WARS1 protein	decreases^expression	18422750
WARS1	7453	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of WARS1 mRNA	increases^expression	22378314|29453283
WARS1	7453	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of WARS1 protein	increases^expression	29453283
WARS1	7453	Urethane	D014520	51-79-6	Urethane results in decreased expression of WARS1 mRNA	decreases^expression	28818685
WARS1	7453	Valproic Acid	D014635	99-66-1	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WARS1 mRNA	affects^cotreatment|increases^expression	27188386
WARS1	7453	Valproic Acid	D014635	99-66-1	Valproic Acid affects the expression of WARS1 mRNA	affects^expression	25979313
WARS1	7453	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of WARS1 mRNA	increases^expression	23179753|25192806|26272509|29154799
WARS1	7453	Zidovudine	D015215	30516-87-1	[Zidovudine co-treated with Lamivudine] results in increased expression of WARS1 mRNA	affects^cotreatment|increases^expression	15784690
YARS1	8565	1-Butanol	D020001	71-36-3	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of YARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
YARS1	8565	1-Methyl-3-isobutylxanthine	D015056	28822-58-4	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of YARS1 mRNA	affects^cotreatment|decreases^expression	28628672
YARS1	8565	1-Methyl-4-phenylpyridinium	D015655	48134-75-4	1-Methyl-4-phenylpyridinium results in increased expression of YARS1 mRNA	increases^expression	24810058
YARS1	8565	2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine	C532162		[PIK3CA gene mutant form results in increased susceptibility to 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine] which results in decreased expression of YARS1 mRNA	decreases^expression|increases^response to substance	20453058
YARS1	8565	2,2',4,4'-tetrabromodiphenyl ether	C511295		2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of YARS1 mRNA	increases^expression	19095052
YARS1	8565	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	27188386
YARS1	8565	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	27188386
YARS1	8565	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	C459179		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	27188386
YARS1	8565	Acetaminophen	D000082	103-90-2	Acetaminophen results in decreased expression of YARS1 mRNA	decreases^expression	25596134
YARS1	8565	Acetaminophen	D000082	103-90-2	Acetaminophen results in increased expression of YARS1 mRNA	increases^expression	29067470
YARS1	8565	adefovir dipivoxil	C106812	142340-99-6	adefovir dipivoxil results in decreased expression of YARS1 mRNA	decreases^expression	25596134
YARS1	8565	Aflatoxin B1	D016604	1162-65-8	Aflatoxin B1 results in decreased methylation of YARS1 intron	decreases^methylation	30157460
YARS1	8565	AM 251	C103505		AM 251 results in increased expression of YARS1 mRNA	increases^expression	16500647
YARS1	8565	Benzo(a)pyrene	D001564	50-32-8	Benzo(a)pyrene affects the methylation of YARS1 exon	affects^methylation	30157460
YARS1	8565	bisphenol A	C006780	80-05-7	bisphenol A results in decreased expression of YARS1 mRNA	decreases^expression	20678512
YARS1	8565	bisphenol A	C006780	80-05-7	bisphenol A results in increased expression of YARS1 mRNA	increases^expression	29275510
YARS1	8565	bisphenol F	C000611646		[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of YARS1 mRNA	affects^cotreatment|decreases^expression	28628672
YARS1	8565	C646 compound	C584509		C646 compound results in increased expression of YARS1 mRNA	increases^expression	26191083
YARS1	8565	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride affects the localization of YARS1 protein	affects^localization	18261755
YARS1	8565	Cadmium Chloride	D019256	10108-64-2	Cadmium Chloride results in increased expression of YARS1 mRNA	increases^expression	25596134
YARS1	8565	Carbamazepine	D002220	298-46-4	Carbamazepine affects the expression of YARS1 mRNA	affects^expression	25979313
YARS1	8565	chloroacetaldehyde	C004656	107-20-0	chloroacetaldehyde results in decreased expression of YARS1 mRNA	decreases^expression	25596134
YARS1	8565	chloropicrin	C100187	76-06-2	chloropicrin results in increased expression of YARS1 mRNA	increases^expression	26352163
YARS1	8565	Cidofovir	D000077404	113852-37-2	Cidofovir affects the expression of YARS1 mRNA	affects^expression	25596134
YARS1	8565	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of YARS1 mRNA	decreases^expression	25596134
YARS1	8565	Cisplatin	D002945	15663-27-1	Cisplatin results in decreased expression of YARS1 protein	decreases^expression	20540955
YARS1	8565	Cisplatin	D002945	15663-27-1	YARS1 protein affects the susceptibility to Cisplatin	affects^response to substance	16217747
YARS1	8565	Clodronic Acid	D004002	10596-23-3	Clodronic Acid results in decreased expression of YARS1 mRNA	decreases^expression	25596134
YARS1	8565	Copper Sulfate	D019327	7758-98-7	Copper Sulfate results in increased expression of YARS1 mRNA	increases^expression	19549813
YARS1	8565	Cyclosporine	D016572	59865-13-3	Cyclosporine results in increased expression of YARS1 mRNA	increases^expression	20106945|21163907|21632981|25562108|25596134|27989131
YARS1	8565	Dexamethasone	D003907	50-02-2	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of YARS1 mRNA	affects^cotreatment|decreases^expression	28628672
YARS1	8565	dorsomorphin	C516138		[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	27188386
YARS1	8565	dorsomorphin	C516138		[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	27188386
YARS1	8565	dorsomorphin	C516138		[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	27188386
YARS1	8565	Enzyme Inhibitors	D004791		[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of YARS1 protein	decreases^activity|increases^O-linked glycosylation	23301498
YARS1	8565	epigallocatechin gallate	C045651	989-51-5	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	22079256
YARS1	8565	Estradiol	D004958	50-28-2	Estradiol results in increased expression of YARS1 mRNA	increases^expression	20106945
YARS1	8565	Fenofibrate	D011345	49562-28-9	Fenofibrate results in increased expression of YARS1 mRNA	increases^expression	25596134
YARS1	8565	Fluorouracil	D005472	51-21-8	TP53 protein affects the reaction [Fluorouracil results in decreased expression of YARS1 mRNA]	affects^reaction|decreases^expression	15016801
YARS1	8565	Gasoline	D005742		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of YARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
YARS1	8565	Gasoline	D005742		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of YARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
YARS1	8565	Ibuprofen	D007052	15687-27-1	Ibuprofen results in increased expression of YARS1 mRNA	increases^expression	25596134
YARS1	8565	ICG 001	C492448		ICG 001 results in increased expression of YARS1 mRNA	increases^expression	26191083
YARS1	8565	Indomethacin	D007213	53-86-1	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of YARS1 mRNA	affects^cotreatment|decreases^expression	28628672
YARS1	8565	Lamivudine	D019259	134678-17-4	[Zidovudine co-treated with Lamivudine] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	15784690
YARS1	8565	Leflunomide	D000077339	75706-12-6	Leflunomide results in increased expression of YARS1 mRNA	increases^expression	28988120
YARS1	8565	mercuric bromide	C042720	7789-47-1	mercuric bromide results in increased expression of YARS1 mRNA	increases^expression	26272509
YARS1	8565	mercuric bromide	C042720	7789-47-1	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	27188386
YARS1	8565	methylmercuric chloride	C004925	115-09-3	methylmercuric chloride results in increased expression of YARS1 mRNA	increases^expression	23179753|28001369
YARS1	8565	Nickel	D009532	7440-02-0	Nickel results in increased expression of YARS1 mRNA	increases^expression	24768652
YARS1	8565	ochratoxin A	C025589	303-47-9	ochratoxin A results in decreased expression of YARS1 mRNA	decreases^expression	30559759
YARS1	8565	ochratoxin A	C025589	303-47-9	ochratoxin A results in increased methylation of YARS1 promoter	increases^methylation	30559759
YARS1	8565	oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine	C472349		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of YARS1 mRNA	affects^expression	17655762
YARS1	8565	oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine	C472349		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Particulate Matter affects the expression of YARS1 mRNA]	affects^expression|increases^reaction	17655762
YARS1	8565	oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine	C472349		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Vehicle Emissions affects the expression of YARS1 mRNA]	affects^expression|increases^reaction	17655762
YARS1	8565	oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine	C472349		Particulate Matter promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of YARS1 mRNA]	affects^expression|increases^reaction	17655762
YARS1	8565	oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine	C472349		Vehicle Emissions promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of YARS1 mRNA]	affects^expression|increases^reaction	17655762
YARS1	8565	Oxygen	D010100	7782-44-7	Oxygen deficiency results in decreased expression of YARS1 mRNA	decreases^expression	25596134
YARS1	8565	Particulate Matter	D052638		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of YARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
YARS1	8565	Particulate Matter	D052638		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of YARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
YARS1	8565	Particulate Matter	D052638		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Particulate Matter affects the expression of YARS1 mRNA]	affects^expression|increases^reaction	17655762
YARS1	8565	Particulate Matter	D052638		Particulate Matter affects the expression of YARS1 mRNA	affects^expression	17655762
YARS1	8565	Particulate Matter	D052638		Particulate Matter promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of YARS1 mRNA]	affects^expression|increases^reaction	17655762
YARS1	8565	p-Chloromercuribenzoic Acid	D020245	59-85-8	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	27188386
YARS1	8565	p-Chloromercuribenzoic Acid	D020245	59-85-8	p-Chloromercuribenzoic Acid results in increased expression of YARS1 mRNA	increases^expression	26272509
YARS1	8565	pentabromodiphenyl ether	C086401	32534-81-9	pentabromodiphenyl ether analog results in increased expression of YARS1 mRNA	increases^expression	19095052
YARS1	8565	perfluorononanoic acid	C584865		perfluorononanoic acid results in increased expression of YARS1 mRNA	increases^expression	32588087
YARS1	8565	perfluorooctane sulfonic acid	C076994	1763-23-1	perfluorooctane sulfonic acid results in increased expression of YARS1 mRNA	increases^expression	32588087
YARS1	8565	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of YARS1 mRNA	increases^expression	32588087
YARS1	8565	perfluorooctanoic acid	C023036	335-67-1	perfluorooctanoic acid results in increased expression of YARS1 protein	increases^expression	26879310
YARS1	8565	Phenobarbital	D010634	50-06-6	Phenobarbital affects the expression of YARS1 mRNA	affects^expression	19159669
YARS1	8565	Phenobarbital	D010634	50-06-6	Phenobarbital results in increased expression of YARS1 mRNA	increases^expression	19084549
YARS1	8565	Phenylmercuric Acetate	D010662	62-38-4	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	27188386
YARS1	8565	Phenylmercuric Acetate	D010662	62-38-4	Phenylmercuric Acetate results in increased expression of YARS1 mRNA	increases^expression	26272509
YARS1	8565	Polycyclic Aromatic Hydrocarbons	D011084		[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of YARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
YARS1	8565	Polycyclic Aromatic Hydrocarbons	D011084		[Gasoline results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of YARS1 mRNA	affects^cotreatment|increases^abundance|increases^expression	29432896
YARS1	8565	potassium chromate(VI)	C027373	7789-00-6	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	22079256
YARS1	8565	potassium chromate(VI)	C027373	7789-00-6	potassium chromate(VI) results in increased expression of YARS1 mRNA	increases^expression	22079256
YARS1	8565	Resveratrol	D000077185		Resveratrol affects the localization of YARS1 protein	affects^localization	25533949
YARS1	8565	Resveratrol	D000077185		Resveratrol binds to and results in decreased activity of YARS1 protein	affects^binding|decreases^activity	25533949
YARS1	8565	Resveratrol	D000077185		Resveratrol promotes the reaction [PARP1 protein binds to YARS1 protein]	affects^binding|increases^reaction	25533949
YARS1	8565	Resveratrol	D000077185		[Resveratrol promotes the reaction [PARP1 protein binds to YARS1 protein]] which results in increased ADP-ribosylation of PARP1 protein	affects^binding|increases^ADP-ribosylation|increases^reaction	25533949
YARS1	8565	Resveratrol	D000077185		YARS1 protein affects the reaction [Resveratrol results in increased acetylation of TP53 protein]	affects^reaction|increases^acetylation	25533949
YARS1	8565	Resveratrol	D000077185		YARS1 protein affects the reaction [Resveratrol results in increased ADP-ribosylation of PARP1 protein]	affects^reaction|increases^ADP-ribosylation	25533949
YARS1	8565	Sunitinib	D000077210		Sunitinib results in increased expression of YARS1 mRNA	increases^expression	31533062
YARS1	8565	tanespimycin	C112765		[tanespimycin co-treated with VER 155008] results in decreased expression of YARS1 protein	affects^cotreatment|decreases^expression	31370342
YARS1	8565	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of YARS1 mRNA	increases^expression	22378314|29453283
YARS1	8565	Thapsigargin	D019284	67526-95-8	Thapsigargin results in increased expression of YARS1 protein	increases^expression	29453283
YARS1	8565	tris(1,3-dichloro-2-propyl)phosphate	C016805	13674-87-8	tris(1,3-dichloro-2-propyl)phosphate results in increased expression of YARS1 mRNA	increases^expression	26179874
YARS1	8565	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of YARS1 mRNA	increases^expression	22378314|29453283
YARS1	8565	Tunicamycin	D014415	11089-65-9	Tunicamycin results in increased expression of YARS1 protein	increases^expression	29453283
YARS1	8565	Valproic Acid	D014635	99-66-1	Valproic Acid results in decreased methylation of YARS1 gene	decreases^methylation	29154799
YARS1	8565	Valproic Acid	D014635	99-66-1	Valproic Acid results in increased expression of YARS1 mRNA	increases^expression	23179753
YARS1	8565	Vehicle Emissions	D001335		oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine promotes the reaction [Vehicle Emissions affects the expression of YARS1 mRNA]	affects^expression|increases^reaction	17655762
YARS1	8565	Vehicle Emissions	D001335		Vehicle Emissions affects the expression of YARS1 mRNA	affects^expression	17655762
YARS1	8565	Vehicle Emissions	D001335		Vehicle Emissions promotes the reaction [oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine affects the expression of YARS1 mRNA]	affects^expression|increases^reaction	17655762
YARS1	8565	VER 155008	C550733		[tanespimycin co-treated with VER 155008] results in decreased expression of YARS1 protein	affects^cotreatment|decreases^expression	31370342
YARS1	8565	Zidovudine	D015215	30516-87-1	[Zidovudine co-treated with Lamivudine] results in increased expression of YARS1 mRNA	affects^cotreatment|increases^expression	15784690
YARS1	8565	Zoledronic Acid	D000077211		Zoledronic Acid results in decreased expression of YARS1 mRNA	decreases^expression	25596134
